Citrus Sinensis ID: 003272
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.924 | 0.984 | 0.526 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.942 | 0.924 | 0.486 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.930 | 0.952 | 0.501 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.937 | 0.927 | 0.466 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.961 | 0.935 | 0.458 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.941 | 0.926 | 0.469 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.946 | 0.947 | 0.462 | 0.0 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.935 | 0.914 | 0.477 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.948 | 0.931 | 0.454 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.940 | 0.927 | 0.452 | 0.0 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 857 bits (2213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/837 (52%), Positives = 571/837 (68%), Gaps = 66/837 (7%)
Query: 4 LKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIW 63
L +LII LF I A D + Q++++G+T+VS SFE+GFFSPG S++RYLGIW
Sbjct: 7 LHLLIIS--LFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIW 64
Query: 64 FKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSR----A 119
+KKI+ TV WVANRD+PL D SG L +S G +L L N N I+WSS+ +
Sbjct: 65 YKKISLQTVVWVANRDSPLYDLSGTLKVSENG---SLCLFNDRNHIIWSSSSSPSSQKAS 121
Query: 120 AQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLM 179
+NP+ +L++GNLVV+ N DD D ++WQS DYP L GMK G+N VTGLNR +
Sbjct: 122 LRNPIVQILDTGNLVVR----NSGDDQD-YIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 180 SSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTF 239
+SW++ DDP+ YT +DP+GVPQ LKK S + +R G WNGL +TGMP L+PNP+Y +
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 240 EFVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDN 299
E+V E EV+Y +KL N SV T M +N G +QR+TW+++ + W + ++D CD
Sbjct: 237 EYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMDSCDQ 293
Query: 300 YALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHG-DGFLKL 358
Y LCG Y SCNI+ +SP C CL+GF K+P W D S GC R+ L+C G DGFLK+
Sbjct: 294 YTLCGSYGSCNIN-ESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKI 352
Query: 359 KTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVL 418
+K+PDTR + DKN+ L ECK++C RNC+C+AY+ D+R GG GC+LWF DLIDI+
Sbjct: 353 SKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY 412
Query: 419 PEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRN 478
E GQD+YVR+A+SE+ ++R + ++
Sbjct: 413 NENGQDLYVRLASSEIETLQRESSRVSSR------------------------------- 441
Query: 479 YGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE 538
+QE +E++ELP D T+ +AT FS NKLG+GGFGPVYKG L
Sbjct: 442 ------KQE---------EEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLAC 486
Query: 539 GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598
GQE+AVKRLS++S QGVEEFKNE LIAKLQHRNLVK+LG C +ER+L+YEY PNKSL
Sbjct: 487 GQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSL 546
Query: 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658
D FIFD R + LDW R II GIARG+LYLH DSRLRIIHRDLKASNVLLD++MN KI
Sbjct: 547 DSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKI 606
Query: 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718
SDFG+AR G D+TEANT RVVGTYGYMSPEY IDG FS+KSDVFSFGVLVLEIVSG+RN
Sbjct: 607 SDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRN 666
Query: 719 RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS-LSEAIRCIQVGLLCVQQIPED 777
RGF + +H+ NLLGHAW+ +++D+ E+ID+++ +SC+ +SE +R I +GLLCVQQ P+D
Sbjct: 667 RGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKD 726
Query: 778 RPNMLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
RPNM VVLMLS E L P+QPGFF ERNL S++ S + S N + S+++ R
Sbjct: 727 RPNMSVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/830 (48%), Positives = 559/830 (67%), Gaps = 44/830 (5%)
Query: 31 SIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLS 90
+I T+VS FELGFF PG YLGIW+K I+ T WVANRD PLS G L
Sbjct: 39 TISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLK 98
Query: 91 MSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNP-VAVLLESGNLVVKEKDGNDNDDPDHF 149
+S + LV+L+ ++ VWS+N+ ++P VA LL++GN V+++ + N PD
Sbjct: 99 IS----DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD---SKNSAPDGV 151
Query: 150 LWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKK 209
LWQSFD+P+ TLL MKLG + TG NR + SWKS DDP+ ++++ ++ G P+ L
Sbjct: 152 LWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWN 211
Query: 210 GSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTIG 269
+ YR+G WNG+ ++G+P++QP F F +++ EV Y F++ S V + + I++ G
Sbjct: 212 RESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSG 271
Query: 270 DVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEGFEPKSP 329
+QRFTW+E + W +F DQCD Y CG Y C+ ++ SP C C++GF+P++P
Sbjct: 272 LLQRFTWIETAQNWN---QFWYAPKDQCDEYKECGVYGYCDSNT-SPVCNCIKGFKPRNP 327
Query: 330 GDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCS 389
W + D S GC RKT L+C GDGF++LK +K+PDT A VD+ I + EC++ C R+C+
Sbjct: 328 QVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCN 387
Query: 390 CTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQV 449
CTA+AN+D+RG GSGC+ W +L DI+ + GQD+YVR+AA++L K+ R AK
Sbjct: 388 CTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDL----EDKRNRSAK-- 441
Query: 450 TIIITSILLATGVILLGAIVYIWKKKHRNYGKTD----DRQ----ELYSNE--------- 492
II +SI ++ ++L I ++WK+K + + D Q +L NE
Sbjct: 442 -IIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHI 500
Query: 493 -KGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS 551
+ ++ +++ELP+ +++ + AT+NFS NKLG+GGFG VYKG L++GQE+AVKRLSK+S
Sbjct: 501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560
Query: 552 GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVL 611
QG +EFKNE LIA+LQH NLV+LL CC E++L+YEYL N SLD +FD +R+ L
Sbjct: 561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
+WQ R II GIARGLLYLH DSR RIIHRDLKASN+LLD M PKISDFGMAR FG D+
Sbjct: 621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680
Query: 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731
TEANT +VVGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEI+S KRN+GFY++D NLL
Sbjct: 681 TEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740
Query: 732 GHAWQLWIQDRPAELIDKSLYDSCSL---SEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
G W+ W + + E+ID + DS S E +RCIQ+GLLCVQ+ EDRP M V+LML
Sbjct: 741 GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800
Query: 789 SGER-SLPQPKQPGFFTERNLPESESSSSKQNLS---STNEISFSMLEAR 834
E ++PQPK PG+ ER+L +++SSSSKQ + N+I+ S+L+AR
Sbjct: 801 GSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/825 (50%), Positives = 549/825 (66%), Gaps = 49/825 (5%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFS---PGKSKSRYLGIWFKKIATGTVTWVANRDA 80
+ I+ + +++G+T+ S + F+LGFFS + + R+LG+W+ + V WVANR+
Sbjct: 26 NVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNN 83
Query: 81 PLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAA----QNPVAVLLESGNLVVK 136
PL SG L++S G+ L L + + +WSS+ S A NP+ + SGNL+
Sbjct: 84 PLYGTSGFLNLSSLGD---LQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI-- 138
Query: 137 EKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYG 196
+D + LWQSFDYP +T+LAGMKLG N T + +SSWK+ DP+ ++T
Sbjct: 139 -----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLS 193
Query: 197 IDPSGVPQAMLKKG--STIRYRAGSWNGLHWTGMPQL-QPNPVYTFEFVSNENEVFYRFK 253
+D G+PQ +L+K S+ YR GSWNGL +TG P + + N ++ ++F S+ EV Y +
Sbjct: 194 LDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWT 253
Query: 254 LINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHS 313
+ V + +V+N G + RF +W L + D+CD Y++CG YA C I+S
Sbjct: 254 PRHRIV-SRLVLNNTGKLHRFI-QSKQNQWILA---NTAPEDECDYYSICGAYAVCGINS 308
Query: 314 -DSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVD 372
++P C CL+GF+PKS W + + GC + P NC+ D F+K +K+PDT ++ D
Sbjct: 309 KNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYD 368
Query: 373 -KNIILLE-CKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMA 430
KN + LE CK CS NCSCTAYAN+D+R GG GCLLWF DL+D++ GQD+Y+RM
Sbjct: 369 AKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMG 428
Query: 431 ASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKTDDRQELYS 490
KIE K ++V ++ ++A V+L+ KK + Y + R
Sbjct: 429 ---FAKIEF-----KGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFR----- 475
Query: 491 NEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS 550
KG +E+++LPIFD KTI ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS +
Sbjct: 476 --KGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSAN 533
Query: 551 SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV 610
SGQGVEEFKNE LIAKLQHRNLV+LLGCC Q +E +L+YEY+PNKSLD+FIFD RS
Sbjct: 534 SGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTE 593
Query: 611 LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670
LDW+ R +II G+ARG+LYLH DSRLRIIHRDLKA NVLLDN+MNPKISDFG+A++FG D
Sbjct: 594 LDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGD 653
Query: 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730
Q+E++TNRVVGTYGYM PEYAIDG FSVKSDVFSFGVLVLEI++GK NRGF HADH NL
Sbjct: 654 QSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNL 713
Query: 731 LGHAWQLWIQDRPAELIDKSLYDSCS-LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
LGH W++W++DR E+ ++ + S + E +RCI V LLCVQQ PEDRP M SVVLM
Sbjct: 714 LGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFG 773
Query: 790 GERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
+ SLP P QPGFFT RN+P+ SS S L S NE+S +ML+ R
Sbjct: 774 SDSSLPHPTQPGFFTNRNVPDISSSLS---LRSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/829 (46%), Positives = 547/829 (65%), Gaps = 47/829 (5%)
Query: 31 SIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLS 90
+I +T++S S+ FELGFF+P S YLGIW+K I T WVANRD PLS +G L
Sbjct: 37 TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 91 MSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAV-LLESGNLVVKEKDGNDNDDPDHF 149
+S G LV+ + ++ VWS+NI ++PVA LL++GN +++ D +
Sbjct: 97 IS----GNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLR-------DSNNRL 145
Query: 150 LWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKK 209
LWQSFD+P+ TLLA MKLG + TG NR++ SWK+ DDP+ E++ ++ S P+ +
Sbjct: 146 LWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICS 205
Query: 210 GSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTIG 269
+I YR+G WNG+ ++ +P + F +++ EV Y +++ +++ + + +N+ G
Sbjct: 206 KESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAG 265
Query: 270 DVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEGFEPKSP 329
+QR TW E T+ W + + D CDNY +CG + C+ +S P+C C++GF+P +
Sbjct: 266 LLQRLTWFETTQSW---KQLWYSPKDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNE 321
Query: 330 GDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCS 389
W + D S GC RKT L+C DGF +LK +K+PDT VD+ I L CKE C +C+
Sbjct: 322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381
Query: 390 CTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQV 449
CTA+AN+D+R GGSGC++W +++D++ + GQD+YVR+AA+EL + ++ K
Sbjct: 382 CTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAEL-------EDKRIKNE 434
Query: 450 TIIITSILLATGVILLGAIVYIWKKKHR--------NYGKTDDRQELYSN----EKGSSK 497
II +SI ++ ++L I + WK+K + N + + L ++ +G +
Sbjct: 435 KIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTS 494
Query: 498 EEME-----LPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG 552
+E + LP+ + + + AT+NFS +NKLG+GGFG VYKG L++G+EIAVKRLSK S
Sbjct: 495 KEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSS 554
Query: 553 QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD 612
QG +EF NE LIAKLQH NLV+LLGCC + E++L+YEYL N SLD +FD TRS L+
Sbjct: 555 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 614
Query: 613 WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
WQ R II GIARGLLYLH DSR RIIHRDLKASNVLLD M PKISDFGMAR FG ++T
Sbjct: 615 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 674
Query: 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG 732
EANT RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEI+SGKRN+GFY+++ NLLG
Sbjct: 675 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 734
Query: 733 HAWQLWIQDRPAELIDKSLYDSCS----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
W+ W + E++D DS S E +RCIQ+GLLCVQ+ EDRP M SV++ML
Sbjct: 735 FVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML 794
Query: 789 SGERS-LPQPKQPGFFTERNLPESESSSSKQ--NLSSTNEISFSMLEAR 834
E + +PQPK+PGF R+ E++SSSS Q + + N+I+ S+++AR
Sbjct: 795 GSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/863 (45%), Positives = 559/863 (64%), Gaps = 61/863 (7%)
Query: 6 ILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSR-YLGIWF 64
+++I+ L I T S+ ++++ I +T+VS FE+GFF ++ SR YLG+W+
Sbjct: 22 MILIHPALSIYINTLSSTESLT----ISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWY 74
Query: 65 KKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPV 124
KK++ T WVANRD PLS+ G L +S G LVLL+ +N VW +N+ ++PV
Sbjct: 75 KKVSDRTYVWVANRDNPLSNAIGTLKIS----GNNLVLLDHSNKPVWWTNLTRGNERSPV 130
Query: 125 -AVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWK 183
A LL +GN V+++ + N+D +LWQSFDYP+ TLL MKLG NL TGLNR ++SW+
Sbjct: 131 VAELLANGNFVMRD---SSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWR 187
Query: 184 SADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVS 243
S+DDP+ ++Y ++ +P+ L + + +R+G WNG+ ++G+P+ Q + F+
Sbjct: 188 SSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIE 247
Query: 244 NENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALC 303
N EV Y F++ N+S + + + + G QR TW + W F +S + QCD Y +C
Sbjct: 248 NNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRF--WSSPVDPQCDTYIMC 305
Query: 304 GPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKV 363
GPYA C++++ SP C C++GF P++ W +GGC R+T L+C GDGF ++K +K+
Sbjct: 306 GPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKL 363
Query: 364 PDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEI-- 421
P+T A VD++I + ECK+ C +C+CTA+AN+D+R GGSGC++W L DI+
Sbjct: 364 PETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAI 423
Query: 422 -GQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHR--- 477
GQD+YVR+AA+++ K K+ K I S+ + V+LL + +WK+K +
Sbjct: 424 DGQDLYVRLAAADIAK----KRNASGK-----IISLTVGVSVLLLLIMFCLWKRKQKRAK 474
Query: 478 ----NYGKTDDRQELYSNE---------KGSSK-EEMELPIFDWKTIVDATDNFSEENKL 523
+ T Q L NE G K EE+ELP+ + +T+V AT+NFS NKL
Sbjct: 475 ASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKL 534
Query: 524 GEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583
G+GGFG VYKG L++G+EIAVKRLSK+S QG +EF NE LIA+LQH NLV++LGCC +
Sbjct: 535 GQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEG 594
Query: 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDL 643
DE++L+YEYL N SLD ++F TR L+W R I G+ARGLLYLH DSR RIIHRDL
Sbjct: 595 DEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDL 654
Query: 644 KASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVF 703
K SN+LLD M PKISDFGMAR F D+TEANT +VVGTYGYMSPEYA+ G+FS KSDVF
Sbjct: 655 KVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVF 714
Query: 704 SFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL------ 757
SFGV+VLEIVSGK+NRGFY+ D+ ++LL + W W + R E++D + DS S
Sbjct: 715 SFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQ 774
Query: 758 -SEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFFTERNLPESESSS 815
E ++CIQ+GLLCVQ++ E RP M SVV M E + +PQPK PG+ R+ E + SS
Sbjct: 775 PQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSS 834
Query: 816 SKQ---NLSST-NEISFSMLEAR 834
S Q N S T N+ + S+++AR
Sbjct: 835 SWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/830 (46%), Positives = 546/830 (65%), Gaps = 45/830 (5%)
Query: 31 SIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLS 90
+I +T++S S+ FELGFF+P S YLGIW+K I T WVANRD PLS +G L
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 91 MSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAV-LLESGNLVVKEKDGNDNDDPDHF 149
+S LV+ + ++ VWS+NI ++PVA LL+ GN V+++ + N+ P F
Sbjct: 97 IS----DNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD---SKNNKPSGF 149
Query: 150 LWQSFDYPSHTLLAGMKLGV-NLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLK 208
LWQSFD+P+ TLL+ MK+G N G NR++ SWK+ DDP+ +++ + SG P+ +
Sbjct: 150 LWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIY 209
Query: 209 KGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTI 268
+I YR+G W G ++ +P ++P F N +V Y +++ +++ +++ +++
Sbjct: 210 NKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSST 269
Query: 269 GDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEGFEPKS 328
G +QR TWME + W + + D CDNY CG Y C+ ++ SP C C++GFEP +
Sbjct: 270 GLLQRLTWMEAAQSW---KQLWYSPKDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN 325
Query: 329 PGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNC 388
+ D S GC RKT L+C DGF++LK +++PDT VDK I L EC+E C + C
Sbjct: 326 E-QAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGC 384
Query: 389 SCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQ 448
+CTA+AN+D+R GGSGC++W L DI+ + GQD+YVR+AA +L + ++ K
Sbjct: 385 NCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDL-------EDKRIKS 437
Query: 449 VTIIITSILLATGVILLGAIVYIWKKKHR----------NYGKTDDR--QELYSNEKGSS 496
II +SI ++ ++L I + WK+K + + ++ D EL + +
Sbjct: 438 KKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT 497
Query: 497 KEE-----MELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS 551
+E +ELP+ +WK + AT+NFS +NKLG+GGFG VYKGML++G+EIAVKRLSK S
Sbjct: 498 SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMS 557
Query: 552 GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVL 611
QG +EF NE LIAKLQH NLV+LLGCC + E++L+YEYL N SLD +FD TRS L
Sbjct: 558 SQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNL 617
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
+WQ R II GIARGLLYLH DSR RIIHRDLKASNVLLD M PKISDFGMAR FG ++
Sbjct: 618 NWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREE 677
Query: 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731
TEANT RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEI+SGKRN+GFY+++ NLL
Sbjct: 678 TEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLL 737
Query: 732 GHAWQLWIQDRPAELIDKSLYDSCS----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787
G W+ W + + E++D D+ S E +RCIQ+GLLCVQ+ EDRP M SV++M
Sbjct: 738 GFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVM 797
Query: 788 LSGERS-LPQPKQPGFFTERNLPESESSSSKQ--NLSSTNEISFSMLEAR 834
L E + +PQPK+PGF R+ E +SSSS Q + + N+++ S+++AR
Sbjct: 798 LGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 722 bits (1864), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/836 (46%), Positives = 527/836 (63%), Gaps = 47/836 (5%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
D I QS+R+GE ++SA + F GFFS G S+ RY+GIW+ +I+ T+ WVANRD P++
Sbjct: 20 DTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPIN 79
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNP--VAVLLESGNLVVKEKDGN 141
D SG++ S RGN + N T +++WS+N VS + P VA L + GNLV+
Sbjct: 80 DTSGMVKFSNRGNLSVYASDNET-ELIWSTN-VSDSMLEPTLVATLSDLGNLVLF----- 132
Query: 142 DNDDP--DHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDP 199
DP W+SFD+P+ T L M+LG GL+R ++SWKS DP + ++
Sbjct: 133 ---DPVTGRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMER 189
Query: 200 SGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSV 259
G PQ +L KG T +R GSW G W+G+P++ ++ FV+NE+EV + + + ++SV
Sbjct: 190 RGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASV 249
Query: 260 PTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNI-HSDSPDC 318
T ++N G + RFTW+ K+W F +QCDNYA CGP C+ S + +C
Sbjct: 250 ITRTMVNETGTMHRFTWIARDKRWN---DFWSVPKEQCDNYAHCGPNGYCDSPSSKTFEC 306
Query: 319 ECLEGFEPKSPGDWYMLDKSGGCGRKTPLN-CKHGDGFLKLKTVKVPDTRYAQVDKNIIL 377
CL GFEPK P W++ D SGGC +K + C DGF+KLK +K+PDT A VD NI L
Sbjct: 307 TCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITL 366
Query: 378 LECKELCSRNCSCTAYANS--DVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELG 435
ECK+ C +NCSC AYA++ + + G GCL W ++D + GQD Y+R+ EL
Sbjct: 367 KECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELA 426
Query: 436 KIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKTD-----------D 484
+ R K + + I+I+ L V+LL I++ ++ R + D
Sbjct: 427 RWNRNGLSGKRRVLLILIS---LIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFD 483
Query: 485 RQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAV 544
E + E+ ++ ELP+FD TIV AT+NFS +NKLG GGFGPVYKG+L EIAV
Sbjct: 484 FDESFRFEQDKARNR-ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAV 542
Query: 545 KRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD 604
KRLS++SGQG+EEFKNE LI+KLQHRNLV++LGCC + +E++LVYEYLPNKSLDYFIF
Sbjct: 543 KRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFH 602
Query: 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+ LDW R I+ GIARG+LYLH DSRLRIIHRDLKASN+LLD+EM PKISDFGMA
Sbjct: 603 EEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMA 662
Query: 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724
R FG +Q E T+RVVGT+GYM+PEYA++G FS+KSDV+SFGVL+LEI++GK+N F+
Sbjct: 663 RIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH-- 720
Query: 725 DHRHNLLGHAWQLWIQDRPAELI----DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
+ NL+GH W LW E+I D+ YD E ++CIQ+GLLCVQ+ DR +
Sbjct: 721 EESSNLVGHIWDLWENGEATEIIDNLMDQETYDE---REVMKCIQIGLLCVQENASDRVD 777
Query: 781 MLSVVLMLS-GERSLPQPKQPGFFTERNLPESESSSSK-QNLSSTNEISFSMLEAR 834
M SVV+ML +LP PK P F + R + K Q S N+++FS ++ R
Sbjct: 778 MSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 712 bits (1838), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/836 (47%), Positives = 539/836 (64%), Gaps = 56/836 (6%)
Query: 31 SIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLS 90
+I +T+VS FELGFF S YLGIW+KKI+ T WVANRD PLS+ G+L
Sbjct: 42 TISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVANRDTPLSNPIGILK 100
Query: 91 MSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFL 150
+S LV+L++++ VWS+N+ + VA LL++GN V++ G+ ++ D FL
Sbjct: 101 IS----NANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR---GSKINESDEFL 153
Query: 151 WQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKG 210
WQSFD+P+ TLL MKLG + GLNR ++SWKS+ DP+ + + ++ G+P+
Sbjct: 154 WQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTS 213
Query: 211 STIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTIGD 270
YR+G W+GL ++G+ ++Q + F N EV Y F++ + + + + INT+G
Sbjct: 214 FLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRLTINTVGR 273
Query: 271 VQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEGFEPKSPG 330
++ F W ++W +F D CD Y +CGPYA C++ S SP C C++GF+P SP
Sbjct: 274 LEGFMWEPTQQEWNMFWFMPK---DTCDLYGICGPYAYCDM-STSPTCNCIKGFQPLSPQ 329
Query: 331 DWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSC 390
DW D +G C RKT L C D F +L +K+P T A VDK I L EC+E C +C+C
Sbjct: 330 DWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNC 388
Query: 391 TAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVT 450
TAYANSD+R GGSGC++W + DI+ GQD++VR+AA+E G+ R+ R
Sbjct: 389 TAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGE---RRTIRGKIIGL 445
Query: 451 IIITSILLATGVILLGAIVY-IWKKKHRN-------YGKTDDRQELY---------SNEK 493
II S++L +L I+Y WKKK + G D QEL
Sbjct: 446 IIGISLML-----VLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRRL 500
Query: 494 GSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ 553
+E++ELP+ +++T+V AT+NFS+ N LG GGFG VYKG L++GQEIAVKRLS+ S Q
Sbjct: 501 LGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQ 560
Query: 554 GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTR-SKVLD 612
G EFKNE LIA+LQH NLV+LL CC DE++L+YEYL N SLD +F+TT+ S L+
Sbjct: 561 GTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLN 620
Query: 613 WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
WQ R II GIARGLLYLH DSR +IIHRDLKASNVLLD M PKISDFGMAR F D+T
Sbjct: 621 WQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDET 680
Query: 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG 732
EANT +VVGTYGYMSPEYA++G+FSVKSDVFSFGVLVLEIVSGKRNRGF+++ +NLLG
Sbjct: 681 EANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLG 740
Query: 733 HAWQLWIQDRPAELIDK---------SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783
+ W+ W + + E++D SL+ E +RCIQ+GLLCVQ+ EDRP M S
Sbjct: 741 YTWENWKEGKGLEIVDSIIVDSSSSMSLFQP---HEVLRCIQIGLLCVQERAEDRPKMSS 797
Query: 784 VVLMLSGER-SLPQPKQPGFFTER-NLPESESSSSKQNLS---STNEISFSMLEAR 834
VVLML E+ +PQPK+PG+ R +L ++SSSS + S + N+I+ S++ AR
Sbjct: 798 VVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/874 (45%), Positives = 539/874 (61%), Gaps = 83/874 (9%)
Query: 7 LIIYSFLFCNIRTASTRDAISLGQSIREG---ETVVSASESFELGFFSPGKSKSRYLGIW 63
L +Y FL+ + A+T I G+S+R+G + +VS ++FELGFFSPG S R+LGIW
Sbjct: 13 LFLYFFLYESSMAANT---IRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 64 FKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNP 123
+ I V WVANR P+SD+SGVL +S GN LVLL+ N VWSSNI S N
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGN---LVLLDGKNITVWSSNIESSTTNNN 126
Query: 124 --VAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSS 181
V + ++GN V+ E D D +W+SF++P+ T L M++ VN TG N S
Sbjct: 127 NRVVSIHDTGNFVLSETD------TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVS 180
Query: 182 WKSADDPARSEYTYGIDPSGVPQAMLKKGSTIR-YRAGSWNGLHWTGMPQ--LQPNPVYT 238
W+S DP+ Y+ G+DPSG P+ +L +G+ R +R+G WN +TG+P L N +Y
Sbjct: 181 WRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYG 240
Query: 239 FEFVSNENE---VFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILD 295
F+ S +E V++ + + SV + G + W E KKW +F
Sbjct: 241 FKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKW---TKFQSEPDS 297
Query: 296 QCDNYALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHG--- 352
+CD Y CG + C++ + C C+ G+E S G+W S GC R+TPL C+
Sbjct: 298 ECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISV 352
Query: 353 --DGFLKLKTVKVPDTRYAQVDKNIILLE-CKELCSRNCSCTAYANSDVRGGGSGCLLWF 409
D FL LK+VK+PD + + N++ E C+E C RNCSC AY+ GG GC++W
Sbjct: 353 GEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWN 406
Query: 410 HDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAI- 468
DL+D++ G +++R+A SE+G + RK K I+ + GVIL+G
Sbjct: 407 QDLVDLQQFEAGGSSLHIRLADSEVG------ENRKTKIAVIVAVLV----GVILIGIFA 456
Query: 469 VYIWKKKHRN------YGKTDDRQELYSNE------------------KGSSKEEMELPI 504
+ +W+ K + GK D + ++ +G + ELP+
Sbjct: 457 LLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPV 516
Query: 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALL 564
F I AT++F +EN+LG GGFGPVYKG+L +G+EIAVKRLS SGQGV+EFKNE +L
Sbjct: 517 FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIIL 576
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIA 624
IAKLQHRNLV+LLGCC + +E++LVYEY+PNKSLD+F+FD T+ ++DW+ R II GIA
Sbjct: 577 IAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIA 636
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
RGLLYLH DSRLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q EANT RVVGTYG
Sbjct: 637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYG 696
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744
YMSPEYA++GLFSVKSDV+SFGVL+LEIVSGKRN ++H +L+G+AW L+ R
Sbjct: 697 YMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH-GSLIGYAWYLYTHGRSE 755
Query: 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML-SGERSLPQPKQPGFF 803
EL+D + +CS EA+RCI V +LCVQ +RPNM SV+LML S +L P+QP F
Sbjct: 756 ELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFT 815
Query: 804 -TERNLPESESS--SSKQNLSSTNEISFSMLEAR 834
T RN + + SS+Q + S+NEI+ +++ R
Sbjct: 816 STRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/836 (45%), Positives = 513/836 (61%), Gaps = 52/836 (6%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
+ I QS+++G+ + S + F GFFS G SK RY+GIW+ +++ T+ WVANRD P++
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNP--VAVLLESGNLVVKEKDGN 141
D SG++ S RGN N T I WS++++ Q P VA L + GNLV+ +
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPI-WSTDVID-MIQEPALVAKLSDLGNLVLLDPVTG 140
Query: 142 DNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSG 201
+ W+SF++P++TLL MK G +G++R+M+SW+S DP TY I+ G
Sbjct: 141 KS------FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRG 194
Query: 202 VPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPT 261
PQ M+ KG T+ +R GSW G W+G+P++ ++ FV+N +EV + ++++SV T
Sbjct: 195 FPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTT 254
Query: 262 MMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCN-IHSDSPDCEC 320
MV+N G +QRF W KKW F D+CD Y CG C+ ++ +C C
Sbjct: 255 RMVLNETGTLQRFRWNGRDKKW---IGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSC 311
Query: 321 LEGFEPKSPGDWYMLDKSGGCGR-KTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLE 379
L G+EPK+P DW++ D S GC R K C +GF KLK VK+P+T VD NI L E
Sbjct: 312 LPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKE 371
Query: 380 CKELCSRNCSCTAYANS--DVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKI 437
C++ C +NCSC AYA++ + + G GCL W +++D + GQD Y+R+ SEL +
Sbjct: 372 CEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARW 431
Query: 438 ERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKT-------------DD 484
K K++ +I+ S++ ++L+ Y+ K++ R D
Sbjct: 432 NGNGASGK-KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDL 490
Query: 485 RQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAV 544
E ELP+F+ TI AT+NF+ +NKLG GGFGPVYKG+L G EIAV
Sbjct: 491 EDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAV 550
Query: 545 KRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD 604
KRLSKSSGQG+EEFKNE LI+KLQHRNLV++LGCC + +E++LVYEYLPNKSLDYFIF
Sbjct: 551 KRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFH 610
Query: 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+ LDW R II GI RG+LYLH DSRLRIIHRDLKASNVLLDNEM PKI+DFG+A
Sbjct: 611 EEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLA 670
Query: 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724
R FG +Q E +TNRVVGTYGYMSPEYA+DG FS+KSDV+SFGVL+LEI++GKRN FY
Sbjct: 671 RIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY-- 728
Query: 725 DHRHNLLGHAWQLWIQDRPAELIDKSL----YDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
+ NL+ H W W E+IDK + YD E ++C+ +GLLCVQ+ DRP+
Sbjct: 729 EESLNLVKHIWDRWENGEAIEIIDKLMGEETYDE---GEVMKCLHIGLLCVQENSSDRPD 785
Query: 781 MLSVVLMLSGER-SLPQPKQPGFFTER-----------NLPESESSSSKQNLSSTN 824
M SVV ML LP PK P F R N P E+SS+ +++ T+
Sbjct: 786 MSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTD 841
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.976 | 0.979 | 0.624 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.972 | 0.998 | 0.597 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.983 | 0.986 | 0.571 | 0.0 | |
| 255569631 | 868 | S-locus-specific glycoprotein S13 precur | 0.978 | 0.940 | 0.576 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.972 | 0.991 | 0.572 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.976 | 0.336 | 0.564 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.928 | 0.987 | 0.593 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.956 | 0.970 | 0.574 | 0.0 | |
| 224115106 | 755 | predicted protein [Populus trichocarpa] | 0.902 | 0.997 | 0.622 | 0.0 | |
| 224117334 | 829 | predicted protein [Populus trichocarpa] | 0.952 | 0.957 | 0.580 | 0.0 |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/828 (62%), Positives = 626/828 (75%), Gaps = 14/828 (1%)
Query: 1 MEGLKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYL 60
+ G IL +++FL + AST D ++ GQSIR+G+ +VSA SFELGFFSPG SK RYL
Sbjct: 5 ISGFIILFVHTFLLISAIRAST-DTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYL 63
Query: 61 GIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAA 120
GIW++KI+ GTV WVANR+ PL+D SG L ++ +G L+LLNS+ D +WSSN SR A
Sbjct: 64 GIWYQKISAGTVVWVANRETPLNDSSGALIVTDQG---ILILLNSSKDAIWSSN-ASRTA 119
Query: 121 QNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMS 180
QNPV LL+SGNLVVK+ ND+ ++FLWQSFDYP TLL GMK G N+VTGL+R +S
Sbjct: 120 QNPVMKLLDSGNLVVKDI----NDNSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLS 175
Query: 181 SWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFE 240
SWKS++DPA+ E+T+ IDP G Q +L +G I YR G+WNG WTG PQL+PN +YT+
Sbjct: 176 SWKSSNDPAQGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYG 235
Query: 241 FVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNY 300
F+S E++Y+F LINSSV + +V+N+ G QRFTW+ T W ARFS +LDQCD+Y
Sbjct: 236 FISTATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSW---ARFSAVLLDQCDDY 292
Query: 301 ALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKT 360
ALCG Y SCN++ P C CLEGF PKSP DW + + S GC R+T L+C GD FL+
Sbjct: 293 ALCGAYGSCNVNK-QPVCACLEGFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGG 351
Query: 361 VKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPE 420
VK+PD + VD + L ECK+LC +NCSC AYANSD+RGGGSGCLLWF +LID + L
Sbjct: 352 VKLPDMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTT 411
Query: 421 IGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYG 480
GQD+Y+R+AASEL IE+ + K KQ+ II+ +I+ GV++L I+Y +KK +
Sbjct: 412 GGQDLYIRIAASELYNIEKNRSSDK-KQLGIIVGTIITIVGVLVLAFILYARRKKLKKQA 470
Query: 481 KTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQ 540
++ KE+MELP FD TI +ATDNFS NKLGEGGFG VYKG LIEGQ
Sbjct: 471 NMKTSHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQ 530
Query: 541 EIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDY 600
E+AVKRLSK+SGQG+ EFKNE +LIAKLQHRNLVKLLGCC + DER+L+YEY+PNKSLDY
Sbjct: 531 EVAVKRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDY 590
Query: 601 FIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISD 660
FIFD DW+ +I+GGIARGLLYLH DSRLRIIHRDLKA+NVLLDN MNPKISD
Sbjct: 591 FIFDKKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISD 650
Query: 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720
FG+AR FG DQTEANTN++VGTYGYMSPEYA+DG FSVKSDVFSFGVLVLEIVSGK+NRG
Sbjct: 651 FGLARTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRG 710
Query: 721 FYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
F H DH HNLLGHAW+LW + P ELI++ DSC+LSE IRCI VGLLCVQ+ PEDRPN
Sbjct: 711 FNHPDHHHNLLGHAWRLWNEGMPLELINEPEQDSCTLSEIIRCIHVGLLCVQKRPEDRPN 770
Query: 781 MLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISF 828
M SV++MLS SLPQPKQPGFFTERNLPE ESSSS Q STNEI F
Sbjct: 771 MSSVIVMLSSGISLPQPKQPGFFTERNLPERESSSSNQKSFSTNEICF 818
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2582), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/835 (59%), Positives = 614/835 (73%), Gaps = 24/835 (2%)
Query: 1 MEGLKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYL 60
M + ++ +YS F ++ +S DA++ QS+R+GET+VS SFELGFF+P S SRYL
Sbjct: 1 MGVVDVIFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYL 60
Query: 61 GIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAA 120
G+W+KK + TV WVANR P+S++ G L+++ +G LVLLN TN+IVWSSN S
Sbjct: 61 GLWYKK-SPQTVVWVANRGIPISNKFGTLNVTSQG---ILVLLNGTNNIVWSSN-TSTTV 115
Query: 121 QNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMS 180
QNPVA LL+SGNLVV+ DGNDN D+FLWQSFDYP TLL GMKLG NLVTGLN +S
Sbjct: 116 QNPVAQLLDSGNLVVR--DGNDNK-ADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLS 172
Query: 181 SWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFE 240
SWK ++PA ++T GID G PQ +L+K + I YR GSWNG ++TG P+L+P+P+YTFE
Sbjct: 173 SWKGKENPAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFE 232
Query: 241 FVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNY 300
FV N NEV+++F+L NSSV + + + G VQ FTW T W +FA ++D+C+NY
Sbjct: 233 FVFNRNEVYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFAT---AVVDRCENY 289
Query: 301 ALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKT 360
ALCG A C+ +S SP C+CL+GF KSP +W + +GGC R+TPL+C DGF
Sbjct: 290 ALCGANARCDSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTG 348
Query: 361 VKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPE 420
VK+PDT + D + L+EC+ LC +NCSC AYAN D RG GSGCL WF DLID + L E
Sbjct: 349 VKLPDTSSSWYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAE 408
Query: 421 IGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYG 480
GQDIY+R+AAS+ G + K+++K +I +++L + +++LG + I ++KHR G
Sbjct: 409 GGQDIYIRLAASQSG-VTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNG 467
Query: 481 KTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQ 540
+DR+E EEMELP+ D TI ATDNFS KLGEGGFG VYKG LIEGQ
Sbjct: 468 NFEDRKE----------EEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQ 517
Query: 541 EIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDY 600
EIAVKRLSKSSGQG+ EFKNE LLIAKLQHRNLVKLLGCC DE++L+YEY+PN+SLD
Sbjct: 518 EIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDS 577
Query: 601 FIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISD 660
FIFD TR K LDW R HII GIARGLLYLH DSRLRIIHRD+KASN+LLDNE+NPKISD
Sbjct: 578 FIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISD 637
Query: 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720
FG+AR FG DQTEANT RVVGTYGYMSPEYA+DG FSVKSDVFSFGVLVLEIVSGK+NRG
Sbjct: 638 FGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSGKKNRG 697
Query: 721 FYHADH-RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
F H D+ + NLLGHAW LW P ELID+ DSC+ SEA+RCI V LLCVQQ PEDRP
Sbjct: 698 FCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCIHVALLCVQQRPEDRP 757
Query: 780 NMLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
NM SVVLML E LPQPKQPGFF N PE ++SS+K S NE++ ++L+AR
Sbjct: 758 NMSSVVLMLGSENPLPQPKQPGFFMGSNPPEKDTSSNKHQSHSANEVTVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2511), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/838 (57%), Positives = 626/838 (74%), Gaps = 18/838 (2%)
Query: 1 MEGLKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYL 60
M G IL + S +F ++ ++I+ QS+ +G+T+VS+ FELGFFSPG S++RY+
Sbjct: 8 MGGQTILFLLSIVFFLSIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYM 67
Query: 61 GIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAA 120
GIW+KKI++ TV WVANR+ PL+D SG+L GN L +NSTN +WSSNI SRAA
Sbjct: 68 GIWYKKISSFTVVWVANRNTPLNDSSGMLKFVDHGN---LAFINSTNGTIWSSNI-SRAA 123
Query: 121 QNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMS 180
NPVA LL++GNLVV+ + NDND P++FLWQSFDYP + L GMK G++ VTGLNR ++
Sbjct: 124 INPVAQLLDTGNLVVRAE--NDND-PENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLT 180
Query: 181 SWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFE 240
SWKS DP+ +YT +DP+G+PQ L +GS ++R+G WNGL ++GM L+PNP+YTFE
Sbjct: 181 SWKSPSDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFE 240
Query: 241 FVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNY 300
FV N+ E++Y++++ NSSV + MV++ G +QRFTW++ T+ W L+ + +D CD +
Sbjct: 241 FVFNQEEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTAN---MDNCDRF 297
Query: 301 ALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKT 360
ALCG + CNI+ +SP C+CL+ FEPKS +W D S GC RK PL+C +G+GF+K
Sbjct: 298 ALCGAHGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTG 356
Query: 361 VKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPE 420
+KVPDTR + +K I L EC+E+C +NCSCTAYAN DVR GGSGC+LWF DLIDI+ E
Sbjct: 357 IKVPDTRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNE 416
Query: 421 IGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYG 480
GQDIY+R+AAS I++ + R K+V II+ + L +L + + +K++
Sbjct: 417 NGQDIYIRIAAS---VIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQ 473
Query: 481 KTDDRQELYSNEKGSSKE----EMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGML 536
T + + + E+ +KE ++ELP+FD T+ DAT+ FS NKLG+GGFGPVYKG+L
Sbjct: 474 LTREGNVVTNPEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGIL 533
Query: 537 IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596
+GQEIAVKRLSK S QG+ EF+NE + IAKLQHRNLVKLLGCC + +ER+L+YEY+PNK
Sbjct: 534 QDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNK 593
Query: 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656
SLD FIFD R+ +LDW R II GIARGLLYLH DSRLRIIHRDLKASN+LLD EMNP
Sbjct: 594 SLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNP 653
Query: 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
KISDFGMAR+FG D+T ANT+R+VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG+
Sbjct: 654 KISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGR 713
Query: 717 RNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPE 776
+NRGF HA+H+ NLLGHAW L + RP +LID+S+ D+C +SE +R I+V LLCVQ+ PE
Sbjct: 714 KNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPE 773
Query: 777 DRPNMLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
DRP M VVLMLS + LPQPK+PGFFTER+L SS+ K +SS NE++ ++LEAR
Sbjct: 774 DRPKMSIVVLMLSSDIVLPQPKEPGFFTERDLSNDSSSTIKHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255569631|ref|XP_002525781.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223534931|gb|EEF36617.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 970 bits (2507), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/843 (57%), Positives = 630/843 (74%), Gaps = 27/843 (3%)
Query: 1 MEGLKILIIY-SFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRY 59
M+ IL+I+ S+L +I T++ D I++ QS+ +GET+VSA ESF+LGFFSPG S++RY
Sbjct: 44 MDDTSILVIFCSYLLLSITTSTAADTINITQSVTDGETLVSAGESFKLGFFSPGNSRTRY 103
Query: 60 LGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRA 119
LGIW+ K++ TV WVANR+ PL D SGVL ++ + L LLN +WSSN V+ A
Sbjct: 104 LGIWYNKVSVMTVVWVANRETPLIDSSGVLKIT---DHRILALLNHNGSKIWSSN-VTMA 159
Query: 120 AQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLM 179
A+NPVA LL+SGNL+VK+ +G+DN P++FLWQSFDYP +TLL GMKLG N+ TGL+R +
Sbjct: 160 ARNPVAQLLDSGNLIVKD-EGDDN--PENFLWQSFDYPCNTLLPGMKLGRNIATGLDRYI 216
Query: 180 SSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTF 239
SSWK+ DP+R +TYG+DP+G P+ +L++ S R+RAG WNG ++G QL NP++ +
Sbjct: 217 SSWKTPSDPSRGNFTYGLDPAGYPEMILRENSIERFRAGPWNGRSYSGTSQLNVNPIFKY 276
Query: 240 EFVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDN 299
EFV NE E++Y F+L+NSSV + MVIN G +QRF W E +KW L+ D CD
Sbjct: 277 EFVINETEIYYDFQLLNSSVLSRMVINENGILQRFIWAERERKWRLYFTIQ---TDDCDQ 333
Query: 300 YALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLK 359
YALCG +ASCNI S+S C CL GF PK P +W D SGGC RKTPLNC DGF K
Sbjct: 334 YALCGAFASCNIKSNSY-CSCLNGFVPKFPKEWDQADWSGGCVRKTPLNCS-SDGFQKYL 391
Query: 360 TVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLP 419
K+P+TR + ++++ L +CK +C +NCSCT YAN D+R G SGCLLWF D+ID L
Sbjct: 392 AFKLPETRKSWFNRSMNLEDCKNMCVKNCSCTVYANLDIREGESGCLLWFSDVIDTTELD 451
Query: 420 EIGQDIYVRMAASELG-------KIERRKQQRKAKQVTIIITSILLATGVIL-LGAIVYI 471
GQDIY+RM+AS+LG KI+ + +K Q+ II++S+L A + L L I+Y+
Sbjct: 452 GDGQDIYIRMSASQLGVAHDDDPKIQSKSNVKK--QMRIILSSLLSAGMMSLSLAVILYV 509
Query: 472 WKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPV 531
W+KK + GK E+ +N+KG KEE++LP+FD+ TI AT NFS+ NKLGEGGFG
Sbjct: 510 WRKKQKKEGKAIGILEISANDKGE-KEELKLPLFDFGTIACATCNFSDANKLGEGGFG-- 566
Query: 532 YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591
G L +GQEIAV+RLSK+S QGV+EF NE L IAKLQHRNLV+LLGCC Q +E++L+YE
Sbjct: 567 -LGNLKDGQEIAVRRLSKNSNQGVDEFMNEVLHIAKLQHRNLVRLLGCCIQSEEKLLIYE 625
Query: 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651
++PNKSLD+FIFD T+SK+LDW R HII GIARGLLYLH DSRLRIIHRDLKA N+LLD
Sbjct: 626 FMPNKSLDFFIFDQTKSKLLDWPKRYHIINGIARGLLYLHQDSRLRIIHRDLKAGNILLD 685
Query: 652 NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 711
EMNPKISDFG AR F ++TEA+T++VVGT+GYMSPEYAIDGL+S+KSDVFSFGV+VLE
Sbjct: 686 YEMNPKISDFGPARCFWGNETEASTDKVVGTHGYMSPEYAIDGLYSMKSDVFSFGVIVLE 745
Query: 712 IVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCV 771
IVSGKRNRGFYH +H+ NLLGHAW+L R E+ID S+ +SC+LSE +R + VGLLCV
Sbjct: 746 IVSGKRNRGFYHPEHQLNLLGHAWKLHKDGRSTEMIDGSMINSCNLSEVLRSVHVGLLCV 805
Query: 772 QQIPEDRPNMLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSML 831
QQ EDRP+M + V MLSGE +LP+PKQPGFFTER+ E+ SSSS +N +S+N ++ ++
Sbjct: 806 QQSLEDRPSMSAAVYMLSGESALPEPKQPGFFTERDCTEANSSSSIKNFNSSNGLTITLP 865
Query: 832 EAR 834
+AR
Sbjct: 866 DAR 868
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2488), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/832 (57%), Positives = 620/832 (74%), Gaps = 21/832 (2%)
Query: 5 KILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWF 64
+++ ++S++ +R ++ D+I+ Q I++GET++SA +FELGF G SK++YLGIW+
Sbjct: 6 ELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWY 65
Query: 65 KKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPV 124
KK+ TV WVANR+ P++D SG L ++ +G +LV+LN +N ++WSSN A P
Sbjct: 66 KKVTPRTVVWVANRELPVTDSSGXLKVTDQG---SLVILNGSNGLIWSSNSSRSARN-PT 121
Query: 125 AVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKS 184
A LL+SGNLV+K GND+D PD+FLWQSFDYP TLL GMK G N VTGL+R +SSWKS
Sbjct: 122 AQLLDSGNLVIKS--GNDSD-PDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKS 178
Query: 185 ADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSN 244
DDP++ ++TYG+DPSG PQ L+ GST+ +R+G WNG+ + G P+L+PNPV+ + FV N
Sbjct: 179 NDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFN 238
Query: 245 ENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCG 304
E E+++ +KL+NSSV + +V+N G+VQR W+ TK W ++ S D CD+YALCG
Sbjct: 239 EKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVY---STAYKDDCDSYALCG 295
Query: 305 PYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVP 364
Y++CNIH SP C C++GF PK P W +D S GC RKT L+C+ GDGF K VK+P
Sbjct: 296 AYSTCNIHR-SPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLP 354
Query: 365 DTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQD 424
DTR + ++++ L EC LC RNCSC+AY NSD++GGGSGCLLWF DLIDIK E GQD
Sbjct: 355 DTRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQD 414
Query: 425 IYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIV--YIWKKKHRNYGKT 482
Y+RMAASEL I + ++R +I++++ +A G+ILL +V Y+ KK+ + G T
Sbjct: 415 FYIRMAASELDAISKVTKRR-----WVIVSTVSIA-GMILLSLVVTLYLLKKRLKRKGTT 468
Query: 483 DDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEI 542
+ E E +E++ELP+F TI++AT NFS NKLGEGGFGPVYKGML +G+EI
Sbjct: 469 ELNNE--GAETNERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEI 526
Query: 543 AVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI 602
AVKRLSK S QG++EFKNE + I+KLQHRNLVKLLGCC +E++L+YEY+PNKSL++FI
Sbjct: 527 AVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFI 586
Query: 603 FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662
FD +S VLDW R II GIARGLLYLH DSRLRIIHRDLKA NVLLDNEMNP+ISDFG
Sbjct: 587 FDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFG 646
Query: 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722
MAR+FG ++T A T RVVGTYGYMSPEYAIDG++SVKSDVFSFGVL LEI+SGKRNRGF
Sbjct: 647 MARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFN 706
Query: 723 HADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNML 782
H DH NLLGHAW L+++ P ELID S+ + + SE +R + VGLLCVQ+ P+DRPNM
Sbjct: 707 HPDHDLNLLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNVGLLCVQRHPDDRPNMS 766
Query: 783 SVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
SVVLMLS E +LPQPK+PGFFTERN+ E++S K + S NE + ++LE R
Sbjct: 767 SVVLMLSSEGALPQPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITILEGR 818
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2484), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/868 (56%), Positives = 621/868 (71%), Gaps = 54/868 (6%)
Query: 1 MEGLKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYL 60
MEG L++ +F +R + D +++ Q I +GET+ SA SFELGFFSP S++RY+
Sbjct: 1 MEGFATLVL---VFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYV 57
Query: 61 GIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAA 120
GIW+KK+AT TV WVANR PL+ SG+L ++ RG LV+LN TN +WSSN SR A
Sbjct: 58 GIWYKKVATRTVVWVANRQIPLTASSGILKVTDRG---TLVILNGTNTTIWSSN-SSRPA 113
Query: 121 QNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMS 180
QNP A LL+SGNLV+K +GND+D ++FLWQSFDYP +TLL GMK G N VTGL+R +S
Sbjct: 114 QNPNAQLLDSGNLVMK--NGNDSDS-ENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLS 170
Query: 181 SWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFE 240
SWK+ DDP+ +TY +DP G PQ +++ GST+ +R+G WNGL ++G PQL+PN VY++
Sbjct: 171 SWKTTDDPSIGNFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYA 230
Query: 241 FVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNY 300
F+ N+ E +Y F+L+NSSV T +V++ G QRFTW++ T W L +S D CD+Y
Sbjct: 231 FIFNDKETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWIL---YSSAQTDDCDSY 287
Query: 301 ALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKT 360
ALCG Y C I+ SP CEC++GFEPK +W M D S GC R TP+ C+ +GFLK
Sbjct: 288 ALCGVYGICEINR-SPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSG 346
Query: 361 VKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPE 420
VK+PDTR + ++++ L EC LC NCSCTAY NSD+RGGGSGCLLWF DLIDI+ E
Sbjct: 347 VKLPDTRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTE 406
Query: 421 IGQDIYVRMAASELG--------KIERRKQQRKAKQVTI------------------IIT 454
GQD Y+RMA SELG +I Q K T +I
Sbjct: 407 NGQDFYIRMAKSELGMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIV 466
Query: 455 SILLATGVILLGAIVYIW---KKKHRNYGKTDDRQELYS--NEKGSS----KEEMELPIF 505
S + G+ILL ++ ++ KK+ R G LYS N KG+ +E++ELP+F
Sbjct: 467 STVSIVGIILLSLVLTLYVLRKKRLRRKG-----NNLYSKHNCKGAEINEREEDLELPLF 521
Query: 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLI 565
D TI++ATDNFS +NKLGEGGFGPVYKGML +G+EIAVKRLSK S QG++EFKNE I
Sbjct: 522 DLDTILNATDNFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHI 581
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
+KLQHRNLVKLLGCC +E++L+YEY+PNKSLD+FIFD +S VLDW R II GIAR
Sbjct: 582 SKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIAR 641
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
GLLYLH DSRLRIIHRDLKA NVLLDNEMNP+ISDFGMAR+F +++EA T RVVGTYGY
Sbjct: 642 GLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGY 701
Query: 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745
MSPEYAIDG++S+KSDVFSFGVLVLEIV+GKRNRGF H DH NLLGHAW L+++ +P E
Sbjct: 702 MSPEYAIDGVYSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLE 761
Query: 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQPGFFTE 805
LID S+ DSC+ SE +R + VGLLCVQ+ P+DRP+M SVVLMLS E +L QPK+PGFFTE
Sbjct: 762 LIDASMGDSCNQSEVLRALNVGLLCVQRSPDDRPSMSSVVLMLSSESALHQPKEPGFFTE 821
Query: 806 RNLPESESSSSKQNLSSTNEISFSMLEA 833
RN+ E SS+SK + S NE + +++E
Sbjct: 822 RNMLEGSSSASKHAIFSGNEHTITLIEV 849
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2483), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/832 (59%), Positives = 592/832 (71%), Gaps = 58/832 (6%)
Query: 3 GLKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGI 62
G++ L +YSFL IR ++ D IS GQ I +G+T+VSA ++FELGFFSPG S RYLGI
Sbjct: 11 GIRGLFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGI 70
Query: 63 WFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQN 122
W+KK +TGTV WVANR+ P+ D SGVL + +G L+LLN T D+VWSSN + N
Sbjct: 71 WYKKFSTGTVVWVANRENPIFDHSGVLYFTNQG---TLLLLNGTKDVVWSSNRTT-PKNN 126
Query: 123 PVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSW 182
PVA LLESGNLVVK DGND++ P+ FLWQSFDYP T L MKLG NLVTGL+ +SSW
Sbjct: 127 PVAQLLESGNLVVK--DGNDSN-PESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSW 183
Query: 183 KSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFV 242
KS DDPAR EY+ GIDP G Q + KKG I++RAGSWNG+ +TG +L+PNPVY +EFV
Sbjct: 184 KSLDDPARGEYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEFV 243
Query: 243 SNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYAL 302
N+ EV++ F+L+NSSV + V+N G V+R TW+ +W R+ DQCD Y+
Sbjct: 244 LNDKEVYFNFELLNSSVASRFVVNASGVVERLTWISQMHRW---TRYFAVGEDQCDAYSF 300
Query: 303 CGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVK 362
CG A CNI SP C CL+GFEPKS DW D SGGC R+T L C G+GF+K +K
Sbjct: 301 CGSNAKCNI-DKSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMK 359
Query: 363 VPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIG 422
+PDT + + +I L EC+ELC + CSC AYAN+DVRGGGSGCLLWF DLID++ G
Sbjct: 360 LPDTSSSWYNTSISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNTG 419
Query: 423 QDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKT 482
QD+Y+RMAAS LGK++ I+ + H
Sbjct: 420 QDLYIRMAASYLGKMKN----------------------------ILEMDYDSH------ 445
Query: 483 DDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEI 542
S KEE+ELPI D TI AT NFS KLGEGGFG VYKG L GQ+I
Sbjct: 446 ------------SRKEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTLY-GQDI 492
Query: 543 AVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI 602
AVKRLS SGQG+EEFKNE LLIAKLQHRNLVKLLGCC + DER+L+YEY+PNKSLDYFI
Sbjct: 493 AVKRLSMYSGQGIEEFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNKSLDYFI 552
Query: 603 FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662
FD +RSK+LDW R II GIARGLLYLH DSRLRIIHRDLKASNVLLD +MNPKISDFG
Sbjct: 553 FDQSRSKLLDWPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFG 612
Query: 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722
MAR FG +QTEANT RVVGTYGYM+PEYA++GLFSVKSD+FSFGVLVLEIVSG++NRGF+
Sbjct: 613 MARIFGGNQTEANTKRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVLEIVSGRKNRGFF 672
Query: 723 HADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNML 782
+H NL+GHAW+LW+++R EL D +L S +LSE IR I VGLLCVQQ P+DRPNM
Sbjct: 673 SHNHHLNLVGHAWKLWMEERSLELTDNTLGASHALSEIIRYIHVGLLCVQQQPDDRPNMS 732
Query: 783 SVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
+ VLML GE SLPQPKQPGFF ERN+P +ESSSS +STN I+ + R
Sbjct: 733 TAVLMLGGESSLPQPKQPGFFLERNVPRTESSSSNYKSTSTNGITMTAQYPR 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2468), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/836 (57%), Positives = 610/836 (72%), Gaps = 38/836 (4%)
Query: 19 TASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANR 78
+A+ + + GQS+++GET++SA +FELGFFS G S+SRYLGIW+K+I TV WV NR
Sbjct: 5 SAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNR 64
Query: 79 DAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEK 138
+ P D GVL ++ +G ++L NST I+WSSN SR A+NPV LL+SGNL+VK+
Sbjct: 65 EVPSFDNLGVLQVNEQG---VIILQNSTKGIIWSSN-SSRTAKNPVLQLLDSGNLIVKDG 120
Query: 139 DGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGID 198
+GN+ PD+ +WQSFD+P +TLL MKLG NL GLNR ++SWKS DDPA+ ++ ID
Sbjct: 121 NGNN---PDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLID 177
Query: 199 PSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSS 258
G PQ +KKG ++ R+G WNGL +TG PQL PNPV+ F FVSN++E++Y ++L N+S
Sbjct: 178 LRGFPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTS 237
Query: 259 VPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDC 318
V + ++++ G ++R W++ T+ W LF FS DQCD Y LCG YASCNI+S P C
Sbjct: 238 VVSRLIVSEKGALERHNWIDRTQSWTLF--FS-VPTDQCDTYLLCGAYASCNINS-YPVC 293
Query: 319 ECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILL 378
CLEGF PKSP DW D S GC R+T L+C GDGF KLK +K+PDT + VD ++ L
Sbjct: 294 SCLEGFVPKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLK 353
Query: 379 ECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIE 438
EC+ +C RNCSC AYANSD+RG SGCLLWF LID++ E GQD+Y+R+AASEL K
Sbjct: 354 ECEGMCLRNCSCLAYANSDIRG--SGCLLWFDHLIDMRKFTEGGQDLYIRIAASELAK-- 409
Query: 439 RRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGK----------------- 481
+ K+V II++ +++ G+ LG+++Y K+K G+
Sbjct: 410 ---GKSHGKRVAIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYI 466
Query: 482 -TDDRQELYSNEKG--SSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE 538
+ +E Y G +KE+ EL FD TI +AT NFS NKLGEGGFGPVYKG L++
Sbjct: 467 ISGLAKETYIENYGDNGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLD 526
Query: 539 GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598
GQEIAVKRLS++SGQG +EFKNE +LIA+LQHRNLVKLLGCC DE++L+YEY+PNKSL
Sbjct: 527 GQEIAVKRLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSL 586
Query: 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658
D FIFD RS +LDW IIGGIARGLLYLH DSRLRIIHRDLKASN+LLD +MNPKI
Sbjct: 587 DSFIFDKKRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKI 646
Query: 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718
SDFG+AR FG DQ ANT RVVGTYGYMSPEYA+DGLFSVKSDVFSFGVLVLEIVSGKRN
Sbjct: 647 SDFGLARTFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRN 706
Query: 719 RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDR 778
RGF H DH NLLGHAW+LW+++R EL DK D S+S+ +RCIQVGLLCVQ++P DR
Sbjct: 707 RGFSHLDHSLNLLGHAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDR 766
Query: 779 PNMLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
P+M +VV+ML E SLPQPKQPGF+TER+ E++SS+SK+ + S NEIS +++E R
Sbjct: 767 PDMSAVVVMLGSESSLPQPKQPGFYTERDPFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115106|ref|XP_002316941.1| predicted protein [Populus trichocarpa] gi|222860006|gb|EEE97553.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/766 (62%), Positives = 576/766 (75%), Gaps = 13/766 (1%)
Query: 44 SFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLL 103
SF LGFFSPG S +RYLGIW+ KI GTV WVANR+ PL +R GVL+++ +G LVL
Sbjct: 3 SFGLGFFSPGSSSNRYLGIWYNKITPGTVVWVANREQPLVNRLGVLNVTGQG---VLVLF 59
Query: 104 NSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLA 163
NSTN VWSSN VSR AQNPV LL+SGNL VK DGNDN+ PD+FLWQSFDYPS TLL
Sbjct: 60 NSTNYAVWSSN-VSRTAQNPVVQLLDSGNLAVK--DGNDNN-PDNFLWQSFDYPSETLLP 115
Query: 164 GMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGL 223
GMK G NLVTGL+R +SSWKSADDPAR ++T+ +DP G Q +L +G TI YR G WNG
Sbjct: 116 GMKWGKNLVTGLDRYISSWKSADDPARGDFTFRLDPRGYNQMLLMRGLTILYRTGIWNGF 175
Query: 224 HWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKW 283
W G+P+ N VY +FVS E +Y F L+NSSVP+ +VIN QR TW+ T W
Sbjct: 176 RWGGVPETISNTVYGEQFVSTATESYYTFDLLNSSVPSRLVINPSSIPQRLTWITQTNLW 235
Query: 284 GLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGR 343
G +S +DQCD Y LCG C+ +S+ C CLE F P++P W D SGGC R
Sbjct: 236 G---SYSVVQIDQCDTYTLCGANGICS-NSNGAVCSCLESFIPRTPESWNKQDWSGGCVR 291
Query: 344 KTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGS 403
+T L CK+GDGFL++ VK+PD + V+ ++ L+EC+ +C NCSC AY NSD+R G S
Sbjct: 292 RTQLGCKNGDGFLQITGVKLPDMSDSWVNTSMSLVECRNMCLSNCSCVAYGNSDIRRGAS 351
Query: 404 GCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVI 463
GC LWF DL D K LP GQD+Y+RMAASEL E++ ++ ++ II T ++ A ++
Sbjct: 352 GCYLWFDDLWDTKHLPLGGQDLYIRMAASELSIYEKKSSSKRKRRRIIIGT-LISAVVLL 410
Query: 464 LLGAIVYIWKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKL 523
+LG ++Y+ +++ GK R + +E G K++MELP FD+ TI +ATD FS NKL
Sbjct: 411 VLGFMLYMRRRRKTRQGKKSIRIDNLKDESGR-KDDMELPAFDFITIKNATDYFSYNNKL 469
Query: 524 GEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583
GEGGFG VYKG L +GQEIAVKRLSK+SGQG++EFKNE +LIAKLQHRNLVKLLGCC +
Sbjct: 470 GEGGFGSVYKGTLTDGQEIAVKRLSKNSGQGLKEFKNEVILIAKLQHRNLVKLLGCCIEG 529
Query: 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDL 643
DER+L+YEY+PNKSLD FIFD +LDWQ +IIGGIARGLLYLH DSRLRIIHRDL
Sbjct: 530 DERMLIYEYMPNKSLDNFIFDKKSRNLLDWQTHMNIIGGIARGLLYLHQDSRLRIIHRDL 589
Query: 644 KASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVF 703
KASNVLLDN MNPKISDFGMAR FG DQ EANTNR+VGTYGY+SPEYA+DGLFS+KSDVF
Sbjct: 590 KASNVLLDNSMNPKISDFGMARIFGGDQIEANTNRIVGTYGYISPEYAVDGLFSIKSDVF 649
Query: 704 SFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRC 763
SFGVLVLEIVSGK+NRGFYH DH HNLLGHAW+LW + RP EL+D ++ DS SLSE +R
Sbjct: 650 SFGVLVLEIVSGKKNRGFYHPDHNHNLLGHAWKLWNEGRPLELMDITIDDSSSLSEILRH 709
Query: 764 IQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQPGFFTERNLP 809
IQVGLLCVQQ P+DRP+M +VV+MLS E SLPQPKQPGF+TERN P
Sbjct: 710 IQVGLLCVQQRPDDRPSMSTVVVMLSSEISLPQPKQPGFYTERNFP 755
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117334|ref|XP_002317544.1| predicted protein [Populus trichocarpa] gi|222860609|gb|EEE98156.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2440), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/829 (58%), Positives = 603/829 (72%), Gaps = 35/829 (4%)
Query: 24 DAISLGQSIRE--GETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAP 81
D I+ QSIR+ G+++VSA SF++GFFSPG SK+RYLGIWF K+A TV WVANR+ P
Sbjct: 18 DTINTTQSIRDIDGDSMVSADGSFKMGFFSPGSSKNRYLGIWFNKVAVMTVVWVANREIP 77
Query: 82 LSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGN 141
L++ SGVL ++ G LVLLN I+WSSN SR+A+ PVA LL+SGNLVVKE+D N
Sbjct: 78 LTNSSGVLRVTGEG---LLVLLNHNESIIWSSN-ASRSARFPVAQLLDSGNLVVKEEDDN 133
Query: 142 DNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSG 201
D ++ LWQSFDYP TLLAGMK+G N +TG +R ++SWK+ DDP+R +T+ DPSG
Sbjct: 134 DLENS---LWQSFDYPCDTLLAGMKMGRNSITGFDRHLTSWKTTDDPSRGNFTFRFDPSG 190
Query: 202 VPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPT 261
P+ +L + S RYR+G WNGL + G PQL+PNPVY +EFV N+ E+FYR++L+N+S+ +
Sbjct: 191 YPEQILTENSIRRYRSGPWNGLRFGG-PQLRPNPVYKYEFVFNDKEIFYRYQLLNNSILS 249
Query: 262 MMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECL 321
+V+ GDVQR TW + T W + I+D C+ YALCG Y SC+I+ +SP C CL
Sbjct: 250 RLVLTQTGDVQRLTWTDETGIWAFYLTL---IVDDCNRYALCGAYGSCDIN-NSPACGCL 305
Query: 322 EGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVDKNIILLECK 381
+GF PK P W M++ S GC R+TPLNC GD F + VK+P+TR + +K++ L +CK
Sbjct: 306 KGFLPKVPRTWDMMNWSDGCARRTPLNCT-GDVFQRYSGVKLPETRKSWFNKSMNLEQCK 364
Query: 382 ELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRK 441
LC +NCSCTAYAN D+R GGSGCLLWF DLIDI+ + GQDIY+RMAASE +
Sbjct: 365 SLCMKNCSCTAYANLDIREGGSGCLLWFSDLIDIRQFNDNGQDIYIRMAASE----QEGT 420
Query: 442 QQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGK----------------TDDR 485
+ K K II+ S++ A ++L +V + +KK + GK +
Sbjct: 421 KSNKTKHTRIIVISVVSAGMLLLGIVLVLLVRKKKQQKGKLTISPAHCNFLRLTLICSNL 480
Query: 486 QELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVK 545
L + KE+ EL +FD TI T+NFS NKLGEGGFGPVYKG+L +GQEIAVK
Sbjct: 481 SILEGRRDDTCKEDPELQLFDLGTITCVTNNFSLTNKLGEGGFGPVYKGILEDGQEIAVK 540
Query: 546 RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT 605
RLSKSS QG++EFKNE + IAKLQHRNLVKLLGCC + DER+L+YE++P KSLD FIFD
Sbjct: 541 RLSKSSRQGLDEFKNEVMHIAKLQHRNLVKLLGCCMEADERMLIYEFMPKKSLDIFIFDR 600
Query: 606 TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665
T S +LDW R HII GIARGLLYLH DSRLRIIHRDLKASN+LLDN MNPKISDFG+AR
Sbjct: 601 THSALLDWPQRYHIINGIARGLLYLHQDSRLRIIHRDLKASNILLDNSMNPKISDFGLAR 660
Query: 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHAD 725
+F ++TEANT RVVGTYGY+SPEYAIDG++SVKSDVFSFGVLVLEIV+G RNR F H D
Sbjct: 661 SFEENETEANTKRVVGTYGYISPEYAIDGIYSVKSDVFSFGVLVLEIVNGNRNRRFCHPD 720
Query: 726 HRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785
H NLLGHAW+L+ + R +ELI + + +SC+LSEA+R I VGLLCVQ P DRP+M SVV
Sbjct: 721 HNLNLLGHAWRLFTEGRSSELITEPIAESCNLSEALRSIHVGLLCVQCHPNDRPSMSSVV 780
Query: 786 LMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLEAR 834
LMLSGE LPQPKQPGFFTER L E+ SSS K S N+ + ++LEAR
Sbjct: 781 LMLSGEGKLPQPKQPGFFTERTLVEANSSSVKNTSCSVNDSTITLLEAR 829
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.522 | 0.556 | 0.482 | 3.1e-234 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.968 | 0.950 | 0.468 | 6.4e-202 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.970 | 0.955 | 0.463 | 1.5e-193 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.964 | 0.953 | 0.458 | 2.5e-193 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.805 | 0.824 | 0.519 | 1.5e-186 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.956 | 0.947 | 0.441 | 1e-180 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.928 | 0.911 | 0.463 | 2.4e-179 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.967 | 0.972 | 0.413 | 1.2e-170 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.924 | 0.909 | 0.425 | 3.2e-159 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.922 | 0.925 | 0.403 | 5.1e-154 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 3.1e-234, Sum P(2) = 3.1e-234
Identities = 219/454 (48%), Positives = 304/454 (66%)
Query: 1 MEGLKIL-IIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRY 59
ME +L ++ LF I A D + Q++++G+T+VS SFE+GFFSPG S++RY
Sbjct: 1 MEATNVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRY 60
Query: 60 LGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIV--S 117
LGIW+KKI+ TV WVANRD+PL D SG L +S G+ L L N N I+WSS+ S
Sbjct: 61 LGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGS---LCLFNDRNHIIWSSSSSPSS 117
Query: 118 RAA--QNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGL 175
+ A +NP+ +L++GNLVV+ N DD D ++WQS DYP L GMK G+N VTGL
Sbjct: 118 QKASLRNPIVQILDTGNLVVR----NSGDDQD-YIWQSLDYPGDMFLPGMKYGLNFVTGL 172
Query: 176 NRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNP 235
NR ++SW++ DDP+ YT +DP+GVPQ LKK S + +R G WNGL +TGMP L+PNP
Sbjct: 173 NRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNP 232
Query: 236 VYTFEFVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILD 295
+Y +E+V E EV+Y +KL N SV T M +N G +QR+TW+++ + W + ++D
Sbjct: 233 IYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMD 289
Query: 296 QCDNYALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHG-DG 354
CD Y LCG Y SCNI+ +SP C CL+GF K+P W D S GC R+ L+C G DG
Sbjct: 290 SCDQYTLCGSYGSCNIN-ESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDG 348
Query: 355 FLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLID 414
FLK+ +K+PDTR + DKN+ L ECK++C RNC+C+AY+ D+R GG GC+LWF DLID
Sbjct: 349 FLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLID 408
Query: 415 IKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQ 448
I+ E GQD+YVR+A+SE+ ++R + +++
Sbjct: 409 IREYNENGQDLYVRLASSEIETLQRESSRVSSRK 442
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1954 (692.9 bits), Expect = 6.4e-202, P = 6.4e-202
Identities = 400/854 (46%), Positives = 560/854 (65%)
Query: 6 ILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFK 65
+LI++ + T S +++++ + T+VS FELGFF PG YLGIW+K
Sbjct: 18 LLILFPAYSISANTLSASESLTISSN----NTIVSPGNVFELGFFKPGLDSRWYLGIWYK 73
Query: 66 KIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNP-V 124
I+ T WVANRD PLS G L +S + LV+L+ ++ VWS+N+ ++P V
Sbjct: 74 AISKRTYVWVANRDTPLSSSIGTLKIS----DSNLVVLDQSDTPVWSTNLTGGDVRSPLV 129
Query: 125 AVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKS 184
A LL++GN V+++ + N PD LWQSFD+P+ TLL MKLG + TG NR + SWKS
Sbjct: 130 AELLDNGNFVLRD---SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKS 186
Query: 185 ADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSN 244
DDP+ ++++ ++ G P+ L + YR+G WNG+ ++G+P++QP F F ++
Sbjct: 187 PDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTS 246
Query: 245 ENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCG 304
+ EV Y F++ S V + + I++ G +QRFTW+E + W +F DQCD Y CG
Sbjct: 247 KEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWN---QFWYAPKDQCDEYKECG 303
Query: 305 PYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVP 364
Y C+ ++ SP C C++GF+P++P W + D S GC RKT L+C GDGF++LK +K+P
Sbjct: 304 VYGYCDSNT-SPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLP 362
Query: 365 DTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQD 424
DT A VD+ I + EC++ C R+C+CTA+AN+D+RG GSGC+ W +L DI+ + GQD
Sbjct: 363 DTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQD 422
Query: 425 IYVRMAASELGKIERRKQQRKAKQV-TIIITSILLATGVILLGAIVYIWKKKHRNYGKTD 483
+YVR+AA++L K+ R AK + + I S+LL I+ ++ K+K +T
Sbjct: 423 LYVRLAATDL----EDKRNRSAKIIGSSIGVSVLLLLSFIIF--FLWKRKQKRSILIETP 476
Query: 484 --DRQ----ELYSNE----------KGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGG 527
D Q +L NE + ++ +++ELP+ +++ + AT+NFS NKLG+GG
Sbjct: 477 IVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGG 536
Query: 528 FGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587
FG VYKG L++GQE+AVKRLSK+S QG +EFKNE LIA+LQH NLV+LL CC E++
Sbjct: 537 FGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKM 596
Query: 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647
L+YEYL N SLD +FD +R+ L+WQ R II GIARGLLYLH DSR RIIHRDLKASN
Sbjct: 597 LIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASN 656
Query: 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 707
+LLD M PKISDFGMAR FG D+TEANT +VVGTYGYMSPEYA+DG+FS+KSDVFSFGV
Sbjct: 657 ILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGV 716
Query: 708 LVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL---SEAIRCI 764
L+LEI+S KRN+GFY++D NLLG W+ W + + E+ID + DS S E +RCI
Sbjct: 717 LLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCI 776
Query: 765 QVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFFTERNLPEXXXXXXXXXXXXT 823
Q+GLLCVQ+ EDRP M V+LML E + +PQPK PG+ ER+L + +
Sbjct: 777 QIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDES 836
Query: 824 ---NEISFSMLEAR 834
N+I+ S+L+AR
Sbjct: 837 WTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1875 (665.1 bits), Expect = 1.5e-193, P = 1.5e-193
Identities = 396/854 (46%), Positives = 552/854 (64%)
Query: 6 ILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFK 65
+ II FL ++ ++ SL +I +T++S S+ FELGFF+P S YLGIW+K
Sbjct: 14 LFIIILFLAFSVYASNFSATESL--TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYK 71
Query: 66 KIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVA 125
I T WVANRD PLS +G L +S LV+ + ++ VWS+NI ++PVA
Sbjct: 72 IIPIRTYVWVANRDNPLSSSNGTLKISDNN----LVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 126 V-LLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGV-NLVTGLNRLMSSWK 183
LL+ GN V+++ + N+ P FLWQSFD+P+ TLL+ MK+G N G NR++ SWK
Sbjct: 128 AELLDYGNFVLRD---SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWK 184
Query: 184 SADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVS 243
+ DDP+ +++ + SG P+ + +I YR+G W G ++ +P ++P F
Sbjct: 185 TTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTE 244
Query: 244 NENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALC 303
N +V Y +++ +++ +++ +++ G +QR TWME + W +S D CDNY C
Sbjct: 245 NNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLW-YSPK--DLCDNYKEC 301
Query: 304 GPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKV 363
G Y C+ ++ SP C C++GFEP + + D S GC RKT L+C DGF++LK +++
Sbjct: 302 GNYGYCDANT-SPICNCIKGFEPMNE-QAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRL 359
Query: 364 PDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQ 423
PDT VDK I L EC+E C + C+CTA+AN+D+R GGSGC++W L DI+ + GQ
Sbjct: 360 PDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQ 419
Query: 424 DIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYG-KT 482
D+YVR+AA +L ++R + +K +I ++ +LL + +I + +K+ R+ +T
Sbjct: 420 DLYVRVAAGDLE--DKRIKSKKIIGSSIGVSILLLLSFIIFH----FWKRKQKRSITIQT 473
Query: 483 D--D---RQELYSNE--KGS----SKEE----MELPIFDWKTIVDATDNFSEENKLGEGG 527
D Q+ NE K S SKE +ELP+ +WK + AT+NFS +NKLG+GG
Sbjct: 474 PIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGG 533
Query: 528 FGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587
FG VYKGML++G+EIAVKRLSK S QG +EF NE LIAKLQH NLV+LLGCC + E++
Sbjct: 534 FGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKM 593
Query: 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647
L+YEYL N SLD +FD TRS L+WQ R II GIARGLLYLH DSR RIIHRDLKASN
Sbjct: 594 LIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASN 653
Query: 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 707
VLLD M PKISDFGMAR FG ++TEANT RVVGTYGYMSPEYA+DG+FS+KSDVFSFGV
Sbjct: 654 VLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGV 713
Query: 708 LVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS----EAIRC 763
L+LEI+SGKRN+GFY+++ NLLG W+ W + + E++D D+ S E +RC
Sbjct: 714 LLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRC 773
Query: 764 IQVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFFTERNLPEXXXXXXXXXXX- 821
IQ+GLLCVQ+ EDRP M SV++ML E + +PQPK+PGF R+ E
Sbjct: 774 IQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDE 833
Query: 822 -XTNEISFSMLEAR 834
N+++ S+++AR
Sbjct: 834 CTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1873 (664.4 bits), Expect = 2.5e-193, P = 2.5e-193
Identities = 391/853 (45%), Positives = 554/853 (64%)
Query: 6 ILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFK 65
ILI++ + T S +++++ + +T++S S+ FELGFF+P S YLGIW+K
Sbjct: 16 ILILFLAFSVSPNTLSATESLTISSN----KTIISPSQIFELGFFNPASSSRWYLGIWYK 71
Query: 66 KIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVA 125
I T WVANRD PLS +G L +S GN LV+ + ++ VWS+NI ++PVA
Sbjct: 72 IIPIRTYVWVANRDNPLSSSNGTLKIS--GNN--LVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 126 V-LLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKS 184
LL++GN +++ D N+ LWQSFD+P+ TLLA MKLG + TG NR++ SWK+
Sbjct: 128 AELLDNGNFLLR--DSNNR-----LLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKT 180
Query: 185 ADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSN 244
DDP+ E++ ++ S P+ + +I YR+G WNG+ ++ +P + F ++
Sbjct: 181 TDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTAS 240
Query: 245 ENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCG 304
+ EV Y +++ +++ + + +N+ G +QR TW E T+ W +S D CDNY +CG
Sbjct: 241 KEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLW-YSPK--DLCDNYKVCG 297
Query: 305 PYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVP 364
+ C+ +S P+C C++GF+P + W + D S GC RKT L+C DGF +LK +K+P
Sbjct: 298 NFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLP 356
Query: 365 DTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQD 424
DT VD+ I L CKE C +C+CTA+AN+D+R GGSGC++W +++D++ + GQD
Sbjct: 357 DTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQD 416
Query: 425 IYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHR------- 477
+YVR+AA+EL ++R + K +I ++ +LL + VI + +K+ R
Sbjct: 417 LYVRLAAAELE--DKRIKNEKIIGSSIGVSILLLLSFVIFH----FWKRKQKRSITIQTP 470
Query: 478 NYGKTDDRQELYSN----EKG-SSKEE----MELPIFDWKTIVDATDNFSEENKLGEGGF 528
N + + L ++ +G +SKE+ +ELP+ + + + AT+NFS +NKLG+GGF
Sbjct: 471 NVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGF 530
Query: 529 GPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588
G VYKG L++G+EIAVKRLSK S QG +EF NE LIAKLQH NLV+LLGCC + E++L
Sbjct: 531 GIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKML 590
Query: 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNV 648
+YEYL N SLD +FD TRS L+WQ R II GIARGLLYLH DSR RIIHRDLKASNV
Sbjct: 591 IYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNV 650
Query: 649 LLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 708
LLD M PKISDFGMAR FG ++TEANT RVVGTYGYMSPEYA+DG+FS+KSDVFSFGVL
Sbjct: 651 LLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVL 710
Query: 709 VLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS----EAIRCI 764
+LEI+SGKRN+GFY+++ NLLG W+ W + E++D DS S E +RCI
Sbjct: 711 LLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCI 770
Query: 765 QVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFFTERNLPEXXXXXXXXXXX-- 821
Q+GLLCVQ+ EDRP M SV++ML E + +PQPK+PGF R+ E
Sbjct: 771 QIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDEC 830
Query: 822 XTNEISFSMLEAR 834
N+I+ S+++AR
Sbjct: 831 TVNQITLSVIDAR 843
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1809 (641.9 bits), Expect = 1.5e-186, P = 1.5e-186
Identities = 366/704 (51%), Positives = 473/704 (67%)
Query: 140 GN--DNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGI 197
GN +D + LWQSFDYP +T+LAGMKLG N T + +SSWK+ DP+ ++T +
Sbjct: 135 GNLISSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSL 194
Query: 198 DPSGVPQAMLKKG--STIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLI 255
D G+PQ +L+K S+ YR GSWNGL +TG P + F++ + +
Sbjct: 195 DTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSL-FDYKFTSSAQEVNYSWT 253
Query: 256 -NSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHS- 313
+ + +V+N G + RF + + W + A + D+CD Y++CG YA C I+S
Sbjct: 254 PRHRIVSRLVLNNTGKLHRFIQSKQNQ-W-ILANTAPE--DECDYYSICGAYAVCGINSK 309
Query: 314 DSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHGDGFLKLKTVKVPDTRYAQVD- 372
++P C CL+GF+PKS W + + GC + P NC+ D F+K +K+PDT ++ D
Sbjct: 310 NTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDA 369
Query: 373 KNIILLE-CKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAA 431
KN + LE CK CS NCSCTAYAN+D+R GG GCLLWF DL+D++ GQD+Y+RM
Sbjct: 370 KNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMG- 428
Query: 432 SELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKTDDRQELYSN 491
KIE K ++V ++ ++A V+L+ KK + Y R E +
Sbjct: 429 --FAKIEF-----KGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRY-----RGENF-- 474
Query: 492 EKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS 551
KG +E+++LPIFD KTI ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS +S
Sbjct: 475 RKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANS 534
Query: 552 GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVL 611
GQGVEEFKNE LIAKLQHRNLV+LLGCC Q +E +L+YEY+PNKSLD+FIFD RS L
Sbjct: 535 GQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTEL 594
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
DW+ R +II G+ARG+LYLH DSRLRIIHRDLKA NVLLDN+MNPKISDFG+A++FG DQ
Sbjct: 595 DWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQ 654
Query: 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731
+E++TNRVVGTYGYM PEYAIDG FSVKSDVFSFGVLVLEI++GK NRGF HADH NLL
Sbjct: 655 SESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLL 714
Query: 732 GHAWQLWIQDRPAELIDKSLYDSCS-LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790
GH W++W++DR E+ ++ + S + E +RCI V LLCVQQ PEDRP M SVVLM
Sbjct: 715 GHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGS 774
Query: 791 ERSLPQPKQPGFFTERNLPEXXXXXXXXXXXXTNEISFSMLEAR 834
+ SLP P QPGFFT RN+P+ NE+S +ML+ R
Sbjct: 775 DSSLPHPTQPGFFTNRNVPDISSSLSLRSQ---NEVSITMLQGR 815
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1754 (622.5 bits), Expect = 1.0e-180, P = 1.0e-180
Identities = 379/859 (44%), Positives = 524/859 (61%)
Query: 7 LIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKK 66
L+I+ L N+ + ST ++ + +IREG++++S ESFELGFF+P S RY+GIW+K
Sbjct: 14 LLIFHQLCSNV-SCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKN 72
Query: 67 IATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAV 126
I TV WVANR+ PL D G L ++ GN LV++N N+ +WS+N V + N VAV
Sbjct: 73 IEPQTVVWVANREKPLLDHKGALKIADDGN---LVIVNGQNETIWSTN-VEPESNNTVAV 128
Query: 127 LLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSAD 186
L ++G+LV+ +D+D + W+SF+ P+ T L GM++ VN G NR WKS
Sbjct: 129 LFKTGDLVLC----SDSDRRKWY-WESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSES 183
Query: 187 DPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQ--PNPVYTFEFVS- 243
DP+ +Y+ GIDP G + ++ +G ++R+G WN +TG+P + N +Y F+ S
Sbjct: 184 DPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSP 243
Query: 244 --NENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYA 301
+ V++ + +SS I G ++F W + + W L T +C+ Y
Sbjct: 244 PDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPST---ECEKYN 300
Query: 302 LCGPYASCNIHS--DSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHG------D 353
CG Y+ C+ DS C C++GFEP W D SGGC R+ PLNC D
Sbjct: 301 RCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQED 360
Query: 354 GFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLI 413
GF LK +KVPD + N CK++C+R+CSC AYA G GC++W DLI
Sbjct: 361 GFTVLKGIKVPDFGSVVLHNNSET--CKDVCARDCSCKAYALVV----GIGCMIWTRDLI 414
Query: 414 DIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYI-- 471
D++ G I +R+A S+LG ++ + II+ S++ G LLG ++I
Sbjct: 415 DMEHFERGGNSINIRLAGSKLGG------GKENSTLWIIVFSVI---GAFLLGLCIWILW 465
Query: 472 ----------WKKKHRNYGKTDDRQELYSNEK-----GSSKEEMELPIFDWKTIVDATDN 516
WKKK + ++ YS+ G + +LPIF + ++ AT +
Sbjct: 466 KFKKSLKAFLWKKKDITVSDIIENRD-YSSSPIKVLVGDQVDTPDLPIFSFDSVASATGD 524
Query: 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
F+EENKLG+GGFG VYKG EG+EIAVKRLS S QG+EEFKNE LLIAKLQHRNLV+L
Sbjct: 525 FAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRL 584
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
LGCC + +E++L+YEY+PNKSLD F+FD ++ LDW+ R +IGGIARGLLYLH DSRL
Sbjct: 585 LGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRL 644
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
+IIHRDLKASN+LLD EMNPKISDFGMAR F Q ANT RVVGTYGYM+PEYA++G+F
Sbjct: 645 KIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIF 704
Query: 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756
S KSDV+SFGVL+LEIVSG++N F DH +L+G+AW LW Q + E+ID + D+
Sbjct: 705 SEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRD 763
Query: 757 LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFFTERNLPEXXXXX 815
++EA+RCI VG+LC Q RPNM SV+LML + S LP P+QP F + N +
Sbjct: 764 VTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNF 823
Query: 816 XXXXXXXTNEISFSMLEAR 834
N+++F+ + R
Sbjct: 824 DGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1741 (617.9 bits), Expect = 2.4e-179, P = 2.4e-179
Identities = 387/835 (46%), Positives = 520/835 (62%)
Query: 7 LIIYSFLFCNIRTASTRDAISLGQSIREG---ETVVSASESFELGFFSPGKSKSRYLGIW 63
L +Y FL+ + A+T I G+S+R+G + +VS ++FELGFFSPG S R+LGIW
Sbjct: 13 LFLYFFLYESSMAANT---IRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 64 FKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNP 123
+ I V WVANR P+SD+SGVL +S GN LVLL+ N VWSSNI S N
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGN---LVLLDGKNITVWSSNIESSTTNNN 126
Query: 124 --VAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSS 181
V + ++GN V+ E D D P +W+SF++P+ T L M++ VN TG N S
Sbjct: 127 NRVVSIHDTGNFVLSE---TDTDRP---IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVS 180
Query: 182 WKSADDPARSEYTYGIDPSGVPQAMLKKGS-TIRYRAGSWNGLHWTGMPQLQ--PNPVYT 238
W+S DP+ Y+ G+DPSG P+ +L +G+ T ++R+G WN +TG+P + N +Y
Sbjct: 181 WRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYG 240
Query: 239 FEFVSNENE---VFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILD 295
F+ S +E V++ + + SV + G + W E KKW +F
Sbjct: 241 FKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKW---TKFQSEPDS 297
Query: 296 QCDNYALCGPYASCNIHSDSPDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNCKHG--- 352
+CD Y CG + C++ + C C+ G+E S G+W S GC R+TPL C+
Sbjct: 298 ECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISV 352
Query: 353 --DGFLKLKTVKVPDTRYAQVDKNIILLE-CKELCSRNCSCTAYANSDVRGGGSGCLLWF 409
D FL LK+VK+PD + + N++ E C+E C RNCSC AY S V GG GC++W
Sbjct: 353 GEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAY--SLV--GGIGCMIWN 406
Query: 410 HDLIDIKVLPEIGQDIYVRMAASELGKIERRK-QQRKAKQVTIIITSI--LLATGVILLG 466
DL+D++ G +++R+A SE+G+ + K A V +I+ I LL
Sbjct: 407 QDLVDLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKK 466
Query: 467 AI--VYIWKKKHRNY-----GKTDDRQELYSNE-----KGSSKEEMELPIFDWKTIVDAT 514
+ Y K + K+ + +S +G + ELP+F I AT
Sbjct: 467 DVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIAT 526
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
++F +EN+LG GGFGPVYKG+L +G+EIAVKRLS SGQGV+EFKNE +LIAKLQHRNLV
Sbjct: 527 NDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLV 586
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+LLGCC + +E++LVYEY+PNKSLD+F+FD T+ ++DW+ R II GIARGLLYLH DS
Sbjct: 587 RLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDS 646
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
RLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q EANT RVVGTYGYMSPEYA++G
Sbjct: 647 RLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEG 706
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754
LFSVKSDV+SFGVL+LEIVSGKRN ++H +L+G+AW L+ R EL+D + +
Sbjct: 707 LFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVT 765
Query: 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFF-TERN 807
CS EA+RCI V +LCVQ +RPNM SV+LML + + L P+QP F T RN
Sbjct: 766 CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRN 820
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1659 (589.1 bits), Expect = 1.2e-170, P = 1.2e-170
Identities = 351/849 (41%), Positives = 514/849 (60%)
Query: 6 ILIIYSFLFC-NIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWF 64
+LI+ L C ++R D I+ R+ ETVVS +F GFFSP S RY GIWF
Sbjct: 4 LLILLLTLICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWF 63
Query: 65 KKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPV 124
I TV WVAN ++P++D SG++S+S+ GN LV+++ + WS+N++ A N
Sbjct: 64 NNIPVQTVVWVANSNSPINDSSGMVSISKEGN---LVVMDGRGQVHWSTNVLVPVAANTF 120
Query: 125 -AVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWK 183
A LL +GNLV+ G N D LW+SF++P + L M L + TG + + SWK
Sbjct: 121 YARLLNTGNLVLL---GTTNTG-DEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWK 176
Query: 184 SADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEF-V 242
S DP+ Y+ G+ P P+ ++ K + +R+G WNG ++ G+P + + FE +
Sbjct: 177 SPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYR-INLFELTL 235
Query: 243 SNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYAL 302
S++N +++ ++++ G V + W ++W + + T +CD YA
Sbjct: 236 SSDNRGSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPST---KCDTYAT 292
Query: 303 CGPYASCNIHSDS-PDCECLEGFEPKSPGDWYMLDKSGGCGRKTPLNC---------KHG 352
CG +ASC + S P C C+ GF+P+S +W + + GC RK PL C +
Sbjct: 293 CGQFASCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKS 352
Query: 353 DGFLKLKTVKVP-DTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHD 411
DGF++++ +KVP + + + ++ +C E C +NCSCTAY+ G GCLLW +
Sbjct: 353 DGFVRVQKMKVPHNPQRSGANEQ----DCPESCLKNCSCTAYSFDR----GIGCLLWSGN 404
Query: 412 LIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYI 471
L+D++ G Y+R+A SE K R + VT+++ + L A V+L +
Sbjct: 405 LMDMQEFSGTGVVFYIRLADSEFKK---RTNRSIVITVTLLVGAFLFAGTVVLALWKIAK 461
Query: 472 WKKKHRNYGKTDDRQE-LYSNEKGS---SKEEM-ELPIFDWKTIVDATDNFSEENKLGEG 526
++K+RN ++R E L SN+ G+ ++ ++ ELP+F+++ + AT+NFS NKLG+G
Sbjct: 462 HREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQG 521
Query: 527 GFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586
GFG VYKG L EG +IAVKRLS++SGQGVEEF NE ++I+KLQHRNLV+LLG C + +ER
Sbjct: 522 GFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEER 581
Query: 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKAS 646
+LVYE++P LD ++FD + ++LDW+ R +II GI RGL+YLH DSRL+IIHRDLKAS
Sbjct: 582 MLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKAS 641
Query: 647 NVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 706
N+LLD +NPKISDFG+AR F ++ E +T RVVGTYGYM+PEYA+ GLFS KSDVFS G
Sbjct: 642 NILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLG 701
Query: 707 VLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQV 766
V++LEIVSG+RN FY+ NL +AW+LW L+D +++ C +E RC+ V
Sbjct: 702 VILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHV 761
Query: 767 GLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQPGFFTERNLPEXXXXXXXXXXXXTNE 825
GLLCVQ DRP++ +V+ MLS E S LP+PKQP F R E N
Sbjct: 762 GLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINN 821
Query: 826 ISFSMLEAR 834
+S + + R
Sbjct: 822 VSLTKITGR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1551 (551.0 bits), Expect = 3.2e-159, P = 3.2e-159
Identities = 355/834 (42%), Positives = 489/834 (58%)
Query: 4 LKILIIYSFLFCNIRTASTRDAISLGQSIREGETVVSASES-FELGFFSPG-KSKSR-YL 60
L L++ C + T D + G+S+ T+VS+ E FE GFF+P K SR YL
Sbjct: 7 LLFLLLAGASLCCVAAQKT-DTLRQGESLSGAATLVSSPEGVFEAGFFAPDPKQPSRQYL 65
Query: 61 GIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTAL--VLLNSTND--IVWSSNIV 116
GIW+ I+ TV WVANR AP + S L+++ G+ L N T D ++WSSN
Sbjct: 66 GIWYHSISPRTVVWVANRVAPATSASPSLTLTVTGDLRVLDGTAANGTADAPLLWSSNTT 125
Query: 117 SRAAQNP--VAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLV-T 173
SRA AVL ++G+L V+ +DG LW SF +P+ T+L+GM++ +
Sbjct: 126 SRAGPRGGYSAVLQDTGSLEVRSEDG--------VLWDSFWHPTDTILSGMRITLQAPGR 177
Query: 174 GLNR--LMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRY-RAGSWNGLHWTGMPQ 230
G L +SW S DP+ Y G+DP QA + K + Y R+G WNG+++ G+P
Sbjct: 178 GPKERMLFTSWASETDPSPGRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPW 237
Query: 231 LQPNPVYTFEFVSNENEV---FYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFA 287
P+Y F + V +Y + N+S+ +V+ D+ + + ++ W L
Sbjct: 238 ---RPLYRSGFTPAIDPVLGNYYTYTATNTSLQRFVVLPNGTDIC-YMVRKSSQDWEL-V 292
Query: 288 RFSGTILDQCDNYALCGPYASCNIHSDSP-DCECLEGFEPKSPGDWYMLDKSGGCGRKTP 346
+ + ++C+ YA CGP A C D C CL+GF PK W + S GC R P
Sbjct: 293 WYQPS--NECEYYATCGPNAKCTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPP 350
Query: 347 LNCK---HGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGS 403
L C+ GDGFL + +K PD Y V C+ +C NCSC AY V +
Sbjct: 351 LGCETNQSGDGFLPMGNIKWPDFSY-WVSTVGDEPGCRTVCLNNCSCGAY----VYTATT 405
Query: 404 GCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIITSILLATGVI 463
GCL W ++LID+ L + +++ ASEL R K TII +L
Sbjct: 406 GCLAWGNELIDMHELQTGAYTLNLKLPASEL-----RGHHPIWKIATIISAIVLFVLAAC 460
Query: 464 LL-----G-----AIVYIWKKKH------RNYGKTDDRQELYSNEKGSSKEEMELPIFDW 507
LL G A+ W+ +H +N D Q + ++ + EL ++
Sbjct: 461 LLLWWKHGRNIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDDVEDGKSHELKVYSL 520
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAK 567
I AT NFS+ NKLGEGGFGPVY G L G+E+AVKRL ++SGQG+EEFKNE +LIAK
Sbjct: 521 DRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAK 580
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
LQHRNLV+LLGCC R+E++LVYEY+PNKSLD F+F+ + ++LDW+ R II GIARGL
Sbjct: 581 LQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGL 640
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
LYLH DSRLR++HRDLKASN+LLD +M PKISDFGMAR FG DQ + NTNRVVGT+GYMS
Sbjct: 641 LYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMS 700
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
PEYA++G+FSVKSDV+ FGVL+LEI++GKR F+ + N+ G+AW+ W +D AELI
Sbjct: 701 PEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELI 760
Query: 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS-LPQPKQP 800
D + SCS+ + +RCI + LLCVQ ++RP++ +V+LMLS + S LP P+ P
Sbjct: 761 DPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPP 814
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1502 (533.8 bits), Expect = 5.1e-154, P = 5.1e-154
Identities = 334/828 (40%), Positives = 493/828 (59%)
Query: 26 ISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDR 85
I+ + G+T+ S +ELGFFSP S+ +Y+GIWFK IA V WVANRD P++
Sbjct: 44 INTSSPLSIGQTLSSPDGVYELGFFSPNNSRKQYVGIWFKNIAPQVVVWVANRDKPVTKT 103
Query: 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDD 145
+ L++S G+ L+LL+ T D++WS+ + + A LL++GNLVV + D
Sbjct: 104 AANLTISSNGS---LILLDGTQDVIWSTG-EAFTSNKCHAELLDTGNLVVID------DV 153
Query: 146 PDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQA 205
LW+SF+ +T+L + ++ G NR+++SW+S DP+ E+T P PQ
Sbjct: 154 SGKTLWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPSPGEFTLEFTPQVPPQG 213
Query: 206 MLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSN--ENEVFYRFKLINSSVPTMM 263
++++GS+ +R+G W ++G+P + + V F + + + + + ++ + + +
Sbjct: 214 LIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKGTASFSYSMLRNYKLSYV 273
Query: 264 VINTIGDVQRFTWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEG 323
+ + G + + W + K W L F CD Y CGP+ C + S +P C CL+G
Sbjct: 274 TLTSEGKM-KILWNDG-KSWKL--HFEAPT-SSCDLYRACGPFGLC-VRSRNPKCICLKG 327
Query: 324 FEPKSPGDWYMLDKSGGCGRKTPLNC----------KHGDGFLKLKTVKVPDTRYAQVDK 373
F PKS +W + + GC R+T L+C K D F + VK PD Y Q+
Sbjct: 328 FVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHMTRVKTPDL-Y-QLAG 385
Query: 374 NIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLID-IKVLPEIGQDIYVRMAAS 432
+ +C + C NCSCTA+A G GCL+W +L+D ++ L + G+ + +R+A+S
Sbjct: 386 FLNAEQCYQDCLGNCSCTAFAYIS----GIGCLVWNRELVDTVQFLSD-GESLSLRLASS 440
Query: 433 ELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKTDDRQELYSNE 492
EL R K I+ T++ L+ VIL+ A W+ +R + ++S++
Sbjct: 441 ELAGSNRTK--------IILGTTVSLSIFVILVFAAYKSWR--YRTKQNEPNPMFIHSSQ 490
Query: 493 KGSSKEEME------LPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKR 546
+K+ ME + +FD TI AT+NFS NKLG+GGFGPVYKG L++G+EIAVKR
Sbjct: 491 DAWAKD-MEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGKLVDGKEIAVKR 549
Query: 547 LSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTT 606
LS SSGQG +EF NE LI+KLQH+NLV+LLGCC + +E++L+YEYL NKSLD F+FD+T
Sbjct: 550 LSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVNKSLDVFLFDST 609
Query: 607 RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666
+DWQ R +II G+ARGLLYLH DSRLR+IHRDLK SN+LLD +M PKISDFG+AR
Sbjct: 610 LKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARM 669
Query: 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
Q + NT RVVGT GYM+PEYA G+FS KSD++SFGVL+LEI+ G++ F ++
Sbjct: 670 SQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRF--SEE 727
Query: 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786
LL +AW+ W + + +L+D++L DS +E RC+Q+GLLCVQ P DRPN L ++
Sbjct: 728 GKTLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQHQPADRPNTLELMS 787
Query: 787 MLSGERSLPQPKQPGFFTERNLPEXXXXXXXXXXXXTNEISFSMLEAR 834
ML+ LP PKQP F + NEI+ S+++ R
Sbjct: 788 MLTTISELPSPKQPTF----TVHSRDDDSTSNDLITVNEITQSVIQGR 831
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5268 | 0.9244 | 0.9846 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01340036 | hypothetical protein (831 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 834 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-44 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-36 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-34 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-32 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-28 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-28 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 5e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-24 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 9e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 98/295 (33%), Positives = 136/295 (46%), Gaps = 66/295 (22%)
Query: 520 ENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNL 573
KLGEG FG VYKG L + E+AVK L + S Q +EEF EA ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
VKLLG CT+ + ++V EY+P L ++ R K L + IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEY 690
IHRDL A N L+ + KISDFG++R D + + +V G +M+PE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750
+G F+ KSDV+SFGVL+ EI + LG +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT----------------LG----------------EE 203
Query: 751 LYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLML 788
Y S +E + ++ G L C + PEDRP +V +L
Sbjct: 204 PYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 95/295 (32%), Positives = 131/295 (44%), Gaps = 67/295 (22%)
Query: 520 ENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNL 573
KLGEG FG VYKG L + E+AVK L + +S Q +EEF EA ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
VKLLG CT+ + +V EY+ L ++ L + IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEY 690
IHRDL A N L+ + KISDFG++R D + + R G +M+PE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750
+G F+ KSDV+SFGVL+ EI + LG +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT----------------LG----------------EQ 202
Query: 751 LYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLML 788
Y S E + ++ G L C + PEDRP +V +L
Sbjct: 203 PYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 93/294 (31%), Positives = 133/294 (45%), Gaps = 59/294 (20%)
Query: 521 NKLGEGGFGPVYKGMLIEGQ----EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVK 575
KLGEG FG VYKG L E+AVK L + S + ++F EA ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFI------FDTTRSKVLDWQNRCHIIGGIARGLLY 629
LLG CT+ + LV EY+ L ++ F + L ++ IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG----- 684
L + +HRDL A N L+ ++ KISDFG++R + T G
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-------GKRN---RGFYHADHRHNLLGHA 734
+M+PE DG+F+ KSDV+SFGVL+ EI + G N + +R
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR------- 225
Query: 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
+P E LY+ + L C Q PEDRP +V L
Sbjct: 226 -----LPKP-EYCPDELYE------------LMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 70/194 (36%), Positives = 101/194 (52%), Gaps = 11/194 (5%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
LGEGGFG VY G+++A+K + K S +EE E ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+ LV EY SL + + L I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 641 RDLKASNVLLDN-EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSV 698
RDLK N+LLD+ K++DFG+++ ++ +VGT YM+PE + G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 699 KSDVFSFGVLVLEI 712
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 73/199 (36%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 522 KLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLG 578
KLG G FG VYK G+ +AVK L K S + + + E ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+D LV EY L ++ +R L I I RGL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL-FS 697
IHRDLK N+LLD KI+DFG+A+ + T VGT YM+PE + G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177
Query: 698 VKSDVFSFGVLVLEIVSGK 716
K DV+S GV++ E+++GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 77/205 (37%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 522 KLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVK 575
KLGEG FG VYKG L ++AVK L + + + EEF EA ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
LLG CTQ + +V EY+P L F+ + L ++ + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY-----MSPEY 690
+HRDL A N L+ + KISDFG++R D G M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPES 175
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSG 715
DG F+ KSDV+SFGVL+ EI +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG-VEEFKNEALLIAKLQHRNLV 574
+ KLGEG FG VY + G+ +A+K + K + E E ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L D+ LV EY L + + L + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLH--- 114
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
I+HRDLK N+LLD + + K++DFG+AR VGT YM+PE +
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 695 LFSVKSDVFSFGVLVLEIVSGK 716
+ D++S GV++ E+++GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 54/119 (45%), Positives = 70/119 (58%), Gaps = 12/119 (10%)
Query: 71 TVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLES 130
TV WVANR PL+D S L + GN LVL + +VWSSN + + VAVL +
Sbjct: 3 TVVWVANRLNPLTDSSYTLILQSDGN---LVLYDGNGRVVWSSNTSGKGS-GCVAVLQDD 58
Query: 131 GNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPA 189
GNLV+ D+ LWQSFD+P+ TLL G K G N+V G +R ++SWKS DP+
Sbjct: 59 GNLVLY-------DNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 521 NKLGEGGFGPVYKGMLIE-GQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
LG G FG VY + + G+ +AVK LS S + +E + E +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 578 GCCTQRDERVL-VY-EYLPNKSLDYFI--F-----DTTRSKVLDWQNRCHIIGGIARGLL 628
G ++ L ++ EY+ SL + F R I GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLA 115
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
YLH I+HRD+K +N+L+D++ K++DFG A+ G +T T V GT +M+P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
E + +D++S G V+E+ +GK
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 56/128 (43%), Positives = 72/128 (56%), Gaps = 13/128 (10%)
Query: 30 QSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVL 89
+ G+T+VS+ FELGFF Y I +K + TV WVANRD P S S L
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNP-SGSSCTL 59
Query: 90 SMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHF 149
++ GN LV+ + + +VWSSN +R N V VLL+ GNLV+ + DGN F
Sbjct: 60 TLQSDGN---LVIYDGSGTVVWSSN-TTRVNGNYVLVLLDDGNLVLYDSDGN-------F 108
Query: 150 LWQSFDYP 157
LWQSFDYP
Sbjct: 109 LWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 42/114 (36%), Positives = 74/114 (64%), Gaps = 4/114 (3%)
Query: 215 YRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTIGDVQRF 274
+R+G WNG+ ++G+P++Q Y + F N EV+Y +++ N+S+ + + +++ G ++RF
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 275 TWMEHTKKWGLFARFSGTILDQCDNYALCGPYASCNIHSDSPDCECLEGFEPKS 328
TW+ +++ W LF DQCD Y CGPY C++ + SP C C++GF PK+
Sbjct: 61 TWIPNSQDWNLFWSAP---KDQCDVYGRCGPYGYCDV-NTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 79/221 (35%), Positives = 114/221 (51%), Gaps = 31/221 (14%)
Query: 517 FSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQ 569
F EE LGEG FG VYKG L +A+K L ++ + +EF+ EA L++ LQ
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF-------------DTTRSKVLDWQNR 616
H N+V LLG CT+ +++EYL + L F+ D T LD +
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 617 CHIIGGIARGLLYL--HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGLDQTE 673
HI IA G+ YL HH +HRDL A N L+ + KISDFG++R + D
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ ++ +M PE + G F+ +SD++SFGV++ EI S
Sbjct: 182 VQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 23/264 (8%)
Query: 517 FSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVK 575
F K+G+GGFG VYK G+E+A+K + S + E+ NE ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
G ++DE +V E+ SL + + ++ L ++ + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLH---S 116
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL 695
IIHRD+KA+N+LL ++ K+ DFG++ N +VGT +M+PE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 696 FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755
+ K+D++S G+ +E+ GK Y L + P L + + S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP---YSELPPMKALFKI----ATNGPPGLRNPEKW-SD 225
Query: 756 SLSEAIRCIQVGLLCVQQIPEDRP 779
+ ++ C+Q+ PE RP
Sbjct: 226 EFKDFLK------KCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 72/198 (36%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
E KLG G FG V+ G ++AVK L K E F EA ++ KL+H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
C++ + +V EY+ SL F+ K L + IA G+ YL I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLF 696
HRDL A N+L+ + KI+DFG+AR D+ A G + +PE A G F
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRF 181
Query: 697 SVKSDVFSFGVLVLEIVS 714
++KSDV+SFG+L+ EIV+
Sbjct: 182 TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 57/127 (44%), Positives = 74/127 (58%), Gaps = 14/127 (11%)
Query: 30 QSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVL 89
++ G+T+VS + FELGFF+ Y I +K + TV WVANRD P+SD S L
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58
Query: 90 SMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHF 149
++ GN LVL + +VWSSN + A N V VLL+ GNLV+ + DGN F
Sbjct: 59 TLQSDGN---LVLYDGDGRVVWSSNT-TGANGNYVLVLLDDGNLVIYDSDGN-------F 107
Query: 150 LWQSFDY 156
LWQSFDY
Sbjct: 108 LWQSFDY 114
|
Length = 114 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-31
Identities = 78/283 (27%), Positives = 122/283 (43%), Gaps = 21/283 (7%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSK---SSGQGVEEFKNEALLIAKLQH-R 571
++ KLGEG FG VY + +A+K L+K S + VE F E ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
N+VKL LV EY+ SL+ + R L I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 632 HDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEAN----TNRVVGTYGYM 686
IIHRD+K N+LLD + K+ DFG+A+ + ++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 687 SPEYAIDGLF---SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743
+PE + S SD++S G+ + E+++G + + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233
Query: 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786
+ S + +S+A + LL P++R + S +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAK--DPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 89/281 (31%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 521 NKLGEGGFGPVYKGMLIE--GQEI--AVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVK 575
+LG G FG V KG+ + G+E+ AVK L + G +EF EA ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
L+G C + + +LV E P L ++ V D + H +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLESK-- 114
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSPEY 690
+HRDL A NVLL N KISDFGM+RA G T G + +PE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPEC 169
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVS--GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
G FS KSDV+S+GV + E S K A+ +L +L RP E
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERL---PRPEECPQ 225
Query: 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+Y + L C + PEDRP +
Sbjct: 226 -EIYS------------IMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 41/232 (17%)
Query: 523 LGEGGFGPVYKG---MLIEGQE---IAVKRLSKSSGQGVEE-FKNEALLIAKLQHRNLVK 575
LGEG FG V+ G L + +AVK L +++ + F+ EA L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFI-----------------FDTTRSKVLDWQNRCH 618
G CT+ D ++V+EY+ + L+ F+ + T S++L
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL------Q 126
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678
I IA G++YL + +HRDL N L+ ++ KI DFGM+R D + R
Sbjct: 127 IAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYR 179
Query: 679 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
V G +M PE + F+ +SDV+SFGV++ EI + + + ++
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 521 NKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLV 574
+LGEG FG V G+++AVK L+ S Q +F+ E ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 575 KLLGCCTQRDERV--LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII---GGIARGLLY 629
K G C + R L+ EYLP+ SL ++ + D N ++ I +G+ Y
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-----QRHRDQINLKRLLLFSSQICKGMDY 124
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT--EANTNRVVGTYGYMS 687
L R IHRDL A N+L+++E KISDFG+A+ D+ + Y +
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS 714
PE FS SDV+SFGV + E+ +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 61/198 (30%), Positives = 106/198 (53%), Gaps = 6/198 (3%)
Query: 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
F+ E KLG G FG V++G+ +A+K L ++F+ E + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
C+ + ++ E + SL F+ + +VL + + +A G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
IHRDL A N+L+ ++ K++DFG+AR D ++ ++ Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 697 SVKSDVFSFGVLVLEIVS 714
S KSDV+SFG+L+ E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ 582
+G+G FG V G GQ++AVK L K + F EA ++ L+H NLV+LLG Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 583 RDERVLVYEYLPNKSL-DYFIFDTTRSK---VLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+ +V EY+ SL DY RS+ V+ + + G+ YL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-----RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY--GYMSPEYAIDGLF 696
+HRDL A NVL+ ++ K+SDFG+A+ EA+ + G + +PE + F
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 697 SVKSDVFSFGVLVLEIVSGKRN 718
S KSDV+SFG+L+ EI S R
Sbjct: 177 STKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEI-AVKR--LSKSSGQGVEEFKNEALLIAKLQHRN 572
+ ++G+G FG VY ++ +K LS S + E+ NE ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRS-------KVLDW--QNRCHIIGGI 623
++K ++ + +V EY L I + ++LDW Q +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------L 112
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
L YLH SR +I+HRD+K N+ L + K+ DFG+++ L T VVGT
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTP 167
Query: 684 GYMSPE------YAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
Y+SPE Y + KSD++S G ++ E+ + K
Sbjct: 168 YYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 76/233 (32%), Positives = 114/233 (48%), Gaps = 34/233 (14%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRL-SKSSGQGVEEFKNEALLI 565
D+ + LG G FG VY+G+ ++AVK L S Q +F EAL++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT----TRSKVLDWQNRCHIIG 621
+K H+N+V+L+G +R R ++ E + L F+ + R L ++
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTN 677
+A+G YL + IHRD+ A N LL + P KI+DFGMAR D A+
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYY 175
Query: 678 RVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-------GKRNR 719
R G +M PE +DG+F+ K+DV+SFGVL+ EI S G+ N+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 77/271 (28%), Positives = 119/271 (43%), Gaps = 43/271 (15%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRL-SKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
LG+G G VYK G+ A+K++ + ++ E + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR----GLLYLHHDSR 635
+ E +V EY+ SL + KV ++ IAR GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGLDYLHTK-- 118
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG- 694
IIHRD+K SN+L++++ KI+DFG+++ L+ T N VGT YMSPE I G
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPE-RIQGE 175
Query: 695 LFSVKSDVFSFGVLVLEIVSGK------RNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
+S +D++S G+ +LE GK F+ L+ I D P +
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------ELMQA-----ICDGPPPSLP 224
Query: 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
+ S + I C+Q+ P+ RP
Sbjct: 225 AEEF-SPEFRDFISA------CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 35/216 (16%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRN 572
N+ + +G G FG VYKG+ +E G +A+K++S + ++ E L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG---------- 622
+VK +G D ++ EY N SL + G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL---------------RQIIKKFGPFPESLVAVYV 105
Query: 623 --IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
+ +GL YLH +IHRD+KA+N+L + K++DFG+A L+ + VV
Sbjct: 106 YQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVV 160
Query: 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
GT +M+PE S SD++S G V+E+++G
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-Q 569
D+F +GEG F V E +E A+K L K + V+ K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 570 HRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
H ++KL Q +E + V EY PN L +I + LD + I L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV--------- 679
YLH IIHRDLK N+LLD +M+ KI+DFG A+ + + +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 680 ---------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
VGT Y+SPE + SD+++ G ++ ++++GK
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 67/207 (32%), Positives = 116/207 (56%), Gaps = 23/207 (11%)
Query: 523 LGEGGFGPVYKGMLI-EGQ----EIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKL 576
LG G FG VYKG+ I EG+ +A+K L + + + +E +EA ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 577 LGCCTQRDERV-LVYEYLPNKSLDYFIF---DTTRSK-VLDWQNRCHIIGGIARGLLYLH 631
LG C +V L+ + +P L ++ D S+ +L+W + IA+G+ YL
Sbjct: 75 LGICLS--SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL- 125
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
R++HRDL A NVL+ + KI+DFG+A+ +D+ E + +M+ E
Sbjct: 126 --EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 692 IDGLFSVKSDVFSFGVLVLEIVS-GKR 717
+ +++ KSDV+S+GV V E+++ G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 69/197 (35%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
KLG G FG V++G+ +AVK L K ++F EA ++ KL+H L++L CT
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 582 QRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+ +V E + SL +Y R+ L + +A G+ YL + IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLFS 697
RDL A NVL+ K++DFG+AR D EA G + +PE A+ FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 698 VKSDVFSFGVLVLEIVS 714
+KSDV+SFG+L+ EIV+
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 78/225 (34%), Positives = 121/225 (53%), Gaps = 31/225 (13%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLS-KSSGQGVEEFKNEALLI 565
+T F EE LGE FG VYKG L + Q +A+K L K+ G EEFK+EA++
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF-------------DTTRSKVLD 612
++LQH N+V LLG T+ +++ Y + L F+ D T L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 613 WQNRCHIIGGIARGLLYL--HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGL 669
+ HI+ IA G+ +L HH ++H+DL NVL+ +++N KISD G+ R +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
D + N ++ +MSPE + G FS+ SD++S+GV++ E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-28
Identities = 38/67 (56%), Positives = 51/67 (76%), Gaps = 1/67 (1%)
Query: 349 CKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLW 408
C GDGFL+L +K+PDT A VD++I L EC++ C NCSCTAYA +D+R GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 409 FHDLIDI 415
+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
D + + K+GEG G VYK G+E+A+K++ + Q E NE L++ +H
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKH 74
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSL----DYFIFDTTRSKVLDWQNRCHIIGGIARG 626
N+V DE +V EY+ SL ++ ++ + +G
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI------AYVCREVLQG 128
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR--VVGTYG 684
L YLH +IHRD+K+ N+LL + + K++DFG F T+ + R VVGT
Sbjct: 129 LEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPY 181
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
+M+PE + K D++S G++ +E+ G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/244 (29%), Positives = 116/244 (47%), Gaps = 28/244 (11%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
++G G FG V+ G +E +++A+K + + E+F EA ++ KL H LV+L G CT
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
+R LV+E++ + L ++ + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSD 701
DL A N L+ K+SDFGM R F LD ++ + SPE +S KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 702 VFSFGVLVLEIVSGKR---------------NRGF------YHADHRHNLLGHAWQLWIQ 740
V+SFGVL+ E+ S + N GF + + L+ H W+ +
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPE 243
Query: 741 DRPA 744
DRP+
Sbjct: 244 DRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+G FG V + G+ A+K L K + VE E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 579 CCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
Q +E++ LV EY P L + F R++ I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLH- 110
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
L II+RDLK N+LLD + + K++DFG+A+ + + NT GT Y++PE +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ D +S GVL+ E+++GK FY D
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP--FYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 23/210 (10%)
Query: 520 ENKLGEGGFGPVYKGML-IEGQE---IAVKRL-SKSSGQGVEEFKNEALLIAKLQHRNLV 574
E +G G FG V +G L + G++ +A+K L + SS + +F EA ++ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L G T+ +++ EY+ N SLD F+ ++ GIA G+ YL S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMSP 688
+ +HRDL A N+L+++ + K+SDFG++R L+ +EA T G + +P
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEA----TYTTKGGKIPIRWTAP 177
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
E F+ SDV+SFG+++ E++S G+R
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 523 LGEGGFGPVYKGMLI-------EGQEIAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLV 574
LG G FG VY+G +AVK L K ++ Q +EF EA L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFD----TTRSKVLDWQNRCHIIGGIARGLLYL 630
KLLG C + + ++ E + L ++ D +L + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 631 HHDSRLRIIHRDLKASNVLL-----DNEMNPKISDFGMARAFGLDQTEANTNRVVGT--- 682
++ IHRDL A N L+ D + KI DFG+AR D +++ R G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175
Query: 683 -YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE +DG F+ +SDV+SFGVL+ EI++
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 70/208 (33%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+ KLG G FG V+ G ++A+K L K E F EA L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLY 629
+L TQ + ++ EY+ N SL F+ T +K++D + IA G+ +
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLID------MAAQIAEGMAF 117
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
+ R IHRDL+A+N+L+ + KI+DFG+AR ++ A + +PE
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPE 173
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
G F++KSDV+SFG+L+ EIV+ R
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVK 575
F KLGEG +G VYK + E GQ +A+K + + ++E E ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
G + + +V EY S+ + +K L + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL 695
+ IHRD+KA N+LL+ E K++DFG+ + L T A N V+GT +M+PE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 696 FSVKSDVFSFGVLVLEIVSGK 716
++ K+D++S G+ +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 77/219 (35%), Positives = 110/219 (50%), Gaps = 27/219 (12%)
Query: 517 FSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-SSGQGVEEFKNEALLIAKLQH 570
F EE LGE FG +YKG L Q +A+K L ++ Q EF+ EA L+A+L H
Sbjct: 9 FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF--------------DTTRSKVLDWQNR 616
N+V LLG TQ +++EYL L F+ D T LD +
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGLDQTEAN 675
HI IA G+ YL S +H+DL A N+L+ +++ KISD G++R + D
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
++ +M PE + G FS SD++SFGV++ EI S
Sbjct: 184 PKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 523 LGEGGFGPV----YKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
LG+G FG V Y + G+ +AVK+L S+ + + +F+ E ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 578 GCCTQRDER--VLVYEYLPNKSL-DYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLY 629
G C R LV EYLP SL DY D + + Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG---TYGYM 686
L R +HRDL N+L+++E KI DFG+ + D+ E R G + Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+PE + FSV SDV+SFGV++ E+ +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 77/254 (30%), Positives = 122/254 (48%), Gaps = 32/254 (12%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN 572
++ KLG G FG V+ G ++AVK L K E F EA ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
LV+L ++ +V EY+ SL F+ D + L N + +A G+ Y+
Sbjct: 63 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY--GYMSPEY 690
R+ IHRDL+++N+L+ + + KI+DFG+AR L + T R + + +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEA 174
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVS-------GKRNRGFYHADHR--------------HN 729
A+ G F++KSDV+SFG+L+ E+V+ G NR R H
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234
Query: 730 LLGHAWQLWIQDRP 743
L+ W+ ++RP
Sbjct: 235 LMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGV-EEFKNEALLIAKLQHRNLVKLLGCC 580
K+G+G FG VYKG+L E+AVK + + +F EA ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
Q+ +V E +P SL F+ + L + + A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKS 700
RDL A N L+ KISDFGM+R + + +PE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 701 DVFSFGVLVLEIVSG 715
DV+S+G+L+ E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 65/196 (33%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ 582
LG G FG V+ G ++A+K + + + ++F EA ++ KL H NLV+L G CT+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 583 RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRD 642
+ +V EY+ N L ++ R L + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 643 LKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLFSVK 699
L A N L+ + K+SDFG+AR DQ ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 700 SDVFSFGVLVLEIVSG 715
SDV+SFGVL+ E+ S
Sbjct: 182 SDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 521 NKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEF----KNEALLIAKLQHRNLVK 575
++GEG +G VYK G+ +A+K++ E F E L+ KL+H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 576 LLGCCTQRDER--VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
L T + + +V+EY+ + L + D+ K + Q +C + + GL YLH +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKC-YMKQLLEGLQYLHSN 119
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE---- 689
I+HRD+K SN+L++N+ K++DFG+AR + + TNRV+ T Y PE
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 690 -----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D++S G ++ E+ GK
Sbjct: 176 ATRYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 70/193 (36%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
KLG G FG V+ G ++AVK L K V+ F EA L+ LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
+ + ++ EY+ SL F+ KVL IA G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSD 701
DL+A+NVL+ + KI+DFG+AR ++ A + +PE G F++KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSD 186
Query: 702 VFSFGVLVLEIVS 714
V+SFG+L+ EIV+
Sbjct: 187 VWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 30/213 (14%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQG---------VEEFKNEALLIAKLQHRN 572
+G G FG VY GM G+ +AVK++ S ++ E L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSL-----DYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
+V+ LG D + EY+P S+ +Y F+ T + + + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD--QTEANTNR--VVGTY 683
YLH+ IIHRD+K +N+L+DN+ KISDFG+++ + T+ N R + G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+M+PE ++ K+D++S G LV+E+++GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 516 NFSEENKLGEGGFGPVY----KGMLIEGQE--IAVKRLSKSSGQGVE-EFKNEALLIAKL 568
N E LG G FG V+ KG+ EG E + VK L K+ + ++ EF+ E + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV-------LDWQNRCHIIG 621
H+N+V+LLG C + + ++ EY L F+ T+SK L + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKVALCT 124
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
IA G+ +L S R +HRDL A N L+ ++ K+S +++ + N ++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 682 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+++PE + FS KSDV+SFGVL+ E+ +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 12/207 (5%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ 569
++ TD + ++KLG G +G VY+G+ + +AVK L K VEEF EA ++ +++
Sbjct: 3 MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 60
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H NLV+LLG CT+ ++ E++ +L ++ + R + ++ ++ I+ + Y
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEY 119
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY--GYMS 687
L + IHRDL A N L+ K++DFG++R L + T + + +
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTA 173
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS 714
PE FS+KSDV++FGVL+ EI +
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 67/204 (32%), Positives = 107/204 (52%), Gaps = 9/204 (4%)
Query: 516 NFSEENKLGEGGFGPVYKGML-IEGQEIAVKR--LSKSSGQGVEEFKNEALLIAKLQHRN 572
+F NK+G+G FG V+K + + + A+K+ LSK + + EE +EA ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+++ + + +V EY N L + R + L I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+I+HRD+K+ N+ LD N KI D G+A+ + ANT +VGT Y+SPE
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
D ++ KSDV++ GV++ E +GK
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 44/220 (20%)
Query: 517 FSEENKLGEGGFGPVYKGMLIEGQEI-AVK--RLSKSSGQGVEEFKNEAL----LIAKLQ 569
+ + KLGEG +G VYK + EI A+K RL E + AL L+ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELK 56
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI------FDTTRSKVLDWQNRCHIIGGI 623
H N+VKLL + LV+EY + L ++ K + +Q +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ--------L 107
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
RGL Y H S RI+HRDLK N+L++ + K++DFG+ARAFG+ T+ VV T
Sbjct: 108 LRGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TL 162
Query: 684 GYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y +PE Y+ +V D++S G + E+++GK
Sbjct: 163 WYRAPEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-24
Identities = 42/89 (47%), Positives = 52/89 (58%), Gaps = 8/89 (8%)
Query: 345 TPLNCKHG---DGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGG 401
TPLNC DGFLKL VK+PD A I L EC+E C NCSCTAYA ++ G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNN---G 55
Query: 402 GSGCLLWFHDLIDIKVLPEIGQDIYVRMA 430
GCLLW L +++ L G +Y+R+A
Sbjct: 56 SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 55/293 (18%)
Query: 523 LGEGGFGPVYKGMLIEG----QEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LGEG FG V +G L + ++AVK +L + +EEF +EA + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 577 LGCCTQRDER------VLVYEYLPNKSLDYFIFDT---TRSKVLDWQNRCHIIGGIARGL 627
+G C + +++ ++ + L F+ + + L Q + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGLD---QTEANTNRVVGTY 683
YL S IHRDL A N +L +M ++DFG+++ + D Q V
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-------GKRNRGFYHADHRHNLLGHAWQ 736
+++ E D +++ KSDV++FGV + EI + G N Y + L H +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYLRHGNR 233
Query: 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
L +P + +D+ LYD C + P+DRP + +L
Sbjct: 234 L---KQPEDCLDE-LYDLMY-----SCWRAD-------PKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 521 NKLGEGGFGPVYKGMLI--EGQEIAVKRLSKSSGQGVEEFKN---EALLIAKLQHRNLVK 575
+LG G G V K +L G+ +AVK + + K E ++ K +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVG 63
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIA----RGLLYLH 631
G + + EY+ SLD +V I+G IA +GL YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKI-----LKEVQGRIPE-RILGKIAVAVLKGLTYLH 117
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
+IIHRD+K SN+L+++ K+ DFG++ L + A T VGT YM+PE
Sbjct: 118 EK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAKTF--VGTSSYMAPE-R 170
Query: 692 IDGL-FSVKSDVFSFGVLVLEIVSGK 716
I G +SVKSD++S G+ ++E+ +G+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN--EALLIAKLQHRNLVKLLG 578
K+GEG +G VYK + G+ +A+K++ E L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR-------CHIIGGIARGLLYLH 631
+ + LV+E++ DT K++ + R + + +GL + H
Sbjct: 66 VFRHKGDLYLVFEFM----------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
I+HRDLK N+L++ E K++DFG+AR+FG T+ VV T Y +PE
Sbjct: 116 ---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELL 170
Query: 692 I-DGLFSVKSDVFSFGVLVLEIVSGK 716
+ D +S D++S G + E++S +
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQG-VEEFKNEALLIAK 567
+ + +LG+G FG VY+G+ +A+K +++++ EF NEA ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYL-------------PNKSLDYFIFDTTRSKVLDWQ 614
++V+LLG + ++V E + P + + T K +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM- 124
Query: 615 NRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674
IA G+ YL + +HRDL A N ++ ++ KI DFGM R D E
Sbjct: 125 -----AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYET 172
Query: 675 NTNRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ R G +M+PE DG+F+ KSDV+SFGV++ E+ +
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 522 KLGEGGFGPVYKG---MLIEGQE---IAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVK 575
+LGEG FG V+ L+ Q+ +AVK L ++S ++F+ EA L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYF---------IFDTTRSKV---LDWQNRCHIIGGI 623
G CT+ ++V+EY+ + L+ F I L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG-- 681
A G++YL + L +HRDL N L+ + KI DFGM+R D + RV G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 682 --TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
+M PE + F+ +SD++SFGV++ EI + GK+
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 11/200 (5%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
E KLG+G FG V+ G +A+K L K E F EA ++ KL+H LV+L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
++ + +V EY+ SL F+ K L + IA G+ Y+ R+ +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY--GYMSPEYAIDGLFS 697
HRDL+A+N+L+ + K++DFG+AR L + T R + + +PE A+ G F+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 698 VKSDVFSFGVLVLEIVSGKR 717
+KSDV+SFG+L+ E+ + R
Sbjct: 182 IKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 30/208 (14%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLS-----KSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG G FG VY+G+ L +G AVK +S ++ + V++ + E L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 577 LGCCTQRDERVL-VY-EYLPNKSL-----DYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
LG T+R+E L ++ E +P SL Y F ++ Q I GL Y
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--------ILLGLEY 117
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH +HRD+K +N+L+D K++DFGMA+ + G+ +M+PE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPE 171
Query: 690 Y-AIDGLFSVKSDVFSFGVLVLEIVSGK 716
A G + + +D++S G VLE+ +GK
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 70/202 (34%), Positives = 117/202 (57%), Gaps = 20/202 (9%)
Query: 523 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKSSGQGVE-EFKNEALLIAKLQHRNLVKL 576
LG G FG VYKG+ + EG+ + A+K L++++G EF +EAL++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIF---DTTRSKVL-DWQNRCHIIGGIARGLLYLHH 632
LG C + LV + +P+ L ++ D S++L +W + IA+G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
R++HRDL A NVL+ + + KI+DFG+AR D+ E N + +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 693 DGLFSVKSDVFSFGVLVLEIVS 714
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKR--LSKSSGQGVEEFKNEALLIAKLQHRNL 573
F+ +G+G FG VYK + Q +A+K L ++ + +E+ + E +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
K G + + ++ EY S D + LD I+ + GL YLH +
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
IHRD+KA+N+LL E + K++DFG++ ++ NT VGT +M+PE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
+ K+D++S G+ +E+ G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGM---LIEGQE---IAVKRLSK-SSGQGVEEFKNEALLIAK 567
+N +G+G FG V++ L+ + +AVK L + +S +F+ EA L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD-----------TTRSKVLDWQNR 616
H N+VKLLG C L++EY+ L+ F+ +T S N
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 617 CH--------IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AF 667
I +A G+ YL S + +HRDL N L+ M KI+DFG++R +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
D +A+ N + +M PE ++ +SDV+++GV++ EI S
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 64/218 (29%), Positives = 108/218 (49%), Gaps = 39/218 (17%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRL---SKSSGQG-------VEEFKNEALLIAKLQHR 571
+G+G +G VY + + G+ +AVK++ + +G+ V+ ++E + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSL-----DYFIFDTTRSKVLDWQNRCHIIGGIARG 626
N+V+ LG T + + EY+P S+ Y F+ + Q + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR----AFGLDQTEANTNRVVGT 682
L YLH I+HRDLKA N+L+D + KISDFG+++ + DQ + G+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQGS 173
Query: 683 YGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKR 717
+M+PE I +S K D++S G +VLE+ +G+R
Sbjct: 174 VFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 15/215 (6%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KSSGQGVEEFK-NEALLIAKLQHRN 572
++++ K+GEG +G VYKG GQ +A+K++ +S +GV E L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRS-KVLDWQNRCHIIGGIARGLLYLH 631
+V L Q L++E+L Y D+ + +D + + I +G+L+ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
R++HRDLK N+L+DN+ K++DFG+ARAFG+ T+ VV T Y +PE
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVL 173
Query: 692 IDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHAD 725
+ +S D++S G + E+ + + +H D
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT---KKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKNEALLIAK-LQHRN 572
+ E ++LGEG G V K L I A+K ++ +++ L I K +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 573 LVKLLGCCT--QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC--HIIGGIA---- 624
+VK G + EY SLD + KV R ++G IA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
+GL YLH SR +IIHRD+K SN+LL + K+ DFG++ A T GT
Sbjct: 116 KGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSF 168
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
YM+PE +S+ SDV+S G+ +LE+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 82/294 (27%), Positives = 136/294 (46%), Gaps = 64/294 (21%)
Query: 523 LGEGGFGPVYKGMLIEGQ------EIAVKRLSKSSGQG-VEEFKNEALLIAKLQHRNLVK 575
LGEG FG V K + +AVK L +++ + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTR-------------SKVLD---------- 612
L G C+Q +L+ EY SL F+ ++ + S LD
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 613 ------WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666
WQ I+RG+ YL + ++++HRDL A NVL+ KISDFG++R
Sbjct: 128 DLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ + ++ +M+ E D +++ +SDV+SFGVL+ EIV+ N A
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 727 R-HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
R NLL +++ +RP ++C SE + + L C +Q P+ RP
Sbjct: 237 RLFNLLKTGYRM---ERP---------ENC--SEEMYNLM--LTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 73/229 (31%), Positives = 113/229 (49%), Gaps = 40/229 (17%)
Query: 516 NFSEENKLGEGGFGPVYKGM---LIEGQE---IAVKRLSKSSGQGVEEFKNEALLIAKLQ 569
N + +LGEG FG V+ L Q+ +AVK L +S ++F EA L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI----------------FDTTRSKVLDW 613
H ++VK G C + D ++V+EY+ + L+ F+ + T+S++L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML-- 123
Query: 614 QNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673
HI IA G++YL + +HRDL N L+ + KI DFGM+R D
Sbjct: 124 ----HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYS 172
Query: 674 ANTNRVVG----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
+ RV G +M PE + F+ +SDV+S GV++ EI + GK+
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 42/222 (18%)
Query: 523 LGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-------Q 569
LGEG FG V K + E +AVK L + + K+ + L++++ +
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGK 74
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG------- 622
H+N++ LLG CTQ +V EY + +L F+ +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 623 ------IARGLLYLHHDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAF-GLDQTE 673
+ARG+ +L S+ + IHRDL A NVL+ D+ M KI+DFG+AR +D
Sbjct: 135 VSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYR 189
Query: 674 ANTN-RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
TN R+ +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 190 KTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-21
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAK 567
+I D ++ K+G+G G V+ + + GQE+A+K+++ E NE L++ +
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
L++ N+V L DE +V EYL SL D +D + + L
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
+LH + ++IHRD+K+ NVLL + + K++DFG +Q++ +T +VGT +M+
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
PE + K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 45/241 (18%)
Query: 516 NFSEENKLGEGGFGPVY-----------------KGMLIEGQEIAVKRLSKSSGQGV-EE 557
NF E KLGEG FG V+ +AVK L + E+
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 558 FKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI--------FDTTRSK 609
F E ++++L N+ +LLG CT ++ EY+ N L+ F+ SK
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 610 VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669
L + ++ IA G+ YL L +HRDL N L+ KI+DFGM+R
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---- 178
Query: 670 DQTEANTN-------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722
++ R +M+ E + G F+ KSDV++FGV + EI++ R + +
Sbjct: 179 ---NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 723 H 723
H
Sbjct: 236 H 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 30/262 (11%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLS-KSSGQGVEEFKNEALLIAKLQH---RNLVKLL 577
+G G +G VY+G + G+ +A+K ++ + V + + E L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
G + ++ EY S+ + ++ + + II + L Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LF 696
+IHRD+KA+N+L+ N N K+ DFG+A L+Q + + VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756
K+D++S G+ + E+ +G ++D A L + +P L D S
Sbjct: 180 DTKADIWSLGITIYEMATGNPP----YSDVD---AFRAMMLIPKSKPPRLEDNGY--SKL 230
Query: 757 LSEAIRCIQVGLLCVQQIPEDR 778
L E + C+ + P++R
Sbjct: 231 LREFV------AACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 30/224 (13%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QH 570
D T F +GEG +G VYK + ++ ++ EE K E ++ K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 571 RNLVKLLGCCTQRDERV------LVYEYLPNKSLDYFIFDTTRSKVLDWQNR-------C 617
N+ G +++ LV E S+ T K L + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV------TDLVKGLRKKGKRLKEEWIA 116
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677
+I+ RGL YLH ++IHRD+K N+LL K+ DFG++ LD T N
Sbjct: 117 YILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRN 171
Query: 678 RVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+GT +M+PE D + +SDV+S G+ +E+ GK
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 69/215 (32%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN 572
D E LG+G +G VY + Q IA+K + + + V+ E L + L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDW----QNRCHII---GGIAR 625
+V+ LG ++ + E +P SL RSK W N II I
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLS----ALLRSK---WGPLKDNEQTIIFYTKQILE 119
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGLDQTEANTNRVVGTY 683
GL YLH +I+HRD+K NVL++ KISDFG + R G++ T GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTL 173
Query: 684 GYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGK 716
YM+PE G + +D++S G ++E+ +GK
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVE-EFKNEALLIAKLQHRNLVKLLGCCT 581
LG+G FG V+KG L + +AVK + Q ++ +F +EA ++ + H N+VKL+G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
QR +V E +P D+ F + L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 642 DLKASNVLLDNEMNPKISDFGMAR--------AFGLDQTEANTNRVVGTYGYMSPEYAID 693
DL A N L+ KISDFGM+R + GL Q + +PE
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK---------WTAPEALNY 168
Query: 694 GLFSVKSDVFSFGVLVLEIVS 714
G +S +SDV+S+G+L+ E S
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 83/307 (27%), Positives = 130/307 (42%), Gaps = 75/307 (24%)
Query: 520 ENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
+ +LGEG FG V+ + +AVK L + ++F+ EA L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVL--DWQNR-----------CHII 620
VK G C D ++V+EY+ + L+ F+ ++ D Q R HI
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
IA G++YL + +HRDL N L+ + KI DFGM+R D + RV
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 681 G----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ 736
G +M PE + F+ +SDV+SFGV++ EI + + Q
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT------------------YGKQ 224
Query: 737 LWIQDRPAELID---------------KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
W Q E+I+ K +YD + L C Q+ P+ R N+
Sbjct: 225 PWFQLSNTEVIECITQGRVLERPRVCPKEVYD------------IMLGCWQREPQQRLNI 272
Query: 782 LSVVLML 788
+ +L
Sbjct: 273 KEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 68/200 (34%), Positives = 109/200 (54%), Gaps = 11/200 (5%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+ KLG+G FG V+ G ++A+K L K E F EA ++ KL+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
++ + +V E++ SL F+ + K L + IA G+ Y+ R+ I
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY--GYMSPEYAIDGLFS 697
HRDL+A+N+L+ + + KI+DFG+AR L + T R + + +PE A+ G F+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 698 VKSDVFSFGVLVLEIVSGKR 717
+KSDV+SFG+L+ E+V+ R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKR-----LSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+G FG VY ++ G+E+AVK+ S + + V + E L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 577 LGCCTQRDERVLVYEYLPNKSLD-----YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
GC + + EY+P S+ Y T ++ Q I G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ--------ILEGVEYLH 121
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR---AFGLDQTEANTNRVVGTYGYMSP 688
+ I+HRD+K +N+L D+ N K+ DFG ++ T + V GT +MSP
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSP 176
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
E + K+DV+S G V+E+++ K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
+LG G FG V+ G ++A+K +++ + E+F EA ++ KL H LV+L G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
Q+ +V E++ N L ++ R L + + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSD 701
DL A N L+ + K+SDFGM R + LD +++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 702 VFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEA 760
V+SFGVL+ E+ + GK ++ ++L+ RP +L ++Y
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY---RP-KLASMTVY-------- 231
Query: 761 IRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+V C + PE RP ++ ++
Sbjct: 232 ----EVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 522 KLGEGGFGPVY----KGML---------IEGQE--IAVKRL-SKSSGQGVEEFKNEALLI 565
KLGEG FG V+ +G+ +GQ +AVK L + + +F E ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD-TTRSKV--------LDWQNR 616
++L++ N+++LLG C D ++ EY+ N L+ F+ S + N
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676
++ IA G+ YL + L +HRDL N L+ N KI+DFGM+R
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
R V +M+ E + G F+ SDV++FGV + E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLS------KSSGQGVEEFKNEALLIAKLQHRNLV 574
LG+G +G VY G+ +GQ IAVK++ ++ + E+ + E L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFI--FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+ LG C + + E++P S+ + F V C I G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHN 120
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF---GLDQTEANTNRVV-GTYGYMSP 688
+ ++HRD+K +NV+L K+ DFG AR GL T +N + + GT +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
E + + KSD++S G V E+ +GK
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 9e-21
Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 21/217 (9%)
Query: 508 KTIV---DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL 563
+TIV D ++ K+G+G G VY + + GQE+A+K+++ E NE L
Sbjct: 9 RTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL 68
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
++ + +H N+V L DE +V EYL SL + +T + I +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAV 120
Query: 624 ARGLL----YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679
R L +LH + ++IHRD+K+ N+LL + + K++DFG +Q++ +T +
Sbjct: 121 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--M 175
Query: 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
VGT +M+PE + K D++S G++ +E+V G+
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 523 LGEGGFG--------PVYKGMLIEGQEIAVKRLSKSSGQGVEE-FKNEALLIAKLQHRNL 573
LGEG FG P G G+ +AVK L + GQ +K E ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 574 VKLLGCCTQRDERV--LVYEYLPNKSL-DYFI-FDTTRSKVLDWQNRCHIIGGIARGLLY 629
VK GCC+++ + L+ EY+P SL DY +++L + + I G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ-----TEANTNRVVGTYG 684
LH IHRDL A NVLLDN+ KI DFG+A+A E + V
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---- 175
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ + E + FS SDV+SFGV + E+++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLS-KSSGQGVEEFK-NEALLIAKLQHRNLVKLLG 578
K+GEG +G VYK + G+ +A+K++ ++ +GV E L+ +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 579 CCTQRDERVLVYEYLP---NKSLD---YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
++ LV+E+L K +D D K +Q + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQGIAYCH- 116
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
S R++HRDLK N+L+D E K++DFG+ARAFG+ T+ VV T Y +PE +
Sbjct: 117 -SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 172
Query: 693 DG-LFSVKSDVFSFGVLVLEIVSGK 716
+S D++S G + E+V+ +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 75/283 (26%), Positives = 139/283 (49%), Gaps = 38/283 (13%)
Query: 518 SEENKLGEGGFGPVYKGML-IEGQE---IAVKRLSKS-SGQGVEEFKNEALLIAKLQHRN 572
+++ +G G FG V++G+L + G++ +A+K L + + ++F +EA ++ + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+++L G T+ +++ EY+ N +LD ++ D ++ GIA G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL-- 123
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG--YMSPEY 690
S + +HRDL A N+L+++ + K+SDFG++R D E G + +PE
Sbjct: 124 -SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEA 181
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
F+ SDV+SFG+++ E++S G+R W + + + K
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPY---------------WDMSNHE-----VMK 221
Query: 750 SLYDSCSLSEAIRC----IQVGLLCVQQIPEDRPNMLSVVLML 788
++ D L + C Q+ L C QQ RP + +V +L
Sbjct: 222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 522 KLGEGGFGPVYKG----MLIEGQEIAVKRLSKSSGQG-VEEFKNEALLIAKLQHRNLVKL 576
KLG+G FG V +G + +AVK L +++F EA ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDW---QNRCHIIGGIARGLLYLHHD 633
G ++V E P SL D R L C IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL--DQTEANTNRVVGTYGYMSPEYA 691
R IHRDL A N+LL ++ KI DFG+ RA D + V + + +PE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 692 IDGLFSVKSDVFSFGVLVLEIVS 714
FS SDV+ FGV + E+ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 39/273 (14%)
Query: 521 NKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
NK+G G FG VY + L G+ +AVK R+ + + ++E +E ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 578 GCCTQRDERVLVYEYLPNKSLDYF-----IFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
G R++ + EY +L+ I D +V Q + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ--------LLEGLAYLHS 117
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT--NRVVGTYGYMSPEY 690
I+HRD+K +N+ LD+ K+ DFG A + T + GT YM+PE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 691 AIDGLFSVK---SDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
G +D++S G +VLE+ +GKR D+ ++ H + +P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL--DNEFQIMFH---VGAGHKP---- 225
Query: 748 DKSLYDSCSLS-EAIRCIQVGLLCVQQIPEDRP 779
+ DS LS E + C++ P+ RP
Sbjct: 226 --PIPDSLQLSPEGKDFLD---RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 77/268 (28%), Positives = 128/268 (47%), Gaps = 38/268 (14%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
E KLG G FG V+ + ++AVK + K VE F EA ++ LQH LVKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 580 CTQRDERVLVYEYLPNKSL-DYFIFDTTRS----KVLDWQNRCHIIGGIARGLLYLHHDS 634
T ++ ++ E++ SL D+ D K++D+ + IA G+ ++
Sbjct: 70 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIE--- 119
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
+ IHRDL+A+N+L+ + KI+DFG+AR ++ A + +PE G
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 178
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRN--RGFYHADHRHNLLGHAWQLWIQDR-PAELIDKSL 751
F++KSDV+SFG+L++EIV+ R G + + L +++ + P EL +
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYN--- 234
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
+ + C + PE+RP
Sbjct: 235 --------------IMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 24/213 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KSSGQGVEEFK-NEALLIAKLQHR 571
D + + K+GEG +G VYK + + IA+K++ + +GV E L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 572 NLVKLLGCCTQRDERVLVYEYLP---NKSLDY---FIFDTTRSKVLDWQNRCHIIGGIAR 625
N+V+L LV+EYL K +D F + K +Q I R
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------ILR 113
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGLDQTEANTNRVVGTYG 684
G+ Y H S R++HRDLK N+L+D N K++DFG+ARAFG+ T+ VV T
Sbjct: 114 GIAYCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLW 168
Query: 685 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
Y +PE + +S D++S G + E+V+ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 23/205 (11%)
Query: 523 LGEGGFGPVYKGMLI--EGQEI--AVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLVKLL 577
+G+G FG VY G LI +GQ+I AVK L++ + + VE+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 578 GCCTQRDERVLV-YEYLPNKSLDYFIFDTTRS-KVLDWQNRCHIIG---GIARGLLYLHH 632
G C + LV Y+ + L FI T + V D +IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD------LIGFGLQVAKGMEYL-- 114
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPE 689
+ + +HRDL A N +LD K++DFG+AR D+ + + G +M+ E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMALE 172
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVS 714
F+ KSDV+SFGVL+ E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 34/270 (12%)
Query: 517 FSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKN---EALLIAKLQHRN 572
FS+ ++G G FG VY + E+ A+K++S S Q E++++ E + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
++ GC + LV EY + D K L + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+ +IHRD+KA N+LL K+ DFG A A N VGT +M+PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 693 ---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
+G + K DV+S G+ +E+ +R ++ N + + + + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESP------ 232
Query: 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
S SE R C+Q+IP+DRP
Sbjct: 233 -ALQSGHWSEYFRNFVDS--CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
+LG G FG V G ++A+K + + S +EF EA ++ KL H LV+L G CT
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
++ +V EY+ N L ++ + + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLFSV 698
DL A N L+D++ K+SDFG++R + LD ++ VG+ + PE + FS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSS---VGSKFPVRWSPPEVLLYSKFSS 180
Query: 699 KSDVFSFGVLVLEIVS-GK 716
KSDV++FGVL+ E+ S GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 68/199 (34%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 523 LGEGGFGPVYKGMLIEGQE-----IAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG G FG VYKG+ I E +A+K L + +S + +E +EA ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 577 LGCCTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
LG C + LV + +P L DY + R D N C IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV---QIAKGMSYLEE--- 127
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL 695
+R++HRDL A NVL+ + + KI+DFG+AR +D+TE + + +M+ E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 696 FSVKSDVFSFGVLVLEIVS 714
F+ +SDV+S+GV V E+++
Sbjct: 188 FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 35/232 (15%)
Query: 503 PIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEG---QEIAVKRLSKSSGQG-VEEF 558
P+ +W I ++ +GEG FG V K + + + A+KR+ + + + +F
Sbjct: 2 PVLEWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 54
Query: 559 KNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSL-DY------------FIFD 604
E ++ KL H N++ LLG C R L EY P+ +L D+ F
Sbjct: 55 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+ + L Q H +ARG+ YL S+ + IHRDL A N+L+ KI+DFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 665 RAFGLDQTEANTNRVVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
R E + +G +M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 172 RG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 514 TDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRL-------SKSSGQGVEEFKNEALLI 565
NF E K+G+G F VYK + L++G+ +A+K++ +K+ ++E L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK-VLDWQNRCHIIGGIA 624
+L H N++K L + +E +V E L I + K ++ + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
L ++H S+ RI+HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEI 712
YMSPE + ++ KSD++S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 70/219 (31%), Positives = 112/219 (51%), Gaps = 34/219 (15%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEAL------LIAKLQ------- 569
LGEG FG V + E I R ++ V+ K+ A LI++++
Sbjct: 20 LGEGCFGQVVRA---EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI-----------FDTTRS--KVLDWQNR 616
H+N++ LLG CTQ ++ EY +L F+ FD T+ + L +++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GLDQTEAN 675
+ARG+ YL +SR R IHRDL A NVL+ + KI+DFG+AR +D +
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+N + +M+PE D +++ +SDV+SFG+L+ EI +
Sbjct: 194 SNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 40/258 (15%)
Query: 523 LGEGGFGPVYKGMLIEGQEI---AVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
LGEG FG V +G L + I AVK +++ + +E+F +EA+ + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 578 GCCTQRDER------VLVYEYLPNKSLDYFIFDT---TRSKVLDWQNRCHIIGGIARGLL 628
G C Q E V++ ++ + L F+ + + L Q + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT-YGYMS 687
YL S IHRDL A N +L+ MN ++DFG+++ + R+ +++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKWIA 182
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS-------GKRNRGFYH--------------ADH 726
E D +++ KSDV+SFGV + EI + G N Y D
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDG 242
Query: 727 RHNLLGHAWQLWIQDRPA 744
++L+ W L +DRP+
Sbjct: 243 LYSLMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 10/209 (4%)
Query: 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAK 567
++ D ++ K+G+G G VY + I GQE+A+K+++ E NE L++ +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
++ N+V L DE +V EYL SL D +D + + L
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
+LH + ++IHRD+K+ N+LL + + K++DFG +Q++ +T +VGT +M+
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
PE + K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 73/294 (24%), Positives = 116/294 (39%), Gaps = 32/294 (10%)
Query: 523 LGEGGFGPVYK-GMLIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+GGFG V + G+ A K+L K +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+D+ LV + L Y I++ I GL +LH + RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSV 698
++RDLK NVLLD+ N +ISD G+A + GT GYM+PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 699 KSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758
D F+ G + E+++G R + + + + + E DK S
Sbjct: 174 SVDWFALGCTLYEMIAG---RSPFR-QRKEKVEKEELKRRTLEMAVEYPDK-------FS 222
Query: 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQPGFFTERNLPESE 812
+ + LL + PE R S + ++ F + N E
Sbjct: 223 PEAKDLCEALLQ--KDPEKRLGCR--------GGSADEVREHPLFKDLNWRRLE 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQG-VEEFKNEALLIAKLQ 569
D + F++ ++G+G FG VYKG+ +E+ A+K + + +E+ + E ++++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
+ + G + + ++ EYL S D + L+ I+ I +GL Y
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDY 116
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH + R IHRD+KA+NVLL + + K++DFG+A L T+ N VGT +M+PE
Sbjct: 117 LHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPE 171
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ K+D++S G+ +E+ G+
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ 582
+G+G FG V G G ++AVK + + + F EA ++ +L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 583 RDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
+ +V EY+ SL ++ RS VL + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSD 701
DL A NVL+ + K+SDFG+ + Q + +PE + FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181
Query: 702 VFSFGVLVLEIVSGKR 717
V+SFG+L+ EI S R
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 65/208 (31%), Positives = 113/208 (54%), Gaps = 20/208 (9%)
Query: 517 FSEENKLGEGGFGPVYKGMLI-EGQEI----AVKRLSK-SSGQGVEEFKNEALLIAKLQH 570
F + LG G FG VYKG+ I EG+++ A+K L + +S + +E +EA ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSL-DYFIFDTTR---SKVLDWQNRCHIIGGIARG 626
++ +LLG C + L+ + +P L DY +L+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
+ YL R++HRDL A NVL+ + KI+DFG+A+ G D+ E + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ E + +++ +SDV+S+GV V E+++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 78/269 (28%), Positives = 120/269 (44%), Gaps = 27/269 (10%)
Query: 521 NKLGEGGFGPVYKGMLIEGQE-IAVKR--LSKSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
+G G VY + + E +A+KR L K V+E + E +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
DE LV YL SL + + LD ++ + +GL YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAF--GLDQTEANTNRVVGTYGYMSPEYAIDGL 695
IHRD+KA N+LL + + KI+DFG++ + G D+T VGT +M+PE
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 696 -FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL---IDKSL 751
+ K+D++SFG+ +E+ +G A + L +Q+ P L D
Sbjct: 183 GYDFKADIWSFGITAIELATG-------AAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
Y S S + I LC+Q+ P RP
Sbjct: 236 Y-SKSFRKMIS------LCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 523 LGEGGFGPVYK-GMLIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+GGFG V M G+ A K+L+K +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV-LDWQNRCHIIGGIARGLLYLHHDSRLR 637
+ + LV + L Y I++ C I GL +LH R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
II+RDLK NVLLDN+ N +ISD G+ A L ++ T GT G+M+PE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGL--AVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 698 VKSDVFSFGVLVLEIVSGK---RNRG 720
D F+ GV + E+++ + R RG
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCT 581
+G G +G VYKG ++ ++A ++ +G EE K E ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 582 QR------DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
++ D+ LV E+ S+ I T+ L + +I I RGL +LH
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI--- 692
++IHRD+K NVLL K+ DFG++ LD+T N +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 693 --DGLFSVKSDVFSFGVLVLEIVSG 715
D + KSD++S G+ +E+ G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 516 NFSEENKLGEGGFGPVYK-GMLIEGQEIAVKR--LSKSSGQGVEEFKNEALLIAKLQHRN 572
+F KLG+G +G VYK L + Q A+K L S + E+ NE ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 573 LVK-----LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRS-KVLDWQNRCHIIGGIARG 626
++ L G + +V EY P L I + K++ Q I + RG
Sbjct: 61 IISYKEAFLDGN-----KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L LH +I+HRDLK++N+LL KI D G+++ L + A T +GT YM
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QIGTPHYM 168
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+PE +S KSD++S G L+ E+ +
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 81/288 (28%), Positives = 136/288 (47%), Gaps = 52/288 (18%)
Query: 522 KLGEGGFGPVY----KGMLIEGQE--IAVKRLSKSSGQGVE-EFKNEALLIAKLQHRNLV 574
+LG+G FG VY KG++ + E +A+K +++++ EF NEA ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR-----------CHIIGGI 623
+LLG +Q +++ E + L ++ RS + +N + G I
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT- 682
A G+ YL+ + + +HRDL A N ++ + KI DFGM R D E + R G
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKG 181
Query: 683 ---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739
+MSPE DG+F+ SDV+SFGV++ EI + Y +L + +
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVLRFVMEGGL 239
Query: 740 QDRPAELIDKSLYDSCS--LSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785
D+P D+C L E +R +C Q P+ RP+ L ++
Sbjct: 240 LDKP---------DNCPDMLFELMR------MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQHR 571
+F +G+G FG V + +++ A+K ++K V NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARG 626
LV L + LV + L L Y + F + K I I
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIVLA 112
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L YLH IIHRD+K N+LLD + + I+DF +A + T GT GYM
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYM 166
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
+PE +SV D +S GV E + GKR
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQG-VEEFKNEALLIAKLQ 569
D + F++ K+G+G FG V+KG+ Q++ A+K + + +E+ + E ++++
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
+ K G + + ++ EYL S D LD I+ I +GL Y
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDY 116
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH + + IHRD+KA+NVLL K++DFG+A L T+ N VGT +M+PE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPE 171
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ K+D++S G+ +E+ G+
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 28/267 (10%)
Query: 523 LGEGGFGPVYK------GMLIEGQEIAVKRLSKSSGQGV-EEFKNEALLIAKLQHRNLVK 575
LG G F Y+ G L+ +++ R + S + V E + E L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
+LG + L E++ S+ + + K N + RGL YLH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE---QLLRGLSYLHEN-- 122
Query: 636 LRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGLDQTEAN--TNRVVGTYGYMSPEYAI 692
+IIHRD+K +N+L+D+ +I+DFG A T A +++GT +M+PE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752
+ DV+S G +++E+ + K ++A+ N L +++ + +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLALIFKIASATTAPSIPE---- 234
Query: 753 DSCSLSEAIRCIQVGLLCVQQIPEDRP 779
LS +R V L C++ PEDRP
Sbjct: 235 ---HLSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
+GEG FG V +G GQ++AVK + + F E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
+ V E + +L F+ R+ V Q +A G+ YL +++HR
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQ-LLQFSLDVAEGMEYLESK---KLVHR 124
Query: 642 DLKASNVLLDNEMNPKISDFGMARA--FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVK 699
DL A N+L+ + K+SDFG+AR G+D ++ + +PE FS K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSSK 177
Query: 700 SDVFSFGVLVLEIVSGKR 717
SDV+S+GVL+ E+ S R
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 525 EGGFGPVYKGMLIEG-----QEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLG 578
EG FG ++ G+LI+ +E+ VK + + + V E+ L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 579 CCTQRDERVLVYEYLPNKS-LDYF-----IFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
C + E V N L F + + + L Q H+ IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGLDQ--TEANTNRVVGTYGYMSPE 689
+ +IH+D+ A N ++D E+ KI+D ++R F +D N NR V +M+ E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMALE 189
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVS 714
++ +S SDV+SFGVL+ E+++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQG-VEEFKNEALLIAKLQ 569
D + F++ ++G+G FG V+KG+ Q++ A+K + + +E+ + E ++++
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
+ K G + + ++ EYL S D R+ D ++ I +GL Y
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDY 116
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH + + IHRD+KA+NVLL + + K++DFG+A L T+ N VGT +M+PE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPE 171
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ K+D++S G+ +E+ G+
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-19
Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 36/284 (12%)
Query: 441 KQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKTDDRQEL--YSNEKGSSKE 498
K+ RK IT L A V+ L A +++ + N EL NE G+
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL-------ELKRVENEDGT--- 669
Query: 499 EMELPIFDWK-----TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG 552
EL FD K TI D + EEN + G G YKG I+ G + VK ++ +
Sbjct: 670 -WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 553 QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD 612
E + + KLQH N+VKL+G C L++EY+ K+L + + L
Sbjct: 729 IPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LS 778
Query: 613 WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
W+ R I GIA+ L +LH ++ +L +++D + P + + D
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837
Query: 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
++ Y++PE + KSD++ FG++++E+++GK
Sbjct: 838 CFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 51/226 (22%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN-----------EAL 563
+ + KLGEG + VYK E G+ +A+K++ + E K E
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIK 54
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLP--------NKSLDYFIFDTTRSKVLDWQN 615
L+ +L+H N++ LL + LV+E++ +KS+ D K
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI---KSYMLM- 110
Query: 616 RCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675
RGL YLH I+HRDLK +N+L+ ++ K++DFG+AR+FG
Sbjct: 111 -------TLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKM 159
Query: 676 TNRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
T++VV T Y +PE LF + D++S G + E++
Sbjct: 160 THQVV-TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGM---LIEGQ---EIAVKRLSKSSGQGVEEFKNEALL---- 564
+N S LG G FG V + L + ++AVK L K + E EAL+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSER---EALMSELK 90
Query: 565 -IAKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG 622
++ L H N+V LLG CT +++ EY L F+ R L ++
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQ 149
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+A+G+ +L + IHRDL A NVLL + KI DFG+AR D
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE + +++ +SDV+S+G+L+ EI S
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 6e-19
Identities = 60/222 (27%), Positives = 112/222 (50%), Gaps = 10/222 (4%)
Query: 496 SKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQG 554
S EE+ + ++ D ++ K+G+G G VY M + GQE+A+++++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 555 VEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQ 614
E NE L++ + ++ N+V L DE +V EYL SL D +D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEG 116
Query: 615 NRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674
+ + L +LH + ++IHRD+K+ N+LL + + K++DFG +Q++
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172
Query: 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ +VGT +M+PE + K D++S G++ +E++ G+
Sbjct: 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 67/206 (32%), Positives = 113/206 (54%), Gaps = 13/206 (6%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKSSGQGVEEFK-NEALLIAKLQHR 571
NF + K+GEG +G VYK + G+ +A+K RL + +GV E L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
N+VKLL ++ LV+E+L ++ L F+ + S + + ++ + +GL + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCH 117
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
R++HRDLK N+L++ E K++DFG+ARAFG+ T+ VV T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 172
Query: 692 IDG-LFSVKSDVFSFGVLVLEIVSGK 716
+ +S D++S G + E+V+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 521 NKLGEGGFGPVYKGMLIEGQEIAV-KRLSKSSGQGVE--EFKNEALLIAKLQHRNLVKLL 577
+G+G FG V K +I V K + + E + +E ++ +L+H N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 578 GCCTQRDERVL--VYEYLPNKSLDYFIFDTTRSK--------------VLDWQNRCHIIG 621
R + L V EY L I + + +L CH
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH--- 122
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
++HRDLK +N+ LD N K+ DFG+A+ G D + A T VG
Sbjct: 123 -------NRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVG 172
Query: 682 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
T YMSPE + KSD++S G L+ E+ +
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 523 LGEGGFGPVY--------KGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+G G FG V+ K ++I ++I V++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+ + ++V EY P +L +I S +LD H I LL LHH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQI---LLALHHVH 118
Query: 635 RLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
I+HRDLK N+LLD ++M KI DFG+++ +++ VVGT Y+SPE
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEG 175
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKR 717
++ KSD+++ G ++ E+ S KR
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-18
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 34/270 (12%)
Query: 517 FSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKN---EALLIAKLQHRN 572
F++ ++G G FG VY + E+ A+K++S S Q E++++ E + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
++ GC + LV EY + D K L I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+ +IHRD+KA N+LL K++DFG A + N VGT +M+PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 693 ---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
+G + K DV+S G+ +E+ +R ++ N + + + + P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESPT----- 243
Query: 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
S S+ R C+Q+IP+DRP
Sbjct: 244 --LQSNEWSDYFRNFVDS--CLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
+++ ++G G +G VYK I E+ A+K + G E + E ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR----GLLY 629
V G +RD+ +V EY SL I+ TR + + Q I + R GL Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ-----IAYVCRETLKGLAY 116
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH IHRD+K +N+LL + + K++DFG++ L T A +GT +M+PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171
Query: 690 YA---IDGLFSVKSDVFSFGVLVLEIVSGK 716
A G + K D+++ G+ +E+ +
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 19/216 (8%)
Query: 508 KTIVDATD---NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL 563
+ +VD D K+GEG G V G+++AVK++ Q E NE +
Sbjct: 9 QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV 68
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
++ QH N+V++ DE +V E+L +L + T +++ + Q + +
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAT-VCLAV 124
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR---VV 680
+ L +LH +IHRD+K+ ++LL ++ K+SDFG Q R +V
Sbjct: 125 LKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLV 176
Query: 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
GT +M+PE + + D++S G++V+E+V G+
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 84/298 (28%), Positives = 142/298 (47%), Gaps = 55/298 (18%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGML-IEGQE---IAVKRLSKS-SGQGVEEFKNEALLI 565
+DA+ E +G G FG V G L + G+ +A+K L + + +F +EA ++
Sbjct: 1 IDAS-CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQ-NRCHIIG--- 621
+ H N++ L G T+ ++V EY+ N SLD F+ + D Q ++G
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLR 113
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
GIA G+ YL S + +HRDL A N+L+++ + K+SDFG++R D A T R
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--- 167
Query: 682 TYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHA 734
G + +PE F+ SDV+S+G+++ E++S G+R
Sbjct: 168 --GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--------------- 210
Query: 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRC----IQVGLLCVQQIPEDRPNMLSVVLML 788
W++ QD + K++ + L + C Q+ L C Q+ +RP +V +L
Sbjct: 211 WEMSNQD-----VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 34/219 (15%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEAL------LIAKLQ------- 569
LGEG FG V ++ E I + +K V+ K++A L+++++
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI-----------FDTTR--SKVLDWQNR 616
H+N++ LLG CTQ ++ EY +L ++ FDT + + L +++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGLDQTEAN 675
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR +D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
TN + +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 194 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 522 KLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVE-EFKNEALLIAKLQHRNLVKLLGC 579
++G G FG V+ G L + +AVK ++ ++ +F EA ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
CTQ+ +V E + + D+ F T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 640 HRDLKASNVLLDNEMNPKISDFGMAR--AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
HRDL A N L+ + KISDFGM+R G+ + ++ + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 698 VKSDVFSFGVLVLEIVS 714
+SDV+SFG+L+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 515 DNFSEENKLGEGGFGPVY----KGMLIEGQE-------------IAVKRLSKSSGQGVE- 556
+ + KLGEG FG V+ +GM + +AVK L + + +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 557 EFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI--------FDTTRS 608
+F E ++++L+ N+++LL C D ++ EY+ N L+ F+ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 609 KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668
+ + + IA G+ YL S L +HRDL N L+ KI+DFGM+R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
R V +MS E + G F+ SDV++FGV + EI++
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 34/218 (15%)
Query: 520 ENKLGEGGFGPVYKGMLI-EGQEI--AVKRLSK-SSGQGVEEFKNEALLIAKL-QHRNLV 574
E+ +GEG FG V + M+ +G ++ A+K L + +S +F E ++ KL H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDW----------------QNRCH 618
LLG C R + EY P +L F+ +S+VL+ Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678
+A G+ YL S + IHRDL A NVL+ + KI+DFG++R E +
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-----EEVYVKK 175
Query: 679 VVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+G +M+ E +++ KSDV+SFGVL+ EIVS
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 523 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKL 576
LG G FG V+KG+ I EG I A+K + SG Q +E + L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
LG C + LV + P SL + LD Q + IA+G+ YL
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
R++HR+L A N+LL ++ +I+DFG+A D + + +M+ E + G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 697 SVKSDVFSFGVLVLEIVS 714
+ +SDV+S+GV V E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 522 KLGEGGFGPVYKGMLIEGQE-----------------IAVKRL-SKSSGQGVEEFKNEAL 563
KLGEG FG V+ ++ Q+ +AVK L ++ +F E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF------DTTRSKVLDWQNRC 617
++++L+ N+++LLG C D ++ EY+ N L+ F+ C
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 618 ----------HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667
H+ IA G+ YL S L +HRDL N L+ + KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
R V +M+ E + G F+ SDV++FGV + EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFK-NEALLIAKLQHRNL 573
NF + KLGEG + VYKG EI A+K + + +G E L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V+L ++ +LV+EY+ +K L ++ LD + +G+ + H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT--NRVVGTYGYMSPEYA 691
R++HRDLK N+L++ K++DFG+ARAFG+ NT N VV T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI---PVNTFSNEVV-TLWYRAPDVL 172
Query: 692 IDG-LFSVKSDVFSFGVLVLEIVSGK 716
+ +S D++S G ++ E+++G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 63/211 (29%), Positives = 114/211 (54%), Gaps = 22/211 (10%)
Query: 520 ENKLGEGGFGPVYKGML-IEGQE---IAVKRL-SKSSGQGVEEFKNEALLIAKLQHRNLV 574
E +G G FG V +G L + G+ +A+K L S + + +F +EA ++ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQ-NRCHIIG---GIARGLLYL 630
L G T+ +++ E++ N +LD F+ + D Q ++G GIA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG---TYGYMS 687
S + +HRDL A N+L+++ + K+SDFG++R D ++ +G + +
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
PE F+ SDV+S+G+++ E++S G+R
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 82/289 (28%), Positives = 134/289 (46%), Gaps = 48/289 (16%)
Query: 522 KLGEGGFGPVYKGM---LIEGQ---EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLV 574
+LG+G FG VY+G +I+G+ +AVK +++S S + EF NEA ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR-----------CHIIGGI 623
+LLG ++ ++V E + + L ++ RS + +N + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT- 682
A G+ YL+ + +HRDL A N ++ ++ KI DFGM R D E + R G
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 181
Query: 683 ---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739
+M+PE DG+F+ SD++SFGV++ EI S Y +L
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFVMDGGY 239
Query: 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
D+P D+C R + +C Q P+ RP L +V +L
Sbjct: 240 LDQP---------DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 522 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKSSGQGV-EEFKNEALLIAKLQHRNLVKLL 577
+LG G FG V KG M + ++A+K L + + V +E EA ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
G C + + +LV E L+ F+ + + + N ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY--GYMSPEYAIDGL 695
+HRDL A NVLL N+ KISDFG+++A G D + R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174
Query: 696 FSVKSDVFSFGVLVLEIVS 714
FS +SDV+S+G+ + E S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 526 GGFGPVY---KGMLIEGQEIAVKRLSKSSGQG---VEEFKNEALLIAKLQHRNLVKLLGC 579
G +G V+ K G A+K + K+ V++ E ++++ Q +VKL
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 580 CTQRDERV-LVYEYLPN-------KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
Q + + LV EYLP +++ D R I I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYLH 110
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFG------MARAFGLDQTEANTNRVVGTYGY 685
IIHRDLK N+L+D+ + K++DFG + R L+ E R+VGT Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
++PE + S D +S G ++ E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 523 LGEGGFGPVY------KGMLIEGQEIAVKRLS-KSSGQGVEEFKNEALLIAKLQHRNLVK 575
LGEG FG V +G G+++AVK L +S G + + K E ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 576 LLGCCTQRDER--VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
G CT+ L+ E+LP+ SL ++ L Q + + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT--EANTNRVVGTYGYMSPEYA 691
SR + +HRDL A NVL+++E KI DFG+ +A D+ + + Y +PE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 692 IDGLFSVKSDVFSFGVLVLEIVS 714
I F + SDV+SFGV + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKN---EALLIAK 567
D + F +++G G FG VY E+ AVK++S S Q E++++ E + +
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
L+H N ++ GC + LV EY + D K L I G +GL
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGL 134
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
YLH + +IHRD+KA N+LL K++DFG A + N VGT +M+
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMA 185
Query: 688 PEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744
PE + +G + K DV+S G+ +E+ +R ++ N + + + D P
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNDSPT 239
Query: 745 ELIDKSLYDSCSLSEAIRCIQVGLL--CVQQIPEDRPNMLSVV 785
S +++ R G + C+Q+IP++RP ++
Sbjct: 240 -------LQSNEWTDSFR----GFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 34/270 (12%)
Query: 517 FSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN---EALLIAKLQHRN 572
F++ ++G G FG VY + + +A+K++S S Q E++++ E + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
++ GC + LV EY + D I + + K L I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE--Y 690
R IHRD+KA N+LL K++DFG A + N VGT +M+PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVIL 184
Query: 691 AID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
A+D G + K DV+S G+ +E+ +R ++ + L A Q+ L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA-----QNDSPTL--- 234
Query: 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
S S+ R C+Q+IP+DRP
Sbjct: 235 ---SSNDWSDYFR--NFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 513 ATDNFSE---ENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVE-EFKNEALLIAK 567
A + SE N++G G G VYK + G+ A+K + + V + E ++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
+ H N+VK E ++ E++ SL+ + + D Q + I G+
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGI 181
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
YLH R I+HRD+K SN+L+++ N KI+DFG++R L QT N VGT YMS
Sbjct: 182 AYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMS 236
Query: 688 PEY--------AIDGLFSVKSDVFSFGVLVLEIVSGK 716
PE A DG D++S GV +LE G+
Sbjct: 237 PERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+G FG VY ++ G+E+A K++ S + + V + E L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 577 LGCCTQRDERVLV--YEYLPNKSLD-----YFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
GC R E+ L EY+P S+ Y + ++ Q I G+ Y
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--------ILEGMSY 121
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GLDQTEANTNRVVGTYGYMSP 688
LH + I+HRD+K +N+L D+ N K+ DFG ++ + + V GT +MSP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724
E + K+DV+S G V+E+++ K Y A
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ 569
V+ D + +LG+G FG VYK E G A K + S + +E+F E ++++ +
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK 60
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H N+V L ++ ++ E+ +LD + + R L ++ + L +
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNF 118
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH ++IHRDLKA N+LL + + K++DFG++ A T + +GT +M+PE
Sbjct: 119 LH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKS-TLQKRDTFIGTPYWMAPE 173
Query: 690 YAI-----DGLFSVKSDVFSFGVLVLEI 712
D + K+D++S G+ ++E+
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKSSGQGVEEFKNEALLIA 566
D + LGEG FG V + E +AVK L + + K+ + L++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVS 69
Query: 567 KLQ-------HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI-----------FDTTR- 607
+++ H+N++ LLG CTQ ++ EY +L ++ +D R
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 608 -SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666
+ + +++ +ARG+ YL + + IHRDL A NVL+ KI+DFG+AR
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 667 F-GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+D + TN + +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 187 VNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 44/206 (21%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL----LIAK 567
++ KLGEG FG VYK I+ G+ +A+K++ + + + F AL ++ K
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD----YFIF---DTTRSKVLDWQN----R 616
L+H N+V L+ + E Y + D S +L+ +
Sbjct: 64 LKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE 114
Query: 617 CHIIG---GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF------ 667
I + G+ YLH I+HRD+KA+N+L+DN+ KI+DFG+AR +
Sbjct: 115 SQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 668 ----GLDQTEANTNRVVGTYGYMSPE 689
G T TN VV T Y PE
Sbjct: 172 PKGGGGGGTRKYTNLVV-TRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 522 KLGEGGFGPVYKGMLI--EGQEI--AVKRLSKSSGQGV-EEFKNEALLIAKLQHRNLVKL 576
+GEG FG VY+G+ + E ++I AVK + V E+F EA ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+G T+ + +V E P L ++ LD + ++ L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
R +HRD+ A NVL+ + K+ DFG++R D++ ++ +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRF 185
Query: 697 SVKSDVFSFGVLVLEIVS 714
+ SDV+ FGV + EI+
Sbjct: 186 TSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLI 565
D + D F +G G +G VYKG ++ ++A ++ + EE K E ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 566 AKL-QHRNLVKLLGCCTQR------DERVLVYEYLPNKSLDYFIFDTTRSKVL-DWQNRC 617
K HRN+ G ++ D+ LV E+ S+ + +T + + DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--A 124
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677
+I I RGL +LH ++IHRD+K NVLL K+ DFG++ LD+T N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN 179
Query: 678 RVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSG 715
+GT +M+PE D + +SD++S G+ +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 33/214 (15%)
Query: 517 FSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSG-QGVEEFK-NEALLIAKLQ---H 570
+ E ++GEG +G VYK L G+ +A+K++ +G+ E L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 571 RNLVKLLGCC-TQRDER----VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
N+V+LL C R +R LV+E++ ++ L ++ + + + ++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 626 GLLYLH-HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
G+ +LH H RI+HRDLK N+L+ ++ KI+DFG+AR + + A T+ VV T
Sbjct: 119 GVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLW 171
Query: 685 YMSPE------YAIDGLFSVKSDVFSFGVLVLEI 712
Y +PE YA V D++S G + E+
Sbjct: 172 YRAPEVLLQSSYA----TPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 39/282 (13%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRL-------SKSSGQGVEEFKNEALLIAK 567
NF E K+G G F VY+ L++G +A+K++ +K+ ++E L+ +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEID----LLKQ 58
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD-----WQNRCHIIGG 622
L H N++K + +E +V E L I + K L W+ +
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ H SR R++HRD+K +NV + K+ D G+ R F T A++ +VGT
Sbjct: 119 LE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742
YMSPE + ++ KSD++S G L+ E+ + FY G L+ +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFY---------GDKMNLYSLCK 218
Query: 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSV 784
E D S SE +R Q+ +C+ PE RP++ V
Sbjct: 219 KIEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKR--LSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
++GEG G V+K E G+ +A+K+ L + G + E + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCH-----IIGGIARGLL----Y 629
VLV EY+P + S+VL ++ + R LL Y
Sbjct: 67 VFPHGSGFVLVMEYMP----------SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
+H I+HRDLK +N+L+ + KI+DFG+AR F ++ +++ V T Y +PE
Sbjct: 115 MH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KSSGQGVEEFKNEALLIAKLQHR 571
NF E K+G G F VY+ L++ + +A+K++ + ++ E L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD-----WQNRCHIIGGIARG 626
N++K L + +E +V E L I + K L W+ + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
H SR R++HRD+K +NV + K+ D G+ R F T A++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
SPE + ++ KSD++S G L+ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 523 LGEGGFGPVYKGML-IEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG GGFG V + + + A+K + K E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 579 CCTQRDERVLVY---EYLPNKSLDYFIFDTTRSKVL--DWQNRCHIIGGIARGLLYLHHD 633
T +D++ +Y EY L + R + L ++ R I + YLH+
Sbjct: 60 -RTFKDKK-YIYMLMEYCLGGEL----WTILRDRGLFDEYTAR-FYIACVVLAFEYLHN- 111
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
II+RDLK N+LLD+ K+ DFG A+ Q T GT Y++PE ++
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
+ D +S G+L+ E+++G+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 61/197 (30%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
+LG+G FG VYK E G A K + S + +E++ E ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+ ++ E+ P ++D + + R + + Q + I + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-ICRQMLEALQYLH---SMKIIH 133
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-----DGL 695
RDLKA NVLL + + K++DFG++ A + +T + +GT +M+PE + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS-AKNV-KTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 696 FSVKSDVFSFGVLVLEI 712
+ K+D++S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 46/132 (34%), Positives = 72/132 (54%), Gaps = 13/132 (9%)
Query: 587 VLVYEYLPNKSLD--YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK 644
+ E++ SLD Y ++L I + GL YL++ RI+HRD+K
Sbjct: 79 CMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMHRDIK 131
Query: 645 ASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFS 704
SN+L+++ K+ DFG++ L + A+T VGT YMSPE G ++VKSDV+S
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGE--LINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 705 FGVLVLEIVSGK 716
G+ ++E+ GK
Sbjct: 188 LGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 33/222 (14%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQ------GVEEFKNEALLIAK 567
D F ++GEG +G VYK G+ +A+K++ + + + E K ++ +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 568 LQHRNLVKLLGCCTQRDERV----------LVYEYLPNKSLDYFIFDTTRSKVLDW--QN 615
L HRN+V L T + + + LV+EY+ D+ + S ++ + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDH 117
Query: 616 RCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675
+ + GL Y H + L HRD+K SN+LL+N+ K++DFG+AR + +++
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 676 TNRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVSGK 716
TN+V+ T Y PE + + + DV+S G ++ E+ + K
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 523 LGEGGFGPV------YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+GGFG V G + +++ KRL K SG+ + + E L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+ LV + L Y I++ + L+ + H I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
I++RD+K NVLLD++ N ++SD G+ A L + T R GT GYM+PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQR-AGTNGYMAPEILKEEPY 171
Query: 697 SVKSDVFSFGVLVLEIVSGK 716
S D F+ G + E+V+G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFK--NEALLIAKLQHRNLVKLLG 578
KLGEG + VYKG+ I GQ +A+K +S + +GV F EA L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
++ V+EY+ Y I L N + + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL-FS 697
+HRDLK N+L+ K++DFG+ARA + ++ ++ VV T Y P+ + +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 698 VKSDVFSFGVLVLEIVSGK 716
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFK--------NEALLIAKLQHR 571
+ +LG+G FG VY ++ + + +A +RL V E EA L++KL H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
+VK +RD ++ EY + LD + + + +N+ + + LL +H
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLLGVH 120
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
+ + RI+HRDLKA N+ L N + KI DFG++R A T GT YMSPE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177
Query: 692 IDGLFSVKSDVFSFGVLVLEI 712
+ KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 63/219 (28%), Positives = 110/219 (50%), Gaps = 34/219 (15%)
Query: 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEAL------LIAKLQ------- 569
LGEG FG V ++ E + ++ ++ + V+ K++A LI++++
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF-------------DTTRSKVLDWQNR 616
H+N++ LLG CTQ ++ EY +L ++ + L +++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GLDQTEAN 675
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR +D +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
TN + +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 200 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 521 NKLGEGGFGPVYKGM------LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+KLGEG + VYKG L+ +EI RL G + E L+ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
L LV+EYL +K L ++ D ++ N + + RGL Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
R +++HRDLK N+L++ K++DFG+ARA + T+ +N VV T Y P+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGS 179
Query: 695 L-FSVKSDVFSFGVLVLEIVSGK 716
+S + D++ G + E+ +G+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 523 LGEGGFGPVYKGMLIEG---QEIAVKRLSK-SSGQGVEEFKNEALLIAKL-QHRNLVKLL 577
+GEG FG V K + + + A+KR+ + +S +F E ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 578 GCCTQRDERVLVYEYLPNKSL-DY------------FIFDTTRSKVLDWQNRCHIIGGIA 624
G C R L EY P+ +L D+ F + + L Q H +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
RG+ YL S+ + IHRDL A N+L+ KI+DFG++R E + +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 174
Query: 685 --YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 522 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKSSGQGV--EEFKNEALLIAKLQHRNLVKL 576
+LG G FG V KG M + +AVK L + +E EA ++ +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+G C + + +LV E L+ F+ ++K + +N ++ ++ G+ YL +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL- 695
+HRDL A NVLL + KISDFG+++A G D+ N + + YA + +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171
Query: 696 ---FSVKSDVFSFGVLVLEIVS 714
FS KSDV+SFGVL+ E S
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 40/284 (14%)
Query: 523 LGEGGFGPVYK-------GMLIEGQEIAVKRLS-----KSSGQGVEEFKNEALLIAK-LQ 569
LG G FG VYK L+ +EI V + + + + + +E +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
H N+V+ + D +V + + L ++F + + + +I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
YLH + R I+HRDL +N++L + I+DFG+A+ Q E+ VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
E + + K+DV++FG ++ ++ + FY N+L A + I
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYST----NMLSLATK----------IV 226
Query: 749 KSLYDSCSLSEAIRCIQVGLL---CVQQIPEDRPNMLSVVLMLS 789
+++Y+ L E + V + C+ E RP+++ V M+S
Sbjct: 227 EAVYE--PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 517 FSEENKLGEGGFGPV------YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
F + LG+GGFG V G + +++ KR+ K G+ + NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
R +V L +D LV + L + I+ + + I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGLEDL 118
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H + RI++RDLK N+LLD+ + +ISD G+A QT VGT GYM+PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 172
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ ++ D ++ G L+ E+++G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 522 KLGEGGFGPVYKGMLIEGQEI-AVKRLS-KSSGQGVEEFK-NEALLIAKLQHRNLVKLLG 578
K+GEG +G V+K E EI A+KR+ +GV E L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+ LV+EY ++ L + FD+ + D + + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFS 697
+HRDLK N+L++ K++DFG+ARAFG+ + VV T Y P+ L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 698 VKSDVFSFGVLVLEIVSGKR 717
D++S G + E+ + R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 65/259 (25%), Positives = 118/259 (45%), Gaps = 42/259 (16%)
Query: 516 NFSEENKLGEGGFGPVY--KGMLIEGQEIAVKR--LSKSSGQGVEEFKNEALLIAKLQHR 571
+ K+GEG FG +Y K + + +K L+K + E K E +L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-----TRSKVLDWQNRCHIIGGIARG 626
N+V + +V EY L I + ++L W + I+ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
L ++H +I+HRD+K+ N+ L N M K+ DFG+AR L+ + VGT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYY 168
Query: 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN--------------RGFYH------AD 725
+SPE + ++ K+D++S G ++ E+ + K +G++ +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR 228
Query: 726 HRHNLLGHAWQLWIQDRPA 744
+L+ +++ +DRP+
Sbjct: 229 DLRSLISQLFKVSPRDRPS 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 521 NKLGEGGFGPVYKGM------LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
KLGEG + V+KG L+ +EI RL G + E L+ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
L LV+EYL +K L ++ D ++ N + I RGL Y H
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH--- 121
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-D 693
R +++HRDLK N+L++ K++DFG+ARA + T+ +N VV T Y P+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGS 179
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
+S + D++ G + E+ SG+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+G FG VY + G+E+AVK++ S + + V + E L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 577 LGCCTQRDERVL--VYEYLPNKSLDYFI--FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
GC ER L E++P S+ + + V R I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLHS 124
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GLDQTEANTNRVVGTYGYMSPEYA 691
+ I+HRD+K +N+L D+ N K+ DFG ++ + + V GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ K+D++S G V+E+++ K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL----LIAKLQHRNLVKL 576
+GEG +G V K G+ +A+K+ +S E+ K AL ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYF-------IFDTTRSKVLDWQNRCHIIGGIARGLLY 629
++ LV+EY+ L+ D RS WQ + + + Y
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIWQ--------LLQAIAY 115
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
H IIHRD+K N+L+ K+ DFG ARA T+ V T Y +PE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPE 171
Query: 690 YAI-DGLFSVKSDVFSFGVLVLEIVSG 715
+ D + DV++ G ++ E++ G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 40/220 (18%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRL---SKSSGQGVEEFKNEALLIAKLQHR 571
F + N++GEG +G VY+ G+ +A+K++ ++ G + + E L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 572 NLVKLLGCCT--QRDERVLVYEY--------LPNKSLDYFIFDTTRSKVLDWQNRCHIIG 621
N+V+L D LV EY L N F ++ K L Q
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQ------- 116
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ RGL YLH + IIHRDLK SN+LL ++ KI+DFG+AR +GL T +VV
Sbjct: 117 -LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV- 170
Query: 682 TYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
T Y +PE L + D+++ G ++ E+++ K
Sbjct: 171 TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRL-----SKSSGQGVEEFKNEALLIAKLQ 569
N+ LG G FG VY + G+E+AVK++ S+ + + V + E L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 570 HRNLVKLLGCCTQRDERVL--VYEYLPNKSLDYFI--FDTTRSKVLDWQNRCHIIGGIAR 625
H +V+ GC +E+ L EY+P S+ + + V R I +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-----QILQ 117
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGLDQTEANTNRVVGTYG 684
G+ YLH + I+HRD+K +N+L D+ N K+ DFG + R + + V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+MSPE + K+DV+S V+E+++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 67/203 (33%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLV 574
LG+G FG V +L E + AVK L K VE E ++A +H L
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 575 KLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+L C Q +R+ V EY+ L + I RS D I GL +LH
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
II+RDLK NVLLD+E + KI+DFGM + L T+ GT Y++PE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILSY 170
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++ GVL+ E+++G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 64/262 (24%), Positives = 119/262 (45%), Gaps = 41/262 (15%)
Query: 522 KLGEGGFGPVYKGMLIE--GQEIAVKRL---SKSSGQGVEEFKNEALL--IAKLQHRNLV 574
++GEG +G V+K ++ G+ +A+KR+ + G + + A+L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 575 KLLGCCT-QRDER----VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
+L CT R +R LV+E++ Y D + + ++ + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH R++HRDLK N+L+ + K++DFG+AR + + VV T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL--------WIQD 741
+ ++ D++S G + E+ R + + + LG + W +D
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236
Query: 742 ----------RPAELIDKSLYD 753
+ A+ I+K + D
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTD 258
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEA-LLIAKLQHRNLVKLL 577
LG+G FG V L E G+ AVK L K VE E +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 578 GCCTQRDERVL-VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
CC Q +R+ V E++ L +F +S+ D I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
II+RDLK NVLLD+E + K++DFGM + + +T GT Y++PE + L+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLY 173
Query: 697 SVKSDVFSFGVLVLEIVSG 715
D ++ GVL+ E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 30/218 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRL-SKSSGQGVEEFKNEALLIAKLQH- 570
++ + ++G G FG V K ML + G +AVKR+ S + + + ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC---HIIGGIA--- 624
+VK G + + + E L + SLD F V + I+G IA
Sbjct: 63 PYIVKFYGALFREGDCWICME-LMDISLDKFY-----KYVYEVLKSVIPEEILGKIAVAT 116
Query: 625 -RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-LDQTEANTNRVVGT 682
+ L YL + L+IIHRD+K SN+LLD N K+ DFG++ G L + A T R G
Sbjct: 117 VKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKT-RDAGC 170
Query: 683 YGYMSPE----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
YM+PE A DG + V+SDV+S G+ + E+ +GK
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 523 LGEGGFGPV------YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+GGFG V G + +++ KR+ K G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+D LV + L + I++ D Q + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RE 121
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR-VVGTYGYMSPEYAIDGL 695
RI++RDLK N+LLD+ + +ISD G+A + E T R VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 696 FSVKSDVFSFGVLVLEIVSGK 716
++ D + G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN---EAL 563
KT+ + D + + +G G +G V + G+++A+K+LS+ Q K E
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELR 66
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYE--YLPNKSLDYFIFDTTRSKVLDWQNRCHIIG 621
L+ + H N++ LL T + ++ YL + + + + + L + ++
Sbjct: 67 LLKHMDHENVIGLLDVFT-PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY 125
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
I RGL Y+H IIHRDLK SN+ ++ + KI DFG+AR T+ V
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVA 177
Query: 682 TYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
T Y +PE ++ + ++ D++S G ++ E+++GK
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL----LIAKLQHRNLVKL 576
+GEG +G V K E GQ +A+K+ +S + K A+ ++ +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
+ ++ LV+E++ + LD D +R + +Q I RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ--------ILRGIEFCH 117
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
+ IIHRD+K N+L+ K+ DFG AR E T+ V T Y +PE
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELL 172
Query: 692 I-DGLFSVKSDVFSFGVLVLEIVSG 715
+ D + D+++ G LV E+++G
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 69/229 (30%), Positives = 103/229 (44%), Gaps = 52/229 (22%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN 572
D+ +LG G +G V K M G +AVKR+ A + ++ Q R
Sbjct: 1 DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRI-------------RATVNSQEQKRL 46
Query: 573 LVKL-----LGCCTQ---------RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC- 617
L+ L C R+ V + + + SLD F KV D
Sbjct: 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFY-----KKVYDKGLTIP 101
Query: 618 -HIIGGIA----RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
I+G IA + L YLH S+L +IHRD+K SNVL++ K+ DFG++ L +
Sbjct: 102 EDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY--LVDS 157
Query: 673 EANTNRVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIVSGK 716
A T G YM+PE I+ + VKSDV+S G+ ++E+ +G+
Sbjct: 158 VAKTID-AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 30/216 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRL---SKSSG---QGVEEFKNEALLIAK 567
D + + N++ EG +G VY+ + EI A+K+L + G + E LL K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--K 60
Query: 568 LQHRNLVKL----LGCCTQRDERVLVYEYLPN--KSLDYFIFDTTRSKVLDWQNRCHIIG 621
LQH N+V + +G + D+ +V EY+ + KSL +T + L + +C ++
Sbjct: 61 LQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKC-LML 113
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ G+ +LH + I+HRDLK SN+LL+N KI DFG+AR +G + T VV
Sbjct: 114 QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV- 168
Query: 682 TYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGK 716
T Y +PE + +S D++S G + E+++ K
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 59/187 (31%), Positives = 92/187 (49%), Gaps = 29/187 (15%)
Query: 521 NKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKNEAL----LIAKLQHRNLVK 575
K+G+G FG V+K + ++I A+K++ E F AL ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLKHENVVN 75
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTR---SKVLDWQNRCHIIGGIAR------- 625
L+ C R Y K Y +F+ + +L +N + I +
Sbjct: 76 LIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN---TNRVVGT 682
GL Y+H R +I+HRD+KA+N+L+ + K++DFG+ARAF L + TNRVV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 683 YGYMSPE 689
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 523 LGEGGFGP--VYK----GMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+G FG +Y+ L+ +E+ + RLS+ + NE ++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+ ++ EY +L Y + ++ + + + I + Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
I+HRD+K N+ L K+ DFG+++ G + + A T VVGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756
+ KSD+++ G ++ E+++ KR + A N L ++ + S+Y S
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT---FDAT---NPLNLVVKIVQGNYTPV---VSVYSS-- 227
Query: 757 LSEAIRCIQVGLLCVQQIPEDRP 779
I + +QQ PE RP
Sbjct: 228 -----ELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
K+GEG G V G+++AVK + Q E NE +++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+E ++ E+L +L + T L+ + + + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKS 700
RD+K+ ++LL + K+SDFG D + + +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 701 DVFSFGVLVLEIVSGK 716
D++S G++V+E+V G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 515 DNFSEENKLGEGGFGPVYKGML-IEGQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHR 571
D++ + KLGEG + VYKG + G+ +A+K RL + G + EA L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
N+V L ++ LV+EY+ Y L +N + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
I+HRDLK N+L+ + K++DFG+ARA + + +N VV T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVL 175
Query: 692 IDGL-FSVKSDVFSFGVLVLEIVSG 715
+ +S D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIAV-KRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
+LG+G FG VYK E +A K + S + +E++ E ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+ ++ E+ ++D + + R + + Q R + L YLH + +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-----DGL 695
RDLKA N+L + + K++DFG++ +T + +GT +M+PE + D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 696 FSVKSDVFSFGVLVLEI 712
+ K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 39/209 (18%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS----SGQGVEEFKNEALLIAKLQHRNLVKLL 577
LG G FG V + A+K LSK+ Q VE NE ++ ++H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
G Q D + LV EY+P L + F ++ Q + L YLH
Sbjct: 68 GS-FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ--------VVLALEYLH 118
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
L I++RDLK N+LLD++ KI+DFG A+ + + T + GT Y++PE
Sbjct: 119 S---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE-- 168
Query: 692 IDGLFSVK-----SDVFSFGVLVLEIVSG 715
+ K D ++ G+L+ E+++G
Sbjct: 169 ---IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 48/286 (16%)
Query: 520 ENKLGEGGFGPVYKGML-IEGQE---IAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLV 574
E LG G FG + +G L + + +A+ L S + F EAL + + H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIF----DTTRSKVLDWQNRCHIIGGIARGLLYL 630
+L G T+ + ++V EY+ N +LD F+ +++ ++ G+A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL 123
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA--NTNRVVGTYGYMSP 688
S + +H+ L A VL+++++ KIS F + D++EA T + +P
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAP 177
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
E FS SDV+SFG+++ E++S G+R W + QD +
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPY---------------WDMSGQD-----V 217
Query: 748 DKSLYDSCSLSEAIRCI----QVGLLCVQQIPEDRPNMLSVVLMLS 789
K++ D L C Q+ L C Q+ +RP + +LS
Sbjct: 218 IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
K+GEG G V G+++AVK++ Q E NE +++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
DE +V E+L +L D ++ + + + R L YLH+ +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKS 700
RD+K+ ++LL ++ K+SDFG + + +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 701 DVFSFGVLVLEIVSGK 716
D++S G++V+E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 69/208 (33%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVE-EFKNEALLIAKLQHRNLV 574
LG+G FG V ML E + A+K L K VE +L +H L
Sbjct: 3 LGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 575 KLLGCCTQRDERVL-VYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLL 628
L C Q E + V EYL L + I FD R++ II G L
Sbjct: 60 HLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG----LQ 110
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
+LH II+RDLK NVLLD + + KI+DFGM + + +A+T GT Y++P
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAP 165
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
E ++ D +SFGVL+ E++ G+
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 561 EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII 620
EA+L+ + H +++++ +V LP+ S D + + T RS+ L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
I GL YLH RIIHRD+K N+ +++ I D G A+ +
Sbjct: 164 KQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLA 217
Query: 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
GT +PE ++ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 523 LGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+G FG V+ L Q A+K L K VE E +++ + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 579 CCTQRDERVL-VYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
C Q E + V EYL L + I FD R+ + C GL +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--------GLQFLHS 114
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
I++RDLK N+LLD + + KI+DFGM + L +A T GT Y++PE +
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILL 169
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
++ D +SFGVL+ E++ G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+G FG V + L Q++AVK L S +EEF EA + + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 577 LGCCTQRDER------VLVYEYLPNKSLDYFIFDTTRSK---VLDWQNRCHIIGGIARGL 627
+G + + +++ ++ + L F+ + + L Q + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GLDQTEANTNRVVGTYGY 685
YL S IHRDL A N +L+ M ++DFG+++ G + +++ +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKW 181
Query: 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
++ E D +++ SDV++FGV + EI++
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 517 FSEENKLGEGGFGPVYKGMLIE---GQEIAVKRL--SKSSGQGVEEFK-NEALLIAKLQH 570
+ E +G G +G VYK G+E A+K+ K G+ + E L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 571 RNLVKLLGCCTQRDERV--LVYEYLPNKSLDYFIFDTTRS----------KVLDWQNRCH 618
N+V L+ + ++ L+++Y L I ++ K L WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ---- 116
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFG--LDQT 672
I G+ YLH + ++HRDLK +N+L+ E KI D G+AR F L +
Sbjct: 117 ----ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL-KP 168
Query: 673 EANTNRVVGTYGYMSPE 689
A+ + VV T Y +PE
Sbjct: 169 LADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 19/221 (8%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYK-GMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIA 566
+++ D TD + +G+G +G VYK +G AVK L S EE + E ++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73
Query: 567 KL-QHRNLVKLLGCCTQRDERV-----LVYEYLPNKSLDYFIFDTTR-SKVLDWQNRCHI 619
L H N+VK G + D+ V LV E S+ + + LD +I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 620 IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679
+ G GL +LH++ RIIHRD+K +N+LL E K+ DFG++ L T N
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTS 188
Query: 680 VGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEIVSG 715
VGT +M+PE D + + DV+S G+ +E+ G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 515 DNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
DNF K+GEG G V + G+ +AVK++ Q E NE +++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V++ DE +V E+L +L D ++ + + + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
+IHRD+K+ ++LL ++ K+SDFG + + +VGT +M+PE
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
+ + D++S G++V+E+V G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 522 KLGEGGFGPVYKGMLI----EGQEIAVKRL--SKSSGQGVEEFKNEALLIAKLQHRNLVK 575
K+GEG FG K +L+ +G++ +K + SK S + EE + E +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRS------KVLDWQNRCHIIGGIARGLLY 629
+ +V +Y L Y + R ++LDW + L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDW---------FVQICLA 113
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
L H +I+HRD+K+ N+ L + K+ DFG+AR L+ T +GT Y+SPE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPE 171
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ ++ KSD+++ G ++ E+ + K
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 19/198 (9%)
Query: 526 GGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN----EALLIAKLQHRNLVKLLGCC 580
G FG VY G A+K L KS + N A+++ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+D LV EYL I L I + G+ LH IIH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIH 120
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVK- 699
RD+K N+L+D + K++DFG++R GL+ + VGT Y++PE I G+ K
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-GLEN-----KKFVGTPDYLAPE-TILGVGDDKM 173
Query: 700 SDVFSFGVLVLEIVSGKR 717
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 521 NKLGEGGFGPVYKGML-IEGQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
+KLGEG + V+KG + +A+K RL G + E L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 578 GCCTQRDERVLVYEYLPNKSLDYF-----IFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
LV+EYL + Y + K+ +Q + RGL Y H
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQ--------LLRGLSYCHK 121
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+I+HRDLK N+L++ + K++DFG+ARA + T+ +N VV T Y P+ +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLL 176
Query: 693 DGL-FSVKSDVFSFGVLVLEIVSGK 716
+S D++ G ++ E+ +G+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
+GEG FG + +L++ Q+ A+K RL KSS VE+ + EA+L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+V EY L I R K+ I+ + L + H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDT---ILQWFVQMCLGVQHIHEK 119
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
R++HRD+K+ N+ L K+ DFG AR A T VGT Y+ PE + +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177
Query: 697 SVKSDVFSFGVLVLEIVSGK 716
+ KSD++S G ++ E+ + K
Sbjct: 178 NNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 517 FSEENKLGEGGFGPV------YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
F + LG+GGFG V G + + + KR+ K G+ + NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
+ +V L +D LV + L + I++ + + I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDL 118
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H ++ ++RDLK N+LLD+ + +ISD G+ A + + E+ R VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGL--AVKIPEGESIRGR-VGTVGYMAPEV 172
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ +++ D + G L+ E++ G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 523 LGEGGFGPV------YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576
LG+GGFG V G + +++ KR+ K G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+D LV + L + I++ D + I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAAEITCGLEDLH---RE 121
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR-VVGTYGYMSPEYAIDGL 695
RI++RDLK N+LLD+ + +ISD G+A ++ E T R VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNER 177
Query: 696 FSVKSDVFSFGVLVLEIVSGK 716
++ D + G L+ E++ GK
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 45/214 (21%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
KLGEG + VYKG + GQ +A+K RL G + EA L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIA------------RG 626
+ LV+EYL DT + +D GG++ RG
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCG-----GGLSMHNVRLFLFQLLRG 115
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L Y H R++HRDLK N+L+ K++DFG+ARA + ++ +N VV T Y
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYR 170
Query: 687 SPEYAIDGL-----FSVKSDVFSFGVLVLEIVSG 715
P D L +S D++ G + E+ +G
Sbjct: 171 PP----DVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 509 TIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSK--SSGQGVEEFKNEALLI 565
T+ + T+ + + +G G FG V + GQ +A+K++ K S+ + E L+
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
L+H N++ L E + Y + L + S+ L+ Q + + I R
Sbjct: 64 KHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
GL Y+H ++HRDLK SN+L++ + KI DFG+AR Q T V Y Y
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-Y 171
Query: 686 MSPEYAID-GLFSVKSDVFSFGVLVLEIVSGK 716
+PE + + V+ D++S G + E++ GK
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 521 NKLGEGGFGPVYKGM-LIEGQEIAVKRL--------SKSSGQGVEEFK------NEALLI 565
LGEG +G V K + G+ +A+K++ Q V E ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVL--DWQNRCHIIGGI 623
+++H N++ L+ + D LV + + + K+ + Q +C I+ I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKC-ILLQI 128
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD------------- 670
GL LH +HRDL +N+ ++++ KI+DFG+AR +G
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 671 QTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGK 716
+ E T++VV T Y +PE + + D++S G + E+++GK
Sbjct: 186 RREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 522 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKN--EALLIAKLQ-HRNLVKLL 577
+LG+G FG VY E E+ A+K++ K EE N E + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
+ DE V+EY+ +L Y + + K II I +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV----VGTYGYMSPEYAI- 692
HRDLK N+L+ KI+DFG+AR E + V T Y +PE +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
+S D+++ G ++ E+ + +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
++F ++G G +G VYK + G+ A+K + G+ + E +++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V G +RD+ + E+ SL I+ T L ++ +GL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI- 692
+ +HRD+K +N+LL + + K++DFG++ + T A +GT +M+PE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 693 --DGLFSVKSDVFSFGVLVLEI 712
G ++ D+++ G+ +E+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEA---LLIAKLQHRN 572
LG G FG V +L E G+ A+K L K + VE E +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 573 LVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
LV L C Q ++ V V EY L I + V + GL YLH
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGLDQTEANTNRVVGTYGYMSPEY 690
+ +I++RDLK N+LLD E KI+DFG+ + G T+ GT +++PE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLAPEV 172
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSG 715
+ ++ D + GVL+ E++ G
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 67/214 (31%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 523 LGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+G FG V L +G+ AVK L K VE E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 579 CCTQ-RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
C Q ++ V E+L L + I D R D I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
II+RDLK NV+LD + + KI+DFGM + A+T GT Y++PE ++
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYT 174
Query: 698 VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731
D +SFGVL+ E++ G+ +H D L
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP---FHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 36/207 (17%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
++G G +G VYK + G+ AVK + G + E ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIA------------RGLL 628
R++ + EY SL Q+ H+ G ++ +GL
Sbjct: 76 LSREKLWICMEYCGGGSL---------------QDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
YLH ++ HRD+K +N+LL + + K++DFG+A + T A +GT +M+P
Sbjct: 121 YLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAP 175
Query: 689 EYAI---DGLFSVKSDVFSFGVLVLEI 712
E A +G ++ D+++ G+ +E+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 39/227 (17%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN---EAL 563
KTI + + + + +G G +G V + G +AVK+LS+ Q + K E
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELR 68
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF--IFDTTRSKVLDWQN--RCH- 618
L+ ++H N++ LL T P +SL+ F ++ T D N +C
Sbjct: 69 LLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 619 --------IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670
+I I RGL Y+H IIHRDLK SN+ ++ + KI DFG+AR
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 168
Query: 671 QTEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
T+ V T Y +PE ++ + ++ D++S G ++ E+++G+
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQG---VEEFKNEALL--IAKLQHRNLVK 575
++G G +G VYK G +A+K + + + + + ALL + H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 576 LLGCC----TQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
L+ C T R+ +V LV+E++ Y D L + ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H + I+HRDLK N+L+ + K++DFG+AR + + VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ ++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 522 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFK---NEALLIAKLQHRNLVKLL 577
++G+GG+G V+ + EI A+KR+ KS + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
Q DE + L EY+P D+ + + R ++ + LH L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
IHRDLK N L+D + K++DFG+++ T AN+ VVG+ YM+PE +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGKGY 175
Query: 697 SVKSDVFSFGVLVLEIVSG 715
D +S G ++ E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 67/229 (29%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN---------EALLIAKLQHRN 572
+G G +G V + G+++A+K++S F + E L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYF--------IFDTTRSKV------LDWQNRCH 618
++ LL + L S + F + +T KV L + +
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN--T 676
+ I RGL YLH +IHRDLK SN+L+++ + KI DFG+AR D+ E T
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 677 NRVVGTYGYMSPE---------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
VV T Y +PE AI D++S G + E+++ K
Sbjct: 165 EYVV-TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 24/200 (12%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVE-EFKNEALLIAKLQHRNLVKLLGCC 580
LG G G VYK L+ + +AVK + ++ + +E ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 581 TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIA----RGLLYLHHDSRL 636
+ + E++ SLD + + H++G IA +GL YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLW---SL 114
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
+I+HRD+K SN+L++ K+ DFG++ L + A T VGT YM+PE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQ--LVNSIAKT--YVGTNAYMAPERISGEQY 170
Query: 697 SVKSDVFSFGVLVLEIVSGK 716
+ SDV+S G+ +E+ G+
Sbjct: 171 GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 523 LGEGGFGPVYKGMLIE--GQE--IAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVK 575
LG+G FG V ML E G + A+K L K VE E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 576 LLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII---GGIARGLLYLH 631
L C Q +R+ V EY+ L Y I + K H + IA GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK------EPHAVFYAAEIAIGLFFLH 118
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NV+LD E + KI+DFGM + T GT Y++PE
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEII 173
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++FGVL+ E+++G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 54/224 (24%)
Query: 521 NKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKN---------EALLIAKL-Q 569
KLG+G +G V+K + +E+ A+K++ + F+N E + + +L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD--------TTRSKVLDWQNRCHIIG 621
H N+VKLL V + +K + Y +F+ R+ +L+ ++ +I+
Sbjct: 66 HPNIVKLLN----------VIKAENDKDI-YLVFEYMETDLHAVIRANILEDVHKRYIMY 114
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV-- 679
+ + L Y+H S +IHRDLK SN+LL+++ K++DFG+AR+ + E N V
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLT 170
Query: 680 --VGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
V T Y +PE L D++S G ++ E++ GK
Sbjct: 171 DYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQ-----GVEEFKNEALLI 565
D + + +GEG +G V G ++A+K++S Q + E K ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 566 AKLQHRNLVKLLGCCTQRD-----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII 620
+ +H N++ +L + +V E + ++ +++ L + + +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFL 112
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV- 679
I RGL Y+H + ++HRDLK SN+LL+ + KI DFG+AR D +T +
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167
Query: 680 --VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
V T Y +PE ++ K+ D++S G ++ E++S +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKNEAL----LIAKLQHRNLVKLL 577
+GEG +G V K E +EI A+K+ S EE K L ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
+R + LV+EY+ L+ + + + V + R +I I + + + H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND--- 120
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
I+HRD+K N+L+ + K+ DFG AR + + AN V T Y SPE + +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 698 VKSDVFSFGVLVLEIVSGK 716
D++S G ++ E+ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ARG+ +L SR + IHRDL A N+LL KI DFG+AR D
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D +++ +SDV+SFGVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVK 575
LG+G FG V ML E + A+K L K VE E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 576 LLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
L C Q +R+ V EY+ L Y I + K I+ GL +LH
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFFLH--- 118
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
R II+RDLK NV+LD+E + KI+DFGM + +D T GT Y++PE
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYIAPEIIAYQ 176
Query: 695 LFSVKSDVFSFGVLVLEIVSGK 716
+ D +++GVL+ E+++G+
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+G FG V L E+ A+K L K V+ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 579 CCTQRDERVL-VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG-IARGLLYLHHDSRL 636
CC Q +R+ V EY+ L +F RS+ D + R + L++LH R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLH---RH 115
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
+I+RDLK N+LLD E + K++DFGM + G+ T GT Y++PE + +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELEY 173
Query: 697 SVKSDVFSFGVLVLEIVSGK 716
D ++ GVL+ E+++G+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL----LIAKLQHRNLVKL 576
K+GEG +G V+K E GQ +A+K+ +S V K AL ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+ ++ + LV+EY + L+ + + II + + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCH---KH 119
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-DGL 695
IHRD+K N+L+ + K+ DFG AR L + V T Y +PE + D
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 696 FSVKSDVFSFGVLVLEIVSG 715
+ DV++ G + E+++G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 51/219 (23%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
+G G G VYK + G +AVK++ ++ + EE K R L+ L
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-----------RILMDLDVVLK 69
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC--------------HIIGGIA--- 624
D +V K YFI D+ ++ + C I+G +
Sbjct: 70 SHDCPYIV------KCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAI 123
Query: 625 -RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-LDQTEANTNRVVGT 682
+ L YL + +IHRD+K SN+LLD N K+ DFG++ G L ++A T R G
Sbjct: 124 VKALHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKT-RSAGC 177
Query: 683 YGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGK 716
YM+PE ID + +++DV+S G+ ++E+ +G+
Sbjct: 178 AAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKR-LSKSSGQGV--EEFKNEALLIAKLQH 570
D + + K+GEG +G VYK G+ +A+K+ + +G+ + +LL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 571 RNLVKLLGCCTQRDERV------LVYEYLPNKSLDYFIFDTTR--SKVLDWQNRCHIIGG 622
+V+LL +E+ LV+EYL + L F+ R + L + +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGLDQTEANTNRVVG 681
+ +G+ + H + ++HRDLK N+L+D + KI+D G+ RAF + ++ T+ +V
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV- 173
Query: 682 TYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSG 715
T Y +PE + +S D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN--EALL 564
KT+ + + + +G G +G V Q++AVK+LS+ + + E L
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF--IFDTTRSKVLDWQN--RCH-- 618
+ ++H N++ LL T P S++ F ++ T D N +C
Sbjct: 68 LKHMKHENVIGLLDVFT------------PATSIENFNEVYLVTNLMGADLNNIVKCQKL 115
Query: 619 -------IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
+I + RGL Y+H IIHRDLK SNV ++ + +I DFG+AR Q
Sbjct: 116 SDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----Q 167
Query: 672 TEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
+ V T Y +PE ++ + ++ D++S G ++ E++ GK
Sbjct: 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 35/94 (37%), Positives = 59/94 (62%), Gaps = 6/94 (6%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ RGL YL + +I+HRD+K SN+L+++ K+ DFG++ L + AN+ VGT
Sbjct: 108 VLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMANS--FVGT 161
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
YMSPE ++V+SD++S G+ ++E+ G+
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVK 575
LG+G FG V +L+ G+ A+K L K + V E+ ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG-IARGLLYLHHDS 634
L +D V EY+ L F +R +V ++R G I L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG- 114
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
+I++RDLK N++LD + + KI+DFG+ + D T GT Y++PE D
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDN 170
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ D + GV++ E++ G+ FY+ DH
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 523 LGEGGFGPVYKGMLI----EGQEIAVKRLSKSSGQGVEEF--KNEALLIAKLQHRNLVKL 576
LG+G FG V+ I GQ A+K L K++ + + K E ++A++ H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK--VLDWQNRCHIIGGIARGLLYLHHDS 634
+ L+ ++L + D F T SK + ++ + +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFL--RGGDLF---TRLSKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
L II+RDLK N+LLD E + K++DFG+++ +D E GT YM+PE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRR 173
Query: 695 LFSVKSDVFSFGVLVLEIVSG 715
+ +D +SFGVL+ E+++G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 67/205 (32%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVK 575
LG+G FG V ML E + A+K L K VE E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 576 LLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII---GGIARGLLYLH 631
L C Q +R+ V EY+ L Y I R K H + IA GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK------EPHAVFYAAEIAIGLFFLH 118
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NV+LD+E + KI+DFGM + D T GT Y++PE
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEII 173
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++FGVL+ E+++G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 523 LGEGGFGPVYKGMLIE---------GQEIAVKR-LSKSSGQGVEEFKNEALLIAKLQHRN 572
LG+G F +YKG+L GQE++V + S + F A L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
LVKL G C RDE ++V EY+ LD F+ + L W + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 633 DSRLRIIHRDLKASNVLL----DNEMNP---KISDFGMARAFGLDQTEANTNRVVGTYGY 685
+++H ++ N+L+ NE K+SD G+ + E R+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----PW 170
Query: 686 MSPEYAIDGLFSVKS--DVFSFGVLVLEIVSG 715
++PE +G S+ D +SFG +LEI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 42/214 (19%)
Query: 523 LGEGGFGPVYKGMLI----EGQEIAVKRLS--KSSGQGVEEFKNEALLIAKLQHRNLVK- 575
+G+G +G V L+ +G++ +K+L+ +S + + + EA L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 576 -------------LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG 622
++G C D +Y L + ++V++W +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWFVQ------ 110
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
IA L YLH I+HRDLK NV L K+ D G+AR A+T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
YMSPE + ++ KSDV++ G V E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVK 575
LG+G FG V +L+ G+ A+K L K + V E+ ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG-IARGLLYLHHDS 634
L D V EY L F +R +V + R G I L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 115
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
+++RD+K N++LD + + KI+DFG+ + D A GT Y++PE D
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDN 170
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ D + GV++ E++ G+ FY+ DH
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 38/201 (18%)
Query: 539 GQEIAVKRLSKSSGQGVEE---FKNEALLIAKLQHRNLVKLLGCCTQRDERVL-VYEYLP 594
G E+A+K L + + + F+ E L A+L H N+V LL + V+EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 595 NKSLDYFI--------FDTTR--SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK 644
++L + +T R +VLD H +G I+HRDLK
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAH-----NQG-----------IVHRDLK 106
Query: 645 ASNVLL---DNEMNPKISDFGMARAF-----GLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
N+++ + K+ DFG+ T T V+GT Y +PE
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 697 SVKSDVFSFGVLVLEIVSGKR 717
+ SD++++G++ LE ++G+R
Sbjct: 167 TPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
D+ +G G FG V+ I A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 571 RNLVKLLGCCTQRDERVL--VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
+++L T+ D+R L + EY+P L F + + + + I L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYA-SEIVCALE 115
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
YLH I++RDLK N+LLD E + K++DFG A+ D+T + GT Y++P
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEYLAP 167
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
E + D ++ G+L+ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 37/216 (17%)
Query: 517 FSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVK 575
+ + +G G G V + G +AVK+LS+ F+N+ AK +R LV
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV- 72
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYF--------IFDTTRSKV----LDWQNRCHIIGGI 623
LL C ++ L+ + P KSL+ F + D +V LD + +++ +
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
G+ +LH IIHRDLK SN+++ ++ KI DFG+AR A TN ++ Y
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------ACTNFMMTPY 182
Query: 684 ----GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
Y +PE + + D++S G ++ E+V G
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 53/232 (22%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS----SGQGVEEFKNEALLIAKLQHRNLVKLL 577
+G G FG V+ + ++ A+K L KS Q + + E ++A +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKLY 67
Query: 578 GCCTQRDERVL--VYEYLPNKSL-----DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
+ +DE L V EY+P L +F ++ IA +L L
Sbjct: 68 --YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IAELVLAL 114
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG---------------------- 668
+L IHRD+K N+L+D + + K++DFG+ +
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 669 -----LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
Q N VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 504 IFDWKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEA 562
IFD + D +D + +G+G +G V+K + G + AVK L E
Sbjct: 9 IFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN 66
Query: 563 LLIAKLQHRNLVKLLGCCTQRDERV-----LVYEYLPNKSL-DYFIFDTTRSKVLDWQNR 616
+L A H N+VK G ++D + LV E S+ D R + ++
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676
+I+ GL +LH + + IHRD+K +N+LL E K+ DFG++ L T
Sbjct: 127 AYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRR 181
Query: 677 NRVVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEIVSG 715
N VGT +M+PE +D + + DV+S G+ +E+ G
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 46/132 (34%), Positives = 67/132 (50%), Gaps = 21/132 (15%)
Query: 604 DTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663
DT S LD + +A+G+ +L + IHRD+ A NVLL + KI DFG+
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 664 ARAFGLDQTEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
AR ++N VV +M+PE D +++V+SDV+S+G+L+ EI S GK
Sbjct: 259 AR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
Query: 718 -------NRGFY 722
N FY
Sbjct: 314 PYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ARG+ +L SR + IHRDL A N+LL KI DFG+AR D
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D +++ +SDV+SFGVL+ EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 521 NKLGEGGFGPVYK------GMLIEGQEIAVKRLSKSSGQGVEEFK-NEALLIAKLQHR-- 571
++LG+G +G VYK G+ + +EI RL ++E K N+ ++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 572 --NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
+V G + EY+ SLD ++ + I + +GL +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
L + IIHRD+K +NVL++ K+ DFG++ L + A TN +G YM+PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPE 171
Query: 690 Y------AIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ ++V+SDV+S G+ +LE+ G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--SSGQGVEEFKNEALL 564
KTI + D + + ++G G +G V + G ++A+K+L + S + E L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF--------IFDTTRSKVLDWQNR 616
+ ++H N++ LL T P+ SLD F T K++ +
Sbjct: 68 LKHMKHENVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 617 C-----HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
++ + +GL Y+H IIHRDLK N+ ++ + KI DFG+AR Q
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 167
Query: 672 TEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
T++ V T Y +PE ++ + ++ D++S G ++ E+++GK
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQE----IAVKRLSKSS----GQGVEEFKNEALLIAK 567
NF LG G +G V+ + G + A+K L K++ + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 568 LQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
++ + L Q D ++ L+ +Y+ L F + R + + + + + G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L +LH +L II+RD+K N+LLD+ + ++DFG+++ F D+ E GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 687 SPEYAI--DGLFSVKSDVFSFGVLVLEIVSG 715
+P+ DG D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
I RGL YLH I+HRD+K N+L+++ KI DFG+AR D+++ T VV
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 683 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
Y Y +PE + ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+A+G+ +L SR + IHRDL A N+LL KI DFG+AR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D +++++SDV+SFGVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-10
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 34/206 (16%)
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
LL +HH +IHRD+K++N+LL + K+ DFG ++ + ++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746
+PE +S K+D+FS GVL+ E+++ KR F + E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP--FDGENME-----------------EV 253
Query: 747 IDKSL---YDSC--SLSEAIRCIQVGLLCVQQIPEDRP------NMLSVVLMLSGERSLP 795
+ K+L YD S+S ++ I LL P+ RP NM L +SG +
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIV 311
Query: 796 QPKQPGFFTE-RNLPESESSSSKQNL 820
Q QPGF R+ + +KQ L
Sbjct: 312 Q-TQPGFSGPLRDTISRQIQQTKQLL 336
|
Length = 496 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 34/95 (35%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ RGL YL + +I+HRD+K SN+L+++ K+ DFG++ ++ N VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 164
Query: 682 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
T YMSPE +SV+SD++S G+ ++E+ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 67/241 (27%), Positives = 108/241 (44%), Gaps = 42/241 (17%)
Query: 523 LGEGGFGPVYKGMLIE----GQ----EIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
LG+G F ++KG+ E G+ E+ +K L KS E F A ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY-LHHD 633
G C DE ++V EY+ SLD ++ + W+ +A+ L + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE------VAKQLAWALHFL 116
Query: 634 SRLRIIHRDLKASNVLLDNEM-----NP---KISDFGMARAFGLDQTEANTNRVVGTYGY 685
+ H ++ A NVLL E NP K+SD G++ + E R+ +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEILLERI----PW 170
Query: 686 MSPEYAIDGL-FSVKSDVFSFGVLVLEIVSG----------KRNRGFYHADHRHNLLGHA 734
+ PE + S+ +D +SFG + EI SG ++ FY + RH L
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQLPAPK 228
Query: 735 W 735
W
Sbjct: 229 W 229
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
IA +L L H +L II+RD+K N+LLD+E + ++DFG+++ F L + E GT
Sbjct: 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGT 169
Query: 683 YGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVSG 715
YM+PE G D +S GVL E+++G
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
D + +G G +G V + G+++A+K++ + + +AK
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTL 52
Query: 571 RNLVKLLGCCTQR----DERVLVYEYL-PNKSLD---YFIFDTTRSKV---------LDW 613
R L K+L R D + + + L P + Y + D S + L
Sbjct: 53 REL-KIL-----RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTE 106
Query: 614 QNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673
++ + + + RGL Y+H + +IHRDLK SN+L++ + +I DFGMAR TE
Sbjct: 107 EHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 674 ANT--NRVVGTYGYMSPEYAIDGLFSV-----KSDVFSFGVLVLEIVSGKR 717
V T Y +PE L S+ D++S G + E++ G+R
Sbjct: 164 HKYFMTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 36/197 (18%)
Query: 536 LIEGQEIAVKRLSKSSGQGVEEFKN---EALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592
+ GQ +A+K+LS+ Q V K E +L+ + H+N++ LL T
Sbjct: 38 TVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT----------- 85
Query: 593 LPNKSLDYF--------IFDTTRSKV----LDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
P KSL+ F + D +V LD + +++ + G+ +LH IIH
Sbjct: 86 -PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIH 141
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL-FSVK 699
RDLK SN+++ ++ KI DFG+AR G T VV Y Y +PE I G+ +
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE-VILGMGYKEN 197
Query: 700 SDVFSFGVLVLEIVSGK 716
D++S G ++ E++ G
Sbjct: 198 VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 18/206 (8%)
Query: 521 NKLGEGGFGPVYKG---MLIEGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKL 576
+++G G FG V G + + VK L S+ F E +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC--HIIGGIARGLLYLHHDS 634
LG C + +LV E+ P L ++ Q + +A GLL+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGLDQTEANTNRVVGTYGYMSPEYAI- 692
+ IH DL N L +++ KI D+G+A + D V +++PE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 693 --DGLFSVK----SDVFSFGVLVLEI 712
L S+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 515 DNFSEENKLGEGGFGPVYK------GMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL 568
D+F + ++LG G G V+K G+++ + I ++ Q + E + ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC--HIIGGIA-- 624
+V G E + E++ SLD +VL R I+G ++
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLD---------QVLKKAGRIPEQILGKVSIA 111
Query: 625 --RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+GL YL + +I+HRD+K SN+L+++ K+ DFG++ ++ N VGT
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 165
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
YMSPE +SV+SD++S G+ ++E+ G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 55/189 (29%), Positives = 94/189 (49%), Gaps = 28/189 (14%)
Query: 540 QEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD 599
+ +A+K+LS+ F+N+ AK +R LV L+ C ++ L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 600 YF--------IFDTTRSKV----LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647
F + D +V LD + +++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 707
+++ ++ KI DFG+AR G + T VV Y Y +PE + + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 708 LVLEIVSGK 716
++ E++ G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQGVEEFKN---EALLIAKLQHRNLVK 575
LG+G FG V +L++ G+ A+K L K +E + E ++ +H L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG-IARGLLYLHHDS 634
L D V EY L F +R +V ++R G I L YLH S
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--S 113
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
+++RDLK N++LD + + KI+DFG+ + D T GT Y++PE D
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDN 171
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ D + GV++ E++ G+ FY+ DH
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ARG+ +L + +HRDL A NVLL KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D L++ SDV+S+G+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN--EALLIAKLQ-HRNLVKL 576
K+GEG F V K + G+ A+K + K + +E+ N E + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 577 LGCCTQRDERVL----------VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
+ R L +YE + + R K +Q + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRK---RPLPEKRVKSYMYQ--------LLKS 112
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L ++H + I HRD+K N+L+ ++ K++DFG R G+ T + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYR 165
Query: 687 SPEYAI-DGLFSVKSDVFSFGVLVLEIVS 714
+PE + DG + K D+++ G + EI+S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 523 LGEGGFGPV---YKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+G G G V Y +L + +A+K+LS+ F+N+ AK +R LV L+ C
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 580 CTQRDERVLVYEYLPNKSLDYF--------IFDTTRSKV----LDWQNRCHIIGGIARGL 627
++ L+ + P KSL+ F + D +V LD + +++ + G+
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
+LH IIHRDLK SN+++ ++ KI DFG+AR G + T VV Y Y +
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 186
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
PE + + D++S G ++ E+V K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 47/147 (31%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H LV L C V EY+ L +F R + L ++ I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH II+RDLK NVLLD+E + K++D+GM + GL + T+ GT Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++ GVL+ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLG 578
+G GGFG VY + G+ A+K L K QG NE ++++ L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS-LVSTGDCPFIV 60
Query: 579 CCT----QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
C T D+ + + + L Y + ++ V + I GL ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
+++RDLK +N+LLD + +ISD G+A F + A+ VGT+GYM+PE G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 695 L-FSVKSDVFSFGVLVLEIVSG 715
+ +D FS G ++ +++ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQE----IAVKRLSKSS----GQGVEEFKNEALLIAK 567
NF LG G +G V+ + G + A+K L K++ + VE + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 568 LQHRNLVKLLGCCTQRDERV-LVYEYLPNKSL-------DYFIFDTTRSKVLDWQNRCHI 619
++ + L Q + ++ L+ +Y+ + D F D R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR-----------F 109
Query: 620 IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679
G +L L H +L I++RD+K N+LLD+E + ++DFG+++ F L + + T
Sbjct: 110 YSG--EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSF 166
Query: 680 VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSG 715
GT YM+PE K+ D +S G+L+ E+++G
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
+L L H +++RDLK +N+LLD + +ISD G+A F + A+ VGT+GYM
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 162
Query: 687 SPEYAIDGL-FSVKSDVFSFGVLVLEIVSG 715
+PE G+ + +D FS G ++ +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 67/261 (25%), Positives = 119/261 (45%), Gaps = 50/261 (19%)
Query: 480 GKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEG 539
K D +E S+ + ++E E + D ++ N +G G FG VY+ + I+
Sbjct: 32 DKKLDEEE-RSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT 90
Query: 540 QE-IAVKRLSKSSGQGVEEFKNEALLIAK-LQHRNLVKLLGC----CTQRDERVL----V 589
E +A+K++ + ++KN LLI K L H N++ L C +++E+ + V
Sbjct: 91 SEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 590 YEYLP-------------NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
E++P N +L F+ K+ +Q + R L Y+H S+
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ--------LCRALAYIH--SKF 190
Query: 637 RIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL 695
I HRDLK N+L+D N K+ DFG A+ Q + + + Y +PE +
Sbjct: 191 -ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGAT 246
Query: 696 -FSVKSDVFSFGVLVLEIVSG 715
++ D++S G ++ E++ G
Sbjct: 247 NYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 26/81 (32%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 350 KHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSR-NCSCTAYANSDVRGGGSGCLLW 408
K D F++L K+P + L EC C NCSC ++ ++ G GCLLW
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 409 -FHDLIDIKVLPEIGQDIYVR 428
L D ++ P G D+Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSK--SSGQGVEEFKNEALL 564
KT+ + + ++ ++G G +G V + G+++A+K+LS+ S + E L
Sbjct: 8 KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67
Query: 565 IAKLQHRNLVKLLGCCTQR---DERVLVYEYLPNKSLDY-----FIFDTTRSKVLDWQNR 616
+ +QH N++ LL T DE Y +P D + + L +Q
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML 127
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676
C GL Y+H IIHRDLK N+ ++ + KI DFG+AR +A
Sbjct: 128 C--------GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEM 171
Query: 677 NRVVGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
V T Y +PE ++ + ++ D++S G ++ E+++GK
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 9/149 (6%)
Query: 522 KLGEGGFGPVYKGMLIEG---QEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLL 577
++G G FG V G + G ++ VK L S+ Q +F EA LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVL--DWQNRCHIIGGIARGLLYLHHDSR 635
G CT+ +LV E+ P L ++ +++++ D + IA GLL+LH ++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMA 664
IH DL N LL ++ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 42/220 (19%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL----- 576
LG G G V+ + + + +AVK++ + Q V+ E +I +L H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 577 ---------LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC---HI---IG 621
+G T+ + +V EY+ +T + VL+ Q H +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM----------ETDLANVLE-QGPLSEEHARLFMY 121
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGLDQTEANTNRV- 679
+ RGL Y+H + ++HRDLK +NV ++ E + KI DFG+AR +D ++ +
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLS 176
Query: 680 --VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
+ T Y SP + K+ D+++ G + E+++GK
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 523 LGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQGVEEFKN---EALLIAKLQHRNLVK 575
LG+G FG V +L+ G+ A+K L K +E + E+ ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG-IARGLLYLHHDS 634
L D V EY L F +R +V ++R G I L YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALGYLH--- 112
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV-VGTYGYMSPEYAID 693
+++RDLK N++LD + + KI+DFG+ + ++ T + GT Y++PE D
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEYLAPEVLED 169
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ D + GV++ E++ G+ FY+ DH
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 523 LGEGGFGPVYKGMLIEGQE----IAVKRLSKS----SGQGVEEFKNEALLIAKLQHRNLV 574
LG+GG+G V++ + G + A+K L K+ + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 575 KLLGCCTQRDERVLVYEYLPNKSL-------DYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
L+ + L+ EYL L F+ DT C + I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA----------CFYLSEISLAL 113
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
+LH II+RDLK N+LLD + + K++DFG+ + + T +T GT YM+
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMA 168
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
PE + D +S G L+ ++++G
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 47/143 (32%), Positives = 75/143 (52%), Gaps = 13/143 (9%)
Query: 577 LGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
L C Q + R+ V E++ L +F R + L ++ I+ L +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY--AID 693
II+RDLK NVLLD E + K++D+GM + G+ + T+ GT Y++PE D
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAPEILRGED 172
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
FSV D ++ GVL+ E+++G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-09
Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)
Query: 794 LPQPKQPGFFTERNLPESESSSSKQ--NLSSTNEISFSMLEAR 834
+PQPKQPGF R+ E++SSSS Q + N+++ S+++AR
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQ--EIAVKRLSKSS---GQGVEEFKNEALLIAKLQ 569
++F+ LG G FG V +A+KR KS + V+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H V L G LV E++ ++F F R+K C I Y
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTF-LRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
L L I++RDLK N+LLD + K++DFG A+ + T + GT Y++PE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSG 715
++ +D ++ G+ + EI+ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 9e-09
Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 23/181 (12%)
Query: 544 VKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE---YLPNKSLDY 600
+ + K+ + + +NE L + +L H N++K+ E +L E Y+ + D+
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247
Query: 601 FIFDTTRSKVLDWQNRC------HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM 654
++ + DW++R I+ + + Y+H ++IHRD+K N+ L+ +
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 655 NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEIV 713
+ DFG A F + EA VGT SPE A DG + +D++S G+++L+++
Sbjct: 305 KIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
Query: 714 S 714
S
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
IA +L L H + I++RDLK N+LLD + + DFG+++A D TN GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGT 159
Query: 683 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSG 715
Y++PE +D ++ D +S GVLV E+ G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
LV L C LV EY+ L +F R + L ++ I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
II+RDLK NVLLD + + K++D+GM + GL + T+ GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++ GVL+ E+++G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
+G+G FG V + + Q I A+K + K+ S V E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 579 CCTQRDERVLVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
++ LV ++ L + + FD +R++ A L L +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY-----------TAELLCALENL 109
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN-TNRVVGTYGYMSPEYAI 692
+ +I+RDLK N+LLD + + + DFG+ + L+ + + TN GT Y++PE +
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 693 DGLFSVKSDVFSFGVLVLEIVSG 715
++ D ++ GVL+ E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE---GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL 568
+F ++ +G G FG V ++ E G A+K + KS + + V F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLP--------NKSLDYFIFDTTRSKVLDWQNRCHII 620
+ +L +D LV EY P N+ D F D +
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY----------- 107
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
+A +L +H ++ +HRD+K NVL+D + K++DFG A ++ N+ V
Sbjct: 108 --LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPV 164
Query: 681 GTYGYMSPEY--AIDG----LFSVKSDVFSFGVLVLEIVSGK 716
GT Y++PE ++G + V+ D +S GV+ E++ G+
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+A+G+ +L + IHRDL A N+LL + KI DFG+AR D +N VV
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND-----SNYVVKG 274
Query: 683 YG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE + +++ +SDV+S+G+L+ EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 38/213 (17%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN---------EALLIAKLQHRN 572
+G G +G V E +++A+K+++ + F N E L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 573 LVKLLGCC--TQRDERVLVYEYLPNKSLDYFIFDT------TRSKVLDWQNRCHIIGGIA 624
++ + R+ VY + Y + DT S+ L + + + +
Sbjct: 66 VIAIKDIMPPPHREAFNDVY-------IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
RGL Y+H + ++HRDLK SN+LL+ + KI DFG+AR ++ + T VV T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRW 173
Query: 685 YMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGK 716
Y +PE ++ ++ DV+S G + E++ K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 561 EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII 620
EA ++ + H ++++L G T L+ LP D + + + + C I+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI----AICDIL 185
Query: 621 G---GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677
+ R + YLH + RIIHRD+KA N+ +++ + + DFG A F +D
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYY 241
Query: 678 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
GT +PE + D++S G+++ E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFK-NEALLIAKLQHRNLVKLL 577
E K+G G +G VYK +G++ L + G G+ E L+ +L+H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 578 GC-CTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY-----L 630
+ D +V L+++Y + + I R+ + + + G+ + LLY +
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDL--WHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGI 121
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGLD-QTEANTNRVVGTYG 684
H+ ++HRDLK +N+L+ E P KI+D G AR F + A+ + VV T+
Sbjct: 122 HYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 685 YMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
Y +PE + K+ D+++ G + E+++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN----EALLIAKLQHRNLVKLL 577
+G+G FG V +G+ AVK L K + +E K+ +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
D+ V +Y+ L + + F R++ + IA L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE--------IASALGYLH- 113
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
L II+RDLK N+LLD++ + ++DFG+ + G+ + T+ GT Y++PE
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPEVLR 169
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
+ D + G ++ E++ G FY D
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 516 NFSEENKLGEGGFGPV----YKGMLIEGQEIAVKRLSKSS---GQGVEEFKNEALLIAKL 568
+F LG G FG V +KG G+ A+K L K + V+ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 569 QHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVL---DWQNRCHIIGGIA 624
H +V ++ C Q + RV + E++ L F R D H +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH--AELV 128
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
YLH II+RDLK N+LLDN+ + K++DFG A+ + T + GT
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
Y++PE D ++ GVL+ E ++G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+A G+ +L + +HRDL A NVL+ KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE + L++ SDV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 17/150 (11%)
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK-VLDWQNRCHIIGGIARGLL 628
+ N +KL T VL+ +Y+ + L FD + + L II + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 629 YLH-HDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGLDQTEANTNRVVGTYGYM 686
LH H IIH D+K NVL D + + D+G+ + G GT Y
Sbjct: 124 DLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYF 173
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
SPE + V D ++ GVL E+++GK
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFK-NEALLIAKLQHRNLVKLL 577
E K+G G +G VYK +G++ L + G G+ E L+ +L+H N++ L
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 578 GC-CTQRDERV-LVYEYLPNKSLDYFIFD-----TTRSKVLDWQNRCHIIGGIARGLLYL 630
+ D +V L+++Y + F + L ++ I G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGLD-QTEANTNRVVGTYG 684
H + ++HRDLK +N+L+ E P KI+D G AR F + A+ + VV T+
Sbjct: 125 HAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 685 YMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
Y +PE + K+ D+++ G + E+++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 523 LGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKN----EALLIAKLQHRNLVKLL 577
+G+G FG V ++G+ AVK L K +E K+ +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
++ V +++ L F R + IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLH---SIN 116
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
I++RDLK N+LLD++ + ++DFG+ + G+ Q++ T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPYD 174
Query: 698 VKSDVFSFGVLVLEIVSG 715
D + G ++ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-07
Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKS-SGQGV--EEFKNEALLIAKLQHRNLVKLL 577
+G+GG G VY + + +A+K++ + S + + F EA + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD--WQNRC---------------HII 620
C+ D VY +P +I T +L WQ I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE------- 673
I + Y+H S+ ++HRDLK N+LL I D+G A L++ +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 674 ---------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
++VGT YM+PE + S +D+++ GV++ ++++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GLDQTEANTNRVV 680
I GL Y+H + ++HRDLK N+L++ + KI DFG+AR F + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 681 GTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
T Y +PE + K+ DV+S G ++ E++ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 7/157 (4%)
Query: 561 EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII 620
E ++ + HR ++ L+ + +V +P D F + RS L + I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGPLPLEQAITIQ 191
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
+ L YLH IIHRD+K N+ LD N + DFG A
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
GT SPE + K+D++S G+++ E+
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGLDQTEANTNRVVGTY 683
R L Y+H + + HRDLK N+L + + KI DFG+AR AF T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 684 GYMSPEYAIDGLFSVKS----DVFSFGVLVLEIVSGK 716
Y +PE G F K D++S G + E+++GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
IA +L +H +L +HRD+K NVLLD + +++DFG D T ++ VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166
Query: 683 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIVSGK 716
Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+G G FG V Q++ A+K LSK + F E I + V L C
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 580 CTQRDERV-LVYEYLPNKSLDYFI--FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
Q D+ + +V EY+P L + +D W A +L L +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSM 161
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT-EANTNRVVGTYGYMSPEY----A 691
+IHRD+K N+LLD + K++DFG +D+T + VGT Y+SPE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSG 715
DG + + D +S GV + E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 66/243 (27%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKSS----GQGVEEFKNEALLIAKLQHRNLVKLL 577
+G G FG V + I A+K+L KS Q V + E ++A+ + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67
Query: 578 GCCTQRDER--VLVYEYLPNKSL-------DYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
+ +DE L+ EYLP + D F + TR IA +L
Sbjct: 68 --YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETIL 112
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------LDQTEANTNR 678
+ +L IHRD+K N+LLD + + K+SDFG+ L +
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 679 --------------------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 712
VGT Y++PE + ++ + D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 713 VSG 715
+ G
Sbjct: 233 LVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 523 LGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKN----EALLIAKLQHRNLVKLL 577
+G+G FG V +G AVK L K + +E + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
++ V +Y+ L F R + +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLH---SLN 116
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
II+RDLK N+LLD++ + ++DFG+ + G++ E T+ GT Y++PE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 698 VKSDVFSFGVLVLEIVSG 715
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 31/207 (14%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEEFKN----EALLIAKLQHRNLVKLL 577
+G+G FG V ++ AVK L K + +E K+ +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHI-------IGGIARGLLYL 630
D+ V +Y+ L Y + + RC + IA L YL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL----------QRERCFLEPRARFYAAEIASALGYL 112
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN--TNRVVGTYGYMSP 688
H L I++RDLK N+LLD++ + ++DFG+ + + E N T+ GT Y++P
Sbjct: 113 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAP 165
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSG 715
E + D + G ++ E++ G
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 522 KLGEGGFGPVYKGMLIEGQEIA---VKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLL 577
++G G FG V + +A VK L ++ + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTT----RSKVLDWQNR-CHIIGGIARGLLYLHH 632
G C + +LV+EY L ++ S++L Q C I A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTHMH- 116
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGLDQTEANTNRVVGTYGYMSPEYA 691
+ +H DL N L +++ K+ D+G+ + + D E ++ V +++PE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELV 173
Query: 692 I---DGLFSVK----SDVFSFGVLVLEI 712
GL + + S+V++ GV + E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+A +L + +L +HRD+K NVLLD + +++DFG D T +N VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166
Query: 683 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIVSGK 716
Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 49/181 (27%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSSGQGVEEFKNEALL----- 564
D+F KLGEG FG VYK L+ + +K+ + G VE + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 565 -IAKLQHRNLVKLLGCCTQRDERVLVYEY---------LPNKSLDY----FIFDTTRS-- 608
A + L + + DE LV+ Y + +K Y ++ +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 609 KVLDWQNRCHIIGGIARGLLY----LHHDSRLRIIHRDLKASNVLLDNEMNP-KISDFGM 663
K L+ +N+ II I R +L+ LH I+HRD+K N++ KI D G
Sbjct: 248 KGLERENK--IIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 664 A 664
A
Sbjct: 303 A 303
|
Length = 566 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSSGQGVEE---FKNEALLIAKLQH 570
++F +G G FG V +++ A+K LSK + F E ++A
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 571 RNLVKLLGCCTQRDERVL--VYEYLPNKSL-----DYFIFDTTRSKVLDWQNRCHIIGGI 623
+V+L +D++ L V EY+P L +Y I + W
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWA-----RFYT 148
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD-QTEANTNRVVGT 682
A +L L + IHRD+K N+LLD + K++DFG + +T VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGT 206
Query: 683 YGYMSPEY----AIDGLFSVKSDVFSFGVLVLEIVSG 715
Y+SPE DG + + D +S GV + E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 41/126 (32%), Positives = 60/126 (47%), Gaps = 30/126 (23%)
Query: 618 HIIGGIARGLL----YLHH----DSRLRIIHRDLKASNVLLD-------------NEMN- 655
H I I R LL Y H+ + R++HRDLK N+ L N +N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 656 ---PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSV--KSDVFSFGVLVL 710
KI DFG+++ G+ E+ + VGT Y SPE + S KSD+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 711 EIVSGK 716
E+ SGK
Sbjct: 235 ELCSGK 240
|
Length = 1021 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-05
Identities = 20/84 (23%), Positives = 32/84 (38%), Gaps = 13/84 (15%)
Query: 349 CKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRN---CSCTAYANSDVRGGGSGC 405
CK L +K+ T+ D EC C +N SC A+ + R C
Sbjct: 5 CKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKARK---QC 55
Query: 406 LLW-FHDLIDIKVLPEIGQDIYVR 428
L + F+ + ++ G D+Y
Sbjct: 56 LWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY----AIDG 694
IHRD+K N+LLD + K++DFG + + VGT Y+SPE DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 695 LFSVKSDVFSFGVLVLEIVSG 715
+ + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 30/147 (20%), Positives = 54/147 (36%), Gaps = 15/147 (10%)
Query: 518 SEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV--K 575
S L G VY + + +K S + + + E ++ L + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
+L L+ E++ ++LD + + + I +A L LH
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFG 662
L + H DL N+L+D+ I D+
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 49/153 (32%), Positives = 69/153 (45%), Gaps = 28/153 (18%)
Query: 526 GGFGPVYKGML-IEGQEIAVKRLSKS---SGQGVEEFKNE--ALLIAKLQHRNLVKLLGC 579
G FG VY G + AVK + K+ + V + + E AL ++K +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF--IVHLYYS 72
Query: 580 CTQRDERVLVYEYLPN---KSL----DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+ LV EYL KSL YF + I +A L YLH
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK----------YISEVALALDYLH- 121
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665
R IIHRDLK N+L+ NE + K++DFG+++
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 24/81 (29%), Positives = 47/81 (58%)
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
+++HRDLK++N+ L K+ DFG ++ + + + GT Y++PE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 697 SVKSDVFSFGVLVLEIVSGKR 717
S K+D++S GV++ E+++ R
Sbjct: 249 SKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 48/172 (27%), Positives = 71/172 (41%), Gaps = 40/172 (23%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
++F +G+G FG V L++ G+ A+K L KS E FK + L K +
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 571 RNL--------VKLLGCCTQRDERVLVYEYLPNKSL-------DYFIFDTTRSKVLDWQN 615
L V L L+ E+LP L D F D TR
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY------ 106
Query: 616 RCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667
+A +L + +L IHRD+K N+L+D + K+SDFG++ F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY--AI 692
+L +HRD+K N+L+D + +++DFG D T ++ VGT Y+SPE A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178
Query: 693 D---GLFSVKSDVFSFGVLVLEIVSGK 716
+ G + + D +S GV + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 42/186 (22%), Positives = 78/186 (41%), Gaps = 19/186 (10%)
Query: 542 IAVKR--LSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD 599
+AVK+ L S + ++ + E + +LQH N++ + E +V + S +
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 600 YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659
+ T + L I+ + L Y+H IHR +KAS++LL + +S
Sbjct: 88 DLL-KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLS 143
Query: 660 DFGMARAFGLDQTEANTNRVVGTYG--------YMSPEYAIDGL--FSVKSDVFSFGVLV 709
+ + RVV + ++SPE L ++ KSD++S G+
Sbjct: 144 GLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 710 LEIVSG 715
E+ +G
Sbjct: 201 CELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAK 567
++F +G G FG V L++ G A+K L K+ + V + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF--DTTRSKVLDWQNRCHIIGGIAR 625
+VK+ + L+ E+LP + + DT + + IA
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--------IAE 109
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----------------RAFGL 669
+L + +L IHRD+K N+LLD++ + K+SDFG+ +
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 670 DQTEANTN-----------------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 712
D T N N VGT Y++PE + ++ D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 713 VSG 715
+ G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAK 567
D+F +G G FG V L++ G A+K L K+ + V + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF--DTTRSKVLDWQNRCHIIGGIAR 625
+VK+ + L+ E+LP + + DT + + IA
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY--------IAE 109
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GLDQTE----------- 673
+L + +L IHRD+K N+LLD + + K+SDFG+ +TE
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 674 ------ANTNR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 712
N+ R VGT Y++PE + ++ D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 713 VSG 715
+ G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 523 LGEGGFGPVYKGMLI-----------EGQEIAV--KRLSKSSGQGVEEFKNEALLIAKLQ 569
LG G +Y G+L +EI V K L S F A ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H+++V L G C + E ++V E++ LD F+ +S VL + + +A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSDVLTTPWKFKVAKQLASALSY 120
Query: 630 LHHDSRLRIIHRDLKASNVLL-----DNEMNP--KISDFGMARAFGLDQTEANTNRVVGT 682
L D L +H ++ N+LL D E P K+SD G+ T + V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSRQECVER 171
Query: 683 YGYMSPEYAIDG-LFSVKSDVFSFGVLVLEI 712
+++PE D S+ +D +SFG + EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 22/160 (13%)
Query: 560 NEALLIAKLQHRNLVKLLGCCTQRDERV---LVYEYLPNKSLDYFIFDTTRSKVLDWQNR 616
+EA L+ +L H ++ LL D RV L LP D + + R + L
Sbjct: 209 HEARLLRRLSHPAVLALL------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQ- 261
Query: 617 CHIIGGIARGLL----YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGLDQ 671
+ +AR LL Y+H + IIHRD+K NVL++ + + DFG A A G
Sbjct: 262 ---VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315
Query: 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 711
T + + GT +PE ++ D++S G+++ E
Sbjct: 316 TPFHYG-IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 60/240 (25%), Positives = 93/240 (38%), Gaps = 65/240 (27%)
Query: 522 KLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQGVEEFKN---EALLIAKLQHRNLV 574
LG+G G V+ L+ G+ A+K L K + K E ++A L H L
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 575 KLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR-------- 625
L Q + + LV +Y P L + + K L + +AR
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEE--------VARFYAAEVLL 114
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF---------GMARAFGL------- 669
L YLH L I++RDLK N+LL + +SDF + L
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 670 -----------DQTEANTNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSG 715
++ +N VGT Y++PE I G +V D ++ G+L+ E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 24/114 (21%), Positives = 45/114 (39%), Gaps = 29/114 (25%)
Query: 559 KNEALLIAKLQHRNLVKLLGCCT------QRDERVLVYEYLPNKSLDYFIFDTTRSKVLD 612
+ EA L+ + + G T +E+ +V EY+ K L +
Sbjct: 384 RAEARLL------SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEGNP------ 431
Query: 613 WQNRCHIIG-GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665
+G +A+ LH + I+H DL SN ++ ++ + DFG+ +
Sbjct: 432 --ELVRKVGEIVAK----LH---KAGIVHGDLTTSNFIVRDD-RLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 26/113 (23%)
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA---N 675
I+ G RGL YLH + IHR++KAS++L IS G+ GL + N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 676 TNRVVGTYGY----------MSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGK 716
+ Y + +SPE L ++VKSD++S G+ E+ +G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL--------------DQT 672
L YLH+ I+HRDLK N+L+ + + K++DFG+++ GL D
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTTNLYEGHIEKDTR 169
Query: 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
E +V GT Y++PE + + D ++ G+++ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 517 FSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQHRN 572
F + LG G FG V ++ + A+K L K + V K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+VKL +D V +Y+P + + R +V I + + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVH- 118
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667
++ IHRD+K N+L+D + + K++DFG+ F
Sbjct: 119 --KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 37/181 (20%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 545 KRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG----CCTQRDERVLVYEYLPNKSLDY 600
K+ K ++ +NE + ++ N++K+ G L+ EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 601 FIFDTTRSKVLDWQNRCHIIGGIARGLLYLH-HDSRLRIIHRDLKASNVLLDNEMNPKIS 659
+ + K L ++ + + +GL L+ + ++ +++L + + L+ KI
Sbjct: 112 VL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165
Query: 660 DFGMARAFGLDQTEANTN-RVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIVSG 715
GL++ ++ + V Y S + D +FS +K D++S GV++ EI +G
Sbjct: 166 ------CHGLEKILSSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTG 218
Query: 716 K 716
K
Sbjct: 219 K 219
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.38 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.61 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.3 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.94 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.92 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.65 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.57 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.57 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.51 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.46 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.39 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.2 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.69 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.6 | |
| PLN02236 | 344 | choline kinase | 96.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.42 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.72 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.52 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.5 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.03 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.03 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=465.71 Aligned_cols=289 Identities=43% Similarity=0.718 Sum_probs=256.5
Q ss_pred CcCccCHHHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEE
Q 003272 501 ELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580 (834)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 580 (834)
....|+++++..||++|...+.||+|+||.||+|.+.+|..||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999998765443156799999999999999999999999
Q ss_pred EeCC-eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 581 TQRD-ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 581 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 89999999999999999999999998899999999999999999999999
Q ss_pred eeccccccCCCccccccccc-cccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRV-VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||+|+........ .... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+.........+..|++..+
T Consensus 220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431111 1112 89999999999999999999999999999999999999887655455556888888889
Q ss_pred hccCcccccCcccc-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 739 IQDRPAELIDKSLY-DSCSL-SEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 739 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+...+++|+.+. ...+. .++.++.+++.+|++.+|++||+|.||+++|+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 88999999999987 55554 68889999999999999999999999999996654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=391.98 Aligned_cols=253 Identities=33% Similarity=0.510 Sum_probs=207.5
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-eeEEEEeecCC
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-ERVLVYEYLPN 595 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~~~ 595 (834)
..+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3446999999999999995544499999976432 22669999999999999999999999999988 79999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccCCCcccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 674 (834)
|+|..+++.. ....+++..+++++.|||+||.|||+..+ ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999765 45679999999999999999999999874 99999999999999997 99999999998764321 2
Q ss_pred ccccccccccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 675 NTNRVVGTYGYMSPEYAI--DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~--~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......||+.|||||++. ..+|+.|+|||||||+||||+||+.||..... ...+..... ...+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~---------~~~R 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVV---------GGLR 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh---------cCCC
Confidence 223378999999999999 56999999999999999999999999764322 111111111 1122
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+..++.+||+.||++||++.+++.+|+.+
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 222223555788899999999999999999999999855
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=384.11 Aligned_cols=255 Identities=32% Similarity=0.471 Sum_probs=215.1
Q ss_pred CcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+...++||+|-||+||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|...+..+||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999977779999999664 344578999999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 676 (834)
+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.... .
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~ 361 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S 361 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence 99999965 34667999999999999999999999998 9999999999999999999999999999655444333 2
Q ss_pred ccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 677 ~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++.... .++.+.++...+-..
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcCCC
Confidence 23455778999999999999999999999999999999 6666432111 122233444444455
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
+..++..+++|+..||+.+|++|||++.+...|+....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 66678899999999999999999999999999987644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.70 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=204.0
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-eeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-ERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~ 593 (834)
++..+.||+|..|+|||+.+.. ++.+|+|.+... .....+++.+|++++++.+||+||.++|.|.... ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 3446789999999999999865 788999999554 4455678999999999999999999999999988 599999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
.+|+|+.++.. .+.+++...-+|+.+|++||.|||+.. +||||||||+||||+..|.+||+|||.++.+...
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999853 366999999999999999999999632 4999999999999999999999999999987433
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....... ..... .......+.+..+.+.
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~-Ll~~Iv~~ppP~lP~~---- 305 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFE-LLCAIVDEPPPRLPEG---- 305 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHH-HHHHHhcCCCCCCCcc----
Confidence 3455899999999999999999999999999999999999999976531111 11111 1111111112111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....++..++..||++||.+||++.|+++
T Consensus 306 ----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 ----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 24457888999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=393.76 Aligned_cols=260 Identities=30% Similarity=0.453 Sum_probs=215.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
.+....++||+|+||+||+|...+ .+-||||.+++.... ..++|++|++++..++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445556799999999999998643 456999999876554 7889999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCC-----------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 588 LVYEYLPNKSLDYFIFDTTR-----------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
+|+|||..|+|.+||..... ...|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999963211 233889999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++.+...+.......-.-+.+|||||.|..++||.+||||||||+|||+++ |+.|+.....+ ++.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVI 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVI 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHH
Confidence 9999999998866554443333455789999999999999999999999999999998 66664322111 122
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
.....+++ -.++..++.+++.|++.||+.+|++||+++||...|+....
T Consensus 716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22222222 34566677899999999999999999999999999987543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=355.13 Aligned_cols=199 Identities=32% Similarity=0.518 Sum_probs=179.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
..+|...++||+|+||+||+|++.. +.+||||.+.+. ..+..+....|+.+|+.++|||||++++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3578888899999999999999865 899999999765 5666778899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC------CCeEEeeeccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE------MNPKISDFGMA 664 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~------~~~kl~DfGla 664 (834)
|||.+|+|..+++. .+.+++.+...++.|||.||++||+.+ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 347999999999999999999999998 9999999999999764 46899999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
+.+.. .......+|++.|||||+++..+|+.|+|+||+|++||++++|+.||+.
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99853 2333458999999999999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.72 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=210.3
Q ss_pred cCCcccCccccCCcccEEEEEE-eCCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.+|...+.||+|||+.+|+++. ..|+.||+|++.+. .....+...+|+++.+.|+|||||+++++|.+.+..+||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999998 66999999999764 3456678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|+|++++|..++. +++.+++.+++.+++||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999884 5678999999999999999999999998 999999999999999999999999999998655
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.... ...+|||.|.|||++.....+..+||||+|||+|-|+.|++||+.....+ ....... .+..
T Consensus 172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~---~~Y~--- 236 (592)
T KOG0575|consen 172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKL---NEYS--- 236 (592)
T ss_pred cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHh---cCcc---
Confidence 4433 34899999999999999899999999999999999999999987422111 1111111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+.....+..+|+..+|+.||.+|||+++|+.
T Consensus 237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233346778999999999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=380.91 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=216.4
Q ss_pred CcccCccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..+.++||.|.||+|++|+++- ...||||.++.. .++...+|..|+.+|++++||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4567899999999999999853 457999999865 45667899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
||+||+||.||.... ..+++.++..++++||.||.||-+.+ +|||||.++||||+.+..+|++|||+++.+..+.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999996543 45899999999999999999999988 9999999999999999999999999999875544
Q ss_pred cc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 672 TE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 672 ~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. ..+....-+.+|.|||.+...++|.+||||||||++||.++ |.+|+ ++. ...++...++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY--Wdm--------------SNQdVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDM--------------SNQDVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc--ccc--------------chHHHHHHHHh
Confidence 22 22222223568999999999999999999999999999877 88883 111 11222333444
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
..+-..+++++..|.+||+.|||+|-.+||.+.+|+.+|+.....
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 555567888999999999999999999999999999999876443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.84 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=199.8
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
.+.|...+.||+|+||.|-+|.... |+.||||++++... .......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3567888999999999999998654 99999999976421 122345799999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC---CCeEEeeec
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFG 662 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfG 662 (834)
.|+||||+++|.|-+++-. .+.+.+..-..+++|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999888854 345677777889999999999999999 9999999999999755 789999999
Q ss_pred cccccCCCccccccccccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+|+..+ ....+...+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.....+. .+ .++..
T Consensus 325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl----~eQI~ 395 (475)
T KOG0615|consen 325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL----KEQIL 395 (475)
T ss_pred hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH----HHHHh
Confidence 999875 233455689999999999998764 3348899999999999999999985322211 01 11222
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.++.... .....+..++..+++.+||..||++||++.|+++
T Consensus 396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2211110 1112233457888999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.39 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=208.6
Q ss_pred cCCcccCccccCCcccEEEEEE-eCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEE-EEEeCCe-eEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLG-CCTQRDE-RVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV 589 (834)
.+|.+.++||+|.||+|||+.. .+|..||.|.++-. +.+..+....|+.+|++|+|||||++++ .+.+..+ +.||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3477788999999999999985 56999999998743 4566678899999999999999999998 4555555 8999
Q ss_pred EeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCC-CceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 590 YEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSR-LRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
|||+..|+|...+... ...+.++++.+++++.|++.||.++|..-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999988643 445679999999999999999999998431 24999999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... ...+|||.||+||.+...+|+.||||||+||++|||..-+.||... ++... ......++...+.
T Consensus 179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-CKKIEQGDYPPLP 249 (375)
T ss_pred cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-HHHHHcCCCCCCc
Confidence 6654433 3489999999999999999999999999999999999999997531 22221 1222222211111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
+......+..|+..|+..||+.||+...+++-+..
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 14456688899999999999999996666655543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.74 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=200.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||+||.++..+ ++.+|+|++++. .....+..++|..+|.+++||.||+++-.+.+.+.++||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4678999999999999999999766 888999999765 234567889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||+.+|.|..+|. +...+++....-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 3456889999999999999999999998 99999999999999999999999999996533
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. ..+...+||+.|||||++....|+.++|.||+|+++|||++|.+||...+... .......++
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k------- 241 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGK------- 241 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCc-------
Confidence 32 23344899999999999999999999999999999999999999976432211 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 779 (834)
+ ...+.-...+..+++...++.||++|.
T Consensus 242 -~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 011111233667889999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=325.30 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=205.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-cc-HHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-QG-VEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+...++|+|+||.|||.+..+ |+.||||++.+... .. .+-.++|+++|++++|+|||.|+.+|.....+.||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467788899999999999999876 99999999976543 22 3446889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|++..-|+++-. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 999987777652 3456899999999999999999999998 99999999999999999999999999999853
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA--------WQLWIQDR 742 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 742 (834)
.....+.++.|+.|+|||.+.+ ..|...+|||++||++.||++|.+.+....+-+....+... ...+....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2233345889999999999987 68999999999999999999999876443332222211111 11111111
Q ss_pred ------cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 743 ------PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 743 ------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
+.+.-++...+..-+....-+++++..|++.||.+|++-++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1122222222222222233678999999999999999999987
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=375.76 Aligned_cols=259 Identities=32% Similarity=0.463 Sum_probs=211.8
Q ss_pred cCCcccCccccCCcccEEEEEEeC--Ce----EEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE--GQ----EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++.+..+.||+|+||.||+|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667799999999999999765 43 4899999775 4567789999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCC----CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 588 LVYEYLPNKSLDYFIFDTTR----SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
+++|||++|+|..||.+.+. ...|+..+.+.++.|||+|+.||++++ +|||||.++|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976532 345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
|+.+.............-...|||||.+..+.+|.|+|||||||+|||++| |..|+......+ ....+.++-
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhCC
Confidence 996654444333333345578999999999999999999999999999999 666654222111 111111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
+-..+..++..+++|+..||+.+|++||++..|++.++.+.
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 22345556778999999999999999999999999887653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.81 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=207.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
..+.+.....||+|.||+||+|.|.+ .||||++... .....+.|++|+..+++-+|.||+-++|+|..... .||.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 34455667799999999999999954 7999999764 34577899999999999999999999999998877 9999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
.+|++.+|..+++.. ...++..+.+.||+|||+||.|||.++ |||||||..||+|.+++.+||+|||++..-..-
T Consensus 467 qwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred hhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999754 356888999999999999999999998 999999999999999999999999998764322
Q ss_pred ccccccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.-........|...|||||+++. .+|+.++||||||+++|||++|..|+.....+. ++ .....+. -..
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---Ii----fmVGrG~--l~p 612 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---II----FMVGRGY--LMP 612 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---eE----EEecccc--cCc
Confidence 22222233567789999999974 479999999999999999999999976322111 10 0011110 011
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
|.. ........++.+|+..||..++++||.+.+|+.+|+....
T Consensus 613 d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 110 1122345578889999999999999999999998887654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.69 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=203.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
..++|+..++||+|+||.||+|... .++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888999999999999999742 25679999997543 23456789999999999 8999999999987654
Q ss_pred -eeEEEEeecCCCChhhHhhccCC--------------------------------------------------------
Q 003272 585 -ERVLVYEYLPNKSLDYFIFDTTR-------------------------------------------------------- 607 (834)
Q Consensus 585 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 607 (834)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988864211
Q ss_pred ---CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccccccccc
Q 003272 608 ---SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684 (834)
Q Consensus 608 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 684 (834)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999988 99999999999999999999999999987543322222223456778
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHH
Q 003272 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRC 763 (834)
Q Consensus 685 y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 763 (834)
|+|||++.+..++.++||||||+++|||++ |..|+....... ........+.... .+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMR---------APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCC---------CCCCCCHHH
Confidence 999999999999999999999999999997 998875322111 0111111111100 111223467
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 764 IQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 764 ~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.+++.+||+.||++||++.||+++|+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=327.17 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=209.0
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.+.|+...+||.|..++||+|+. +.+..||||++.-. .....+.+++|+..+..++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 36788899999999999999996 44889999999643 33446889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
||..||+.++++..- ...+++..+..|++++++||.|||+++ .||||||+.||||+.+|.+||+|||....+-...
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999986543 344999999999999999999999998 9999999999999999999999999876653322
Q ss_pred cc--cccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 672 TE--ANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 672 ~~--~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.+ ......+||+.|||||+++. ..|+.|+||||||++..||.+|..||..+.+... . ..-..+.+....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------L-l~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------L-LLTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------H-HHHhcCCCCCcc
Confidence 21 11145789999999999654 3699999999999999999999999876554321 1 111222222222
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+..+........+.+++..||+.||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 112222222233447788999999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.88 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=208.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
...|....+||+|+.|.||.+.-. .++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 455777789999999999999854 4889999999776666667789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
|++|+|.+.+. ...+++.++..|.+++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999988873 445999999999999999999999998 99999999999999999999999999988765554
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
... ..+||+.|||||++....|..|+||||||++++||+-|.+|+=...+ +...+.....+. .++
T Consensus 425 KR~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~-P~l------ 489 (550)
T KOG0578|consen 425 KRS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGT-PKL------ 489 (550)
T ss_pred ccc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCC-CCc------
Confidence 333 38999999999999999999999999999999999999999532111 111111111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.|+++||++.|+++
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 112233447788999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=337.06 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=204.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHH-HHHHHHHHHHhcc-CCceeeEEEEEEeCC-eeEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVE-EFKNEALLIAKLQ-HRNLVKLLGCCTQRD-ERVL 588 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 588 (834)
..++|...++||.|.||.||+|+-.+ |..||||++++......+ .-.+|+..|++|+ |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45688899999999999999999654 889999999766443322 2367999999998 999999999999988 9999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|||||+. +|.+++.+ +.+.+++..+..|+.||++||+|+|.+| +.||||||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999965 77777754 3778999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccccccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH-----HHHhhcc-
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA-----WQLWIQD- 741 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-----~~~~~~~- 741 (834)
... -.+.++.|+.|+|||++. .+-|+.+.|+|++|||++|+.+-++.|......+...-+-.+ +..|.++
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 432 233488999999999875 568999999999999999999999876532221111000000 0000000
Q ss_pred --------CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 742 --------RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 742 --------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
+.....-..+. ..-+....++.+++.+|++.||.+|||+.|.++.-
T Consensus 239 ~La~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00001100111 11122556788999999999999999999999753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.79 Aligned_cols=255 Identities=28% Similarity=0.403 Sum_probs=201.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC--eeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD--ERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 591 (834)
.++...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356677899999999999999865 8999999987654444677899999999999999999999855554 6899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeeccccccCC-
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGL- 669 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~- 669 (834)
|+++|+|.+++..... .+++..+..+++||++||+|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965432 6999999999999999999999998 999999999999999 79999999999988753
Q ss_pred CccccccccccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
...........||+.|||||++.++. ...++|||||||++.||+||++|+... .................
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP---- 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC----
Confidence 11112223478999999999999643 335999999999999999999996532 00111111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
..+........+++..|++.||+.|||+.+++.-.
T Consensus 243 -----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 -----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22222344677899999999999999999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.07 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=202.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-----------------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKL 576 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 576 (834)
++|...++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999998643 3469999987543 3345679999999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhhHhhccC----------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEe
Q 003272 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTT----------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640 (834)
Q Consensus 577 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 640 (834)
++++.+.+..++||||+++++|.+++.... ....+++..+.+++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998875321 1134788999999999999999999988 999
Q ss_pred ccCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCC--CC
Q 003272 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK--RN 718 (834)
Q Consensus 641 ~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~--~p 718 (834)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998764333222233345678899999999889999999999999999999754 45
Q ss_pred CCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 719 RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
+..... ................ .. ....++..+..+.+++.+||+.||++||++.+|++.|++
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 432211 1111111111111100 00 001112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.34 Aligned_cols=252 Identities=27% Similarity=0.344 Sum_probs=205.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 588 (834)
..+|...+.||+|+|++|++|+..+ ++++|||++.+. ..+..+-...|-..|.+| .||.|++|+-.|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3568888899999999999999765 899999999764 233445667788999999 89999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|+||+++|.|..++... ..+++...+.++.+|+.||+|||+.+ ||||||||+|||||+++++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999543 56899999999999999999999998 9999999999999999999999999999985
Q ss_pred CCccc---------ccc--ccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 669 LDQTE---------ANT--NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 669 ~~~~~---------~~~--~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
..... ... ...+||..|.+||++.+...+..+|+|+||||||.|+.|++||.... +.....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFq----- 297 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQ----- 297 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHH-----
Confidence 33221 111 34789999999999999999999999999999999999999975321 111111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
++.++ + -.+++..++.+.+|+.+.|..||.+|++..+|.+-.
T Consensus 298 ----kI~~l-~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 ----KIQAL-D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----HHHHh-c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11111 1 112222335677899999999999999999988643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=330.90 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=199.0
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 589 (834)
+.|+.+++||+|.||.||||+.. .|+.||+|+++... .....-..+|+.+|++|+||||++|.+...+. ...+||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45777889999999999999965 48999999997653 23334557899999999999999999999887 679999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+|||+. +|.-++.. ..-.++..++..+++||+.||+|+|+.+ |+|||||.+|||||++|.+||+|||||+.+..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999987 55555422 2335889999999999999999999998 99999999999999999999999999998765
Q ss_pred CccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC------
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR------ 742 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 742 (834)
......++ .+-|..|+|||++.+. .|+.++|+||.||||.||+.|++.+......+. +..+........
T Consensus 271 ~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 271 SGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhcccc
Confidence 55444443 6789999999999885 799999999999999999999987543222111 111111111111
Q ss_pred --cc--ccc------CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 743 --PA--ELI------DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 743 --~~--~~~------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+. ..+ ...+.+. ........++|+..+|..||++|.|+.++++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 10 000 0111110 01113356788999999999999999999854
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=305.13 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=204.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcc-c-HHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ-G-VEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|...++||+|.||.||+|+... |+.||||+++..... + .....+|+..|+.++|+||+.+++++-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467888999999999999999754 999999999754221 2 2456889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
||+. +|+..+.+ +...+...++..++.++++|++|||+.. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9976 78888854 3457899999999999999999999998 9999999999999999999999999999987554
Q ss_pred cccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc------
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA------ 744 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 744 (834)
..... .+-|..|+|||.+.+. .|+..+|+||.|||+.||+-|.+-+.. +.+...+......+......
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG---~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG---DSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC---CchHHHHHHHHHHcCCCCcccCcccc
Confidence 43322 3789999999999875 699999999999999999998865432 22222222222222222111
Q ss_pred cccCcc--------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 745 ELIDKS--------LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 745 ~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
.+.|-. .....-......+.+|+..++..||.+|+++.|++++=
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 111110 01112223344668999999999999999999998763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.03 Aligned_cols=259 Identities=31% Similarity=0.400 Sum_probs=206.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeCC----eE-EEEEEecc---cCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEG----QE-IAVKRLSK---SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g----~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
.++....++||+|+||.||+|++..+ .. ||||..+. .......+|++|+++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 34555568999999999999998642 23 89999874 346678899999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++|||+|.+|+|+++|.... ..++..++..++.+.|.||+|||+.+ +|||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999996532 26999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.-. ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...... .+......
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~---- 377 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVK---- 377 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHh----
Confidence 643 11111112245679999999999999999999999999999999 77775322111 11111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
....-..+...+..+..++.+||+.+|++||+|.++.+.|+.....
T Consensus 378 ----~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 378 ----NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ----cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 1111122224455677888899999999999999999999876443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.08 Aligned_cols=245 Identities=19% Similarity=0.282 Sum_probs=197.4
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCccc---HHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeEEEEeec
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQG---VEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERVLVYEYL 593 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~ 593 (834)
..||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999997653332 5778899999999999999999999877 34678999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++|+|.+++.. .+.+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999854 34689999999999999999999985 5 7899999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 673 EANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+. ........
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~----~~i~~~~~------- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY----DLIINKNN------- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcCC-------
Confidence 12467889999999976 68999999999999999999999997532211 111 11111100
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
....+......+.+++.+||+.||++||++.||++.|+...
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01112223446888999999999999999999999998653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.29 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=203.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||.||+|++. .+..||||+++... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 356888899999999999999742 25689999996442 33456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCC----------------------------------------------------------
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 607 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 607 (834)
.++||||+++|+|..++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988854211
Q ss_pred --------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 608 --------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 608 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124789999999999999999999987 999999999999999999999999999876433222
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.......++..|+|||++.+..++.++||||||+++|||++ |..|+....... . .......+...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~-------- 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRM-------- 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccC--------
Confidence 22222345678999999999999999999999999999998 777764321111 1 11111111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+.....++.+|+.+||+.||++||++.||+++|+..
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=334.03 Aligned_cols=266 Identities=27% Similarity=0.411 Sum_probs=216.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
+.+.+.+.++||+|-||+|.......+..||||+++.... ...++|..|+++|.+++|||||+|+|+|...+..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4566778899999999999999997789999999987644 455899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
||++|+|..|+..+... .+.-....+|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||+++-+....
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999665322 2455667789999999999999988 9999999999999999999999999999887766
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS--GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
......+.+-+.+|||||.+..+++|.++|||+||+++||+++ ...|++.... ....+..-..+ .+.....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~-~~~~~~~--- 764 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFF-RDQGRQV--- 764 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhc-CCCCcce---
Confidence 6666666777899999999999999999999999999999865 5666542211 11111111111 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+..++..+++++++||..|-++||+++++...|+..
T Consensus 765 --~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 --VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1123444566889999999999999999999999999764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.74 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=201.5
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHh--ccCCceeeEEEEEEeCC----eeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAK--LQHRNLVKLLGCCTQRD----ERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV 589 (834)
.....+.||+|.||.||||.+ +++.||||++... ..+.|++|-++... ++|+||+++++.-.... +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 344556899999999999999 5599999999653 44678888888875 48999999999876555 79999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc------CCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD------SRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
+||.++|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||+
T Consensus 287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999994 46799999999999999999999986 356899999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCC-CCcccccch------
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL-FS-----VKSDVFSFGVLVLEIVSGKRNRGF-YHADHRHNL------ 730 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-----~~sDV~S~Gvil~elltg~~p~~~-~~~~~~~~~------ 730 (834)
|..+........+...+||.+|||||++.+.. +. .+.||||+|.+||||++.-.-... ..++....+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99987666666666689999999999997652 22 368999999999999996543221 011111111
Q ss_pred ---hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 731 ---LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 731 ---~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.+..+.....++.+-.+...-.. ...+.-+.+.+..||..||+.|.|+.=|.+.+.+..
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11112222111111111111111 134556778999999999999999998888877653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.22 Aligned_cols=240 Identities=28% Similarity=0.414 Sum_probs=198.9
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
.++-||.|+.|.||+|++ .++.||||++++.. ..++.-|++|+|+||+.+.|+|.....++||||||+.|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 356899999999999999 67899999985432 3478889999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
...|. .+..+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||-++.+... ..+..
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 99994 3456888889999999999999999987 999999999999999999999999999876422 22344
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..||..|||||++.+.+.++|+|||||||+||||+||..|+...+ ....+ | .+-...+.-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd--ssAII-------w------GVGsNsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD--SSAII-------W------GVGSNSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc--hheeE-------E------eccCCcccccCccc
Confidence 789999999999999999999999999999999999999954211 11110 1 01111222234445
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
++.-+.-|+.+||+..|..||++.+|+.-|+-
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 56677778999999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=343.96 Aligned_cols=260 Identities=28% Similarity=0.418 Sum_probs=202.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 585 (834)
.++|...++||+|+||.||+++.. ++..||||+++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888899999999999998852 24579999997543 33456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccC-----------------------------------------------------------
Q 003272 586 RVLVYEYLPNKSLDYFIFDTT----------------------------------------------------------- 606 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 606 (834)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875321
Q ss_pred --------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 607 --------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 607 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1134788999999999999999999987 99999999999999999999999999987643322222222
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL 757 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 757 (834)
..++..|+|||++.+..++.++|||||||++|||++ |+.|+....... .. ......+ .....+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~---------~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRG---------YQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHcc---------cCccCCC
Confidence 345678999999999999999999999999999997 999875322111 01 0111111 0000111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 758 SEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 758 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+..+.+++.+||+.||++||++.+|+++|+..
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=377.13 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=211.1
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
...+...+.||+|+||.||+|+. .++..||||+++..... ...|++.+++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 44577788999999999999997 46899999998654322 23468889999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++. .++|..+.+++.||++||+|||+.+..+|+||||||+||+++.++.+++. |+.+......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999984 38999999999999999999997766679999999999999999988876 6655443211
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
....+++.|+|||++.+..++.++|||||||++|||++|+.|++.... ....+..+.............+|+.+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 123678899999999999999999999999999999999999753222 223344444443334445556666654
Q ss_pred C--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 753 D--SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 753 ~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
. ..+..++.++.+++.+||+.||++||+|.||+++|+....
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 3355677788999999999999999999999999987643
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.68 Aligned_cols=250 Identities=35% Similarity=0.510 Sum_probs=193.4
Q ss_pred ccCccccCCcccEEEEEEe-----CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 519 EENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999997 2678999999653 333478999999999999999999999999988889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++... ....+++..+..|+.||++||.|||+.+ ++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999764 2456899999999999999999999987 99999999999999999999999999988633222
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
............|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+ ..........
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~----~~~~~~~~~~------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEI----IEKLKQGQRL------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHH----HHHHHTTEET-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc----cccccccccc-------
Confidence 222233556789999999999999999999999999999999 6777543211 111 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
..+......+.+++.+||+.+|++||++.+|++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112234678899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.77 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=202.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc----Cc-ccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS----SG-QGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDE 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 585 (834)
..++|...+.||+|.||+|+.|... .++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568899999999999999999865 4899999977553 12 34556778999999998 9999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeeccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMA 664 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla 664 (834)
.++||||+.+|.|.+.+.. ...+.+....++++||+.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999854 456888999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCCccccccccccccccccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGL-FS-VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...+. .....+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~----~ki~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLY----RKIRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHH----HHHhcCC
Confidence 9874 1222334589999999999999977 86 78999999999999999999986411 11111 1111111
Q ss_pred cccccCccccCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 743 PAELIDKSLYDSCSLSE-AIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
. .++... ...+..|+.+|++.||.+|+++.+|+
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 011111 44788899999999999999999999
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.92 Aligned_cols=257 Identities=31% Similarity=0.509 Sum_probs=205.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++|+..+.||+|+||.||+|.... ...||+|.+.... .....+|.+|+..+.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467778899999999999998744 2579999986543 334567899999999999999999999999989999
Q ss_pred EEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC
Q 003272 588 LVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM 654 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 654 (834)
++|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998864321 145889999999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHH
Q 003272 655 NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGH 733 (834)
Q Consensus 655 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 733 (834)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+...... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999987643332222333456788999999998999999999999999999998 98886432211 1
Q ss_pred HHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 734 AWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 734 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.......+... ..+...+.++.+|+.+||+.||++||++.||++.|+.
T Consensus 235 ~~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111111 1222344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.75 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=206.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..|+..++||+|.||.||||.... ++.||+|++.-. .....+...+|+.++.+++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667899999999999999865 888999999643 456678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
|.+|++.+.+. ....+++..+.-++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999883 3445588888899999999999999998 99999999999999999999999999988755444
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.. ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+.-.++.. +.-++-+..-
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAP 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCC
Confidence 43 44899999999999998899999999999999999999999965443321 1111211111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..........+.+++..||+.||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1122233346788999999999999999999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.08 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=211.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.+....++||.|-||.||.|.|+. ...||||.+++ +.-..++|..|+.+|+.++|||+|+|+|+|......|||.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345667899999999999999976 77899999965 4456789999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
.+|+|.++|.... +..++-...+.++.||+.||+||...+ +|||||.++|+|+.++..+|++|||+++.+..+...
T Consensus 346 ~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999999996543 445777888999999999999999988 999999999999999999999999999987544433
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....-.+.|.|||-+....++.|+|||+|||+||||.| |..|+. ..+ ... +-+++.+..+
T Consensus 422 A-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP---Gid----lSq---------VY~LLEkgyR 484 (1157)
T KOG4278|consen 422 A-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP---GID----LSQ---------VYGLLEKGYR 484 (1157)
T ss_pred c-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC---Ccc----HHH---------HHHHHhcccc
Confidence 2 222445678999999999999999999999999999998 666632 111 111 2223333444
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
-+.+..++..+++|+++||+..|.+||++.|+.+.+|
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 4455667778999999999999999999999999886
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.43 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=204.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 584 (834)
..++|.+.++||+|+||.||+|+... +..||||+++... ....+.|.+|+.+++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678889999999999999998632 3469999996543 334567999999999995 999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccC----------------------------------------------------------
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT---------------------------------------------------------- 606 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 606 (834)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875421
Q ss_pred -----------------------------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 607 -----------------------------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 607 -----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
....+++..+..++.||++||.|||+.+ |+|+||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0134788899999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccch
Q 003272 652 NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNL 730 (834)
Q Consensus 652 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 730 (834)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+. .+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH
Confidence 999999999999987643332222233456788999999999999999999999999999997 888864321111 00
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
......+. ....+......+.+++.+||+.||++||++.+|+++|+..
T Consensus 350 ----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ----YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ----HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 11111110 0011122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.49 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=201.3
Q ss_pred cCCcccCccccCCcccEEEEEEe----CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788889999999999999864 36689999997643 23446789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 346899999999999999999999988 99999999999999999999999998765422
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... .......++..|+|||.+.+..++.++||||||+++||+++ |+.|+...... .+. .....+..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~~~----- 226 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVI----KAVEDGFR----- 226 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCC-----
Confidence 211 11112345678999999999999999999999999999775 99886432111 111 11111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
...+...+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01122234467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.24 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=203.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|...+.||+|.||.||||+.+. .+.||+|.+.+. ..+..+.+.+|++++++++|||||.+++.+....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567788899999999999999765 889999999764 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+.+ +|..++. ....++++.+..++.++..||.|||+.. |+|||+||+||||+..+.+|++|||+|+....+
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9987 9988884 3456999999999999999999999988 999999999999999999999999999987543
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
......+.||+.|||||++.+.+|+..+|.||+||++||+.+|++||-.. . +.... .....+.+
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---s---i~~Lv-~~I~~d~v-------- 217 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---S---ITQLV-KSILKDPV-------- 217 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---H---HHHHH-HHHhcCCC--------
Confidence 23334588999999999999999999999999999999999999996311 0 11000 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+..++...++.||.+|.+..+++.
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 112233446778888999999999999999874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.39 Aligned_cols=255 Identities=30% Similarity=0.435 Sum_probs=205.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999988 999999999999999999999999999877532211
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. ......+..|+|||.+.+..++.++||||||++++||++ |+.|+..... .. ......... .
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~----~~~~~~~~~---------~ 222 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AE----VLQQVDQGY---------R 222 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HH----HHHHHHcCC---------C
Confidence 1 111223457999999999999999999999999999999 8888642211 11 111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234578889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.62 Aligned_cols=199 Identities=27% Similarity=0.360 Sum_probs=174.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+++... +..+|+|.+.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3678899999999999999999764 7889999986542 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 345889999999999999999999853 3999999999999999999999999999765322
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12235789999999999999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=302.60 Aligned_cols=236 Identities=27% Similarity=0.319 Sum_probs=196.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||.|+||.|.+.+.+. |..+|+|++.+.. -++.+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467778899999999999999764 8899999997653 245567788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|-|-.+++ +.+.++....+.+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999984 4557999999999999999999999998 99999999999999999999999999998632
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.+...+||+.|+|||++....+..++|-|+|||++|||+.|.+||...... .......++++
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v------- 258 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKV------- 258 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCcc-------
Confidence 245689999999999999999999999999999999999999997532221 11122222211
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDR 778 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 778 (834)
.++......+.+|+...++.|-.+|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222223356678888888888888
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.85 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=205.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3568889999999999999999888889999998643 234578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..+..++.+|+.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 2446889999999999999999999987 999999999999999999999999999876432221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ... ........ .
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~-----~--- 223 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVM----SALQRGYR-----M--- 223 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCCC-----C---
Confidence 1 122345678999999998899999999999999999998 88886422111 111 11111100 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.........+.+++.+|++.+|++||+++++.++|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.80 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=201.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.+|+..+.||+|+||.||+|++.. +. .||+|+++... ....+++.+|+.+++.++||||++++|+|... ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468888999999999999998643 33 38999986543 34567899999999999999999999999764 5789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988543 345889999999999999999999988 9999999999999999999999999999875
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.............+..|+|||++.+..++.++||||||+++|||++ |+.|++..... .+ ........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~--~~- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGE--RL- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCC--CC-
Confidence 4333222222344678999999999999999999999999999998 88886532111 01 11111110 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
..+......+.+++.+||+.+|++||++.+++..|.....
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0111223467889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=316.28 Aligned_cols=252 Identities=28% Similarity=0.402 Sum_probs=201.2
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..+.||+|+||.||++.+.++..+|+|.+... ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999988889999988643 3345689999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|+|.+++... ...+++..+..++.+|+.||.|||+.+ |+|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988542 235889999999999999999999988 999999999999999999999999999865332221
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .... .....+.. ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~----~~i~~~~~--~~~~---- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVV----EMISRGFR--LYRP---- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCC--CCCC----
Confidence 1112345568999999998889999999999999999999 8888643211 1111 11111110 0111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
......+.+++.+||+.+|++||++.|++++|.
T Consensus 224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.69 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=203.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
..++|+..++||+|+||.||+|... .+..||||++.... .....+|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999863 24679999986432 2345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCC-------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR-------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854221 234678899999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~----~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---Q----VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHH
Confidence 99999986643322222222345778999999998899999999999999999999 67776432111 1 1111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
........ .+...+..+.+++.+||+.+|++||++.|++++|++
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.71 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=210.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
...+|+..++||.|+||.||+|...+++.+|+|.+........+++.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999988999999999876665677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998653 2456899999999999999999999988 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.. ....++..|+|||.+.+..++.++||||||+++++|++ |+.|+...... ... .....+ .
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~---------~ 221 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVY----DQITAG---------Y 221 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHHhC---------C
Confidence 11 12445678999999998899999999999999999998 88886432211 111 111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
....+......+.+++.+||+.||++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111122334567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.83 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=204.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++|...+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998743 478999999765443 5678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhccC-----------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 588 LVYEYLPNKSLDYFIFDTT-----------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 2345889999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++...............+++.|+|||++.+..++.++||||||++++||++ |..|+...... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----
Confidence 9999999986533222222223445778999999999999999999999999999998 99886422111 111
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.....+... ..+......+.+++.+||+.||++||++.||++.|+
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111111 111123346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=320.17 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=198.3
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
|+..+.||+|+||+||++... +++.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999874 58999999986532 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988775432 345899999999999999999999988 99999999999999999999999999987532211
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ............ .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~--------- 221 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKED-Q--------- 221 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhcc-c---------
Confidence 123578999999999999999999999999999999999999976432211 011111111000 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
...+......+.+|+.+||+.||++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122346778999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.26 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=202.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
..++|+.+++||+|+||.||+++-.+ |..+|+|++++.. ....+..+.|-.+|...+++.||+|+-.|.+.+.++|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 35778999999999999999999766 9999999998763 4566788999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+|+|++..+|. +...|++.....++.+++-|+..||+.+ +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999994 4567999999999999999999999998 9999999999999999999999999986542
Q ss_pred CC--------------------c-ccc-----c-------------------cccccccccccCccccccCCCCchhhHH
Q 003272 669 LD--------------------Q-TEA-----N-------------------TNRVVGTYGYMSPEYAIDGLFSVKSDVF 703 (834)
Q Consensus 669 ~~--------------------~-~~~-----~-------------------~~~~~gt~~y~APE~~~~~~~t~~sDV~ 703 (834)
.. . ... . ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0 000 0 0124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC---
Q 003272 704 SFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN--- 780 (834)
Q Consensus 704 S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt--- 780 (834)
|+|||+|||+.|.+||....+.+ .+.....-+ ..+..........+..+|+.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~-------T~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQE-------TYRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 99999999999999986433221 111111100 001111111122467789999999 9999975
Q ss_pred HHHHHH
Q 003272 781 MLSVVL 786 (834)
Q Consensus 781 ~~ev~~ 786 (834)
++||.+
T Consensus 439 ~~EIK~ 444 (550)
T KOG0605|consen 439 AEEIKK 444 (550)
T ss_pred HHHHhc
Confidence 566654
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=321.56 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=208.0
Q ss_pred cCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|+..+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777789999999999999853 245699999876666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC
Q 003272 589 VYEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN 655 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 655 (834)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1235899999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHH
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHA 734 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 734 (834)
+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999986643322222233456788999999999999999999999999999998 998864322111 1
Q ss_pred HHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
......+..... ....+..+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111111111 1123446789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=319.11 Aligned_cols=257 Identities=31% Similarity=0.454 Sum_probs=202.0
Q ss_pred cCCcccCccccCCcccEEEEEEe-----CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..++||+|+||.||+|... .+..||+|.+... ......+|.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35677789999999999999852 3678999999643 33445688999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCC--------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC
Q 003272 589 VYEYLPNKSLDYFIFDTTR--------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM 654 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 654 (834)
||||+++++|.+++..... ...+++.....++.||+.||.|||+.+ ++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 235789999999999999999999988 99999999999999999
Q ss_pred CeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHH
Q 003272 655 NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGH 733 (834)
Q Consensus 655 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 733 (834)
.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..|+...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~---- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E---- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H----
Confidence 999999999987643332222233445678999999988889999999999999999998 88786421110 0
Q ss_pred HHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 734 AWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 734 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
........... ..+......+.+++.+|++.||++||++.+|.+.|..
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111 1111223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=328.66 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=202.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+|...+ ++.||||+++... ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999999865 8899999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 345889999999999999999999988 99999999999999999999999999986532
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+......+ .. ...... ...+...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~----~~i~~~--~~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TW----ENLKYW--KETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HH----HHHHhc--cccccCC
Confidence 2233678999999999999999999999999999999999999975322211 00 111000 0000000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
............+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000011223467789999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=329.43 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=202.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC-C
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR-D 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 584 (834)
.++|++.++||+|+||.||+|...+ ++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3578889999999999999997422 4789999986543 23446788899999999 899999999988654 5
Q ss_pred eeEEEEeecCCCChhhHhhccCC---------------------------------------------------------
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTR--------------------------------------------------------- 607 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 607 (834)
..++++||+++++|..++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988753211
Q ss_pred -CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccccccccccc
Q 003272 608 -SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686 (834)
Q Consensus 608 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 686 (834)
...++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999987 9999999999999999999999999998764433322233355677899
Q ss_pred CccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHH
Q 003272 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQ 765 (834)
Q Consensus 687 APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 765 (834)
|||++.+..++.++|||||||+++||++ |..|+......+ .+ ......... ...+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~~---------~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EF----CRRLKEGTR---------MRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HH----HHHHhccCC---------CCCCccCCHHHHH
Confidence 9999999999999999999999999998 988864321111 00 111111100 0111122346889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 766 VGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 766 l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
++.+||+.+|++||++.||+++|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=313.82 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=200.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--------------ccHHHHHHHHHHHHhccCCceeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--------------QGVEEFKNEALLIAKLQHRNLVKLLG 578 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g 578 (834)
.++|+..+.||+|.||.|-+|+.. +++.||||++.+... ...+..++|+.+|++++|+|||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 477999999999999999999864 489999999975311 12468899999999999999999999
Q ss_pred EEEeC--CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 579 CCTQR--DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 579 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
+..+. +..|||+|||..|.+...- .....++..+.+++++++..||+|||.++ ||||||||+|+||+++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 98765 5689999999998875432 22223899999999999999999999999 9999999999999999999
Q ss_pred EEeeeccccccCCC---ccccccccccccccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 003272 657 KISDFGMARAFGLD---QTEANTNRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729 (834)
Q Consensus 657 kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~----~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~ 729 (834)
||+|||.+..+... .........+||+.|+|||....+. .+.+.||||+||+||.|+.|+.||-. +....
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~~~~ 326 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DFELE 326 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---chHHH
Confidence 99999999876322 1122223478999999999998743 35688999999999999999999631 11100
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
+ ...++...+.....++.-+.+.+|+.++|++||+.|.+..+|..-.-
T Consensus 327 l------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 L------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1 11222333333333345567889999999999999999999976653
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=316.12 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=204.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC----CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+|.+.. ...||||.++... .....+|.+|+.++.+++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999999753 3579999986543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998543 236899999999999999999999987 99999999999999999999999999998752
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
...........++..|+|||.+.+..++.++||||||++++||++ |..|+...... . ...........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---D----VIKAVEDGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---H----HHHHHHcCCCC----
Confidence 222222222345678999999998899999999999999999998 88886422111 0 11111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.60 Aligned_cols=265 Identities=21% Similarity=0.256 Sum_probs=200.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..+.||+|+||.||+++... ++.||||+++... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468889999999999999999864 7889999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|++++++..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987766542 2346889999999999999999999987 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH--------HHHHHhhc-cC
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG--------HAWQLWIQ-DR 742 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~-~~ 742 (834)
.. ......+++.|+|||++.+..++.++|||||||++|||++|+.||............. .....+.. ..
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 2223568999999999999899999999999999999999999975432211100000 00000000 00
Q ss_pred cccccCccccCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDS------CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......+..... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 00112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.03 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=204.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.+|...++||+|+||.||+|...+ ++.||+|++... ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 347778899999999999999765 889999998643 344578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988543 2346899999999999999999999987 999999999999999999999999999876433221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.......+..|+|||.+.+..++.++||||||++++||++ |..|+...... ......... ..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~---------~~ 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKG---------YR 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC---------CC
Confidence 1112334568999999999999999999999999999998 88886432111 111111111 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111222335678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.40 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=206.7
Q ss_pred cCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|...+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999852 245689999976666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccC----------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 589 VYEYLPNKSLDYFIFDTT----------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999885332 2235899999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999986643322222223445778999999998899999999999999999998 888864222111 1111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
...+..... +......+.+++.+||+.+|.+||++.||++.|+...
T Consensus 235 i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111111 1112236788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.92 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=201.6
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|...+.||+|+||.||+|...++..+|+|.+... ....++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357778899999999999999877778999998643 3345789999999999999999999999999889999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999988543 236899999999999999999999988 999999999999999999999999999876432221
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .......+....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------- 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRLY-------- 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCCC--------
Confidence 1112345678999999998889999999999999999998 888865322111 111111111100
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112357788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.05 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=195.7
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
++||+|+||.||+|+.. +++.+|+|.+.... ......|.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999975 58899999876443 34456799999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988532 345889999999999999999999988 99999999999999999999999999876532211111111
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL 757 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 757 (834)
...+..|+|||.+.+..++.++||||||++++||++ |..|+....... ........ .....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQG---------VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC---------CCCCCcc
Confidence 223457999999999999999999999999999998 777764321110 01111110 1111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 758 SEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 758 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
..+..+.+++.+|++.+|++||++.+|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23446788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.70 Aligned_cols=256 Identities=27% Similarity=0.348 Sum_probs=207.1
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
-|+..+-||.|+.|.|-.|++.. |+.+|||++.+. .......+.+|+.+|+.+.|||++++++++.+..++++|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 46678899999999999999754 999999999754 22334567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|-|.+++. +.+.++..+..+++.||+.|+.|+|+.+ |+||||||+|+|||..+++||+|||+|..- .
T Consensus 93 yv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---~ 163 (786)
T KOG0588|consen 93 YVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---V 163 (786)
T ss_pred ecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence 999999988874 4567999999999999999999999998 999999999999999999999999999763 2
Q ss_pred cccccccccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
........+|.+.|.|||++.+.+|. .++||||.|||||.|++|+.||+ ++....++. +...+..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLl----KV~~G~f------- 229 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLL----KVQRGVF------- 229 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHH----HHHcCcc-------
Confidence 33334458999999999999999985 68999999999999999999986 222222211 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCCCCCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM--LSGERSLPQP 797 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~--L~~~~~~~~p 797 (834)
..+.....++.+|+.+|+..||+.|.|++||.+- |.+....+.+
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 1122233467889999999999999999999863 4554444433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.78 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=196.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|...++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 48899999986542 23345778999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 887776432 345789999999999999999999988 99999999999999999999999999986533221
Q ss_pred ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc----------
Q 003272 673 EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD---------- 741 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 741 (834)
. .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...........
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 T--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred c--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhcccc
Confidence 1 123567899999999875 5689999999999999999999999754322111 11110100000
Q ss_pred --CcccccCccccCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 --RPAELIDKSLYDS----CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 --~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+..... ........+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00111235678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.89 Aligned_cols=272 Identities=26% Similarity=0.372 Sum_probs=201.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-----CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 587 (834)
++|+..+.||+|+||.||++... .++.||+|++........+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999753 4788999999776666678899999999999999999999987543 4588
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+|+||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 345899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccccc-cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 668 GLDQTEAN-TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 668 ~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
........ .....++..|+|||++.+..++.++||||||++++||++|..+........................+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43322111 11123345699999999889999999999999999999987664221100000000000000000000001
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+...............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111222345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.20 Aligned_cols=263 Identities=22% Similarity=0.233 Sum_probs=210.6
Q ss_pred hcCCcccCccccCCcccEEEEE-EeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----eeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-----ERV 587 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 587 (834)
.++|++.++||+|||+-||.++ +.+++.+|+|++.....+..+..++|++..++++|||+++++++..... ..+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 4568899999998877788899999999999999999999998875443 489
Q ss_pred EEEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 588 LVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
|+++|...|+|.+.+... .++..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999998887543 34457999999999999999999999986 4799999999999999999999999999876
Q ss_pred cCCCcccc-------ccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 003272 667 FGLDQTEA-------NTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ 736 (834)
Q Consensus 667 ~~~~~~~~-------~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 736 (834)
........ .-.....|..|+|||.+. +...++++|||||||+||+|+.|..||+..-..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------- 247 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------- 247 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence 53221110 011246789999999885 446889999999999999999999998742110
Q ss_pred HhhccCc-ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 737 LWIQDRP-AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 737 ~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.+.+ ..+....+.-.-.....+.+.+++.+|++.||.+||++.+++..++..
T Consensus 248 ---GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 ---GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 112222222222223566889999999999999999999999988754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=337.87 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=212.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCC-eEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEE-EEe------C
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEG-QEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGC-CTQ------R 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~------~ 583 (834)
...++++.+.|.+|||+.||.+....+ .++|+|++-..++...+..++|+.+|++|. |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345677889999999999999998776 999999998788889999999999999996 9999999993 222 1
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
-+.+|.||||++|.|-+++..... ..|++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 357899999999999999864433 33999999999999999999999985 7899999999999999999999999999
Q ss_pred ccccCCCcccccc-------ccccccccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH
Q 003272 664 ARAFGLDQTEANT-------NRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH 733 (834)
Q Consensus 664 a~~~~~~~~~~~~-------~~~~gt~~y~APE~~---~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~ 733 (834)
|............ -...-|+.|+|||++ .+.++++|+|||+|||+||-|+....||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s----------- 261 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES----------- 261 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-----------
Confidence 8754332211000 012358899999987 4678999999999999999999999998631
Q ss_pred HHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 734 AWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 734 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
-...+++....-...+.+..++.+|+..||+.||++||++-+|+..+-.++..
T Consensus 262 --------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 262 --------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11223333333333456778999999999999999999999999888766443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.88 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=203.4
Q ss_pred cCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.+|...++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999742 356799999877666667889999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCC------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 589 VYEYLPNKSLDYFIFDTTR------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
++||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998864321 135889999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+......+ . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A----I 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H----H
Confidence 9999999976543222222222345678999999999999999999999999999998 888864211111 0 0
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
......... ..+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111110 0111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=339.89 Aligned_cols=252 Identities=17% Similarity=0.180 Sum_probs=202.0
Q ss_pred CCcccCccccCCcccEEEEEEeC--CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.|...+.||+|+||.||++.... ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48888999999999999998643 5778888875555555567888999999999999999999999999999999999
Q ss_pred CCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 594 PNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 594 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 23446889999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ........+...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~-------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVLYGKYD-------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC--------
Confidence 22233467999999999999999999999999999999999999997432110 011111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122346788999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=321.26 Aligned_cols=199 Identities=27% Similarity=0.362 Sum_probs=173.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4678999999999999999999864 7889999886542 2344678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++.. ...+++..+..++.+|+.||.|||+.+ +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999998853 345889999999999999999999752 3999999999999999999999999998765321
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
......++..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235688999999999988999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.33 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=199.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..+.||+|+||+||+|.+.. ++ .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467778899999999999999743 44 47888875433 234467888888999999999999999875 455789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ......+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~--~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERL--A 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcC--C
Confidence 3332222333556778999999999999999999999999999998 888864321111 1 0111111110 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
.+ ......+.+++.+||+.+|++||++.|+++.|+....
T Consensus 232 ~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 1122356788999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.22 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=201.5
Q ss_pred CCcccCccccCCcccEEEEEEeC------CeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
+|+..++||+|+||.||+|...+ ++.||+|+++.... ...+.|.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667899999999999998643 47899999975433 234678899999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhcc-------------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC
Q 003272 589 VYEYLPNKSLDYFIFDT-------------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN 655 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 655 (834)
++||+++++|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999987421 11235888999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHH
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHA 734 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 734 (834)
+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |..|+...... ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence 99999999887643332222233456778999999998899999999999999999998 77775422111 11
Q ss_pred HHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.......... ..+...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 1122334467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.98 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=201.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeC---------------CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE---------------GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLL 577 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 577 (834)
.++|+..++||+|+||.||++...+ ...||+|+++.. .....+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999987642 235899998654 333456799999999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhhHhhccCC---------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCce
Q 003272 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTR---------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNV 648 (834)
Q Consensus 578 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 648 (834)
+++...+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999998854221 124789999999999999999999988 99999999999
Q ss_pred eecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhC--CCCCCCCCccc
Q 003272 649 LLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG--KRNRGFYHADH 726 (834)
Q Consensus 649 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg--~~p~~~~~~~~ 726 (834)
++++++.+||+|||++..+.............++..|+|||++.+..++.++||||||++++||+++ ..|+.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999865433222222234456789999999999999999999999999999984 44543222111
Q ss_pred ccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
........+........ ...+...+..+.+++.+||+.||++||+|.+|++.|+.
T Consensus 241 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111000000 01111223478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.89 Aligned_cols=265 Identities=27% Similarity=0.398 Sum_probs=204.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-----------------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVK 575 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 575 (834)
.++|+..++||+|+||.||++...+ +..||+|++.... ....+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999998643 2458999987543 345678999999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhhHhhccC--------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003272 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTT--------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647 (834)
Q Consensus 576 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 647 (834)
+++++...+..++++||+++++|..++.... ....+++..++.++.||+.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986432 1236899999999999999999999987 9999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcc
Q 003272 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS--GKRNRGFYHAD 725 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt--g~~p~~~~~~~ 725 (834)
|++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999987543332222333556788999999998899999999999999999998 5555432111
Q ss_pred cccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 726 HRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..........+......... ..+...+.++.+++.+|++.||++||++.||++.|+.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111111111111 1112223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.98 Aligned_cols=245 Identities=20% Similarity=0.232 Sum_probs=198.4
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||++... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 48899999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999988853 345889999999999999999999988 999999999999999999999999999875321
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+...... . ..........
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~----~~~~i~~~~~------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---G----IYEKILAGKL------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHhCCc-------
Confidence 12356899999999999989999999999999999999999997532111 1 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~~ 787 (834)
..+......+.+++.+||+.||.+||+ +.|+++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011112336778999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.21 Aligned_cols=278 Identities=23% Similarity=0.308 Sum_probs=207.5
Q ss_pred cCCcCccCHHHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHh--ccCCceeeE
Q 003272 499 EMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAK--LQHRNLVKL 576 (834)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l 576 (834)
.+++|.+-..++ ..+....+.||+|.||+||+|.+ .|..||||++... .++.+.+|.++.+. |+|+||+.+
T Consensus 198 GSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 198 GSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhh
Confidence 355665544443 34567788999999999999999 7889999999543 34677888888885 599999999
Q ss_pred EEEEEeCC----eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-----CCCceEeccCCCCc
Q 003272 577 LGCCTQRD----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-----SRLRIIHRDLKASN 647 (834)
Q Consensus 577 ~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~DLkp~N 647 (834)
++.-..++ +++||.+|.++|||.++|. +..++....++++..+|.||++||.+ +++.|.|||||+.|
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 98865543 5899999999999999993 46799999999999999999999964 78899999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCc--cccccccccccccccCccccccCC----C--CchhhHHHHHHHHHHHHhCC---
Q 003272 648 VLLDNEMNPKISDFGMARAFGLDQ--TEANTNRVVGTYGYMSPEYAIDGL----F--SVKSDVFSFGVLVLEIVSGK--- 716 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~APE~~~~~~----~--t~~sDV~S~Gvil~elltg~--- 716 (834)
|||.+++.+.|+|+|||....... .....+..+||.+|||||++...- + -..+||||||.++||+...-
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999999999999999998875442 233345688999999999996532 2 23699999999999997522
Q ss_pred -------CCCCCCCcccccchhHHHHHHhhccCcccccCcccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 717 -------RNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY-DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 717 -------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
.||....+ ....+ . ....--..+-+.|.+. .-.+.+.+..+.+++..||..+|..|-|+--|.+.|
T Consensus 427 gi~eey~~Pyyd~Vp-~DPs~-e----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVP-SDPSF-E----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CEehhhcCCcccCCC-CCCCH-H----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 22211100 00111 0 0000001111222221 223445677888999999999999999999999998
Q ss_pred ccCCC
Q 003272 789 SGERS 793 (834)
Q Consensus 789 ~~~~~ 793 (834)
.+...
T Consensus 501 ~~l~~ 505 (513)
T KOG2052|consen 501 AKLSN 505 (513)
T ss_pred HHHhc
Confidence 87654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.68 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=202.5
Q ss_pred CCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
+|...+.||+|+||.||+|+... ...+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46677899999999999998642 3578999886543 2345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccC---------------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003272 589 VYEYLPNKSLDYFIFDTT---------------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 647 (834)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999987 9999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 003272 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADH 726 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~ 726 (834)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999987643322222223455678999999988889999999999999999998 88886422111
Q ss_pred ccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+...... .....+......+.+++.+|++.+|++||++.|+++.|+...
T Consensus 237 ------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111111 011111222346888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.45 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=201.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|...+.||+|++|.||+|.+.+ +..||+|.+.... ......|..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999999854 5678999886443 33446799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCC----CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC---CeEEe
Q 003272 587 VLVYEYLPNKSLDYFIFDTTR----SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM---NPKIS 659 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~ 659 (834)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998864321 235899999999999999999999988 99999999999998654 59999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||+++.+..............+..|+|||++.+..++.++|||||||+++||++ |+.||....... +. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----EFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHH
Confidence 9999987633222111222334568999999999999999999999999999997 888865322111 11 111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.... ....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 01112223456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=325.37 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=194.0
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+.||+|+||.||++... +|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 48899999997542 334467888999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 676 (834)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888753 346899999999999999999999988 9999999999999999999999999987542211 112
Q ss_pred ccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCC
Q 003272 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756 (834)
Q Consensus 677 ~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 756 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+ ......+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~----~~~~~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL----FELILMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HH----HHHHHcCCC----------CCC
Confidence 2367899999999999999999999999999999999999997422111 01 111111110 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 757 LSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 757 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12234678899999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.20 Aligned_cols=268 Identities=28% Similarity=0.400 Sum_probs=201.9
Q ss_pred CC-cccCccccCCcccEEEEEE-----eCCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--Cee
Q 003272 516 NF-SEENKLGEGGFGPVYKGML-----IEGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DER 586 (834)
Q Consensus 516 ~~-~~~~~LG~G~fg~Vy~g~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 586 (834)
+| ...++||+|+||+||++.. .+++.||+|.++... ......|.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7788999999999988653 247789999987543 23457889999999999999999999998664 357
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 899999999999998843 34899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccc-cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQTEAN-TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
......... .....++..|+|||.+.+..++.++||||||++++||++|..|+....... .................+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhh
Confidence 643322111 112345667999999998899999999999999999999998864322110 000000000000011111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.++.......+...+..+.+++.+||+.+|++||++++|+++|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1222221122233445788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.67 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=200.3
Q ss_pred CcccCccccCCcccEEEEEEeC----CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe-----
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE----- 585 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 585 (834)
|...+.||+|+||.||+|.+.. +..||+|+++... ....+++.+|+..++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998753 3679999987532 3345689999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhHhhccC---CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 586 -RVLVYEYLPNKSLDYFIFDTT---RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 586 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
.++++||+++++|..++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
|+++................+..|+|||.+.+..++.++||||||++++||++ |..|+..... ..+. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~----~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIY----DYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHc
Confidence 99987643332222222345678999999988899999999999999999999 8887642211 1111 11111
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+... ..+......+.+++.+||+.||++||++.||++.|++.
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11222344788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.41 Aligned_cols=243 Identities=22% Similarity=0.253 Sum_probs=197.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||+++... ++.||||.+... .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 568888999999999999999864 889999998653 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999988853 345788999999999999999999988 999999999999999999999999999876322
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .........+...
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~------ 233 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLK------ 233 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcC------
Confidence 1 235789999999999999999999999999999999999999742111 0111111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVV 785 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~ 785 (834)
.+......+.+++.+||+.||++||+ +.+++
T Consensus 234 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 ----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 11112235778999999999999997 67776
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.13 Aligned_cols=251 Identities=28% Similarity=0.394 Sum_probs=200.0
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+|+..+.||+|+||.||++.+..+..+|+|.+.+.. ....+|.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467788999999999999998777789999986433 2346788999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999988543 236899999999999999999999988 9999999999999999999999999998653221111
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ........ ...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~---------~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSAGY---------RLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHcCC---------cCC
Confidence 111233457999999999999999999999999999999 788865322111 1 11111110 001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.+...+..+.+++.+||+.+|++||++.||+++|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11123447889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.52 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=191.4
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556678999999999999975 48999999986543 234567899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|... ...++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99998543 23567788899999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~-----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||....... ....... ......
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~-~~~~~~----- 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCA-ICMSQP----- 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHH-HhccCC-----
Confidence 1223578999999998743 234568999999999999999999976322111 1100000 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..........+.+++.+||+.||++||++.||++.
T Consensus 294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112233467889999999999999999999864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=310.20 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=202.0
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..++||+|+||.||+|+..+...||+|+++... ...++|.+|+.++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688999999999999999998777789999996532 34468999999999999999999999874 45689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2345799999999999999999999987 999999999999999999999999999876433221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....++..|+|||++.+..++.++||||||+++|||++ |..|+...... .. ........ .
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~~---------~ 221 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGY---------R 221 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcCC---------C
Confidence 1 122445678999999998899999999999999999999 77776422111 11 11111110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 01122344577899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.48 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=205.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
..++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578888999999999999998743 367999998754 233456788999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhcc-------------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 585 ERVLVYEYLPNKSLDYFIFDT-------------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
..+++|||+++++|..++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999988532 22356899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccch
Q 003272 652 NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNL 730 (834)
Q Consensus 652 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 730 (834)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 999999999999987644332222222345678999999998899999999999999999998 888754221111
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.......+. ....+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus 243 ---~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111111 0111222345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.11 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=205.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEe-CCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-RDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 586 (834)
.++|...+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999866 788999998654 23445678999999999999999999999876 4678
Q ss_pred EEEEeecCCCChhhHhhccCCC-----CCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRS-----KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
++++||+++++|..++...... ..+++..++.++.+|+.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 56899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
|+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... ..+ ......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEM----AAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHH----HHHHHc
Confidence 99986643322222222445678999999998899999999999999999999 9988643211 111 111111
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+.. . ......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 235 ~~~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GYR--L-------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCC--C-------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 100 0 01111234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.87 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=203.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecc--cCcccHHHHHHHHHHHHhccCCceeeEEEEEEe-----CC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-----RD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~ 584 (834)
...+|...+.||+|+||.|..+.... |..||||++.. ......++-.+|+.+|+.++|+||+.+.+.+.. .+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566667899999999999998754 89999999974 344566788999999999999999999999865 35
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++|+|+| ..+|...+. ..+.|+......++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 457887773 3345999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH--------HHH
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG--------HAW 735 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~--------~~~ 735 (834)
+...........+..+.|..|.|||++.+ ..||.+.||||.|||+.||++|++.|...+.-+...++- ...
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 99865433344456889999999998865 579999999999999999999999876544322222111 011
Q ss_pred HHhhccCcccccCcccc------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 QLWIQDRPAELIDKSLY------DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+.....+..... ...-+......++|+.+||..||.+|+|++|.++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111111110000 0001112235678999999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.96 Aligned_cols=241 Identities=21% Similarity=0.238 Sum_probs=192.1
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||+|+||.||++...+ ++.||+|++++. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999764 789999998653 234456788999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 345899999999999999999999988 9999999999999999999999999998643222 12234
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......... ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~-~~~~~~~~~~----------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NE-MYRKILQEPL----------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HH-HHHHHHcCCC----------CCCCc
Confidence 6789999999999999999999999999999999999999753211 11 1111111110 01112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
....+.+++.+||+.||++||++.++.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 234677899999999999998654444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.06 Aligned_cols=246 Identities=30% Similarity=0.434 Sum_probs=194.8
Q ss_pred ccccCCcccEEEEEEe---CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 522 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+||+|+||.||+|.+. ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999753 47889999986443 234578999999999999999999999875 55778999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc-
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN- 675 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~- 675 (834)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 345889999999999999999999988 99999999999999999999999999987644332211
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...... .. ......+.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~~---------~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGER---------ME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCC---------CC
Confidence 112334578999999988889999999999999999998 99887532211 11 111111111 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.+......+.+++.+||+.||++||++.+|++.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 122234467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.89 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=202.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccCc-ccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 585 (834)
.++|...++||+|+||.||+|++.+ +..||||+++.... ...+.+.+|+.++.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 3457778899999999999998642 46899999975432 33457899999999997 9999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccC-----------------------------------------------------------
Q 003272 586 RVLVYEYLPNKSLDYFIFDTT----------------------------------------------------------- 606 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 606 (834)
.++|+||+++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999886421
Q ss_pred ------------------------------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 607 ------------------------------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 607 ------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
....+++..+..++.||+.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124678888999999999999999887 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+......+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 9999999999999987543222122222456788999999998889999999999999999998 888864321111
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
........+. ....+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 350 ---~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 ---QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111111110 0011112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.39 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=196.9
Q ss_pred cccCccccCCcccEEEEEEeCC-e--EEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------Cee
Q 003272 518 SEENKLGEGGFGPVYKGMLIEG-Q--EIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------DER 586 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~g-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 586 (834)
...++||+|+||.||+|.+.+. . .+|+|.++.. .....+.+..|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999998653 2 5899988653 234467889999999999999999999987542 246
Q ss_pred EEEEeecCCCChhhHhhccC---CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 587 VLVYEYLPNKSLDYFIFDTT---RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
++++||+++|+|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999988874321 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .. .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE----IYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcCC
Confidence 987643322111222345678999999999999999999999999999999 7777643111 11 111111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
... ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 1112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.18 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=206.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe--------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++|...+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999999742 24579999986542 34557889999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
...++||||+++++|.+++..... ...+++.++..++.||++||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999864321 245889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
++++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987644333222233455678999999998899999999999999999998 6776532211
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLP 795 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~ 795 (834)
.........+... ..+......+.+++.+||+.+|++||++.||++.|+++....
T Consensus 246 --~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 --EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1111111111111 111223456788999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=339.08 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=204.3
Q ss_pred HHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC---
Q 003272 511 VDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD--- 584 (834)
Q Consensus 511 ~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 584 (834)
....++|...++||+|+||+||++... +++.||||++... .......+.+|+..+..++|+|+++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334578999999999999999999864 5899999998654 3344567889999999999999999988765432
Q ss_pred -----eeEEEEeecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 585 -----ERVLVYEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 585 -----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999886432 2356899999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~-~~~~~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------E-EVMHKT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------H-HHHHHH
Confidence 999999876443333333346799999999999999999999999999999999999999753211 1 111111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+... ..+......+.+++.+||+.||++||++.++++.
T Consensus 258 ~~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 1122233467889999999999999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.92 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=201.5
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..++||+|+||.||++...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56788899999999999999988888999999965433 3567999999999999999999999875 456889999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999988643 2345899999999999999999999988 999999999999999999999999999876432211
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||.+.+..++.++||||||++++||++ |..|+..... .... ...... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~----~~~~~~---------~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVL----EQVERG---------YRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHcC---------CCC
Confidence 1112345668999999988899999999999999999999 8888643211 1111 111111 001
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+......+.+++.+|++.+|++|||+.++.++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=314.84 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=195.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999976 488999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|++ ++|.+++.. ....++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 466666533 2345888999999999999999999988 9999999999999999999999999997653222
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc------c
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP------A 744 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ 744 (834)
. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ............... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 1 1223567899999999875 468899999999999999999999986422110 000001000000000 0
Q ss_pred c--ccCcc-cc--CCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 E--LIDKS-LY--DSCSL-------SEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~--~~d~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ..++. .. ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00000 00 00000 01235678999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.22 Aligned_cols=258 Identities=24% Similarity=0.304 Sum_probs=193.6
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----eeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-----ERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 589 (834)
.|...+++|.|+||.||+|++.+ +..||||++-...+ ---.|+++|+++.|||||+|+-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999865 68999999854322 1135899999999999999998885532 24689
Q ss_pred EeecCCCChhhHhhc-cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeecccccc
Q 003272 590 YEYLPNKSLDYFIFD-TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF 667 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~~ 667 (834)
|||||. +|...+.. ......++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999998 66666643 233456888888999999999999999987 9999999999999966 89999999999998
Q ss_pred CCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc---
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP--- 743 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 743 (834)
..+... ..+..++.|+|||.+.+. .|+.+.||||.||++.||+-|++-|......+ .+......+.....
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d---QL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD---QLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 654433 236789999999999875 79999999999999999999998865432222 22222222211111
Q ss_pred -------ccccCccccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 744 -------AELIDKSLYDS-----CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 744 -------~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+.-.+.+... .......+..+++.++++.+|.+|.++.|+++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111111 222334577889999999999999999999843
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.73 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=194.1
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----eeE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-----ERV 587 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 587 (834)
+|+..++||+|+||.||+|... +++.||||++... ......++.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999975 4899999998643 2234457889999999999999999999886432 479
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+. ++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 578777743 345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccc-cccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------HHHHH
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL--------GHAWQ 736 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~--------~~~~~ 736 (834)
...... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322211 11233578999999999876 67899999999999999999999997532211100000 00000
Q ss_pred HhhccCcccccCc---cccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 737 LWIQDRPAELIDK---SLYD---SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 737 ~~~~~~~~~~~d~---~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
........+.+.. .... ...+.....+.+++.+||+.||++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000 0000 0000112356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.93 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=203.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
..++|+..++||+|+||.||+|...+ +..||+|.+.... ......+.+|+..+++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997642 4579999886543 2334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCC-------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR-------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
.++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864221 234677889999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+...... . ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~----~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---Q----VLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHH
Confidence 99999986543222221222345678999999999999999999999999999998 67775321111 0 1111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
...+... ..+......+.+++.+|++.||++||++.++++.|+...
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111110 011122357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.99 Aligned_cols=259 Identities=16% Similarity=0.169 Sum_probs=193.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..+|+..++||+|+||.||++.... ++.||+|+... +.+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999998754 88999997532 4578899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+. ++|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 577776643 345889999999999999999999987 9999999999999999999999999997542211
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc----ccchhHHHHHHhhccC------
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH----RHNLLGHAWQLWIQDR------ 742 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~------ 742 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-...... ................
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112223579999999999999999999999999999999999998752211100 0000111111000000
Q ss_pred ----ccccc-------CccccCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 ----PAELI-------DKSLYDSC----SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ----~~~~~-------d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+.. ........ .......+.+|+.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000 0122446788999999999999999999984
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.43 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=193.1
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+.||+|+||.||++... +|+.||+|+++.. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 4889999999754 2334567788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 676 (834)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 99888743 346899999999999999999999988 99999999999999999999999999875422211 12
Q ss_pred ccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCC
Q 003272 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756 (834)
Q Consensus 677 ~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 756 (834)
....|++.|+|||++.+..++.++|||||||++|||++|+.|+....... . ......... . .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~----~~~~~~~~~------~----~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L----FELILMEEI------R----FP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcCCC------C----CC
Confidence 23578999999999999999999999999999999999999975321110 1 011111110 0 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 757 LSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 757 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12234677899999999999998 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=319.50 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=194.2
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 4889999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 676 (834)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 346899999999999999999999988 9999999999999999999999999987642221 112
Q ss_pred ccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCC
Q 003272 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756 (834)
Q Consensus 677 ~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 756 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ......... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~----~~~~~~~~~----------~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L----FELILMEDI----------KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---H----HHHhccCCc----------cCC
Confidence 23578999999999999999999999999999999999999974321110 0 011111000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003272 757 LSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVLM 787 (834)
Q Consensus 757 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~ 787 (834)
......+.+++.+||+.||++|| ++.|+++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12234677899999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.95 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=209.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC---C--eEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE---G--QEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~---g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
.+.....++||.|-||.||+|+..+ | -.||||..+.. .....+.|..|+.+|+.++|||||+|+|.|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445566799999999999999644 3 35899998764 44557899999999999999999999999975 5789
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+|||.++.|.|..+|.. +...|+......++.||+.||+|||+.. +|||||.++|||+...--+||+|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999964 3456889999999999999999999987 999999999999999999999999999998
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
..+...... ...-+..|||||.+.-.++|.++|||.|||++||++. |..||-... ..++-..
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~ 604 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGH 604 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEE
Confidence 655443322 4556789999999999999999999999999999987 888864321 1222223
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
+...-+...++.++..++.|+.+||..+|.+||.+.|+...|+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 3333344567778889999999999999999999999988875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=316.54 Aligned_cols=240 Identities=28% Similarity=0.352 Sum_probs=188.6
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||+|...+ ++.||+|.++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999755 7889999997532 23345566677776654 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
|+|..++.. ...++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888853 345889999999999999999999987 9999999999999999999999999998653222 22
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+ ........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---EL----FDSILNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCC----------CCC
Confidence 23367899999999999989999999999999999999999997532211 11 11111110 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNML-SVV 785 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 785 (834)
+......+.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112234567899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.37 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=192.5
Q ss_pred cCCcccCccccCCcccEEEEEEe--CCeEEEEEEecccC--cccHHHHHHHHHHHHhc---cCCceeeEEEEEEe-----
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI--EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKL---QHRNLVKLLGCCTQ----- 582 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 582 (834)
++|+..++||+|+||.||++... +++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 37889999986532 22334566777777765 69999999999853
Q ss_pred CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 583 RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 583 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
....++||||++ ++|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999997 5887777543 2345899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+++..... .......+++.|+|||++.+..++.++|||||||++|||++|+.||......+ .............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 99875432 22233568999999999998899999999999999999999999975432211 1111111000000
Q ss_pred c----------ccccCcccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 P----------AELIDKSLY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~----------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. .....+... ..........+.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000 0000112345678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.05 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=205.5
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999975 5889999987542 2334457899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||+++++|..++.... ....++...+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875322 2345889999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...... .........
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~-~~~~~~~~~----- 226 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLC-QKIEQCDYP----- 226 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHH-HHHhcCCCC-----
Confidence 3221 1235678899999999888899999999999999999999999632111 111111 111110000
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011122335678899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.34 Aligned_cols=265 Identities=24% Similarity=0.370 Sum_probs=201.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-----------------CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-----------------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVK 575 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 575 (834)
.++|+..++||+|+||.||++... ++..+|+|+++.. .....++|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357888999999999999998532 2346899998754 3344578999999999999999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhhHhhccCC--------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003272 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTR--------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647 (834)
Q Consensus 576 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 647 (834)
+++++...+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998864321 234788899999999999999999988 9999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcc
Q 003272 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS--GKRNRGFYHAD 725 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt--g~~p~~~~~~~ 725 (834)
||+++++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999987643322222222344678999999888899999999999999999998 55665422111
Q ss_pred cccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 726 HRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
+ ........+.... ..... ..+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 241 ~---~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQG-RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhcc-ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111100 00000 0111233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=319.89 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=209.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe-eEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE-RVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 590 (834)
++|...+++|+|+||.++..+.. +++.+++|++.-. .....+...+|+.++++++|||||.+.+.+.+.+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999988765 4778999988643 34455577899999999999999999999999998 99999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
+|+++|++.+.+.... ...++++.++.++.||+.|+.|||+.. |+|||||+.|||++.+..+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986543 567899999999999999999999777 999999999999999999999999999998655
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. ....++||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+.. .+.. ......
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~--------ki~~~~---- 222 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL--------KINRGL---- 222 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH--------HHhhcc----
Confidence 42 334489999999999999999999999999999999999999987543221 1111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....+.....++..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123344455678889999999999999999999876
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=313.34 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=202.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..++||+|+||.||++... .+..||+|++.... ....++|.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999864 36789999987543 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccC-------------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003272 587 VLVYEYLPNKSLDYFIFDTT-------------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 647 (834)
++|+||+++++|..++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1134788999999999999999999987 9999999999
Q ss_pred eeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 003272 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADH 726 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~ 726 (834)
|++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999886543322111222344667999999998899999999999999999998 77775321111
Q ss_pred ccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
........+... ..+......+.+++.+||+.+|++||++.||++.|++
T Consensus 240 ------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111111 0111233578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.61 Aligned_cols=254 Identities=28% Similarity=0.385 Sum_probs=192.7
Q ss_pred CccccCCcccEEEEEEeC---CeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+.||+|+||.||+|.+.+ +..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998654 45799999865432 33457889999999999999999999999999999999999999
Q ss_pred ChhhHhhccC--CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 597 SLDYFIFDTT--RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 597 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2234677888899999999999999988 9999999999999999999999999997654332222
Q ss_pred ccccccccccccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 675 NTNRVVGTYGYMSPEYAIDG-------LFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~-------~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+......+ ... ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLT----YTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHH----HHhhcccCCC
Confidence 22335577889999998642 35789999999999999996 998875332211 110 0011111122
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.++.+.. .....+.+++..|+ .+|++||++.||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12235677888998 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.58 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=197.5
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||.||+|... .++.||+|.+... .....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35677889999999999999864 4889999998654 233456799999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..+. .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999996542 3678889999999999999999988 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+......................... .+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~- 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-----VL- 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----CC-
Confidence 223578899999999999899999999999999999999999975432221111110111111111110 11
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
........+.+++.+|++.+|++||+++|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011122367889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.93 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=202.9
Q ss_pred cCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 586 (834)
++|...++||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888999999999999999752 24579999987543 33456789999999999 799999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|..++.... ...+++.++..++.+|+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999985432 234899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... . .......+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~~--- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEGY--- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcCC---
Confidence 644322222222445778999999999999999999999999999998 888864221110 0 011111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
....+......+.+++.+|++.+|++||++.||++.|+.
T Consensus 262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.00 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=204.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998753 3689999986543 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCC-------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 587 VLVYEYLPNKSLDYFIFDTTR-------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
++||||+++++|..++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234789999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ |+.|+...... .+ ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~----~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EV----LKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HH----HHHH
Confidence 9999987643322222223456788999999998889999999999999999998 88886432111 11 1111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+.... .+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 111124578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=311.03 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=202.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCe----EEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQ----EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..++||+|+||+||+|++. +++ .||+|+++.. .....+++.+|+.++..++|+||+++++++.. ....+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999864 344 4899998654 33445678899999999999999999999875 45789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999988542 346899999999999999999999988 9999999999999999999999999998775
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +. .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~--- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGERL--- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcC---
Confidence 3332222222344678999999999999999999999999999998 888864322111 11 111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLP 795 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~ 795 (834)
..+......+.+++.+||+.||++||++.++++.|+.....+
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011122346788999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=316.63 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=203.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC--------CeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++|...++||+|+||.||++...+ ...+|+|.++... .....++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578899999999999999998532 3569999997542 34456788999999999 799999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
+..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999864321 235899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999986643222121222334568999999999899999999999999999998 7777642211
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
............. ..+......+.+++.+|++.+|++||+|.+|++.|+.+.
T Consensus 249 --~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 --EELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred --HHHHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111111111111 111222346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.63 Aligned_cols=245 Identities=23% Similarity=0.276 Sum_probs=199.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC--CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|...++||+|+||.||+|...+ +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568888999999999999998654 368999998653 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999998853 345889999999999999999999988 99999999999999999999999999987532
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... . .......+..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~----~~~~i~~~~~------ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---L----IYQKILEGII------ 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCC------
Confidence 2 12357899999999999988999999999999999999999997532111 0 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~ 787 (834)
..+......+.+++.+|++.||++|+ +++++++.
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111223567899999999999995 89988754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.46 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=202.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 587 (834)
..++|...++||+|.||+|+++.+.. ++.+|||.+++. .....+..+.|.+++... +||.|+.|+.++...++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 44679999999999999999999865 788999999876 456778889999998887 5999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+.+|++..+. ....+++....-++..|+.||.|||+++ ||+||||.+|||||.+|++||+|||+++.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999943333 4567999999999999999999999998 999999999999999999999999999975
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. ....+.+.+||+.|||||++.+..|+.++|-|||||+||||+.|+.||...+.+ ++.
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~F 577 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVF 577 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHH
Confidence 32 223456699999999999999999999999999999999999999997532221 122
Q ss_pred CccccC--CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 748 DKSLYD--SCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 748 d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
|..+.. .++.-...+.+.++.+.+..+|++|.-+
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222211 2333445577889999999999999877
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.68 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=200.6
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|...++||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4678888999999999999998777789999886433 34567899999999999999999999875 456889999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999988643 2345899999999999999999999987 999999999999999999999999999876432211
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ... ......... .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~---------~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REV----LEQVERGYR---------M 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCCC---------C
Confidence 1122345678999999998899999999999999999999 8888642111 111 111111100 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+...+..+.+++.+||+.||++||++.+|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.45 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=202.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|...++||+|+||.||+|...+++.||+|.+.... ...++|.+|+.++++++|+||+++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 35688889999999999999998889999999986543 3456899999999999999999999986 456789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 2356899999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....++..|+|||.+....++.++||||||++++||++ |+.|+...... .. ..........
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~-------- 222 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EV----IQNLERGYRM-------- 222 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HH----HHHHHcCCCC--------
Confidence 1 112345678999999998899999999999999999999 99887422111 11 1111111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+......+.+++.+|++.+|++||++++++.+|+.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111223468889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.82 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=201.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-C--eEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-G--QEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888899999999999998754 3 34788888643 334556899999999999 799999999999999999999
Q ss_pred EeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 590 YEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||++...... ........+..|+|||++.+..++.++|||||||+++||++ |..|+....... ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999998643211 11111223457999999998899999999999999999997 988864322111 11
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLP 795 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~ 795 (834)
.....+ .....+......+.+++.+||+.+|.+||+++++++.|+......
T Consensus 229 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111 000111122346788999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.80 Aligned_cols=251 Identities=30% Similarity=0.428 Sum_probs=211.0
Q ss_pred cccCccccCCcccEEEEEEe-CC----eEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 518 SEENKLGEGGFGPVYKGMLI-EG----QEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~-~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
...++||+|+||+||||.+- +| -+||+|++.+. ..+..+++.+|+..|.+++||||++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 44679999999999999973 33 36899998764 4456789999999999999999999999998766 889999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|||.|.|.++++.+ +..+--+..+.|..|||+||.|||.+. ++||||.++||||..-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999998653 455778899999999999999999987 9999999999999999999999999999998777
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.+.......-.+.|||-|.+....|++++|||||||++||++| |..|.+-...+ ++.+++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhcc
Confidence 6666655566788999999999999999999999999999999 77775432221 223333333
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.+-..++....++..++.+||..|+..||+++++...+.+
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 3345567778899999999999999999999999877653
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.43 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=202.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-C---eEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..++||+|+||.||+|+... + ..+|+|.++... ....+++.+|+.++.+++|+||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788899999999999999753 3 379999986542 34456899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999988542 246899999999999999999999988 99999999999999999999999999987643
Q ss_pred Ccccccc-ccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 670 DQTEANT-NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~~~~~-~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... .....+..|+|||++.+..++.++||||||+++|||++ |+.|+...... . .........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~----~~~~i~~~~----- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---E----VMKAINDGF----- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---H----HHHHHhcCC-----
Confidence 2221111 11223457999999998889999999999999999997 99996432211 1 111111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112234678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.72 Aligned_cols=247 Identities=30% Similarity=0.392 Sum_probs=196.8
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD 599 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 599 (834)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999875533 33457889999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccccc
Q 003272 600 YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679 (834)
Q Consensus 600 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 679 (834)
.++... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 887532 245789999999999999999999987 999999999999999999999999998764322211 11123
Q ss_pred cccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 680 ~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
.++..|+|||++....++.++||||||++++||++ |..|+...... .......... ....+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGY---------RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCC---------CCCCCCC
Confidence 44567999999998899999999999999999998 88886422111 1111111110 0011122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.56 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=194.4
Q ss_pred ccccCCcccEEEEEEe---CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 522 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
.||+|+||.||+|.+. .+..||+|++.... ....++|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999874 35679999986553 234567999999999999999999999875 457899999999999
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc-c
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN-T 676 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~ 676 (834)
|.+++.. ....+++..+++++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 2346899999999999999999999987 99999999999999999999999999986543322111 1
Q ss_pred ccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 677 ~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
....++..|+|||.+....++.++||||||+++|||++ |+.|+...... ........+. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGK---------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCC---------CCCC
Confidence 11233568999999988889999999999999999996 99886432111 0111111111 1112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223345778899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.84 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=207.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999986 5899999988632 2334578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||+++++|..++.... ....+++..+..++.+|++||.|||+.+ |+|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998885432 2455899999999999999999999988 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ...... ......+.
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~-~~~~~~~~------- 224 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSL-CKKIEKCD------- 224 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHH-HhhhhcCC-------
Confidence 3221 122467889999999998889999999999999999999999964221 111110 01111111
Q ss_pred cccCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 750 SLYDSCSL-SEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 750 ~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+. .....+.+++.+||+.+|++||++.+|+++|+..
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 011111 3344678899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.25 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=193.8
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||++.... ++.||||++++. .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999999754 889999999753 223445688899999988 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999887743 346899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--ccchhHHHHHHhhccCcccccCccccC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH--RHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|++...... .................
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 233678999999999999999999999999999999999999986432211 11111111111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPN------MLSVV 785 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~ev~ 785 (834)
..+......+.+++.+||+.||++||+ +.+++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 011122346788999999999999997 66775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.10 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=190.4
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||++.... ++.||+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999754 789999999754 233455678888888877 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999887743 346899999999999999999999988 9999999999999999999999999987542211 11
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc--cchhHHHHHHhhccCcccccCccccC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR--HNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .....+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2236789999999999999999999999999999999999999854222111 1111111111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
..+......+.+++.+||+.||++||+.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1112223467789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.68 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=200.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|+..++||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++|+||+++++.+...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 356888999999999999999974 5889999999765555566788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999988843 345889999999999999999999987 99999999999999999999999999987632221
Q ss_pred ccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 673 EANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. .....++..|+|||.+. ...++.++||||||++++||++|+.|+.......... ..... ....+
T Consensus 162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~~ 229 (267)
T cd06646 162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQPP 229 (267)
T ss_pred c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCCC
Confidence 1 12246788999999884 3457889999999999999999999863221111000 00000 00001
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
.... .......+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 111234678899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.84 Aligned_cols=249 Identities=28% Similarity=0.370 Sum_probs=205.7
Q ss_pred CcccCccccCCcccEEEEEEeC--Ce--EEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE--GQ--EIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~--g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
....++||+|.||.|++|.|.. |. .||||.++..... ....|.+|+..|.+|+|+|+++|+|...+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445689999999999999864 44 5899999765433 67899999999999999999999999987 78899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
.++.|+|.+.|++ .....+-......++.|||.||.||.++. +|||||.++|+||-....+||+|||+.+.++.+.
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999977 45567888999999999999999999988 9999999999999999999999999999986654
Q ss_pred ccccc-ccccccccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 672 TEANT-NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG-KRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 672 ~~~~~-~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
....+ ....-...|+|||.+....++.++|||+|||++|||+++ ..|+- ... .-.+.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~---G~~-------------g~qIL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV---GCR-------------GIQILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC---CCC-------------HHHHHHhccc
Confidence 43332 334456689999999999999999999999999999994 44421 111 1122334444
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.-+-..+..+.+++++++..||..+|.+||++..|..
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 4344456677889999999999999999999999973
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.29 Aligned_cols=259 Identities=25% Similarity=0.315 Sum_probs=195.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcc-cH-HHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ-GV-EEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 589 (834)
+.|+..++|++|.||.||+|+... ++.||+|+++..... +. -...+|+.+|.+.+|||||.+-.+.... +..++|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 568888999999999999999765 788999999754321 11 1357899999999999999998887543 568999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||||+. +|..++.. ..+.+...++.-++.|+++|++|||... |+|||||++|+|+...|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 78777753 3467888999999999999999999987 99999999999999999999999999999865
Q ss_pred CccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... ..+..+-|..|+|||.+.+. .|+...|+||+|||+.||+++++.|......+ .+....... +.+.+.+-
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d---Ql~~If~ll--GtPte~iw 302 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID---QLDKIFKLL--GTPSEAIW 302 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH---HHHHHHHHh--CCCccccC
Confidence 422 22346789999999999875 69999999999999999999998764322211 111111111 11111111
Q ss_pred c-------------------cccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 K-------------------SLYDSCSLS-EAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~-------------------~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+ .+...+... ..+.-++|+...+..||.+|.|++|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1 111111111 2235567888999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=299.36 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=198.8
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcc--cHHHHHHHHHHHHhccCCc-eeeEEEEEEeCC------
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ--GVEEFKNEALLIAKLQHRN-LVKLLGCCTQRD------ 584 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 584 (834)
..|...++||+|+||+||+|+... |+.||+|+++-.... ......+|+.++++++|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345666789999999999999754 899999999755332 2345678999999999999 999999998877
Q ss_pred eeEEEEeecCCCChhhHhhccCCC-CCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRS-KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
..++|+||+.. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999965 777777543322 45777899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
|+....+... ....++|..|+|||++.+. .|+...||||+|||+.||++++..|..... ...+...........
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCC
Confidence 9987544332 2336789999999999886 799999999999999999998887643222 112222222221111
Q ss_pred c------ccccCccc--cC---CCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 743 P------AELIDKSL--YD---SCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 743 ~------~~~~d~~l--~~---~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. ..+.+-.. .. ..+. .......+++.+|++.+|.+|.++..++.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 01111110 00 0000 011366789999999999999999999875
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.71 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=205.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||++... +++.+|||.+... ......++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46777889999999999999964 6899999988643 2334568899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||+++++|.+++... .....+++..+..++.+|++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999987542 23456899999999999999999999988 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... .....++..|+|||++.+..++.++||||||+++|||++|..|+.....+ ... ...... ....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~-----~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIE-----QCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHH-Hhhhhh-----cCCCC
Confidence 3221 12356888999999999889999999999999999999999996421111 000 000110 00001
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.. ........+.+++.+||+.+|++||||.+|.++++..
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01 1112344688899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.61 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=199.7
Q ss_pred hcCCcccCccccCCcccEEEEEE------eCCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC-C
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML------IEGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR-D 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 584 (834)
.++|+..++||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999974 247889999997543 33456788999999999 789999999988654 4
Q ss_pred eeEEEEeecCCCChhhHhhccCC---------------------------------------------------------
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTR--------------------------------------------------------- 607 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 607 (834)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999988753210
Q ss_pred -------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccccc
Q 003272 608 -------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680 (834)
Q Consensus 608 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 680 (834)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999987 9999999999999999999999999998753332222222244
Q ss_pred ccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHH
Q 003272 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSE 759 (834)
Q Consensus 681 gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 759 (834)
++..|+|||.+.+..++.++||||||++++||++ |..|+....... .+ ......+..... +...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~~~---------~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMRA---------PDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCCCCC---------CCCC
Confidence 5678999999999999999999999999999997 888864321110 01 111111111000 0111
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 760 AIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 760 ~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+.+++.+||+.+|++||++.||++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.15 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=202.9
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..+.||.|+||.||++.. .++.||+|.+..... ..+++.+|+.++.+++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4677888999999999999987 588999999976544 56789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999885432 236899999999999999999999988 99999999999999999999999999987632211
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
....+..|+|||.+....++.++||||||++++||++ |..|+...... .+ ......+...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~--------- 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPHVEKGYRM--------- 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhcCCCC---------
Confidence 2344568999999998899999999999999999997 88886432111 11 1111111000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+...+..+.+++.+|++.+|++||++.|++.+|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.33 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=189.6
Q ss_pred CccccCCcccEEEEEEeC---CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
++||+|+||.||+|...+ ...+|+|.+.... ......|.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999998654 3568888876443 334467889999999999999999999999999999999999999
Q ss_pred ChhhHhhccCC--CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 597 SLDYFIFDTTR--SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 597 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 234568888999999999999999988 9999999999999999999999999987643322211
Q ss_pred ccccccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 675 NTNRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~-------~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+...... .. ...........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV----LKQVVREQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH----HHHHhhccCccC
Confidence 1223455678999998743 356889999999999999999 67775422111 01 111111111222
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.++.+. ......+.+++..|+ .||++||+++||+++|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 122335566778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.25 Aligned_cols=250 Identities=28% Similarity=0.366 Sum_probs=202.9
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||+|++|.||+++.. +++.|++|.+... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999975 4889999998643 344567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2456899999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....+++.|+|||++.+..++.++||||||++++||++|+.|+...... ........+...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-------- 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFP-------- 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC--------
Confidence 1 12356788999999999999999999999999999999999997532211 111111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111233468889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.90 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=203.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC--------CeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
.+|.+.+.||+|+||.||++.... +..||+|.++.. .....+++.+|+.++.++ +|+||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997532 236899988643 234467899999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
..++++||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999886421 2245889999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccch
Q 003272 652 NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNL 730 (834)
Q Consensus 652 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 730 (834)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999987643222222222344568999999999999999999999999999998 77775422111
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
............ ..+......+.+++.+|++.+|++||++.|+++.|+....
T Consensus 244 --~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 --ELFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111111111111 1111223467889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.09 Aligned_cols=246 Identities=28% Similarity=0.362 Sum_probs=194.4
Q ss_pred cccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 48899999986532 23346678899999999999999999999999999999999999999
Q ss_pred hhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccc
Q 003272 599 DYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677 (834)
Q Consensus 599 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 677 (834)
...+.... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 88875432 3456899999999999999999999988 999999999999999999999999999876433221 22
Q ss_pred cccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCH
Q 003272 678 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL 757 (834)
Q Consensus 678 ~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 757 (834)
...|++.|+|||++.+..++.++||||||+++|||++|+.|+........ ........ ..... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~--------~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRI--------LNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhh--------cccCC--CCcc
Confidence 35789999999999999999999999999999999999999753221110 00000100 00000 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 758 SEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 758 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2344678899999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.09 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=195.8
Q ss_pred CCcccCccccCCcccEEEEEEe----CCeEEEEEEeccc----CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKS----SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 586 (834)
+|+..++||+|+||.||++... .++.||+|++.+. .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778889999999999998753 4789999998653 223345688899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999888853 345889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|+........ ...........
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~---- 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC---- 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC----
Confidence 5332221 12235789999999999865 478899999999999999999999753222111 11111111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
++. .+......+.+++.+||+.||++|| +++++++
T Consensus 227 --~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 --DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 1112233577899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.84 Aligned_cols=256 Identities=31% Similarity=0.453 Sum_probs=205.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..++|...++||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998788899999986533 3457899999999999999999999999988899999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998543 2346899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.. ......+..|+|||.+.+..++.++||||||++++||++ |+.|+...... ... ...... .
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~~---------~ 221 (261)
T cd05034 159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVL----EQVERG---------Y 221 (261)
T ss_pred hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC---------C
Confidence 11 112334568999999998899999999999999999998 88886422111 111 111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
....+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.21 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=199.3
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.|+..++||+|+||+||++... +++.||||++.... ......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999875 48899999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2345899999999999999999999988 9999999999999999999999999998753222
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.|+....... ............
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~---------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED---------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc----------
Confidence 1 123568899999999998899999999999999999999999975322111 000011100000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~ 787 (834)
....+......+.+++.+||+.||++|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111222344678899999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.47 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=202.0
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...++||+|+||+||++... +++.||||+++... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999986 48899999997542 245567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999987 999999999999999999999999999876433
Q ss_pred c---------------------------cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003272 671 Q---------------------------TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYH 723 (834)
Q Consensus 671 ~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~ 723 (834)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999975322
Q ss_pred cccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 003272 724 ADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-MLSVVLM 787 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~~ 787 (834)
.. ......... . ..+...........+.+++.+|++ ||.+||+ +.|+++.
T Consensus 235 ~~-------~~~~~i~~~-~-----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ-------ETYNKIINW-K-----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-------HHHHHHhcc-C-----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 011111110 0 000000001123467788999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=317.46 Aligned_cols=241 Identities=23% Similarity=0.337 Sum_probs=192.4
Q ss_pred CccccCCcccEEEEEEe----CCeEEEEEEeccc----CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKS----SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++||+|+||.||++... .++.||||+++.. .......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 4788999998753 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999888843 345788889999999999999999988 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ........+..
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~~~--------- 217 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKGKL--------- 217 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC---------
Confidence 122357899999999999888999999999999999999999997532211 01111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234678899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.40 Aligned_cols=248 Identities=29% Similarity=0.385 Sum_probs=198.0
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD 599 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 599 (834)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|+.++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccccc
Q 003272 600 YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679 (834)
Q Consensus 600 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 679 (834)
+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988543 235789999999999999999999988 999999999999999999999999999865422222221223
Q ss_pred cccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 680 ~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..+..|+|||.+.+..++.++||||||++++||++ |..|+....... ........ .....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcC---------CCCCCCcc
Confidence 34567999999998899999999999999999999 777754321110 11111110 00011122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.+..+.+++.+|++.+|++||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3447888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.75 Aligned_cols=248 Identities=26% Similarity=0.328 Sum_probs=204.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..+.||+|.||.||.|+... +-.||+|++.+. ..+...++.+|+++-..|+||||+++++++.+....+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4678899999999999999999765 678999998664 234557889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||.+.|.+...|... ..+.++......++.|+|.||.|+|... ||||||||+|+|++..+.+||+|||-+..-..
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999988643 3456888888999999999999999988 99999999999999999999999998876431
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
..-...+||..|.|||+..+...+..+|+|++|++.||++.|.+||+-... +........- ++.
T Consensus 177 ----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------~etYkrI~k~---~~~-- 240 (281)
T KOG0580|consen 177 ----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------SETYKRIRKV---DLK-- 240 (281)
T ss_pred ----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------HHHHHHHHHc---ccc--
Confidence 122348999999999999999999999999999999999999999864321 1112222111 111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+++.+|+..+|.+|.+..|++.
T Consensus 241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12223346788999999999999999999875
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.47 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=200.2
Q ss_pred CCcccCccccCCcccEEEEEEeC-C---eEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.|+..+.||+|+||.||+|.+.. + ..||||.+... .....++|..|+.++++++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999999754 3 36999998654 3445678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|..++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999988543 345899999999999999999999987 999999999999999999999999998866432
Q ss_pred cccccccc-c--cccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 671 QTEANTNR-V--VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 671 ~~~~~~~~-~--~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
........ . ..+..|+|||.+....++.++||||||++++||++ |..|+...... .. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~----~~~i~~~----- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DV----INAIEQD----- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcC-----
Confidence 22111111 1 12457999999999999999999999999999886 98886432111 11 1111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.. ...+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 228 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred Cc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 001112234678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.64 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=188.0
Q ss_pred CccccCCcccEEEEEEeC-------------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 521 NKLGEGGFGPVYKGMLIE-------------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
+.||+|+||.||+|++.. ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 369999999999998632 2358999886655555668899999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC-------eEEee
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN-------PKISD 660 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-------~kl~D 660 (834)
+||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998887532 345899999999999999999999987 999999999999987664 89999
Q ss_pred eccccccCCCccccccccccccccccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcccccchhHHHHHHh
Q 003272 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIV-SGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 661 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDV~S~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|..|+......+ . ...
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~-~~~ 221 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------K-ERF 221 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------H-HHH
Confidence 9998765322 1245678899999887 467899999999999999998 4777653211100 0 001
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
..... .. .......+.+|+.+||+.||++||++.+|++.|+
T Consensus 222 ~~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11100 00 0111346788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.06 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=202.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..+|+..++||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888899999999999999864 4889999999766656667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998842 34789999999999999999999988 99999999999999999999999999876533221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....+++.|+|||.+.+..++.++|||||||+++||++|+.||....... ......... ....
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~~------ 236 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPEL------ 236 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-CCCC------
Confidence 1 122467889999999998889999999999999999999999974322110 000011000 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.+|++||++.||++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011222346778999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.30 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=198.7
Q ss_pred CccccCCcccEEEEEEeC--C--eEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|++|.||+|.+.. + ..||||.+..... ...+.|.+|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999999754 2 3699999977655 567789999999999999999999999988 889999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-c
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE-A 674 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 674 (834)
++|..++..... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998865332 56899999999999999999999987 999999999999999999999999999887543221 1
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+......+ ... .... .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~-~~~~~------- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK----KIDK-EGERL------- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHh-cCCcC-------
Confidence 1123456788999999998899999999999999999998 999864221111 111 0000 00000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
..+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123356888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.72 Aligned_cols=244 Identities=26% Similarity=0.354 Sum_probs=191.8
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHH---HhccCCceeeEEEEEEeCCeeEEE
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLI---AKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
|+..++||+|+||.||++.... ++.||||++++.. ....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5567899999999999998754 8899999997542 23445667776655 456799999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 346899999999999999999999988 99999999999999999999999999875422
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.|+...... .. .........
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~----~~~i~~~~~------ 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EV----FDSIVNDEV------ 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC------
Confidence 11 1223367899999999999999999999999999999999999997532211 01 111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01111234677899999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.48 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=198.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...++||+|+||+||++... +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999875 48899999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988543 246899999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~------~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.|+....... ........ .
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~--~ 225 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNF--Q 225 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcC--C
Confidence 222 222357899999999986 4567899999999999999999999975321110 01111110 0
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... ...........+.+++..|++ +|++||++.++++
T Consensus 226 ~~~----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 RFL----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred Ccc----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 000111123456778889998 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.64 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=190.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC--------
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-------- 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 583 (834)
..++|...++||+|+||.||+|...+ ++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 45679999999999999999999754 8899999885432 2345799999999999999999886432
Q ss_pred CeeEEEEeecCCCChhhHhhc-cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeee
Q 003272 584 DERVLVYEYLPNKSLDYFIFD-TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDF 661 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~Df 661 (834)
...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 136689999986 55555432 234456899999999999999999999988 99999999999999665 7999999
Q ss_pred ccccccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
|+++.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|.+||......+ .+.. .......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCC
Confidence 99987643221 1235679999999998764 68999999999999999999999975322111 1111 1111100
Q ss_pred cCc----------cc-----ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 741 DRP----------AE-----LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 741 ~~~----------~~-----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... .+ .....+...++......+.+|+.+||+.||.+|||+.|+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 00 00001111111223356889999999999999999999983
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.76 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=195.4
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----eeE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-----ERV 587 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 587 (834)
+|+..++||+|+||.||++... +++.||||++... .....+++.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677889999999999999974 5899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+|+||+.+ +|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999974 6666663 2356899999999999999999999988 999999999999999999999999999875
Q ss_pred CCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc--
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA-- 744 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 744 (834)
....... .....+++.|+|||++.+. .++.++|||||||+++||++|+.||........ ..............
T Consensus 154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence 4332221 2234678899999998874 579999999999999999999999864322111 11000000000000
Q ss_pred ---------cccC----c-cc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 ---------ELID----K-SL--YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ---------~~~d----~-~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+.. + .. ...........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 0 00 000111123467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.23 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=193.8
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.|+..++||+|+||+||+|+... ++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999998754 7899999996532 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 345888999999999999999999988 9999999999999999999999999986432100
Q ss_pred cc---------------------------------------------cccccccccccccCccccccCCCCchhhHHHHH
Q 003272 672 TE---------------------------------------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 706 (834)
Q Consensus 672 ~~---------------------------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~G 706 (834)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 003272 707 VLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLL--CVQQIPEDRPNMLSV 784 (834)
Q Consensus 707 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~ev 784 (834)
|++|||++|+.||........ ............. .........+.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999753221110 0000000000000 0000112345566655 566777779999999
Q ss_pred HHH
Q 003272 785 VLM 787 (834)
Q Consensus 785 ~~~ 787 (834)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.80 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=202.6
Q ss_pred cCCcccCccccCCcccEEEEEEe--------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
++|...++||+|+||.||++... ....+|+|.++... .....++..|+.++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57788899999999999999752 24579999987542 34456789999999999 6999999999999988
Q ss_pred eeEEEEeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
..++++||+++++|..++.... ....+++.++..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986432 1245899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccch
Q 003272 652 NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNL 730 (834)
Q Consensus 652 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 730 (834)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H-
Confidence 999999999999987643222221222334567999999999899999999999999999999 78776432111 1
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
........... ..+......+.+++.+|++.+|++||++.|+++.|+...
T Consensus 245 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ---LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111111111 111222346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.23 Aligned_cols=249 Identities=31% Similarity=0.467 Sum_probs=196.2
Q ss_pred CccccCCcccEEEEEEeC----CeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998643 26899999875543 35568999999999999999999999875 5578999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 36899999999999999999999987 99999999999999999999999999987643322111
Q ss_pred -cccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 676 -TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 676 -~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. .........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVI----AMLESGERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHcCCcC---------
Confidence 111233567999999998999999999999999999998 89887532211 111 111111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+...+..+.+++.+|++.+|++||++.+|++.|++..
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.85 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=199.4
Q ss_pred HHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 511 ~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
+.+++.+.....||+|+||.||+|+..+ +..||+|.+........+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3455666666799999999999999654 778999998776666677899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~ 668 (834)
+||+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322112378888999999999999999987 999999999999986 6799999999987653
Q ss_pred CCccccccccccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... ......++..|+|||++.... ++.++||||||++++||++|+.|+........ . .+......
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~--~~~~~~~~----- 228 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---A--MFKVGMFK----- 228 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---h--Hhhhhhhc-----
Confidence 2221 122245788999999986643 78999999999999999999999643211100 0 00000000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+......+.+++.+||+.+|++||++.||+.
T Consensus 229 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001112223346788999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.54 Aligned_cols=250 Identities=34% Similarity=0.482 Sum_probs=202.7
Q ss_pred CccccCCcccEEEEEEeC----CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||++.... +..|++|.++..... ..+++.+|+..+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999864 788999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCC------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 596 KSLDYFIFDTTR------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 596 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367999999999999999999999987 99999999999999999999999999988754
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
...........++..|+|||.+....++.++||||+|++++||++ |..|+...... . ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---E----VLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCC-----
Confidence 432222333567889999999998899999999999999999999 58886543111 1 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
...+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222457888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.00 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=191.6
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||++.... ++.||+|++++.. ....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999754 7889999997542 23456688899999888 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999887743 346899999999999999999999988 9999999999999999999999999987532211 11
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........................ . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~---------~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R---------I 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C---------C
Confidence 23367899999999999999999999999999999999999998643322222222222222211110 0 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
+......+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122356789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.05 Aligned_cols=271 Identities=28% Similarity=0.396 Sum_probs=203.9
Q ss_pred cCCcccCccccCCcccEEEEEEe-----CCeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEe--CCee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDER 586 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 586 (834)
+.|...+.||+|+||.||++.+. .+..+|||.++..... ..+.|.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999864 2678999999765443 56789999999999999999999999877 5578
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 235899999999999999999999987 99999999999999999999999999988
Q ss_pred cCCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... .............+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence 7532221 1111234456799999999889999999999999999999999886432111100 0000000000000001
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.+........+......+.+++.+||+.+|++||+|.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111222335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.50 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=173.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||+||++.... ++.||||++++.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998754 8899999996532 234467888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999998853 356899999999999999999999988 999999999999999999999999999765321
Q ss_pred ccc---------------------------------cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003272 671 QTE---------------------------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717 (834)
Q Consensus 671 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~ 717 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCC
Q 003272 718 NRG 720 (834)
Q Consensus 718 p~~ 720 (834)
||.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=319.10 Aligned_cols=242 Identities=23% Similarity=0.295 Sum_probs=192.6
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
+.||+|+||.||++... .++.||+|++++. ......++..|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 4889999999753 2234567788999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 99888743 3468999999999999999999997 56 99999999999999999999999999875422211 1
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....+. . ......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~----~~~i~~~~~------~----~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L----FELILMEEI------R----F 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---H----HHHHhcCCC------C----C
Confidence 223568999999999999999999999999999999999999974321110 1 011111100 0 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVLM 787 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~ 787 (834)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111233677899999999999996 89998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.71 Aligned_cols=241 Identities=28% Similarity=0.359 Sum_probs=191.4
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccC-CceeeEEEEEEeCCeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH-RNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 590 (834)
+|+..+.||+|+||.||+|...+ ++.||||++++. .....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788899999999999999765 778999999753 23445678889999999966 56888999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999888843 345889999999999999999999988 999999999999999999999999998753221
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+ .........
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~----~~~i~~~~~------- 218 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL----FQSIMEHNV------- 218 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC-------
Confidence 11 122357899999999999999999999999999999999999997532211 11 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
..+......+.+++.+||+.||++||+.
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111123367789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.76 Aligned_cols=240 Identities=27% Similarity=0.348 Sum_probs=189.3
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||++.... |+.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999864 8899999997542 23445667788877754 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987532111 11
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+ ........ +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~----~~~~~~~~------~~~---- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DEL----FESIRVDT------PHY---- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH----HHHHHhCC------CCC----
Confidence 2336789999999999999999999999999999999999999753211 111 11111110 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNML-SVV 785 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 785 (834)
+......+.+++.+||+.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111233677899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.08 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=198.0
Q ss_pred HHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC------
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR------ 583 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 583 (834)
.+++.|+..+.||+|+||.||+|...+ ++.||+|++.... ....++..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456788888999999999999998754 7889999986543 4456788999999998 799999999998753
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
...++||||+++++|..++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999988543 2346889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
+........ ......|+..|+|||++. ...++.++|||||||++|||++|+.|+....... .....
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~ 228 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLI 228 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHH
Confidence 986533221 122356889999999986 3468889999999999999999999974322111 00011
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......... .......+.+++.+||+.+|.+||++.|+++
T Consensus 229 ~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111111 1112346788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.65 Aligned_cols=239 Identities=22% Similarity=0.306 Sum_probs=186.6
Q ss_pred ccccCCcccEEEEEEeC-------------------------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeE
Q 003272 522 KLGEGGFGPVYKGMLIE-------------------------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKL 576 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 576 (834)
+||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 23589999876555556788999999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC--
Q 003272 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-- 654 (834)
Q Consensus 577 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-- 654 (834)
++++.+....++||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888532 346889999999999999999999987 99999999999997654
Q ss_pred -----CeEEeeeccccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcccc
Q 003272 655 -----NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIV-SGKRNRGFYHADHR 727 (834)
Q Consensus 655 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~ell-tg~~p~~~~~~~~~ 727 (834)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3799999988654221 11346778999998876 56899999999999999995 6888864322111
Q ss_pred cchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
... ..... ..+ +......+.+++.+||+.+|++||++.+|++.|+
T Consensus 230 --~~~----~~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KER----FYEKK-------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHH----HHHhc-------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 00000 000 0011235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.52 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=199.7
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-----GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|...+.||+|++|.||++... .++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999875 48899999986432 1234578899999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988853 345888999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccc-cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEAN-TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+..... . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~------ 223 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKIATQP------ 223 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----H-HHHHHHhccC------
Confidence 3221111 1235577899999999998999999999999999999999999642111 0 0011110000
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.....+......+.+++.+||+.+|++||++.|+++.
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011122233467789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.39 Aligned_cols=258 Identities=29% Similarity=0.441 Sum_probs=199.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..+.||+|+||.||+|.+.. +. .||+|.+..... ....++.+|+.++++++||||+++++++... ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 457778899999999999998743 43 478898865432 3345788999999999999999999998754 5679
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988532 335889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ......... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~--~- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---I----PDLLEKGER--L- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCC--C-
Confidence 4333222333445678999999999999999999999999999997 888864221110 1 111111100 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
..+......+.+++..||..+|++||++.++++.|+.....
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01111234678899999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.12 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=196.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+++... ++.||||++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468889999999999999999754 8899999997532 334567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998854 345899999999999999999999988 999999999999999999999999998765321
Q ss_pred cccc------------------------------------ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh
Q 003272 671 QTEA------------------------------------NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714 (834)
Q Consensus 671 ~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt 714 (834)
.... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 003272 715 GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN---MLSVVL 786 (834)
Q Consensus 715 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 786 (834)
|..||....... ......... ..+.-+ . .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~-------~~~~i~~~~-~~~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE-------TYRKIINWK-ETLQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH-------HHHHHHcCC-CccCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999975322110 001111100 000000 0 00112356678888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=337.56 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=201.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+|.... ++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578899999999999999999754 8899999997542 233567999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccC--------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 591 EYLPNKSLDYFIFDTT--------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234677888999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccc----------------cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 003272 663 MARAFGLDQTE----------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726 (834)
Q Consensus 663 la~~~~~~~~~----------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~ 726 (834)
+++........ .......||+.|+|||++.+..++.++|||||||+++||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221100 01122568999999999999999999999999999999999999975321110
Q ss_pred ccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccC
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-NMLSVVLMLSGE 791 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~ 791 (834)
.. .. .. ..++... ......+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 ---i~---~~----~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---IS---YR----DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hh---hh----hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 00 0000000 00012234577899999999999995 677777777643
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.98 Aligned_cols=254 Identities=27% Similarity=0.407 Sum_probs=202.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..++||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999877888999988643 3345689999999999999999999999887 7789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2346889999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......++..|+|||++....++.++||||||++++||++ |+.|+..... ..+ ......+...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~----~~~~~~~~~~-------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEV----IRALERGYRM-------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHhCCCCC--------
Confidence 1112345677999999998889999999999999999999 8888642211 111 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.........+.+++.+|++.+|++||++.++.++|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112233467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.10 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=192.4
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||+|+..+ ++.||+|+++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999765 789999998754 233445677888888866 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 999888743 345889999999999999999999988 99999999999999999999999999876432221 1
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....|++.|+|||++.+..++.++||||||+++|||++|+.|+...... .. ......+.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~----~~~i~~~~~---~-------~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DL----FESILHDDV---L-------Y 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC---C-------C
Confidence 22357899999999999999999999999999999999999997532211 11 111111110 0 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRP-------NMLSVVLM 787 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~ev~~~ 787 (834)
+......+.+++.+||+.||++|| ++.++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111224677899999999999999 78887643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.19 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=204.7
Q ss_pred cCCcccCccccCCcccEEEEEE-eCCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++. +.+..-.+++|+++|..|+||||+.++.+|...+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4678888999999999999986 45999999999765 4556667899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||..+|.|.+++. +...|++.+..++++||..|+.|+|.+. ++|||||.+|||||.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999994 4567999999999999999999999987 999999999999999999999999999886422
Q ss_pred ccccccccccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
......+|.+-|.+||++.+.+|. +.+|-|||||+||-|+.|.-||+..+- ..++ .+...+...
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv----rQIs~GaYr----- 271 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV----RQISRGAYR----- 271 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH----HHhhccccc-----
Confidence 233458999999999999999885 789999999999999999999864321 1111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+..+....-|++|||-.+|++|-|+.+|..-
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 12223345568999999999999999999854
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.32 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=198.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
..++|+..++||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34678899999999999999999754 889999998643 22344567889999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34788889999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .. ..........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~-~~~~i~~~~~- 264 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VG-TYSKIMDHKN- 264 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HH-HHHHHHcCCC-
Confidence 3221 112235789999999998653 478899999999999999999999753211 10 1111111100
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED--RPNMLSVVLM 787 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~~ 787 (834)
. +.-.........+.+++.+||+.+|++ ||++.|+++.
T Consensus 265 ~-----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 S-----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c-----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000001112346778999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.88 Aligned_cols=236 Identities=28% Similarity=0.392 Sum_probs=189.2
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||++.... ++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 889999998753 234456778888888876 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987642221 12
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence 233578999999999999999999999999999999999999975322111 1111111111 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
+......+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11123467789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.63 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=198.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||.||++.... +..+|+|.+.... ....+++.+|++++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368888999999999999998754 7889999886542 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ..+++..+..++.||++||.|||+.. +++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999998542 55889999999999999999999742 3999999999999999999999999998765322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC----------
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR---------- 742 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 742 (834)
......++..|+|||.+.+..++.++||||||++++||++|+.|+.......................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 12235688999999999888899999999999999999999999753221110000000000000000
Q ss_pred -------cccccCcccc---CCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 743 -------PAELIDKSLY---DSC-SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 743 -------~~~~~d~~l~---~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+..+.... ... .......+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 000 00123457899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.52 Aligned_cols=240 Identities=28% Similarity=0.377 Sum_probs=189.8
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||+|...+ ++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999865 7889999997542 23345667788888764 899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 999988843 345889999999999999999999988 99999999999999999999999999875422211 1
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+ ........ +. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~----~~~i~~~~------~~----~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL----FQSIRMDN------PC----Y 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCC------CC----C
Confidence 23357899999999999999999999999999999999999997532211 11 11111110 00 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNML-SVV 785 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 785 (834)
+......+.+++.+||+.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111223577899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=303.66 Aligned_cols=247 Identities=26% Similarity=0.330 Sum_probs=192.2
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||+|+||.||++.... |+.+|+|++.... ....+.+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998754 8999999986432 12334566799999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 88875432 345889999999999999999999988 99999999999999999999999999987643221 123
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..++..|+|||++.+..++.++|||||||++|||++|+.|+........ .. ............. . ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~-~~~~~~~~~~~~~-----~----~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KE-ELKRRTLEDEVKF-----E----HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HH-HHHHHhhcccccc-----c----ccc
Confidence 5688999999999998999999999999999999999999753221110 00 0111111111000 0 011
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
....+.+++.+||+.||++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 233578899999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=320.43 Aligned_cols=194 Identities=22% Similarity=0.273 Sum_probs=166.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..+|...++||+|+||.||++...+ ++.||||.... ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578899999999999999999865 78899996422 3467899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+. ++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 677776643 2346899999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNR 719 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~ 719 (834)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999988653
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.25 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=194.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...++||+|+||+||++... +++.||||++.+. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999875 4889999998653 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 345888999999999999999999988 999999999999999999999999999643210
Q ss_pred ccc------------c---------------------------------ccccccccccccCccccccCCCCchhhHHHH
Q 003272 671 QTE------------A---------------------------------NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSF 705 (834)
Q Consensus 671 ~~~------------~---------------------------------~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~ 705 (834)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc-cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCC---CCH
Q 003272 706 GVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ-DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDR---PNM 781 (834)
Q Consensus 706 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~ 781 (834)
||++|||++|+.||....... . ...... .....+.+ .......+.+++.+|++ +|.+| |++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~---~----~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE---T----YRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH---H----HHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999975322111 0 011110 00000100 00112356778889997 66665 599
Q ss_pred HHHHHH
Q 003272 782 LSVVLM 787 (834)
Q Consensus 782 ~ev~~~ 787 (834)
.|+++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.51 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=201.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC----CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+|.... +..+|+|.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467788999999999999998742 3479999986543 33456889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++... ...+++.++..++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 245899999999999999999999988 99999999999999999999999999987644
Q ss_pred Ccccccc-ccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 670 DQTEANT-NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~~~~~-~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... ....++..|+|||.+.+..++.++||||||++++|+++ |..|+....... .. .....+. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~--~-- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGY--R-- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCC--c--
Confidence 3221111 11233568999999998899999999999999999886 998864322111 11 1111110 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.......+..+.+++.+|++.+|++||+|.++++.|+..
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001112234678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.95 Aligned_cols=252 Identities=29% Similarity=0.447 Sum_probs=200.6
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
.+|+..+.||+|+||.||++.+.+++.+|+|++.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577788999999999999998778899999986433 334679999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888532 235789999999999999999999988 9999999999999999999999999988654322111
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. .....+ .....+.
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~--~~~~~~~--- 224 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV----ETINAG--FRLYKPR--- 224 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHhCC--CCCCCCC---
Confidence 111234578999999998899999999999999999998 88886432211 111 111111 0111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.....+.+++.+||+.+|++||++.|+++.|.
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.08 Aligned_cols=241 Identities=28% Similarity=0.355 Sum_probs=191.6
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 590 (834)
+|...+.||+|+||.||++.... ++.||+|++++.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 46778899999999999998764 7799999987542 23345667788888777 6899999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888743 345889999999999999999999988 999999999999999999999999999764322
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+. ........
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~----~~i~~~~~------- 218 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF----QSIMEHNV------- 218 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC-------
Confidence 11 222367899999999999999999999999999999999999997532211 111 11111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
..+......+.+++.+|++.||++|++.
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111223467889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.43 Aligned_cols=251 Identities=31% Similarity=0.463 Sum_probs=197.3
Q ss_pred CccccCCcccEEEEEEeC-------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998753 2579999886543 24466889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC----CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-----CeEEeeecc
Q 003272 593 LPNKSLDYFIFDTT----RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-----NPKISDFGM 663 (834)
Q Consensus 593 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-----~~kl~DfGl 663 (834)
+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2245889999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~----~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVL----QHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHH----HHHhcCC
Confidence 986643322222222345678999999999999999999999999999998 88886422111 111 0111100
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
....+...+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001112234567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.01 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=193.3
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
+|+..++||+|+||.||++.... ++.||||++.+.. ....+.+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999999754 8899999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|.+++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 345888899999999999999999988 9999999999999999999999999985431100
Q ss_pred c-----------------------------------------ccccccccccccccCccccccCCCCchhhHHHHHHHHH
Q 003272 672 T-----------------------------------------EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 710 (834)
Q Consensus 672 ~-----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ 710 (834)
. ........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011246899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 003272 711 EIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP---NMLSVVLM 787 (834)
Q Consensus 711 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~ev~~~ 787 (834)
||++|+.||......+. . ........ .... .........+.+++.+|+ .+|.+|+ ++.|+++-
T Consensus 236 ell~G~~Pf~~~~~~~~------~-~~i~~~~~-~~~~-----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------Q-LKVINWET-TLHI-----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------H-HHHhccCc-cccC-----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999754321110 0 00000000 0000 000111234556666765 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.98 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=198.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce--EEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+|.+.+ +. .+|+|+++.. .....+++.+|+.++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467778899999999999999753 43 4688877543 234556889999999999 899999999999999999999
Q ss_pred EeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 590 YEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
+||+++++|..++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235889999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++..... ........+..|+|||++.+..++.++||||||++++||++ |..|+...... ...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~---- 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---- 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHH----
Confidence 99999998643211 11111234567999999988889999999999999999998 99886422111 111
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....... ....+......+.+++.+||+.+|++||++.+++++|+..
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111100 0001111233578899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=300.24 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=197.5
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEE-eCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT-QRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~E~~ 593 (834)
++|...+.||+|+||.||++.. .|..||+|.++.. ...+.|.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678888999999999999986 5788999998543 23567999999999999999999999865 445689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..+..++.+|+.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988543 2345889999999999999999999988 9999999999999999999999999988653221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+.... +.. .......+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~-~~~~~~~~~~~-------- 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKD-VVPRVEKGYKM-------- 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHH-HHHHHhcCCCC--------
Confidence 12344568999999998899999999999999999998 888864211 111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=318.45 Aligned_cols=238 Identities=24% Similarity=0.276 Sum_probs=190.3
Q ss_pred CccccCCcccEEEEEE----eCCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 521 NKLGEGGFGPVYKGML----IEGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
+.||+|+||.||++.. ..|+.+|+|++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 247899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999888843 345899999999999999999999988 9999999999999999999999999998653321 1
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ......... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~----~~~i~~~~~----------~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ET----MTMILKAKL----------G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HH----HHHHHcCCC----------C
Confidence 222367899999999999888999999999999999999999997532211 01 111111110 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 783 (834)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122346778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.78 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=195.7
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|...++||+|+||.||+|+.. .++.||+|+++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999875 47889999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 676666432 345889999999999999999999988 99999999999999999999999999976533222
Q ss_pred ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH--------HHHHHhhccCc
Q 003272 673 EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG--------HAWQLWIQDRP 743 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~ 743 (834)
. .....+++.|+|||.+.+ ..++.++||||||++++||++|+.||......+...... ..+......
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (309)
T cd07872 160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN-- 235 (309)
T ss_pred c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch--
Confidence 1 122467889999998865 468999999999999999999999975432211100000 000000000
Q ss_pred ccccCccccC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKSLYD-------SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+..+..... .........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000112335678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.74 Aligned_cols=241 Identities=29% Similarity=0.358 Sum_probs=192.8
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||++.... ++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 789999999754 233456678888888887 799999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 999888743 346899999999999999999999988 99999999999999999999999999875322211 1
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... . .......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~----~~~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---E----LFQSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---H----HHHHHHcCCC----------CC
Confidence 22356899999999999999999999999999999999999997532211 1 1111111111 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNM-----LSVVL 786 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 786 (834)
+......+.+++.+||+.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11223467889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.74 Aligned_cols=240 Identities=20% Similarity=0.264 Sum_probs=187.4
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHH-HHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEAL-LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||++... +|+.+|+|++.+. .....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 4889999999653 2233345555654 46678999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999887743 346899999999999999999999988 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+...... . .......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~----~~~~~~~~~~------~----~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---E----MYDNILHKPL------V----L 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---H----HHHHHHcCCc------c----C
Confidence 23367899999999999999999999999999999999999997532111 0 1111111110 0 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
.+.....+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 112234677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=302.28 Aligned_cols=252 Identities=30% Similarity=0.449 Sum_probs=197.6
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccH--HHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGV--EEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
|+..++||+|+||+||+++... ++.+|+|++........ .....|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5667899999999999999866 67899999976543322 23456999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|..++. ....+++..+..++.||++||.+||+.+ |+|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999986 3456899999999999999999999988 9999999999999999999999999998641 122
Q ss_pred cccccccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~-~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+............. .... ..... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~-~~~~~----~~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILK-RPLPS----SSQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHH-THHHH----HTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccc-ccccc----ccc
Confidence 2233467889999999998 7889999999999999999999999975431111111110 0000 00000 000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
........+.+++..||+.||++||++.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001157889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.30 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=196.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
..++|+..++||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999864 788999998642 22334568899999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999998843 34788899999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... .......||+.|+|||++... .++.++||||+||++|||++|+.||..... ... .........
T Consensus 194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~-~~~i~~~~~- 264 (370)
T cd05621 194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGT-YSKIMDHKN- 264 (370)
T ss_pred cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCCc-
Confidence 2221 122346799999999998754 378899999999999999999999753211 111 111111000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED--RPNMLSVVLM 787 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~~ 787 (834)
.+...........+.+++..|++.+|.+ ||++.|+++.
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000011112335667888888865544 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=302.42 Aligned_cols=249 Identities=29% Similarity=0.459 Sum_probs=193.6
Q ss_pred CccccCCcccEEEEEEeC-Ce--EEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||+|.+.+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999855 33 5788988643 334556889999999999 899999999999999999999999999
Q ss_pred CChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 596 KSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 596 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1235889999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
++...... ........+..|+|||++....++.++||||||++++||++ |+.|+...... .. .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~----~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL----YEKLPQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HH----HHHHhCC
Confidence 98643211 11111233567999999988899999999999999999997 88886421110 11 1111111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
... ..+......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000 01111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=318.39 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=197.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC---CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
..+|...++||+|+||.||++...+ +..||||.+... +.+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3579999999999999999997533 578999988543 24568999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|++. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 56767662 3456899999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc----
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL---- 746 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 746 (834)
..........||+.|+|||++....++.++|||||||++|||++|+.|+...........+........... .+.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~-~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP-LEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc-cccCCcc
Confidence 333333346799999999999999999999999999999999999999743322211111111111100000 000
Q ss_pred ----------cCccccCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 747 ----------IDKSLYDSCS-------LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 747 ----------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.......... ......+.+++.+||+.||++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0113456789999999999999999999876
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.99 Aligned_cols=262 Identities=26% Similarity=0.382 Sum_probs=200.6
Q ss_pred CCcccCccccCCcccEEEEEEe-----CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERV 587 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 587 (834)
-|...++||+|+||.||++... .+..||+|.++... ....+.+.+|+.++++++|+||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4677889999999999999742 47789999986543 34456899999999999999999999998775 5688
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999988532 235899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc--------cccchhHHHHHHh
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHAD--------HRHNLLGHAWQLW 738 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~ 738 (834)
...... .......++..|+|||.+.+..++.++||||||++++||++++.|....... .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 1112345677899999999888999999999999999999987653211000 0000000000001
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+. ........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1100 0011122345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.97 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=202.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|...++||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 467888999999999999999964 5899999999766656667889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998842 35789999999999999999999987 99999999999999999999999999876543322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+.......... .....+ .+.
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~~-- 234 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPE-- 234 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CCC--
Confidence 1 123567889999999999889999999999999999999999974322111000 000000 000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+......+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011122345678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=322.09 Aligned_cols=200 Identities=24% Similarity=0.394 Sum_probs=171.3
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
+|+..++||+|+||+||+|+... ++.||+|++.+.. ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999998754 7889999986542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998853 245788899999999999999999988 9999999999999999999999999975431100
Q ss_pred c---------------------------------------------ccccccccccccccCccccccCCCCchhhHHHHH
Q 003272 672 T---------------------------------------------EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 706 (834)
Q Consensus 672 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~G 706 (834)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 003272 707 VLVLEIVSGKRNRGF 721 (834)
Q Consensus 707 vil~elltg~~p~~~ 721 (834)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.84 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=189.2
Q ss_pred CccccCCcccEEEEEEeC--------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998643 234888888665555667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC--------eEEeeeccc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN--------PKISDFGMA 664 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------~kl~DfGla 664 (834)
+++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 236899999999999999999999988 999999999999987765 599999988
Q ss_pred cccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCcccccchhHHHHHHhhccC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGK-RNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ........
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~ 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYEDR 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHHcc
Confidence 654321 224577889999999874 5799999999999999999995 4432211110 00011100
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
...+......+.+++.+||+.||++||+++++++.|+
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111122246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.90 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=189.6
Q ss_pred CccccCCcccEEEEEEeCCe---EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 521 NKLGEGGFGPVYKGMLIEGQ---EIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
++||+|+||+||+|...++. .+++|.+.... ....+.|.+|+..++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999865433 46677765433 345678999999999999999999999999999999999999999
Q ss_pred ChhhHhhccCC-CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 597 SLDYFIFDTTR-SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 597 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
+|..++..... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99998865322 234677788899999999999999987 99999999999999999999999999865322221112
Q ss_pred cccccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 676 TNRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVSG-KRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~-------~~~t~~sDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... .. .......+....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~----~~~~~~~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE----VLNHVIKDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH----HHHHHHhhcccccC
Confidence 223567889999998753 2457899999999999999975 556432111 11 11111222223333
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
++.+.... ...+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 43333222 235677888999 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=305.23 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=198.7
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 45566789999999999998754 7889999986443 344567899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|..++. ...+++..+..++.+|++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+......
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 9999988873 245889999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+....... .. ....... . .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~----~~~~~~~-----~----~ 219 (277)
T cd06642 158 --RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL----FLIPKNS-----P----P 219 (277)
T ss_pred --hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH----hhhhcCC-----C----C
Confidence 122467889999999999899999999999999999999999864221111 00 0000000 1 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.........+.+++.+||+.+|++||+|.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122234567889999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.46 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=202.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|+..++||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999866 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++.. ....+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998843 2356899999999999999999999988 99999999999999999999999999987643321
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ........ +.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-----~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP-----PTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC-----CCC--
Confidence 122345788999999999889999999999999999999999997532221100 00000000 000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.+|++||++.||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111222346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=303.29 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=201.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.+|+..++||+|+||.||+|.+.+ |. .+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788899999999999998753 32 58999886554 3345688999999999999999999999987 78899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 334899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............++..|+|||.+....++.++||||||++++|+++ |+.|+......+ + .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---I----PDLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHhCCCC----
Confidence 3322222222234568999999988899999999999999999998 999865322111 1 111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+.+++.+||..+|++||++.++++.|+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.35 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=198.0
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
|+..++||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5567789999999999999865 778899998766666677899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 9998887532 346899999999999999999999988 99999999999999999999999999876532211 1
Q ss_pred cccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 676 TNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+...... ..... ..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHH-HhhcCCCCCC---
Confidence 22356889999999984 345788999999999999999999986432110 00001 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111123467889999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=299.12 Aligned_cols=238 Identities=24% Similarity=0.420 Sum_probs=188.4
Q ss_pred CccccCCcccEEEEEEeCCe-----------EEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 521 NKLGEGGFGPVYKGMLIEGQ-----------EIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999986533 5788887654433 6789999999999999999999999988 778999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-------CeEEeeec
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-------NPKISDFG 662 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-------~~kl~DfG 662 (834)
+||+++++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 26899999999999999999999987 99999999999999888 79999999
Q ss_pred cccccCCCccccccccccccccccCccccccC--CCCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhh
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSG-KRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+....... ....+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KERFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HHHHHh
Confidence 9987543 1124566789999999876 789999999999999999995 55543221110 000111
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
... .. +......+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~--~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH--RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC--CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00 0001157788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=302.44 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=201.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++|+..++||+|+||.||+|+... .+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888999999999999999642 457999988654433 4578999999999999999999999999989999
Q ss_pred EEEeecCCCChhhHhhccCCC------CCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 588 LVYEYLPNKSLDYFIFDTTRS------KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
+||||+++++|.+++...... ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 26899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
|+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..|+..... ... ......
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~----~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEV----LNRLQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHH----HHHHHc
Confidence 99876432211 11222456778999999988889999999999999999999 6777532111 011 111111
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
..... ......+..+.+++.+||+.+|++||++.|++++|+
T Consensus 234 ~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 011122347888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.23 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=209.0
Q ss_pred ccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 003272 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDY 600 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 600 (834)
+||+|.||+||.|+..+ ...+|||.+.+......+-+.+|+.+-++++|.|||+++|.+.+++..-+.||.+|+|+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999766 56799999988877778889999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCC--CHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeEEeeeccccccCCCccccccc
Q 003272 601 FIFDTTRSKVL--DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTN 677 (834)
Q Consensus 601 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~ 677 (834)
++.. .-.++ ++.++-.+.+||++||.|||+.. |||||||-.||||+ -.|.+||+|||-++.+. ...+-+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence 9853 23344 67888889999999999999988 99999999999996 67899999999998873 3334455
Q ss_pred cccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 678 RVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 678 ~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
...||..|||||++..+ .|..++|||||||++.||.||++||-...... .+.... + --..-...
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkV--G------myKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKV--G------MYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhhhhh--c------ceecCCCC
Confidence 58899999999999876 48999999999999999999999974221111 010000 0 00122345
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccCCCCCCCCCC
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL--MLSGERSLPQPKQP 800 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~~~~~~p~~p 800 (834)
+.+..+++..++++|+.+||.+||++.++++ +|+.-...+.|+.+
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 6677788899999999999999999999985 45544444444443
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=305.57 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=201.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.+|+..++||.|++|.||+|... +++.||+|.+........+.+.+|+..++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 58999999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|..++.. ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998842 35899999999999999999999988 999999999999999999999999998875433221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.|+........ . ............
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~-~~~~~~~~~~~~------ 236 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------L-YLIATNGTPELQ------ 236 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhcCCcccC------
Confidence 1235678899999999988899999999999999999999999753222110 0 001101100100
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+++.+||+.||++||++.+|++
T Consensus 237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11112235778999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.34 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=195.9
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..++||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 48899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++ ++|..++........+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777754444467899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH----------HHHhh--
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA----------WQLWI-- 739 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~-- 739 (834)
......+++.|+|||++.+. .++.++||||||++++||++|+.|+....... ...... +....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 11224568899999988654 57899999999999999999999875322110 000000 00000
Q ss_pred ---ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 ---QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
............. ........++.+++.+||+.||++|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 000112346678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.12 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=201.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..+.||.|++|.||+|.... ++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 367788899999999999999764 8899999986543 34556789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998843 26899999999999999999999988 99999999999999999999999999988754321
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... . ...........+.
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~----~~~~~~~~~~~~~----- 219 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---V----LFLIPKNNPPSLE----- 219 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---H----HHHhhhcCCCCCc-----
Confidence 1223567889999999999889999999999999999999999975322111 0 0111111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. .....+.+++.+||+.+|++||+++++++
T Consensus 220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 02336778999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=311.21 Aligned_cols=237 Identities=22% Similarity=0.272 Sum_probs=186.1
Q ss_pred CccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHH-HHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEAL-LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||+||++... +|+.||+|++.+.. ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999985 48999999996532 223344555554 56778999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999888743 346889999999999999999999988 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~------~~---- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------E-MYDNILNKPL------RL---- 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------H-HHHHHHcCCC------CC----
Confidence 23357899999999999999999999999999999999999997532111 0 1111111110 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNML 782 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 782 (834)
.......+.+++.+||+.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111234678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.90 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=201.9
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||+||++... +++.||+|++.... ....+++.+|++++..++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999975 48899999886543 34457899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++.. ...+++..+..++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999988743 345899999999999999999999742 39999999999999999999999999987542211
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc-----cchhHHHHHHhhccCccccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR-----HNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 747 (834)
.....++..|+|||++.+..++.++|||||||+++||++|+.|+........ ..+.... .........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--- 231 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-QQIVQEPPP--- 231 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH-HHHhhccCC---
Confidence 2235788999999999888999999999999999999999999764322111 0011110 111111000
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.+ .....+..+.+++.+|++.||++||++.||+++.-
T Consensus 232 --~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 --RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred --CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 01113346788999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.45 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=201.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..|+..++||.|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 356677899999999999999754 8899999987543 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.. ..+++.....++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988742 35888999999999999999999987 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......++..|+|||.+.+..++.++||||||++++||++|+.|+........ . . .+.....
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~----~---------~~~~~~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---L----F---------LIPKNNP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---h----h---------hhhcCCC
Confidence 12224678899999999988899999999999999999999999653221110 0 0 0000111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233455678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.61 Aligned_cols=191 Identities=23% Similarity=0.316 Sum_probs=163.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
...+|+..+.||+|+||.||+|.... ++.||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 45679999999999999999999864 678999975432 23568999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
++. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 577666643 3456899999999999999999999988 999999999999999999999999999754221
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
.......||..|+|||++.+..++.++|||||||++|||+++..+
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 112235689999999999999999999999999999999986655
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.06 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=198.7
Q ss_pred CCcccCccccCCcccEEEEEEeC--CeEEEEEEeccc----------CcccHHHHHHHHHHHHh-ccCCceeeEEEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKS----------SGQGVEEFKNEALLIAK-LQHRNLVKLLGCCTQ 582 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 582 (834)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999865 678999987532 12234567788888875 799999999999999
Q ss_pred CCeeEEEEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecCCCCeEEee
Q 003272 583 RDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDNEMNPKISD 660 (834)
Q Consensus 583 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~D 660 (834)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887432 234568999999999999999999996 44 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 661 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... .. .......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~-~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LS-LATKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HH-HHHHHhh
Confidence 99998754332 22335688899999999998899999999999999999999998642111 00 0111111
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
...... . .......+.+++.+||+.||++||++.||..+|+
T Consensus 228 ~~~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111100 0 1112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=300.39 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=190.9
Q ss_pred CccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEe-CCeeEEEEeecC
Q 003272 521 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-RDERVLVYEYLP 594 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 594 (834)
+.||+|+||.||+|.+.+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998643 457999998543 33456788999999999999999999998764 455789999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE- 673 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 673 (834)
+++|..++... ...+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234678888999999999999999987 999999999999999999999999999765322111
Q ss_pred -cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 674 -ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR-NRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 674 -~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.......++..|+|||.+....++.++||||||+++|||++|.. |+... ....+. .....+...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~----~~~~~~~~~------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDIT----VYLLQGRRL------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHH----HHHhcCCCC-------
Confidence 11112445678999999988899999999999999999999654 43221 111111 111111100
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.85 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=199.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+.|+..++||+|+||.||+|.... ++.+++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568888999999999999999865 8899999997766667788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|..++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998877432 345899999999999999999999987 99999999999999999999999999876432211
Q ss_pred cccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
......++..|+|||++. ...++.++|||||||++|||++|+.|+...... . ..............
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~- 236 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R-VLLKIAKSEPPTLS- 236 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------H-HHHHHhcCCCccCC-
Confidence 112356788999999985 345788999999999999999999986432211 0 01111111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+++.+||+.+|++||++.++++
T Consensus 237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11122346778999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=293.62 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=207.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||.|.-|+||++.+.+ +..+|+|++.+. ..+...+...|.++|+.++||.|++|+..+...+..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346667899999999999999876 588999999765 3455667788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|||++|+|..+++. +..+.++...++.++.+++-||+|||-.| ||.|||||+||||.++|++.|+||.|+..+...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999888754 45677999999999999999999999998 999999999999999999999999987543110
Q ss_pred ----------------------------------c--------------------cccccccccccccccCccccccCCC
Q 003272 671 ----------------------------------Q--------------------TEANTNRVVGTYGYMSPEYAIDGLF 696 (834)
Q Consensus 671 ----------------------------------~--------------------~~~~~~~~~gt~~y~APE~~~~~~~ 696 (834)
. .....+..+||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0011223579999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCC
Q 003272 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPE 776 (834)
Q Consensus 697 t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~ 776 (834)
+.++|.|+|||++|||+.|.-||....... ....++-+.+.-...+.....+.+|+++.|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999975432211 11222333332222234455788999999999999
Q ss_pred CCCC----HHHHHH--HhccC
Q 003272 777 DRPN----MLSVVL--MLSGE 791 (834)
Q Consensus 777 ~RPt----~~ev~~--~L~~~ 791 (834)
+|.. +.||.+ +.++.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred hhhccccchHHhhcCccccCC
Confidence 9998 888764 34444
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.15 Aligned_cols=253 Identities=22% Similarity=0.382 Sum_probs=198.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|...++||+|+||.||+|+... ++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 467778899999999999998754 8899999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++.. ...+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999998743 346899999999999999999999988 99999999999999999999999999876542211
Q ss_pred cccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 674 ANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+....... .. . ...... ...+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~----~-~~~~~~---~~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--AL----F-LMTKSN---FQPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hH----H-hhhccC---CCCCc
Confidence 122356889999999874 4568899999999999999999999863221110 00 0 000000 00001
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.... ......+.+++.+|++.+|++||++.+|++.
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1100 0112357789999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.31 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=196.6
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
|+..++||+|+||.||++.... ++.||||.+.... ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5667889999999999998764 8899999986542 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999998885432 345889999999999999999999987 99999999999999999999999999876532221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....|+..|+|||++.+..++.++||||||+++|||++|+.|+....... ..... ...... .. ..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~-~~~~~~-~~----~~-- 223 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEV-ERLVKE-VQ----EE-- 223 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHH-Hhhhhh-hh----hh--
Confidence 122468999999999999999999999999999999999999975322110 00000 000000 00 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
........+.+++..||+.||++||+ +.|+++
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11112235778999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.65 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=194.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD----- 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 584 (834)
..++|+..++||+|+||.||++.... |+.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34789999999999999999998754 889999998643 2334567889999999999999999999986543
Q ss_pred -eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 585 -ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 585 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 479999999764 444442 23788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc------------chh
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH------------NLL 731 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~------------~~~ 731 (834)
++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .+.
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9764322 1122357889999999999999999999999999999999999998543211100 000
Q ss_pred HH---HHHHhhccCc-------ccccCcccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 732 GH---AWQLWIQDRP-------AELIDKSLY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 732 ~~---~~~~~~~~~~-------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.. ....+..... .+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000000 000000000 00011123467889999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.40 Aligned_cols=237 Identities=21% Similarity=0.275 Sum_probs=185.0
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHH-HHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEAL-LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||+++... ++.||+|++.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 8899999986532 223344555554 57788999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|...+.. ...++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999887743 345788889999999999999999987 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+..... .. ......... + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~----~~~~i~~~~--------~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQ----MYDNILHKP--------L--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HH----HHHHHhcCC--------C--CC
Confidence 2335789999999999998999999999999999999999999743211 00 111111110 0 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNML 782 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 782 (834)
+......+.+++.+||+.||++||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 122334678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.44 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=195.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|...++||+|+||.||+|.... ++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 568889999999999999998754 7899999986443 33345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 98 4787777432 345889999999999999999999988 99999999999999999999999999976533221
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------HHHHHHhhccC-
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL--------GHAWQLWIQDR- 742 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~- 742 (834)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.|+......+..... ...+.......
T Consensus 160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1 1224568899999988654 5788999999999999999999997543221110000 00000000000
Q ss_pred cccccCccccCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDS----CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000 00112335678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.76 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=198.4
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccC------cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS------GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
+|...+.||+|+||+||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998789999999886432 12345688999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 235789999999999999999999988 99999999999999999999999999886532
Q ss_pred Cc----cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 670 DQ----TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 670 ~~----~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.. .........++..|+|||.+.+..++.++||||||++++||++|+.|+....... . .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~--- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRG--- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccC---
Confidence 11 1111223568889999999998889999999999999999999999975321110 0 000000000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 226 -~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011 11223346788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.23 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=200.1
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+|+..++||+|+||.||++... .++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 4889999998643 3345578889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|..++... ....++...+..++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 3445789999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......+++.|+|||++.+..++.++||||||+++++|++|+.|+...... .. ......+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~----~~~~~~~~~~~-------- 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NL----ILKVCQGSYKP-------- 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HH----HHHHhcCCCCC--------
Confidence 112356888999999999889999999999999999999999997532110 01 11111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+......+.+++.+||+.||++||++.||+..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.92 Aligned_cols=258 Identities=20% Similarity=0.227 Sum_probs=198.6
Q ss_pred HHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC
Q 003272 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD 584 (834)
Q Consensus 509 ~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 584 (834)
++....++|+..+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 344456889999999999999999999864 788999998642 2233456788999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998843 34788889999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+.+..... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... ... ......
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~-~~~i~~ 261 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT-YSKIMN 261 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHH-HHHHHc
Confidence 87643221 112346799999999998754 378999999999999999999999753211 111 111111
Q ss_pred c-CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 003272 741 D-RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED--RPNMLSVVLML 788 (834)
Q Consensus 741 ~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~~L 788 (834)
. ...... ........+.+++.+|++.++.+ ||++.|+++..
T Consensus 262 ~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1 001111 11122345677889999844443 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.09 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=196.1
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
|+..++||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 48899999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998875432 346899999999999999999999988 99999999999999999999999999976532211
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....|+..|+|||.+.+..++.++||||||++++||++|..|+....... ............. .
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~--~------- 222 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE--E------- 222 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc--c-------
Confidence 123578999999999998899999999999999999999999975322111 0000111111000 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
.........+.+++..|++.||++||+ +.+++.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122335678999999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.47 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=197.6
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcc---------cHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQ---------GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
+|...+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3666789999999999999875 4789999988654221 23568889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++|+||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999998843 345888999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccc----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 666 AFGLDQTEA----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 666 ~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.+..+.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAI-FKIGE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHH-HHHhc-
Confidence 774321111 111245788999999999889999999999999999999999997532110 000 00000
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+ ..+......+.+++.+||+.||.+||++.||++
T Consensus 227 ----~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ----NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 112223346788999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.37 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=203.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|+..++||.|+||.||++.... ++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3578888999999999999999754 778999999776556678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ...++...+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999987542 246889999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~---~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. .....++..|+|||.+... .++.++||||||++++||++|+.|+........ . ....... ....
T Consensus 157 ~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~-~~~~~~~---~~~~ 224 (262)
T cd06613 157 K--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------L-FLISKSN---FPPP 224 (262)
T ss_pred c--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhcc---CCCc
Confidence 1 1225678899999999776 889999999999999999999999753221110 0 0001110 0001
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+ .........+.+++.+||+.+|.+||++.+|+.
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 112233457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.27 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=191.0
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhc---cCCceeeEEEEEEeC-----C
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKL---QHRNLVKLLGCCTQR-----D 584 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 584 (834)
+|+..+.||+|+||+||++...+ ++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788899999999999999764 8899999986532 22234566777777665 799999999988642 3
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++|+||+++ +|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 777776432 2345899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc-
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP- 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 743 (834)
+....... .....++..|+|||++.+..++.++|||||||+++||++|++||....... ..............
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 87643221 123567889999999999899999999999999999999999875322111 11111110000000
Q ss_pred ---------ccccCccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 ---------AELIDKSL---YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ---------~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+.. .....+.....+.+++.+|++.||++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00111122346788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.09 Aligned_cols=261 Identities=25% Similarity=0.330 Sum_probs=200.6
Q ss_pred HHHHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEE---
Q 003272 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCT--- 581 (834)
Q Consensus 507 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~--- 581 (834)
++.+..+.++|+..+.||+|+||.||++.... ++.+|+|.+... .....++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34555678899999999999999999998754 789999988543 22346788899999999 7999999999884
Q ss_pred --eCCeeEEEEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 582 --QRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 582 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
.++..++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 23456889999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH 733 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~ 733 (834)
+|||+++........ .....|++.|+|||.+.. ..++.++|||||||++|||++|+.|+....... .
T Consensus 166 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~---- 237 (286)
T cd06638 166 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--A---- 237 (286)
T ss_pred ccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--H----
Confidence 999999876432221 223568899999998853 457889999999999999999999965322110 0
Q ss_pred HHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 734 AWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 734 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. ............++ ......+.+++.+||+.||++||++.||++.
T Consensus 238 ~-~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 L-FKIPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred H-hhccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 00001110111111 1122357889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.42 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=197.2
Q ss_pred CcccCccccCCcccEEEEEEeC----CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 584 (834)
|...+.||+|+||.||+|.+.. ++.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567789999999999998642 688999998654 2345677899999999999999999999886543
Q ss_pred eeEEEEeecCCCChhhHhhccC---CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT---RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
..++++||+++++|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 2235789999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
|+++...............++..|++||.+.+..++.++||||||+++|||++ |+.|+..... ..+.. ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN----YLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH----HHHc
Confidence 99987643322222222345678999999998899999999999999999999 7777542111 11111 1111
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
... + ..+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 01112334788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=309.49 Aligned_cols=241 Identities=28% Similarity=0.368 Sum_probs=190.8
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 590 (834)
+|+..+.||+|+||.||++.... ++.||+|++.+. .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999998754 889999999753 2334566788888888885 577888999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999888843 345899999999999999999999988 999999999999999999999999998764322
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. .........
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~----~~~i~~~~~------- 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---EL----FQSIMEHNV------- 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC-------
Confidence 21 122356899999999999999999999999999999999999997532211 11 111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111223467789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.98 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=198.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888899999999999999864 8899999986542 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|..++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887632 345899999999999999999999987 9999999999999999999999999998764432
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH--------HHhhccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW--------QLWIQDR 742 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 742 (834)
. ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+......+......... ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 2 1122457789999999876 568899999999999999999999975322211100000000 0000000
Q ss_pred -cccccCccccCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 -PAELIDKSLYDSCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 -~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......+......+. .....+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000001111101111 12346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.98 Aligned_cols=196 Identities=25% Similarity=0.384 Sum_probs=159.1
Q ss_pred cCccccCCcccEEEEEEe---CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe--CCeeEEEEeecC
Q 003272 520 ENKLGEGGFGPVYKGMLI---EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDERVLVYEYLP 594 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 594 (834)
.++||+|+||+||+|... .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 458999999999999864 36789999986432 23567889999999999999999998854 346789999987
Q ss_pred CCChhhHhhccC------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee----cCCCCeEEeeeccc
Q 003272 595 NKSLDYFIFDTT------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA 664 (834)
Q Consensus 595 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla 664 (834)
+ +|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6666553211 1235889999999999999999999988 9999999999999 45678999999999
Q ss_pred cccCCCccc-cccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 665 RAFGLDQTE-ANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 665 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
+........ .......+|+.|+|||++.+ ..++.++||||+||+++||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876433221 12234678999999999877 4589999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.82 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=201.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|++.++||.|+||.||++... ++..+|+|.+........+.|.+|+.++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467888899999999999999975 4889999999766666677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988542 246899999999999999999999998 99999999999999999999999999876533221
Q ss_pred ccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 673 EANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....++..|+|||.+. ...++.++||||||+++|||++|+.|+...... .. ...........+.
T Consensus 159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~~~ 229 (280)
T cd06611 159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RV-LLKILKSEPPTLD 229 (280)
T ss_pred c--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HH-HHHHhcCCCCCcC
Confidence 1 12356888999999985 345778999999999999999999997532111 00 0111111111010
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+......+.+++.+||+.+|++||++.+|++-
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111123367789999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.02 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=202.1
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||.|+||.||.+.... ++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 57788999999999999988644 889999998643 344567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 356899999999999999999999987 99999999999999999999999999987643332
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......+++.|+|||.+.+..++.++||||||++++||++|+.|++..... . .......+....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~-~~~~~~~~~~~~------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------N-LVVKIVQGNYTP------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHcCCCCC-------
Confidence 222356889999999998888999999999999999999999987532111 1 111111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112223467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=282.25 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=202.0
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC----c----ccHHHHHHHHHHHHhc-cCCceee
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS----G----QGVEEFKNEALLIAKL-QHRNLVK 575 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~----~----~~~~~~~~E~~~l~~l-~H~niv~ 575 (834)
+..+-.....+|...+.||.|..+.|-+..... |+++|+|++.... . .-.++-..|+.+|+++ .||+|+.
T Consensus 8 d~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~ 87 (411)
T KOG0599|consen 8 DKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID 87 (411)
T ss_pred chhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 334444556788888999999999999887754 8899999885421 1 1234556799999998 6999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC
Q 003272 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN 655 (834)
Q Consensus 576 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 655 (834)
+.+++......++|+|.|+.|.|-++|.. .-.+++++..+|++|+.+|++|||... ||||||||+|||+|++.+
T Consensus 88 l~D~yes~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 88 LQDVYESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN 161 (411)
T ss_pred eeeeccCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence 99999999999999999999999999843 345899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~ 729 (834)
+||+|||++..+.... .....+||++|+|||.+.. ..|+..+|+|++|||+|-|+.|.+||= +... ..
T Consensus 162 i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQ-ml 235 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQ-ML 235 (411)
T ss_pred eEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHH-HH
Confidence 9999999999875432 2334899999999998852 358889999999999999999999952 1100 00
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
++ ....++... .....-.+......+|+.+||+.||.+|.|++|+++
T Consensus 236 ML----R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 ML----RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HH----HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 01 111111110 111112223446778999999999999999999874
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.16 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=196.7
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|...+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++.+++|+|++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4578889999999999999975 67889999986432 34688999999999999999999999865 45799999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|..++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986432 345889999999999999999999987 9999999999999999999999999987643211
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....+..|+|||.+.+..++.++||||||++++||++ |+.|+......+ .......+. ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGY---------RM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCC---------CC
Confidence 11334568999999998899999999999999999998 888864322111 111111111 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
......+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.38 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=194.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------ 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 583 (834)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 4889999999653 233456788899999999999999999988543
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
...++||||+++ ++...+. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 347999999976 4545442 24788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hhH-------H--
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN-LLG-------H-- 733 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~-~~~-------~-- 733 (834)
++...... ......+|+.|+|||++.+..++.++|||||||+++||++|+.||.......... ... .
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98653221 1223578999999999999999999999999999999999999975322111000 000 0
Q ss_pred -----HHHHhhccCc--ccccCc-----ccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 734 -----AWQLWIQDRP--AELIDK-----SLY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 734 -----~~~~~~~~~~--~~~~d~-----~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....+..... ..+..+ .+. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 000000 000 00111123467889999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.05 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=200.3
Q ss_pred cCCcccCccccCCcccEEEEEEeCC----eEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEG----QEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|...++||+|+||.||+|...+. ..||||...... ....+.+.+|+.++++++|+||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577788999999999999987542 468999886554 4456789999999999999999999998865 567899
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++... ...+++..++.++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 235899999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
..... .....++..|+|||.+....++.++||||||++++||++ |..|+......+ .. .....+...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~~~~---- 227 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VI----GRIENGERL---- 227 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HH----HHHHcCCcC----
Confidence 32211 112334568999999988889999999999999999996 999875322111 11 111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+......+.+++.+|+..+|++||++.+++..|+...
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.39 Aligned_cols=240 Identities=21% Similarity=0.254 Sum_probs=186.1
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHH-HHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEA-LLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||++.... ++.||+|++.+.. ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 7789999986532 22233444444 456778999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+.......++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988853 345778888899999999999999988 9999999999999999999999999997542211 12
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~----~~~i~~~~~----------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM----YDNILNKPL----------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HH----HHHHHhCCc----------CC
Confidence 23467899999999999999999999999999999999999997532111 01 111111100 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
.......+.+++.+|++.||.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 112234677899999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.09 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=198.9
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..+.||+|+||.||++... .++.||+|.++.. .....+++.+|+.++.+++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778889999999999999986 4899999988653 333456889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|..++........+++..+..++.+|+.||.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999998865433457899999999999999999999742 39999999999999999999999999987653221
Q ss_pred ccccccccccccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~------~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+..... ...... .........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~-~~~~~~~~~--- 227 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQ-LSAIVDGDP--- 227 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHH-HHHHhhcCC---
Confidence 1224578899999998554 358899999999999999999999743211 111100 001111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1122224456788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.25 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=203.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+..++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999965 47889999986532 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++........+++.....++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cc--ccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 673 EA--NTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 673 ~~--~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. ......++..|+|||.+... .++.++||||||++++||++|+.|+....... .. .........
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~-----~~~~~~~~~----- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VL-----MLTLQNDPP----- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hH-----HHHhcCCCC-----
Confidence 21 22335688899999998877 78999999999999999999999975322111 00 011111111
Q ss_pred cccCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSC-SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+.... .......+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111100 1122346788999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=295.70 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=191.5
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-----GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERV 587 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 587 (834)
+|...+.||+|+||.||++...+ ++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 67888999999999999998754 8899999886432 23345788999999999999999999988653 5678
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+++||+++++|.+++.. ...+++.....++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 83 l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999998853 235889999999999999999999887 999999999999999999999999999865
Q ss_pred CCCcc-ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 668 GLDQT-EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 668 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
..... ........++..|+|||.+.+..++.++||||||++++||++|+.|+..... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~----- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP----- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC-----
Confidence 32211 1111224578899999999988899999999999999999999999753211 00011100000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+ ..+......+..++ +||..+|++||+++||++
T Consensus 226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011 11122223344455 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=305.65 Aligned_cols=200 Identities=26% Similarity=0.343 Sum_probs=171.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999754 889999999642 2234566889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999988532 345889999999999999999999988 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 221 1122568999999999863 457889999999999999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=295.01 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=198.7
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-----GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999986 68999999986533 23557899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998853 245889999999999999999999988 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.. ......++..|+|||.+.... ++.++|+||||+++++|++|+.|+..... ..............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~---- 221 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP---- 221 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC----
Confidence 32 123356788999999988776 89999999999999999999999753221 00011100001110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122346778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.03 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=199.0
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-CeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-DERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 591 (834)
+|+..+.||+|++|.||++.... ++.+|+|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999999754 788999998643 234456789999999999999999999887644 45789999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++... ....+++.++..++.+++.|+++||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888643 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|++.... .... .....+...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~-~~~~~~~~~------- 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLV-YRIIEGKLP------- 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHH-HHHHhcCCC-------
Confidence 2 12235678899999999999999999999999999999999998753211 1111 111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+......+.+++.+|++.+|++||++.++++.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122233468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.63 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=196.7
Q ss_pred ccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 519 EENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
....||+|+||.||++... ++..||||.+........+.+.+|+..+++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3457999999999999875 488999999876555666789999999999999999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 677 (834)
|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++........ ...
T Consensus 106 L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 106 LTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9988732 35889999999999999999999987 99999999999999999999999999876533222 122
Q ss_pred cccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCH
Q 003272 678 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL 757 (834)
Q Consensus 678 ~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 757 (834)
...++..|+|||.+.+..++.++||||||++++||++|+.|+...... ... ..... .+.+.+... .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~----~~~~~-----~~~~~~~~~--~ 242 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM----RRIRD-----NLPPRVKDS--H 242 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHh-----cCCCccccc--c
Confidence 356889999999998889999999999999999999999996532111 000 01110 111111111 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 758 SEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 758 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.....+..++.+|++.||.+||++.|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122356788999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=298.99 Aligned_cols=263 Identities=27% Similarity=0.345 Sum_probs=203.2
Q ss_pred cCHHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEe
Q 003272 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ 582 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 582 (834)
+...++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445666667899999999999999999999975 48899999985432 2346778899999998 89999999999875
Q ss_pred CC-----eeEEEEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 583 RD-----ERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 583 ~~-----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 589999999999999887532 23456899999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~ 731 (834)
||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+....... .+
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~- 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TL- 242 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HH-
Confidence 99999998876432221 1224678899999998643 36889999999999999999999964321110 00
Q ss_pred HHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 732 GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..........+.+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 243 ----~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 ----FKIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HHHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111111111 11223367889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=315.13 Aligned_cols=201 Identities=24% Similarity=0.374 Sum_probs=173.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||++.... ++.||+|+++.. .....+.+.+|+.++.+++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 367888999999999999998764 889999999653 2334567888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998853 346889999999999999999999988 999999999999999999999999998755321
Q ss_pred ccc---------------------------------cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003272 671 QTE---------------------------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717 (834)
Q Consensus 671 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~ 717 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113468999999999999999999999999999999999999
Q ss_pred CCCC
Q 003272 718 NRGF 721 (834)
Q Consensus 718 p~~~ 721 (834)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.31 Aligned_cols=250 Identities=35% Similarity=0.511 Sum_probs=198.7
Q ss_pred cccCccccCCcccEEEEEEeC-----CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 518 SEENKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
...+.||.|+||.||++...+ +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999865 378999999655433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++..... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999854321 22899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
..... ...++..|+|||.+.+..++.++||||+|++++||++ |..|+..... ..+ ..........
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~------ 223 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEV----LEYLKKGYRL------ 223 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHhcCCCC------
Confidence 22111 2336789999999988889999999999999999998 6777543111 111 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
.........+.+++.+|++.+|++|||+.|++++|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111344678899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=309.70 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=194.7
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------ 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 583 (834)
..++|...++||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999999998754 889999999653 233456788999999999999999999987543
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
...++||||+++ +|...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5555552 24788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH-------
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ------- 736 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~------- 736 (834)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 98653221 12235789999999999999999999999999999999999999754321110 000000
Q ss_pred -----------HhhccCc-------ccccCcccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 737 -----------LWIQDRP-------AELIDKSLY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 737 -----------~~~~~~~-------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....... ..+....+. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 000000000 00011123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=323.81 Aligned_cols=265 Identities=20% Similarity=0.233 Sum_probs=190.3
Q ss_pred HHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccC------CceeeEEEEEE
Q 003272 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH------RNLVKLLGCCT 581 (834)
Q Consensus 509 ~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~ 581 (834)
++...+++|++.++||+|+||+||++.... ++.||||+++... ...+++..|+.++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344456889999999999999999998754 7889999996432 233456778888777754 45888998886
Q ss_pred eC-CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCC-----
Q 003272 582 QR-DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEM----- 654 (834)
Q Consensus 582 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~----- 654 (834)
.. .+.++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+. + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 54 5688999987 5677776643 34689999999999999999999974 6 99999999999998765
Q ss_pred -----------CeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003272 655 -----------NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYH 723 (834)
Q Consensus 655 -----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~ 723 (834)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764321 1223678999999999999999999999999999999999999986433
Q ss_pred cccccchhHHH-------H-HHhhccCccccc----------Ccc----ccCCC---CHHHHHHHHHHHHHcccCCCCCC
Q 003272 724 ADHRHNLLGHA-------W-QLWIQDRPAELI----------DKS----LYDSC---SLSEAIRCIQVGLLCVQQIPEDR 778 (834)
Q Consensus 724 ~~~~~~~~~~~-------~-~~~~~~~~~~~~----------d~~----l~~~~---~~~~~~~l~~l~~~Cl~~dP~~R 778 (834)
..+....+... + .........++. ++. +.... .......+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 21111110000 0 000000000000 000 00000 00112356789999999999999
Q ss_pred CCHHHHHH
Q 003272 779 PNMLSVVL 786 (834)
Q Consensus 779 Pt~~ev~~ 786 (834)
||+.|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=294.13 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=197.5
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc----------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCC
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG----------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD 584 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 584 (834)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 488999998853211 12346888999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 46889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+...............++..|+|||.+.... ++.++||||||++++|+++|..|+..... . ...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~-~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----I-AAMFKL-GNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----H-HHHHHh-hccc
Confidence 8754322222223356788999999987654 88999999999999999999999642111 0 001111 1111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....+... ........+.+++.+||+.+|++||++.+|++.
T Consensus 229 ~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111 111234577889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=301.38 Aligned_cols=196 Identities=26% Similarity=0.386 Sum_probs=158.5
Q ss_pred cCccccCCcccEEEEEEeC---CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe--CCeeEEEEeecC
Q 003272 520 ENKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDERVLVYEYLP 594 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 594 (834)
..+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3589999999999999753 5789999986532 23467889999999999999999999854 456789999988
Q ss_pred CCChhhHhhcc------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee----cCCCCeEEeeeccc
Q 003272 595 NKSLDYFIFDT------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA 664 (834)
Q Consensus 595 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla 664 (834)
+ +|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 555554311 12235889999999999999999999988 9999999999999 56678999999999
Q ss_pred cccCCCccc-cccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 665 RAFGLDQTE-ANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 665 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
+........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876433221 12233578899999999876 4589999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.97 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=184.0
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc---cCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL---QHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
||+|+||+||+|+... ++.||||++.+.. ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998754 8899999986532 22233455566666655 699999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 999888743 345899999999999999999999988 99999999999999999999999999876432221 1
Q ss_pred cccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 676 TNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
.....||..|+|||++.+. .++.++|||||||++|||++|+.|+...... ........+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~-~~~~------ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKV-RFPK------ 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCC-CCCC------
Confidence 2336789999999998764 4899999999999999999999997432111 11111111111 0100
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRP----NMLSVVL 786 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~ev~~ 786 (834)
......+.+++.+||+.||++|| ++.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01223567899999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=298.23 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=197.2
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcc-----cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQ-----GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
+|+..++||+|++|.||+|... +++.||||+++..... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999975 4889999999754322 345677899999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+ +++|..++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885432 36899999999999999999999988 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc-------
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD------- 741 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 741 (834)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|.+++...... .............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 3221 122356778999998865 46789999999999999999997765432211 1111111100000
Q ss_pred --CcccccCccccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 742 --RPAELIDKSLYDSC-----SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 742 --~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.............. .......+.+++.+||+.+|++||++.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000111 11224577899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.56 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=198.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||.||++...+ ++.||+|++..... ...+.+.+|+++++.++|+||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 467888999999999999999864 88999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|..+... ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887632 234899999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH-----------hh
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL-----------WI 739 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~ 739 (834)
. ......++..|+|||++.+ ..++.++||||||++++||++|++|+......+ ........ ..
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 2 1223457889999999875 457889999999999999999998875322110 00000000 00
Q ss_pred ccCc-ccccCccccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 QDRP-AELIDKSLYD-----SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ~~~~-~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... .....+.... .........+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 0000000000 001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.08 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=200.1
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..++||+|+||.||++... +++.||+|++... .....+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 4889999998643 234456889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887532 2335789999999999999999999987 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....+++.|+|||++.+..++.++||||||++++||++|+.|+..... .... .....+...
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~-~~~~~~~~~-------- 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLV-LKIIRGSYP-------- 219 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHH-HHHhcCCCC--------
Confidence 1 1224578899999999988999999999999999999999998653211 1111 111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.+|++||+|.+|++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111223446788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=302.51 Aligned_cols=198 Identities=20% Similarity=0.255 Sum_probs=163.7
Q ss_pred cCccccC--CcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 520 ENKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 520 ~~~LG~G--~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
.++||+| +|++||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 68899999875 48899999996542 2344567889999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE- 673 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~- 673 (834)
+++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999885432 235899999999999999999999988 999999999999999999999999865443211110
Q ss_pred ----cccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 674 ----ANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 674 ----~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
.......++..|+|||++.+ ..++.++|||||||+++||++|+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01112346678999999976 4689999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=281.26 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=196.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++.|+.-+.||+|.|+.|++.... .|+.+|+|++... .....+++.+|+++-+.|+||||++|...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356777789999999999998754 4899999987532 3457788999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec---CCCCeEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~ 667 (834)
|+|.++.|-.-+- .+...++...-..++||+++|.|+|..+ |||||+||+|+||. ..--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999855442 2355778888899999999999999998 99999999999994 3346899999999988
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ..-....||++|||||++...+|+..+|||+.||+||-|+.|.+||-.. ....+. +....+. .
T Consensus 164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rly----e~I~~g~----y 229 (355)
T KOG0033|consen 164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLY----EQIKAGA----Y 229 (355)
T ss_pred CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHH----HHHhccc----c
Confidence 622 2223478999999999999999999999999999999999999996321 111111 1111111 1
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
|- .+..-....++..+|+++||..||.+|.|+.|.+
T Consensus 230 d~--~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 230 DY--PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CC--CCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 10 0111111233667899999999999999999876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.61 Aligned_cols=255 Identities=19% Similarity=0.206 Sum_probs=194.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...++||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999999764 788999998652 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 245889999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
... ......|++.|+|||++.. ..++.++||||||+++|||++|+.|+...... . ...........-
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~~ 227 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNHEERF 227 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------H-HHHHHHcCCCcc
Confidence 221 1123568999999999875 46788999999999999999999997532111 1 111111110000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED--RPNMLSVVLM 787 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~~ 787 (834)
-+.+. .......+.+++.+|++.++++ |++++++++.
T Consensus 228 ~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000 0112346777888888865544 4678888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=298.65 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=200.0
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEe-
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ- 582 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 582 (834)
+..++..+.+.|+..+.||+|+||.||+|.... ++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 455555677889999999999999999999754 8899999985433 3446788899999998 79999999999853
Q ss_pred -----CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 583 -----RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 583 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
....+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45689999999999999988543 2345788889999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH
Q 003272 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG 732 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 732 (834)
|+|||++........ ......++..|+|||++. ...++.++||||||+++|||++|+.|+........
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----- 234 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----- 234 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----
Confidence 999999876532211 122356888999999986 34688899999999999999999999743211100
Q ss_pred HHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 733 HAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ...... .+.+. .......+.+++.+||+.||.+||++.||++
T Consensus 235 -~~-~~~~~~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 -LF-LIPRNP-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hh-hHhhCC-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000 01110 1112346788999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=302.02 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=207.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 587 (834)
..+.|+..+.||+|.||.||+++... |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999999876 99999999976533 24568999999999998 999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC----CCeEEeeecc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE----MNPKISDFGM 663 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGl 663 (834)
+|||++.+|.|.+.+... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999998888654 2999999999999999999999988 9999999999999633 5799999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||........ . .....+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--~-----~~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--F-----LAILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--H-----HHHHcCCC
Confidence 998754 3334458999999999999999999999999999999999999999754322111 1 11111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......-......+.+++..|+..||.+|+++.++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1122222333456778999999999999999999998
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.35 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=197.1
Q ss_pred ccCccccCCcccEEEEEEeC-CeEEEEEEecc----cCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe--eEEEEe
Q 003272 519 EENKLGEGGFGPVYKGMLIE-GQEIAVKRLSK----SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE--RVLVYE 591 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 591 (834)
...+||+|+|-+||||.... |-+||--.++. ......++|..|+.+|+.|+|+|||+++.++.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34589999999999999754 77777544432 234556899999999999999999999999987765 778999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~ 670 (834)
.|..|+|..++... +.++.+.+..|++||++||.|||++. ++|||||||-.||+|+. -|.+||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999998543 45888999999999999999999986 68999999999999974 579999999999987433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
... .+.|||.|||||+.. ..|.+.+|||||||+++||+|+.+|+.- ..+ ....+.+...+.....+.+.
T Consensus 200 ~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n-~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 200 HAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTN-PAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred ccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCC-HHHHHHHHHcCCCHHHhhcc
Confidence 322 278999999999887 7899999999999999999999999531 111 22334444444433333221
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL--MLSG 790 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~ 790 (834)
- -..+.+++.+|+.. .++||++.|++. +|..
T Consensus 269 ~--------dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 K--------DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred C--------CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 12567899999999 999999999984 4443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.76 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=200.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||.||+|...+ ++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999999864 789999998653 23345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|++++.+..+.. ....+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999987776653 2345899999999999999999999988 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhc-c
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA--------WQLWIQ-D 741 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~-~ 741 (834)
.. ......++..|+|||++.+. .++.++||||||++++||++|+.|+......+........ ...+.. .
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 22235678899999999888 8899999999999999999999887532111100000000 000000 0
Q ss_pred -----CcccccCcc-ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 742 -----RPAELIDKS-LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 742 -----~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
......++. .....+......+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000000 0001111224678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.23 Aligned_cols=255 Identities=18% Similarity=0.202 Sum_probs=193.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468888999999999999999865 778999998642 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 345889999999999999999999988 999999999999999999999999999765332
Q ss_pred ccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .... ........ .
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~-~~i~~~~~-~ 226 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETY-GKIMNHKE-R 226 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHH-HHHhCCCc-c
Confidence 22 1122357899999999986 34688999999999999999999999753211 1111 11111100 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIP--EDRPNMLSVVLM 787 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP--~~RPt~~ev~~~ 787 (834)
..-+. ........+.+++.+|+..++ ..||++.|+++.
T Consensus 227 ~~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 001123356677778775544 447899988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=293.45 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=194.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-----cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--Cee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-----GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DER 586 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 586 (834)
.+|+..++||+|+||.||+|...+ ++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999999754 8899999885321 22356788999999999999999999988764 457
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+++|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988853 234788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQT-EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... . ..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~-~~~~~-~~~~--- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----A-AIFKI-ATQP--- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----H-HHHHH-hcCC---
Confidence 532211 11122356888999999999888999999999999999999999997422110 0 00000 0000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.....+......+..++.+|+. +|++||+++||++.
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111233334466778888885 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=293.22 Aligned_cols=261 Identities=24% Similarity=0.304 Sum_probs=200.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 590 (834)
++|+..++||.|++|.||++...+ ++.+|+|.+..... ....++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367788899999999999999854 88999999875432 4557799999999999999999999998654 3689999
Q ss_pred eecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||+++++|.+++... .....++...+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876532 23455889999999999999999999988 99999999999999999999999999876532
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..... ...........+.+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~- 230 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIEL-LSYIVNMPNPELKD- 230 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHH-HHHHhcCCchhhcc-
Confidence 211 124567889999999999999999999999999999999999764322111 11111 11111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.... .......+.+++.+||+.+|++|||+.||++.
T Consensus 231 ~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 231 EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1110 11224567899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=293.40 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=200.3
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe--CCeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 590 (834)
+|+..+.||.|+||.||++... +++.+|+|.+... .....+++.+|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999875 4788999998643 23445678899999999999999999998764 34578999
Q ss_pred eecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcC--CCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
||+++++|..++... .....+++..++.++.+|+.||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988543 22456899999999999999999999332 234999999999999999999999999999887
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+...... .+ ........
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~----~~~~~~~~----- 226 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QL----ASKIKEGK----- 226 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HH----HHHHhcCC-----
Confidence 543321 12356889999999999988999999999999999999999997543211 11 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....+......+.+++.+|++.+|++||++.+|++.
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111222334578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.89 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=197.3
Q ss_pred ccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 519 EENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 488999999876555556788999999999999999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 677 (834)
|..++.. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..+... ..
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~ 175 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RK 175 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--cc
Confidence 9887732 45889999999999999999999988 999999999999999999999999998765433221 22
Q ss_pred cccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCH
Q 003272 678 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSL 757 (834)
Q Consensus 678 ~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 757 (834)
...++..|+|||++.+..++.++||||||++++||++|+.|+....... . . .......... .. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~---~-~~~~~~~~~~-----~~--~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A---M-KRLRDSPPPK-----LK--NAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---H-HHHhccCCCC-----cc--ccC
Confidence 3568899999999998899999999999999999999999975322111 0 0 1111110000 00 011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 758 SEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 758 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.....+.+++.+|++.+|++||++.+|++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122357789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=327.78 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=196.1
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 587 (834)
..++|.+.++||+|+||+||++.... +..||+|.+... .......|..|+.++.+++|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44689999999999999999999755 778999988643 233456789999999999999999999988553 5689
Q ss_pred EEEeecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCC----CceEeccCCCCceeecCC---------
Q 003272 588 LVYEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSR----LRIIHRDLKASNVLLDNE--------- 653 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~DLkp~NILl~~~--------- 653 (834)
|||||+++++|..++.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999886432 23469999999999999999999998542 349999999999999642
Q ss_pred --------CCeEEeeeccccccCCCccccccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003272 654 --------MNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGFYH 723 (834)
Q Consensus 654 --------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~~~ 723 (834)
..+||+|||++..+..... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3489999999987643221 223578999999999864 458899999999999999999999975321
Q ss_pred cccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 724 ADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
. +. .......... .+. .......+.+|+..||+.+|.+||++.|++
T Consensus 248 ~-----~~-qli~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 248 N-----FS-QLISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred c-----HH-HHHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 1 11 1111111110 000 011234678899999999999999999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.33 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=200.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999865 89999999975432 24567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+.+++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988532 3456899999999999999999999987 999999999999999999999999998765322
Q ss_pred ccc---------------------------cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003272 671 QTE---------------------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYH 723 (834)
Q Consensus 671 ~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~ 723 (834)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01122467889999999998889999999999999999999999975322
Q ss_pred cccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 003272 724 ADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN----MLSVVL 786 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~ev~~ 786 (834)
... .+ .... +..............+.+++.+||+.||++||+ +.|++.
T Consensus 237 ~~~--~~-----~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE--TF-----SNIL--------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH--HH-----HHHh--------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 110 00 0111 111100111113457889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.31 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=198.3
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
-|+..++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+..+.+++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3666789999999999999874 47899999886432 344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|..++. ...+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..+......
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 9999998874 245889999999999999999999987 999999999999999999999999998876432211
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....++..|+|||.+.+..++.++||||||++++||++|..|+....... .......... .
T Consensus 158 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 219 (277)
T cd06641 158 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP---------P 219 (277)
T ss_pred --hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCC---------C
Confidence 122467889999999988889999999999999999999999864321110 0011111110 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112233467789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.40 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=192.9
Q ss_pred HHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR----- 583 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 583 (834)
...++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999875 47899999986532 23445678899999999999999999887543
Q ss_pred -CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 584 -DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 584 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 678877763 345899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+++..... .....+++.|+|||++.+ ..++.++|||||||+++||++|+.||....... ......... ..
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~-~~ 234 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVV-GT 234 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHh-CC
Confidence 99875322 123568999999999877 578999999999999999999999975322110 000000000 00
Q ss_pred CcccccC-----------ccccCCCCH--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 742 RPAELID-----------KSLYDSCSL--------SEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 742 ~~~~~~d-----------~~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...+... ..+. ..+. .....+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000 0000 011246789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.13 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=195.6
Q ss_pred CCcccCccccCCcccEEEEEEeC---CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERV 587 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 587 (834)
+|+..++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999754 7899999997633 34456788999999999999999999999888 7899
Q ss_pred EEEeecCCCChhhHhhccC-C-CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC----CCCeEEeee
Q 003272 588 LVYEYLPNKSLDYFIFDTT-R-SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN----EMNPKISDF 661 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~Df 661 (834)
+||||+++ +|..++.... . ...++...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 5555543222 2 236889999999999999999999988 999999999999999 999999999
Q ss_pred ccccccCCCcc-ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc-ch-h----HH
Q 003272 662 GMARAFGLDQT-EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH-NL-L----GH 733 (834)
Q Consensus 662 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~-~~-~----~~ 733 (834)
|++..+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+......... .. . ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122235678899999988764 5889999999999999999999997643322200 00 0 00
Q ss_pred HHHHhhcc------------CcccccCccccCCCC---H--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 734 AWQLWIQD------------RPAELIDKSLYDSCS---L--------SEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 734 ~~~~~~~~------------~~~~~~d~~l~~~~~---~--------~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....+... ......+.......+ . .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 000000000000000 0 22346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.43 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=201.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999864 47899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998843 35789999999999999999999988 999999999999999999999999998765433221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....+++.|+|||.+....++.++||||||+++||+++|+.|+........... ....+ ....
T Consensus 172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~ 235 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPEL 235 (293)
T ss_pred --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCC
Confidence 1224678899999999888899999999999999999999999753222111000 00000 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223467789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.93 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=199.1
Q ss_pred CCcccCccccCCcccEEEEEE-eCCeEEEEEEecccC------cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSS------GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999986 348899999986432 1235688999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeecccccc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF 667 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~ 667 (834)
|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 346889999999999999999999988 99999999999998776 5999999999876
Q ss_pred CCCccc--cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 668 GLDQTE--ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 668 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+....... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~------ 225 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIAS------ 225 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhc------
Confidence 433211 11123567889999999988889999999999999999999999975322111 1111100000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+......+.+++.+|++.+|++||++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011222334457788999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=290.68 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=199.0
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||+|+||.||++... .++.+|||.+... .....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999999875 4888999998654 234467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccCCCc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGLDQ 671 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~ 671 (834)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345899999999999999999999988 99999999999998654 58999999998764332
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... .. . ..........+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~---~-~~~~~~~~~~~----- 221 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---AL---V-LKIMSGTFAPI----- 221 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HH---H-HHHHhcCCCCC-----
Confidence 1 12256788999999999888999999999999999999999987532211 01 1 11111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11123467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.70 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=199.7
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|...++||+|+||.||+|... +++.|++|.++.... ...+++.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999875 588999999876544 3677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.. ...+++..+..++.+|++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998853 345789999999999999999999988 99999999999999999999999999987644322
Q ss_pred ccc--cccccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 673 EAN--TNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 673 ~~~--~~~~~gt~~y~APE~~~~~~---~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... .....++..|+|||++.... ++.++||||||++++||++|+.|+...... ...... ........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAGHKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcCCCCCCC
Confidence 211 11256788999999998766 889999999999999999999997532211 000000 0001100110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. .......+.+++.+||+.+|++||++.|++.
T Consensus 229 -----~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 -----D--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----c--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0111335678999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.75 Aligned_cols=256 Identities=19% Similarity=0.234 Sum_probs=200.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||++.... ++.||+|.+.+.. ....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367888999999999999999755 7899999987543 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|..++.. ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 245899999999999999999999987 999999999999999999999999998742111
Q ss_pred ccc-------------cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 671 QTE-------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 671 ~~~-------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~----~~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---E----ELFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H----HHHHH
Confidence 000 011124578899999999988999999999999999999999999642111 1 11111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..... ...+.. .......+.+++.+||+.+|++||+..++.+.|+.
T Consensus 228 ~~~~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 011111 01223457889999999999999998888877775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.91 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=199.0
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 58899999987543 33456899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+ +++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998885432 56899999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC------ccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR------PAE 745 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 745 (834)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++..... ............... ..+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 112235688899999998654 468999999999999999999776542211 111111111000000 000
Q ss_pred ccC------ccc----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 746 LID------KSL----YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 746 ~~d------~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+.+ +.. ...........+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000 000011223577899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=294.00 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=199.1
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC------
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 584 (834)
++++|+..+.||+|++|.||+|... .++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999985 478899999865433 446899999999999 7999999999997654
Q ss_pred eeEEEEeecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875432 2456899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
+......... .....++..|+|||.+.. ..++.++||||||++++||++|+.|+....... . ....
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-----~~~~ 230 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A-----LFKI 230 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H-----HHHh
Confidence 8765432221 223568889999998753 347789999999999999999999974221110 0 0111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+ .........+.+++.+||..||++|||+.+|++
T Consensus 231 ~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111 111123446788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.94 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=204.4
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+|+..+.||+|++|.||+++..+ ++.|+||++..... ...+.+.+|+..+.+++|+||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57788899999999999999875 89999999876543 45678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++++|.+++... ..++...+..++.||++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999998543 568999999999999999999999 87 99999999999999999999999999987643332
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... ........
T Consensus 156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~-~~~~~~~~--------- 220 (264)
T cd06623 156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELM-QAICDGPP--------- 220 (264)
T ss_pred cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHH-HHHhcCCC---------
Confidence 21 23567889999999999899999999999999999999999975432211 11111 11111111
Q ss_pred CCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 753 DSCSLS-EAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 753 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...+.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111 34578889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.84 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999986 48899999987653 345567899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++++|.+++.... ..++...+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999885432 568899999999999999999999 76 99999999999999999999999999876532211
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. ...++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ....... ..........
T Consensus 157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~------- 223 (265)
T cd06605 157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELL-QYIVNEPPPR------- 223 (265)
T ss_pred h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHH-HHHhcCCCCC-------
Confidence 1 1567889999999999999999999999999999999999975332111 1111111 1111111101
Q ss_pred CCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 753 DSCSLS-EAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 753 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+.. ....+.+++.+||+.+|++||++.+++..
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 --LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111 33467889999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.92 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=195.1
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++++|...++||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 488999999865432 33346788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+. +++...+... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666555322 245788889999999999999999987 999999999999999999999999999765332
Q ss_pred ccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc--------
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD-------- 741 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 741 (834)
... .....++..|+|||++.+. .++.++||||||++++||++|+.|++...... ......+......
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhh
Confidence 211 1224568899999998754 57889999999999999999999976432210 1111111110000
Q ss_pred -----CcccccCccccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 -----RPAELIDKSLYDS-----CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 -----~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+......... ........+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 00112346778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.05 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=193.2
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..++||+|+||.||+++.. .|+.+|+|+++... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999985 48899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++ +|..++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 666665432 345899999999999999999999988 99999999999999999999999999986643221
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc------Cccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD------RPAE 745 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 745 (834)
. .....++..|+|||++.+. .++.++||||||++++||++|+.|+.... ................ ....
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 1 1224568899999998764 47899999999999999999998853211 1111111000000000 0000
Q ss_pred ccCcc----ccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 LIDKS----LYD-----SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 ~~d~~----l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+.. ... .........+.+++.+||+.||.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 000 001112346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.74 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=194.9
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|++|.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999975 488999999865432 2335677899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++ +|..++... ...+++.....++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877543 236889999999999999999999988 99999999999999999999999999876432211
Q ss_pred ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc-------
Q 003272 673 EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA------- 744 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 744 (834)
. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.|+..... ........+.........
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 112346788999999875 4688999999999999999999998743221 000111111110000000
Q ss_pred --cc-------c-CccccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 --EL-------I-DKSLYDS-CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 --~~-------~-d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+. . ...+... ........+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0 0000000 01111246778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.66 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=197.7
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc-ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+|+..++||.|++|.||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999985 488999999876533 33467788999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 85 78777755444456899999999999999999999987 999999999999999999999999999765432211
Q ss_pred cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc---------Cc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD---------RP 743 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 743 (834)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+......+ ............ ..
T Consensus 157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence 1224568899999988664 57899999999999999999999975332211 110000000000 00
Q ss_pred ccccCccc------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKSL------YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
........ .....+.....+.+++.+|++.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00011122346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=291.01 Aligned_cols=247 Identities=24% Similarity=0.427 Sum_probs=197.0
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhcc---CCceeeEEEEEEeCCeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 590 (834)
.|+..++||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 3667789999999999999974 5889999998654 3345567889999999996 999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. ..+++.....++.+|+.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+........ . ........ +
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~~-----~ 220 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSKP-----P 220 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCCC-----C
Confidence 321 2235688899999998754 578999999999999999999999753221110 0 00000001 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+... .....+.+++.+||+.||++||++.|++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 12346788999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=290.63 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=205.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.-|...+.||+|.|..|-++++- .|..||||++.+.. ......+.+|++.|+.++|||||+|+.+......++||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34666778999999999888753 59999999997753 3344578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee-cCCCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~~kl~DfGla~~~~~~ 670 (834)
.-.+|+|.+++..+ ...+.+....+++.||..|+.|+|+.+ +|||||||+||.+ .+-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999998654 346899999999999999999999988 9999999999987 46678999999999877433
Q ss_pred ccccccccccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. .....+|...|-|||++.+..|+ +++||||||||||.|++|+.||..-.+.+ .+..++|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence 2 23347899999999999998886 68999999999999999999985322211 11223332
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. -..+.....+|.+|+..||+.||.+|-+.+||+..
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2 23455566789999999999999999999999853
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.45 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=198.1
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 5889999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|.+++.. ..+++..+..++.||+.||+|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999998843 45889999999999999999999988 999999999999999999999999988765432221
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+..... ... .......... .+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~-~~~~~~~~~~-----~~~~-- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQA-MKRIRDNLPP-----KLKN-- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHH-HHHHHhcCCC-----CCcc--
Confidence 1225688899999999988899999999999999999999999642111 111 1111111111 1110
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.92 Aligned_cols=247 Identities=29% Similarity=0.417 Sum_probs=193.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...++||+|+||.||+|... +++.||+|.+..... ...+++.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888889999999999999975 488999999864322 3345788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||+++ ++.+++... ...+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 665555322 345899999999999999999999988 99999999999999999999999999876532
Q ss_pred CccccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
. ....++..|+|||++. ...++.++||||||+++|||++|+.|+...... ..... ........
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~~~- 233 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNDSPT- 233 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcCCCCC-
Confidence 2 1246778999999884 356889999999999999999999986422110 00000 00010000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+ ........+.+++.+||+.+|++||++.+|++.
T Consensus 234 ----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 111234467889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=284.03 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=203.4
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLVY 590 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 590 (834)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667789999999999999986 488999999865542 4567899999999999999999999999988 8899999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++... ..+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 37899999999999999999999987 999999999999999999999999999887544
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
..........++..|+|||.+....++.++||||||+++++|++|+.|+.... ........... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~---------~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS---------SG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc---------cC
Confidence 32111233567889999999998889999999999999999999999976433 11111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+......+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122222457888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.99 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=202.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++.|+..+.||+|++|.||+|... +++.|++|++..... ..+.+.+|++++++++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888889999999999999986 488999999976544 56788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++.... ..+++..+..++.+|+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999986432 37999999999999999999999987 9999999999999999999999999987654322
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .. ............+
T Consensus 171 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~~--- 238 (286)
T cd06614 171 SK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------AL-FLITTKGIPPLKN--- 238 (286)
T ss_pred hh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCCCCCcc---
Confidence 11 122457789999999998889999999999999999999999965322211 00 0111111111110
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.+++.+|++.+|.+||++.+|+.
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=291.61 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=194.4
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999875 48899999986432 22346789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+. ++|..++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5787777543 2356899999999999999999999987 99999999999999999999999999886643222
Q ss_pred ccccccccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc----------
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD---------- 741 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~-~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 741 (834)
. .....++..|+|||.+.+.. ++.++||||||++++||++|+.|+...... ..+... .......
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRI-FRTLGTPDEVVWPGVTS 230 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HHHhCCCChhhhhhhhH
Confidence 1 12245678899999887644 688999999999999999999987532111 111100 0000000
Q ss_pred ------CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 ------RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 ------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.........+.. ........+.+++.+|++.||++||+++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 00111235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=284.24 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=202.5
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
|.+..+||+|+||.|||+.+.+ |+.+|+|++.. ....+++..|+.++++.+.+++|+++|.+.....+++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 5566799999999999999866 99999999854 34568899999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
|+..+.+.. +++.|.+.++..+++..++||+|||... -||||||+.||||+-+|.+||+|||.|..+... -..
T Consensus 113 GSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK 185 (502)
T KOG0574|consen 113 GSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK 185 (502)
T ss_pred CcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence 999998853 5678999999999999999999999876 899999999999999999999999999776322 222
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.+.+.||+.|||||++..-.|..++||||+|+...||.-|++|+...++....-+ . --.+......
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------I-------PT~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------I-------PTKPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------c-------cCCCCCCCCC
Confidence 3458899999999999999999999999999999999999999653322111000 0 0011111112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+..-...+-+++..||-..|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2333456778999999999999999988775
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=293.64 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=196.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 589 (834)
++|+..+.||+|+||.||+|.... ++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 468888899999999999999864 8899999996543 22334677899999999999999999999877 889999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 888777442 236899999999999999999999988 99999999999999999999999999987654
Q ss_pred CccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-hh-------HHHHHHhhc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN-LL-------GHAWQLWIQ 740 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~-~~-------~~~~~~~~~ 740 (834)
.... .....++..|+|||.+.+. .++.++||||||++++||++|+.|+.......... +. ...|..+..
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3211 1224567899999998764 46899999999999999999999976432211000 00 000110000
Q ss_pred ------cCcccccCccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 741 ------DRPAELIDKSLYDSCSLS-EAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 741 ------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..........+....+.. ....+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111111111 2445778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=297.19 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=201.9
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecc--cCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSK--SSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..|+++++||.||.+.||++...+.+.+|+|++.. .+.+...-|++|+.+|.+| .|.+||+|++|-..++.+++|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45888999999999999999988888889888753 3567788999999999999 59999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|- ..+|..+|.... .....| .+..+..|++.++.++|+++ |||.||||.|+|+-+ |.+||+|||+|..+..+.
T Consensus 441 ~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 86 458888885432 233445 77889999999999999998 999999999999865 589999999999998887
Q ss_pred cccccccccccccccCccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGL-----------FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~-----------~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+......-+||..||+||.+.... .+.++||||+|||||+|+.|+.||..+.. . -
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~-------~ 579 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------Q-------I 579 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------H-------H
Confidence 776666789999999999985432 56789999999999999999999753211 0 1
Q ss_pred cCcccccCccccCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 741 DRPAELIDKSLYDSCS-LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.++..+.|+...-.++ .....++++++..||+.||++||+..|+++-
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233444443211111 1111238899999999999999999999864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=303.12 Aligned_cols=194 Identities=25% Similarity=0.357 Sum_probs=167.8
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhcc-C-----CceeeEEEEEEeCCeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-H-----RNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 588 (834)
+|++.+.||+|.||.|.|+.... ++.||||+++. ...-..+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999998765 89999999954 4445567788999999996 4 489999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC--CeEEeeeccccc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM--NPKISDFGMARA 666 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~--~~kl~DfGla~~ 666 (834)
|+|.+.. +|.+++.... ...++...++.++.||+.||..||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 266 VfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999855 8889986543 445999999999999999999999887 99999999999997554 699999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
....-. ...-++.|+|||++.+.+|+.+.||||||||+.||++|.+.|.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 532221 3566789999999999999999999999999999999987654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.15 Aligned_cols=245 Identities=29% Similarity=0.418 Sum_probs=194.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
+.|...+.||.|+||.||.++... .+.||||++..+.. ..++.+..|+..|.+++|||+|.+.|++......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 346677899999999999999754 77899999976544 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|||-+ +-.+++.- ..+++-..++..|..+.+.||+|||+.+ .||||||+.||||++.|.+||+|||.|.+....
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99965 55555522 3467889999999999999999999998 999999999999999999999999999875332
Q ss_pred ccccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
+..+|||.|||||++. .+.|+-|+||||+|++..||.-.++|.-. ......+.. ......
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--MNAMSALYH-----IAQNes---- 242 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYH-----IAQNES---- 242 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--chHHHHHHH-----HHhcCC----
Confidence 3378999999999985 46899999999999999999999988321 111111111 111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
|.+. ..+=...+.+++..||+.-|.+|||.+++++
T Consensus 243 -PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111 2223446778999999999999999998764
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=291.96 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=196.1
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEEEe
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLVYE 591 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 591 (834)
|+..++||+|++|.||+|+..+ ++.+|+|++.... ....+.+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4567899999999999999865 8899999997653 33446788999999999999999999999888 78999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787777432 246899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc-------
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP------- 743 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 743 (834)
.. ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ..............
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 21 1222456788999998765 468999999999999999999999975332211 11111110000000
Q ss_pred ----------ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 ----------AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ----------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.......+...+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000011112457789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=291.44 Aligned_cols=243 Identities=26% Similarity=0.296 Sum_probs=197.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 367888999999999999999764 8899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. ...++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999988854 356899999999999999999999987 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.|+..... .........+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKV------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCc-------
Confidence 2235688999999999888899999999999999999999999753221 011111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVV 785 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~ 785 (834)
..+......+.+++.+||+.||.+|| +++|++
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 01111234677899999999999999 667765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.37 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=190.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHH-HHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALL-IAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..+.||+|+||.||++.... |+.||+|+++... .....++..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 367888999999999999999764 8999999987543 2333455666664 556789999999999999999999999
Q ss_pred ecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 592 YLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 592 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|++ ++|..++... .....+++..+..++.||+.||+|||+. + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787776432 2345689999999999999999999986 5 99999999999999999999999999987532
Q ss_pred CccccccccccccccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
... .....++..|+|||.+.+ ..++.++|+||||++++||++|+.|+...... . ..... ........
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~-~~~~~~~~ 227 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQ-VVEEPSPQ 227 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHH-HHhcCCCC
Confidence 211 122457889999998865 45688999999999999999999997432110 0 00111 11111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+. .......+.+++.+||+.+|++||++.+|++
T Consensus 228 ~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 0112346788999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.66 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=201.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+.+.++..||.|+||.||++...+ +-..|-|.+...+....+.|.-|+++|....||+||+|++.+...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345566789999999999998765 3345778887777888899999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
.+|-.+..+... ...|....+..+.++++.||.|||++. |||||||+.|||++-+|.++|+|||.+........
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q- 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ- 185 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHh-
Confidence 999999987543 457999999999999999999999998 99999999999999999999999998765422211
Q ss_pred cccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.-....||+.|||||+.+ ..+|+.++||||||++|.||..+.+|-.. .+..+ +........+..++.
T Consensus 186 -kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMR-VllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 186 -KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMR-VLLKIAKSEPPTLLQ 257 (1187)
T ss_pred -hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHH-HHHHHhhcCCCcccC
Confidence 122378999999999875 56899999999999999999999988321 11111 112223333333333
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
|.- -...+.+++.+||..||+.||++.++++
T Consensus 258 PS~-------Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 PSH-------WSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cch-------hhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222 2235677889999999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=283.34 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=202.4
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 588999999976655567889999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999987 99999999999999999999999999987654322
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
.....++..|+|||.+....++.++||||||+++++|++|+.|+....... ...............
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIATNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhcCCCCcCc------
Confidence 233567889999999998889999999999999999999999865322111 000011111111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.......+.+++.+||+.||++||++.|+++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11113467889999999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=293.12 Aligned_cols=263 Identities=23% Similarity=0.299 Sum_probs=193.1
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe-----
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE----- 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~----- 585 (834)
++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999975 48899999886542 22346788999999999 56999999999887665
Q ss_pred eEEEEeecCCCChhhHhhccCC--CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeec
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR--SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFG 662 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfG 662 (834)
.++||||+++ +|..++..... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 77777654322 346899999999999999999999988 999999999999998 8899999999
Q ss_pred cccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+++.+....... ....+++.|+|||++.+ ..++.++||||||++++||++|..|+....... .+.. ........
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTP 231 (295)
T ss_pred cceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCC
Confidence 998653322111 12356788999998865 457999999999999999999999875321110 0000 00000000
Q ss_pred Cc------ccccC----cc----ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 RP------AELID----KS----LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 ~~------~~~~d----~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ....+ +. ......+.....+.+++.+||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000 00 000001123346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=291.22 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=192.8
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|...++||+|+||.||++.... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 44556789999999999998754 8899999986543 334567889999999996 99999999999998899999999
Q ss_pred cCCCChhhHhhc--cCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 593 LPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 593 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
++. ++..+... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 875 54443211 11235689999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CccccccccccccccccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~---~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... ....++..|+|||++.+. .++.++||||||+++|||++|+.|+.... ...... ........
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~-~~~~~~~~--- 228 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQL-TQVVKGDP--- 228 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHH-hhhcCCCC---
Confidence 2211 224578899999999776 68999999999999999999999975322 111111 11111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+.+...........+.+++.+||+.+|++||++.+|++.
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112234468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=287.44 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=198.7
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||+|+||.||++.... |..+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47778899999999999999865 889999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccCCCc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGLDQ 671 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~ 671 (834)
+++++|.+++... ....+++..+..++.+|++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988543 2335799999999999999999999988 99999999999999886 46999999998764322
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.. .....+++.|+|||++.+..++.++||||||++++||++|+.|+.... ....... ........
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~-~~~~~~~~------ 221 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLK-ICQGYFAP------ 221 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcccCCC------
Confidence 11 122467889999999988889999999999999999999999964321 1111111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
........+.+++.+|++.+|++||++.||++.
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111223467889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=293.63 Aligned_cols=251 Identities=28% Similarity=0.396 Sum_probs=194.8
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.|...+.||+|+||.||+++.. ++..||+|++.... ....+++.+|++++++++|+|++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3666789999999999999975 48899999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++ +|.+++.. ....+++..+..++.+|+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 66666532 2345899999999999999999999988 999999999999999999999999998754321
Q ss_pred cccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
....++..|+|||++. ...++.++||||||++++||++|+.|+...... .. ..........
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~----~~~~~~~~~~---- 242 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA----LYHIAQNESP---- 242 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HH----HHHHHhccCC----
Confidence 2246788999999974 456889999999999999999999986422110 00 0111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
..........+.+++.+||+.+|.+||++.+|++.+-....
T Consensus 243 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 243 ----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 00111223457889999999999999999999986654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=290.59 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=194.1
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
|+..++||.|++|.||+|... +|..||+|++.... ....+.+.+|+.++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999975 58999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
+ ++|..++.... ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68888874332 246899999999999999999999987 999999999999999999999999999765432211
Q ss_pred cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc---------Cc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD---------RP 743 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~ 743 (834)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+....... .+.. ........ .+
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChHHhhhhhhc
Confidence 1223567899999988664 57899999999999999999999975322211 0000 00000000 00
Q ss_pred ccccCcc------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKS------LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+..... ............+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000011112246788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=297.62 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=195.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------ 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 583 (834)
..++|+..+.||+|+||.||++... .++.||+|++... .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999975 4889999998643 233446778899999999999999999988543
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
...++||||+.+ +|...+.. .++...+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 67666532 2888999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc------------ch-
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH------------NL- 730 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~------------~~- 730 (834)
++....... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...+..... .+
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987643221 22246788999999999999999999999999999999999997533211000 00
Q ss_pred --hHHHHHHhhccCc-------ccccCcccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 731 --LGHAWQLWIQDRP-------AELIDKSLY----DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 731 --~~~~~~~~~~~~~-------~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.......+..... .++...... ..........+.+++.+||+.||++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000000 011111000 00111234567899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=300.96 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=194.5
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----ee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-----ER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 586 (834)
.++|...++||+|+||.||+|... +|+.||+|++... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 4889999998643 2334567889999999999999999999876543 57
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++|+||+++ +|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 6666652 346899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccc-ccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc-
Q 003272 667 FGLDQTEA-NTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP- 743 (834)
Q Consensus 667 ~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 743 (834)
........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 64322111 1123567899999998765 568999999999999999999999874322110 00000000000000
Q ss_pred --ccccCcc-------c--cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 744 --AELIDKS-------L--YDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 744 --~~~~d~~-------l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+.+.. . ....+ +.....+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 00000 1123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=292.89 Aligned_cols=267 Identities=22% Similarity=0.322 Sum_probs=192.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe-----
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE----- 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 585 (834)
.++|+..++||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999975 48899999986432 2233456789999999999999999999876543
Q ss_pred ---eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 586 ---RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 586 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
.++||||+.+ +|...+.. ....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 67666532 2235899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 663 MARAFGLDQTE--ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 663 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876432221 111234577889999988664 478899999999999999999988753322111111110000000
Q ss_pred ccCcc-----cccCcc-ccCC---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 QDRPA-----ELIDKS-LYDS---------CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ~~~~~-----~~~d~~-l~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+... ...+.. .... ........+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000000 0000 00011235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=298.28 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=196.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC--Cee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR--DER 586 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 586 (834)
..++|+..+.||+|+||.||+|... .++.+|+|++... .......+..|+.++.++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999976 4889999988542 233445678899999999 999999999998654 368
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 488777733 26889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc---cccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------HHH
Q 003272 667 FGLDQTE---ANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL--------GHA 734 (834)
Q Consensus 667 ~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~--------~~~ 734 (834)
+...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12233568899999998765 46788999999999999999999997532221100000 000
Q ss_pred HHHhhccCcccccCcccc------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 735 WQLWIQDRPAELIDKSLY------DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+..+.......+++.... ..........+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000111110000 00001124467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=288.53 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=200.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
+.|+..++||+|+||.||-.+... |+.+|.|++.+. ..++.....+|-.+|.+++.+.||.+--.+...+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457788899999999999998765 889999988653 3455667788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
..|.+|+|..+|..... ..+++...+.++.+|+-||++||... ||.|||||+|||||+.|+++|+|+|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999977654 67999999999999999999999988 999999999999999999999999999987544
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
... ...+||.+|||||++.++.|+...|.||+||+||||+.|+.||..+... .-.+-+|.+
T Consensus 341 ~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------vk~eEvdrr 401 (591)
T KOG0986|consen 341 KPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------VKREEVDRR 401 (591)
T ss_pred Ccc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------hhHHHHHHH
Confidence 332 2258999999999999999999999999999999999999997532111 001112222
Q ss_pred cc---CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 751 LY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 751 l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
.. ..++....+++..+....|+.||++|.--
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11 12334445567778888999999999643
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=312.76 Aligned_cols=200 Identities=22% Similarity=0.360 Sum_probs=158.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC--CeEEEEE------------------EecccCcccHHHHHHHHHHHHhccCCc
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE--GQEIAVK------------------RLSKSSGQGVEEFKNEALLIAKLQHRN 572 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 572 (834)
..++|+..++||+|+||+||++.+.. +...++| ++. ........+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999987643 2222222 111 12233457889999999999999
Q ss_pred eeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCC--CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTR--SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 573 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
|+++++++...+..++|+|++.. +|..++..... ...........++.||+.||.|||+.+ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999865 55555433211 122345667789999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
+.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999998764332221 2235789999999999999999999999999999999998854
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=286.44 Aligned_cols=247 Identities=26% Similarity=0.292 Sum_probs=199.9
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
+|...+.||.|+||.||++.... ++.||+|.+.+.. ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788899999999999999864 8899999997542 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|..++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988432 46889999999999999999999988 9999999999999999999999999988764332
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
......++..|+|||.+.+..++.++||||||+++++|++|+.|+....... .......... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------c
Confidence 1223567889999999998889999999999999999999999976433211 1111111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNM--LSVV 785 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~ev~ 785 (834)
....+......+.+++.+||+.||.+||++ .|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011122233578899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=289.19 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=195.0
Q ss_pred cCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 520 ENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
..+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999875 5899999998655555667899999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 887732 35789999999999999999999987 99999999999999999999999999876543221 1223
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..++..|+|||.+.+..++.++||||||++++||++|..|+....... .. ....... ...+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~----~~~~~~~-----~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----KMIRDNL-----PPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhhC-----CcccCC--ccc
Confidence 567889999999988889999999999999999999999965321111 00 0011000 011100 011
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2335678899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=283.99 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=193.4
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999864 8899999986542 23456799999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999854 235889999999999999999999987 9999999999999999999999999998764332 1223
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+. .. ....... .......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~--------~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----ME-IYNDILK--------GNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HH-HHHHHhc--------cCCCCCCCcc
Confidence 567889999999988889999999999999999999999975432111 10 0111110 0001111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
....+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2457889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=302.10 Aligned_cols=203 Identities=30% Similarity=0.456 Sum_probs=176.8
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------CeeEE
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------DERVL 588 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 588 (834)
+...+.||+|+||.||+|+... |+.||||.+++. .....+....|++++++++|+|||++++.=.+. ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3455689999999999999654 999999999764 445667889999999999999999999875443 35789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec--CCCC--eEEeeeccc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD--NEMN--PKISDFGMA 664 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~--~kl~DfGla 664 (834)
|||||.+|+|...+....+...|+..+.+.++.+++.||.|||+++ |+||||||.||++- ++|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999999889999999999999999999999999888 99999999999994 3343 599999999
Q ss_pred cccCCCccccccccccccccccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHAD 725 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~ 725 (834)
+.++.+. ......||..|.+||++. .+.|+..+|.|||||++||.+||..||......
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9986443 344589999999999998 488999999999999999999999998765444
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=290.96 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=194.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD----- 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 584 (834)
..++|+..++||+|+||.||+|.... ++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45788899999999999999999864 8899999986542 233456788999999999999999999987655
Q ss_pred -----eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 585 -----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 585 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
..++|+||+++ ++..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 55555532 2346899999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||++..+....... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+...... ..........
T Consensus 159 dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred cccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 999998764332211 112345778999998865 45789999999999999999999987532211 1111111111
Q ss_pred hccCcc---cc--------cCc------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 739 IQDRPA---EL--------IDK------SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 739 ~~~~~~---~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...... .+ .+. ...... ...+..+.+++.+||+.+|++||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110000 00 000 000000 012346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.51 Aligned_cols=263 Identities=25% Similarity=0.321 Sum_probs=193.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 588 (834)
.++|+..++||+|+||.||+|.... |+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4678889999999999999999754 88999999864322 2234567899999999999999999998765 46899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+.+ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 777776432 256899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc------
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD------ 741 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 741 (834)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ............
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhch
Confidence 33211 112345778999999875 568899999999999999999999975322111 111111100000
Q ss_pred -----Cccccc--CccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 742 -----RPAELI--DKSLYDSC---SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 742 -----~~~~~~--d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...... ........ .......+.+++.+|++.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00000000 00113456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=285.21 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=185.6
Q ss_pred ccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHh---ccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAK---LQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
.||+|+||.||++...+ ++.+|+|.+.+.. ......+.+|..++.. .+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999754 8899999886532 1222344555544443 479999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|..++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988743 345899999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....++..|+|||.+.. ..++.++||||||++++||++|+.|+......... ..... .. ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~-~~-----~~~~---- 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRM-TL-----TVNV---- 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHH-hh-----cCCc----
Confidence 122468999999999864 56899999999999999999999997532221110 00000 00 0011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVLM 787 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~ 787 (834)
..+......+.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11222334678899999999999999 59999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=287.88 Aligned_cols=259 Identities=24% Similarity=0.307 Sum_probs=196.6
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999975 488999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++ +|..++... ...+++..+..++.+|+.||.|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 86 777766432 246899999999999999999999988 99999999999999999999999999987754431
Q ss_pred cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC---cccccC-
Q 003272 674 ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR---PAELID- 748 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d- 748 (834)
......++..|+|||.+.+. .++.++||||||+++++|++|+.|+......+ ............. .....+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence 11224577889999999876 78999999999999999999998875322211 1111111100000 000000
Q ss_pred ----------ccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 ----------KSL--YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ----------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... ...........+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=283.53 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=201.7
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..++||+|++|.||+++.. +++.+|+|.+.... .....++.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999865 47899999986532 33456788899999999999999999999999999999999
Q ss_pred cCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 593 LPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 593 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
+++++|..++... .....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999987542 22356899999999999999999999988 9999999999999999999999999998765431
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.....++..|+|||.+.+..++.++|+||||++++||++|+.|+...... . ..........
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~----~~~~~~~~~~-------- 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---D----LRYKVQRGKY-------- 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHhcCCC--------
Confidence 12245788999999999999999999999999999999999997532211 0 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11222344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=284.03 Aligned_cols=244 Identities=26% Similarity=0.330 Sum_probs=190.8
Q ss_pred cccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 48899999986532 23345678899999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 99886433 246899999999999999999999988 9999999999999999999999999987654311 1122
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+......... . ......... ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~----~~~~~~~~~------~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---E----ELKRRTLEM------AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---H----HHHhccccc------cccCCcc
Confidence 45778999999998888999999999999999999999997532221100 0 000000000 0011112
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 759 EAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 244678899999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=285.93 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=189.8
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeeEEEEEEeC--CeeEEEEe
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQR--DERVLVYE 591 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 591 (834)
|+..++||+|+||.||+|... +++.||+|+++... .........|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999875 48899999987542 222234457888888885 99999999999887 88999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++ +|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 676666432 246899999999999999999999988 999999999999999 999999999998764322
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH-----------Hhh
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ-----------LWI 739 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~ 739 (834)
.. ....++..|+|||.+.. ..++.++|||||||+++||++|..|+......+ ....... ...
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 21 22457889999997654 567899999999999999999999875332211 1111100 000
Q ss_pred ccCcccccCccccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 QDRPAELIDKSLYD----SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.........+.... .........+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001123567889999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=288.14 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=192.7
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 48899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~ 670 (834)
|++. +|..++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 676665322 2234678888899999999999999987 999999999999985 557999999999865432
Q ss_pred ccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc--
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI-- 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 747 (834)
... .....+++.|+|||++.+ ..++.++||||||+++++|++|+.|+......+ ........... ......
T Consensus 157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~-~~~~~~~~ 230 (294)
T PLN00009 157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGT-PNEETWPG 230 (294)
T ss_pred ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC-CChhhccc
Confidence 211 122456889999998876 457899999999999999999999975322111 00000000000 000000
Q ss_pred -----C---------ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 -----D---------KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 -----d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+ ........+.....+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000001112345788999999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=315.00 Aligned_cols=261 Identities=28% Similarity=0.375 Sum_probs=205.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC--------CeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ 582 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 582 (834)
..+++...+.||+|.||.|++|.... ...||||.++... ....+.+..|+.+|+.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34555666699999999999998542 4579999997653 35677899999999998 69999999999999
Q ss_pred CCeeEEEEeecCCCChhhHhhccC-----C------C--CCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcee
Q 003272 583 RDERVLVYEYLPNKSLDYFIFDTT-----R------S--KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649 (834)
Q Consensus 583 ~~~~~lV~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 649 (834)
....++|+||+..|+|..++...+ . . ..++..+.+.++.|||.||+||++.. +|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997654 0 1 23889999999999999999999987 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCcccccc-ccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccc
Q 003272 650 LDNEMNPKISDFGMARAFGLDQTEANT-NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHR 727 (834)
Q Consensus 650 l~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~ 727 (834)
|.++..+||+|||+|+........... ....-...|||||.+....|+.|+|||||||+||||++ |..|+...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~----- 525 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI----- 525 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-----
Confidence 999999999999999976544333211 11113557999999999999999999999999999999 55554210
Q ss_pred cchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
............+ -+-..+..+..++++++..||+.+|++||++.++++.++..
T Consensus 526 -~~~~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 -PPTEELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -CcHHHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0001111122222 22223344456788999999999999999999999999873
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-31 Score=277.95 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=203.4
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..+.||.|+||.||++... +++.+++|++..... ...+++.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999986 388999999875432 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 593 LPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 593 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
+++++|.+++.... ....+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886432 2467999999999999999999999987 9999999999999999999999999998764433
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ......+++.|+|||.+.+..++.++||||+|+++++|++|+.|++.... .. ............
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~------ 222 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LE-LALKILKGQYPP------ 222 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HH-HHHHHhcCCCCC------
Confidence 1 22235678899999999988899999999999999999999999753221 11 111111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+......+.+++.+||+.+|++||++.|+++.
T Consensus 223 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111233467889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=285.06 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=181.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeCC----eEEEEEEecccCcccH-----------HHHHHHHHHHHhccCCceeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEG----QEIAVKRLSKSSGQGV-----------EEFKNEALLIAKLQHRNLVKLLG 578 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g 578 (834)
.++|.+.++||+|+||.||+|...+. ..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999997553 3556665322221110 11122334455668999999999
Q ss_pred EEEeCC----eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC
Q 003272 579 CCTQRD----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM 654 (834)
Q Consensus 579 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 654 (834)
++.... ..++++|++.. ++.+.+.. ....++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 34677777644 44444422 223567888999999999999999987 99999999999999999
Q ss_pred CeEEeeeccccccCCCccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 003272 655 NPKISDFGMARAFGLDQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729 (834)
Q Consensus 655 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~ 729 (834)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.|+...... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GN 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hH
Confidence 9999999999876432211 1122356999999999999999999999999999999999999997643211 11
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
+.......+. ..+....+.. ......+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFI----KRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHH----HHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111110 0011111100 111346788999999999999999999998874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=297.56 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=195.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----Ce
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 585 (834)
.++|...++||+|+||+||+++... ++.||||.+... ......++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578899999999999999998754 889999998653 233456778899999999999999999987654 34
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 577777642 346899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH--------HH
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA--------WQ 736 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~ 736 (834)
...... .......++..|+|||.+.+ ..++.++||||||+++++|++|+.|+............... +.
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764322 11223567889999998875 46889999999999999999999997532211100000000 00
Q ss_pred HhhccCcccc-------cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 737 LWIQDRPAEL-------IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 737 ~~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.......... .+.... .........+.+++.+||+.+|++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 000000 0011234567899999999999999999999866
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=286.49 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=191.8
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||.||+|...+ ++.||||+++... .....++..|+.++.+.. |+||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788899999999999999865 8999999997543 234456677777777774 9999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|+++ ++..++... ...+++..+..++.+|+.||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9864 666665432 23689999999999999999999974 5 999999999999999999999999999776432
Q ss_pred ccccccccccccccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~----~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ....++..|+|||.+.... ++.++||||||+++|||++|+.|+....... . .............
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~~~~~~ 239 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----E-VLTKILQEEPPSL 239 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----H-HHHHHhcCCCCCC
Confidence 221 1235678999999987554 7889999999999999999999975321110 0 0111111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.. ......++.+++.+||+.||++||++.++++.
T Consensus 240 ~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00123467889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=284.47 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=196.5
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|++++.+++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 89999999865432 4567889999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc------
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT------ 672 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~------ 672 (834)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988543 36899999999999999999999988 99999999999999999999999999886543321
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
........++..|+|||.+.....+.++||||||++++||++|+.|+....... .......+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKIE-------- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcC--------
Confidence 112223567889999999988889999999999999999999999975322111 01111111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00000013567889999999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.87 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=200.2
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|+..++||+|++|.||+++.. .++.|++|.+..... ...+.+.+|++++.+++|+|++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999876 478999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988432 56899999999999999999999987 99999999999999999999999999987754332
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....++..|+|||.+....++.++||||+|+++++|++|+.|+..... .. ..+ ........
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~-~~~-~~~~~~~~-------- 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MA-ALF-RIVQDDHP-------- 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HH-HHH-HHhccCCC--------
Confidence 1 1235678899999999888889999999999999999999998653221 00 000 11111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111122346778999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.89 Aligned_cols=245 Identities=24% Similarity=0.260 Sum_probs=189.1
Q ss_pred CccccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHH-HhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLI-AKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.||+|+||.||+|.... ++.||||.+++... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999998754 88999999865432 2223444555444 445899999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998853 245889999999999999999999987 99999999999999999999999999876432
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
.....++..|+|||.+.+..++.++||||||++++||++|..|+...... ............ .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccC------CCCcc
Confidence 12246788999999998888999999999999999999999997532211 111111111110 00011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.......+.+++.+||+.+|++||++.++.+.|+-
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11223467889999999999999988777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=277.76 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=214.7
Q ss_pred HHHHHHHhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEE
Q 003272 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGC 579 (834)
Q Consensus 507 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 579 (834)
.+++....++++....+-+|.||.||+|.|.+ .+.|.||.++.. +..+...+..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 35566667788888899999999999997643 456788888654 44566789999999999999999999999
Q ss_pred EEeC-CeeEEEEeecCCCChhhHhh-----ccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC
Q 003272 580 CTQR-DERVLVYEYLPNKSLDYFIF-----DTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE 653 (834)
Q Consensus 580 ~~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 653 (834)
+++. +..+++|.++.-|+|..|+. +....+.++-.+...++.|++.||+|||..+ |||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8765 56899999999999999997 5555667888899999999999999999998 9999999999999999
Q ss_pred CCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhH
Q 003272 654 MNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLG 732 (834)
Q Consensus 654 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 732 (834)
.++||+|=.+++.+-..+........-.+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999999998755544444444456779999999999999999999999999999998 777743222211
Q ss_pred HHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 733 HAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+...+....+-..+..++.+++.++.-||..+|++||+.+++++-|.+.
T Consensus 507 ----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 507 ----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111111222233455667899999999999999999999999998753
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=277.84 Aligned_cols=247 Identities=21% Similarity=0.239 Sum_probs=187.6
Q ss_pred HHHHhcCCcccCcc--ccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe
Q 003272 510 IVDATDNFSEENKL--GEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 510 ~~~~~~~~~~~~~L--G~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 585 (834)
+....++|+..+.+ |+|+||.||++... .+..+|+|.+........ |+.....+ +|+||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445667776666 99999999999875 478899999865322211 22222222 79999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMA 664 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla 664 (834)
.++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999988532 37899999999999999999999988 99999999999999998 9999999998
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+...... ...++..|+|||++.+..++.++||||||++++||++|+.|+....... ..... ..... ....
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~--~~~~ 227 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES-LLKRQ--QKKL 227 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH-HHHhh--cccC
Confidence 8754221 2457889999999999899999999999999999999999976222111 11111 00000 0000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-MLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 786 (834)
. ........+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 ~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 P---------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred C---------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 11123346788999999999999996 688873
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=280.66 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=194.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC--Cee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-----SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DER 586 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 586 (834)
.+|+..+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468888999999999999999754 889999987532 223456889999999999999999999998664 457
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++++||+++++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988843 234788999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcc-ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQT-EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... ........++..|+|||++.+..++.++||||||++++||++|+.|+..... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~---- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQP---- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCC----
Confidence 532111 1111235688899999999988899999999999999999999999642111 01111111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+......+.+++.+|++ +|..||+..+++.
T Consensus 226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111222333467789999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=296.53 Aligned_cols=267 Identities=21% Similarity=0.314 Sum_probs=196.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 586 (834)
.++|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888999999999999999754 8999999987542 2345678889999999999999999988753 3468
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 588887743 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcccc--ccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH--------HHH
Q 003272 667 FGLDQTEA--NTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG--------HAW 735 (834)
Q Consensus 667 ~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~--------~~~ 735 (834)
........ ......++..|+|||.+.+ ..++.++||||||++++||++|+.||............. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64332211 1123578889999999866 468899999999999999999999975322111000000 000
Q ss_pred HHhhccCcccccCccc-cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 736 QLWIQDRPAELIDKSL-YDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.....+...+..+... ..... ......+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000001111111000 00011 1224578899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=286.87 Aligned_cols=260 Identities=21% Similarity=0.264 Sum_probs=190.2
Q ss_pred CccccC--CcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G--~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
..||+| +||+||++... .|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357776 89999999875 58999999986432 23457889999999999999999999999999999999999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc-
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA- 674 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~- 674 (834)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998885432 235889999999999999999999987 9999999999999999999999998654332111110
Q ss_pred ----ccccccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH-------------
Q 003272 675 ----NTNRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW------------- 735 (834)
Q Consensus 675 ----~~~~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~------------- 735 (834)
......++..|+|||++.+. .++.++||||||++++||++|+.|+....... .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 00112345679999999764 47899999999999999999999975432110 0000000
Q ss_pred ---HH-------hhccC---------cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 ---QL-------WIQDR---------PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ---~~-------~~~~~---------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ...+. .....+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 00000 00011111111122334567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=283.85 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=198.5
Q ss_pred CCcccCccccCCcccEEEEEEe----CCeEEEEEEecccC----cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSS----GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 586 (834)
+|+..+.||+|++|.||+++.. ++..||||.+++.. ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999999853 46789999986532 23446788999999999 699999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888743 345889999999999999999999987 99999999999999999999999999887
Q ss_pred cCCCccccccccccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+....... .....++..|+|||.+.+.. .+.++||||||++++||++|..|+...... ....... ......
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~-~~~~~~--- 227 (288)
T cd05583 155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEIS-RRILKS--- 227 (288)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHH-HHHHcc---
Confidence 64332211 12246788999999987665 788999999999999999999997432111 0111111 111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
. ...+......+.+++.+||+.+|++|||+.++...|+..
T Consensus 228 ---~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ---K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 011112234677899999999999999999998888753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.97 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=193.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 584 (834)
.++|...+.||+|+||.||+|+.. .++.||||++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378988999999999999999975 4899999998653 2233456889999999999999999999986543
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++|+||+.. +|..++ ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999874 665544 235889999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH------
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL------ 737 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------ 737 (834)
+..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ........
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 764321 122467889999999876 468899999999999999999999975322111 01000000
Q ss_pred -----hhccCcccccCc---cccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCCC
Q 003272 738 -----WIQDRPAELIDK---SLYDS---CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM--LSGERS 793 (834)
Q Consensus 738 -----~~~~~~~~~~d~---~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~--L~~~~~ 793 (834)
.........+.. ..... ..+.....+.+++.+||+.||++||++.|++.. ++..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000000 00000 000122357789999999999999999999843 555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=284.17 Aligned_cols=263 Identities=24% Similarity=0.287 Sum_probs=193.5
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-ccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
|...+.||+|++|+||+|+..+ ++.|+||++..... .......+|+..+.+++ |+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567899999999999999865 78899999865432 22234567899999998 999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
+++|..++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778887775432 346899999999999999999999988 99999999999999999999999999987543221
Q ss_pred cccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch--------hHHHH--HHhhccC
Q 003272 674 ANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL--------LGHAW--QLWIQDR 742 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~--------~~~~~--~~~~~~~ 742 (834)
.....++..|+|||++.. ..++.++||||||++++||++|+.|+..........- ....+ .......
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122567889999998854 4678999999999999999999988753322110000 00000 0000000
Q ss_pred cccccCcccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 743 PAELIDKSLY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 743 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....+..... ..........+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000 00001113568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=288.03 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=196.5
Q ss_pred HHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe-CCe
Q 003272 510 IVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-RDE 585 (834)
Q Consensus 510 ~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 585 (834)
+...+++|+..++||.|+||.||++... +++.||||++.+. .....+.+.+|+.++.+++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446789999999999999999999865 5889999988643 22345678899999999999999999999865 557
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++|+||+. ++|..++. ...+++.....++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||++.
T Consensus 85 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 889999984 57877763 235788888999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------HHHHH
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL--------GHAWQ 736 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~--------~~~~~ 736 (834)
..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+............ .....
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 64321 122456788999998866 56899999999999999999999987533211100000 00000
Q ss_pred HhhccCcccccCcc-ccCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 737 LWIQDRPAELIDKS-LYDSCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 737 ~~~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....+...+++... .....+. .....+.+++.+|++.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111111000 0011111 123578899999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=311.09 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=188.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-------
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------- 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 583 (834)
-..+|+..+.||+||||.|||++.. ||+.+|||++.-. +........+|+.++++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467888899999999999999864 7999999999654 344556788899999999999999997443210
Q ss_pred --------------------------------------------------------------------------------
Q 003272 584 -------------------------------------------------------------------------------- 583 (834)
Q Consensus 584 -------------------------------------------------------------------------------- 583 (834)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhh
Q 003272 584 --------------------------------DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631 (834)
Q Consensus 584 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 631 (834)
..++|-||||+..++.+++.+..... .-...++++++|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 01467788888888877774432111 35677899999999999999
Q ss_pred hcCCCceEeccCCCCceeecCCCCeEEeeeccccccC----------------CCccccccccccccccccCccccccC-
Q 003272 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------------LDQTEANTNRVVGTYGYMSPEYAIDG- 694 (834)
Q Consensus 632 ~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~APE~~~~~- 694 (834)
+.+ ||||||||.||+||++..+||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998721 00111123457899999999999765
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHccc
Q 003272 695 --LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQ 772 (834)
Q Consensus 695 --~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 772 (834)
+|+.|+|+||+||||+||+. ||.... +.. .....+..+.+..- ..+...++..-.+++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa----~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERA----SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH--HHH----HHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999986 332211 100 01111222222211 12233344455689999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003272 773 QIPEDRPNMLSVVLM 787 (834)
Q Consensus 773 ~dP~~RPt~~ev~~~ 787 (834)
.||.+|||+.|++..
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999853
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.80 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=203.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
...|.+.+.||+|.|++|..|+... +..||+|.+.+.. ....+.+.+|+++|+.++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4568888999999999999999765 9999999998763 334456889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+.+|.+.+++.... .+.......++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999986543 3555888899999999999999998 99999999999999999999999999998752
Q ss_pred ccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.......+|++.|.|||++.+..| ++++|+||+|++||-|++|..||+.. .+.++-++
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-------------------~lk~Lr~r 266 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-------------------NLKELRPR 266 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-------------------ccccccch
Confidence 233345899999999999998775 57899999999999999999998631 11222222
Q ss_pred cccCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSC--SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+.+.+ +.....+|.++++++|-.+|.+|++++++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 222222 2222347889999999999999999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=287.42 Aligned_cols=247 Identities=30% Similarity=0.415 Sum_probs=192.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
+.|...+.||+|+||.||+|+... ++.+|+|.+... .....+++.+|+.+++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 346667889999999999999754 788999998642 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+. +++...+... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5776665322 345889999999999999999999987 999999999999999999999999998765321
Q ss_pred ccccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....++..|+|||.+. ...++.++||||||++++||++|+.|+....... .. .........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~----~~~~~~~~~--- 232 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL----YHIAQNESP--- 232 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HH----HHHhhcCCC---
Confidence 1246788999999975 3567889999999999999999999864321110 00 001111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
.. ........+.+++.+||+.+|++||++.+|+...
T Consensus 233 --~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 --AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --Cc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00 1112334677899999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=287.18 Aligned_cols=264 Identities=23% Similarity=0.289 Sum_probs=191.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 584 (834)
.++|+..++||+|+||.||+|... +++.+|||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999975 488999999865322 22346788999999999999999999875543
Q ss_pred --eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 585 --ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 585 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
..++|+||+.. ++...+.. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999876 55555533 2346899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCcccc---------ccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH
Q 003272 663 MARAFGLDQTEA---------NTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG 732 (834)
Q Consensus 663 la~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 732 (834)
+++......... ......+++.|+|||.+.+. .++.++||||||++++||++|++|+....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 998764322111 11224567889999988654 58899999999999999999999875322211 111
Q ss_pred HHHHHhhccC---------cccccCccccCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 733 HAWQLWIQDR---------PAELIDKSLYDSCS-------LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 733 ~~~~~~~~~~---------~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......... .....+.......+ ......+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111100000 00000000000000 111246788999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=284.95 Aligned_cols=244 Identities=29% Similarity=0.424 Sum_probs=189.3
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
|...++||+|+||+||+|+.. .++.|++|++..... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999875 488999999864322 3345788899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+.+ ++.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 964 66555532 2345899999999999999999999988 99999999999999999999999999864321
Q ss_pred ccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 673 EANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.....++..|+|||++. ...++.++||||||++++||++|..|+...... ....... ........
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~-- 241 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNDSPTLQ-- 241 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHH-hcCCCCCC--
Confidence 12356788999999984 456889999999999999999999986422110 0011111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112357789999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=289.44 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=193.9
Q ss_pred hcCCcc-cCccccCCcccEEEEEEe-CCeEEEEEEecccCccc--------------HHHHHHHHHHHHhccCCceeeEE
Q 003272 514 TDNFSE-ENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQG--------------VEEFKNEALLIAKLQHRNLVKLL 577 (834)
Q Consensus 514 ~~~~~~-~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~ 577 (834)
.++|.. .+.||+|+||+||+|... .++.||||+++...... ...+.+|+.++.+++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 467999999999999975 48899999986542221 12577899999999999999999
Q ss_pred EEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 578 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
+++...+..++||||++ ++|.+++.. ...+++.....++.||+.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 588777742 345889999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCcc------------ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 003272 658 ISDFGMARAFGLDQT------------EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724 (834)
Q Consensus 658 l~DfGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~ 724 (834)
|+|||+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987641110 1111123467889999998764 478999999999999999999998753322
Q ss_pred ccccchhHHHHHHhhccCcccc---------------cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 725 DHRHNLLGHAWQLWIQDRPAEL---------------IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+ ................. ..+... .........+.+++.+||+.+|++||+++|++..
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11 11111111111000000 000000 0011123467789999999999999999999863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.77 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=199.0
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-----eeE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-----ERV 587 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 587 (834)
+|...+.||+|++|.||+++..+ ++.||||++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57788899999999999999865 8899999987643 445578999999999999999999999988775 789
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++ +|..++.. ...+++..+..++.+|+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 77777743 337899999999999999999999988 999999999999999999999999999886
Q ss_pred CCCccc-cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh-------
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW------- 738 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 738 (834)
...... .......++..|+|||.+.+. .++.++||||||+++++|++|+.|+......+. ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhH
Confidence 543210 112235678899999999887 889999999999999999999999753322110 00000000
Q ss_pred ----hccCcccccCc-cccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 739 ----IQDRPAELIDK-SLYD-----SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 739 ----~~~~~~~~~d~-~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
......+.+.. .... .........+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 0000 0011123467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=279.76 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=185.2
Q ss_pred ccccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHH---HhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLI---AKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
.||+|+||.||++...+ ++.||+|.+.+... .....+..|..++ ....|+||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 88999999865421 2222344554443 34579999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999888743 346999999999999999999999987 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.|+.......... ....... ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~--- 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVE--- 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCC---
Confidence 1235688999999999754 68999999999999999999999975432211100 0000000 0111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
.+......+.+++.+|++.+|++|| ++.++++
T Consensus 218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111234678899999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=280.53 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=191.9
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc--ccHHHHHHHHHHHHhc---cCCceeeEEEEEEeCCe-----
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG--QGVEEFKNEALLIAKL---QHRNLVKLLGCCTQRDE----- 585 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 585 (834)
|+..++||+|+||.||+|+... ++.+|+|+++.... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999999865 89999999964322 2234566788777666 59999999999988776
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.+++|||+++ +|.+++.... ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7877764322 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc--
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP-- 743 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 743 (834)
........ ....++..|+|||.+.+..++.++||||||++++||++|+.|+......+ ..............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHh
Confidence 76433221 22356788999999999999999999999999999999988865322111 11111110000000
Q ss_pred --------ccccCcccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 --------AELIDKSLY---DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 --------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......... ..........+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0111123456778999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=285.25 Aligned_cols=260 Identities=19% Similarity=0.206 Sum_probs=189.2
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455555555555554 6899999998654 345567899999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-----
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE----- 673 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~----- 673 (834)
.+++.... ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99886432 345889999999999999999999988 999999999999999999999999988765321110
Q ss_pred cccccccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH----hhc-------
Q 003272 674 ANTNRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL----WIQ------- 740 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~------- 740 (834)
.......++..|+|||++... .++.++||||||++++||++|+.|+....... ......... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence 111224567789999998763 58899999999999999999999975322110 010000000 000
Q ss_pred cCccc----ccCccc----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 741 DRPAE----LIDKSL----YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 741 ~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..... ..++.. ...........+.+++.+||+.||++||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000000 011112233567889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.73 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=193.0
Q ss_pred CCcccCccccCCcccEEEEEEe----CCeEEEEEEecccC----cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSS----GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 586 (834)
+|+..+.||+|+||.||++... +|..||+|++.... ....+++.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3677889999999999999863 58899999986532 23346788899999999 699999999999998899
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++|+||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
........ .....++..|+|||.+... .++.++||||||+++++|++|+.|+..... .......... .....
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~-~~~~~-- 228 (290)
T cd05613 155 FHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRR-ILKSE-- 228 (290)
T ss_pred cccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHH-hhccC--
Confidence 64322211 1235678899999998753 467899999999999999999999753211 1111111111 10000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
...+......+.+++.+||+.||++|| ++.+++.
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001112234677899999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=265.76 Aligned_cols=203 Identities=27% Similarity=0.402 Sum_probs=167.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-----CeEEEEEEecccCc-cc-HHHHHHHHHHHHhccCCceeeEEEEEEe-CCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSSG-QG-VEEFKNEALLIAKLQHRNLVKLLGCCTQ-RDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-----g~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 585 (834)
...|+...+||+|.+|.||++.-.+ ...+|+|+++.... .+ -....+|+.+++.++|+||+.|..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999996433 23689999975422 11 2456889999999999999999999887 677
Q ss_pred eEEEEeecCCCChhhHhhc--cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC----CCeEEe
Q 003272 586 RVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE----MNPKIS 659 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~ 659 (834)
.++++||.+. +|...++- ..+.+.++...+..|+.||+.|+.|||+.= |+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 56555542 334467899999999999999999999976 9999999999999877 999999
Q ss_pred eeccccccCCCccc-cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 660 DFGMARAFGLDQTE-ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 660 DfGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
|||+++.+...-.. .....++-|..|+|||.+.+. .||.+.|||+.|||+.||++-.+.|.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999998654322 233457889999999999885 69999999999999999999887663
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=285.17 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=193.4
Q ss_pred HHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC----
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD---- 584 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 584 (834)
...++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999865 4889999998543 2233457889999999999999999999986543
Q ss_pred --eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 585 --ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 585 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 668887763 245899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH--------
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH-------- 733 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-------- 733 (834)
++...... .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+....... .....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 236 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPS 236 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 99865322 122456889999999876 458899999999999999999999975322110 00000
Q ss_pred --HHHHhhccCcccccCc--ccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 734 --AWQLWIQDRPAELIDK--SLY----DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 734 --~~~~~~~~~~~~~~d~--~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
................ ... ..........+.+++.+|++.||++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 000 0001112235778999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=318.63 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=200.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
-+-++....+||.|.||.||-+...+ |.-.|+|.++-. .....+...+|+.++..++|||+|+++|+=.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34556677899999999999998655 888899977543 345667889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||||++|+|.+++.. +...++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999843 344666667778899999999999999 99999999999999999999999999998865
Q ss_pred Ccc--ccccccccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 670 DQT--EANTNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 670 ~~~--~~~~~~~~gt~~y~APE~~~~~~---~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+.. ....+...||+.|||||++.+.. -..+.||||+||++.||+||++|+..++.+-. .......+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a------IMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA------IMYHVAAGHK- 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH------HHhHHhccCC-
Confidence 431 12224578999999999997643 45689999999999999999999654332211 0111112221
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...+.....+-.+++..|++.||++|-++.|++..
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12233333455678999999999999888877654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=280.65 Aligned_cols=249 Identities=28% Similarity=0.345 Sum_probs=199.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 589 (834)
++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 4899999998653 2234467889999999998 99999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998853 336999999999999999999999988 99999999999999999999999999987643
Q ss_pred Cccc------------------cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 003272 670 DQTE------------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731 (834)
Q Consensus 670 ~~~~------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~ 731 (834)
.... .......++..|+|||.+....++.++||||||++++++++|+.|+...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~- 230 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT- 230 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH-
Confidence 3211 1122345788999999998888999999999999999999999997532210 00
Q ss_pred HHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 003272 732 GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM----LSVVL 786 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~ev~~ 786 (834)
. ..... .....+......+.+++.+||+.+|++||++ +++++
T Consensus 231 --~-~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 --F-QKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --H-HHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 00000 0011112224567899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=290.66 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=196.1
Q ss_pred HHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 507 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
..++...+++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456667899999999999999999999864 58899999986532 23346788899999999999999999988643
Q ss_pred ------CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 584 ------DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 584 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
...+++++++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3367788876 678877763 235899999999999999999999988 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 003272 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ 736 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 736 (834)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... .......
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 9999998764321 123567889999999876 568899999999999999999999975322111 0000000
Q ss_pred Hhh-----------ccCcccc---cCccccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 737 LWI-----------QDRPAEL---IDKSLYD---SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 737 ~~~-----------~~~~~~~---~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
... ....... +...... .........+.+++.+|++.||.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0000000 0000000 0000123467899999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=288.53 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=192.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC---------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--------- 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------- 583 (834)
..+|...+.||.|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3688999999999999999999754 889999998766666677899999999999999999999776543
Q ss_pred -----CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeE
Q 003272 584 -----DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPK 657 (834)
Q Consensus 584 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~k 657 (834)
...++|+||++ ++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47877763 235889999999999999999999988 99999999999997 456789
Q ss_pred EeeeccccccCCCcccc-ccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hH--
Q 003272 658 ISDFGMARAFGLDQTEA-NTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL-LG-- 732 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~-~~-- 732 (834)
|+|||+++.+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.|+........... ..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998753221111 1122457889999998755 4688899999999999999999999753221110000 00
Q ss_pred -----HHHHHhhccCcccccCccccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 733 -----HAWQLWIQDRPAELIDKSLYDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 733 -----~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......................+ ......+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000000000 112246778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=278.36 Aligned_cols=249 Identities=26% Similarity=0.340 Sum_probs=193.5
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-----SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
+|...++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57788899999999999998754 445666665432 122344677899999999999999999999999999999
Q ss_pred EeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
+||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887542 23456899999999999999999999987 999999999999975 569999999988764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.... ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+.... ..... .....+..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~-~~~~~~~~----- 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVV-LRIVEGPT----- 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHH-HHHHcCCC-----
Confidence 3222 1223567889999999988889999999999999999999999864211 11111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+......+.+++.+||+.+|++||++.|+++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112233457788999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=287.76 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=189.5
Q ss_pred CCcccCccccCCcccEEEEEEeC---CeEEEEEEecccC--cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC----Ce
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSS--GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR----DE 585 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 585 (834)
+|+..+.||+|+||.||++.... +..||+|++.... ....+.+.+|+.+++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999753 6789999986532 22356788999999999 599999999876433 34
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++++||+. ++|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688888886 57877773 2456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH--------
Q 003272 666 AFGLDQTE--ANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA-------- 734 (834)
Q Consensus 666 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------- 734 (834)
.+...... .......++..|+|||.+.+ ..++.++||||||+++++|++|+.|+......+ .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 76432211 11233578899999998765 468999999999999999999999875432111 00000
Q ss_pred ---HHHhhccCcccccC------ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 735 ---WQLWIQDRPAELID------KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 735 ---~~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
.............. ..............+.+++.+|++.||++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000000000 0000000111234678899999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.87 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=195.9
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
|+..++||+|++|.||+|+..+ ++.+|+|.+.... ....+.+..|+.++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999865 8999999997653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58988885432 46899999999999999999999988 999999999999999999999999999876433221
Q ss_pred cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc-chh-------HHHHHHhhcc---
Q 003272 674 ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH-NLL-------GHAWQLWIQD--- 741 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~-~~~-------~~~~~~~~~~--- 741 (834)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+......... .+. ...+.....-
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 1223456789999998776 8899999999999999999999887432211100 000 0000000000
Q ss_pred --CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 --RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 --~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......... ....+.....+.+++.+||+.+|++||++.+|+.
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 0000111446889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=260.35 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=188.1
Q ss_pred cccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeecC
Q 003272 518 SEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
+....||.|..|.|++.+... |..+|||.+..+. ....+++...+.++.+-+ .|.||+.+|+|......++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 345579999999999999765 8899999997764 344566777777766654 8999999999999999999999985
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
. -++.++.. ..+++++.-+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++||+|||++..+-....
T Consensus 175 ~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 175 T-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred H-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 4 34555533 2345888888899999999999998865 699999999999999999999999999977632222
Q ss_pred ccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 675 NTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.....|.+.|||||.+.- ..|+.++||||||+.|+||.||+.|+..-..+- . .......+.+ ..++...
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e-----~ltkvln~eP-P~L~~~~ 319 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-E-----VLTKVLNEEP-PLLPGHM 319 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-H-----HHHHHHhcCC-CCCCccc
Confidence 223578899999999853 468999999999999999999999975322211 0 1111222222 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+++++..||+.|+.+||...++++
T Consensus 320 ------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 320 ------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 12336778999999999999999999875
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=263.15 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=199.9
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEE-EeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++++...++ +.||+|+++.|--++ +..|.++|||++.+.......+..+|++++... .|+||+.|+.++.+.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3555555553 479999999998877 456999999999988888888999999999998 599999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC---eEEee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN---PKISD 660 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~D 660 (834)
...+||||-|.+|+|..++.. ++.+++.+..++.++|+.||.+||..+ |.||||||+|||-..... +||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 999999999999999999853 456899999999999999999999998 999999999999975543 79999
Q ss_pred eccccccCCC-----ccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc--
Q 003272 661 FGMARAFGLD-----QTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH-- 728 (834)
Q Consensus 661 fGla~~~~~~-----~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~-- 728 (834)
|.++.-+..+ ...+.....+|...|||||+.. ...|+.+.|.||||||||-|++|.+||-.....+..
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 9887654221 1222233578889999999863 235889999999999999999999998654332211
Q ss_pred --chhHHHHHHhhccCcccccCccccCCCCHH----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 729 --NLLGHAWQLWIQDRPAELIDKSLYDSCSLS----EAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 729 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..-....+.+.+ .+++ .- -.++.. ...+..+++...+..|+.+|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFe-sIQE----Gk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFE-SIQE----GK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHH-HHhc----cC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000111111111 1110 00 012222 2334567888888899999999998875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=265.09 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=193.8
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++....||.|+||+|+|-.++. |+.+|||+++... ....++++.|.+...+- +.||||+++|.+..+...|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3345589999999999988754 9999999998654 36667888888876665 7999999999999999999999999
Q ss_pred CCCChhhHhhc--cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 594 PNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 594 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
.- ||+.+-.. ..+...+++.-+-+|..-+.+||.||.... .|||||+||+||||+..|.+||+|||++..+...
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 54 67655321 123345788888888889999999998754 6999999999999999999999999998766322
Q ss_pred cccccccccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
...+...|...|||||.+... .|+.+|||||||++|+|+.||+.|+.-++. ..+.. .....+.+..+..+
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql-~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQL-CQVVIGDPPILLFD 293 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHH-HHHHcCCCCeecCc
Confidence 222336788999999999643 489999999999999999999999653322 11111 12222333222211
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. ........+.+++-.|+-+|.++||...++.++
T Consensus 294 ~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 K----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 112234577889999999999999999998765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=287.69 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=193.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe----
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE---- 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 585 (834)
..++|...+.||+|++|.||+|.... ++.||||++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45789999999999999999999864 789999998653 22344667889999999999999999988766554
Q ss_pred --eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 586 --RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 586 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
.++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688887742 45899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc-h-------hHHH
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN-L-------LGHA 734 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~-~-------~~~~ 734 (834)
+...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......... + ....
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9875332 222467888999999865 367899999999999999999999975322110000 0 0000
Q ss_pred HHHhhccCcccccCccccC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 735 WQLWIQDRPAELIDKSLYD------SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+........+...... .........+.+++.+|++.+|++|||+.||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000000000 000112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=303.76 Aligned_cols=145 Identities=30% Similarity=0.414 Sum_probs=130.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|.+.++||+|+||.||+|... .++.||||+++... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 48899999996532 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
||+++++|..++.. ...+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998853 245788999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=272.26 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=194.5
Q ss_pred cCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccC-------cccHHHHHHHHHHHHhccCCceeeEEEEEE-eCCe
Q 003272 515 DNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSS-------GQGVEEFKNEALLIAKLQHRNLVKLLGCCT-QRDE 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~ 585 (834)
++|-..++||+|||+.||++.. .+.+.||||+-..+. ....+...+|.++-+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5677788999999999999985 457889999864321 123455678999999999999999999985 4567
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec---CCCCeEEeeec
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFG 662 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfG 662 (834)
.+-|+|||++.+|+.+|. ..+.+++++...|+.||+.||.||.+.. ++|||.||||.||||. .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999994 4567999999999999999999999875 7899999999999995 45789999999
Q ss_pred cccccCCCccc-----cccccccccccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH
Q 003272 663 MARAFGLDQTE-----ANTNRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH 733 (834)
Q Consensus 663 la~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~ 733 (834)
++++++.+... ..+....||..|++||.+.- .+++.|+||||+|||+|..+.|+.||+.... ...++.+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHhh
Confidence 99998654333 22345679999999998853 3588999999999999999999999874222 1111111
Q ss_pred HHHHhhccCcccccCc-cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 734 AWQLWIQDRPAELIDK-SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 734 ~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
.. ++.. .+.....+.-..+...++++||+..-++|....++.
T Consensus 697 -------NT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 -------NT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------hc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00 0110 011111111223556789999999999998877764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=263.58 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=191.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|.||+|.+.+-+. ++.+|+|++++.. ......-..|-++|+..+||.+..|.-.+...+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 568888999999999999998654 8899999998763 233445567899999999999999998899999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||..+|.|..+|. +.+.+++...+.+-..|..||.|||+.+ ||.||||.+|.|||++|++||+|||+.+.--.
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-
Confidence 9999999988873 4566888888889999999999999988 99999999999999999999999999986322
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
....+...+||+.|+|||++....|..++|.|.+||++|||++|+.||- ..++...+. ... +.+
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy--n~dh~kLFe-----LIl---~ed----- 384 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY--NKDHEKLFE-----LIL---MED----- 384 (516)
T ss_pred -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc--ccchhHHHH-----HHH---hhh-----
Confidence 2223445899999999999999999999999999999999999999964 333321110 000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 779 (834)
+ .++.....+...|+.-.|..||.+|.
T Consensus 385 ~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 L--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred c--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0 11111222455677788899999995
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=266.58 Aligned_cols=236 Identities=27% Similarity=0.335 Sum_probs=190.8
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
||+|+||.||++...+ ++.+|+|.+..... .....+..|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 7999999999999764 88999999876432 2456889999999999999999999999999999999999999999
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 678 (834)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988533 35899999999999999999999987 9999999999999999999999999998764322 12233
Q ss_pred ccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 679 ~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
..++..|+|||.+.+...+.++|+||||++++||++|+.|+..... ... ....... . ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~----~~~~~~~--------~--~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI----YEKILKD--------P--LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHhcC--------C--CCCCCC
Confidence 5678899999999888899999999999999999999999753221 001 1111110 0 011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLS 783 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~e 783 (834)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=282.17 Aligned_cols=239 Identities=23% Similarity=0.234 Sum_probs=189.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++.|.....+|.|+|+.|-++.... ++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5678888889999999999988654 88899999976522 234567565555 79999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee-cCCCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~~kl~DfGla~~~~~~ 670 (834)
.+.++-+.+.+... ...-..+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99998887766432 2222677789999999999999998 9999999999999 58999999999999876443
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
....+-|..|.|||++....|+.++|+||||++||+|++|+.|+.....+ . .......
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~----ei~~~i~----------- 527 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I----EIHTRIQ----------- 527 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H----HHHHhhc-----------
Confidence 23356788999999999999999999999999999999999997533222 0 0111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+.+.........+|+.+|||.||.+||+|.++..
T Consensus 528 -~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 -MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11122233346678999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=263.86 Aligned_cols=220 Identities=20% Similarity=0.130 Sum_probs=174.6
Q ss_pred CCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhc
Q 003272 526 GGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD 604 (834)
Q Consensus 526 G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 604 (834)
|.+|.||++.... ++.+|+|+++... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999754 8899999996543 334555666667899999999999999999999999999999888753
Q ss_pred cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccccccccc
Q 003272 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684 (834)
Q Consensus 605 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 684 (834)
. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 2 35899999999999999999999987 9999999999999999999999999886653221 12345678
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHH
Q 003272 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCI 764 (834)
Q Consensus 685 y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 764 (834)
|+|||.+....++.++||||+|++++||++|+.|+....... ..... ...+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT----LNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc----cCCcccCCHHHH
Confidence 999999988889999999999999999999998753211100 00000 011112234677
Q ss_pred HHHHHcccCCCCCCCCHH
Q 003272 765 QVGLLCVQQIPEDRPNML 782 (834)
Q Consensus 765 ~l~~~Cl~~dP~~RPt~~ 782 (834)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=272.90 Aligned_cols=193 Identities=30% Similarity=0.463 Sum_probs=168.0
Q ss_pred cCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
.+.||+|-||+||-|+... |+.||||++.+. ..+...+.++|+.+|++++||.||.+.-.|...+..++|||-+.+-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4689999999999999754 999999999764 4456688999999999999999999999999999999999999665
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeeccccccCCCccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla~~~~~~~~~ 673 (834)
-|+-.| . .+...|+......++.||+.||.|||.++ |+|+||||+||||.. ..++||+|||+|++++.....
T Consensus 649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 454444 3 23456888888899999999999999998 999999999999953 347999999999998654332
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
..++||+.|+|||++++..|...-|+||.|||+|--++|..||.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 23899999999999999999999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=257.93 Aligned_cols=238 Identities=27% Similarity=0.360 Sum_probs=191.4
Q ss_pred CcccEEEEEEeC-CeEEEEEEecccCccc-HHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhc
Q 003272 527 GFGPVYKGMLIE-GQEIAVKRLSKSSGQG-VEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD 604 (834)
Q Consensus 527 ~fg~Vy~g~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 604 (834)
+||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999865 8999999997655444 78999999999999999999999999999999999999999999998854
Q ss_pred cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccccccccc
Q 003272 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684 (834)
Q Consensus 605 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 684 (834)
.. .+++..+..++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2889999999999999999999987 9999999999999999999999999998865432 2233567889
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHH
Q 003272 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCI 764 (834)
Q Consensus 685 y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 764 (834)
|+|||.+....++.++||||||+++++|++|..|+.... ..... .......... .. .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~----~~~~~~~~~~-~~------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLEL----FKKIGKPKPP-FP------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHH----HHHHhccCCC-Cc------cccccCCHHHH
Confidence 999999998889999999999999999999998865321 11111 1111111000 00 00000334788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 003272 765 QVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 765 ~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=251.16 Aligned_cols=252 Identities=21% Similarity=0.234 Sum_probs=191.7
Q ss_pred HhcCCccc-CccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEe----CCe
Q 003272 513 ATDNFSEE-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ----RDE 585 (834)
Q Consensus 513 ~~~~~~~~-~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 585 (834)
.+++|.+. ++||-|-.|.|.....+. ++.+|+|++... ...++|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666544 589999999999988765 888999998543 3457788776655 69999999998754 456
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeec
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFG 662 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfG 662 (834)
+++|||.|++|.|...+.+. ....+++.+...|++||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 88999999999998888553 3456899999999999999999999998 999999999999963 4568999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+|+.-. ........+-|+.|.|||++...+|+...|+||+||++|-|++|.+||--.+. ..+..-.......+.
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ 283 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC
Confidence 999743 23344557899999999999999999999999999999999999999632111 111111111111110
Q ss_pred cccccCccccCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSE-AIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. + .......+ .+...++++..|..+|.+|.|+.+++.
T Consensus 284 y-~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 Y-E------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c-c------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0 0 01112222 345667999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=278.44 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=178.6
Q ss_pred HhcCCcccCccccCCcccEEEEEE-----------------eCCeEEEEEEecccCcccHHHH--------------HHH
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGML-----------------IEGQEIAVKRLSKSSGQGVEEF--------------KNE 561 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~E 561 (834)
..++|++.++||+|+||+||+|.+ ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999974 2356899999865433222333 346
Q ss_pred HHHHHhccCCce-----eeEEEEEEe--------CCeeEEEEeecCCCChhhHhhccCC---------------------
Q 003272 562 ALLIAKLQHRNL-----VKLLGCCTQ--------RDERVLVYEYLPNKSLDYFIFDTTR--------------------- 607 (834)
Q Consensus 562 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 607 (834)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677787753 3568999999999999998864211
Q ss_pred CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccC
Q 003272 608 SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687 (834)
Q Consensus 608 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~A 687 (834)
...+++..+..++.||+.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123577889999999999999999987 99999999999999999999999999976533211 11112345789999
Q ss_pred ccccccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCccccc----chhHHHHHHhhc
Q 003272 688 PEYAIDGLF----------------------SVKSDVFSFGVLVLEIVSGKR-NRGFYHADHRH----NLLGHAWQLWIQ 740 (834)
Q Consensus 688 PE~~~~~~~----------------------t~~sDV~S~Gvil~elltg~~-p~~~~~~~~~~----~~~~~~~~~~~~ 740 (834)
||.+..... ..+.||||+||+++||++|.. |+......... .-....|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998864321 124699999999999999875 44311100000 000001111111
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIP---EDRPNMLSVVL 786 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~ev~~ 786 (834)
.. .+-.. .........+++.++|..+| .+|+|+.|+++
T Consensus 459 ~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11 11111 11122356778888998765 78999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=231.29 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=193.4
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+|...++||+|.+|+||+|+..+ ++.||+|+++-.. +..-....+|+-+++.++|.|||++++.......+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566799999999999999765 7789999987542 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
|.. +|..+.. .-...++.+....++.|+++||.++|+++ +.||||||+|.||+.+|.+|++|||+++.++..-.
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 4544432 22456888999999999999999999998 99999999999999999999999999999876543
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCC-CCCCCcccccchhHHHHHHh--hcc---Cccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRN-RGFYHADHRHNLLGHAWQLW--IQD---RPAE 745 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~--~~~---~~~~ 745 (834)
... ..+-|..|.+|+++.+. -|+...|+||-|||+.|+....+| |...+. ...+....+..- .++ .+..
T Consensus 157 cys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 CYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred eee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCcccc
Confidence 322 24678999999999886 588999999999999999986555 322221 122222222211 111 1223
Q ss_pred ccCccccCCCCH----HH-HH----HHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 746 LIDKSLYDSCSL----SE-AI----RCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 746 ~~d~~l~~~~~~----~~-~~----~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
+.|-.....++. .+ +. .=.++....+.-+|.+|.++++.++.
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 333333222221 11 11 22466777777899999999988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=287.02 Aligned_cols=259 Identities=21% Similarity=0.243 Sum_probs=166.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-----CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEE------EE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC------CT 581 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 581 (834)
..++|...++||+|+||.||+|++.+ +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999854 58899999854321 1112221 1111222222222111 24
Q ss_pred eCCeeEEEEeecCCCChhhHhhccCCC-----------------CCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCC
Q 003272 582 QRDERVLVYEYLPNKSLDYFIFDTTRS-----------------KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK 644 (834)
Q Consensus 582 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 644 (834)
.....++|+||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566799999999999998887543210 01123345679999999999999987 9999999
Q ss_pred CCceeecC-CCCeEEeeeccccccCCCccccccccccccccccCccccccC----------------------CCCchhh
Q 003272 645 ASNVLLDN-EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG----------------------LFSVKSD 701 (834)
Q Consensus 645 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~t~~sD 701 (834)
|+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999876433221 22336788999999976432 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC-c---ccccCcc----ccCCC--CHHHHHHHHHHHHHcc
Q 003272 702 VFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR-P---AELIDKS----LYDSC--SLSEAIRCIQVGLLCV 771 (834)
Q Consensus 702 V~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~d~~----l~~~~--~~~~~~~l~~l~~~Cl 771 (834)
||||||+||||+++..+.+. . +..........+. . ...+.+. +...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~----~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS----N---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch----H---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997765321 0 0000000000000 0 0001110 00000 0001123457999999
Q ss_pred cCCCCCCCCHHHHHH
Q 003272 772 QQIPEDRPNMLSVVL 786 (834)
Q Consensus 772 ~~dP~~RPt~~ev~~ 786 (834)
+.||++|||+.|+++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=277.89 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=208.3
Q ss_pred cCHHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEe
Q 003272 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ 582 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 582 (834)
.+++.+.+.++.|++.+.||.|.+|.||+++.. +++.+|+|++... ....++...|.++++.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 455666667888999999999999999999864 5889999998543 44557788899999888 79999999999864
Q ss_pred -----CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 583 -----RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 583 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
++.+|||||||.+||.-+++.... ...+.|..+..|++.++.||.+||... ++|||||=.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 467999999999999999997655 778999999999999999999999887 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhH
Q 003272 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG 732 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 732 (834)
|.|||++..+...... .+...||+.|||||++... .|+..+|+||||++..||--|.+|+-..++...
T Consensus 164 LvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----- 236 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 236 (953)
T ss_pred Eeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence 9999999877543333 3347899999999999643 478899999999999999999999543222110
Q ss_pred HHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 733 HAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...... +|.+.-..+..=...+.+++..||..|-++||++.++++
T Consensus 237 --LF~IpR-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 --LFLIPR-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --hccCCC-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000001 111111122333457788999999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=260.20 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=196.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhcc-C-C----ceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-H-R----NLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~ 586 (834)
+++|.+...+|+|.||.|-...... +..||||+++ +.....+..+-|+++++++. + | -+|.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH-HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6889999999999999999988655 6889999995 44555677788999999993 2 2 367788889999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC--------------
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-------------- 652 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------------- 652 (834)
++|+|.+ +-|+.+++... .-.+++...+..++.|+++++++||+.. ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 44778888543 3456889999999999999999999987 999999999999932
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 003272 653 ------EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726 (834)
Q Consensus 653 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~ 726 (834)
...+||+|||.|..-... ....+.|..|.|||++.+-.++..+||||+||||+|+.+|...|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 245899999999874322 234788999999999999999999999999999999999998764333211
Q ss_pred ccchhHHHHHHhhccCcccccCcc------------------------c---------cCCCCHHHHHHHHHHHHHcccC
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKS------------------------L---------YDSCSLSEAIRCIQVGLLCVQQ 773 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~------------------------l---------~~~~~~~~~~~l~~l~~~Cl~~ 773 (834)
...+. +......+..++.+. . .-.....+...+++|+..||..
T Consensus 317 HLaMM----erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 317 HLAMM----ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred HHHHH----HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 11111 111111111111110 0 0122345667899999999999
Q ss_pred CCCCCCCHHHHHH
Q 003272 774 IPEDRPNMLSVVL 786 (834)
Q Consensus 774 dP~~RPt~~ev~~ 786 (834)
||.+|+|+.|+++
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=262.22 Aligned_cols=240 Identities=29% Similarity=0.377 Sum_probs=188.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
.+|....+||+|+||.|.++.... .+-+|||++++.. ....+--+.|-++|... +-|.++.++.++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 357778899999999999998654 4568999998752 23344456677777766 578999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+.+|+|-.++.. -..+.+.....+|.+||-||-+||+.+ ||.||||..|||||.+|++||+|||+.+.--.
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999854 344667788889999999999999998 99999999999999999999999999986322
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
+ ...+...+||+.|+|||++...+|...+|.|||||+||||+.|++||+..+.++ +.. .+.+.
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~------------aI~eh 565 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ------------AIMEH 565 (683)
T ss_pred C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH------------HHHHc
Confidence 2 233445899999999999999999999999999999999999999987543322 111 11121
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 779 (834)
.. .++.....+...+....+-.+|.+|.
T Consensus 566 nv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 23333444556667777788888884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=288.79 Aligned_cols=258 Identities=22% Similarity=0.240 Sum_probs=200.8
Q ss_pred HHHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecc---cCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 508 ~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
.++.-..++|++.++||+|+||.|...+... ++.+|.|++.+ ........|++|-.+|..-+.+=|+.++-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4445556889999999999999999999866 77899999976 2344556799999999988899999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
..+|+|||||+||+|-.++... ..++......++..|.-||.-||+.| +|||||||.|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999998543 26899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAI----D-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
+-.+..+.. ......+|||.|.+||++. + +.|+..+|.||+||++|||+.|.-||-. ..+......-.
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm 294 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIM 294 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHh
Confidence 887754433 3344589999999999995 2 5789999999999999999999999631 11211111111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN---MLSVVL 786 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~ev~~ 786 (834)
.......+.+ ...-.....+|+.+.+. +|+.|.. ++++-.
T Consensus 295 ~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111111111 11123355666666654 7888887 888764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=233.86 Aligned_cols=204 Identities=26% Similarity=0.349 Sum_probs=166.5
Q ss_pred HHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEE
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 588 (834)
...+.+.....||+|++|.|-+-++. +|+..|||+++.. ..+..++...|+.+..+- .+|.+|.++|........++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 34455666778999999999887764 5999999999765 344556777788766654 79999999999998999999
Q ss_pred EEeecCCCChhhHhhc-cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 589 VYEYLPNKSLDYFIFD-TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
.||.|.- ||+.|-.. ..+...+++..+-+|+..+.+||.|||++- .+||||+||+||||+.+|++||||||++-.+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999965 77766432 234567899999999999999999999964 6999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~----~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
...-. .+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 43221 122467889999998853 3689999999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-29 Score=276.54 Aligned_cols=245 Identities=26% Similarity=0.338 Sum_probs=184.3
Q ss_pred CcccCccccCCccc-EEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 517 FSEENKLGEGGFGP-VYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 517 ~~~~~~LG~G~fg~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
|...+.+|.|+.|+ ||+|.. +|++||||++-... ..-..+|+..++.- +|||||++++.-.+...+++..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789999875 799988 88999999985432 23457899999887 69999999998888899999999995
Q ss_pred CCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---C--CCeEEeeeccccccC
Q 003272 595 NKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---E--MNPKISDFGMARAFG 668 (834)
Q Consensus 595 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~--~~~kl~DfGla~~~~ 668 (834)
- +|++++... .......-...+.++.|+++||++||+.+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4 899988653 11111222455778899999999999977 999999999999975 3 578999999999987
Q ss_pred CCccccc-cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 669 LDQTEAN-TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG-KRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 669 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+..... .....||.+|+|||++....-+.++||||+||++|+.++| .+||+-.-. +.+........+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-------R~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-------RQANILTGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-------hhhhhhcCccceeee
Confidence 6654422 3457799999999999999889999999999999999997 889863111 100000000000000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
. ...++ ...+|+.+|++++|..||++.+|+
T Consensus 736 -----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 -----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 01111 567899999999999999999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-30 Score=246.46 Aligned_cols=199 Identities=26% Similarity=0.488 Sum_probs=159.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecc-cCccc-HHHHHHHHHHHHhccCCceeeEEEEEEeC--------
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSK-SSGQG-VEEFKNEALLIAKLQHRNLVKLLGCCTQR-------- 583 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~-~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 583 (834)
..|+...+||+|.||+||+++..+ |+.||+|++-- +...+ -..-.+|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 346667799999999999999765 78889987633 22211 13456799999999999999998887432
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
...++|+.+|+. +|.-++.+ ....++..++.++++++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347899999976 55555532 2346889999999999999999999887 99999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 003272 664 ARAFGLDQT--EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNR 719 (834)
Q Consensus 664 a~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~ 719 (834)
++.+..... .......+.|..|++||.+.+ ..|+++.|||.-||++.||.++.+-+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 988743322 222233566999999999887 47999999999999999999998764
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=225.61 Aligned_cols=111 Identities=46% Similarity=0.789 Sum_probs=80.6
Q ss_pred CCcEEEeeCCCCCCCCC--CceEEEEecCCcceEEEecCCCceEEEe-ecccccCCCcEEEEecCCCEEEEecCCCCCCC
Q 003272 69 TGTVTWVANRDAPLSDR--SGVLSMSRRGNGTALVLLNSTNDIVWSS-NIVSRAAQNPVAVLLESGNLVVKEKDGNDNDD 145 (834)
Q Consensus 69 ~~t~vW~Anr~~p~~~~--~~~l~l~~~G~~~~lvl~~~~~~~vWst-~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~ 145 (834)
++||||+|||+.|+... .++|.|+.||| |||.++.++++|+| ++...+.....|+|+|+|||||++.+
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGn---Lvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~------ 71 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGN---LVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS------ 71 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSE---EEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT------
T ss_pred CcccccccccccccccccccccceECCCCe---EEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec------
Confidence 46999999999999543 48899999999 99999999999999 54444335778999999999999643
Q ss_pred CCceeeeeccCCccccccCCeeeeeeccCCceEEEEeccCCCCC
Q 003272 146 PDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPA 189 (834)
Q Consensus 146 ~~~~lWQSFd~PTDtlLpg~~l~~~~~tg~~~~l~sw~s~~dps 189 (834)
+.+|||||||||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus 72 -~~~lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 72 -GNVLWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp -SEEEEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred -ceEEEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 5699999999999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=239.89 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=194.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
++|...++||+|+|.+|..+.+.. .+.+|+|++++. ....++..+.|-.+..+. +||.+|-|..++.....+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 567888999999999999999865 677899999764 445566777888777776 799999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
.||+++|+|-.+. .+...|+++....+..+|.-||.|||+.+ ||.||||..|||||..|++||.|+|+.+.-..
T Consensus 330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999997766 34556899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc-cchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR-HNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d 748 (834)
+ ...+...+||+.|.|||++++..|...+|.|++||+++||+.|+.||+..-.+.. .+-..+..+...+.++.
T Consensus 404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---- 477 (593)
T KOG0695|consen 404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---- 477 (593)
T ss_pred C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----
Confidence 2 2334558999999999999999999999999999999999999999986543322 22222222222222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 779 (834)
.+.....+...++..-+.+||.+|.
T Consensus 478 ------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111222445566677788888874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=258.14 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=196.8
Q ss_pred cCCcccCccccCCcccEEEEEEeCCe-EEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++.....||-|+||.|=+...+... .+|+|.+++. .....+....|-.+|...+.|.||+++-.+.+....++.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455567999999999998875533 3899988764 3455677889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|-|-+|.|...+. .+..++..+...++.-+.+|++|||+.+ ||.|||||+|.+||.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999984 3556888888889999999999999998 999999999999999999999999999998644
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
..+...+||+.|.|||++.+...+.++|.||||++++||++|.+||...++....+++ ..+. |.
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------LkGi-----d~- 637 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------LKGI-----DK- 637 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------Hhhh-----hh-
Confidence 3455689999999999999999999999999999999999999998755443332221 1110 00
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 780 (834)
-.++........+|+.+.+..+|.+|.-
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 0122223345667888888999999976
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=214.24 Aligned_cols=110 Identities=45% Similarity=1.043 Sum_probs=105.9
Q ss_pred EeeCCCCcceeecCCCcCCCCceEEEEeecCceEEEEEEecCCCceeEEEEcccCcEEEEEEecCCceeEEEEeecCCcc
Q 003272 215 YRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFARFSGTIL 294 (834)
Q Consensus 215 ~~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~~~~~s~~~~~~l~~~G~l~~~~w~~~~~~w~~~~~~~~~~~ 294 (834)
||+|+|||..|+|+|++..+..+.+.|+.+++|.+|+|.+.+.+.++|++|+.+|++|+|.|++..+.|.+.| .+|.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~---~~p~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFW---SAPK 77 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEE---Eecc
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999999 7899
Q ss_pred ccCCCCCCCCCCccCCCCCCCCCccccCCCccCC
Q 003272 295 DQCDNYALCGPYASCNIHSDSPDCECLEGFEPKS 328 (834)
Q Consensus 295 d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~~ 328 (834)
|+||+|+.||+||+|+.+ ..|.|+||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence 999999999999999876 788999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=229.94 Aligned_cols=211 Identities=36% Similarity=0.557 Sum_probs=183.4
Q ss_pred cccCCcccEEEEEEeC-CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChhh
Q 003272 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDY 600 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 600 (834)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999999654332 35789999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeeccccccCCCccccccccc
Q 003272 601 FIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGLDQTEANTNRV 679 (834)
Q Consensus 601 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 679 (834)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 45889999999999999999999997 999999999999999 89999999999987643321 12225
Q ss_pred cccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHH
Q 003272 680 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLS 758 (834)
Q Consensus 680 ~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 758 (834)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999999887 888999999999999998
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 759 EAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 759 ~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4678899999999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=240.02 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=190.2
Q ss_pred CcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----CeeEE
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DERVL 588 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 588 (834)
.+..+.||.|+||.||..+.+ +|+.||+|++..-. -...+++.+|+.++.-++|.|++..++..... ++.++
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345678999999999999875 49999999986432 23457889999999999999999988876443 34677
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
+.|.|.. +|...+. ..+.++-..+.-++.||++||.|||+.+ |.||||||.|.|++.+-.+||+|||+++...
T Consensus 135 ~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 8888754 6666653 3456888888889999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH--------HHHHhh
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH--------AWQLWI 739 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~ 739 (834)
.++....+ ..+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|....+-....++-. +.+..-
T Consensus 208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 55554443 35678999999999885 699999999999999999988876643332221111100 000000
Q ss_pred ccCcccccCc--------cccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 740 QDRPAELIDK--------SLYDS-CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 740 ~~~~~~~~d~--------~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
++.-..++.. .+..- .+...-.+...+...++..||+.|.+..+.+.-+.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1100011111 11100 01111123455677888999999999999887653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=250.89 Aligned_cols=200 Identities=24% Similarity=0.392 Sum_probs=170.4
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
-|..++.||-|+||+|.++.-.| ...+|.|.+++.+ +......+.|-.+|...+.+=||+|+-.|.+.+.+++||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 37778899999999999998655 5568999998764 3455678889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC---
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG--- 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~--- 668 (834)
|+++|++-.+|. +-..+.+...+.++.++..|+++.|..+ +|||||||.|||||.+|++||.||||+.-+.
T Consensus 710 YIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999988884 3456888888889999999999999988 9999999999999999999999999975431
Q ss_pred ------CCc-cc------------------------------cccccccccccccCccccccCCCCchhhHHHHHHHHHH
Q 003272 669 ------LDQ-TE------------------------------ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 711 (834)
Q Consensus 669 ------~~~-~~------------------------------~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~e 711 (834)
.+. .. ......+||+.|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000 00 00112569999999999999999999999999999999
Q ss_pred HHhCCCCCCC
Q 003272 712 IVSGKRNRGF 721 (834)
Q Consensus 712 lltg~~p~~~ 721 (834)
|+.|+.||-.
T Consensus 864 m~~g~~pf~~ 873 (1034)
T KOG0608|consen 864 MLVGQPPFLA 873 (1034)
T ss_pred HhhCCCCccC
Confidence 9999999754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=223.51 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=190.1
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCC--eeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRD--ERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV 589 (834)
.++|++.+++|+|.+++||.|.. .+.+.++||+++.. ..+.+++|+.+|..|. ||||++|++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788999999999999999984 45788999999643 2357899999999996 999999999987754 46899
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~~~ 668 (834)
+||+.+.+...+- +.++...+...+.++++||.|+|+.| |.|||+||+|++||.. -.++|+|+|+|....
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876554 35778889999999999999999998 9999999999999955 479999999998875
Q ss_pred CCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc----
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP---- 743 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 743 (834)
..... +-.+.+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||-.-.. ....+...+... ..+++
T Consensus 185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVL-Gt~el~~Yl 259 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVL-GTDELYAYL 259 (338)
T ss_pred CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHh-ChHHHHHHH
Confidence 43322 22456778999999876 4688899999999999999999999732222 122222222111 00000
Q ss_pred ---ccccCccccC---------------CCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 ---AELIDKSLYD---------------SCSLS-EAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ---~~~~d~~l~~---------------~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.-.+|+.... ..... ...+.++++...|..|-.+|||+.|...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0011111110 00000 1246678888999999999999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=236.40 Aligned_cols=133 Identities=28% Similarity=0.362 Sum_probs=110.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhcc-----C---CceeeEEEEEEe--
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-----H---RNLVKLLGCCTQ-- 582 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~-- 582 (834)
..+|...++||-|.|++||++.... .+.||+|+++ ......+....|+.+|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3689999999999999999998654 7789999984 44455567788999999883 3 479999999865
Q ss_pred --CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 583 --RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 583 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
+.+.++|+|++-. +|..+|... .-+.++...+.+|++||+.||.|||..+ +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4679999999855 555555432 3466999999999999999999999987 699999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=244.41 Aligned_cols=200 Identities=21% Similarity=0.245 Sum_probs=171.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhcc------CCceeeEEEEEEeCCe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ------HRNLVKLLGCCTQRDE 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~ 585 (834)
...+|.+....|+|-|++|.+|.... |++||||++..+ +.-.+.=+.|+++|++|+ --|.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 45789988999999999999998754 889999999654 333345577999999995 3578999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMA 664 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla 664 (834)
+|||+|-+. .+|.+.|......-.|....+..++.|+.-||..|...+ |+|.||||.|||+++.. .+||||||.|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 999999874 488999987777777999999999999999999999988 99999999999998765 6899999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
-....+... .+.....|.|||++.+.+|+...|+||.||+||||.||+..|..
T Consensus 585 ~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 585 SFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 876433322 25567799999999999999999999999999999999987654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=201.55 Aligned_cols=115 Identities=45% Similarity=0.763 Sum_probs=99.6
Q ss_pred ccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEEecCCCce
Q 003272 30 QSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDI 109 (834)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~ 109 (834)
++|.+|++|+|++|.|++|||.+......+.+|||.+.+ .++||.|||+.|. ...+.|.|..||+ |+|.|.+|.+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGn---Lvl~~~~g~~ 76 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGN---LVIYDGSGTV 76 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCC---eEEEcCCCcE
Confidence 468889999999999999999987654489999999877 8999999999994 4478899999999 9999999999
Q ss_pred EEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCC
Q 003272 110 VWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYP 157 (834)
Q Consensus 110 vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~P 157 (834)
+|+|++.. +....+|+|+|+|||||++.+ +.+||||||||
T Consensus 77 vW~S~~~~-~~~~~~~~L~ddGnlvl~~~~-------~~~~W~Sf~~P 116 (116)
T cd00028 77 VWSSNTTR-VNGNYVLVLLDDGNLVLYDSD-------GNFLWQSFDYP 116 (116)
T ss_pred EEEecccC-CCCceEEEEeCCCCEEEECCC-------CCEEEcCCCCC
Confidence 99999754 344567999999999999554 45999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-25 Score=224.55 Aligned_cols=198 Identities=33% Similarity=0.456 Sum_probs=171.2
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999876 889999999765544 67889999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|..++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998854321 1789999999999999999999987 999999999999999999999999999887543211
Q ss_pred ccccccccccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 675 NTNRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~-~~~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
......++..|++||.+ ....++.++|||+||++++||++|+.|+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 12235677889999998 66678889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=226.29 Aligned_cols=272 Identities=24% Similarity=0.290 Sum_probs=195.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------e
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------E 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 585 (834)
.+|...+.+|.|.- .|-.+... .+++||+|++... .....++..+|..++..++|+|+++++.++.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777788999988 55555432 3889999988543 3345567788999999999999999999986543 4
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++|||+|.. +|...+. -.++-+++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7899999954 7777764 34778889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc----------------cc
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR----------------HN 729 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~----------------~~ 729 (834)
.-+.+ -..+.++.|+.|.|||++.+..+.+.+||||+||++.||++|...|...+--+. ..
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 74322 234457889999999999998899999999999999999999976542111000 00
Q ss_pred hhHHHHHHhhccCcc-------c-ccCccccC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hc---cCCCC
Q 003272 730 LLGHAWQLWIQDRPA-------E-LIDKSLYD--SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM--LS---GERSL 794 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~-------~-~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~--L~---~~~~~ 794 (834)
+...+... .....+ + +.|..... ..+......+.+++.+||-.||++|.+++++++- ++ ...++
T Consensus 244 L~~~~r~y-v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev 322 (369)
T KOG0665|consen 244 LQPTVRNY-VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEV 322 (369)
T ss_pred hhHHHHHH-hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccc
Confidence 11111111 111111 1 11111100 1111223345679999999999999999999864 33 33444
Q ss_pred CCCCCC
Q 003272 795 PQPKQP 800 (834)
Q Consensus 795 ~~p~~p 800 (834)
++|+.+
T Consensus 323 ~ap~pe 328 (369)
T KOG0665|consen 323 EAPPPE 328 (369)
T ss_pred cCCCCc
Confidence 444444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=238.23 Aligned_cols=195 Identities=27% Similarity=0.376 Sum_probs=163.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc--------ccHHHHHHHHHHHHhcc---CCceeeEEEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG--------QGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQ 582 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 582 (834)
.+|...+.||.|+||.|+.++++. ..+|+||.+.+..- ...-..-.|+++|..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458888999999999999999865 66789998865311 11112345999999997 9999999999999
Q ss_pred CCeeEEEEeec-CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 583 RDERVLVYEYL-PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 583 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
.+..+|++|-. ++.+|-+++ ...+.+++.+...|++||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999986 455666666 34567999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCC
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVSGKRNR 719 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDV~S~Gvil~elltg~~p~ 719 (834)
|.|......... ..+||..|.|||++.+.+|- ..-|||++|++||-++....|+
T Consensus 715 gsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999876443332 37899999999999998875 4589999999999999887774
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=226.76 Aligned_cols=200 Identities=28% Similarity=0.439 Sum_probs=165.6
Q ss_pred HHHHhcCCcccCccccCCcccEEEEEEeC----CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 510 IVDATDNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 510 ~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
+....+.|...++||+|.|++||++++.. .+.||+|.+...+.. .+..+|+++|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445678889999999999999998643 678999998665433 5689999999999 5999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeecc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGM 663 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGl 663 (834)
...+|+||++.....++.. .++...+..+++.+..||+++|..+ ||||||||+|+|.+. -++-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999888873 3678899999999999999999998 999999999999985 45789999999
Q ss_pred ccccCCCc-------------cc-----------------------------cccccccccccccCcccccc-CCCCchh
Q 003272 664 ARAFGLDQ-------------TE-----------------------------ANTNRVVGTYGYMSPEYAID-GLFSVKS 700 (834)
Q Consensus 664 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~APE~~~~-~~~t~~s 700 (834)
|...+... .. .......||++|.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97321000 00 00012458999999999876 4678999
Q ss_pred hHHHHHHHHHHHHhCCCCCC
Q 003272 701 DVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 701 DV~S~Gvil~elltg~~p~~ 720 (834)
||||.|||++-+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999973
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=211.82 Aligned_cols=252 Identities=20% Similarity=0.348 Sum_probs=185.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEE-EEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGC-CTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 591 (834)
+.|.+.+.||+|.||.+-++.+.. .+.+++|.+... ....++|.+|...--.| .|.||+.-++. +...+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 457788899999999999999865 678999988543 34567888888765555 68999987765 555677889999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee-c-CCCCeEEeeeccccccCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL-D-NEMNPKISDFGMARAFGL 669 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~-~~~~~kl~DfGla~~~~~ 669 (834)
|+|.|+|..-+. ...+.+....+++.|+++|+.|+|+.. +||||||.+|||| + +..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999987763 345777888899999999999999998 9999999999999 3 445899999999887543
Q ss_pred CccccccccccccccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.-.. ..-+..|.|||..... ...+.+|||.||++++.+++|..|+.. .......-+.|..|..+...
T Consensus 176 tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk---a~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 TVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK---ASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred eehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh---hhccCchHHHHHHHhcccCc
Confidence 2111 2234579999977432 245779999999999999999999642 22222223445556555554
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L 788 (834)
.+.+ ....+. ..+.++..+-+..+|++|-...++.++-
T Consensus 248 ~~P~--~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPK--KFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCch--hhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 3322 112222 2455667788899999996666666554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-25 Score=239.32 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=198.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+....+|.|.+|.|||++... +...|||.++-.......-.++|+.+++.-+|+|||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45678888999999999999999754 88899999987777777788899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+.+|+|.+.-+. ..++++.++....+..++||+|||+.+ =+|||||=.|||+++.|.+|++|||.+-.+...-
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999887643 356888999999999999999999998 7999999999999999999999999987653211
Q ss_pred cccccccccccccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 672 TEANTNRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~---~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.......||+.|||||+. +.+.|..++|||++|+...|+---++|.-..++.. + ..... ....+
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~-l~LmT---kS~~q 233 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------A-LFLMT---KSGFQ 233 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------H-HHHhh---ccCCC
Confidence 112237899999999987 35679999999999999999987777621111100 0 00000 01111
Q ss_pred c-cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 K-SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+ .+++.-.. ...+.+++..|+-.+|++||+++.+++
T Consensus 234 pp~lkDk~kw--s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKDKTKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccCCccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 11111111 235667899999999999999987764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=189.82 Aligned_cols=113 Identities=49% Similarity=0.806 Sum_probs=97.9
Q ss_pred ccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEEecCCCce
Q 003272 30 QSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDI 109 (834)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~ 109 (834)
+.|..+++|+|++|.|++|||.+... ..+.+|||++.+ .++||+|||+.|+.. ++.|.|..||+ |+|.+.+|.+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGn---Lvl~~~~g~~ 75 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGN---LVLYDGDGRV 75 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCC---EEEEeCCCCE
Confidence 45788899999999999999998654 688999999887 899999999999876 48899999999 9999999999
Q ss_pred EEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccC
Q 003272 110 VWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDY 156 (834)
Q Consensus 110 vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~ 156 (834)
+|+|++. .+....+|+|+|+|||||++++ +.+|||||||
T Consensus 76 vW~S~t~-~~~~~~~~~L~ddGnlvl~~~~-------~~~~W~Sf~~ 114 (114)
T smart00108 76 VWSSNTT-GANGNYVLVLLDDGNLVIYDSD-------GNFLWQSFDY 114 (114)
T ss_pred EEEeccc-CCCCceEEEEeCCCCEEEECCC-------CCEEeCCCCC
Confidence 9999975 2344567999999999999554 3599999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=262.57 Aligned_cols=196 Identities=19% Similarity=0.233 Sum_probs=137.5
Q ss_pred hccC-CceeeEEEEE-------EeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCce
Q 003272 567 KLQH-RNLVKLLGCC-------TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638 (834)
Q Consensus 567 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 638 (834)
.++| .||+++++++ .+.+..++++|++ .++|.+++... ...+++.+++.++.||++||.|||+.+ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5788888877 3334577888987 55999998532 345899999999999999999999988 9
Q ss_pred EeccCCCCceeecC-------------------CCCeEEeeeccccccCCCcc--------------ccccccccccccc
Q 003272 639 IHRDLKASNVLLDN-------------------EMNPKISDFGMARAFGLDQT--------------EANTNRVVGTYGY 685 (834)
Q Consensus 639 vH~DLkp~NILl~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 685 (834)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666676654211000 0001124578899
Q ss_pred cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHH
Q 003272 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQ 765 (834)
Q Consensus 686 ~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 765 (834)
||||++.+..++.++|||||||+||||++|..|+.... ... ..... ....+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~~----~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLRH----RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHHH----hhcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999887743100 000 00000 0011110 111234567
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 003272 766 VGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 766 l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
++.+||+++|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=198.91 Aligned_cols=165 Identities=19% Similarity=0.195 Sum_probs=122.3
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
|+|.+++.. ....+++..++.++.||++||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 678888853 2346999999999999999999999875 999999999999999 99998753321
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
..|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ...... .......... + ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~----~~~~~~~~~~--~--~~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILE----ILLNGMPADD--P--RDRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHH----HHHHHhccCC--c--cccc
Confidence 3578999999999999999999999999999999999999743211 011111 1111000000 0 0001
Q ss_pred CHH-HH--HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 756 SLS-EA--IRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 756 ~~~-~~--~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
... .. ..+.+++.+||+.+|++||++.|+++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111 11 258899999999999999999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=211.42 Aligned_cols=166 Identities=19% Similarity=0.186 Sum_probs=129.1
Q ss_pred HhcCCcccCccccCCcccEEEEEEe--CCeEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI--EGQEIAVKRLSKS-----SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
..++|...++||+|+||+||+|... +++.||||++... .....+.|.+|++++++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 4578999999999999999999875 4777899987532 12235679999999999999999853322 246
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccC-CCCceeecCCCCeEEeeeccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDL-KASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DfGla 664 (834)
.++||||+++++|.... ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||++
T Consensus 93 ~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 93 DGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred cEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 79999999999996321 101 1467889999999999988 999999 999999999999999999999
Q ss_pred cccCCCccccc------cccccccccccCccccccC
Q 003272 665 RAFGLDQTEAN------TNRVVGTYGYMSPEYAIDG 694 (834)
Q Consensus 665 ~~~~~~~~~~~------~~~~~gt~~y~APE~~~~~ 694 (834)
+.+........ .....+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97744321111 1246788899999998543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=196.66 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=189.3
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
..+|.+...|+.|+|++ .|..+++|++... ....-+.|.+|.-.++.+.||||.+++|.|.....+.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34799999999999999 5667778887543 23344679999999999999999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe--eeccccccCCCccccc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS--DFGMARAFGLDQTEAN 675 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~--DfGla~~~~~~~~~~~ 675 (834)
|...++... .-..+..+..+++.+||+|++|||+..+ -|.---|.+..|+||++.+++|+ |-.++..
T Consensus 274 lynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq--------- 342 (448)
T KOG0195|consen 274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------- 342 (448)
T ss_pred HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee---------
Confidence 999997643 3457778899999999999999999873 24445699999999999988875 3222111
Q ss_pred cccccccccccCccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 676 TNRVVGTYGYMSPEYAIDGLF---SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~---t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....-.+.||+||.+...+- -.++|+|||+++||||.|...||....+.+... .+.-..++
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglr 407 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLR 407 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccc
Confidence 111234578999999987653 357999999999999999999986443322111 11112333
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...++.....+.+|+.-|+..||.+||.+..|+-.||.-
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 445555666788999999999999999999999998853
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-19 Score=196.87 Aligned_cols=259 Identities=23% Similarity=0.250 Sum_probs=189.0
Q ss_pred CCcccCccccCCcccEEEEEEeCC--eEEEEEEecccCcccHHHHHHHHHHHHhccC----CceeeEEEEE-EeCCeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEG--QEIAVKRLSKSSGQGVEEFKNEALLIAKLQH----RNLVKLLGCC-TQRDERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 588 (834)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997553 4788887765433333378889999988873 6888888888 46778899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-----CCeEEeeecc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-----MNPKISDFGM 663 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-----~~~kl~DfGl 663 (834)
||+.. +.+|.++..... .+.++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99986 668888764433 567999999999999999999999998 9999999999999755 4689999999
Q ss_pred cc--ccCCCcc----c--cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 003272 664 AR--AFGLDQT----E--ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 664 a~--~~~~~~~----~--~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 735 (834)
++ ....... . .......||..|+++....+...+.+.|+||++.++.|++.|..|+........ .
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~---- 246 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---K---- 246 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---H----
Confidence 98 3211111 1 112235699999999999999999999999999999999999988533221111 0
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.............. .....+.+ +.++...+-..+..++|....+...|+..
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHhhhhcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 01111111111111 11223333 33444444458999999999999988654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-19 Score=191.71 Aligned_cols=262 Identities=28% Similarity=0.364 Sum_probs=196.0
Q ss_pred CcccCccccCCcccEEEEEEeCCeEEEEEEecccCcc---cHHHHHHHHHHHHhccCC-ceeeEEEEEEeCCeeEEEEee
Q 003272 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ---GVEEFKNEALLIAKLQHR-NLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 592 (834)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999986 78899998765332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccCCCc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGLDQ 671 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~ 671 (834)
+.++++..++........+.......++.+++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633211136888999999999999999999998 99999999999999998 79999999998664433
Q ss_pred ccc----ccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 672 TEA----NTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 672 ~~~----~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
... ......++..|+|||.+.. ..+....|+||+|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 2345789999999999987 57889999999999999999999995433221 0011111111111100
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223456778889999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-20 Score=217.42 Aligned_cols=255 Identities=19% Similarity=0.209 Sum_probs=183.0
Q ss_pred cccCccccCCcccEEEEEEeC-CeEEEEEEecc---cC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 518 SEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---SS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~---~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
...+.+|.|++|.|+...... ....+.|.++. .. .+....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345689999999777766432 33344443321 11 111122445666667789999988777776666666669
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||++. +|..++.. ...+...++..+++|+..|+.|+|+.+ |.|||||++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 88888733 236888899999999999999999998 999999999999999999999999999887665
Q ss_pred ccc--cccccccccccccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTE--ANTNRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~--~~~~~~~gt~~y~APE~~~~~~~t~~-sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ......+|...|+|||.+....|.+. .||||.|+++..|++|+.|+......+... . ... .....-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~------~~~-~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K------TNN-YSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h------hhc-cccccc
Confidence 554 45556889999999999999998864 899999999999999999865432222110 0 000 000000
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...-........+.+...++.++|+.||.+|.||++|++.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000011122334577889999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-19 Score=177.32 Aligned_cols=140 Identities=17% Similarity=0.154 Sum_probs=108.5
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcc--c-------HHHH-----------------HHHHHHHHhccCCce
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ--G-------VEEF-----------------KNEALLIAKLQHRNL 573 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~ni 573 (834)
...||+|+||.||+|...+|+.||||+++..... . ..+| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999878999999999754211 1 1222 349999999988776
Q ss_pred eeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHh-hhcCCCceEeccCCCCceeecC
Q 003272 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL-HHDSRLRIIHRDLKASNVLLDN 652 (834)
Q Consensus 574 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DLkp~NILl~~ 652 (834)
.....+. ....++||||++++++..... ....++......++.||+.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 223489999999987754432 224688899999999999999999 6777 99999999999998
Q ss_pred CCCeEEeeeccccccC
Q 003272 653 EMNPKISDFGMARAFG 668 (834)
Q Consensus 653 ~~~~kl~DfGla~~~~ 668 (834)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=208.35 Aligned_cols=252 Identities=19% Similarity=0.216 Sum_probs=183.3
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccC-cccHHHHHHHHHHHH--hccCCceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS-GQGVEEFKNEALLIA--KLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++...+.||.+.|=+|.+++.++|. |+||++-+.. ....+.|.++++-++ .++|||.+++.-.-......+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 8999986553 455666766655554 45899999998776666677888899
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
..+ +|.+.+ ..++.+...+...|+.||+.||..+|..+ |+|||||.+||||+.-.-+.|+||..-+.......
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 866 565555 45667888899999999999999999998 99999999999999999999999988766533222
Q ss_pred cc-----ccccccccccccCccccccC----------C-CCchhhHHHHHHHHHHHHhC-CCCCCCCCcccccchhHHHH
Q 003272 673 EA-----NTNRVVGTYGYMSPEYAIDG----------L-FSVKSDVFSFGVLVLEIVSG-KRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 673 ~~-----~~~~~~gt~~y~APE~~~~~----------~-~t~~sDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~ 735 (834)
.+ .......-.+|.|||.+... . .+++-||||+||++.||++- +++|+.. .+..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH--
Confidence 11 11223344589999987431 2 67889999999999999995 6666531 11111
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+.........++.. + +-..++++++.|++.||++|.++++.++.-.|.
T Consensus 248 r~~~~~~~e~~Le~-I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEK-I-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hccCccCHHHHHHh-C-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00001111111111 0 011567899999999999999999999885553
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=180.08 Aligned_cols=171 Identities=12% Similarity=0.146 Sum_probs=132.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHH---H------HHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVE---E------FKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
..++|+..++||.|+||.||.... ++..+|||.+++......+ . |.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 358899999999999999999655 6778999999765333222 2 67899999999999999999886543
Q ss_pred --------CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC
Q 003272 584 --------DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN 655 (834)
Q Consensus 584 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 655 (834)
...+|+|||+++.+|.++.. ++. ....+|+.+|..+|+.+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 34569999999999998 99999999999999988
Q ss_pred eEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHH
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 713 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ell 713 (834)
++|+|||.......+... ..+.....+..++|+|+||+.+....
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988764211111 11334445667899999999987554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=171.31 Aligned_cols=141 Identities=18% Similarity=0.187 Sum_probs=111.5
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCccc--------------------------HHHHHHHHHHHHhccCCce
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQG--------------------------VEEFKNEALLIAKLQHRNL 573 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 573 (834)
...||+|++|.||+|...+|+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45899999999999998789999999987542110 1224578999999999988
Q ss_pred eeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecC
Q 003272 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDN 652 (834)
Q Consensus 574 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 652 (834)
.....+... ..+|||||++++++..... ....++......++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 3489999999886543321 12347788899999999999999999 77 99999999999999
Q ss_pred CCCeEEeeeccccccCC
Q 003272 653 EMNPKISDFGMARAFGL 669 (834)
Q Consensus 653 ~~~~kl~DfGla~~~~~ 669 (834)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=192.25 Aligned_cols=216 Identities=23% Similarity=0.313 Sum_probs=161.0
Q ss_pred HhccCCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003272 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKA 645 (834)
Q Consensus 566 ~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 645 (834)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++++|++||+|||... -..|+.|++
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 568899999999999999999999999999999999965 3456999999999999999999999865 239999999
Q ss_pred CceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCC-------CCchhhHHHHHHHHHHHHhCCCC
Q 003272 646 SNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL-------FSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 646 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~t~~sDV~S~Gvil~elltg~~p 718 (834)
+|+++|....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999988764211111111122345799999997641 46779999999999999999999
Q ss_pred CCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 719 RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
++........ ......... .....+.|.+.... +....+..++..||..+|++||++..|-..++..
T Consensus 158 ~~~~~~~~~~---~eii~~~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDP---DEIILRVKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCCh---HHHHHHHHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 8653332221 111111111 11222222222111 2233688899999999999999999999888754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=177.15 Aligned_cols=232 Identities=21% Similarity=0.296 Sum_probs=152.3
Q ss_pred CcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhcc----------CCceeeEEEEEE-
Q 003272 517 FSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQ----------HRNLVKLLGCCT- 581 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~g~~~- 581 (834)
+...+.||.|+++.||.++..+ ++++|||++.-. .....+++++|...+..+. |-.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456789999999999999876 899999988533 3445678888876665532 222322222221
Q ss_pred e--------CC--------eeEEEEeecCCCChhhHhh---ccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEec
Q 003272 582 Q--------RD--------ERVLVYEYLPNKSLDYFIF---DTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641 (834)
Q Consensus 582 ~--------~~--------~~~lV~E~~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 641 (834)
. .. ..+++|+-+ .++|..++. ... ....+....++.+..|+++.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1 11 235677776 557776643 221 1234556677788899999999999998 9999
Q ss_pred cCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCcccccc--------CCCCchhhHHHHHHHHHHHH
Q 003272 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLEIV 713 (834)
Q Consensus 642 DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~t~~sDV~S~Gvil~ell 713 (834)
||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999887764322111 234578999997744 25789999999999999999
Q ss_pred hCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 003272 714 SGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDR 778 (834)
Q Consensus 714 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 778 (834)
|++.|++....+..... ....+. ..++.+..|+..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999875433221110 233455 667788899999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=169.44 Aligned_cols=198 Identities=21% Similarity=0.315 Sum_probs=163.7
Q ss_pred CCcccCccccCCcccEEEEE-EeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.|++.++||+|.||.++.|+ +-+++.||||.=.. .....++..|.+..+.| ..++|...+-|-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68899999999999999998 45789999997433 33446788899999988 5789999988888888999999987
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-----CCeEEeeeccccccC
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-----MNPKISDFGMARAFG 668 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-----~~~kl~DfGla~~~~ 668 (834)
+-||+++..- -...++.++++-+|.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+...
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 5577776522 1345899999999999999999999998 9999999999999633 458899999999875
Q ss_pred CCcccc-----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 669 LDQTEA-----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 669 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
...+.. ......||.+||+---..+...+.+.|.=|+|-+++..+-|..|+.-
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 433321 12236799999999988999999999999999999999999999643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=160.93 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=162.2
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhccC-CceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH-RNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 591 (834)
..+|...++||.|+||.+|.|.. .+|.+||||.=+. .....++.-|..+...++| ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 36799999999999999999985 4699999998543 3334577889999999975 678888888899999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC---CCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~~ 668 (834)
.. +-+|+++..-- ...++.++.+-++-|++.-++|+|..+ +|||||||+|+|..-+ ..+.++|||+|+...
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 55787765322 235788899999999999999999998 9999999999999644 468899999999874
Q ss_pred CCcccc-----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 669 LDQTEA-----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 669 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
...+.. ......||.+|.+--...+...+.+.|+=|+|.+|..+--|..|+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 332221 1123679999999887777778889999999999999999999964
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=161.37 Aligned_cols=182 Identities=19% Similarity=0.127 Sum_probs=137.3
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEEEecccCcc----cHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeec
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ----GVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
....|++|+||+||.+.- .+..++.+.+.....- ....|.+|+++|++++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 6788888888654321 1225889999999995 5889999886 4569999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccC-CCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDL-KASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++.+|...+. . ....++.+++++|.++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9988864431 0 11357789999999999998 999999 79999999999999999999986543221
Q ss_pred c------c-----ccccccccccccCccccccC-CC-CchhhHHHHHHHHHHHHhCCCC
Q 003272 673 E------A-----NTNRVVGTYGYMSPEYAIDG-LF-SVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 673 ~------~-----~~~~~~gt~~y~APE~~~~~-~~-t~~sDV~S~Gvil~elltg~~p 718 (834)
. . .+.....++.|+.|+...-- .. -...+.++.|..+|.++|++.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~ 206 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL 206 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence 0 0 01123357788888865332 22 3567888999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-17 Score=194.97 Aligned_cols=200 Identities=24% Similarity=0.267 Sum_probs=159.4
Q ss_pred HHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc---CCceeeEEEEEEeCCee
Q 003272 510 IVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQRDER 586 (834)
Q Consensus 510 ~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 586 (834)
++...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....- +|.-=.+++.+|+ -+.|..+...+.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34455779999999999999999999988999999987554322 1222223333333 23444555555667788
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-------CCCCeEEe
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-------NEMNPKIS 659 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-------~~~~~kl~ 659 (834)
+||+||.+.|+|.+++. ..+.++|.....++.|+++-+++||..+ |||+||||+|+||. +...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999985 5677999999999999999999999998 99999999999994 33468999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
|||.+..+..-.........+.|-.+-.+|+..+.+++.++|.|.++-+++-|+.|++.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999776433233334457788999999999999999999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=161.83 Aligned_cols=137 Identities=20% Similarity=0.285 Sum_probs=106.3
Q ss_pred CcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-----cCCceeeEEEEEEeCC---e-eE
Q 003272 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-----QHRNLVKLLGCCTQRD---E-RV 587 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 587 (834)
+...++||+|+||.||. +++....+||++........+.+.+|+.++..+ .||||++++|++.+.. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 444333479988665445567899999999999 5799999999998864 2 33
Q ss_pred EEEee--cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHH-HHhhhcCCCceEeccCCCCceeecC----CCCeEEee
Q 003272 588 LVYEY--LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL-LYLHHDSRLRIIHRDLKASNVLLDN----EMNPKISD 660 (834)
Q Consensus 588 lV~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~D 660 (834)
+|+|| +++++|.+++... .++.. ..++.+++.++ +|||+.+ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 6689999999432 24444 35677888777 9999998 999999999999974 34799999
Q ss_pred eccc
Q 003272 661 FGMA 664 (834)
Q Consensus 661 fGla 664 (834)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 4433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-17 Score=182.32 Aligned_cols=250 Identities=27% Similarity=0.313 Sum_probs=183.9
Q ss_pred ccccCCcccEEEEE----EeCCeEEEEEEecccCc--ccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeecC
Q 003272 522 KLGEGGFGPVYKGM----LIEGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~----~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
.+|+|.||.|+... ...|+-+|.|.+++... ......+.|..++..++ ||.+|++.-.+......+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998754 22367788888865422 11125667888888886 9999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|.|-..+. .....+..........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999877763 3345667777778888999999999988 99999999999999999999999999987532211
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
.+||..|||||++. ....++|-||||++.+||++|-.||.. + .+..++.. ...
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~----------------~~~~Il~~--~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D----------------TMKRILKA--ELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H----------------HHHHHhhh--ccC
Confidence 28899999999998 557789999999999999999999753 0 00111110 112
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHhcc------------CCCCCCCCCCCccccc
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNM--LSVVLMLSG------------ERSLPQPKQPGFFTER 806 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~ev~~~L~~------------~~~~~~p~~p~~~~~~ 806 (834)
.+......+..++..+...+|..|.-. ..+.+.++. .+..+.|..|....++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~ 271 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITER 271 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchh
Confidence 233334455667778888888888755 344444431 1334556666665544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.3e-16 Score=156.66 Aligned_cols=134 Identities=22% Similarity=0.286 Sum_probs=113.4
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCcc--------cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ--------GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+.||+|++|.||+|.. .|..++||+....... ...++.+|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7778999986533211 124578899999999999998888777777889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887432 12 78899999999999999988 99999999999999 78999999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=157.22 Aligned_cols=143 Identities=17% Similarity=0.163 Sum_probs=110.4
Q ss_pred CCcccCccccCCcccEEEEE--EeCCeEEEEEEecccCcc------------------------cHHHHHHHHHHHHhcc
Q 003272 516 NFSEENKLGEGGFGPVYKGM--LIEGQEIAVKRLSKSSGQ------------------------GVEEFKNEALLIAKLQ 569 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 569 (834)
-|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 457999999998653210 0123568999999997
Q ss_pred CCc--eeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCc
Q 003272 570 HRN--LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647 (834)
Q Consensus 570 H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 647 (834)
+.+ +.++++. ...++||||+++.+|...... ...+.......++.||+.++.+||+.+ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 4444443 235899999999888655421 223555667899999999999999876 49999999999
Q ss_pred eeecCCCCeEEeeeccccccC
Q 003272 648 VLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~ 668 (834)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=153.17 Aligned_cols=145 Identities=20% Similarity=0.220 Sum_probs=112.1
Q ss_pred HHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcc----------------------cHHHHHHHHHHHH
Q 003272 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ----------------------GVEEFKNEALLIA 566 (834)
Q Consensus 509 ~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~ 566 (834)
++......|...+.||+|+||.||++...+|+.||||++...... ....+..|...+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333347778899999999999999878999999987543210 1123567888899
Q ss_pred hccCCc--eeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCC
Q 003272 567 KLQHRN--LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK 644 (834)
Q Consensus 567 ~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 644 (834)
.+.|++ +...++. ...++||||+++++|..... ......++.+|+.++.++|+.+ |+|+|||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 4444442 34589999999999876541 0345678899999999999987 9999999
Q ss_pred CCceeecCCCCeEEeeeccccccCC
Q 003272 645 ASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 645 p~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|+||++++++.++|+|||++..+..
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.3e-17 Score=174.32 Aligned_cols=174 Identities=22% Similarity=0.324 Sum_probs=131.1
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
.+++.|+++...+|.+++.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999777677778999999999999999999 54 999999999999999999999999998
Q ss_pred cccCCCc----cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhh
Q 003272 665 RAFGLDQ----TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 665 ~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
....... ........+||..||+||.+.+..|+.|+||||||++|+|++. -.-+++- ....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------~~t~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------IATL 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------------HHhh
Confidence 7765433 1233445789999999999999999999999999999999997 2222110 0001
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 783 (834)
.+.-...+++....+.+. -+.++.+++...|.+||+..+
T Consensus 470 ~d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 111111222222222222 245788999999999994444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=153.06 Aligned_cols=130 Identities=24% Similarity=0.346 Sum_probs=107.2
Q ss_pred ccccCCcccEEEEEEeCCeEEEEEEecccCc--------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG--------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.||+|+||.||+|.+ ++..+++|+...... ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678899998654221 12356778999999999888766666666677789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763211 078999999999999988 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=177.88 Aligned_cols=146 Identities=19% Similarity=0.320 Sum_probs=116.5
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEE-ecccCc-------ccHHHHHHHHHHHHhccCCceeeEE
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKR-LSKSSG-------QGVEEFKNEALLIAKLQHRNLVKLL 577 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~ 577 (834)
++.........|...++||+|+||+||+|.+.+. .+++|+ +.+... ...+++.+|++++.+++|++++...
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3443334445566788999999999999987544 444443 322111 1235688999999999999999888
Q ss_pred EEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 578 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
.++......++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence 88887778899999999999988873 35678999999999999988 9999999999999 678999
Q ss_pred Eeeecccccc
Q 003272 658 ISDFGMARAF 667 (834)
Q Consensus 658 l~DfGla~~~ 667 (834)
|+|||+++..
T Consensus 468 liDFGla~~~ 477 (535)
T PRK09605 468 LIDFGLGKYS 477 (535)
T ss_pred EEeCcccccC
Confidence 9999999763
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.4e-16 Score=126.46 Aligned_cols=66 Identities=56% Similarity=1.132 Sum_probs=59.0
Q ss_pred cCCCCceEEeEeecCCCccccccchhhhHHHHHHHhccCCceeeeecccccCCCcceeeeccccccc
Q 003272 349 CKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDI 415 (834)
Q Consensus 349 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~c~~~~~~l~~~ 415 (834)
|+.+|+|+++++|++|++....++.+.++++|++.|++||||+||+|.++. ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556789999999999999877777789999999999999999999998765 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.5e-15 Score=153.07 Aligned_cols=198 Identities=20% Similarity=0.255 Sum_probs=135.8
Q ss_pred cCCceeeEEEEEEe---------------------------CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHH
Q 003272 569 QHRNLVKLLGCCTQ---------------------------RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIG 621 (834)
Q Consensus 569 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 621 (834)
+|||||++.++|.+ ...+++||...+. +|..++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence 59999999887643 2246788877654 6777763 33466777888999
Q ss_pred HHHHHHHHhhhcCCCceEeccCCCCceee--cCCC--CeEEeeeccccccCCCc----cccccccccccccccCcccccc
Q 003272 622 GIARGLLYLHHDSRLRIIHRDLKASNVLL--DNEM--NPKISDFGMARAFGLDQ----TEANTNRVVGTYGYMSPEYAID 693 (834)
Q Consensus 622 ~ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~--~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~APE~~~~ 693 (834)
|+++|+.|||.++ |.|||||++|||| |+|. .+.|+|||++-.-.... .....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 3444 46899999875432210 1111122557778999998865
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHH
Q 003272 694 GL------FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG 767 (834)
Q Consensus 694 ~~------~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 767 (834)
.+ .-.|+|.|+.|-+.||++....||- ..++. .++ ...+.+.++.. .+...+..+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY--~rGem--~L~--~r~Yqe~qLPa---------lp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY--KRGEM--LLD--TRTYQESQLPA---------LPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccc--ccchh--eec--hhhhhhhhCCC---------CcccCChHHHHHH
Confidence 33 2358999999999999999999863 21111 000 00111122211 2223334678899
Q ss_pred HHcccCCCCCCCCHHHHHHHhc
Q 003272 768 LLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 768 ~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
...++.||++||+..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999877666664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-14 Score=134.66 Aligned_cols=134 Identities=21% Similarity=0.197 Sum_probs=114.6
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccC--CceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH--RNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999844 7899999865433 5678999999999976 589999998888788999999998877
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6433 5567778899999999999987555699999999999999989999999998865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=140.85 Aligned_cols=136 Identities=21% Similarity=0.269 Sum_probs=98.1
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcc--cHHHH----------------------HHHHHHHHhccCCc--e
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ--GVEEF----------------------KNEALLIAKLQHRN--L 573 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--i 573 (834)
.+.||+|+||.||+|...+++.||||+++..... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999998653211 11111 34556666664433 4
Q ss_pred eeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecC
Q 003272 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDN 652 (834)
Q Consensus 574 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 652 (834)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999999654322111000 11 5678899999999999999 76 99999999999999
Q ss_pred CCCeEEeeecccccc
Q 003272 653 EMNPKISDFGMARAF 667 (834)
Q Consensus 653 ~~~~kl~DfGla~~~ 667 (834)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-14 Score=165.85 Aligned_cols=210 Identities=21% Similarity=0.266 Sum_probs=137.8
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.+|..++.|..|++|.||..++.. .+.+|.|+= +..- +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhhc--cccccCCccee-------------------
Confidence 568888999999999999998765 667888432 2110 0000 11122233332
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc-
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT- 672 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~- 672 (834)
|+=...+.. .+.++ .+++.+++|||+.+ |+|||+||.|.+|+.-|++|+.|||+.+.......
T Consensus 136 --gDc~tllk~---~g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKN---IGPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhccc---CCCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 222222311 12222 12378899999988 99999999999999999999999999987532111
Q ss_pred ------------ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 673 ------------EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 673 ------------~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+.....++||+.|.|||++....|...+|.|++|+|+||.+-|..||....+ +.+......
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~vis---- 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVIS---- 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhh----
Confidence 1112347899999999999999999999999999999999999999753222 122211110
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
+ ..+. .+.+.....++..++.+.|+++|..|---
T Consensus 273 d-~i~w------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 273 D-DIEW------PEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred h-hccc------cccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 0 0001 11122223456778888999999999533
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-13 Score=140.38 Aligned_cols=134 Identities=19% Similarity=0.246 Sum_probs=104.6
Q ss_pred Cccc-cCCcccEEEEEEeCCeEEEEEEecccC-------------cccHHHHHHHHHHHHhccCCce--eeEEEEEEeCC
Q 003272 521 NKLG-EGGFGPVYKGMLIEGQEIAVKRLSKSS-------------GQGVEEFKNEALLIAKLQHRNL--VKLLGCCTQRD 584 (834)
Q Consensus 521 ~~LG-~G~fg~Vy~g~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 584 (834)
..|| .|+.|+||+... ++..++||++.... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999987 47789999885321 1223567889999999998875 67777654432
Q ss_pred e----eEEEEeecCC-CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 585 E----RVLVYEYLPN-KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 585 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 688887743 224433 3578999999999998 9999999999999999999999
Q ss_pred eeccccc
Q 003272 660 DFGMARA 666 (834)
Q Consensus 660 DfGla~~ 666 (834)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-12 Score=146.83 Aligned_cols=141 Identities=23% Similarity=0.310 Sum_probs=100.8
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccH----------------------------------------HHHH
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGV----------------------------------------EEFK 559 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 559 (834)
.+.||.|++|.||+|++.+|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999865421110 0244
Q ss_pred HHHHHHHhcc----CCceeeEEEEE-EeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHH-HHHHhhhc
Q 003272 560 NEALLIAKLQ----HRNLVKLLGCC-TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR-GLLYLHHD 633 (834)
Q Consensus 560 ~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 633 (834)
+|+..+.++. |.+-+.+-..+ ......+|||||+++++|.++...... .. .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666555552 32223332333 224567999999999999877632111 11 34556776666 46788887
Q ss_pred CCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 634 ~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
+ ++|+|+||.||++++++++++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-14 Score=164.77 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=184.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC--CeEEEEEEecccC--cccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 589 (834)
..|...+.||+|+|+.|-.....+ ...+|+|.+.... ....++...|..+-..+. |.|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 346667789999999998877644 4456777665433 233334445776666776 99999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhh-hcCCCceEeccCCCCceeecCCC-CeEEeeecccccc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH-HDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF 667 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~ 667 (834)
.+|..++++...+.. ......+....-..+.|+..++.|+| ..+ +.|+|+||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998776631 11223555666778999999999999 776 99999999999999999 9999999999988
Q ss_pred CC-Cccccccccccc-cccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 668 GL-DQTEANTNRVVG-TYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 668 ~~-~~~~~~~~~~~g-t~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.. +.........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|.+......... ..+....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNK-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeecccc--
Confidence 76 555555556778 9999999999885 44677999999999999999999965433322110 0011110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......+ .........++...++..+|+.|.+.+++..
T Consensus 248 ~~~~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLP----WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCc----cccCChhhhhcccccccCCchhccccccccc
Confidence 0000001 1111224556777888899999999888753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-13 Score=139.15 Aligned_cols=205 Identities=21% Similarity=0.221 Sum_probs=139.8
Q ss_pred HHHHHhccCCceeeEEEEEEeC-----CeeEEEEeecCCCChhhHhhccCC-CCCCCHHhHHHHHHHHHHHHHHhhhcCC
Q 003272 562 ALLIAKLQHRNLVKLLGCCTQR-----DERVLVYEYLPNKSLDYFIFDTTR-SKVLDWQNRCHIIGGIARGLLYLHHDSR 635 (834)
Q Consensus 562 ~~~l~~l~H~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 635 (834)
..-|-.+.|.|||+++.++.+. ....++.|||..|++..+|.+... ...+......+|+.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445566799999999988554 347899999999999999976433 456888888999999999999999976
Q ss_pred CceEeccCCCCceeecCCCCeEEeeecc--ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHH
Q 003272 636 LRIIHRDLKASNVLLDNEMNPKISDFGM--ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 713 (834)
Q Consensus 636 ~~ivH~DLkp~NILl~~~~~~kl~DfGl--a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ell 713 (834)
++|+|+++..+.|++..++-+||.--.- ....-.......+....+-++|.|||.=.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7899999999999999999888753211 11100011111222345678999999877777788999999999999998
Q ss_pred hCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 714 SGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 714 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+..-....... .. ..+.+.....+..+. .-..++..|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS~---~~------------~ee~ia~~i~~len~----lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESK---VE------------VEENIANVIIGLENG----LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcce---ee------------hhhhhhhheeeccCc----cccCcCcccccCCCCCCcchhhhhc
Confidence 876532111000 00 000000011110010 1123667899999999999998763
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.4e-13 Score=112.38 Aligned_cols=71 Identities=23% Similarity=0.388 Sum_probs=62.0
Q ss_pred cCCCCceEEeEeecCCCccccccchhhhHHHHHHHhcc---CCceeeeecccccCCCcceeeecccc-ccccccCcCccc
Q 003272 349 CKHGDGFLKLKTVKVPDTRYAQVDKNIILLECKELCSR---NCSCTAYANSDVRGGGSGCLLWFHDL-IDIKVLPEIGQD 424 (834)
Q Consensus 349 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~c~~~~~~l-~~~~~~~~~~~~ 424 (834)
|....+|+++.+|++|++.. .+++||++.|++ ||||+||+|.+. +++|.+|++++ .+++..+..+++
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44457899999999999864 689999999999 999999999753 36899999999 999888878899
Q ss_pred ceeh
Q 003272 425 IYVR 428 (834)
Q Consensus 425 lyvr 428 (834)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=111.05 Aligned_cols=80 Identities=51% Similarity=0.941 Sum_probs=65.3
Q ss_pred CCCcCCC---CceEEeEeecCCCccccccchhhhHHHHHHHhccCCceeeeecccccCCCcceeeeccccccccccCcCc
Q 003272 346 PLNCKHG---DGFLKLKTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHDLIDIKVLPEIG 422 (834)
Q Consensus 346 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~c~~~~~~l~~~~~~~~~~ 422 (834)
+++|..+ ++|++++++++|+..+.. .++++++|++.|++||+|+||+|.+ ++++|.+|...+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567544 689999999999886543 7789999999999999999999974 3679999999998876654456
Q ss_pred ccceehhh
Q 003272 423 QDIYVRMA 430 (834)
Q Consensus 423 ~~lyvrv~ 430 (834)
..+|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.8e-11 Score=116.09 Aligned_cols=131 Identities=21% Similarity=0.137 Sum_probs=98.1
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCcee-eEEEEEEeCCeeEEEEeecCCCCh
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV-KLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
.+.|+.|.++.||+... .+..+++|....... ....+..|+..+..+.+.+++ +++.+. ....++|||++++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35789999999999987 478899998754432 223567899999998765554 444433 3346899999999887
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC--CCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
.... .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 111345688999999999986 23469999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.2e-10 Score=132.61 Aligned_cols=145 Identities=17% Similarity=0.192 Sum_probs=94.3
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCccc------------------------------H----H----
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG------------------------------V----E---- 556 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~------------------------------~----~---- 556 (834)
.|+. +.||+|++|.||+|++.+ |+.||||+++...... . +
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999988 9999999997542110 0 1
Q ss_pred --HHHHHHHHHHhcc----CCceeeEEEEEEe-CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHH-HHH
Q 003272 557 --EFKNEALLIAKLQ----HRNLVKLLGCCTQ-RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR-GLL 628 (834)
Q Consensus 557 --~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~ 628 (834)
.|.+|+..+.++. +.+.+.+-..+.+ ....+|||||++++.+.++..-. ....+. ..++...++ -+.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~--~~g~d~---~~la~~~v~~~~~ 274 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR--AAGTDM---KLLAERGVEVFFT 274 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH--hcCCCH---HHHHHHHHHHHHH
Confidence 1344554444442 4444444444433 45689999999999997642111 111111 122222222 122
Q ss_pred HhhhcCCCceEeccCCCCceeecCCC----CeEEeeeccccccCC
Q 003272 629 YLHHDSRLRIIHRDLKASNVLLDNEM----NPKISDFGMARAFGL 669 (834)
Q Consensus 629 yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGla~~~~~ 669 (834)
.++..+ ++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 275 Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 333444 99999999999999888 999999999988743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1e-10 Score=129.74 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=173.2
Q ss_pred CCcccCcccc--CCcccEEEEEE--e-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeE
Q 003272 516 NFSEENKLGE--GGFGPVYKGML--I-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 516 ~~~~~~~LG~--G~fg~Vy~g~~--~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 587 (834)
.+-..+.+|. |.+|.||.+.. . ++..+|+|+-+.... .....=.+|+..-.++ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556678999 99999999987 3 478899998543222 2222334566666666 5999999989999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHH----HHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeec
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR----GLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFG 662 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfG 662 (834)
+-.|++. .+|..+.+. ....++....+....+... ||.++|... ++|-|+||.||++..+ ...++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999986 566666543 2344666677777777777 999999998 9999999999999999 889999999
Q ss_pred cccccCCCccccc---cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 663 MARAFGLDQTEAN---TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 663 la~~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+...+........ ..+..+...|++||... +.++.++|+|++|.++.|.+++.......-.. .|....
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccccc
Confidence 9988865432111 12235777899999664 56788999999999999999988653211000 011111
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. .+.+... .. ...++..++..+++.+|..|++.+++..
T Consensus 340 ~~---~ip~e~~-~~----~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QG---YIPLEFC-EG----GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc---cCchhhh-cC----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 1111111 00 1123344788899999999998877653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.4e-09 Score=104.27 Aligned_cols=136 Identities=13% Similarity=0.090 Sum_probs=98.7
Q ss_pred CccccCCcccEEEEEEeC-------CeEEEEEEecccCc----------------------ccHHHHH----HHHHHHHh
Q 003272 521 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKSSG----------------------QGVEEFK----NEALLIAK 567 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-------g~~vavK~l~~~~~----------------------~~~~~~~----~E~~~l~~ 567 (834)
..||.|--+.||.|.-.+ +..+|||+.+.... ...+.+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998643 47999998853210 0122333 79999998
Q ss_pred ccC--CceeeEEEEEEeCCeeEEEEeecCCCChhh-HhhccCCCCCCCHHhHHHHHHHHHHHHHHh-hhcCCCceEeccC
Q 003272 568 LQH--RNLVKLLGCCTQRDERVLVYEYLPNKSLDY-FIFDTTRSKVLDWQNRCHIIGGIARGLLYL-HHDSRLRIIHRDL 643 (834)
Q Consensus 568 l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DL 643 (834)
+.. -++.+++++ ..-+|||||+.+..+.. .+. ...++......+..+++.+|..| |..+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 456666654 56789999998754422 121 11244456677889999999999 7777 999999
Q ss_pred CCCceeecCCCCeEEeeeccccccC
Q 003272 644 KASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 644 kp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.3e-09 Score=108.95 Aligned_cols=142 Identities=19% Similarity=0.243 Sum_probs=109.3
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCc-ccHHHHHHHHHHHHhccC--CceeeEEEEEEeCC---eeEEEEeecC
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQH--RNLVKLLGCCTQRD---ERVLVYEYLP 594 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 594 (834)
+.|+.|..+.||+....+|..+++|....... ....++..|+.+++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999998754332 245678999999999975 34577777766542 5689999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS---------------------------------------- 634 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 634 (834)
+.++...+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 34667777788888888888888531
Q ss_pred -------------CCceEeccCCCCceeecC--CCCeEEeeeccccc
Q 003272 635 -------------RLRIIHRDLKASNVLLDN--EMNPKISDFGMARA 666 (834)
Q Consensus 635 -------------~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~ 666 (834)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.7e-09 Score=115.86 Aligned_cols=229 Identities=18% Similarity=0.197 Sum_probs=151.1
Q ss_pred eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhH
Q 003272 537 IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR 616 (834)
Q Consensus 537 ~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~ 616 (834)
.++.+|.|...+...........+-+..++.++||||++++....+....+||.|.+. -|...+.. +.-...
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3588888888876655445567788899999999999999999999999999999863 24444422 234556
Q ss_pred HHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCC
Q 003272 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696 (834)
Q Consensus 617 ~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 696 (834)
...+.||+.||.+||+.+ .++|++|.-..|+|++.|..||++|.++.....-.. .......-..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 677899999999999766 499999999999999999999999988765421111 111122223466676543322
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCC--CCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCC
Q 003272 697 SVKSDVFSFGVLVLEIVSGKRNRG--FYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQI 774 (834)
Q Consensus 697 t~~sDV~S~Gvil~elltg~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d 774 (834)
-..|.|-||++++|++.|..+.. ....+..... ..+..-+.+. ........ ..+++..|....
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~------------~~~~~~k~~~-~~~~~r~n-~~~~~~~~~~~~ 246 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKA------------LIELYCKKLG-ATELKRPN-KLRFILECRLLG 246 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccCcchhhhccCccchh------------HHHHHHHHhc-cccccccc-hhhHHHHHHhcc
Confidence 34699999999999999943211 0001110000 0000000000 00111111 445677788888
Q ss_pred CCCCCCHHHHHHHhccCCC
Q 003272 775 PEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 775 P~~RPt~~ev~~~L~~~~~ 793 (834)
+-.|--.-+++.+|++..-
T Consensus 247 gff~n~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 247 GFFRNDFVDTLLFLEELRL 265 (690)
T ss_pred ccccchHHHHHHHHHhccc
Confidence 8888888888888887643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.6e-09 Score=100.28 Aligned_cols=131 Identities=23% Similarity=0.319 Sum_probs=103.1
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEe-ccc--Cc-----ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRL-SKS--SG-----QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l-~~~--~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..+++|+-+.+|.+.+. |..+++|.- ++. .+ -..++-.+|+.++.+++--.|....-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999774 444666643 222 11 1234567799999999877777777777888889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998887432 2567788888889999988 99999999999998776 99999999975
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.7e-10 Score=124.49 Aligned_cols=249 Identities=20% Similarity=0.178 Sum_probs=174.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEe--CCeEEEEEEecccCcccHHHH--HHHHHHHHhc-cCCceeeEEEEEEeCCeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI--EGQEIAVKRLSKSSGQGVEEF--KNEALLIAKL-QHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~--~g~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 587 (834)
...+|..+.+||.|.|+.|++.... ++..+++|.+.+.......+. ..|+.+...+ .|.++++....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567888899999999999987643 477889998866533322222 3355555555 5889999888888888888
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeeccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARA 666 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~~ 666 (834)
+--||++++++...+ .-...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987766 22345777888999999999999999877 9999999999999886 7889999999875
Q ss_pred cCCCccccccccccccccc-cCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQTEANTNRVVGTYGY-MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y-~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
+..... .....+..| .+|+......+..+.|++|||.-+.|.+++..-.+-.. . +.....+...
T Consensus 417 ~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--~--------~~~i~~~~~p- 481 (524)
T KOG0601|consen 417 LAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--Q--------SLTIRSGDTP- 481 (524)
T ss_pred cceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcccc--c--------ceeeeccccc-
Confidence 321111 112223344 36666667788999999999999999999875421100 0 0000111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.+ +. ....+..++..++..++..||.+.++..+.+..
T Consensus 482 ----~~----~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 482 ----NL----PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----CC----Cc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 01 11 112344566678899999999999988776654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-08 Score=96.03 Aligned_cols=144 Identities=24% Similarity=0.316 Sum_probs=107.5
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEE-Eeccc-------CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVK-RLSKS-------SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK-~l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
....|-+|+-+.|+++.+ .|+...|| ++.+. ..-..++.++|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 345789999999999998 56665555 33332 1223457788999999997767766666777888889999
Q ss_pred eecCC-CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC---CeEEeeeccccc
Q 003272 591 EYLPN-KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARA 666 (834)
Q Consensus 591 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~ 666 (834)
||+++ .++.+++....... ........+++.|-+.+.-||... |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 46677775433322 222333678899999999999988 99999999999996554 358999999865
Q ss_pred c
Q 003272 667 F 667 (834)
Q Consensus 667 ~ 667 (834)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6e-08 Score=105.32 Aligned_cols=169 Identities=22% Similarity=0.309 Sum_probs=127.3
Q ss_pred cccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeEEEEeecCC-CChhhH
Q 003272 528 FGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERVLVYEYLPN-KSLDYF 601 (834)
Q Consensus 528 fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~-gsL~~~ 601 (834)
-.+.||+... +|..+++|+++....+....-..-++.++++.|.|+|++..++.. ...+++||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578898853 699999999954333333334556889999999999999988763 3458999999986 455554
Q ss_pred hhcc------------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 602 IFDT------------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 602 l~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
.+.. ......++..++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|.-..+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4322 12335778999999999999999999998 88899999999999999999998887766543
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
+.... +. -..+-|.=-||.+++.|.||...
T Consensus 446 d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 32111 11 12356888999999999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-07 Score=98.03 Aligned_cols=140 Identities=17% Similarity=0.109 Sum_probs=100.2
Q ss_pred ccccCCcccEEEEEEeCCeEEEEEEecccCcc-cH----------HHHHHHHHHHHhccCCce--eeEEEEEEe-----C
Q 003272 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ-GV----------EEFKNEALLIAKLQHRNL--VKLLGCCTQ-----R 583 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~-~~----------~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----~ 583 (834)
.+-.-....|++..+ +|+.+.||+....... .. ..+.+|...+.++...+| ++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344334445777766 7889999987432211 11 247889999998854444 444555543 2
Q ss_pred CeeEEEEeecCCC-ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-------CCC
Q 003272 584 DERVLVYEYLPNK-SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-------EMN 655 (834)
Q Consensus 584 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------~~~ 655 (834)
..-+||+|++++. +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999986 7888874221 233456677889999999999999998 999999999999985 467
Q ss_pred eEEeeeccccc
Q 003272 656 PKISDFGMARA 666 (834)
Q Consensus 656 ~kl~DfGla~~ 666 (834)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=93.37 Aligned_cols=126 Identities=26% Similarity=0.298 Sum_probs=83.1
Q ss_pred cEEEEEEeCCeEEEEEEecccC--------------c------------ccHHHHHHHHHHHHhccCC--ceeeEEEEEE
Q 003272 530 PVYKGMLIEGQEIAVKRLSKSS--------------G------------QGVEEFKNEALLIAKLQHR--NLVKLLGCCT 581 (834)
Q Consensus 530 ~Vy~g~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 581 (834)
.||.|...+|..+|||..+... . .......+|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999885421 0 0123456799999999765 456666442
Q ss_pred eCCeeEEEEeecC--CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHH-hhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 582 QRDERVLVYEYLP--NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY-LHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 582 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
.-.|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 55554433111 1134556677888886666 46776 9999999999999988 9999
Q ss_pred eeeccccccC
Q 003272 659 SDFGMARAFG 668 (834)
Q Consensus 659 ~DfGla~~~~ 668 (834)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-08 Score=119.26 Aligned_cols=249 Identities=18% Similarity=0.241 Sum_probs=159.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
..+.+.+.+-+-+|.++.++.+.-.. |...+.|...... ....+....+-.+.-..+||-+++..-.+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34567777788899999998765322 4444444433221 1112222223222223345666655544555677899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
+++|..+++|...++... .++..-....+..+..+++|||... +.|+|++|.|+|+..+++.+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988775432 3444445556677888999999876 8999999999999999999999998433221
Q ss_pred CC-------------------------ccc----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003272 669 LD-------------------------QTE----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNR 719 (834)
Q Consensus 669 ~~-------------------------~~~----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~ 719 (834)
.- ... .......+|+.|.+||.+.+......+|.|++|++++|.++|..|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 000 1122356899999999999999999999999999999999999997
Q ss_pred CCCCcccccchhHHHHHHhhccCcccccCccc-cCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003272 720 GFYHADHRHNLLGHAWQLWIQDRPAELIDKSL-YDSCSLSEAIRCIQVGLLCVQQIPEDRPNML 782 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 782 (834)
....... . .+ .++.... ....+........+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~---~--------f~----ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ---I--------FE----NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhh---h--------hh----ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 5322211 0 00 0110000 0111222233455666777788888887766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=8.2e-07 Score=94.22 Aligned_cols=259 Identities=15% Similarity=0.116 Sum_probs=150.6
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceee--------EEEEEEeCCeeEEE
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVK--------LLGCCTQRDERVLV 589 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~--------l~g~~~~~~~~~lV 589 (834)
..+.||+|+-+.+|-- .+-..-+-|++.........+-. ..|... .||-+-. |+|- ......-+.
T Consensus 15 ~gr~LgqGgea~ly~l--~e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTL--GEVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeec--chhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence 4568999999999943 23222344777655443322222 222332 4554332 1111 111124466
Q ss_pred EeecCCCC-hhhHhhcc---CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 590 YEYLPNKS-LDYFIFDT---TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 590 ~E~~~~gs-L~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
|..+++.- ...+.... ..-...+|...++.++.||.+.+.||..+ .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 66665542 22222111 12245789999999999999999999998 8899999999999999999999855443
Q ss_pred ccCCCccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcc-cccchhH--HHHH
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSG-KRNRGFYHAD-HRHNLLG--HAWQ 736 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg-~~p~~~~~~~-~~~~~~~--~~~~ 736 (834)
... ........+|...|.+||.-. +-.-+...|-|.+|+++++++.| ++|+.-.... ...+..+ .+..
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 321 222223367889999999754 23356789999999999999987 8887532211 1111111 1111
Q ss_pred Hhhcc-CcccccCccccCCCCHH-HHHHHHHHHHHcccC--CCCCCCCHHHHHHHhcc
Q 003272 737 LWIQD-RPAELIDKSLYDSCSLS-EAIRCIQVGLLCVQQ--IPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 737 ~~~~~-~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~--dP~~RPt~~ev~~~L~~ 790 (834)
.+... +-..-..+.. ...+.+ .+..+..+..+|+.. ++.-||+++..+..|..
T Consensus 243 ~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 243 RFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 11100 0000001111 111211 123555677788864 36789999999888753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.1e-06 Score=99.73 Aligned_cols=160 Identities=18% Similarity=0.295 Sum_probs=103.0
Q ss_pred CcCccCHHHHHHHh------------cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCccc--------------
Q 003272 501 ELPIFDWKTIVDAT------------DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQG-------------- 554 (834)
Q Consensus 501 ~~~~~~~~~~~~~~------------~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~-------------- 554 (834)
..|.|++++..... ..|+. +.|+.++-|.||+|++.+|+.||||+.+......
T Consensus 100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~ 178 (517)
T COG0661 100 RVPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL 178 (517)
T ss_pred CCCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence 35667766544322 23432 5899999999999999999999999987542211
Q ss_pred ----------------HH----------HHHHHHHHHHhc----c-CCceeeEEEEEEeCCeeEEEEeecCCCChhhHhh
Q 003272 555 ----------------VE----------EFKNEALLIAKL----Q-HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF 603 (834)
Q Consensus 555 ----------------~~----------~~~~E~~~l~~l----~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 603 (834)
.+ .|..|+.-+.++ + .+++.-..=+..-.....|+|||+++-.+.+...
T Consensus 179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~ 258 (517)
T COG0661 179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA 258 (517)
T ss_pred HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence 01 123344444444 1 3343332223334567899999999998888753
Q ss_pred ccCCCCCCCHHhHHHHHHHHHHH-HHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 604 DTTRSKVLDWQNRCHIIGGIARG-LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 604 ~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
... ...+-+. ++..++++ +..+-..+ ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 259 l~~--~g~d~k~---ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 259 LKS--AGIDRKE---LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHh--cCCCHHH---HHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222 3344333 33333332 22222233 99999999999999999999999999887643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.4e-06 Score=86.83 Aligned_cols=135 Identities=21% Similarity=0.249 Sum_probs=94.6
Q ss_pred cccCccccCCcccEEEEEEeCCeEEEEEEecccCc----------------------ccHHHHHHHHHHHHhccCC--ce
Q 003272 518 SEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG----------------------QGVEEFKNEALLIAKLQHR--NL 573 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~--ni 573 (834)
.+.++||-|--+.||.|..++|.++|||.-+.... .......+|.+.|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999996542100 0123346688888888544 56
Q ss_pred eeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC
Q 003272 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE 653 (834)
Q Consensus 574 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 653 (834)
.+.+++ +.-.+||||+++-.|...- ++......++..|++-+.-+-..+ |||+|+.+-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 666554 4457999999886653321 123333444455555555444555 9999999999999999
Q ss_pred CCeEEeeecccccc
Q 003272 654 MNPKISDFGMARAF 667 (834)
Q Consensus 654 ~~~kl~DfGla~~~ 667 (834)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.2e-06 Score=85.70 Aligned_cols=107 Identities=24% Similarity=0.272 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHHhccCC--ceeeEEEEEEeCC----eeEEEEeecCCC-ChhhHhhccCCCCCCCHHhHHHHHHHHHHHH
Q 003272 555 VEEFKNEALLIAKLQHR--NLVKLLGCCTQRD----ERVLVYEYLPNK-SLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627 (834)
Q Consensus 555 ~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 627 (834)
.....+|...+..+... ...+.+++..... ..+||+|++++. +|.+++.... .++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34678888888888543 3456666665532 348999999884 7888875422 156667789999999999
Q ss_pred HHhhhcCCCceEeccCCCCceeecCCC---CeEEeeecccccc
Q 003272 628 LYLHHDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARAF 667 (834)
Q Consensus 628 ~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~~ 667 (834)
.-||+.+ |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=9.9e-06 Score=80.59 Aligned_cols=138 Identities=16% Similarity=0.166 Sum_probs=102.8
Q ss_pred cccCCcccEEEEEEeCCeEEEEEEeccc------CcccHHHHHHHHHHHHhccCCc--eeeEEEEEE-eC----CeeEEE
Q 003272 523 LGEGGFGPVYKGMLIEGQEIAVKRLSKS------SGQGVEEFKNEALLIAKLQHRN--LVKLLGCCT-QR----DERVLV 589 (834)
Q Consensus 523 LG~G~fg~Vy~g~~~~g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~~----~~~~lV 589 (834)
-|+||-+-|++-.+ +|+.+-+|+-... .+.....|.+|...|.++...+ +.++. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789899998766 5667999987521 1346678999999999985433 44444 332 11 236799
Q ss_pred EeecCC-CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC--eEEeeeccccc
Q 003272 590 YEYLPN-KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARA 666 (834)
Q Consensus 590 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DfGla~~ 666 (834)
+|-+++ .+|.+++.... ....+...+..++.+|+..+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997653 57877774322 234677778899999999999999998 999999999999986666 99999987654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.3e-07 Score=74.26 Aligned_cols=72 Identities=35% Similarity=0.716 Sum_probs=55.8
Q ss_pred CceEEeEeecCCCccccccchhhhHHHHHHHhcc-CCceeeeecccccCCCcceeeec-cccccccccCcCcccceeh
Q 003272 353 DGFLKLKTVKVPDTRYAQVDKNIILLECKELCSR-NCSCTAYANSDVRGGGSGCLLWF-HDLIDIKVLPEIGQDIYVR 428 (834)
Q Consensus 353 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~c~~~~-~~l~~~~~~~~~~~~lyvr 428 (834)
..|++++++.+++..... ....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+....+..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 468999999999665433 456799999999999 99999999975 457999999 7777766445555566654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.9e-07 Score=105.42 Aligned_cols=152 Identities=16% Similarity=0.218 Sum_probs=99.3
Q ss_pred HHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-------cccccccccccccCcccccc
Q 003272 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE-------ANTNRVVGTYGYMSPEYAID 693 (834)
Q Consensus 621 ~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-------~~~~~~~gt~~y~APE~~~~ 693 (834)
.+++.||.|+|... ++||++|.|++|.++..+..||+.|+++......... ...........|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999865 6999999999999999999999999987654321110 01111234568999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHccc
Q 003272 694 GLFSVKSDVFSFGVLVLEIVSGKRN-RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQ 772 (834)
Q Consensus 694 ~~~t~~sDV~S~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 772 (834)
...+.++|+||+|++++.+..|..+ +......... . ..... .+.. ........+.++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~-~~~~~------~~~~-~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----S-FSRNL------LNAG-AFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-----h-hhhcc------cccc-cccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999955544 2211110000 0 00000 0000 011112233455566667889
Q ss_pred CCCCCCCCHHHHHHH
Q 003272 773 QIPEDRPNMLSVVLM 787 (834)
Q Consensus 773 ~dP~~RPt~~ev~~~ 787 (834)
.++..||++.++...
T Consensus 251 ~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI 265 (700)
T ss_pred CCcccCcchhhhhcc
Confidence 999999988777654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.4e-05 Score=80.40 Aligned_cols=139 Identities=17% Similarity=0.194 Sum_probs=85.2
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCce--eeEEEEEEeCCeeEEEEeecCCCC-
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL--VKLLGCCTQRDERVLVYEYLPNKS- 597 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~E~~~~gs- 597 (834)
.+||+|..+.||+. .+..+++|...... ......+|.+.+..+..-.+ .+.+++....+...+|||++++..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47999999999983 35567888875433 33456889999998865444 667777777777889999999863
Q ss_pred hhhHh---------------------hccCCCCCCCHHhHH-HHHH----------HHHH-HHHHhhhc-CCCceEeccC
Q 003272 598 LDYFI---------------------FDTTRSKVLDWQNRC-HIIG----------GIAR-GLLYLHHD-SRLRIIHRDL 643 (834)
Q Consensus 598 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivH~DL 643 (834)
+...+ |... .......... .+.. .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 0011111110 0000 0011 11122111 2235789999
Q ss_pred CCCceeecCCCCeEEeeeccccc
Q 003272 644 KASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 644 kp~NILl~~~~~~kl~DfGla~~ 666 (834)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.8e-06 Score=91.71 Aligned_cols=141 Identities=17% Similarity=0.231 Sum_probs=90.8
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCccc-------------------------------------HHHHHHHHH
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQG-------------------------------------VEEFKNEAL 563 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 563 (834)
+.||.-+.|.||+|++++|+.||||+.+...... +-.|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5899999999999999999999999986542221 012334444
Q ss_pred HHHhc----cCCce---eeEEEEE-EeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCC
Q 003272 564 LIAKL----QHRNL---VKLLGCC-TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635 (834)
Q Consensus 564 ~l~~l----~H~ni---v~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 635 (834)
-..+. .|-++ |++-.++ .-...+.|+||||++..+.+...- ....++...+.. .+.++ |++..-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~---~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILN---KLVEA--YLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHH---HHHHH--HHHHHHh
Confidence 33333 45551 1222222 224578999999999988766432 123344444333 33333 2222222
Q ss_pred CceEeccCCCCceeecC----CCCeEEeeeccccccC
Q 003272 636 LRIIHRDLKASNVLLDN----EMNPKISDFGMARAFG 668 (834)
Q Consensus 636 ~~ivH~DLkp~NILl~~----~~~~kl~DfGla~~~~ 668 (834)
.+++|+|-+|.||+++. ++.+.+.|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 24999999999999983 6789999999988764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.12 E-value=8.1e-06 Score=74.20 Aligned_cols=86 Identities=23% Similarity=0.364 Sum_probs=59.6
Q ss_pred EEecCCcceEEEecCC-CceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCCeeee
Q 003272 91 MSRRGNGTALVLLNST-NDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGV 169 (834)
Q Consensus 91 l~~~G~~~~lvl~~~~-~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~~l~~ 169 (834)
...||+ +|+.+.. +.+||++|+......+..+.|.++|||||++.+ +.++|+| .|.
T Consensus 26 ~q~dgn---lV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-------g~~vW~S---~t~---------- 82 (114)
T smart00108 26 MQNDYN---LILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-------GRVVWSS---NTT---------- 82 (114)
T ss_pred CCCCEE---EEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-------CCEEEEe---ccc----------
Confidence 345777 8998765 589999997443334467899999999999543 3488987 111
Q ss_pred eeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeC
Q 003272 170 NLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAG 218 (834)
Q Consensus 170 ~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg 218 (834)
...|.+.+.++++|...++-.++ .+.|.+.
T Consensus 83 ------------------~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf 112 (114)
T smart00108 83 ------------------GANGNYVLVLLDDGNLVIYDSDG-NFLWQSF 112 (114)
T ss_pred ------------------CCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence 12456788999999887664433 5678653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.3e-05 Score=75.20 Aligned_cols=137 Identities=18% Similarity=0.169 Sum_probs=91.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHH---------HHHHHHHhccC---CceeeEEEEE-
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFK---------NEALLIAKLQH---RNLVKLLGCC- 580 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~---------~E~~~l~~l~H---~niv~l~g~~- 580 (834)
..+|...+.+-......|.+-.. +|..+++|..+.......+.|+ +++..+.+++. .....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46677777787777777777665 6788999988765544434333 23333333422 2222322222
Q ss_pred ----EeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 581 ----TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 581 ----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
......+++|||+++..|.++.. ++. .++..|.+++.-||+.| ++|+|.+|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 22244679999999988755431 221 35566888899999998 99999999999999655 9
Q ss_pred EEeeeccccc
Q 003272 657 KISDFGMARA 666 (834)
Q Consensus 657 kl~DfGla~~ 666 (834)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.6e-05 Score=77.42 Aligned_cols=105 Identities=26% Similarity=0.259 Sum_probs=83.6
Q ss_pred HHHHHHHHhccC-CceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCc
Q 003272 559 KNEALLIAKLQH-RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637 (834)
Q Consensus 559 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 637 (834)
.+|..+++.+++ +++.+++|+| ..++|.||.+.+++...-....+-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 6999999999 45789999987765322100011224689999999999999999999865556
Q ss_pred eEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 638 IIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 638 ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+...|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.2e-05 Score=74.78 Aligned_cols=154 Identities=18% Similarity=0.203 Sum_probs=98.0
Q ss_pred CHHHHHHHhcCCcccC---ccccCCcccEEEEEEeCCeEEEEEEecccCcc---------cHHH---------------H
Q 003272 506 DWKTIVDATDNFSEEN---KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ---------GVEE---------------F 558 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~---~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~---------~~~~---------------~ 558 (834)
+++.+.....+..+.. .|.+|--+.||+|.-.++..+|||+++..... +..+ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3445555545544433 46678888999998878999999999643211 1111 2
Q ss_pred HHHHHHHHhcc--CCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCC
Q 003272 559 KNEALLIAKLQ--HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636 (834)
Q Consensus 559 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 636 (834)
..|..-|.++. +-.+.+.+++. .-.|||||+.......-.. ..-.+.......+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 23566666653 33444444442 3479999987652211110 0111222356667778888888777633
Q ss_pred ceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 637 ~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
++||+||..-|||+. ++.+.|+||+-|....+
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 399999999999999 88999999998876543
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.1e-05 Score=59.62 Aligned_cols=45 Identities=60% Similarity=0.877 Sum_probs=40.6
Q ss_pred cCCCCCCCCCCCcccccCCCCCCCCCccC--CCCccceeEeeeeccC
Q 003272 790 GERSLPQPKQPGFFTERNLPESESSSSKQ--NLSSTNEISFSMLEAR 834 (834)
Q Consensus 790 ~~~~~~~p~~p~~~~~~~~~~~~~s~~~~--~~~s~~~~~~~~~~~~ 834 (834)
+...+|.|++|+|+..|...+..+|++.+ +..|.|++++|.|++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 35679999999999999988888888777 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.92 E-value=3e-05 Score=70.66 Aligned_cols=84 Identities=18% Similarity=0.279 Sum_probs=59.0
Q ss_pred cCCcceEEEecCC-CceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCCeeeeeec
Q 003272 94 RGNGTALVLLNST-NDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLV 172 (834)
Q Consensus 94 ~G~~~~lvl~~~~-~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~~l~~~~~ 172 (834)
||+ +|+.+.. +.++|++|+.........+.|.++|||||++.+ +.++|||=-.
T Consensus 30 dgn---lv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-------g~~vW~S~~~---------------- 83 (116)
T cd00028 30 DYN---LILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-------GTVVWSSNTT---------------- 83 (116)
T ss_pred eEE---EEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-------CcEEEEeccc----------------
Confidence 677 8888764 589999997433344567889999999999543 3488886321
Q ss_pred cCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 173 TGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 173 tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
.+.+.+.+.++++|+..++-.+ ..+.|.+..
T Consensus 84 ---------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 ---------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 1245688899999987776544 456787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00014 Score=75.95 Aligned_cols=141 Identities=15% Similarity=0.130 Sum_probs=85.0
Q ss_pred ccccCCc-ccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeecCCCChh
Q 003272 522 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYLPNKSLD 599 (834)
Q Consensus 522 ~LG~G~f-g~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 599 (834)
.|-.|.. ..||+... ++..++||+..... ......|++++..+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 78899876 35788888875432 345678998888883 444567777776666789999999998775
Q ss_pred hHh-------------------hccCC-CCCCC--HHhHHHHHH--------------------HHHHHHHHhhh----c
Q 003272 600 YFI-------------------FDTTR-SKVLD--WQNRCHIIG--------------------GIARGLLYLHH----D 633 (834)
Q Consensus 600 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 633 (834)
... +.... ..... ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11000 00110 000000000 01111122211 1
Q ss_pred CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 634 ~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
..+.++|+|+.|.|||++++....|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999987788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.89 E-value=8.4e-05 Score=76.66 Aligned_cols=143 Identities=21% Similarity=0.219 Sum_probs=84.4
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCC--ceeeEEEEEEeC---CeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHR--NLVKLLGCCTQR---DERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~~ 595 (834)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+.... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999866 68999987543 4556788899998888533 345666654332 346899999999
Q ss_pred CChhh----------------Hh---hcc-CCCCCCCHHh---------HHHH------------HHHHHH-HHHHhhh-
Q 003272 596 KSLDY----------------FI---FDT-TRSKVLDWQN---------RCHI------------IGGIAR-GLLYLHH- 632 (834)
Q Consensus 596 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~- 632 (834)
..+.. .+ +.. .......+.. .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 11 111 0111111100 0000 111222 2333332
Q ss_pred ---cCCCceEeccCCCCceeec-CCCCeEEeeeccccc
Q 003272 633 ---DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA 666 (834)
Q Consensus 633 ---~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~ 666 (834)
.....++|+|+.|.|||++ +++.+-|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3e-06 Score=94.61 Aligned_cols=189 Identities=17% Similarity=0.129 Sum_probs=134.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc-eeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN-LVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 591 (834)
.+.-+...+.+++|+.++++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..++..+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 33444555678999999999887544444445554322 44566889999999999 7777777777888999999
Q ss_pred ecCCC-ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 592 YLPNK-SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
++..+ +-..... .....+...+...+.+.-+++++|||+.. =+|+| ||+..+ +..|..||+....+...
T Consensus 315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 2111110 00111333444556667778999999864 48888 777766 67899999998776433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNR 719 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~ 719 (834)
. ......+++.++|||+.....+..+.|+|+.|+-..++--|-+|.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 2 223467899999999999999999999999998777777776663
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00028 Score=70.46 Aligned_cols=129 Identities=16% Similarity=0.230 Sum_probs=91.1
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEEEecccC----------------cccHHHHHHHHHHHHhcc------CCceeeE
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS----------------GQGVEEFKNEALLIAKLQ------HRNLVKL 576 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 576 (834)
....||+|+.-.||. +++.....||+..... ....+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999994 5667778899886554 223466777777666665 8899999
Q ss_pred EEEEEeCCeeEEEEeecCC--C----ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 577 LGCCTQRDERVLVYEYLPN--K----SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 577 ~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
+|+.......-+|+|.+.+ | +|.+++. ...++. ...+.+.+ -..||-+.+ |+.+||+|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998754 2 4666663 233444 33343343 445665555 9999999999999
Q ss_pred cCC--C--CeEEee
Q 003272 651 DNE--M--NPKISD 660 (834)
Q Consensus 651 ~~~--~--~~kl~D 660 (834)
... + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 533 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0006 Score=83.79 Aligned_cols=79 Identities=18% Similarity=0.339 Sum_probs=57.8
Q ss_pred cCccccCCcccEEEEEEeCC---eEEEEEEecccC-cccHHHHHHHHHHHHhcc-CCce--eeEEEEEEeC---CeeEEE
Q 003272 520 ENKLGEGGFGPVYKGMLIEG---QEIAVKRLSKSS-GQGVEEFKNEALLIAKLQ-HRNL--VKLLGCCTQR---DERVLV 589 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 589 (834)
.++|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876553 467778764322 123457889999999995 6665 7778887654 357899
Q ss_pred EeecCCCCh
Q 003272 590 YEYLPNKSL 598 (834)
Q Consensus 590 ~E~~~~gsL 598 (834)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00049 Score=71.35 Aligned_cols=73 Identities=16% Similarity=0.278 Sum_probs=45.6
Q ss_pred CccccCCcc-cEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCC---ceeeEEEEEEeCC---eeEEEEeec
Q 003272 521 NKLGEGGFG-PVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHR---NLVKLLGCCTQRD---ERVLVYEYL 593 (834)
Q Consensus 521 ~~LG~G~fg-~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~E~~ 593 (834)
+.|+.|+.. .||+. +..+++|..+. ......+..|.+.+..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467877776 48864 23577776543 22345788999999887532 2344444333222 347899999
Q ss_pred CCCChh
Q 003272 594 PNKSLD 599 (834)
Q Consensus 594 ~~gsL~ 599 (834)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00097 Score=66.04 Aligned_cols=134 Identities=27% Similarity=0.388 Sum_probs=94.5
Q ss_pred CcCccCHHHHHHHhcCCcccCccccCCc-ccEEEEEEeCCeEEEEEEecc---cC--------c----------ccHHHH
Q 003272 501 ELPIFDWKTIVDATDNFSEENKLGEGGF-GPVYKGMLIEGQEIAVKRLSK---SS--------G----------QGVEEF 558 (834)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~LG~G~f-g~Vy~g~~~~g~~vavK~l~~---~~--------~----------~~~~~~ 558 (834)
.+..|+. .+.+++..+.||.|.- |.|||..+ +|+.+|+|.++. .. . ....-|
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 3445655 2377888899999999 99999998 788999999421 10 0 112357
Q ss_pred HHHHHHHHhcc---CCce--eeEEEEEEeCC------------------eeEEEEeecCCCChhhHhhccCCCCCCCHHh
Q 003272 559 KNEALLIAKLQ---HRNL--VKLLGCCTQRD------------------ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQN 615 (834)
Q Consensus 559 ~~E~~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 615 (834)
..|-+..++|+ +.++ |+.+|+..-.. .+.||.||++... .+.
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~--- 166 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ--- 166 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc---
Confidence 78988888884 4566 89999873321 2356777765532 111
Q ss_pred HHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 616 RCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 616 ~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 167 -~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 -IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 223456777788899887 999999999987 5689999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00066 Score=64.96 Aligned_cols=130 Identities=22% Similarity=0.257 Sum_probs=88.0
Q ss_pred cccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 518 SEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
...+.|++|.+|.||+|.+ .|.++|+|+-+..+ ....+..|++++..++-.++.+=+-++ +.-.+.|||+.+-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence 3456899999999999998 55588999875443 346788999999999876665433222 22345599999878
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCC-CCceeecCCCCeEEeeeccccc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK-ASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk-p~NILl~~~~~~kl~DfGla~~ 666 (834)
|...-... + .+-+..+++.---|...+ |-|+.|. |..++|.++..+.|+||..|..
T Consensus 99 L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 76654211 1 122334555533344444 8898884 5666666666999999998874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0019 Score=69.35 Aligned_cols=79 Identities=16% Similarity=0.145 Sum_probs=57.4
Q ss_pred CcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccC---CceeeEEEEEEeC---CeeEEEE
Q 003272 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH---RNLVKLLGCCTQR---DERVLVY 590 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~ 590 (834)
....+.||.|..+.||+-...++ .+++|..+.. .....|..|+..++.+.- ..+.++++.+... +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456899999999999876555 4666765331 123588999999998843 4678888887543 5689999
Q ss_pred eecCCCCh
Q 003272 591 EYLPNKSL 598 (834)
Q Consensus 591 E~~~~gsL 598 (834)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00068 Score=81.39 Aligned_cols=195 Identities=20% Similarity=0.191 Sum_probs=134.3
Q ss_pred HHHHHHHHhccCCceeeEEEEEEeCCeeE----EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC
Q 003272 559 KNEALLIAKLQHRNLVKLLGCCTQRDERV----LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634 (834)
Q Consensus 559 ~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 634 (834)
.-|...+.++.|+|++.++.+..+....- +..|++..-++...+. ....++....+.+..++.+||+|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34677788889999999999987765443 3346777766666663 3456788889999999999999999985
Q ss_pred CCceEeccCCCC---ceeecCCCCeEEe--eeccccccCCCccccccccccccccccCccccccCCCCc--hhhHHHHHH
Q 003272 635 RLRIIHRDLKAS---NVLLDNEMNPKIS--DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSV--KSDVFSFGV 707 (834)
Q Consensus 635 ~~~ivH~DLkp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~--~sDV~S~Gv 707 (834)
..|.-|..+ +.-.+.++...++ ||+..+.+....... ....+..+.|||......+.. ..|+|.+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 555555554 5555667777777 998887764332221 133455788888887665554 479999999
Q ss_pred HHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 708 LVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 708 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+..+..|..+.... ..+..+++... . . ........|+..+++.|++..+++..
T Consensus 381 l~~~~~~~~~i~~~~------------------~~~~~~l~~~~----~-~---~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS------------------AVPVSLLDVLS----T-S---ELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccc------------------cchhhhhcccc----c-h---hhhhhhhhhcchhhhhccchhhhhhc
Confidence 999999988653211 01111111111 0 0 34566778999999999999999876
Q ss_pred h
Q 003272 788 L 788 (834)
Q Consensus 788 L 788 (834)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0012 Score=59.69 Aligned_cols=100 Identities=26% Similarity=0.436 Sum_probs=63.6
Q ss_pred CEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEee-CCCCCCCCCCceEEEEecCCcceEEEecCCCceEEEee
Q 003272 36 ETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVA-NRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSN 114 (834)
Q Consensus 36 ~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~A-nr~~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~ 114 (834)
+.+.+.+|.|.|-|-.-|+ |-|. . ...+++|.. +...... ..+.+.|..||| |||.|..+.++|+|.
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GN---lvl~d~~~~~lW~Sf 79 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-D--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGN---LVLYDSSGNVLWQSF 79 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-E--TTTEEEEE--S-TTSS--SSEEEEEETTSE---EEEEETTSEEEEEST
T ss_pred cccccccccccceECCCCe-----EEEE-c--CCCCEEEEecccCCccc-cCeEEEEeCCCC---EEEEeecceEEEeec
Confidence 3455555778888876554 4443 2 236779999 4333332 367899999999 999999999999994
Q ss_pred cccccCCCcEEEEec--CCCEEEEecCCCCCCCCCceeeeeccCCc
Q 003272 115 IVSRAAQNPVAVLLE--SGNLVVKEKDGNDNDDPDHFLWQSFDYPS 158 (834)
Q Consensus 115 ~~~~~~~~~~a~Lld--~GNlVl~~~~~~~~~~~~~~lWQSFd~PT 158 (834)
. ....+.+...+ .||++ ...+ ..+.|.|=+.|.
T Consensus 80 ~---~ptdt~L~~q~l~~~~~~-~~~~-------~~~sw~s~~dps 114 (114)
T PF01453_consen 80 D---YPTDTLLPGQKLGDGNVT-GKND-------SLTSWSSNTDPS 114 (114)
T ss_dssp T---SSS-EEEEEET--TSEEE-EEST-------SSEEEESS----
T ss_pred C---CCccEEEeccCcccCCCc-cccc-------eEEeECCCCCCC
Confidence 2 23445566666 89998 5322 248898876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0013 Score=69.11 Aligned_cols=139 Identities=18% Similarity=0.131 Sum_probs=79.9
Q ss_pred ccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEeecCCCChhh
Q 003272 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYEYLPNKSLDY 600 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 600 (834)
.+..|-...+|+... ++..+++|..........-...+|..+++.+....+ .+++... ...+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456788889998874 677888887644322211235778888888864434 3344432 2368999999876532
Q ss_pred H-----------------hhccC-CCCCCCHHhH-HHHHHHH---------HHHHHHhhhc-----CCCceEeccCCCCc
Q 003272 601 F-----------------IFDTT-RSKVLDWQNR-CHIIGGI---------ARGLLYLHHD-----SRLRIIHRDLKASN 647 (834)
Q Consensus 601 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~ivH~DLkp~N 647 (834)
. +|... ....++.... ..+..++ .+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1111222211 1111111 1112222111 12358999999999
Q ss_pred eeecCCCCeEEeeeccccc
Q 003272 648 VLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~ 666 (834)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0017 Score=67.21 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=81.6
Q ss_pred CccccCCcccEEEEEEeC--CeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEeecCCCC
Q 003272 521 NKLGEGGFGPVYKGMLIE--GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
+.|..|-...+|+....+ +..+++|+........ -...+|+.++..+...++ +++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467888888999987654 5788899775432221 233468888888854444 44444332 247999999876
Q ss_pred hhhH-----------------hhccCCC--------CCCC-HHhHHHHHH----------------------HHH---HH
Q 003272 598 LDYF-----------------IFDTTRS--------KVLD-WQNRCHIIG----------------------GIA---RG 626 (834)
Q Consensus 598 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------~ia---~g 626 (834)
+... ++..... .... |..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 1111111 0111 222222211 111 11
Q ss_pred HH-Hhhhc-CCCceEeccCCCCceeecC-CCCeEEeeeccccc
Q 003272 627 LL-YLHHD-SRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA 666 (834)
Q Consensus 627 L~-yLH~~-~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~ 666 (834)
|. .+... .+..++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11 11111 2346999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0027 Score=70.35 Aligned_cols=75 Identities=19% Similarity=0.227 Sum_probs=54.4
Q ss_pred CccccCCcccEEEEEEeCC-eEEEEEEeccc-----C--cccHHHHHHHHHHHHhcc---CCceeeEEEEEEeCCeeEEE
Q 003272 521 NKLGEGGFGPVYKGMLIEG-QEIAVKRLSKS-----S--GQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 589 (834)
+.||.|.+..||+....+| +.|+||.-... . ....+++..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4799999999999998776 58999984311 1 234567788888888762 2456667666 34567899
Q ss_pred EeecCCCC
Q 003272 590 YEYLPNKS 597 (834)
Q Consensus 590 ~E~~~~gs 597 (834)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0024 Score=68.75 Aligned_cols=143 Identities=19% Similarity=0.177 Sum_probs=86.2
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeeEEEE------EEeCCeeEEEEe
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN--LVKLLGC------CTQRDERVLVYE 591 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 591 (834)
.+.|..|....+|+.... +..+++|+... ....+...|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457888888899998764 45788898754 23356677888888875433 4444432 122345689999
Q ss_pred ecCCCChhh----H----------hhccCC--------CCCCCHHhHH----------HHHHHHHHHHHHhhh----cCC
Q 003272 592 YLPNKSLDY----F----------IFDTTR--------SKVLDWQNRC----------HIIGGIARGLLYLHH----DSR 635 (834)
Q Consensus 592 ~~~~gsL~~----~----------l~~~~~--------~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 635 (834)
++++..+.. . ++.... .....|.... .....+..++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0 111000 0112222211 011123334445443 123
Q ss_pred CceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 636 ~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
..++|+|+.|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987788999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0063 Score=65.67 Aligned_cols=141 Identities=24% Similarity=0.331 Sum_probs=83.1
Q ss_pred CccccCCcccEEEEEEeC-------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 592 (834)
+.|..|-...+|+....+ ++.+++|+...... ......+|..++..+...++ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 356667777899887654 47899999755432 22355778888888754333 34555543 2358999
Q ss_pred cCCCChhhH-----------------hhccCCCC------CCC--HHhHHH--------------------------HHH
Q 003272 593 LPNKSLDYF-----------------IFDTTRSK------VLD--WQNRCH--------------------------IIG 621 (834)
Q Consensus 593 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 621 (834)
+++..+... +|...... ..+ |..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766321 11111110 000 111111 111
Q ss_pred HHHHHHHHhhh------cCCCceEeccCCCCceeecCC----CCeEEeeeccccc
Q 003272 622 GIARGLLYLHH------DSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 666 (834)
Q Consensus 622 ~ia~gL~yLH~------~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~ 666 (834)
.+...+..|.. ..+..++|+|+.+.||+++++ +.+.++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 234579999999999999985 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.037 Score=60.18 Aligned_cols=143 Identities=18% Similarity=0.203 Sum_probs=77.3
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeeEEEE------EEeCCeeEEEEe
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN--LVKLLGC------CTQRDERVLVYE 591 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 591 (834)
.+.|+.|....+|+....+| .+++|++... ..+....|+.++..|...+ +.+.+.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677788889999876555 6888987521 2233344555555553222 3333321 122456789999
Q ss_pred ecCCCChhh-----H---------hhccCC--------CCCCCH-HhHHH------------HHHH-HHHHHHHhhhc--
Q 003272 592 YLPNKSLDY-----F---------IFDTTR--------SKVLDW-QNRCH------------IIGG-IARGLLYLHHD-- 633 (834)
Q Consensus 592 ~~~~gsL~~-----~---------l~~~~~--------~~~l~~-~~~~~------------i~~~-ia~gL~yLH~~-- 633 (834)
|+++..+.. . ++.... ...+.| ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 111110 001112 11111 1111 11122232211
Q ss_pred --CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 634 --SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 634 --~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
-+..++|+|++|.||+++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999776568999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.012 Score=62.62 Aligned_cols=76 Identities=21% Similarity=0.268 Sum_probs=49.2
Q ss_pred CcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc---CCceeeEEEEEEeCCeeEEEEeec
Q 003272 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.+..+.++.|....+|+.. .+++.+.||.-. ......|..|++-|+.|. --.+.+++++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678989999999877 578889999875 333457888999888883 455778888887777789999999
Q ss_pred CCC
Q 003272 594 PNK 596 (834)
Q Consensus 594 ~~g 596 (834)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0018 Score=53.52 Aligned_cols=49 Identities=16% Similarity=0.348 Sum_probs=35.0
Q ss_pred EeecCCCccccccchhhhHHHHHHHhccCCceeeeecccccCCCcceeeeccc
Q 003272 359 KTVKVPDTRYAQVDKNIILLECKELCSRNCSCTAYANSDVRGGGSGCLLWFHD 411 (834)
Q Consensus 359 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~c~~~~~~ 411 (834)
+++.++..+.... ...+.++|+..|+.||+|.||.|.. +...|+++...
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 4555555444322 2568899999999999999999974 34678776653
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.024 Score=62.24 Aligned_cols=141 Identities=17% Similarity=0.223 Sum_probs=83.5
Q ss_pred CccccCCcccEEEEEEeC-----CeEEEEEEecccCcccHHHHHHHHHHHHhccCCcee-eEEEEEEeCCeeEEEEeecC
Q 003272 521 NKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV-KLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 594 (834)
+.|-.|-.-.+|+..+.+ ++.+++|+..........+ .+|..++..+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 356567778899987543 3678999886554433333 6788888888654543 455655322 5899998
Q ss_pred CCChhhH-----------------hhccC-C--CCCCCHHhHHHHHHHH-----------------HHHHHHh----hh-
Q 003272 595 NKSLDYF-----------------IFDTT-R--SKVLDWQNRCHIIGGI-----------------ARGLLYL----HH- 632 (834)
Q Consensus 595 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~- 632 (834)
+.++... +|... . .....|..+.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7766421 11111 0 0112233333333221 1111122 21
Q ss_pred cCCCceEeccCCCCceeecC-CCCeEEeeeccccc
Q 003272 633 DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA 666 (834)
Q Consensus 633 ~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~ 666 (834)
..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 46899999988754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.064 Score=58.00 Aligned_cols=144 Identities=22% Similarity=0.231 Sum_probs=82.2
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeeEEEEE------EeCCeeEEEEe
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN--LVKLLGCC------TQRDERVLVYE 591 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 591 (834)
.+.++.|....+|+....+| .+++|+..... ..++...|++++..|...+ +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789998876445 57788775421 2344556677777664222 34444321 12345689999
Q ss_pred ecCCCChhh--------------HhhccCCC---------CCCCHHhHHH------------HHHHHHHHHHHhhh----
Q 003272 592 YLPNKSLDY--------------FIFDTTRS---------KVLDWQNRCH------------IIGGIARGLLYLHH---- 632 (834)
Q Consensus 592 ~~~~gsL~~--------------~l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~---- 632 (834)
|+++..+.. .++..... ....|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865321 01110000 0111221110 11223344555533
Q ss_pred cCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 633 ~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
..+..++|+|+++.||++++++...|.||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2235699999999999999887778999987743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.022 Score=60.51 Aligned_cols=31 Identities=23% Similarity=0.506 Sum_probs=25.9
Q ss_pred CceEeccCCCCceeecCCCC-eEEeeeccccc
Q 003272 636 LRIIHRDLKASNVLLDNEMN-PKISDFGMARA 666 (834)
Q Consensus 636 ~~ivH~DLkp~NILl~~~~~-~kl~DfGla~~ 666 (834)
..++|+|++|.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997565 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.01 Score=62.14 Aligned_cols=145 Identities=17% Similarity=0.191 Sum_probs=92.9
Q ss_pred cCHHHHHHHhcC---CcccCccccCCcccEEEEEEeCCeEEEEEEeccc---------Cc---------c----cHHHHH
Q 003272 505 FDWKTIVDATDN---FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS---------SG---------Q----GVEEFK 559 (834)
Q Consensus 505 ~~~~~~~~~~~~---~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~---------~~---------~----~~~~~~ 559 (834)
++|-.|.....+ +...++||-|--+.||.+...+|++.++|.-+-. .. . ..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 344444433333 5678899999999999999988999998854211 00 0 011234
Q ss_pred HHHHHHHhcc-CC-ceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCc
Q 003272 560 NEALLIAKLQ-HR-NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637 (834)
Q Consensus 560 ~E~~~l~~l~-H~-niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 637 (834)
.|...|+.+. |. -+.+.+++ +.-++|||++.+-.|.... ...+..++..- +..-+--|..++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G--- 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG--- 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC---
Confidence 5788888874 32 23444444 3457899998887664432 12333333333 333334445555
Q ss_pred eEeccCCCCceeecCCCCeEEeeecccc
Q 003272 638 IIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 638 ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
+||+|..--||+++++..++++||--..
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999996443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.052 Score=58.16 Aligned_cols=144 Identities=15% Similarity=0.229 Sum_probs=79.5
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecc--cCcccHHHHHHHHHHHHhccC--CceeeEEEEEEeCC--eeEEEEeecC
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSK--SSGQGVEEFKNEALLIAKLQH--RNLVKLLGCCTQRD--ERVLVYEYLP 594 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~ 594 (834)
+++-.|..-.+|.... .+++++|+ ... ..........+|..+|+.+.- .-+.+.++.|.++. ..+.||++.+
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3443343344454443 27778887 321 223344556677888877643 23344566676665 5699999998
Q ss_pred CCChhhHhhccC-----------------------------------CCCCCCHHhHHHHH--------HHHHHHHHHhh
Q 003272 595 NKSLDYFIFDTT-----------------------------------RSKVLDWQNRCHII--------GGIARGLLYLH 631 (834)
Q Consensus 595 ~gsL~~~l~~~~-----------------------------------~~~~l~~~~~~~i~--------~~ia~gL~yLH 631 (834)
+..+...+.... .++.-.|......+ -....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 843322111000 00011121111100 01112233443
Q ss_pred hc-----CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 632 HD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 632 ~~-----~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+. ++..++|+|+++.|++++.+..+-+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 32 234699999999999999998899999999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.044 Score=58.62 Aligned_cols=142 Identities=19% Similarity=0.183 Sum_probs=93.7
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccC-----c----ccHHH-----------------HHHHHHHHHhccCCce
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS-----G----QGVEE-----------------FKNEALLIAKLQHRNL 573 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~-----~----~~~~~-----------------~~~E~~~l~~l~H~ni 573 (834)
...|..|--+.||.++-.+|..+|||+++.+. . .+..+ ...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34688999999999999899999999986431 0 11111 2236677777754443
Q ss_pred eeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC
Q 003272 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE 653 (834)
Q Consensus 574 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 653 (834)
.-.--... ..-.|||+++.......- ..+...++...+..+-.+++.-|.-|.+.+ ++||.||.--|+|+- +
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 22111111 123689999864322111 112334666677888888888888888777 599999999999985 4
Q ss_pred CCeEEeeeccccccCC
Q 003272 654 MNPKISDFGMARAFGL 669 (834)
Q Consensus 654 ~~~kl~DfGla~~~~~ 669 (834)
|.+.|+|.+-+...+.
T Consensus 301 G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDH 316 (520)
T ss_pred CEEEEEEccccccCCC
Confidence 5899999887765443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.18 Score=55.96 Aligned_cols=73 Identities=14% Similarity=0.112 Sum_probs=49.8
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccC-------cccHHHHHHHHHHHHhcc---CCceeeEEEEEEeCCeeEEE
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS-------GQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 589 (834)
.+.||.|....||+... +++.++||+-.... .....+-..|+..|+.+. ..++.+++.++. +.-+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 45799999999999776 45679999764211 113344455566666553 247777888876 456888
Q ss_pred EeecCC
Q 003272 590 YEYLPN 595 (834)
Q Consensus 590 ~E~~~~ 595 (834)
||+++.
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.11 Score=56.54 Aligned_cols=73 Identities=18% Similarity=0.227 Sum_probs=48.4
Q ss_pred ccccCCcccEEEEEEeCC-eEEEEEEecc-------cCcccHHHHHHHHHHHHhcc--CCc-eeeEEEEEEeCCeeEEEE
Q 003272 522 KLGEGGFGPVYKGMLIEG-QEIAVKRLSK-------SSGQGVEEFKNEALLIAKLQ--HRN-LVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~g-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lV~ 590 (834)
.||.|...-||++..++| +.|+||.-.. .-+...++..-|...|.... -|. +.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999998654 6899996532 11334556667777776652 343 334443 3455667999
Q ss_pred eecCCC
Q 003272 591 EYLPNK 596 (834)
Q Consensus 591 E~~~~g 596 (834)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.098 Score=53.11 Aligned_cols=31 Identities=32% Similarity=0.512 Sum_probs=21.9
Q ss_pred CceEeccCCCCceee-cCCCCeEEeeeccccc
Q 003272 636 LRIIHRDLKASNVLL-DNEMNPKISDFGMARA 666 (834)
Q Consensus 636 ~~ivH~DLkp~NILl-~~~~~~kl~DfGla~~ 666 (834)
..+.|+||.|.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.18 Score=55.06 Aligned_cols=141 Identities=16% Similarity=0.232 Sum_probs=80.6
Q ss_pred CccccCCcccEEEEEEeC----CeEEEEEEecccCcccHHHHHHHHHHHHhccCCcee-eEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV-KLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~ 595 (834)
+.|..|=.-.+|+....+ +..|++|+......... .-.+|..+++.+...++. ++++++. . . +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcC
Confidence 355557777888876543 23788998765443322 236788888888655553 4565552 2 2 48999977
Q ss_pred CChhhH-----------------hhccC-C-CC-CCCHHhHHHHHHHH----------------------HHHHH----H
Q 003272 596 KSLDYF-----------------IFDTT-R-SK-VLDWQNRCHIIGGI----------------------ARGLL----Y 629 (834)
Q Consensus 596 gsL~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~gL~----y 629 (834)
..+..- +|... . .. ..-|..+.++..++ .+-+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 655220 11111 0 01 11233333332221 11111 1
Q ss_pred hhh-cCCCceEeccCCCCceeecC-CCCeEEeeeccccc
Q 003272 630 LHH-DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA 666 (834)
Q Consensus 630 LH~-~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~ 666 (834)
+.. ..+..+.|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12235899999999999975 57899999988754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 834 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-37 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-25 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-140
Identities = 102/304 (33%), Positives = 159/304 (52%), Gaps = 19/304 (6%)
Query: 501 ELPIFDWKTIVDATDNFSEE------NKLGEGGFGPVYKGMLIEGQEIAVKRLSK----S 550
F + + + T+NF E NK+GEGGFG VYKG + +AVK+L+ +
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDIT 69
Query: 551 SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV 610
+ + ++F E ++AK QH NLV+LLG + D+ LVY Y+PN SL + +
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 611 LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670
L W RC I G A G+ +LH + IHRD+K++N+LLD KISDFG+ARA
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730
T+R+VGT YM+PE + G + KSD++SFGV++LEI++G + L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLL 243
Query: 731 LGHAWQLWIQDRP-AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
L ++ +++ + IDK + + + V C+ + RP++ V +L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 790 GERS 793
+
Sbjct: 303 EMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-137
Identities = 120/292 (41%), Positives = 164/292 (56%), Gaps = 5/292 (1%)
Query: 504 IFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVE-EFKNEA 562
F + + A+DNFS +N LG GGFG VYKG L +G +AVKRL + QG E +F+ E
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 563 LLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK-VLDWQNRCHIIG 621
+I+ HRNL++L G C ER+LVY Y+ N S+ + + S+ LDW R I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
G ARGL YLH +IIHRD+KA+N+LLD E + DFG+A+ T T V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 682 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN--RGFYHADHRHNLLGHAWQLWI 739
T G+++PEY G S K+DVF +GV++LE+++G+R D LL L
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791
+ + L+D L + E + IQV LLC Q P +RP M VV ML G+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-116
Identities = 103/295 (34%), Positives = 163/295 (55%), Gaps = 6/295 (2%)
Query: 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALL 564
+ +AT+NF + +G G FG VYKG+L +G ++A+KR + S QG+EEF+ E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV-LDWQNRCHIIGGI 623
++ +H +LV L+G C +R+E +L+Y+Y+ N +L ++ + + + W+ R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GLDQTEANTNRVVGT 682
ARGL YLH + IIHRD+K+ N+LLD PKI+DFG+++ LDQT +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742
GY+ PEY I G + KSDV+SFGV++ E++ + NL A + +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQP 797
+++D +L D + + C+ EDRP+M V+ L L +
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 9e-91
Identities = 66/307 (21%), Positives = 123/307 (40%), Gaps = 28/307 (9%)
Query: 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALL 564
+ + + G FG V+K + + +AVK Q + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 565 IAKLQHRNLVKLLGCCTQRD----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHII 620
+ ++H N+++ +G + + L+ + SL F+ ++ V+ W CHI
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 621 GGIARGLLYLHHD-------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673
+ARGL YLH D + I HRD+K+ NVLL N + I+DFG+A F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 674 ANTNRVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH 728
+T+ VGT YM+PE + ++ D+++ G+++ E+ S ++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 729 NLLGHAWQLWIQDRPAELIDK-----SLYDSCSLSEAIRCI-QVGLLCVQQIPEDRPNML 782
Q + E++ L D + + + C E R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 783 SVVLMLS 789
V ++
Sbjct: 308 CVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-73
Identities = 72/339 (21%), Positives = 127/339 (37%), Gaps = 51/339 (15%)
Query: 500 MELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFK 559
ME + ++ DN +G G +G VYKG L + + +AVK S ++ Q F
Sbjct: 1 MEAAASEP-SL--DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFI 53
Query: 560 NEA--LLIAKLQHRNLVKLLGCCT-----QRDERVLVYEYLPNKSLDYFIFDTTRSKVLD 612
NE + ++H N+ + + R E +LV EY PN SL ++ D
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSD 109
Query: 613 WQNRCHIIGGIARGLLYLHHD------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666
W + C + + RGL YLH + + I HRDL + NVL+ N+ ISDFG++
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 667 F------GLDQTEANTNRVVGTYGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEI 712
+ + VGT YM+PE ++G ++ + D+++ G++ EI
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 713 VSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK--------SLYDSCSLSEAIRCI 764
+ + ++ ++ ++ +
Sbjct: 229 FMRCTDLFPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 765 QVGLL--CVQQIPEDRPNMLSVVLMLSG-ERSLPQPKQP 800
+ C Q E R ++ + K
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-60
Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 13/246 (5%)
Query: 473 KKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVY 532
K H ++ +D N + + D + D + + K+G G FG V+
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGD----DM--DIPWCD-LNIKEKIGAGSFGTVH 54
Query: 533 KGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590
+ G ++AVK L + + V EF E ++ +L+H N+V +G TQ +V
Sbjct: 55 RAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650
EYL SL + + + LD + R + +A+G+ YLH+ I+HR+LK+ N+L+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLV 172
Query: 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 710
D + K+ DFG++R T ++ GT +M+PE D + KSDV+SFGV++
Sbjct: 173 DKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 711 EIVSGK 716
E+ + +
Sbjct: 231 ELATLQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-57
Identities = 73/216 (33%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 516 NFSE---ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS----SGQGVEEFKNEALLIAKL 568
+F+E E +G GGFG VY+ G E+AVK Q +E + EA L A L
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
+H N++ L G C + LV E+ L+ + K + + IARG+
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMN 119
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGLDQTEANTNRVV 680
YLH ++ + IIHRDLK+SN+L+ ++ KI+DFG+AR +T +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSA--A 175
Query: 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
G Y +M+PE +FS SDV+S+GVL+ E+++G+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-56
Identities = 75/321 (23%), Positives = 125/321 (38%), Gaps = 35/321 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
E +G G FG V K +++A+K++ S + F E ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
KL G C LV EY SL + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 635 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
+IHRDLK N+LL KI DFG A D TN G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753
+S K DVFS+G+++ E+++ ++ + + W + RP L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRP------PLIK 227
Query: 754 SC--SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML-SGERSLPQPKQPGFFTERNLPE 810
+ + + C + P RP+M +V ++ R P +P + P
Sbjct: 228 NLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY-----PC 276
Query: 811 SESSSSKQNLSSTNEISFSML 831
S ++ + F+
Sbjct: 277 QHSLPPGEDGRVEPYVDFAEF 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-55
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+G FG K E G+ + +K L + + F E ++ L+H N++K +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+ + EY+ +L I W R IA G+ YLH + I
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR------------VVGTYGYM 686
IHRDL + N L+ N ++DFG+AR ++T+ R VVG +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
+PE + K DVFSFG+++ EI+
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-55
Identities = 74/313 (23%), Positives = 147/313 (46%), Gaps = 51/313 (16%)
Query: 494 GSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG 552
GS + LP I E ++G+GGFG V+KG L++ +A+K L
Sbjct: 5 GSEFPKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 553 QG-------VEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT 605
+G +EF+ E +++ L H N+VKL G +V E++P L + + D
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD- 114
Query: 606 TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-----EMNPKISD 660
++ + W + ++ IA G+ Y+ + I+HRDL++ N+ L + + K++D
Sbjct: 115 -KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 661 FGMARAFGLDQTEANTNRVVGTYGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718
FG+++ Q+ + + ++G + +M+PE A + ++ K+D +SF +++ I++G+
Sbjct: 173 FGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG- 226
Query: 719 RGFYHADHRHNLLGHAWQLWIQD-RPAELIDKSLYDSC--SLSEAIRCIQVGLLCVQQIP 775
+ ++ + + + + RP ++ + C L I LC P
Sbjct: 227 --PF-DEYSYGKIKFINMIREEGLRP------TIPEDCPPRLRNVIE------LCWSGDP 271
Query: 776 EDRPNMLSVVLML 788
+ RP+ +V L
Sbjct: 272 KKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 516 NFSE---ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQH 570
+F + KL E G ++KG +G +I VK L S + +F E + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 571 RNLVKLLGCCTQRDER--VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
N++ +LG C L+ ++P SL + + + V+D +ARG+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMA 125
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
+LH L I L + +V++D +M +IS + +F + + +++P
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAP 177
Query: 689 EYAIDG----LFSVKSDVFSFGVLVLEIVSGK 716
E A+ +D++SF VL+ E+V+ +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-53
Identities = 66/281 (23%), Positives = 129/281 (45%), Gaps = 28/281 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRN 572
+ ++G G FG VYKG ++AVK L+ + + Q ++ FKNE ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
++ +G T + +V ++ SL + + + + I ARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH- 137
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE--- 689
IIHRDLK++N+ L + KI DFG+A ++ G+ +M+PE
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
+S +SDV++FG+++ E+++G+ Y + +N + +L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPDL--S 248
Query: 750 SLYDSC--SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
+ +C + + C+++ ++RP+ ++ +
Sbjct: 249 KVRSNCPKRMKRLMA------ECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-51
Identities = 68/333 (20%), Positives = 124/333 (37%), Gaps = 51/333 (15%)
Query: 489 YSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLS 548
+ SS LP+ +TI ++G+G +G V+ G G+++AVK
Sbjct: 14 LIEQSQSSGSGSGLPLLVQRTI---AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFF 69
Query: 549 KSSGQGVEEFKNEA--LLIAKLQHRNLVKLLGCCTQRDERV----LVYEYLPNKSLDYFI 602
+ E ++H N++ + + L+ +Y N SL ++
Sbjct: 70 T---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126
Query: 603 FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR-----IIHRDLKASNVLLDNEMNPK 657
+S LD ++ + GL +LH + I HRDLK+ N+L+
Sbjct: 127 ----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
Query: 658 ISDFGMARAF--GLDQTEANTNRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVL 708
I+D G+A F ++ + N VGT YM PE +D + +D++SFG++
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLI 241
Query: 709 VLEIVSGKRNRG--------FYHADHRHNLLGHAWQLWIQD--RPAELIDKSLYDSC--S 756
+ E+ + G ++ ++ RP ++ D C
Sbjct: 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP-SFPNRWSSDECLRQ 300
Query: 757 LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+ + + C P R L V L+
Sbjct: 301 MGKLMT------ECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 73/313 (23%), Positives = 121/313 (38%), Gaps = 53/313 (16%)
Query: 516 NFSE---ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQH 570
F + +G+G FG VY G E+A++ + + ++ FK E + + +H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
N+V +G C ++ ++L + D VLD I I +G+ YL
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR---VVGTYGYMS 687
H I+H+DLK+ NV DN I+DFG+ G+ Q ++ G +++
Sbjct: 147 H---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 688 PE---------YAIDGLFSVKSDVFSFGVLVLEIVSGK---RNRGFYHADHRHNLLGHAW 735
PE FS SDVF+ G + E+ + + + + W
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---------IW 253
Query: 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLP 795
Q+ +P L + + I I L C E+RP ++ ML LP
Sbjct: 254 QMGTGMKP-NLSQ------IGMGKEISDIL--LFCWAFEQEERPTFTKLMDML---EKLP 301
Query: 796 Q----PKQPGFFT 804
+ PG F
Sbjct: 302 KRNRRLSHPGHFW 314
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 66/299 (22%), Positives = 118/299 (39%), Gaps = 42/299 (14%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEA--LLIAKLQHRNLVKLL 577
+G+G +G V++G +G+ +AVK S + + + E L+H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 578 GCCT----QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+ L+ Y SL ++ + LD + I+ IA GL +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 634 SRLR-----IIHRDLKASNVLLDNEMNPKISDFGMAR--AFGLDQTEANTNRVVGTYGYM 686
I HRDLK+ N+L+ I+D G+A + +Q + N VGT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 687 SPE------YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG--------FYHADHRHNLLG 732
+PE + D+++FG+++ E+ + G FY
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 733 HAWQLWIQD--RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
++ D RP I + +L+ + ++ C Q P R L + L+
Sbjct: 245 DMRKVVCVDQQRPN--IPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-49
Identities = 71/337 (21%), Positives = 126/337 (37%), Gaps = 47/337 (13%)
Query: 483 DDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEI 542
+ + +S LP+ +TI + +G+G FG V++G G+E+
Sbjct: 13 GTTLKDLIYDMTTSGSGSGLPLLVQRTI---ARTIVLQESIGKGRFGEVWRGKW-RGEEV 68
Query: 543 AVKRLSKSSGQGVEEFKNEA--LLIAKLQHRNLVKLLGCCTQRDERV----LVYEYLPNK 596
AVK S + + EA L+H N++ + + + LV +Y +
Sbjct: 69 AVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 125
Query: 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-----SRLRIIHRDLKASNVLLD 651
SL FD + + + A GL +LH + + I HRDLK+ N+L+
Sbjct: 126 SL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181
Query: 652 NEMNPKISDFGMARAF--GLDQTEANTNRVVGTYGYMSPEYAIDGLFSV-------KSDV 702
I+D G+A D + N VGT YM+PE +D ++ ++D+
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADI 240
Query: 703 FSFGVLVLEIVSGKRNRG--------FYHADHRHNLLGHAWQLWIQD--RPAELIDKSLY 752
++ G++ EI G +Y + ++ + RP I
Sbjct: 241 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN--IPNRWQ 298
Query: 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+L + ++ C R L + LS
Sbjct: 299 SCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 9e-47
Identities = 80/351 (22%), Positives = 131/351 (37%), Gaps = 62/351 (17%)
Query: 468 IVYIWKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGG 527
+ Y H +Y + GS+ E+ + F+ + + +LG+G
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLK-------FLQQLGKGN 53
Query: 528 FGPVYKGMLI-----EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ 582
FG V G+ +AVK+L S+ + + +F+ E ++ LQH N+VK G C
Sbjct: 54 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 583 RDERV--LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
R L+ EYLP SL ++ + +D I +G+ YL R IH
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL---GTKRYIH 168
Query: 641 RDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSPEYAIDGL 695
RDL N+L++NE KI DFG+ + D+ V G + +PE +
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESK 224
Query: 696 FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755
FSV SDV+SFGV++ E+ + A+ +I
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----------------FMRMIGNDKQGQM 267
Query: 756 SLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
+ I ++ C RP+ + L +
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 77/355 (21%), Positives = 120/355 (33%), Gaps = 71/355 (20%)
Query: 476 HRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGM 535
H ++ G+ + + P + + LGEG FG V
Sbjct: 4 HHHHHHHHH---------GALEVLFQGPGDPT--VFHK-RYLKKIRDLGEGHFGKVSLYC 51
Query: 536 LI-----EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV-- 587
G+ +AVK L +G Q +K E ++ L H +++K GCC
Sbjct: 52 YDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111
Query: 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASN 647
LV EY+P SL ++ + I G+ YLH IHRDL A N
Sbjct: 112 LVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARN 164
Query: 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDV 702
VLLDN+ KI DFG+A+A V G + +PE + F SDV
Sbjct: 165 VLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDV 220
Query: 703 FSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIR 762
+SFGV + E+++ H + ++
Sbjct: 221 WSFGVTLYELLT------------------HCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 763 CIQVG-----------------LLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQP 800
++ G C + RP +++ +L Q + P
Sbjct: 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-45
Identities = 73/299 (24%), Positives = 115/299 (38%), Gaps = 55/299 (18%)
Query: 520 ENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+LG+G FG V G+ +AVK+L S+ + + +F+ E ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 575 KLLGCCTQRDERV--LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
K G C R L+ EYLP SL ++ + +D I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMS 687
R IHRDL N+L++NE KI DFG+ + D+ V G + +
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
PE + FSV SDV+SFGV++ E+ + A+ +I
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----------------FMRMI 228
Query: 748 DKSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
+ I ++ C RP+ + L +
Sbjct: 229 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 81/327 (24%), Positives = 129/327 (39%), Gaps = 58/327 (17%)
Query: 520 ENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
++LG+G FG V G +AVK+L S +F+ E ++ L +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 575 KLLGCCTQRDERV--LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
K G + LV EYLP+ L F+ LD I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMS 687
R +HRDL A N+L+++E + KI+DFG+A+ LD+ VV G + +
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746
PE D +FS +SDV+SFGV++ E+ + ++
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSAEFLR 239
Query: 747 IDKSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
+ D +LS + ++ G LC P+DRP+ ++ L
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
Query: 790 GERSLPQPKQPGFFTERNLPESESSSS 816
S + + FT + S S
Sbjct: 300 MLWSGSRGCETHAFTAHPEGKHHSLSF 326
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-44
Identities = 75/324 (23%), Positives = 119/324 (36%), Gaps = 66/324 (20%)
Query: 492 EKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRL-SK 549
+ K++ L ++ ++G G FG V+ G L + +AVK
Sbjct: 101 HRAVPKDKWVLNH----------EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET 150
Query: 550 SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK 609
+F EA ++ + H N+V+L+G CTQ+ +V E + F+ T
Sbjct: 151 LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGA 208
Query: 610 VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669
L + ++G A G+ YL IHRDL A N L+ + KISDFGM+R
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
Query: 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729
A+ + +PE G +S +SDV+SFG+L+ E S
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS--------------- 310
Query: 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLCVQ 772
LG P Y + S + ++ G C
Sbjct: 311 -LG--------ASP--------YPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWA 353
Query: 773 QIPEDRPNMLSVVLMLSGERSLPQ 796
P RP+ ++ L R +
Sbjct: 354 YEPGQRPSFSTIYQELQSIRKRHR 377
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 66/306 (21%), Positives = 119/306 (38%), Gaps = 59/306 (19%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRL-SKSSGQGVEEFKNEALLIAKL 568
LGEG FG V G+++AVK L +S G + + K E ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 569 QHRNLVKLLGCCTQRDERV--LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
H N+VK G CT+ L+ E+LP+ SL ++ ++ + + I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-- 684
+ YL + +HRDL A NVL+++E KI DFG+ +A D+ V
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDS 191
Query: 685 ---YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQ 740
+ +PE + F + SDV+SFGV + E+++ +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD-------------------SSP 232
Query: 741 DRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLS 783
+ + +++ + ++ G C + P +R + +
Sbjct: 233 MALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 784 VVLMLS 789
++
Sbjct: 293 LIEGFE 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 84/336 (25%), Positives = 131/336 (38%), Gaps = 88/336 (26%)
Query: 494 GSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRL 547
G+ + + + IV + +LGEG FG V+ + +AVK L
Sbjct: 1 GAMHSGIHVQHIKRRDIVL-------KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL 53
Query: 548 SKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF------ 601
+ ++F+ EA L+ LQH ++VK G C D ++V+EY+ + L+ F
Sbjct: 54 KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGP 113
Query: 602 -------IFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM 654
L HI IA G++YL + +HRDL N L+ +
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANL 170
Query: 655 NPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLV 709
KI DFGM+R D + R VG + +M PE + F+ +SDV+SFGV++
Sbjct: 171 LVKIGDFGMSR----DVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
Query: 710 LEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG-- 767
EI + G +P + S +E I CI G
Sbjct: 226 WEIFT----------------YGK--------QP--------WFQLSNTEVIECITQGRV 253
Query: 768 ---------------LLCVQQIPEDRPNMLSVVLML 788
L C Q+ P+ R N+ + +L
Sbjct: 254 LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 42/262 (16%)
Query: 477 RNYGKTDDRQELYSN-EKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGM 535
+ + + N + S + + + +LGEG FG V+
Sbjct: 12 TEGKGSGLQGHIIENPQYFSDACVHHIK----------RRDIVLKWELGEGAFGKVFLAE 61
Query: 536 LI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589
+ +AVK L ++S ++F+ EA L+ LQH+++V+ G CT+ ++V
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121
Query: 590 YEYLPNKSLDYF------------IFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
+EY+ + L+ F + L + +A G++YL + L
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLH 178
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSPEYAI 692
+HRDL N L+ + KI DFGM+R D + R VG +M PE +
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESIL 233
Query: 693 DGLFSVKSDVFSFGVLVLEIVS 714
F+ +SDV+SFGV++ EI +
Sbjct: 234 YRKFTTESDVWSFGVVLWEIFT 255
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 3e-43
Identities = 78/290 (26%), Positives = 122/290 (42%), Gaps = 62/290 (21%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
++G G FG V+ G + ++A+K + + E+F EA ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
C ++ LV E++ + L ++ T+ + + + + G+ YL +I
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLF 696
HRDL A N L+ K+SDFGM R DQ ++T GT + SPE +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182
Query: 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756
S KSDV+SFGVL+ E+ S G P Y++ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS----------------EGK--------IP--------YENRS 210
Query: 757 LSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
SE + I G C ++ PEDRP ++ L+
Sbjct: 211 NSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKSSGQGV-EEFKNEALLIAKLQHRNL 573
LG G FG VYKG+ I E +A+K L +++ +E +EA ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+LLG C L+ + +P L ++ + + Q + IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSP 688
R++HRDL A NVL+ + KI+DFG+A+ G ++ E + G +M+
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
E + +++ +SDV+S+GV V E+++ G +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 82/330 (24%), Positives = 136/330 (41%), Gaps = 77/330 (23%)
Query: 521 NKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNL 573
+LG+G FG VY+G+ +A+K +++ +S + EF NEA ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYF-------IFDTTRSKVLDWQNRCHIIGGIARG 626
V+LLG +Q +++ E + L + + + + G IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY- 685
+ YL + + +HRDL A N ++ + KI DFGM R D E + R G G
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 202
Query: 686 ----MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741
MSPE DG+F+ SDV+SFGV++ EI + L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LAE-------- 238
Query: 742 RPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSV 784
+P Y S + +R + G +C Q P+ RP+ L +
Sbjct: 239 QP--------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 785 VLMLSGERSLPQPKQPGFFTERN-LPESES 813
+ + E + +++E N LPE E
Sbjct: 291 ISSIKEEMEPGFREVSFYYSEENKLPEPEE 320
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-43
Identities = 81/311 (26%), Positives = 130/311 (41%), Gaps = 82/311 (26%)
Query: 520 ENKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-SSGQGVEEFKNEALLIAKLQHRN 572
+LGE FG VYKG L + Q +A+K L + G EEF++EA+L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYF-------------IFDTTRSKVLDWQNRCHI 619
+V LLG T+ +++ Y + L F D T L+ + H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 620 IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679
+ IA G+ YL S ++H+DL NVL+ +++N KISD G+ R + A+ ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 680 VGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA 734
+M+PE + G FS+ SD++S+GV++ E+ S G
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGL- 228
Query: 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPED 777
+P Y S + + I+ + C + P
Sbjct: 229 -------QP--------YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSR 273
Query: 778 RPNMLSVVLML 788
RP + L
Sbjct: 274 RPRFKDIHSRL 284
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-43
Identities = 77/290 (26%), Positives = 118/290 (40%), Gaps = 62/290 (21%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+LG G FG V G ++AVK + K +EF EA + KL H LVK G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
C++ +V EY+ N L ++ + K L+ + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLF 696
HRDL A N L+D ++ K+SDFGM R DQ ++ GT + +PE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182
Query: 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756
S KSDV++FG+L+ E+ S LG P YD +
Sbjct: 183 SSKSDVWAFGILMWEVFS----------------LGK--------MP--------YDLYT 210
Query: 757 LSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
SE + + G C ++PE RP ++ +
Sbjct: 211 NSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 520 ENKLGEGGFGPVYKGMLIEG----QEIAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLV 574
+G G FG VY G L++ AVK L++ + V +F E +++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 575 KLLGCCTQRDERVL-VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
LLG C + + L V Y+ + L FI + ++ +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMS 687
+ + +HRDL A N +LD + K++DFG+AR D + V G +M+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS 714
E F+ KSDV+SFGVL+ E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-43
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+G+G FG V G G ++AVK + + + F EA ++ +L+H NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 580 CTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+ + +V EY+ SL ++ + VL + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMSPEYAI 692
+HRDL A NVL+ + K+SDFG+ + + + + +PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187
Query: 693 DGLFSVKSDVFSFGVLVLEIVS 714
+ FS KSDV+SFG+L+ EI S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 498 EEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQE----IAVKRLSK-SSG 552
+++ +P + + +G+G FG VY G I+ + A+K LS+ +
Sbjct: 12 KDVLIP-HERVVTH-------SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 553 QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL-VYEYLPNKSLDYFIFDTTRSKVL 611
Q VE F E LL+ L H N++ L+G + + Y+ + L FI +
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNP 121
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
++ +ARG+ YL + + +HRDL A N +LD K++DFG+AR D
Sbjct: 122 TVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR----DI 174
Query: 672 TEANTNRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ V + + E F+ KSDV+SFGVL+ E+++
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 62/289 (21%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+LG G FG V G ++A+K + K +EF EA ++ L H LV+L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
CT++ ++ EY+ N L ++ Q + + + YL + +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLF 696
HRDL A N L++++ K+SDFG++R D+ ++ G+ + PE + F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198
Query: 697 SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCS 756
S KSD+++FGVL+ EI S LG P Y+ +
Sbjct: 199 SSKSDIWAFGVLMWEIYS----------------LGK--------MP--------YERFT 226
Query: 757 LSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLML 788
SE I G C + ++RP ++ +
Sbjct: 227 NSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 96/378 (25%), Positives = 135/378 (35%), Gaps = 99/378 (26%)
Query: 470 YIWKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSE---------- 519
Y H +Y + GS + E + +T TD
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSI 62
Query: 520 -------------ENKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-SSGQGVEEFK 559
LG G FG VY+G + ++AVK L + S Q +F
Sbjct: 63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 122
Query: 560 NEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI----FDTTRSKVLDWQN 615
EAL+I+K H+N+V+ +G Q R ++ E + L F+ ++ L +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 616 RCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGLDQT 672
H+ IA G YL IHRD+ A N LL KI DFGMAR D
Sbjct: 183 LLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIY 235
Query: 673 EANTNRVVGTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR 727
A R G M PE ++G+F+ K+D +SFGVL+ EI S
Sbjct: 236 RAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------------- 281
Query: 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLC 770
LG+ P Y S S E + + G C
Sbjct: 282 ---LGY--------MP--------YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQC 322
Query: 771 VQQIPEDRPNMLSVVLML 788
Q PEDRPN ++ +
Sbjct: 323 WQHQPEDRPNFAIILERI 340
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 520 ENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
++KLG G +G VY+G+ +AVK L K VEEF EA ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
CT+ ++ E++ +L ++ + + ++ I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN-----RVVGTYGYMSPEYAID 693
IHRDL A N L+ K++DFG++R D A+ + + +PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 694 GLFSVKSDVFSFGVLVLEIVS 714
FS+KSDV++FGVL+ EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-42
Identities = 87/305 (28%), Positives = 122/305 (40%), Gaps = 76/305 (24%)
Query: 520 ENKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-SSGQGVEEFKNEALLIAKLQHRN 572
LG G FG VY+G + ++AVK L + S Q +F EAL+I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFI----FDTTRSKVLDWQNRCHIIGGIARGLL 628
+V+ +G Q R ++ E + L F+ ++ L + H+ IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
YL IHRD+ A N LL KI DFGMAR D A+ R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206
Query: 686 -----MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740
M PE ++G+F+ K+D +SFGVL+ EI S LG+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------------LGY------- 243
Query: 741 DRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLS 783
P Y S S E + + G C Q PEDRPN
Sbjct: 244 -MP--------YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294
Query: 784 VVLML 788
++ +
Sbjct: 295 ILERI 299
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-41
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+G+G FG V G G ++AVK + + + F EA ++ +L+H NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 580 CTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+ + +V EY+ SL ++ R VL + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY--MSPEYAIDGLF 696
+HRDL A NVL+ + K+SDFG+ + EA++ + G +PE + F
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 697 SVKSDVFSFGVLVLEIVS 714
S KSDV+SFG+L+ EI S
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 520 ENKLGEGGFGPVYKGMLI---EGQEI--AVKRLSKSSG-QGVEEFKNEALLIAKLQHRNL 573
LG G FG V+KG+ I E +I +K + SG Q + + L I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V+LLG C LV +YLP SL + L Q + IA+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG-----YMSP 688
++HR+L A NVLL + +++DFG+A D + + +M+
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMAL 186
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVS 714
E G ++ +SDV+S+GV V E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 87/374 (23%), Positives = 146/374 (39%), Gaps = 68/374 (18%)
Query: 468 IVYIWKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGG 527
+ Y H +Y + GS + L F + + + + + +G G
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLK-FTTE--IHPSC-VTRQKVIGAGE 56
Query: 528 FGPVYKGMLIEGQE-----IAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
FG VYKGML +A+K L + + +F EA ++ + H N+++L G +
Sbjct: 57 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116
Query: 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641
+ +++ EY+ N +LD F+ + ++ GIA G+ YL + + +HR
Sbjct: 117 KYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHR 171
Query: 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY--MSPEYAIDGLFSVK 699
DL A N+L+++ + K+SDFG++R D EA G +PE F+
Sbjct: 172 DLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 700 SDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSE 759
SDV+SFG+++ E+++ G RP Y S E
Sbjct: 231 SDVWSFGIVMWEVMT----------------YGE--------RP--------YWELSNHE 258
Query: 760 AIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLSGERSLPQP-KQPG 801
++ I G + C QQ RP +V +L P K
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318
Query: 802 FFTERNLPESESSS 815
F R S+S
Sbjct: 319 DFDPRVSIRLPSTS 332
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 70/298 (23%)
Query: 520 ENKLGEGGFGPVYKGMLI----EGQEIAVKRL-SKSSGQGVEEFKNEALLIAKLQHRNLV 574
E +G G G V G L +A+K L + + + +F +EA ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L G T+ ++V EY+ N SLD F+ T ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMSP 688
L +HRDL A NVL+D+ + K+SDFG++R D A T T G + +P
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
E FS SDV+SFGV++ E+++ G RP
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA----------------YGE--------RP----- 254
Query: 749 KSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
Y + + + I ++ G L C + RP +V +L
Sbjct: 255 ---YWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQE---IAVKRL-SKSSGQGVEEFKNEALLIAKL-QHRNLV 574
++ +GEG FG V K + + A+KR+ +S +F E ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYF-------------IFDTTRSKVLDWQNRCHIIG 621
LLG C R L EY P+ +L F + + L Q H
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN---- 677
+ARG+ YL S+ + IHRDL A N+L+ KI+DFG++R G + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204
Query: 678 -RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
R +M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+LG G FG V+ G ++AVK L K + F EA L+ +LQH+ LV+L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
TQ + ++ EY+ N SL F+ T L + IA G+ ++ I
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLF 696
HRDL+A+N+L+ + ++ KI+DFG+AR ++ A G + +PE G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187
Query: 697 SVKSDVFSFGVLVLEIVS 714
++KSDV+SFG+L+ EIV+
Sbjct: 188 TIKSDVWSFGILLTEIVT 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 37/272 (13%)
Query: 468 IVYIWKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFD-WKTIVDATDNFSEENKLGEG 526
+ Y +K+K + Y E Y + + +LP + W+ +N LG G
Sbjct: 2 VDYKYKQKPK-YQVRWKIIESYEGNSYTFIDPTQLPYNEKWE--FPR-NNLQFGKTLGAG 57
Query: 527 GFGPVYKGML--IEGQE----IAVKRL-SKSSGQGVEEFKNEALLIAKL-QHRNLVKLLG 578
FG V + + ++ +AVK L S + E +E +++ L QH N+V LLG
Sbjct: 58 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG 117
Query: 579 CCTQRDERVLVYEYLPNKSL-----------DYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
CT +++ EY L + + ++ H +A+G+
Sbjct: 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG--- 684
+L + IHRD+ A NVLL N KI DFG+AR D + V
Sbjct: 178 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYI-VKGNARLP 229
Query: 685 --YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D +++V+SDV+S+G+L+ EI S
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-41
Identities = 68/301 (22%), Positives = 126/301 (41%), Gaps = 25/301 (8%)
Query: 429 MAASELGKIERRKQQRKAKQVTIIITSILLATGVILLGAIVYIWKKKHRNYGKTD---DR 485
M+ + R+ V I + G+ + +I + ++ G +
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 486 QELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEG----QE 541
+ + E+ + + +G G FG VY G L++
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSL-IVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 542 IAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL-VYEYLPNKSLD 599
AVK L++ + V +F E +++ H N++ LLG C + + L V Y+ + L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 600 YFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659
FI + + ++ +A+G+ +L + + +HRDL A N +LD + K++
Sbjct: 180 NFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVA 234
Query: 660 DFGMARAFGLDQTEANTNRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 713
DFG+AR D + + V G +M+ E F+ KSDV+SFGVL+ E++
Sbjct: 235 DFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 714 S 714
+
Sbjct: 291 T 291
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-41
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 520 ENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
++KLG G +G VY+G+ +AVK L K VEEF EA ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
CT+ ++ E++ +L ++ + + ++ I+ + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 339
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSV 698
IHR+L A N L+ K++DFG++R D A+ + +PE FS+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398
Query: 699 KSDVFSFGVLVLEIVS 714
KSDV++FGVL+ EI +
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQE-----IAVKRL-SKSSGQGVEEFKNEALLIAKL 568
F + LG G FG VYKG+ I E +A+K L +S + +E +EA ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
+ ++ +LLG C L+ + +P L ++ + + Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG---- 684
YL R++HRDL A NVL+ + KI+DFG+A+ G ++ E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPI 183
Query: 685 -YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+ E + +++ +SDV+S+GV V E+++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 519 EENKLGEGGFGPVYKGML-IEGQEI--AVKRLSK--SSGQGVEEFKNEALLIAKLQHRNL 573
E+ +LG G FG V KG ++ AVK L + +E EA ++ +L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V+++G C + +LV E L+ ++ +++ + +N ++ ++ G+ YL
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL--- 133
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMS 687
+HRDL A NVLL + KISDFG+++A D+ + +
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
PE FS KSDV+SFGVL+ E S G++
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 520 ENKLGEGGFGPVYKGMLI----EGQEIAVKRLSK--SSGQGVEEFKNEALLIAKLQHRNL 573
LGEG FG V +G L ++AVK + SS + +EEF +EA + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 574 VKLLGCCTQRDERV-----LVYEYLPNKSLDYFI---FDTTRSKVLDWQNRCHIIGGIAR 625
++LLG C + + ++ ++ L ++ T K + Q + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG- 684
G+ YL S +HRDL A N +L ++M ++DFG+++ + R G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQ-GRIAK 210
Query: 685 ----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+++ E D +++ KSDV++FGV + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 75/294 (25%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQE----IAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLV 574
+ +G G FG V G L + +A+K L + + +F EA ++ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L G T+ ++V EY+ N SLD F+ ++ GIA G+ YL S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY--MSPEYAI 692
+ +HRDL A N+L+++ + K+SDFG+ R D EA G SPE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752
F+ SDV+S+G+++ E++S G RP Y
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS----------------YGE--------RP--------Y 251
Query: 753 DSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
S + I+ + G L C Q+ +RP +V +L
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 59/308 (19%), Positives = 112/308 (36%), Gaps = 87/308 (28%)
Query: 520 ENKLGEGGFGPVYKGML--------IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHR 571
LG+G F ++KG+ + E+ +K L K+ E F A +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
+LV G C DE +LV E++ SLD ++ ++ + + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL- 129
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGLDQTEANTNRVVGTY 683
+IH ++ A N+LL E + K+SD G++ V+
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKD 175
Query: 684 GY------MSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ 736
+ PE + ++ +D +SFG + EI S G
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS----------------GG---- 215
Query: 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVG---------------LLCVQQIPEDRPNM 781
D+P + ++ + C+ P+ RP+
Sbjct: 216 ----DKP--------LSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSF 263
Query: 782 LSVVLMLS 789
+++ L+
Sbjct: 264 RAIIRDLN 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRL-SKSSGQGVEEFKNEALLI 565
D + LGEG FG V + E +AVK L ++ + + + +E ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 566 AKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSL-DY------------FIFDTTRSKVL 611
+ +H+N++ LLG CTQ ++ EY +L +Y + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
+++ +ARG+ YL + + IHRDL A NVL+ KI+DFG+AR D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 672 TEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ + T G +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 519 EENKLGEGGFGPVYKGMLIEGQE---IAVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLV 574
+ +LG G FG V +G+ ++ +A+K L + + EE EA ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L+G C + +LV E L F+ + + + N ++ ++ G+ YL
Sbjct: 74 RLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMSP 688
+HRDL A NVLL N KISDFG+++A G D + + +P
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAP 182
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVS-GKR 717
E FS +SDV+S+GV + E +S G++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 41/233 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGML--IEGQE----IAVKRL-SKSSGQGVEEFKNEALLIAK 567
N LGEG FG V K ++G+ +AVK L +S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSL---------------------DYFIFDTT 606
+ H +++KL G C+Q +L+ EY SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 607 RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666
+ L + I++G+ YL + ++++HRDL A N+L+ KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 667 FGLDQTEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
D E ++ + G +M+ E D +++ +SDV+SFGVL+ EIV+
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 74/319 (23%), Positives = 120/319 (37%), Gaps = 90/319 (28%)
Query: 520 ENKLGEGGFGPVYKGMLI------EGQEIAVKRL-SKSSGQGVEEFKNEALLIAKLQHRN 572
+GEG FG V++ +AVK L ++S +F+ EA L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYF---------------------IFDTTRSKVL 611
+VKLLG C L++EY+ L+ F + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
+ I +A G+ YL S + +HRDL N L+ M KI+DFG++R +
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 672 TEANTNRVVGTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
A+ + M PE ++ +SDV+++GV++ EI S
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------------ 271
Query: 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LL 769
G +P Y + E I ++ G L
Sbjct: 272 ----YGL--------QP--------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 311
Query: 770 CVQQIPEDRPNMLSVVLML 788
C ++P DRP+ S+ +L
Sbjct: 312 CWSKLPADRPSFCSIHRIL 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 59/206 (28%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 520 ENKLGEGGFGPVYKGML--IEGQEI--AVKRL---SKSSGQGVEEFKNEALLIAKLQHRN 572
KLG+G FG V +G G+ + AVK L S + +++F E + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 573 LVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
L++L G + +V E P SL + +A G+ YL
Sbjct: 83 LIRLYGVVLT--PPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSP 688
R IHRDL A N+LL KI DFG+ RA + + + +P
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVS 714
E FS SD + FGV + E+ +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 520 ENKLGEGGFGPVYKGMLI----EGQEIAVKRLSK--SSGQGVEEFKNEALLIAKLQHRNL 573
LG+G FG V + L ++AVK L + +EEF EA + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 574 VKLLGCCTQRDERV------LVYEYLPNKSLDYFIFD---TTRSKVLDWQNRCHIIGGIA 624
KL+G + + ++ ++ + L F+ L Q + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
G+ YL S IHRDL A N +L +M ++DFG++R + R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCAS 199
Query: 685 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+++ E D L++V SDV++FGV + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-40
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
E KLG G FG V+ + ++AVK + K VE F EA ++ LQH LVKL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
T+ + ++ E++ SL F+ + IA G+ ++ + I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT---YGYMSPEYAIDGLF 696
HRDL+A+N+L+ + KI+DFG+AR ++ A G + +PE G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362
Query: 697 SVKSDVFSFGVLVLEIVS 714
++KSDV+SFG+L++EIV+
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRL-SKSSGQGVEEFKNEALLI 565
D + LGEG FG V + E +AVK L ++ + + + +E ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 566 AKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSL-DY------------FIFDTTRSKVL 611
+ +H+N++ LLG CTQ ++ EY +L +Y + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
+++ +ARG+ YL + + IHRDL A NVL+ KI+DFG+AR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 672 TEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ + T G +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-40
Identities = 64/195 (32%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
E KLG+G FG V+ G +A+K L K E F EA ++ KL+H LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
++ + +V EY+ SL F K L + IA G+ Y+ R+ +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVK 699
HRDL+A+N+L+ + K++DFG+AR ++ A + +PE A+ G F++K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 700 SDVFSFGVLVLEIVS 714
SDV+SFG+L+ E+ +
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 521 NKLGEGGFGPVYKGMLI------EGQEIAVKRL-SKSSGQGVEEFKNEALLIAKL-QHRN 572
LG G FG V + + +AVK L ++ +E ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 573 LVKLLGCCTQRDERVLV-YEYLPNKSL-DY------------FIFDTTRSKVLDWQNRCH 618
+V LLG CT+ ++V E+ +L Y + L ++
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR D +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205
Query: 679 VVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D +++++SDV+SFGVL+ EI S
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-39
Identities = 79/344 (22%), Positives = 138/344 (40%), Gaps = 85/344 (24%)
Query: 520 ENKLGEGGFGPVYKGMLI--------EGQEIAVKRL-SKSSGQGVEEFKNEALLIAKL-Q 569
LGEG FG V I ++AVK L S ++ + + + +E ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSL-DY------------FIFDTTRSKVLDWQNR 616
H+N++ LLG CTQ ++ EY +L +Y + + L ++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676
+ARG+ YL + + IHRDL A NVL+ + KI+DFG+AR D +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 246
Query: 677 NRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731
+ T G +M+PE D +++ +SDV+SFGVL+ EI + L
Sbjct: 247 YK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----------------L 289
Query: 732 GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG-----------------LLCVQQI 774
G S Y + E + ++ G C +
Sbjct: 290 G----------------GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAV 333
Query: 775 PEDRPNMLSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKQ 818
P RP +V L +L ++ G++ + + + +++
Sbjct: 334 PSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 68/298 (22%), Positives = 113/298 (37%), Gaps = 73/298 (24%)
Query: 520 ENKLGEGGFGPVYKGMLI--EGQEI--AVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLV 574
LGEG FG VY+G+ +G++I AVK K + E+F +EA+++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
KL+G + + ++ E P L +++ S L I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYL---E 130
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG------YMSP 688
+ +HRD+ N+L+ + K+ DFG++R + + +MSP
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRLPIKWMSP 183
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
E F+ SDV+ F V + EI+S G +P
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS----------------FGK--------QP----- 214
Query: 749 KSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLS 789
+ + I ++ G C P DRP +V LS
Sbjct: 215 ---FFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-39
Identities = 88/453 (19%), Positives = 154/453 (33%), Gaps = 97/453 (21%)
Query: 395 NSDVRGGGSGCLLWFHDLIDIKVLPEIGQDIYVRMAASELGKIERRKQQRKAKQVTIIIT 454
+G L F+ + I+ +D + G E +T+
Sbjct: 252 YLTDKGANPTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAPE---------PLTVTAP 302
Query: 455 SILLATGVILL----------GAIVYIWKKKHRNYGKTDDRQELYSNEKGS--SKEEMEL 502
S+ +A + L +I + + +L +NEK S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 503 PIFDWKTIVDATDNFSE---------------ENKLGEGGFGPVYKGMLI--EGQEI--A 543
D+ I+D D ++ +GEG FG V++G+ + E + A
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 544 VKRL-SKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI 602
+K + +S E+F EAL + + H ++VKL+G T+ + ++ E L F+
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL 481
Query: 603 FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662
R LD + ++ L YL R +HRD+ A NVL+ + K+ DFG
Sbjct: 482 --QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722
++R + + +M+PE F+ SDV+ FGV + EI+
Sbjct: 537 LSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM-------- 587
Query: 723 HADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVG--------------- 767
G +P + ++ I I+ G
Sbjct: 588 --------HGV--------KP--------FQGVKNNDVIGRIENGERLPMPPNCPPTLYS 623
Query: 768 --LLCVQQIPEDRPNMLSVVLMLSGERSLPQPK 798
C P RP + LS + +
Sbjct: 624 LMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 68/307 (22%), Positives = 112/307 (36%), Gaps = 73/307 (23%)
Query: 520 ENKLGEGGFGPVYKGMLI--EGQEI--AVKRLSK-SSGQGVEEFKNEALLIAKLQHRNLV 574
+GEG FG V++G+ + E + A+K +S E+F EAL + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 575 KLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
KL+G T+ V ++ E L F+ R LD + ++ L YL
Sbjct: 80 KLIGVITE--NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL--- 132
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN-----RVVGTYGYMSP 688
R +HRD+ A NVL+ + K+ DFG++R + + +M+P
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAP 186
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
E F+ SDV+ FGV + EI+ G +P
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM----------------HGV--------KP----- 217
Query: 749 KSLYDSCSLSEAIRCIQVG-----------------LLCVQQIPEDRPNMLSVVLMLSGE 791
+ ++ I I+ G C P RP + LS
Sbjct: 218 ---FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
Query: 792 RSLPQPK 798
+ +
Sbjct: 275 LEEEKAQ 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-39
Identities = 64/195 (32%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
E KLG+G FG V+ G +A+K L K E F EA ++ KL+H LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
++ + +V EY+ SL F K L + IA G+ Y+ R+ +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVK 699
HRDL+A+N+L+ + K++DFG+AR ++ A + +PE A+ G F++K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 700 SDVFSFGVLVLEIVS 714
SDV+SFG+L+ E+ +
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-39
Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 15/227 (6%)
Query: 495 SSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQE---IAVKRL-SKS 550
S + D K + + + +LG G FG V +G+ ++ +A+K L +
Sbjct: 316 ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375
Query: 551 SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV 610
EE EA ++ +L + +V+L+G C + +LV E L F+ + +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREE 432
Query: 611 LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670
+ N ++ ++ G+ YL +HR+L A NVLL N KISDFG+++A G D
Sbjct: 433 IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 671 QTEANTNRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ + +PE FS +SDV+S+GV + E +S
Sbjct: 490 DSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 36/228 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAK 567
+ S LG G FG V + +AVK L S E +E +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 568 L-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF---------------IFDTTRSKVL 611
L H N+V LLG CT +++ EY L F L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 612 DWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671
D ++ +A+G+ +L + IHRDL A N+LL + KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 672 TEANTNRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+ ++N VV +M+PE + +++ +SDV+S+G+ + E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 49/284 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
+F E +G GGFG V+K I+G+ +KR+ ++ E+ + E +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 574 VKLLGCCTQRDERV----------------LVYEYLPNKSLDYFIFDTTRSKVLDWQNRC 617
V GC D + E+ +L+ +I + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677
+ I +G+ Y+H ++I+RDLK SN+ L + KI DFG+ + + +
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 678 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737
R GT YMSPE + + D+++ G+++ E++ A
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFF------ 228
Query: 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
+ + + + + LL + PEDRPN
Sbjct: 229 -------TDLRDGIISDI-FDKKEKTLLQKLLSKK--PEDRPNT 262
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 44/279 (15%)
Query: 470 YIWKKKHRNYGKTDDRQELYS-NEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGF 528
+ +KK+ R + Q S + + + E +D K +N LG G F
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYE-YDLKWEFPR-ENLEFGKVLGSGAF 58
Query: 529 GPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCC 580
G V ++AVK L + E +E ++ +L H N+V LLG C
Sbjct: 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 581 TQRDERVLVYEYLPNKSL-----------DYFIFDTTRSKVLDWQNRCHIIGG------- 622
T L++EY L + K L+ + +++
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 623 --IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
+A+G+ +L +HRDL A NVL+ + KI DFG+AR D + V
Sbjct: 179 YQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYV-V 230
Query: 681 GTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE +G++++KSDV+S+G+L+ EI S
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 63/298 (21%), Positives = 124/298 (41%), Gaps = 33/298 (11%)
Query: 488 LYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVK- 545
++ + SS ++ ++++ + + K+GEG FG +G++ +K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKE 56
Query: 546 -RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD 604
+S+ S + EE + E ++A ++H N+V+ + +V +Y L I +
Sbjct: 57 INISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-N 115
Query: 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+ + I L ++H +I+HRD+K+ N+ L + ++ DFG+A
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
Query: 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724
R A +GT Y+SPE + ++ KSD+++ G ++ E+ + K + A
Sbjct: 173 RVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA---FEA 227
Query: 725 DHRHNLLGHAWQLWIQDRPAELIDKSLYD--SCSLSEAIRCIQVGLLCVQQIPEDRPN 780
NL+ I + S S +R + L P DRP+
Sbjct: 228 GSMKNLV-------------LKIISGSFPPVSLHYSYDLRSLVSQLFKRN--PRDRPS 270
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
++G G F VYKG+ E+A + K + + FK EA ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 579 CCTQRDER----VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+ VLV E + + +L ++ R KV+ + I +GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 635 RLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
IIHRDLK N+ + + KI D G+A + A V+GT +M+PE +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA--VIGTPEFMAPEM-YE 203
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
+ DV++FG+ +LE+ + +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 65/327 (19%), Positives = 115/327 (35%), Gaps = 58/327 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRN 572
+F LG GGFG V++ ++ A+KR+ E+ E +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 573 LVKLLGC---------CTQRDERVLVY---EYLPNKSLDYFIFDTTRSKVLDWQNRCHII 620
+V+ +V +Y + ++L ++ + + HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV- 679
IA + +LH ++HRDLK SN+ + K+ DFG+ A D+ E
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 680 ---------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730
VGT YMSPE +S K D+FS G+++ E++ F R
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236
Query: 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790
L L + ++ + P +RP ++++
Sbjct: 237 LTDVRNLKFPPLFTQ-------KYPCEYVMVQ------DMLSPSPMERPEAINII----- 278
Query: 791 ERSLPQPKQPGFFTERNLPESESSSSK 817
+ F + + P +
Sbjct: 279 -------ENA-VFEDLDFPGKTVLRQR 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 74/313 (23%), Positives = 125/313 (39%), Gaps = 48/313 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRL---SKSSGQGVEEFKNEALLIAKLQH 570
NF E K+G G F VY+ L++G +A+K++ + + E L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK-------VLDW--QNRCHIIG 621
N++K + +E +V E L I + K V + Q
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------- 144
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ L ++H R++HRD+K +NV + K+ D G+ R F T A++ +VG
Sbjct: 145 -LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 198
Query: 682 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741
T YMSPE + ++ KSD++S G L+ E+ + + FY L I+
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLCKK----IEQ 252
Query: 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQPG 801
+ Y S L + + +C+ PE RP++ V K+
Sbjct: 253 CDYPPLPSDHY-SEELRQLVN------MCINPDPEKRPDVTYV---------YDVAKRMH 296
Query: 802 FFTERNLPESESS 814
T +L
Sbjct: 297 ACTASSLEHHHHH 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 33/239 (13%)
Query: 490 SNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS 548
+ S E + + + LG+G +G VY G + IA+K +
Sbjct: 7 EGDCESDLLEYDYEYDENG----------DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP 56
Query: 549 KSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL------DYFI 602
+ + + E L L+H+N+V+ LG ++ + E +P SL +
Sbjct: 57 ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 603 FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDF 661
+ I GL YLH + +I+HRD+K NVL++ KISDF
Sbjct: 117 LKDNEQTI------GFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF 167
Query: 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKR 717
G ++ L T GT YM+PE ID + +D++S G ++E+ +GK
Sbjct: 168 GTSKR--LAGINPCTETFTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHR 571
+++ +G G +G K +G+ + K L + + +E L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 572 NLVKLLGCCTQRDERVL--VYEYLPNKSLDYFIFDTTRSK-------VLDW--QNRCHII 620
N+V+ R L V EY L I T+ + VL Q
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ------ 119
Query: 621 GGIARGLLYLH--HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678
+ L H D ++HRDLK +NV LD + N K+ DFG+AR D + A T
Sbjct: 120 --LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-- 175
Query: 679 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
VGT YMSPE ++ KSD++S G L+ E+ +
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 34/243 (13%)
Query: 514 TDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN 572
+F E LG+G FG V K ++ + A+K++ + + + +E +L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFI---------FD--TTRSKVLDWQNRCHIIG 621
+V+ +R V + KS + +D + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF------------GL 669
I L Y+H IIHRDLK N+ +D N KI DFG+A+ L
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 670 DQTEANTNRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH 728
+ N +GT Y++ E G ++ K D++S G++ E++ F R
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGMERV 235
Query: 729 NLL 731
N+L
Sbjct: 236 NIL 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNL 573
+S ++G GG V++ + + Q A+K ++ Q ++ ++NE + KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 574 --VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
++L +V E N L+ ++ + K +D R + + +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-- 689
+ I+H DLK +N L+ + K+ DFG+A D T + VGT YM PE
Sbjct: 145 ---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 690 ---------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
S KSDV+S G ++ + GK
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNL--VKL 576
++G GG V++ + + Q A+K ++ Q ++ ++NE + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 577 LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+V E N L+ ++ + K +D R + + +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE------- 689
I+H DLK +N L+ + K+ DFG+A D T + VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 690 ----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
S KSDV+S G ++ + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KSSGQGVEEFKNEALLIAKLQHRNLVKLL 577
KLG GG VY I ++A+K + + + ++ F+ E ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
+ D LV EY+ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
I+HRD+K N+L+D+ KI DFG+A+A + + TN V+GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 698 VKSDVFSFGVLVLEIVSGKR 717
+D++S G+++ E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 29/252 (11%)
Query: 473 KKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVY 532
K R +T+D + + EK + W + + ++G G FG V+
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHW---------MTHQPRVGRGSFGEVH 75
Query: 533 KGMLIE-GQEIAVKRLSKSSGQGVEEFK-NEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590
+ + G + AVK++ +E F+ E + A L +V L G + +
Sbjct: 76 RMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650
E L SL I + L + +G GL YLH RI+H D+KA NVLL
Sbjct: 130 ELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLL 183
Query: 651 DNEMNP-KISDFGMAR---AFGLDQTEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSF 705
++ + + DFG A GL ++ + + GT +M+PE + G K D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSS 242
Query: 706 GVLVLEIVSGKR 717
++L +++G
Sbjct: 243 CCMMLHMLNGCH 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-34
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNL 573
+S ++G GG V++ + + Q A+K ++ Q ++ ++NE + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 574 --VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
++L +V E N L+ ++ + K +D R + + +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-- 689
+ I+H DLK +N L+ + K+ DFG+A D T + VG YM PE
Sbjct: 173 ---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 690 ---------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
S KSDV+S G ++ + GK
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 36/302 (11%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
++ KLGEGGF V L +G A+KR+ Q EE + EA + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 575 KLLGCCTQRDERV----LVYEYLPNKSLDYFIFDTTRSKV-LDWQNRCHIIGGIARGLLY 629
+L+ C + L+ + +L I L ++ GI RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV-------GT 682
+H HRDLK +N+LL +E P + D G + + + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 683 YGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738
Y +PE + ++DV+S G ++ ++ G+ G + L
Sbjct: 207 ISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKGDSVALA 259
Query: 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPK 798
+Q++ S+ S S A+ + ++ V P RP++ ++ L + P P
Sbjct: 260 VQNQ------LSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEALQP-PAPG 310
Query: 799 QP 800
Q
Sbjct: 311 QH 312
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 62/247 (25%), Positives = 109/247 (44%), Gaps = 15/247 (6%)
Query: 474 KKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATD---NFSEENKLGEGGFGP 530
H + D E + G E + +VD D K+GEG G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAAL--RMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 531 VYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589
V G+++AVK + Q E NE +++ QH N+V++ +E ++
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649
E+L +L D L+ + + + + L YLH +IHRD+K+ ++L
Sbjct: 121 MEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173
Query: 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 709
L + K+SDFG + + +VGT +M+PE L++ + D++S G++V
Sbjct: 174 LTLDGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 710 LEIVSGK 716
+E+V G+
Sbjct: 232 IEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 13/213 (6%)
Query: 508 KTIVDATD---NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL 563
++IV D ++ K+G+G G VY M + GQE+A+++++ E NE L
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
++ + ++ N+V L DE +V EYL SL D +D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCREC 125
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
+ L +LH + ++IHRD+K+ N+LL + + K++DFG + ++ + +VGT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTP 180
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+M+PE + K D++S G++ +E++ G+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 68/310 (21%), Positives = 125/310 (40%), Gaps = 25/310 (8%)
Query: 480 GKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE- 538
GK + EL ++ + + K D+F + ++LG G G V+K
Sbjct: 1 GKKLEELELDEQQRKRLEAFL---TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPS 57
Query: 539 GQEIAVKRLSKSSGQGV-EEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597
G +A K + + + E ++ + +V G E + E++ S
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657
LD + ++ + Q + + +GL YL + +I+HRD+K SN+L+++ K
Sbjct: 118 LDQVL---KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIK 172
Query: 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK- 716
+ DFG++ L + AN+ VGT YMSPE +SV+SD++S G+ ++E+ G+
Sbjct: 173 LCDFGVSG--QLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 717 ----RNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQ 772
+ + G A + + R AI + +
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL------LD 282
Query: 773 QIPEDRPNML 782
I + P L
Sbjct: 283 YIVNEPPPKL 292
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 50/220 (22%), Positives = 79/220 (35%), Gaps = 16/220 (7%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKL-QH 570
+F ++LG G +G V+K +G+ AVKR + E K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
V+L + L E SL L + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H ++H D+K +N+ L K+ DFG+ G G YM+PE
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE- 226
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730
+ G + +DVFS G+ +LE+ + + L
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQL 264
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KSSGQGVEEFKNEALLIAKLQ 569
D + F++ K+G+G FG V+KG+ + +A+K + + + +E+ + E ++++
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
+ K G + + ++ EYL S D LD I+ I +GL Y
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDY 134
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH + + IHRD+KA+NVLL K++DFG+A L T+ N VGT +M+PE
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 189
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ K+D++S G+ +E+ G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKSSGQG-VEEFKNEALLIAKLQHRNLVKLL 577
LG GG V+ L + +++AVK R + F+ EA A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 578 --GCCTQRDERV--LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
G + +V EY+ +L + + + +I + L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD-QTEANTNRVVGTYGYMSPEYAI 692
+ IIHRD+K +N+++ K+ DFG+ARA + T V+GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKR 717
+SDV+S G ++ E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ 569
+D + + +LG+G FG VYK E G A K + S + +E++ E ++A
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 74
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H +VKLLG + ++ E+ P ++D + + L + + L +
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNF 132
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH RIIHRDLKA NVL+ E + +++DFG++ +T + +GT +M+PE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPE 187
Query: 690 -----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
D + K+D++S G+ ++E+ +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-31
Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 24/204 (11%)
Query: 522 KLGEGGFGPVYKG--MLIEGQEIAVKRLSKSSGQG-VEEFKNEALLIAKLQHRNLVKLL- 577
+ GG G +Y + G+ + +K L S E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 578 -GCCTQRDERVLVY---EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
T R + Y EY+ +SL ++ + L + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
+ +++ DLK N++L E K+ D G ++ + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSF----GYLYGTPGFQAPEIV-R 250
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKR 717
+V +D+++ G + +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 10/206 (4%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
+ F KLGEG +G VYK + E GQ +A+K++ ++E E ++ +
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDS 83
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
++VK G + + +V EY S+ I R+K L I+ +GL YL
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H R IHRD+KA N+LL+ E + K++DFG+A L T A N V+GT +M+PE
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEV 196
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ ++ +D++S G+ +E+ GK
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 45/205 (21%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 520 ENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQG---VEEFKNEALLIAKLQHRNLVK 575
+G GG G VY+ + + +A+K +S++ + EA +LQ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 576 L--LGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+ G + D ++ + + L + R L I+ I L H
Sbjct: 99 IHDFG---EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH- 151
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
HRD+K N+L+ + + DFG+A A D+ VGT YM+PE
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFS 208
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKR 717
+ + ++D+++ ++ E ++G
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSP 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 60/293 (20%), Positives = 103/293 (35%), Gaps = 55/293 (18%)
Query: 514 TDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKR--LSKSSGQGVEEFKNEALLIAKL-Q 569
T F E K+G G FG V+K + ++G A+KR + + E A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRS-KVLDWQNRCHIIGGIARGLL 628
H ++V+ + D ++ EY SL I + R ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFGL 669
Y+H ++H D+K SN+ + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 670 DQTEANTNRVVGTYGYMSPEYAIDGLFS--VKSDVFSFGVLVLEIVSGKRNRGFYHADHR 727
Q E G +++ E + ++ K+D+F+ + V+ +
Sbjct: 187 PQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE---------PL 230
Query: 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
G W Q R + S +E ++ + + PE RP+
Sbjct: 231 PR-NGDQWHEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRPS 273
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 38/228 (16%), Positives = 66/228 (28%), Gaps = 22/228 (9%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGM------LIEGQEIAVKRLSKSSGQGVEEFKNE 561
+ + LGEG F VY+ Q+ +K ++
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 562 ALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI--FDTTRSKVLDWQNRCHI 619
+ +K ++ VLV E +L I + T KV+
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 620 IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-----------KISDFGMARAFG 668
+ + +H IIH D+K N +L N + D G +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
L T G+ E + ++ + D F V ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRN 572
+ + LG+G V++G + G A+K + S + V+ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 573 LVKLLGCCTQRDER--VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
+VKL + R VL+ E+ P SL + + + + L ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 631 HHDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
I+HR++K N++ D + K++DFG AR D + + + GT Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 687 SPE--------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
P+ + D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFK---NE-AL 563
++ D+ +LG G +G V K + GQ +AVKR+ + +E K + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC--HIIG 621
+ + V G + + + E + + SLD F +V+D I+G
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILG 112
Query: 622 GIAR----GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677
IA L +LH S+L +IHRD+K SNVL++ K+ DFG++ L A +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAK-D 167
Query: 678 RVVGTYGYMSPE----YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH--NLL 731
G YM+PE +SVKSD++S G+ ++E+ + F + L
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGTPFQQL 223
Query: 732 GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
+ + P+ + + S + C+++ ++RP
Sbjct: 224 KQ-----VVEEPSPQLPADKF-SAEFVDFTSQ------CLKKNSKERPT 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 19/210 (9%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNE-ALLIAKLQHRNLV 574
+F ++ LG G G + + + +++AVKR+ E LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+ R + + E +Y + ++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 635 RLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAFGLDQTE-ANTNRVVGTYGYMSP 688
L I+HRDLK N+L+ ++ ISDFG+ + + + + + V GT G+++P
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 689 EY---AIDGLFSVKSDVFSFGVLVLEIVSG 715
E + D+FS G + ++S
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-QGVEEFKNE-ALLIAKLQHR 571
++ + ++G G +G V K + GQ +AVKR+ + + ++ + +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC---HIIGGIAR--- 625
+V+ G + + + E + + S D F V + I+G I
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY-----KYVYSVLDDVIPEEILGKITLATV 135
Query: 626 -GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
L +L + L+IIHRD+K SN+LLD N K+ DFG++ L + A T G
Sbjct: 136 KALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTR-DAGCRP 190
Query: 685 YMSPE----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
YM+PE A + V+SDV+S G+ + E+ +G+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 60/292 (20%), Positives = 115/292 (39%), Gaps = 34/292 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRN 572
+ + LG+G V++G + G A+K + S + V+ E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 573 LVKLLGC--CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
+VKL T +VL+ E+ P SL + + + + L ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 631 HHDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
I+HR++K N++ D + K++DFG AR D + + + GT Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 687 SPE--------YAIDGLFSVKSDVFSFGVLVLEIVSG----------KRNRGFYHADHRH 728
P+ + D++S GV +G +RN+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 729 NLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLL--CVQQIPEDR 778
G + + + SCSLS ++ + +L ++ E
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 74/334 (22%), Positives = 115/334 (34%), Gaps = 39/334 (11%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEE-FKNEALLIAKLQHR 571
+ + +LG GGFG V + + + G+++A+K+ + E + E ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 572 NLVKLL------GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
N+V D +L EY L ++ L ++ I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
L YLH RIIHRDLK N++L + KI D G A+ VGT
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGT 186
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR------NRGFYHADHRHNLLGHAWQ 736
Y++PE ++V D +SFG L E ++G R +H R H
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCV--QQIPEDRPNMLSVVLMLSGERSL 794
+ L LS + L R +
Sbjct: 247 YDDLTGAVKFSSV-LPTPNHLSGILAGKLERWLQCMLMWHQRQRG-------------TD 292
Query: 795 PQPKQPGFFTERNLPESESSSSKQNLSSTNEISF 828
PQ G F + S S N+ S ++
Sbjct: 293 PQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTY 326
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 66/344 (19%), Positives = 115/344 (33%), Gaps = 61/344 (17%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIA 566
+T+ L EGGF VY+ + G+E A+KRL + + E +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 567 KLQ-HRNLVKLLGCCTQRDER-------VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCH 618
KL H N+V+ + E L+ L L F+ L
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678
I R + ++H + IIHRDLK N+LL N+ K+ DFG A + + +
Sbjct: 141 IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 679 ----------VVGTYGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEIVSGKRNRG 720
T Y +PE + + K D+++ G ++ + +
Sbjct: 200 RRALVEEEITRNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ---- 250
Query: 721 FYHADHRHNLLGHAWQLWIQDRPAELIDKSLY---DSCSLSEAIRCIQVGLLCVQQIPED 777
H L I Y + + +L V PE+
Sbjct: 251 --HPFEDGAKLR--------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEE 292
Query: 778 RPNMLSV---VLMLSGERSLPQPKQPGFFTERNLPESESSSSKQ 818
R ++ V + ++ R++ E+N ++ S+
Sbjct: 293 RLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG---VEEFKNEALLIAKLQHRNLVKLLG 578
LG+GGF ++ + + A K + KS E+ E + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
D +V E +SL + R + + + R + + I G YLH R
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 160
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF 696
R+IHRDLK N+ L+ ++ KI DFG+A D + GT Y++PE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218
Query: 697 SVKSDVFSFGVLVLEIVSGK 716
S + DV+S G ++ ++ GK
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 71/236 (30%), Positives = 106/236 (44%), Gaps = 22/236 (9%)
Query: 495 SSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ 553
S L D + D F +G G +G VYKG ++ GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 554 GVEEFKNEALLIAKL-QHRNLVKLLGC------CTQRDERVLVYEYLPNKSL-DYFIFDT 605
EE K E ++ K HRN+ G D+ LV E+ S+ D +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKN 120
Query: 606 TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665
T+ L + +I I RGL +LH ++IHRD+K NVLL K+ DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 666 AFGLDQTEANTNRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
LD+T N +GT +M+PE D + KSD++S G+ +E+ G
Sbjct: 178 --QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG---VEEFKNEALLIAKLQHRNLVKLLG 578
LG+GGF ++ + + A K + KS E+ E + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
D +V E +SL + R K L + + I G YLH R R
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
+IHRDLK N+ L+ ++ KI DFG+A D + GT Y++PE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 698 VKSDVFSFGVLVLEIVSGK 716
+ DV+S G ++ ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 34/296 (11%)
Query: 495 SSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQ 553
S K+ L I + + D ++G G G V+K + G IAVK++ +S +
Sbjct: 6 SGKQTGYLTIGGQRYQAEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 554 GVEEFKN---E-ALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK 609
EE K + +++ +V+ G + + E + +
Sbjct: 65 --EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQG 119
Query: 610 VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669
+ + + I + L YL + +IHRD+K SN+LLD K+ DFG++ L
Sbjct: 120 PIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG--RL 175
Query: 670 DQTEANTNRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724
+A G YM+PE + +++DV+S G+ ++E+ +G+
Sbjct: 176 VDDKAKDR-SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
Query: 725 DHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780
D +L + L+ + S ++ C+ + RP
Sbjct: 235 DFE--VLTK-----VLQEEPPLLPGHMGFSGDFQSFVKD------CLTKDHRKRPK 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEE-FKNEALLIAKLQHRNLVKLLG 578
LG+G F VY+ I G E+A+K + K + G+ + +NE + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 579 CCTQRDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+ LV E N + R K H + I G+LYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR---VVGTYGYMSPEYAID 693
I+HRDL SN+LL MN KI+DFG+A Q + + + GT Y+SPE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 694 GLFSVKSDVFSFGVLVLEIVSGK 716
++SDV+S G + ++ G+
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGR 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 21/234 (8%)
Query: 490 SNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS 548
+ + S ++ ++ + D FS+ ++G G FG VY + + +A+K++S
Sbjct: 31 AGGRAGSLKDPDVA--ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 549 ---KSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT 605
K S + ++ E + KL+H N ++ GC + LV EY + D
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLE 145
Query: 606 TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665
K L + G +GL YLH +IHRD+KA N+LL K+ DFG A
Sbjct: 146 VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 202
Query: 666 AFGLDQTEANTNRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
AN+ VGT +M+PE +G + K DV+S G+ +E+ K
Sbjct: 203 IM----APANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 32/188 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKN--------EALLIA 566
+ + + K+GEG +G VYK +G+ +A+KR+ ++ E L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPN---KSLDYF--IFDTTRSKVLDWQNRCHIIG 621
+L H N+V L+ LV+E++ K LD ++ K+ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ RG+ + H RI+HRDLK N+L++++ K++DFG+ARAFG + T+ VV
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV- 181
Query: 682 TYGYMSPE 689
T Y +P+
Sbjct: 182 TLWYRAPD 189
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 56/228 (24%), Positives = 85/228 (37%), Gaps = 34/228 (14%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNE-ALLIAKLQHRNL 573
+ E LG G G V +G+ +AVKR+ + E LL H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFI----FDTTRSKVLDWQNRCHIIGGIARGLLY 629
++ T + E N +L + K+ N ++ IA G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNP-------------KISDFGMARAFGLDQT--EA 674
LH L+IIHRDLK N+L+ ISDFG+ + Q+
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 675 NTNRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIVSG 715
N N GT G+ +PE + D+FS G + I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 34/190 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN--------EALLI 565
+NF + K+GEG +G VYK G+ +A+K++ ++ E L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPN------KSLDYFIFDTTRSKVLDWQNRCHI 619
+L H N+VKLL ++ LV+E+L + K +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 620 IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRV 679
+ +GL + H R++HRDLK N+L++ E K++DFG+ARAFG T+ V
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEV 164
Query: 680 VGTYGYMSPE 689
V T Y +PE
Sbjct: 165 V-TLWYRAPE 173
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 29/298 (9%), Positives = 63/298 (21%), Gaps = 51/298 (17%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
L G V+ +E ++ A+K + S +E A+L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 579 CC--------------------------TQRDERVLVYEYLP---NKSLDYFIFDTTRSK 609
+L+ F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 610 VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669
+ + R L ++H N+ + + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245
Query: 670 DQTEANTNRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR 727
Y E+ A F+ + + G+ + + F
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785
L + + L + ++ + L R L +
Sbjct: 300 IKGSWKRPSLRVPGTD----SLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAM 351
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN--------EALLI 565
+ + K+GEG +G V+K E + +A+KR+ +++ E L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPN---KSLD--YFIFDTTRSKVLDWQNRCHII 620
+L+H+N+V+L + LV+E+ K D D K +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
+ +GL + H ++HRDLK N+L++ K+++FG+ARAFG + VV
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV 163
Query: 681 GTYGYMSPE 689
T Y P+
Sbjct: 164 -TLWYRPPD 171
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 39/302 (12%), Positives = 79/302 (26%), Gaps = 64/302 (21%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH-------- 570
LG+ + G+ V + +++ K E L + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 571 --------RNLVKLLGCCTQRD-----------ERVLVYEYLPNKSLDYF--IFDTTR-S 608
+LVK R +Y + + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 609 KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668
K L R + + R L LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 669 LDQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYH 723
+ R + L + D ++ G+ + I
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319
Query: 724 ADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783
D + ++ + +R + G L EDR L
Sbjct: 320 -----------------DAALGGSEWIFRSCKNIPQPVRALLEGFLRYP--KEDRLLPLQ 360
Query: 784 VV 785
+
Sbjct: 361 AM 362
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 33/195 (16%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGV-----EEFKNEALL 564
+ ++ F + KLG G + VYKG+ G +A+K + S +G E L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----L 56
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYL----------PNKSLDYFIFDTTRSKVLDWQ 614
+ +L+H N+V+L ++ LV+E++ + K WQ
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 615 NRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674
+ +GL + H + +I+HRDLK N+L++ K+ DFG+ARAFG
Sbjct: 117 --------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNT 164
Query: 675 NTNRVVGTYGYMSPE 689
++ VV T Y +P+
Sbjct: 165 FSSEVV-TLWYRAPD 178
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKN--------EALLIA 566
+ + K+GEG +G VYK G+ A+K++ +E+ E ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPN---KSLDY--FIFDTTRSKVLDWQNRCHIIG 621
+L+H N+VKL + VLV+E+L K LD ++ +K Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ G+ Y H R++HRDLK N+L++ E KI+DFG+ARAFG T+ +V
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV- 162
Query: 682 TYGYMSPE 689
T Y +P+
Sbjct: 163 TLWYRAPD 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGV-----EEFKNEALLIAKL 568
+ + + +KLGEG + VYKG +A+K + +G E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPN---KSLDY--FIFDTTRSKVLDWQNRCHIIGGI 623
+H N+V L LV+EYL + LD I + K+ +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
RGL Y H +++HRDLK N+L++ K++DFG+ARA T+ N VV T
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TL 164
Query: 684 GYMSPE 689
Y P+
Sbjct: 165 WYRPPD 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 18/183 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEE-FKNEAL----LIAKL 568
+ + + LGEG F VYK Q +A+K++ ++ AL L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPN--KSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
H N++ LL + LV++++ + + + + + +G
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIKA-YMLMTLQG 124
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L YLH I+HRDLK +N+LLD K++DFG+A++FG A T++VV T Y
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYR 179
Query: 687 SPE 689
+PE
Sbjct: 180 APE 182
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-27
Identities = 42/218 (19%), Positives = 80/218 (36%), Gaps = 18/218 (8%)
Query: 512 DATDNFSEENKLGEG--GFGPVYKGMLIE-GQEIAVKR--LSKSSGQGVEEFKNEALLIA 566
+ +G+G V G+ + V+R L S + V + E +
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK 81
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIAR 625
H N+V +E +V ++ S D + T ++ +I+ G+ +
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLK 139
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT-----NRVV 680
L Y+HH +HR +KAS++L+ + +S + V
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 681 GTYGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
++SPE + KSD++S G+ E+ +G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
++F LG+G FG VY + +A+K L K+ + + E + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLL 628
N+++L G RV L+ EY P ++ + + D Q I +A L
Sbjct: 69 PNILRLYGYF-HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALS 123
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR---VVGTYGY 685
Y H R+IHRD+K N+LL + KI+DFG + A ++R + GT Y
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 173
Query: 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ PE + K D++S GVL E + GK
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KSSGQGVEEFKNEALLIAKLQHRN 572
D++ + +G G V +++A+KR++ + ++E E +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSL-----DYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
+V +DE LV + L S+ +S VLD I+ + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA---RAFGLDQTEANTNRVVGTYG 684
YLH + IHRD+KA N+LL + + +I+DFG++ G VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 685 YMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+M+PE Y K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGY------DFKADIWSFGITAIELATGA 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 18/235 (7%)
Query: 490 SNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS 548
N + +F ++ + KLG G +G V E A+K +
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71
Query: 549 KS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTT 606
K+ S + E ++ L H N++KL + LV E L FD
Sbjct: 72 KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEI 127
Query: 607 RSK-VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFG 662
+ + + II + G+ YLH I+HRDLK N+LL++ + KI DFG
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
++ F + +GT Y++PE + + K DV+S GV++ +++G
Sbjct: 185 LSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 34/217 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL----LIAKLQ 569
+ + +GEG +G V K + G+ +A+K+ +S + K A+ L+ +L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF-----IFDTTRSKVLDWQNRCHIIGGIA 624
H NLV LL C ++ LV+E++ + LD D + +Q I
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ--------II 134
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
G+ + H IIHRD+K N+L+ K+ DFG AR E + V T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRW 189
Query: 685 YMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
Y +PE L DV++ G LV E+ G+
Sbjct: 190 YRAPEL----LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 40/308 (12%), Positives = 85/308 (27%), Gaps = 75/308 (24%)
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQ--------- 569
LG+ + E G+ V + +++ K E L + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 570 ----------------HRNLVKLLGCCTQRD--ERVLVYEYLPNKSLDYF--IFDTTR-S 608
+ ++++ R +Y + + + + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 609 KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668
K L R + + R L LHH ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 669 LDQTEANTNRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVSGKR 717
+ G+ PE L + D ++ G+++ I
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 718 NRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED 777
D + ++ + +R + G L ED
Sbjct: 312 P--ITK-----------------DAALGGSEWIFRSCKNIPQPVRALLEGFLRYP--KED 350
Query: 778 RPNMLSVV 785
R L +
Sbjct: 351 RLLPLQAM 358
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 13/202 (6%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG-VEEFKNEALLIAKLQ 569
D F + KLG G FG V+ G E +K ++K Q +E+ + E ++ L
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
H N++K+ +V E L + + R K L ++ + L
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 629 YLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
Y H ++H+DLK N+L + KI DFG+A F D+ + GT Y
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALY 192
Query: 686 MSPEYAIDGLFSVKSDVFSFGV 707
M+PE + K D++S GV
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGV 213
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 504 IFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFK 559
+F + +D + + LG+G FG V GQE AVK +SK E
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 560 NEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSK-VLDWQNRCH 618
E L+ +L H N++KL + LV E L FD S+ +
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAAR 130
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGLDQTEAN 675
II + G+ Y+H +I+HRDLK N+LL++ + N +I DFG++ F +
Sbjct: 131 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 184
Query: 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
+GT Y++PE + G + K DV+S GV++ ++SG
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEAL----LIAKLQ 569
+ + + K+GEG +G V+K + GQ +A+K+ +S K AL ++ +L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLK 60
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYF-----IFDTTRSKVLDWQNRCHIIGGIA 624
H NLV LL ++ LV+EY + L K + WQ
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TL 112
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
+ + + H + IHRD+K N+L+ K+ DFG AR ++ + V T
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRW 167
Query: 685 YMSPE 689
Y SPE
Sbjct: 168 YRSPE 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 37/193 (19%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN--------EALLI 565
D + KLGEG +G VYK + + +A+KR+ +E + E L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 566 AKLQHRNLVKLLGCCTQRDERVLVYEYLPN---KSLDYFI-FDTTRSKVLDWQNRCHIIG 621
+LQHRN+++L L++EY N K +D K +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ------- 140
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGLDQTEANT 676
+ G+ + H R +HRDLK N+LL KI DFG+ARAFG T
Sbjct: 141 -LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFT 195
Query: 677 NRVVGTYGYMSPE 689
+ ++ T Y PE
Sbjct: 196 HEII-TLWYRPPE 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 25/251 (9%)
Query: 473 KKKHRNYGKTDDRQELYSNEKGSSKEEMELP----IFDWKTIVDATDNFSE------ENK 522
+ + D + + K +S +++P FD + + +
Sbjct: 37 NEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEI 96
Query: 523 LGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
LG G FG V+K G ++A K + + EE KNE ++ +L H NL++L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 582 QRDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639
+++ VLV EY+ L FD S L + + I G+ ++H ++ I+
Sbjct: 157 SKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYIL 209
Query: 640 HRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
H DLK N+L N KI DFG+AR + + GT +++PE S
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVS 266
Query: 698 VKSDVFSFGVL 708
+D++S GV+
Sbjct: 267 FPTDMWSVGVI 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 46/202 (22%), Positives = 80/202 (39%), Gaps = 15/202 (7%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
D + +LG G FG V++ + G+ K ++ KNE ++ +L H
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLL 628
L+ L + E VL+ E+L L FD + + + GL
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYM 686
++H I+H D+K N++ + + KI DFG+A D+ T +
Sbjct: 164 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFA 217
Query: 687 SPEYAIDGLFSVKSDVFSFGVL 708
+PE +D+++ GVL
Sbjct: 218 APEIVDREPVGFYTDMWAIGVL 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 33/195 (16%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVK--RLSKSSGQGVEEFKNEAL----LIAK 567
+ + K+G+G FG V+K + + A+K + E F AL ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72
Query: 568 LQHRNLVKLLGCCTQRDERV--------LVYEYLPN--KSLDYFIFDTTRSKVLDWQNRC 617
L+H N+V L+ C + LV+++ + L K + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEIKR 128
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN-- 675
++ + GL Y+H + +I+HRD+KA+NVL+ + K++DFG+ARAF L +
Sbjct: 129 -VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 676 -TNRVVGTYGYMSPE 689
TNRVV T Y PE
Sbjct: 185 YTNRVV-TLWYRPPE 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 44/232 (18%)
Query: 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKN-EALL 564
D KT ++ +G G FG V++ L+E E+A+K++ + + FKN E +
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85
Query: 565 IAKLQHRNLVKLLGC----CTQRDERV--LVYEYLP---NKSLDYF-----IFDTTRSKV 610
+ ++H N+V L ++DE LV EY+P ++ ++ K+
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 611 LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGL 669
+Q + R L Y+H + I HRD+K N+LLD K+ DFG A+
Sbjct: 146 YMYQ--------LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-- 192
Query: 670 DQTEANTNRVVGTYGYMSPEYAIDGLF-----SVKSDVFSFGVLVLEIVSGK 716
E N + + Y Y +PE +F + D++S G ++ E++ G+
Sbjct: 193 IAGEPNVSYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKL 568
+ ++ LG+G FG V K QE AVK ++K+ + E L+ KL
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGL 627
H N++KL +V E L FD + K + II + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
Y+H I+HRDLK N+LL++ + + KI DFG++ F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 715
Y++PE + G + K DV+S GV++ ++SG
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KSSGQGVEEFKNEAL------- 563
AT + ++G G +G VYK G +A+K + + G G +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 564 LIAKLQHRNLVKLLGCCTQRDERV-----LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCH 618
+ +H N+V+L+ C LV+E++ ++ L ++ D L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR 678
++ RGL +LH + I+HRDLK N+L+ + K++DFG+AR + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 679 VVGTYGYMSPE 689
VV T Y +PE
Sbjct: 180 VV-TLWYRAPE 189
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 522 KLGEGGFGPVYKGMLIE--GQEIAVKRLSKS-----------------SGQGVEEFKNEA 562
L +G F + L E + A+K+ KS ++FKNE
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 563 LLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSL-DY----FIFDTTRSKVLDWQNRC 617
+I +++ + G T DE ++YEY+ N S+ + F+ D + + Q
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN 677
II + Y+H + I HRD+K SN+L+D K+SDFG + +
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIK 208
Query: 678 RVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
GTY +M PE + +G K D++S G+ + +
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIA 566
T D ++ EN +G G +G V + A K++ K + V+ FK E ++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIAR 625
L H N+++L + LV E L F+ +V + I+ +
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLS 117
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ Y H +L + HRDLK N L + K+ DFG+A F + VGT
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGT 171
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGV 707
Y+SP+ ++GL+ + D +S GV
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVK-----RLSKSSGQGVEEFKNEALLIAK 567
D + +G+G F V + + E GQ+ AVK + + S G E+ K EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARG 626
L+H ++V+LL + +V+E++ L + V H + I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNRVVGTY 683
L Y H IIHRD+K VLL ++ N K+ FG+A G A VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVL 708
+M+PE + DV+ GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 50/251 (19%), Positives = 95/251 (37%), Gaps = 24/251 (9%)
Query: 473 KKKHRNYGKTDDRQELYSNEKGSSKEEMEL-----PIFDWKTIVDATDNFSE----ENKL 523
++K R D++ ++ + S + + + D+ + +L
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 524 GEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ 582
G G FG V++ G A K + E + E ++ L+H LV L
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 583 RDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIH 640
+E V++YE++ L F+ + + + +GL ++H +H
Sbjct: 226 DNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVH 278
Query: 641 RDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSV 698
DLK N++ + + K+ DFG+ Q + GT + +PE A
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 699 KSDVFSFGVLV 709
+D++S GVL
Sbjct: 336 YTDMWSVGVLS 346
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQH 570
+ ++ LG+G FG V K QE AVK ++K+ + E L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLY 629
N++KL +V E L FD + K + II + G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 630 LHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
+H + I+HRDLK N+LL + + + KI DFG++ F + +GT Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI 190
Query: 687 SPEYAIDGLFSVKSDVFSFGV 707
+PE + G + K DV+S GV
Sbjct: 191 APE-VLRGTYDEKCDVWSAGV 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 13/174 (7%)
Query: 548 SKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTR 607
SS ++ + + +N V L + + + + ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 608 SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667
+ + HI IA + +LH ++HRDLK SN+ + K+ DFG+ A
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 668 GLDQTEANTN----------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 711
D+ E VGT YMSPE +S K D+FS G+++ E
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 51/275 (18%), Positives = 90/275 (32%), Gaps = 52/275 (18%)
Query: 491 NEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVK---- 545
+ E F ++++ + + +G+G +G V + + A+K
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 546 -RLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD 604
++ + + + VE K E L+ KL H N+ +L LV E L +
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 605 TTRSKVLDWQNRC-------------------------------------HIIGGIARGL 627
+I+ I L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 628 LYLHHDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGLDQTEANT--NRVVGTY 683
YLH I HRD+K N L + K+ DFG+++ F GT
Sbjct: 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 684 GYMSPE--YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+++PE + + K D +S GVL+ ++ G
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
D+F LG+G FG VY + +A+K L KS + + E + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLY 629
N++++ R L+ E+ P L + + D Q + +A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR---VVGTYGYM 686
H ++IHRD+K N+L+ + KI+DFG + A + R + GT Y+
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYL 179
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
PE K D++ GVL E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 32/193 (16%)
Query: 515 DNFSEENKLGEGGFGPVYKG--MLIEGQEIAVKRLSKSSGQGVEEFKN--------EALL 564
+ ++GEG +G V+K + G+ +A+KR+ V+ + E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 565 IAKLQ---HRNLVKLLGCCTQRDER-----VLVYEYLPNKSLDYFIFDTTRSKVLDWQNR 616
+ L+ H N+V+L CT LV+E++ ++ L ++ D + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 617 CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT 676
++ + RGL +LH R++HRDLK N+L+ + K++DFG+AR + T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 677 NRVVGTYGYMSPE 689
+ VV T Y +PE
Sbjct: 178 SVVV-TLWYRAPE 189
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 37/199 (18%)
Query: 515 DNFSEEN-KLGEGGFGPVYKGMLIE---GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
D F E K+G G +G VYK + ++ A+K++ + +G + + E L+ +L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKH 77
Query: 571 RNLVKLLGCCTQRDER--VLVYEYL-------------PNKSLDYFIFDTTRSKVLDWQN 615
N++ L +R L+++Y + K L +Q
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ- 136
Query: 616 RCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGL-D 670
I G+ YLH + ++HRDLK +N+L+ E KI+D G AR F
Sbjct: 137 -------ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 671 QTEANTNRVVGTYGYMSPE 689
+ A+ + VV T+ Y +PE
Sbjct: 187 KPLADLDPVVVTFWYRAPE 205
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 41/202 (20%), Positives = 80/202 (39%), Gaps = 16/202 (7%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
+ + + LG G FG V++ + + K + G K E ++ +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARH 60
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLL 628
RN++ L +E V+++E++ + F+ T + L+ + + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYM 686
+LH I H D++ N++ + KI +FG AR + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170
Query: 687 SPEYAIDGLFSVKSDVFSFGVL 708
+PE + S +D++S G L
Sbjct: 171 APEVHQHDVVSTATDMWSLGTL 192
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 495 SSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--- 550
+ ++ K +++ + KLG G +G V E A+K + KS
Sbjct: 16 FQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFD 75
Query: 551 ----------SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDY 600
+ EE NE L+ L H N++KL + LV E+ L
Sbjct: 76 KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-- 133
Query: 601 FIFDTTRSK-VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNP 656
F+ ++ D + +I+ I G+ YLH I+HRD+K N+LL+N +N
Sbjct: 134 --FEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188
Query: 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
KI DFG++ F D +GT Y++PE + ++ K DV+S GV++ ++ G
Sbjct: 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
Query: 717 R 717
Sbjct: 245 P 245
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 22/209 (10%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS------GQGVEEFKNEALL 564
D + +LG G F V K G E A K + K G EE + E +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV-LDWQNRCHIIGGI 623
+ ++ H N++ L R + VL+ E + L FD K L + I I
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQI 124
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTNRV 679
G+ YLH +I H DLK N++L ++ P K+ DFG+A +
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVL 708
GT +++PE +++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 514 TDNFSEE----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIA 566
+ FS+ +LG+G F V + + G E A K ++ S + ++ + EA +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIAR 625
KLQH N+V+L + LV++ + L F+ + + H I I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNRVVGT 682
+ Y H I+HR+LK N+LL ++ K++DFG+A + + GT
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGV 707
GY+SPE +S D+++ GV
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 17/222 (7%)
Query: 493 KGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS- 550
++ F +DN+ + +LG+G F V + + G E A K ++
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 551 -SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRS 608
S + ++ + EA + KLQH N+V+L + LV++ + L F+
Sbjct: 67 LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAR 122
Query: 609 KVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMAR 665
+ + H I I + Y H I+HR+LK N+LL ++ K++DFG+A
Sbjct: 123 EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 707
+ + GT GY+SPE +S D+++ GV
Sbjct: 180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS------SGQGVEEFKNEALL 564
D + +LG G F V K G E A K + K G EE + E +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGI 623
+ ++ H N++ L R + VL+ E + L FD + + L + I I
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQI 124
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTNRV 679
G+ YLH +I H DLK N++L ++ P K+ DFG+A +
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVL 708
GT +++PE +++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
D F + LG GGFG V+ + ++ A K+L+K +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLL 628
R +V L + + LV + + Y I++ + I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
+LH + II+RDLK NVLLD++ N +ISD G+A QT+ GT G+M+P
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAP 358
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
E + + D F+ GV + E+++ +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 53/253 (20%)
Query: 490 SNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLS 548
S +K SK + ++++ +G G FG VY+ L + G+ +A+K++
Sbjct: 29 SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 549 KSSGQGVEEFKN-EALLIAKLQHRNLVKLLGCCTQRDERV------LVYEYLPNKSLDYF 601
+ + FKN E ++ KL H N+V+L E+ LV +Y+P
Sbjct: 89 QD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP------- 136
Query: 602 IFDTTRSKVLDWQNRC-------HI---IGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651
T +V +R ++ + + R L Y+H I HRD+K N+LLD
Sbjct: 137 ---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLD 190
Query: 652 NEMNP-KISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-------YAIDGLFSVKSDVF 703
+ K+ DFG A+ L + E N + + Y Y +PE Y + DV+
Sbjct: 191 PDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY-YRAPELIFGATDY------TSSIDVW 241
Query: 704 SFGVLVLEIVSGK 716
S G ++ E++ G+
Sbjct: 242 SAGCVLAELLLGQ 254
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
+ F + LG+GGFG V + ++ A K+L K +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFI-------FDTTRSKVLDWQNRCHIIGG 622
R +V L + + + LV + L + I F R+
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV--------FYAAE 294
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
I GL LH R RI++RDLK N+LLD+ + +ISD G+A QT VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
Query: 683 YGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGK 716
GYM+PE + FS D ++ G L+ E+++G+
Sbjct: 349 VGYMAPE-VVKNERYTFSP--DWWALGCLLYEMIAGQ 382
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLG 578
LGEG F V + A+K L K V E ++++L H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 579 CCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
Q DE++ Y N L +I FD T ++ I L YLH
Sbjct: 98 TF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR--------FYTAEIVSALEYLHG 148
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
IIHRDLK N+LL+ +M+ +I+DFG A+ + +A N VGT Y+SPE
Sbjct: 149 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
+ SD+++ G ++ ++V+G
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS------SGQGVEEFKNEALL 564
+ D + +LG G F V K G + A K + K G E+ + E +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGI 623
+ ++QH N++ L + + +L+ E + L FD + L + + I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQI 123
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTNRV 679
G+ YLH L+I H DLK N++L + P KI DFG+A +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNI 177
Query: 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVL 708
GT +++PE +++D++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS------SGQGVEEFKNEALL 564
D++ +LG G F V K G+E A K + K G EE + E +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGI 623
+ +++H N++ L + + VL+ E + L FD + L + I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQI 117
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTNRV 679
G+ YLH RI H DLK N++L ++ P K+ DFG+A +
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 680 VGTYGYMSPEYAIDGLFSVKSDVFSFGVL 708
GT +++PE +++D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 18/202 (8%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
+ F LG G F V+ G+ A+K + KS +NE ++ K++H
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLL 628
N+V L LV + + L FD R ++ +I + +
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGV-YTEKDASLVIQQVLSAVK 120
Query: 629 YLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
YLH I+HRDLK N+L + I+DFG+++ + GT GY
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGY 173
Query: 686 MSPEYAIDGLFSVKSDVFSFGV 707
++PE +S D +S GV
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGV 195
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGV--------- 555
+ +N+ + LG G V + + +E AVK + + G
Sbjct: 8 GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67
Query: 556 EEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDW 613
E E ++ K+ H N+++L LV++ + L FD T L
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSE 123
Query: 614 QNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673
+ I+ + + LH +L I+HRDLK N+LLD++MN K++DFG + +
Sbjct: 124 KETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK- 179
Query: 674 ANTNRVVGTYGYMSPE------YAIDGLFSVKSDVFSFGV 707
V GT Y++PE + + D++S GV
Sbjct: 180 --LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+G+G F V ++ G+E+A+K + K+ + +++ E ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 580 CTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
L+ EY + DY + + + I + Y H + RI
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCH---QKRI 135
Query: 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE------YAI 692
+HRDLKA N+LLD +MN KI+DFG + F + + G Y +PE Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKY-- 190
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
DG + DV+S GV++ +VSG
Sbjct: 191 DGP---EVDVWSLGVILYTLVSGS 211
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 52/244 (21%), Positives = 98/244 (40%), Gaps = 27/244 (11%)
Query: 481 KTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-G 539
K +D Q + E + DW + + ++ +G G V + + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 540 QEIAVKRLSKSSGQG--------VEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVY 590
E AVK + ++ + E + E ++ ++ H +++ L+ LV+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 591 EYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649
+ + L FD T L + I+ + + +LH I+HRDLK N+L
Sbjct: 180 DLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENIL 232
Query: 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE------YAIDGLFSVKSDVF 703
LD+ M ++SDFG + + + GT GY++PE + + D++
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 704 SFGV 707
+ GV
Sbjct: 290 ACGV 293
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 58/234 (24%), Positives = 90/234 (38%), Gaps = 57/234 (24%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKR-LSKSSGQGVEEFKNEALLIAKL--- 568
D F E G+G FG V G G +A+K+ + F+N L I +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75
Query: 569 -QHRNLVKLLGCCTQRDER-------VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC--- 617
H N+V+L ER +V EY+P T + R
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----------DTLHRCCRNYYRRQVA 125
Query: 618 ----HI---IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGL 669
I + + R + LH S + + HRD+K NVL++ K+ DFG A+ L
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK--L 182
Query: 670 DQTEANTNRVVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+E N + Y Y +PE Y + D++S G + E++ G+
Sbjct: 183 SPSEPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLL 577
E+ LGEG V + + QE AVK + K G E ++ + Q HRN+++L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
+ D LV+E + S+ + + + ++ +A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLH---NK 130
Query: 637 RIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNR-----VVGTYGYMSP 688
I HRDLK N+L ++ KI DF + L+ + + G+ YM+P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 689 E-----YAIDGLFSVKSDVFSFGVL 708
E ++ + D++S GV+
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 21/232 (9%)
Query: 488 LYSNEKGSSKEEMELPIFDWKTIVDATDNFS-EENKLGEGGFGPVYKGMLIE-GQEIAVK 545
++ + SS ++ ++++ + + + +LG G F V + + GQE A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 546 RLSKS--SGQGVEEFKNEALLIAKLQHR-NLVKLLGCCTQRDERVLVYEYLPNKSLDYFI 602
L K E +E ++ + ++ L E +L+ EY +
Sbjct: 61 FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI---- 116
Query: 603 FDTTRSKVLDW---QNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNP 656
F ++ + + +I I G+ YLH + I+H DLK N+LL + +
Sbjct: 117 FSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 708
KI DFGM+R G ++GT Y++PE + +D+++ G++
Sbjct: 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEA---LLIAK 567
++FS +G GGFG VY + ++ A+K L K QG NE L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 568 LQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
+V + +++ + + + L Y + ++ V + I G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILG 304
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
L ++H +++RDLK +N+LLD + +ISD G+A F + + VGT+GYM
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357
Query: 687 SPEYAIDGL---FSVKSDVFSFGVLVLEIVSGK 716
+PE G+ S D FS G ++ +++ G
Sbjct: 358 APEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEE-FKNEALLIAKLQHRNLVKLLGCC 580
LGEG +G V + + + +AVK + E K E + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 581 TQRDERVLVYEYLPNKSL-DYFI----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
+ + + L EY L D ++ Q ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----LMAGVV----YLH---G 123
Query: 636 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE------ 689
+ I HRD+K N+LLD N KISDFG+A F + E N++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSG 715
+ DV+S G+++ +++G
Sbjct: 184 F--HAE---PVDVWSCGIVLTAMLAG 204
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSS----GQGVEEFKNEALLIAKLQHRNLVKL- 576
LGEG +G V + + AVK L K G K E L+ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 577 --LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD-WQNR---CHIIGGIARGLLYL 630
L ++ +V EY + + D+ K Q C +I G+ YL
Sbjct: 73 DVLYNEEKQK-MYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE- 689
H I+H+D+K N+LL KIS G+A A + G+ + PE
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 690 ------YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+ G K D++S GV + I +G
Sbjct: 183 ANGLDTF--SGF---KVDIWSAGVTLYNITTGL 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-21
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKL 568
T+ + +LG+G F V + + + GQE A ++ S + ++ + EA + L
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGL 627
+H N+V+L ++ L+++ + L F+ + + H I I +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAV 123
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNRVVGTYG 684
L+ H + ++HR+LK N+LL +++ K++DFG+A +Q GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPG 178
Query: 685 YMSPEYAIDGLFSVKSDVFSFGV 707
Y+SPE + D+++ GV
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGV 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 56/197 (28%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEE-FKNEALLIAKLQHRNLVKLLGCC 580
LGEG +G V + + + +AVK + E K E + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 581 TQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCH---IIGGIARGLLYLHHDSRL 636
+ + + L EY L D + + + ++ G+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 637 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE------Y 690
I HRD+K N+LLD N KISDFG+A F + E N++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 691 AIDGLFSVKSDVFSFGV 707
DV+S G+
Sbjct: 185 --HAE---PVDVWSCGI 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 51/207 (24%), Positives = 81/207 (39%), Gaps = 30/207 (14%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN 572
TD + + +G G + + + E AVK + KS EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLH 631
++ L +V E + L D R K + ++ I + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 632 HDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
++HRDLK SN+L N + +I DFG A+ + T T +++
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVA 188
Query: 688 PE------YAIDGLFSVKSDVFSFGVL 708
PE Y D++S GVL
Sbjct: 189 PEVLERQGY------DAACDIWSLGVL 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEA----------LLIAKLQHR 571
LG+GGFG V+ G L + ++A+K + ++ G + + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
+++LL ++ +LV E P + D F + T + L G + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH 156
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
++HRD+K N+L+D K+ DFG A L GT Y PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-AL-LHDEPYTD--FDGTRVYSPPEW 209
Query: 691 AIDGLFS-VKSDVFSFGVLVLEIVSG 715
+ + + V+S G+L+ ++V G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--------SGQGVEEFKNEALL 564
D + LG G G V + +++A++ +SK + E +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 565 IAKLQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFD-TTRSKVLDWQNRCHIIGG 622
+ KL H ++K+ E +V E + L FD +K L
Sbjct: 194 LKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 247
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNRV 679
+ + YLH IIHRDLK NVLL ++ KI+DFG ++ G + + T +
Sbjct: 248 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--L 301
Query: 680 VGTYGYMSPE---YAIDGLFSVKSDVFSFGVLV 709
GT Y++PE ++ D +S GV++
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKS--------SGQGVEEFKNEALLIA 566
+S + LG G FG V+ + + +E+ VK + K + + E +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
+++H N++K+L + LV E + LD F F + LD +I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPR-LDEPLASYIFRQLVSA 142
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
+ YL IIHRD+K N+++ + K+ DFG A + GT Y
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196
Query: 687 SPE------YAIDGLFSVKSDVFSFGVLVLEIVSG--------KRNRGFYH 723
+PE Y G + +++S GV + +V + H
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIH 242
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN------EALLIAKLQHR--NL 573
LG GGFG VY G+ + + +A+K + K E N E +L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
++LL + D VL+ E P D F F T R L + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 166
Query: 634 SRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAF--GLDQTEANTNRVVGTYGYMSPE- 689
++HRD+K N+L+D N K+ DFG + GT Y PE
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD------FDGTRVYSPPEW 219
Query: 690 -----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y G + V+S G+L+ ++V G
Sbjct: 220 IRYHRY--HGR---SAAVWSLGILLYDMVCGD 246
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 29/211 (13%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEE--------FKNEALL 564
D + LG G G V + +++A+K +SK + E +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 565 IAKLQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGG 622
+ KL H ++K+ E +V E + L FD +K L
Sbjct: 69 LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 122
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGLDQTEANTNRV 679
+ + YLH IIHRDLK NVLL + + KI+DFG ++ G + + T +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--L 176
Query: 680 VGTYGYMSPE---YAIDGLFSVKSDVFSFGV 707
GT Y++PE ++ D +S GV
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 23/245 (9%)
Query: 473 KKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEE----NKLGEGGF 528
+ G + + S+ S+ + D+ D S+ ++LG G
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66
Query: 529 GPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587
VY+ + A+K L K+ + + E ++ +L H N++KL E
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 588 LVYEYLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKA 645
LV E + L FD + ++ + I + YLH I+HRDLK
Sbjct: 125 LVLELVTGGEL----FDRIVEKGY-YSERDAADAVKQILEAVAYLHE---NGIVHRDLKP 176
Query: 646 SNVLL---DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDV 702
N+L + KI+DFG+++ V GT GY +PE + + D+
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDM 233
Query: 703 FSFGV 707
+S G+
Sbjct: 234 WSVGI 238
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIA 566
D ++ LGEG F K + + Q AVK +SK + E +
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALK 60
Query: 567 KLQ-HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIA 624
+ H N+VKL + LV E L L F+ + K +I+ +
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLV 116
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNRVVG 681
+ ++H + ++HRDLK N+L +E + KI DFG AR D T
Sbjct: 117 SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCF 171
Query: 682 TYGYMSPEYAIDGLFSVKSDVFSFGVL 708
T Y +PE + D++S GV+
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 53/223 (23%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS-----------------SGQGVEEFKNEALL 564
+G+G +G V + A+K LSK + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 565 ------IA---KLQHRNLVKL---LGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLD 612
IA KL H N+VKL L D +V+E + + + K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 613 -WQNRCH---IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668
Q R + +I GI YLH +IIHRD+K SN+L+ + + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSV----KSDVFSFGV 707
+ VGT +M+PE ++ + DV++ GV
Sbjct: 189 GSDALLSN--TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 40/212 (18%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG G FG V G + G ++AVK L++ S V + K E + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 579 CCTQRDERVLVYEYLPNKSL-DYFI----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+ + +V EY+ L DY + ++ L Q I+ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ----ILSAVD----YCH-- 128
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF---GLDQTEANTNRVVGTYGYMSPE- 689
R ++HRDLK NVLLD MN KI+DFG++ +T G+ Y +PE
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPEV 181
Query: 690 -----YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y G + D++S GV++ ++ G
Sbjct: 182 ISGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 11/96 (11%)
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR D + G
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254
Query: 683 ----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS 714
+M+PE D +++++SDV+SFGVL+ EI S
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 31/160 (19%), Positives = 56/160 (35%), Gaps = 19/160 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQG-VEEFKNEALLIAK 567
D LG G FG V + + +AVK L + + +E ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 568 L-QHRNLVKLLGCCTQRDERVLV-YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
+ H N+V LLG CT+ ++V E+ +L ++ R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665
G + + I DLK + + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 21/217 (9%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLI 565
D++ KLG G + V++ + I +++ VK L + + K E ++
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKIL 84
Query: 566 AKLQ-HRNLVKLLGCCTQRDER--VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGG 622
L+ N++ L R LV+E++ N T + +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI------RFYMYE 138
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGLDQTEANTNRVVG 681
I + L Y H S I+HRD+K NV++D+E ++ D+G+A + RV
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVAS 193
Query: 682 TYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGKR 717
Y + PE +D S D++S G ++ ++ K
Sbjct: 194 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 65/251 (25%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN-EALLIAKLQHR 571
+ +S LG G FG V + IE G+ A+K++ + +KN E ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLD-------------------------YFIF--- 603
N++KL+ + P+ I
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 604 DTTRSKVLDWQNRC-------HI---IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE 653
T KVL R I I + R + ++H L I HRD+K N+L++++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 654 MNP-KISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-------YAIDGLFSVKSDVFSF 705
N K+ DFG A+ L +E + + + Y +PE Y + D++S
Sbjct: 178 DNTLKLCDFGSAKK--LIPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLWSI 228
Query: 706 GVLVLEIVSGK 716
G + E++ GK
Sbjct: 229 GCVFGELILGK 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LGEG FG V Q++A+K +S+ + E + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 579 CCTQRDERVLVYEYLPNKSLDYFI----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
T + V+V EY + DY + + Q II I Y H
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQ----IICAIE----YCH--- 125
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE----- 689
R +I+HRDLK N+LLD+ +N KI+DFG++ T+ G+ Y +PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPEVINGK 182
Query: 690 -YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y G + DV+S G+++ ++ G+
Sbjct: 183 LY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG G FG V G + G ++AVK L++ S V + + E + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 579 CCTQRDERVLVYEYLPNKSL-DYFI----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+ + +V EY+ L DY D S+ L Q I+ G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ----ILSGVD----YCH-- 133
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE---- 689
R ++HRDLK NVLLD MN KI+DFG++ + T+ G+ Y +PE
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISG 189
Query: 690 --YAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y G + D++S GV++ ++ G
Sbjct: 190 RLY--AGP---EVDIWSSGVILYALLCGT 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 31/211 (14%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
+G G F V + + ++ A+K ++K V F+ E ++ R + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 579 CCTQRDERV-LVYEYLPNKSLDYFI------FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
Q + + LV EY L + ++ + I + +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--------LAEIVMAIDSVH 179
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-- 689
RL +HRD+K N+LLD + +++DFG D T + VGT Y+SPE
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEIL 235
Query: 690 -----YAIDGLFSVKSDVFSFGVLVLEIVSG 715
G + + D ++ GV E+ G
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 43/201 (21%), Positives = 75/201 (37%), Gaps = 28/201 (13%)
Query: 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
+ LG G G V + GQ+ A+K L S + + E ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88
Query: 578 GCC---TQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDW---QNRCHIIGGIARGLLYL 630
+ ++ E + L F + + + I+ I + +L
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 631 HHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
H I HRD+K N+L + + K++DFG A+ Q T T Y++
Sbjct: 145 H---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT--PCYTPYYVA 197
Query: 688 PEYAIDGLFSVKSDVFSFGVL 708
PE + D++S GV+
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVI 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 21/200 (10%), Positives = 55/200 (27%), Gaps = 41/200 (20%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLL 577
G ++ + +++A+ + ++E + L ++++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 578 GCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLR 637
R ++V E++ SL + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 638 IIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS 697
+ S V +S G V+ M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 698 VKSDVFSFGVLVLEIVSGKR 717
+ D+ G + ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
D+F +G+G FG V + +++ A+K ++K V E ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIA 624
LV L Q +E + +V + L L Y + F K+ I +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
L YL RIIHRD+K N+LLD + I+DF +A +T+ T + GT
Sbjct: 126 MALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKP 179
Query: 685 YMSPE--YAIDGL---FSVKSDVFSFGVLVLEIVSGKR 717
YM+PE + G F+V D +S GV E++ G+R
Sbjct: 180 YMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 37/206 (17%)
Query: 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
LG G G V + ++ A+K L + + E L Q ++V+++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 121
Query: 578 GCC---TQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRC-------HIIGGIARG 626
+ + +V E L L F ++ D ++ I+ I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL----FS----RIQDRGDQAFTEREASEIMKSIGEA 173
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTNRVVGT 682
+ YLH + I HRD+K N+L ++ P K++DFG A+ + T
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS---LTTPCYT 226
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVL 708
Y++PE + D++S GV+
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 34/199 (17%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581
+G G FG + + +AVK + + + E + E + L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 582 QRDERVLVYEYLPNKSL-DYFI----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRL 636
++ EY L + F ++ Q ++ G++ Y H +
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ----LLSGVS----YCH---SM 135
Query: 637 RIIHRDLKASNVLLD--NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE----- 689
+I HRDLK N LLD KI DFG +++ L + VGT Y++PE
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVLLRQ 192
Query: 690 -YAIDGLFSVKSDVFSFGV 707
Y DG +DV+S GV
Sbjct: 193 EY--DGK---IADVWSCGV 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 33/219 (15%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
++F +G G FG V L ++ A+K L+K F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLP--------NKSLDYFIFDTTRSKVLDWQNRCHIIG 621
+ + L Q D + LV +Y +K D + R +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR----------FYLA 182
Query: 622 GIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVG 681
+ + +H +L +HRD+K N+L+D + +++DFG D T ++ VG
Sbjct: 183 EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVG 238
Query: 682 TYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVSG 715
T Y+SPE G + + D +S GV + E++ G
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 69/243 (28%), Positives = 106/243 (43%), Gaps = 18/243 (7%)
Query: 490 SNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLS 548
S S EEME+ + K V + F LG+G FG V A+K L
Sbjct: 124 SPSDNSGAEEMEVSLAKPKHRVTMNE-FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK 182
Query: 549 KS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFD 604
K + V E ++ +H L L Q +R+ V EY L + +
Sbjct: 183 KEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL-- 239
Query: 605 TTRSKVLDWQNRCHIIGG-IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663
+R +V ++R G I L YLH S +++RDLK N++LD + + KI+DFG+
Sbjct: 240 -SRERVFS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGL 295
Query: 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYH 723
+ D T GT Y++PE D + D + GV++ E++ G+ FY+
Sbjct: 296 CKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYN 351
Query: 724 ADH 726
DH
Sbjct: 352 QDH 354
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 44/237 (18%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN----- 560
D + + LG GG G V+ + + +A+K++ +
Sbjct: 3 NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVK 53
Query: 561 ----EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD-YFIFD--------TTR 607
E +I +L H N+VK+ ++ + Y + +
Sbjct: 54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 608 SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARA 666
L ++ + + RGL Y+H + ++HRDLK +N+ ++ E + KI DFG+AR
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 667 FGLDQTEAN--TNRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
+ + +V T Y SP L S + D+++ G + E+++GK
Sbjct: 171 MDPHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 58/257 (22%), Positives = 98/257 (38%), Gaps = 29/257 (11%)
Query: 480 GKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEG 539
K QE +KE+ D F LG G FG V E
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65
Query: 540 QEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV-LVYEYLP 594
A+K L K + +E NE ++ + LVKL + + + +V EY+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVA 124
Query: 595 NKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649
+ + F ++ I YLH L +I+RDLK N+L
Sbjct: 125 GGEMFSHLRRIGRFSEPHARF--------YAAQIVLTFEYLHS---LDLIYRDLKPENLL 173
Query: 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 709
+D + +++DFG A+ + + T + GT ++PE + ++ D ++ GVL+
Sbjct: 174 IDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 710 LEIVSGKRNRGFYHADH 726
E+ +G F+
Sbjct: 229 YEMAAGYPP--FFADQP 243
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 26/214 (12%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
+++ +G G FG V +++ A+K LSK F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLPN----KSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
+V+L Q D + +V EY+P + + ++ +
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--------TAEVVL 179
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
L +H + IHRD+K N+LLD + K++DFG + + VGT Y
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDY 235
Query: 686 MSPE----YAIDGLFSVKSDVFSFGVLVLEIVSG 715
+SPE DG + + D +S GV + E++ G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 34/231 (14%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIA 566
+ ++ + + G +G V G+ EG +A+KR+ + G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 567 K-----------LQHRNLVKLLGCCTQRDERV-----LVYEYLPNKSLDYFIFDTTRSKV 610
K H N++ L +E LV E + L I + V
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIV 130
Query: 611 LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670
+ Q+ + + I GL LH ++HRDL N+LL + + I DF +AR
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH--EA-GVVHRDLHPGNILLADNNDITICDFNLAR--EDT 185
Query: 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
T+ V Y +PE + K D++S G ++ E+ + K
Sbjct: 186 ADANKTHYVT-HRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 40/240 (16%), Positives = 86/240 (35%), Gaps = 41/240 (17%)
Query: 473 KKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVY 532
+ Q+ K + + + D + + +G G +G V
Sbjct: 11 QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70
Query: 533 KGM-LIEGQEIAVKRLSKSSGQGVEEFKNEAL---------LIAKLQHRNLVKLLGCCTQ 582
+ +E + +A+K++ + F++ ++ +L H ++VK+L
Sbjct: 71 EAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123
Query: 583 RDERV-----LVYEYLPNKSLDYFIFDTTRSKVLDWQNR------CHIIGGIARGLLYLH 631
+D +V E D+ K+ ++ + G+ Y+H
Sbjct: 124 KDVEKFDELYVVLEIA----------DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
S I+HRDLK +N L++ + + K+ DFG+AR + + + M+
Sbjct: 174 --SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN----- 560
+ + +G G G V I + +A+K+LS+ F+N
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAK 69
Query: 561 ----EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD-----YFIF---DTTRS 608
E +L+ + H+N++ LL + P KSL+ Y + D
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLC 117
Query: 609 KV----LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+V LD + +++ + G+ +LH S IIHRDLK SN+++ ++ KI DFG+A
Sbjct: 118 QVIQMELDHERMSYLLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
R + T VV T Y +PE + + D++S G ++ E++ G
Sbjct: 175 R--TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLG 578
LG+G FG V A+K L K + V E+ ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 579 CCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
Q +R+ V EY L + + F R++ I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYLH- 122
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+++RD+K N++LD + + KI+DFG+ + D T GT Y++PE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLE 178
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGK 716
D + D + GV++ E++ G+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 43/231 (18%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN------ 560
+ D ++ + +GEG +G V + +A+K++S F++
Sbjct: 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQR 71
Query: 561 ---EALLIAKLQHRNLVKLLGCCTQRDERV-----LVYEYLPNKSLDYFIFDTTRSKVLD 612
E ++ + +H N++ + +V + + L + +++ L
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLS 126
Query: 613 WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
+ C+ + I RGL Y+H S ++HRDLK SN+LL+ + KI DFG+AR D
Sbjct: 127 NDHICYFLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 673 EAN--TNRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
T V T Y +PE + + K D++S G ++ E++S +
Sbjct: 184 HTGFLTEYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 53/238 (22%), Positives = 100/238 (42%), Gaps = 59/238 (24%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN----- 560
KT + + + +G G +G V + G ++A+K+L + F++
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAK 69
Query: 561 ----EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD-----YFIFD------- 604
E L+ ++H N++ LL + P+++LD Y +
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLG 117
Query: 605 -TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663
+ + L ++ + +GL Y+H + IIHRDLK N+ ++ + KI DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIH--AA-GIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVSGK 716
AR + T V T Y +PE + + D++S G ++ E+++GK
Sbjct: 175 ARQADSEMTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 47/232 (20%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKN----- 560
+ + +G G G V + + +A+K+LS+ F+N
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAK 106
Query: 561 ----EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD-----YFIF---DTTRS 608
E +L+ + H+N++ LL + P K+L+ Y + D
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLC 154
Query: 609 KV----LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+V LD + +++ + G+ +LH IIHRDLK SN+++ ++ KI DFG+A
Sbjct: 155 QVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
R + T VV T Y +PE + + D++S G ++ E+V K
Sbjct: 212 R--TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 51/234 (21%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN----- 560
KTI + + + + +G G +G V + G +AVK+LS+ F++
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAK 73
Query: 561 ----EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD-----YFIFD------- 604
E L+ ++H N++ LL + P +SL+ Y +
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLN 121
Query: 605 -TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663
+ + L + +I I RGL Y+H S IIHRDLK SN+ ++ + KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGK 716
AR + T V T Y +PE ++ ++ D++S G ++ E+++G+
Sbjct: 179 ARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
+G G + V L + I A++ + K + ++ + E + H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
C Q + R+ V EY+ L + + ++ I+ L YLH
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYLH 170
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NVLLD+E + K++D+GM + +T GT Y++PE
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEIL 225
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++ GVL+ E+++G+
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 523 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKSS----GQGVEEFKNEALLIAKLQHRNLV 574
LG+GG+G V+ K +I A+K L K+ + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 575 KLLGCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLL 628
L+ Q ++ L+ EYL L + F + + I+ L
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMALG 135
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
+LH + II+RDLK N++L+++ + K++DFG+ + D T +T GT YM+P
Sbjct: 136 HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
E + + D +S G L+ ++++G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 2e-14
Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
LG+G FG V E+ AVK L K VE E +L + L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
C Q +R+ V EY+ L Y I F + IA GL +L
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------AAEIAIGLFFLQ 459
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NV+LD+E + KI+DFGM + D T GT Y++PE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEII 514
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++FGVL+ E+++G+
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
+G G + V L + I A+K + K + ++ + E + H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
C Q + R+ V EY+ L + + ++ I+ L YLH
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYLH 127
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NVLLD+E + K++D+GM + +T GT Y++PE
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPE-I 181
Query: 692 IDGL---FSVKSDVFSFGVLVLEIVSGK 716
+ G FSV D ++ GVL+ E+++G+
Sbjct: 182 LRGEDYGFSV--DWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
LG+G FG V + E ++ AVK L K VE E +L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
CC Q +R+ V E++ L + I FD R++ I L++LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISALMFLH 141
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NVLLD+E + K++DFGM + + T GT Y++PE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEIL 196
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ L+ D ++ GVL+ E++ G
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 32/209 (15%)
Query: 523 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKL 576
LG+G FG V+ K + +++ A+K L K++ + K E ++ ++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 577 LGCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYL 630
Q + ++ L+ ++L L + F K + +A L +L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHL 142
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H L II+RDLK N+LLD E + K++DFG+++ + +A + GT YM+PE
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE- 196
Query: 691 AIDGL---FSVKSDVFSFGVLVLEIVSGK 716
++ S D +SFGVL+ E+++G
Sbjct: 197 VVNRRGHTQSA--DWWSFGVLMFEMLTGT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 50/233 (21%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN----- 560
KT + + +G G +G V + G+++A+K+LS+ F++
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAK 68
Query: 561 ----EALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLD-----YFIF---DTTRS 608
E LL+ +QH N++ LL + P SL Y + T
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQ 116
Query: 609 KV----LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
K+ + +++ + +GL Y+H S ++HRDLK N+ ++ + KI DFG+A
Sbjct: 117 KIMGLKFSEEKIQYLVYQMLKGLKYIH--SA-GVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGK 716
R + T V T Y +PE + ++ D++S G ++ E+++GK
Sbjct: 174 RHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
LG+G FG V E+ AVK L K VE E +L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
C Q +R+ V EY+ L Y I F + IA GL +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIGLFFLQ 138
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
II+RDLK NV+LD+E + KI+DFGM + D T GT Y++PE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEII 193
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGK 716
+ D ++FGVL+ E+++G+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 65/204 (31%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
LG+G FG V+ + + A+K L K VE E +L +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
C Q E + V EYL L Y I FD +R+ I GL +LH
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILGLQFLH 135
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
I++RDLK N+LLD + + KI+DFGM + L + NT GT Y++PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEIL 190
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSG 715
+ ++ D +SFGVL+ E++ G
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEI-AVKRLSKSS----GQGVEEFKNEALLIAKLQ 569
+F LG G FG V+ A+K L K Q VE +E L+++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64
Query: 570 HRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGI 623
H ++++ G Q +++ ++ +Y+ L + F +K +
Sbjct: 65 HPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------AAEV 115
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
L YLH II+RDLK N+LLD + KI+DFG A+ T + GT
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTP 167
Query: 684 GYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSG 715
Y++PE + S+ D +SFG+L+ E+++G
Sbjct: 168 DYIAPE-VVSTKPYNKSI--DWWSFGILIYEMLAG 199
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 523 LGEGGFGPVYKGMLIEGQEI-AVKRLSKS---SGQGVEEFKNE-ALLIAKLQHRNLVKLL 577
+G+G FG V + AVK L K + + +E +L+ ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 578 GCCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
Q +++ V +Y+ L Y + F R++ IA L YLH
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYLH 156
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
L I++RDLK N+LLD++ + ++DFG+ + + +T GT Y++PE
Sbjct: 157 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPE-V 210
Query: 692 IDGL---FSVKSDVFSFGVLVLEIVSGK 716
+ +V D + G ++ E++ G
Sbjct: 211 LHKQPYDRTV--DWWCLGAVLYEMLYGL 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 43/228 (18%), Positives = 86/228 (37%), Gaps = 43/228 (18%)
Query: 488 LYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKR 546
++ + SS E V DN+ ++ +G G +G VY + +A+K+
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVP--DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK 58
Query: 547 LSKSSGQGVEEFKN---------EALLIAKLQHRNLVKLLGCCTQRDERV-----LVYEY 592
+++ F++ E ++ +L+ +++L D +V E
Sbjct: 59 VNRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111
Query: 593 LPNKSLDYFIFDTTRSKV------LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKAS 646
D+ K+ L ++ I+ + G ++H IIHRDLK +
Sbjct: 112 A----------DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--ES-GIIHRDLKPA 158
Query: 647 NVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
N LL+ + + K+ DFG+AR ++ N + +
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 1e-13
Identities = 43/301 (14%), Positives = 92/301 (30%), Gaps = 63/301 (20%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRL--------SKSSGQGVEEFKNEALL 564
T+ K+GEG FG V++ + + +A+K + + S + EE E ++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 565 IAKLQ---------HRNLVKLLGCCTQRDER----VLVYEYLPNKSLD------------ 599
+L + L + + +++ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 600 -YFIF---------DTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649
+ + + R+K+ I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 709
L K+ ++ + + V Y DG VF +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIP----SCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245
Query: 710 LEIVSGKRNRGFYHADHRHNLLGHAWQ--------LWIQDRPAELIDKSLYDSCSLSEAI 761
++ +G + F + W LW+ +++ + + + + A+
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305
Query: 762 R 762
+
Sbjct: 306 K 306
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 60/269 (22%), Positives = 113/269 (42%), Gaps = 43/269 (15%)
Query: 475 KHRNYGKTDDRQELYSNEKGSSKEEMELPIFDWKTIVDAT-------DNFSEENKLGEGG 527
H G + S + G E++ + +T +NF LG G
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66
Query: 528 FGPVY---KGMLIEGQEI-AVKRLSKSS----GQGVEEFKNEALLIAKLQHRN-LVKLLG 578
+G V+ K + ++ A+K L K++ + E + E ++ ++ LV L
Sbjct: 67 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH- 125
Query: 579 CCTQRDERV-LVYEYLPNKSLDYFI-----FDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
Q + ++ L+ +Y+ L + F ++ +G I L +LH
Sbjct: 126 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLALEHLH- 176
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+L II+RD+K N+LLD+ + ++DFG+++ + GT YM+P+ +
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPD-IV 232
Query: 693 DGL-----FSVKSDVFSFGVLVLEIVSGK 716
G +V D +S GVL+ E+++G
Sbjct: 233 RGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 37/180 (20%), Positives = 60/180 (33%), Gaps = 36/180 (20%)
Query: 503 PIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNE 561
K D LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 562 -ALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI----------FDTTRSKV 610
L Q ++V+++ VYE L I F + +
Sbjct: 61 VELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 611 LDW---QNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMA 664
+ I+ I + YLH + I HRD+K N+L ++ K++DFG A
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 34/198 (17%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKN------ 560
+ + + + +F ++ LGEG +G V G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 561 ---EALLIAKLQHRNLVKLLGCCTQRDERV-----LVYEYLPNKSLDYFIFDTTRSKVLD 612
E ++ +H N++ + ++ E + L I +++L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLS 110
Query: 613 WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
+ + I R + LH +IHRDLK SN+L+++ + K+ DFG+AR +D++
Sbjct: 111 DDHIQYFIYQTLRAVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDES 165
Query: 673 EANTNRVVGTYGYMSPEY 690
A+ + G M E+
Sbjct: 166 AADNSEPTGQQSGMV-EF 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 28/201 (13%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALL-- 564
+ + KLG+G +G V+K + G+ +AVK++ + F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 565 ----IAKLQ----HRNLVKLLGCCT-QRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQ 614
I L H N+V LL D V LV++Y+ L I R+ +L+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPV 109
Query: 615 NRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674
++ +++ + + + YLH S ++HRD+K SN+LL+ E + K++DFG++R+F +
Sbjct: 110 HKQYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 675 NTNRVVGTYGYMSPEYAIDGL 695
N + + + L
Sbjct: 167 NNIPLSINENTENFDDDQPIL 187
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 48/225 (21%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ----------- 569
KLG G F V+ ++ +A+K + + E ++E L+ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 570 HRNLVKLLGCCTQRDER----VLVYEYLPNKSLDYFI-------FDTTRSKVLDWQNRCH 618
+++KLL + V+V+E L ++L I K + Q
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ---- 139
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP------KISDFGMARAFGLDQT 672
+ GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 140 ----LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WY 188
Query: 673 EANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
+ + + T Y SPE + G + +D++S L+ E+++G
Sbjct: 189 DEHYTNSIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 28/181 (15%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH-RNLVKLLGC 579
K+G G FG +Y G I G+E+A+K + E+ + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 580 CTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638
+ D V+V E L SL D F F S+ + + + + Y+H +
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 639 IHRDLKASNVLLDNEMNPK---ISDFGMARAFGLDQTEANTNRVV---------GTYGYM 686
IHRD+K N L+ I DFG+A+ + +A T++ + GT Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIPYRENKNLTGTARYA 182
Query: 687 S 687
S
Sbjct: 183 S 183
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 46/219 (21%)
Query: 521 NKLGEGGFGPVYKGM-LIEGQEIAVK---RLSKSSGQGVEEFKNEALLIAKLQHR----- 571
+ +G+G FG V K +E + +A+K Q + E L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 572 -NLVKLLGCCTQRDERVLVYEYL-PN-----KSLDYFIFDTTRSKVLDWQNRCHIIGGIA 624
+V L R+ LV+E L N ++ ++ ++ Q +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ--------MC 167
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGT 682
LL+L L IIH DLK N+LL N KI DFG + + +
Sbjct: 168 TALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQRIYQ 217
Query: 683 Y----GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
Y Y SPE + G+ + + D++S G +++E+ +G+
Sbjct: 218 YIQSRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 34/196 (17%), Positives = 65/196 (33%), Gaps = 34/196 (17%)
Query: 520 ENKLGEGGFGPVYKGM---------LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH 570
++ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 571 RNLVKLLGC------------CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCH 618
KL Q R LV L +SL D + VL ++
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQ 163
Query: 619 IIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAFGLDQT---- 672
+ + L +LH + +H ++ A N+ +D E ++ + +G A +
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 673 -EANTNRVVGTYGYMS 687
E + + G ++S
Sbjct: 221 VEGSRSPHEGDLEFIS 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 42/188 (22%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV-KLLGC 579
K+G G FG +Y G + +E+A+K + + E+ + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 580 CTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNR-------CHIIGGIARGLLYLH 631
+ D VLV + L SL D F ++ +R + + + ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLF----------NFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPK---ISDFGMARAFGLDQTEANTNR---------V 679
S +HRD+K N L+ I DFG+A+ + + +T++ +
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNL 173
Query: 680 VGTYGYMS 687
GT Y S
Sbjct: 174 TGTARYAS 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 37/201 (18%), Positives = 67/201 (33%), Gaps = 48/201 (23%)
Query: 522 KLGEGGFGPVYKGMLIEGQEI------AVKRLSKSSGQGVEEFK-----NEALLIAKLQH 570
+G+GGFG +Y + + + VK +G E K + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 571 RNLVKLLG----------CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR---- 616
+K LG + R ++ + L K+ + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ---------KIYEANAKRFSR 151
Query: 617 ---CHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAFGLDQ 671
+ I L Y+H +H D+KASN+LL+ + ++ D+G+A + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 672 T-----EANTNRVVGTYGYMS 687
GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 43/196 (21%), Positives = 68/196 (34%), Gaps = 44/196 (22%)
Query: 516 NFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH-RNL 573
NF K+G G FG + G L + +A+K S E +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGI 67
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSL-DYFIFDTTRSKVLDWQNR-------CHIIGGIAR 625
++ +V E L SL D F D +R I +
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLIS 116
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAFGLDQTEANTNR-- 678
+ Y+H + +I+RD+K N L+ N I DF +A+ + + T +
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHI 169
Query: 679 -------VVGTYGYMS 687
+ GT YMS
Sbjct: 170 PYREHKSLTGTARYMS 185
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 46/216 (21%)
Query: 523 LGEGGFGPVYKGM-LIEGQEIAVKRL---SKSSGQGVEEFKNEALLIAKLQHR------N 572
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 573 LVKLLGCCTQRDERVLVYEYL-PN-----KSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
++ +L T R+ + +E L N K + F + I +
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS--------ILQC 212
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTY- 683
L LH + RIIH DLK N+LL + K+ DFG + ++ V TY
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVYTYI 260
Query: 684 ---GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y +PE + + + D++S G ++ E+++G
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 6e-08
Identities = 24/134 (17%), Positives = 47/134 (35%), Gaps = 26/134 (19%)
Query: 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPL 82
R+ ++ G+ + G+++ E + L ++ T W +N
Sbjct: 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDH----STSVWASNTGILG 49
Query: 83 SDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGND 142
+ GN V+ ++ +W+S+ R N V VL E GN+V+
Sbjct: 50 KKGC-KAVLQSDGN---FVVYDAEGRSLWASH-SVRGNGNYVLVLQEDGNVVIY------ 98
Query: 143 NDDPDHFLWQSFDY 156
+W + Y
Sbjct: 99 ----GSDIWSTGTY 108
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 41/197 (20%), Positives = 77/197 (39%), Gaps = 44/197 (22%)
Query: 515 DNFSEENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHR 571
++ ++GEG FG +++G L+ Q++A+K + S Q +E++ LL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR-------CHIIGGIA 624
+ + + VLV + L SL+ +LD R +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLED---------LLDLCGRKFSVKTVAMAAKQML 116
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAFGLDQTEANTNR- 678
+ +H S +++RD+K N L+ + + DFGM + + + T +
Sbjct: 117 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY----RDPVTKQH 169
Query: 679 --------VVGTYGYMS 687
+ GT YMS
Sbjct: 170 IPYREKKNLSGTARYMS 186
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 85/641 (13%), Positives = 172/641 (26%), Gaps = 177/641 (27%)
Query: 228 MPQLQPNPVYTFEFVSNENEVFYRFKLINSSVPTMMVI-NTIGDVQRFTWMEHTKKWGLF 286
+ + V F+ + + + L + +++ + + R W +K+ +
Sbjct: 22 LSVFEDAFVDNFDC--KDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV 79
Query: 287 ARFSGTILDQCDNYALC---------GP------YASC--NIHSDSPDC----------- 318
+F +L NY P Y +++D+
Sbjct: 80 QKFVEEVLRI--NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 319 ----ECLEGFEPKSPGDWYMLDKSGGCG---------RKTPLNCKHGDG-F-LKLKTVKV 363
+ L P ++D G G + CK F L LK
Sbjct: 138 LKLRQALLELRP---AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 364 PD-------TRYAQVDKNIILL------------ECKELCSRNCSCTAYANS-----DVR 399
P+ Q+D N + R Y N +V+
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 400 GGGS------GCLLWFHDLI---DIKVLPEIGQDIYVRMAASELGKIERRKQQRK--AKQ 448
+ C + L+ +V + ++ + + K
Sbjct: 255 NAKAWNAFNLSCKI----LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 449 VTIIITSI-LLATGVILLGAIVYIWKKKHRNYGKTDDRQELYSNEKGSSKEEMELPIFDW 507
+ + + I + R+ T D + + +K ++ E L + +
Sbjct: 311 LDCRPQDLPREVLTTNPR-RLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLE- 367
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLI--EGQEIAVKRLS----KSSGQGVEEFKNE 561
E + ++ + + I LS V N+
Sbjct: 368 ----------PAEYR-------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 562 ---ALLIAKLQHRNLVKLLGC-----CTQRDE----RVLVYEYLPNKSLDYFIFDTTRSK 609
L+ K + + + +E R +V Y K+ D D
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS---DDLIPP 467
Query: 610 VLD--WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA 666
LD + IG HH + R V LD + KI A
Sbjct: 468 YLDQYF---YSHIG---------HHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW- 514
Query: 667 FGLDQTEANTNRVVGTY-GYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVSGKRNRGFYHA 724
+ NT + + Y Y+ D + + + F L K +
Sbjct: 515 -NASGSILNTLQQLKFYKPYICDN---DPKYERLVNAILDF----LP----KIEENLICS 562
Query: 725 DHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQ 765
+ +LL ++ + D+++++ EA + +Q
Sbjct: 563 KYT-DLL----RIALMAE-----DEAIFE-----EAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-06
Identities = 62/419 (14%), Positives = 126/419 (30%), Gaps = 116/419 (27%)
Query: 476 HRNYGKTDDRQELYSNEKGSSKEEMELPIF--------DWKTIVDATDN-FSEENKLGEG 526
H ++ + + Y + L +F D K + D + S+E
Sbjct: 3 HHHHMDFETGEHQYQYKD-------ILSVFEDAFVDNFDCKDVQDMPKSILSKE------ 49
Query: 527 GFGPVYKGMLIEGQEIAVKR-----LSKSSGQGVEEFKNEAL------LIAKLQHRNLVK 575
+++ ++ L + V++F E L L++ ++
Sbjct: 50 ----EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE---- 101
Query: 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSR 635
Q +Y ++ +++ + +R + + LL L
Sbjct: 102 ----QRQPSMMTRMYIEQRDR-----LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 636 LRIIHRDL---K---ASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
+ +I L K A +V L ++ K+ DF + F L+ N+ V +
Sbjct: 153 V-LIDGVLGSGKTWVALDVCLSYKVQCKM-DFKI---FWLNLKNCNSPETV-----LEML 202
Query: 690 ----YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL--LGHAWQLWIQD-- 741
Y ID ++ +SD S L + + + R + + L L + +
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262
Query: 742 ----------RPAELIDKSLYDSCSLSEAIRCIQV------------GLL--CVQQIPED 777
R K + D S + LL + P+D
Sbjct: 263 NLSCKILLTTR-----FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 778 RPN-MLSV---VLMLSGERSLPQPKQPGFFTERNLPESESSSSKQNLSSTNEISFSMLE 832
P +L+ L + E + N + L++ E S ++LE
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK---------LTTIIESSLNVLE 367
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 44/200 (22%), Positives = 72/200 (36%), Gaps = 49/200 (24%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIA---VKRLSKSSGQGVEEFK-----NEALLIAKLQHRN 572
K+G GGFG +Y + ++ A VK + +G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 573 LVKLLG----------CCTQRDERVLVYEYLPNKSLDYFIFDTTR----SKVLDWQNRCH 618
+ LG R R +V E L L I S VL
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQ------ 155
Query: 619 IIGGIARGLL----YLHHDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAFGLDQT 672
+ +L Y+H + +H D+KA+N+LL + ++ +D+G++ + +
Sbjct: 156 ----LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 673 -----EANTNRVVGTYGYMS 687
E GT + S
Sbjct: 209 HKQYQENPRKGHNGTIEFTS 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 70/362 (19%), Positives = 109/362 (30%), Gaps = 125/362 (34%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC 580
KLG G F V+ + + +A+K + KS+ E +E ++LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDE------------IRLLKSV 90
Query: 581 TQRDERVLVYEYLPNKSLDYF------------IFDTTRSKVLDWQNRC----------- 617
D E + + LD F +F+ +L W +
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE------------------------ 653
II + +GL YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 654 -------------------------MNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSP 688
+ KI+D G A TE + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSL 262
Query: 689 EYAIDGLFSVKSDVFSFGVLVLEIVSGK-----RNRGFYHADHRH-----NLLG----HA 734
E I ++ +D++S + E+ +G + Y D H LLG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 735 WQLWIQ-----------DRPAELIDKSLYDSC------SLSEAIRCIQVGLLCVQQIPED 777
+L L++ S EA L ++ IPE
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 778 RP 779
R
Sbjct: 383 RA 384
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 22/130 (16%), Positives = 46/130 (35%), Gaps = 26/130 (20%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
+++S S+ G ++ S+ L ++ G W +N S
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCN-----FVLYDS----GKPVWASNTGGLGS 51
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDN 143
L + GN LV+ + +N ++W + + + V VL + N+V+
Sbjct: 52 GCRLTLHNN--GN---LVIYDQSNRVIWQTKTNGKED-HYVLVLQQDRNVVIY------- 98
Query: 144 DDPDHFLWQS 153
+W +
Sbjct: 99 ---GPVVWAT 105
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.0 bits (110), Expect = 1e-05
Identities = 22/167 (13%), Positives = 49/167 (29%), Gaps = 9/167 (5%)
Query: 19 TASTRDAISLGQSIREGETVVSASESFELGFFSPGKS--KSRYLGIWFKKIATGTVTWVA 76
+ Q++ G+ ++S ++ F+L G + +W + +
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIP 69
Query: 77 NRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVK 136
R+ L+ + + +S S N ++L+ +V
Sbjct: 70 LRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVL 124
Query: 137 EKDGNDNDDPDHFLWQSFDYPSHTLLAGMKL--GVNLVTGLNRLMSS 181
+ S L G +L GV G ++L+
Sbjct: 125 VDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 23/125 (18%), Positives = 40/125 (32%), Gaps = 27/125 (21%)
Query: 29 GQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGV 88
GQ++ ++ + + + L + L + G W +N D
Sbjct: 8 GQTLHADHSLQAGA--YTLTIQNKCN-----LVKYQN----GRQIWASNTDR--RGSGCR 54
Query: 89 LSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDH 148
L++ GN LV+ + N+ VW S VL + G V+
Sbjct: 55 LTLLSDGN---LVIYDHNNNDVWGSACWGDNG-KYALVLQKDGRFVIY----------GP 100
Query: 149 FLWQS 153
LW
Sbjct: 101 VLWSL 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-05
Identities = 23/130 (17%), Positives = 46/130 (35%), Gaps = 25/130 (19%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
D ++ G + G ++ + + L ++ W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS 50
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDN 143
VL M GN LV+ + + +W+SN +R N +L N+V+ + N
Sbjct: 51 GC--VLKMQNDGN---LVIYSGSR-AIWASN-TNRQNGNYYLILQRDRNVVIYDNSNN-- 101
Query: 144 DDPDHFLWQS 153
+W +
Sbjct: 102 -----AIWAT 106
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 26/130 (20%), Positives = 44/130 (33%), Gaps = 27/130 (20%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
+ + G+++ GE + + L ++ W N
Sbjct: 2 NILYSGETLSPGEF--LNNGRYVFIMQEDCN-----LVLYDV----DKPIWATNTGGL-- 48
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDN 143
DR LSM GN LV+ + N+ +W+SN N V VL + N+V+
Sbjct: 49 DRRCHLSMQSDGN---LVVYSPRNNPIWASNTGGENG-NYVCVLQKDRNVVIY------- 97
Query: 144 DDPDHFLWQS 153
W +
Sbjct: 98 ---GTARWAT 104
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 38/181 (20%)
Query: 498 EEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS------- 550
+ +E+ W + E+ +G+G + + ++ I +R+ K
Sbjct: 322 DMVEVN---WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLD 378
Query: 551 SGQGVEEFKNEALLIAKLQHRNLVKLLGCCT------QRDERVLVYEYLPNKSLDYFIFD 604
EA + LVK G D + ++ Y+ K I D
Sbjct: 379 ENIRKSRTAREARYL------ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED 432
Query: 605 TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664
+ + IG + LH + +IH DL SN + D ++ I DFG+
Sbjct: 433 NL--------DIAYKIG---EIVGKLH---KNDVIHNDLTTSNFIFDKDL--YIIDFGLG 476
Query: 665 R 665
+
Sbjct: 477 K 477
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 54/232 (23%)
Query: 522 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALL-IAKLQH--------R 571
K+G+G FG V + + AVK + ++ ++++ A + L+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNN 96
Query: 572 NLVKLLGCCTQRDERVLVYEYL-PN-----KSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
N+VK G D L++E L P+ +Y F K+ + I +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIE--------ILK 148
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR------- 678
L YL ++ + H DLK N+LLD+ K G T
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 679 -------------VVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
++ T Y +PE I L + V SD++SFG ++ E+ +G
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 16/114 (14%), Positives = 38/114 (33%), Gaps = 15/114 (13%)
Query: 22 TRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAP 81
R+ + Q + + + + + L + K + + W +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-------LVLTKGSKTNIVWESGTSG- 54
Query: 82 LSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVV 135
+ + + G L + + + V+ SN V + + V +L +G VV
Sbjct: 55 -RGQHCFMRLGHSGE---LDITDDRLNTVFVSNTVGQEG-DYVLILQINGQAVV 103
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 48/235 (20%), Positives = 84/235 (35%), Gaps = 64/235 (27%)
Query: 522 KLGEGGFGPVYKGM--LIEGQEIAVKRLSKSSGQGVEEFKNEALL-IAKLQH-------- 570
LGEG FG V + + ++A+K + + V +++ A L I L+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 571 -RNLVKLLGCCTQRDERVLVYEYL-PN-----KSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
V + + +E L N K ++ + + + +Q +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ--------L 132
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMA 664
L +LH ++ H DLK N+L N +++DFG A
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 665 RAFGLDQTEANTN--RVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
T + + +V T Y PE I L ++ DV+S G ++ E G
Sbjct: 190 -------TFDHEHHTTIVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 4e-04
Identities = 15/66 (22%), Positives = 25/66 (37%), Gaps = 6/66 (9%)
Query: 70 GTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLE 129
W N + + G LV++ + N VW S + +A + V VL
Sbjct: 48 NNPIWATNTGGLGNG--CRAVLQPDGV---LVVITNENVTVWQSPVAGKAG-HYVLVLQP 101
Query: 130 SGNLVV 135
N+V+
Sbjct: 102 DRNVVI 107
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 18/117 (15%), Positives = 40/117 (34%), Gaps = 18/117 (15%)
Query: 19 TASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANR 78
T + + GQ + + + ++ +L L ++ K + T
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLYGGKYGWQSNTHGNGE 54
Query: 79 DAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVV 135
L ++ +G L++ + +WSS S+ V +L + G V+
Sbjct: 55 HC-------FLRLNHKGE---LIIKDDDFKTIWSSRSSSKQG-EYVLILQDDGFGVI 100
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 6e-04
Identities = 25/131 (19%), Positives = 41/131 (31%), Gaps = 30/131 (22%)
Query: 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPL 82
+ + GQ++ + + F+L Y G W + T RD
Sbjct: 3 TNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL-VLYNGNWQ------SNTANNGRDC-- 51
Query: 83 SDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGND 142
L+++ G LV+ N VW S N AV+ G LVV
Sbjct: 52 -----KLTLTDYGE---LVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRLVVF------ 96
Query: 143 NDDPDHFLWQS 153
+++
Sbjct: 97 ----GPSVFKI 103
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.81 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.8 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.78 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.76 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.71 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.63 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.6 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.57 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.53 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.5 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.39 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.12 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.06 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.86 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.83 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.8 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.6 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.6 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.13 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.72 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.73 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.7 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.92 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=441.59 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=213.9
Q ss_pred cCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|...++||+|+||+||+|++. ++..||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778889999999999999874 377899999987777777899999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccC----------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 589 VYEYLPNKSLDYFIFDTT----------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
|||||++|+|.+++.... ....++|.+++.++.|||+||+|||+.+ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996532 2456999999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... . ....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~----~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---E----VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---H----HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHH
Confidence 99999997754444333444679999999999999999999999999999999998 89997532211 1 1122
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+... ..+...+..+.+|+.+||+.||++||||.||++.|+..
T Consensus 243 i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222211 11222345788999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=446.27 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=207.6
Q ss_pred cCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999874 378899999987777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCC------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 589 VYEYLPNKSLDYFIFDTTR------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
|||||++|+|.++++.... ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999865321 246999999999999999999999987 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...... . ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~----~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---E----AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---H----HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---H----HH
Confidence 9999999998754444334445789999999999999999999999999999999999 89997532211 1 11
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
.....+... ..+...+..+.+|+.+||+.||++||||.||++.|+.+...
T Consensus 271 ~~i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 112222111 11222345788999999999999999999999999986543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=439.61 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=211.1
Q ss_pred CCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
+++..++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556779999999999999973 46889999997543 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC
Q 003272 589 VYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN 655 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 655 (834)
|||||++|+|.++|..... ...++|..+++|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964321 245999999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHH
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHA 734 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 734 (834)
+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~---- 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV---- 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HH----
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HH----
Confidence 99999999987754443344445789999999999999999999999999999999998 88897532211 11
Q ss_pred HHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
......+... ..+...+..+.+|+.+||+.||++||||.||++.|+...
T Consensus 257 ~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 VEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1112222111 122234457889999999999999999999999998643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=427.68 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=201.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.+++...++||+|+||+||+|++.+ .||||+++.. .....++|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567788899999999999998743 6999998643 34456789999999999999999999999865 56899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
||++|+|.++++.. ...++|..+..|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999998643 346999999999999999999999987 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.........||+.|||||++.. .+|+.++|||||||+||||+||+.||....... ........+. ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----AS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CC
Confidence 3333445789999999999964 469999999999999999999999975322111 1111111111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+.+ ...+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 111223345788899999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=428.65 Aligned_cols=269 Identities=26% Similarity=0.360 Sum_probs=217.0
Q ss_pred cCHHHHHHHhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccC-CceeeE
Q 003272 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQH-RNLVKL 576 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l 576 (834)
++.++.+...++|+..++||+|+||+||+|.+.. ++.||||+++... ....++|.+|+.++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444555567889999999999999999999753 3689999997653 3445789999999999965 999999
Q ss_pred EEEEEeC-CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEecc
Q 003272 577 LGCCTQR-DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRD 642 (834)
Q Consensus 577 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 642 (834)
+|+|.+. +..++|||||++|+|.++|..... ...++|.+++.++.|||+||+|||+.+ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999965321 345899999999999999999999998 99999
Q ss_pred CCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003272 643 LKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGF 721 (834)
Q Consensus 643 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~ 721 (834)
|||+||||++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765544444455789999999999999999999999999999999998 8999753
Q ss_pred CCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 722 YHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..... ........+... ..+.....++.+++.+||+.||++|||+.||++.|+..
T Consensus 291 ~~~~~------~~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSH------HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22211 111112222111 11222334688999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=416.33 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=207.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.+.|+..++||+|+||+||+|+... |+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3568899999999999999999864 899999999776666667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
|++|+|.+++.. ..+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998853 35899999999999999999999998 99999999999999999999999999998754322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ... ...........+-
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~----~~~i~~~~~~~~~----- 291 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKA----MKMIRDNLPPRLK----- 291 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH----HHHHHHSSCCCCS-----
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH----HHHHHcCCCCCCC-----
Confidence 23347899999999999999999999999999999999999999753211 111 1111111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
........+.+|+.+||+.||++|||+.|+++
T Consensus 292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122346788999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=418.99 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=201.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||+||+|+... |+.||||++... .....++|.+|+.++++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999754 899999999754 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999998543 3445789999999999999999999998 999999999999999999999999999976422
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..+ ......+....
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~----~~~i~~~~~~~------ 244 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNL----VLKIISGSFPP------ 244 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----HHHHHHTCCCC------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH----HHHHHcCCCCC------
Confidence 1222346899999999999999999999999999999999999999853211 111 11111221111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346788999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=418.03 Aligned_cols=267 Identities=22% Similarity=0.266 Sum_probs=199.6
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC----eeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD----ERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 590 (834)
++|...++||+|+||+||+|++ .|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577788999999999999998 789999999965322 1222344666667889999999999998764 579999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-----CCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
|||++|+|.+++.. ..++|..+.+++.|+++||+|||++ ..++|+||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 3589999999999999999999987 23459999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc--------c
Q 003272 666 AFGLDQTE--ANTNRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH--------N 729 (834)
Q Consensus 666 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~--------~ 729 (834)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||..|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443222 222346799999999999764 3678999999999999999998876532221100 0
Q ss_pred hhHHHHHHhhccCcccccCccccC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYD-SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
........... ...++.+.. ..+.+.+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 237 ~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111111111 112222211 11234566788999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=413.63 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=201.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+.|+..++||+|+||+||+|+... |+.||||+++.... +.+|+.++++++|||||++++++.+.+..+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 457788899999999999999754 89999999975322 246999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccCCCcc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGLDQT 672 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 672 (834)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999954 346999999999999999999999988 99999999999999987 699999999998754322
Q ss_pred c---cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 673 E---ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 673 ~---~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+.... ..+...
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i----~~~~~~----- 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKI----ASEPPP----- 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHH----HHSCCG-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHH----HcCCCC-----
Confidence 1 1123367999999999999999999999999999999999999998533221 111111 111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+......+.+++.+||+.||++|||+.||++.|...
T Consensus 275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0011222334678899999999999999999999887543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=401.31 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=195.6
Q ss_pred cccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeEEEE
Q 003272 518 SEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERVLVY 590 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 590 (834)
+..++||+|+||+||+|.... ++.||||++... .....++|.+|+.++++++|||||++++++.. .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 556689999999999999865 889999999653 33456789999999999999999999999865 34579999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~~~ 669 (834)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++ .+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999954 356999999999999999999999875 3599999999999998 478999999999986432
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||...... .........+......
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~-- 251 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF-- 251 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG--
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCC--
Confidence 2 2234789999999998865 6999999999999999999999997522111 1111122221111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 252 --~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --DKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 235778999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=417.67 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=207.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.+.|+..++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4679999999999999999999854 899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
|++|+|.+++.. ..+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998853 35899999999999999999999998 99999999999999999999999999998754322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ... ........... +.
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~----~~~i~~~~~~~-----~~ 368 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKA----MKMIRDNLPPR-----LK 368 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH----HHHHHHSCCCC-----CS
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH----HHHHHcCCCCC-----Cc
Confidence 23347899999999999999999999999999999999999999753211 111 11111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
........+.+|+.+||+.||++|||+.|+++
T Consensus 369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112346788999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=409.38 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=207.8
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||+||+++... |+.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999754 899999999753 3345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999854 346999999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ..+ ......... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~----~~~i~~~~~------~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLI----FAKIIKLEY------D 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCC------C
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHHcCCC------C
Confidence 444445567999999999999999999999999999999999999999853211 111 111111111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
.+......+.+|+.+||+.||++|||++|+.
T Consensus 253 ----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 ----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111223678899999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=391.27 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=188.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 4899999999754 2344568999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 5788888753 346999999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.... ...+ ......+...
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~----~~~i~~~~~~----- 230 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVL----FKNISNGVYT----- 230 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHHTCCC-----
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHH----HHHHHcCCCC-----
Confidence 2 2234789999999999998876 579999999999999999999985321 1111 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+ +......+.+|+.+||+.||++|||+.|+++
T Consensus 231 -~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1112346788999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=398.95 Aligned_cols=247 Identities=23% Similarity=0.277 Sum_probs=194.5
Q ss_pred cCCcccCccccCCcccEEEEEEe----CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..++||+|+||+||+|+.. .++.||||++++.. .....++.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999863 37889999997542 2334578899999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999854 346999999999999999999999998 9999999999999999999999999998753
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... ......+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ..+ ..........
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~----~~~i~~~~~~---- 244 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KET----MTMILKAKLG---- 244 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHCCCC----
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHH----HHHHHcCCCC----
Confidence 322 223347899999999999999999999999999999999999999753221 111 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
.+......+.+|+.+||+.||++||| ++|+++
T Consensus 245 ------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11112346788999999999999998 466653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=395.18 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=188.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC--------
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-------- 584 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 584 (834)
++|+..++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999975 48999999997543 334568999999999999999999999987654
Q ss_pred ----eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEee
Q 003272 585 ----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISD 660 (834)
Q Consensus 585 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 660 (834)
..++||||+++|+|.+++.........++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976554455677888999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCcccc----------ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 003272 661 FGMARAFGLDQTEA----------NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730 (834)
Q Consensus 661 fGla~~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 730 (834)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.. ..+ .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--~~~---~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--QME---R 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--HHH---H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--ccH---H
Confidence 99999875432211 1223579999999999999999999999999999999996 5431 000 0
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ............ ........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 011111111100 01112234567999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=384.11 Aligned_cols=284 Identities=34% Similarity=0.569 Sum_probs=243.4
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
++.++...+++|+..+.||+|+||.||+|.+.+++.||||++........+++.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33445557789999999999999999999987899999999987766777899999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCC-CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR-SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
.++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999865332 235899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+...............||+.|+|||++.+..++.++||||||+++|||++|+.|+.............+.......+...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 87543333223334568999999999999999999999999999999999999987554444444554444555556667
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+++.+...........+.+++.+||+.||++||++.||++.|+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 777877777778888999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=388.22 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=198.4
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEe------CCe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ------RDE 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 585 (834)
++|+..++||+|+||+||+|+.. .|+.||||+++... ....+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 49999999997542 3345678899999999999999999999764 356
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.+||||||+ |+|..++. ....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67888874 3457999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc--cccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 666 AFGLDQ--TEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 666 ~~~~~~--~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||......+ .............
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence 764322 12223457899999999998875 56999999999999999999999985322211 1111111111000
Q ss_pred ccc-----------ccCccc-cCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAE-----------LIDKSL-YDSCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~-----------~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... .+.... ....+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000 000011 11236778999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=377.00 Aligned_cols=291 Identities=41% Similarity=0.657 Sum_probs=243.8
Q ss_pred CcCccCHHHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEE
Q 003272 501 ELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGC 579 (834)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~ 579 (834)
.+..|++.++....++|+..++||+|+||.||+|...+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 355689999999999999999999999999999998789999999997543 2233478999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 580 CTQRDERVLVYEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 580 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
+...+..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+....+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999987543 3345999999999999999999999983233999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cccccchhHHHHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYH--ADHRHNLLGHAWQ 736 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~--~~~~~~~~~~~~~ 736 (834)
+|||+++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.|++... .........+...
T Consensus 176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999998775433222 233568999999999999999999999999999999999999985321 1222333344444
Q ss_pred HhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 737 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.........+.+..+...........+.+++.+||+.||++|||+.||+++|++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 44555667777777778888889999999999999999999999999999999753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=367.41 Aligned_cols=229 Identities=14% Similarity=0.201 Sum_probs=178.3
Q ss_pred cccccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCC----CceEEEEecC
Q 003272 20 ASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDR----SGVLSMSRRG 95 (834)
Q Consensus 20 ~~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~----~~~l~l~~~G 95 (834)
+++.|+|++||+|.+|++|+|++|.|+||||.++ ++|| |+ +.+ |||+||||+|+.++ +++|+|+.||
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 4578999999999999999999999999999542 5677 76 667 99999999999875 7899999999
Q ss_pred CcceEEE--ecCCCceEEEeeccccc----CCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCCeeee
Q 003272 96 NGTALVL--LNSTNDIVWSSNIVSRA----AQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKLGV 169 (834)
Q Consensus 96 ~~~~lvl--~~~~~~~vWst~~~~~~----~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~~l~~ 169 (834)
+ ||| .|++|.+||||++.... ..+++|+|+|+|||||++ + .+|||| |||||||||||||.
T Consensus 82 ~---Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~-------~~lWqS--~ptdtlLpg~~~~~ 147 (276)
T 3m7h_A 82 Q---YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--S-------LALWNG--TPAIPLVPGAIDSL 147 (276)
T ss_dssp S---SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--E-------EEEEES--CTTSCCCCSCTTCE
T ss_pred c---EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--C-------ceeeCc--cccccccccccccc
Confidence 9 888 78889999999964311 235689999999999994 2 399999 99999999999999
Q ss_pred eeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEec-CCeeEEeeCCCCcceeecCCCcCCCCceEEEEeecCc-e
Q 003272 170 NLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKK-GSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNEN-E 247 (834)
Q Consensus 170 ~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~y~~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~-~ 247 (834)
++++|.. | ++.+||++|.|+++++++|. +++++ +..+||++|+|++.. ..+.-+..-.+.+.++.+ .
T Consensus 148 ~l~~g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~ 216 (276)
T 3m7h_A 148 LLAPGSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAV 216 (276)
T ss_dssp EECSSEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCE
T ss_pred ccccCcc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcE
Confidence 9998765 5 67899999999999999995 44444 468999999997532 111112222333334333 3
Q ss_pred EEEEEEecCCCceeEEEEcccCcEEEEEEecCCceeEEEE
Q 003272 248 VFYRFKLINSSVPTMMVINTIGDVQRFTWMEHTKKWGLFA 287 (834)
Q Consensus 248 ~~~~~~~~~~s~~~~~~l~~~G~l~~~~w~~~~~~w~~~~ 287 (834)
..++++ ......|++|+.||++++|.| ...|..++
T Consensus 217 vWsS~t--~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~ 251 (276)
T 3m7h_A 217 LWHSHT--GGHASAVLRLQANGSIAILDE---KPVWARFG 251 (276)
T ss_dssp EEECSC--TTCTTCEEEECTTSCEEEEEE---EEEEESSS
T ss_pred EEEecC--CCCCCEEEEEcCCccEEEEcC---CCeEEccC
Confidence 333333 233458999999999999998 24565554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=375.83 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=170.2
Q ss_pred HHhcCCcccCccccCCcccEEEEEEe----CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCee
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 586 (834)
...++|+..++||+|+||+||+|+.. .++.||||++.... ...++.+|++++..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34678999999999999999999864 36789999986543 345788999999998 699999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeecccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 665 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~ 665 (834)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999882 4899999999999999999999998 9999999999999877 799999999998
Q ss_pred ccCCCccc--------------------------cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 003272 666 AFGLDQTE--------------------------ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 666 ~~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p 718 (834)
........ ......+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432111 111235799999999999875 589999999999999999999999
Q ss_pred CC
Q 003272 719 RG 720 (834)
Q Consensus 719 ~~ 720 (834)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 74
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=356.04 Aligned_cols=284 Identities=36% Similarity=0.569 Sum_probs=232.2
Q ss_pred CCcCccCHHHHHHHhcCCccc------CccccCCcccEEEEEEeCCeEEEEEEeccc----CcccHHHHHHHHHHHHhcc
Q 003272 500 MELPIFDWKTIVDATDNFSEE------NKLGEGGFGPVYKGMLIEGQEIAVKRLSKS----SGQGVEEFKNEALLIAKLQ 569 (834)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~------~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~ 569 (834)
...+.|++.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 456779999999999999877 8999999999999987 6889999998653 2344678999999999999
Q ss_pred CCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcee
Q 003272 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649 (834)
Q Consensus 570 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 649 (834)
||||+++++++...+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999875545567999999999999999999999988 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 003272 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729 (834)
Q Consensus 650 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~ 729 (834)
+++++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.|+........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 99999999999999987654333333344678999999998765 588999999999999999999999764332221
Q ss_pred hhHHHHHHhh--ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 730 LLGHAWQLWI--QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 730 ~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
+.. ...... .......+++.+ ...+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLD-IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTH-HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHH-HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111 111111 122334444433 3346667788999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=389.99 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=206.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|++.++||+|+||.||+++... |+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 689999999999999999999854 8999999997766666778999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC--CCeEEeeeccccccCCCc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DfGla~~~~~~~ 671 (834)
++|+|.+++.. +...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999988843 2356899999999999999999999998 9999999999999854 899999999999875332
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .. ......... . +....
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~----~~~i~~~~~-~-~~~~~ 379 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET----LRNVKSCDW-N-MDDSA 379 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH----HHHHHTTCC-C-CCSGG
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH----HHHHHhCCC-C-CCccc
Confidence 2 23468999999999999999999999999999999999999997532211 11 111111110 0 01111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... ...+.+|+.+||+.||++||++.|+++
T Consensus 380 ~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112 236778999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=388.18 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=197.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHH---HHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNE---ALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..++||+|+||+||+++... |+.||||++.+.. ......+.+| +.++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999999865 8999999996531 2233334444 5566677999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+|||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 346999999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
+.... ....+||+.|||||++.. ..|+.++||||+||+||||++|+.||....... ... .........+
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~-i~~~i~~~~~-- 411 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHE-IDRMTLTMAV-- 411 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHH-HHHHHHHCCC--
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHH-HHHhhcCCCC--
Confidence 64332 234789999999999975 579999999999999999999999985322211 111 1111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
..+......+.+|+.+||+.||++|++ +.||.+
T Consensus 412 --------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 --------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111122346788999999999999998 677763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=362.14 Aligned_cols=267 Identities=27% Similarity=0.411 Sum_probs=203.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
..++|+..++||+|+||+||+|.. .++.||||++.... ....++|.+|+.++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788999999999999999987 78999999987543 344568999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999965443345999999999999999999999875 34999999999999999999999999999865332
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. .........
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~---~~~~~~~~~------- 257 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV---AAVGFKCKR------- 257 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH---HHHHHSCCC-------
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhcCCC-------
Confidence 2 11233678999999999999999999999999999999999999975332111 10 000001000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPK 798 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~ 798 (834)
...+......+.+++.+||+.||++||++.||++.|+.......|+
T Consensus 258 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 258 --LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0111222346788999999999999999999999999875544333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.91 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=210.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|...++||+|+||+||++.... ++.||+|++........+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 578889999999999999999854 8899999997767777789999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999998653 346899999999999999999999998 999999999999999999999999999876433221
Q ss_pred cc------------cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 674 AN------------TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 674 ~~------------~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--------- 235 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------- 235 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---------
Confidence 11 113578999999999999999999999999999999999999875433322111000
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.....+.. .+...+..+.+++.+||+.||++||++.||++.|+...
T Consensus 236 -~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 -VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00001111 11112235778999999999999999999999998763
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=364.96 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=211.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe--------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++|...+.||+|+||.||+|... ++..||||+++... ....+++.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999863 35679999997653 34567899999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999865431 245899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987654433333344567889999999999999999999999999999999 998875322111
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+. .....+.. ...+......+.+++.+||+.||++||++.||++.|+.+
T Consensus 314 ~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LF----KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH----HHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111111 111222334688899999999999999999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.91 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=207.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe----eEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE----RVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lV 589 (834)
.++|+..++||+|+||+||+|+. .++.||||++.... .....+..|+.++.+++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46799999999999999999987 58999999996543 334456678999999999999999999987543 6999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc----------CCCceEeccCCCCceeecCCCCeEEe
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD----------SRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999854 3489999999999999999999988 6 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH-
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH- 733 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~- 733 (834)
|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999887554443334446799999999999863 456789999999999999999999864333222111110
Q ss_pred --------HHHHhhccCcccccCccccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 734 --------AWQLWIQDRPAELIDKSLYDS-CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 734 --------~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.......... .+.+... ........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111111111 1111110 1224456789999999999999999999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=350.61 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=214.1
Q ss_pred CccCHHHHHHHhcC----------CcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCC
Q 003272 503 PIFDWKTIVDATDN----------FSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHR 571 (834)
Q Consensus 503 ~~~~~~~~~~~~~~----------~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ 571 (834)
+.++++++..+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888764 666779999999999999986 5999999999877667778899999999999999
Q ss_pred ceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 572 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999884 245899999999999999999999988 99999999999999
Q ss_pred CCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 003272 652 NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731 (834)
Q Consensus 652 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~ 731 (834)
.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 9999999999999876543222 23467999999999999999999999999999999999999997532111
Q ss_pred HHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 732 GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.............+.. .......+.+++.+||+.||++||++.|+++
T Consensus 248 -~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 -QAMKRLRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHHHHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111111110 1112346788999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.64 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=206.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|+..++||+|+||+||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999864 5899999999776666678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999854 35899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .....
T Consensus 172 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~-~~~~~----- 237 (297)
T 3fxz_A 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPELQ----- 237 (297)
T ss_dssp C--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-SCCCS-----
T ss_pred c--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCC-----
Confidence 2 233679999999999999999999999999999999999999975322111 111111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+++.+||+.||++||++.|+++
T Consensus 238 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11222346788999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=357.14 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=207.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe----CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..++||+|+||.||+|.+. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356888899999999999999984 3557999999764 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999998542 346899999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 669 LDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 669 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~---- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGY---- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTC----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCC----
Confidence 43222 12223456778999999999999999999999999999999 999974322111 111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
....+......+.+++.+||+.||++||++.||+++|+.....
T Consensus 272 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 -----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0111222334788899999999999999999999999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=363.81 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=214.5
Q ss_pred hcCCcccCccccCCcccEEEEEEe--------CCeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++|...++||+|+||.||+|... .+..||||+++.. .....+++.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468889999999999999999863 2467999999754 334557899999999999 999999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999865431 245999999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++++||++ |+.|+......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987754433333444667889999999999999999999999999999999 99886532211
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPK 798 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~ 798 (834)
............ ..+......+.+++.+||+.||++||++.||++.|+.+.......
T Consensus 301 ---~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 301 ---ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp ---HHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred ---HHHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 111111111111 111122346788999999999999999999999998875443333
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.20 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=202.2
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 58899999986442 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999884 3346999999999999999999999988 9999999999999999999999999998764333
Q ss_pred cccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ . ...+..... ...
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~~~~~~~~--~~~-- 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKT--YLN-- 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--H----HHHHHTTCT--TST--
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHHhcccc--cCC--
Confidence 3333345789999999999988765 7899999999999999999999864322111 0 011111100 000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
........+.+|+.+||+.||++|||+.|+++.
T Consensus 230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011123466789999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.83 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=204.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-----CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC--Cee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 586 (834)
.++|+..++||+|+||+||++++. .++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 367889999999999999999852 4889999999877767778899999999999999999999998654 558
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998643 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--------ccc-hhHHHHH
Q 003272 667 FGLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH--------RHN-LLGHAWQ 736 (834)
Q Consensus 667 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~--------~~~-~~~~~~~ 736 (834)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433221 11223457778999999999999999999999999999999998865321100 000 0000011
Q ss_pred HhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 737 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
... .......+...+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 244 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111 1111112223345788899999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=361.15 Aligned_cols=269 Identities=26% Similarity=0.364 Sum_probs=214.3
Q ss_pred cCHHHHHHHhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeE
Q 003272 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKL 576 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 576 (834)
++..+.....++|+..++||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 455666667889999999999999999999853 25789999997643 34456799999999999 89999999
Q ss_pred EEEEEeCCe-eEEEEeecCCCChhhHhhccCC------------------------------------------------
Q 003272 577 LGCCTQRDE-RVLVYEYLPNKSLDYFIFDTTR------------------------------------------------ 607 (834)
Q Consensus 577 ~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 607 (834)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999865432
Q ss_pred ---------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 608 ---------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 608 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999998 99999999999999999999999999987654433
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .............
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~------ 316 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR------ 316 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCC------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCC------
Confidence 333445678899999999999999999999999999999998 999975322211 1111111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.+......+.+++.+||+.||++||++.||++.|+..
T Consensus 317 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 317 ---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111234678899999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=365.67 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=207.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|...++||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999986 58999999987543 2344578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999998542 345899999999999999999999998 9999999999999999999999999998754332
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.........++..|+|||.+....++.++||||||+++|||++ |+.|+....... .......+..
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~------- 333 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGR------- 333 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCC-------
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 2222222345778999999999999999999999999999998 888865322111 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 334 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 --LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222334678899999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.41 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=208.6
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..++||+|+||.||+|...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5788889999999999999999889999999996543 345789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999854 2346899999999999999999999998 999999999999999999999999999876433221
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... ......... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF---------RL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTC---------CC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcCc---------cC
Confidence 2223556788999999999999999999999999999999 898875322111 111111110 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+......+.+++.+||+.||++||++.|+++.|+...
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 111112346788999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.39 Aligned_cols=257 Identities=29% Similarity=0.402 Sum_probs=210.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..++||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788999999999999999999888899999996543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998543 345899999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
. .....+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... .......... ...
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--~~~---- 226 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHR--LYR---- 226 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC--CCC----
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCC--CCC----
Confidence 2 223456778999999999899999999999999999999 999975332211 1111111110 000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
+......+.+++.+||+.||++||++.|+++.|+...+
T Consensus 227 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 ---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11122367889999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.61 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=196.2
Q ss_pred cCCcccCccccCCcccEEEEEEe----CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..++||+|+||.||+|++. .+..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999875 4778999999754 334567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999998542 346899999999999999999999988 99999999999999999999999999987654
Q ss_pred Ccccc-ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 670 DQTEA-NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~~~-~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+ ......+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~----~~~i~~~------ 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DV----IKAVDEG------ 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HH----HHHHHTT------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcC------
Confidence 32211 1122345678999999999999999999999999999998 99997432211 11 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.....+...+..+.+++.+||+.||++||++.+|+++|+..
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11111223345788999999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=370.69 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=211.0
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|...++||+|+||.||+|.+.. +..||||+++... ...++|.+|+.++++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568888999999999999999876 8899999996543 4568899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999986532 345899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ......++..|+|||++....++.++|||||||++|||++ |+.|+...... ... .....+ .
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~---------~ 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY----ELLEKD---------Y 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH----HHHHTT---------C
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC---------C
Confidence 1 1223456788999999999999999999999999999999 88886532211 111 111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
....+......+.+|+.+||+.||++||++.+|+++|+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11122233457888999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=369.42 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=209.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..++|...++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 456788899999999999999999889999999997543 45789999999999999999999999986 6678999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999998532 1235889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.. .....++..|+|||++....++.++||||||+++|||++ |+.|+...... .. ......+.
T Consensus 340 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~----~~~i~~~~--------- 402 (454)
T 1qcf_A 340 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EV----IRALERGY--------- 402 (454)
T ss_dssp HT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHHHHTC---------
T ss_pred ec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCC---------
Confidence 11 122456788999999999999999999999999999999 99997532211 11 11111110
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
....+...+..+.+++.+||+.||++|||+.+|+++|+....
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 011122234578899999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=349.43 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=203.8
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..+.||+|+||.||+|.. ..|+.||||++... .....+++.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999997 45999999999654 3345677899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999988543 45899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... ........+..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~------ 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRGKY------ 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------
Confidence 2 22346799999999999988765 7999999999999999999997532211 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011122346788999999999999999999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.58 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=200.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..++||+|+||+||+|++.. ++ .||+|.+... .....++|.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 568889999999999999999643 43 4688888543 3456678999999999999999999999998754 789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999998653 346899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............+|..|+|||++.+..++.++||||||+++|||++ |+.|+....... +. ......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~------ 235 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKG------ 235 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTT------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcC------
Confidence 5444433444567889999999999999999999999999999999 999975432211 11 111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.....+......+.+++.+||+.||++||++.||++.|+..
T Consensus 236 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111222344688899999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=341.98 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=213.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC--eeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD--ERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 590 (834)
++|...++||+|+||+||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 578899999999999999999865 8999999997543 345678899999999999999999999998765 679999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee----cCCCCeEEeeeccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARA 666 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla~~ 666 (834)
||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555555999999999999999999999998 9999999999999 7888899999999987
Q ss_pred cCCCccccccccccccccccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAI--------DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
...... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... .. .....
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~-~~~~~ 239 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE-VMYKI 239 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HH-HHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HH-HHHHH
Confidence 644322 22357899999999986 578899999999999999999999997543322211 11 11111
Q ss_pred hccCccccc---------------CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 739 IQDRPAELI---------------DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 739 ~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+.+...+ +..............+.+++.+||+.||++||++.|+++-.+...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111111100 001112344566778889999999999999999999999887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=344.42 Aligned_cols=260 Identities=18% Similarity=0.194 Sum_probs=206.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+|... +++.||||++..... .+++.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 367899999999999999999964 589999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC-----eEEeeeccccc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA 666 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DfGla~~ 666 (834)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998643 356999999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 667 FGLDQTEA-----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 667 ~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA- 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence 64332211 123467999999999999999999999999999999999999998654322211111111000000
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+ .+... .+ .+.+++..||+.||.+||++.+|++.|+..
T Consensus 239 ~~~~----~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPIE----VLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCHH----HHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCHH----HHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000 00111 12 678899999999999999999999999643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.48 Aligned_cols=259 Identities=30% Similarity=0.419 Sum_probs=207.2
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..++||+|+||.||+|.+. .++.||||+++.. ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999953 3678999999654 344556789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccC----CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC---CeEEe
Q 003272 587 VLVYEYLPNKSLDYFIFDTT----RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM---NPKIS 659 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~ 659 (834)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986532 2245899999999999999999999998 99999999999999555 59999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..|+....... .....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 9999986533222222334667899999999999999999999999999999998 988875322111 11111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+.. ...+......+.+|+.+||+.||++||++.||++.|+..
T Consensus 300 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 011122234678899999999999999999999999755
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.95 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=212.5
Q ss_pred HHhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD 584 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 584 (834)
...++|+..+.||+|+||.||+|+..+ ++.||||+++... ....+.|.+|+.++++++||||+++++++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 346789999999999999999999853 4889999997643 344578999999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccCC---------------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccC
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTR---------------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDL 643 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL 643 (834)
..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999865321 256899999999999999999999998 999999
Q ss_pred CCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003272 644 KASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFY 722 (834)
Q Consensus 644 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~ 722 (834)
||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987644332223334567889999999999999999999999999999999 99887532
Q ss_pred CcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 723 HADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
... ........+.... .+......+.+++.+||+.||++||++.+|++.|+....
T Consensus 281 ~~~-------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 281 AHE-------EVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CHH-------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ChH-------HHHHHHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 111 1111111211111 112223468889999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.37 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=211.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|...+.||+|+||.||++... +++.||||+++... ....+++.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467889999999999999999863 35789999997543 34567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCC---------------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003272 587 VLVYEYLPNKSLDYFIFDTTR---------------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKA 645 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 645 (834)
++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999865432 234899999999999999999999998 99999999
Q ss_pred CceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 003272 646 SNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHA 724 (834)
Q Consensus 646 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~ 724 (834)
+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987754433333334567889999999999999999999999999999999 9998753322
Q ss_pred ccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 725 DHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.. +. ......... ..+......+.+++.+||+.||++||++.||++.|+..
T Consensus 259 ~~---~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ER---LF----NLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG---HH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HH----HHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 11 111111111 11122334688899999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=338.68 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=196.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC----cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS----GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||+|.. .++.||||+++... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999997 58999999986542 23457899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC--------CCCeEEeee
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN--------EMNPKISDF 661 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--------~~~~kl~Df 661 (834)
|||+++++|.+++. ...+++..+..++.||+.||.|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999883 346899999999999999999999987666999999999999986 778999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
|+++....... ....|++.|+|||.+.+..++.++||||||++++||++|+.|+....... ..... ...
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~ 229 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGV-AMN 229 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHH-HTS
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhh-hcC
Confidence 99987543221 23578999999999999999999999999999999999999975322111 01111 111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
. .....+......+.+++.+||+.||++||++.|+++.|+.
T Consensus 230 ~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 K--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 1111122233468889999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=343.60 Aligned_cols=261 Identities=25% Similarity=0.330 Sum_probs=205.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||++... .++.||+|++.... ....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 367999999999999999999975 48899999985432 33457889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 46899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....... .......
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~-~~~~~~~--- 232 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHI-QDSVPNV--- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHH-SSCCCCH---
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHh-hccCCCc---
Confidence 222 2223367899999999999999999999999999999999999997532211 1111111 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-NMLSVVLMLSGERS 793 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~~~ 793 (834)
........+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0011112234678899999999999998 99999999987644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=342.04 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=205.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..++||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46788899999999999999999888899999996543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999998542 345999999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ......... .
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 239 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL---------R 239 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC---------C
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhccc---------C
Confidence 1223456788999999999999999999999999999998 999975432211 111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011111234678899999999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=351.49 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=208.7
Q ss_pred HhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
..++|...+.||+|+||.||+|... .+..||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999962 3568999999754 334567899999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccCC--------------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCC
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTR--------------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK 644 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 644 (834)
..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999865432 134899999999999999999999998 9999999
Q ss_pred CCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 003272 645 ASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYH 723 (834)
Q Consensus 645 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~ 723 (834)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333334567889999999999999999999999999999998 999875432
Q ss_pred cccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 724 ADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
... . ........ .....+......+.+++.+||+.||++||++.||++.|+....
T Consensus 280 ~~~--~----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDA--N----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSH--H----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHH--H----HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 211 0 11111111 0011112223468889999999999999999999999987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.40 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=199.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHh--ccCCceeeEEEEEEeC----CeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAK--LQHRNLVKLLGCCTQR----DERV 587 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 587 (834)
.++|+..++||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 7899999998643 34566777777776 7999999999997653 4579
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhh--------hcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH--------HDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
+||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346899999999999999999999 655 9999999999999999999999
Q ss_pred eeccccccCCCccc--cccccccccccccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 003272 660 DFGMARAFGLDQTE--ANTNRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVSG----------KRNRGF 721 (834)
Q Consensus 660 DfGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~t~~sDV~S~Gvil~elltg----------~~p~~~ 721 (834)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.|+..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876433222 112235799999999999876 455799999999999999999 666532
Q ss_pred CCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 722 YHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
...... .................+ ............+.+++.+||+.||++|||+.||++.|+.
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDP--SFEDMRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSC--CHHHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCc--chhhhhHHHhccCCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 221111 111111111111110000 0111223456788999999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=345.91 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=210.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccCc-ccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSSG-QGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 585 (834)
.++|+..+.||+|+||.||+|+.. .++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 467889999999999999999852 367899999975433 3457899999999999 99999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCC---------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR---------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
.++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999865432 225899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999988755443333344567889999999999999999999999999999999 998875332211 0
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
........ .. ...+......+.+++.+||+.||++||++.||++.|+..
T Consensus 257 ----~~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 ----FYKMIKEG-FR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ----HHHHHHHT-CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHhccC-CC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11111111 00 011112234678899999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.12 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=199.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE------ 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 585 (834)
.++|+..++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357889999999999999999986 58999999997543 3456789999999999999999999999866542
Q ss_pred ---------------------------------------------------eEEEEeecCCCChhhHhhccCCCCCCCHH
Q 003272 586 ---------------------------------------------------RVLVYEYLPNKSLDYFIFDTTRSKVLDWQ 614 (834)
Q Consensus 586 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 614 (834)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999776555667788
Q ss_pred hHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc----------ccccccccccc
Q 003272 615 NRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE----------ANTNRVVGTYG 684 (834)
Q Consensus 615 ~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~ 684 (834)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999988 999999999999999999999999999887543211 11233579999
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHH
Q 003272 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCI 764 (834)
Q Consensus 685 y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 764 (834)
|+|||++.+..++.++||||||+++|||++|..|+. .. ............. .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~----~~~~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ER----VRIITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HH----HHHHHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HH----HHHHHHhhccCCC---------cccccCChhHH
Confidence 999999999999999999999999999999876521 00 0000111111000 01112234667
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 003272 765 QVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 765 ~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+++.+||+.||++||++.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.65 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||+||+|...+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46899999999999999999999889999999996542 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 67666643 2345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc-----
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE----- 745 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 745 (834)
.. .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||....... ................
T Consensus 174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGT
T ss_pred cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhh
Confidence 21 223578999999999876 568999999999999999999999986433222 1111111111111100
Q ss_pred -----------ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 -----------LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 -----------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+..............+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000001112246788999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=366.03 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=204.7
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..++|+..++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788899999999999999999888899999997543 345789999999999999999999999876 678999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999998532 2245899999999999999999999988 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ......++..|+|||.+....++.++||||||+++|||++ |+.|+...... ........+.
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~--------- 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGY--------- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTC---------
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC---------
Confidence 1 1223456788999999999999999999999999999999 89886532211 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
....+...+..+.+++.+||+.||++|||+.+|+++|+.....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1111223345788999999999999999999999999987544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.61 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=202.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..++||+|+||.||+|.+.. ++ .||+|.+.... ....+++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 578889999999999999999754 44 38888875432 344567888999999999999999999886 567899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998542 356899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~-- 237 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP----DLLEKGERLA-- 237 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH----HHHHTTCBCC--
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCCCC--
Confidence 5444433445678889999999999999999999999999999999 999975432211 11 1111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.+......+.+++.+||+.||++||++.||++.|+...
T Consensus 238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111224677999999999999999999999997653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.73 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=197.6
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..++||+|+||.||++.. .++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5688889999999999999987 5789999998643 34578999999999999999999999876 45899999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC-eEEeeeccccccCCCccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGLDQTE 673 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-~kl~DfGla~~~~~~~~~ 673 (834)
+++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976554456889999999999999999999943334999999999999998886 799999999765322
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....||+.|+|||++.+..++.++||||||++++||++|+.|+....... ....+. ........ ...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~-----~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWA-VHNGTRPP-----LIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHH-HHTTCCCC-----CBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHH-HhcCCCCC-----ccc
Confidence 122468999999999999999999999999999999999999975322211 111111 11111111 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
. ....+.+++.+||+.||++||++.||++.|+..
T Consensus 228 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 228 N----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 233678899999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=360.34 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=204.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC-eeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD-ERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~ 592 (834)
.++|+..++||+|+||.||+|.+ .++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46788889999999999999988 58899999997543 5578999999999999999999999988765 78999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 99999999996532 334789999999999999999999998 999999999999999999999999999864321
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. .....+.
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~--------- 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGY--------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTTC---------
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC---------
Confidence 112356789999999999999999999999999999998 999975332211 11 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111223345788999999999999999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=350.50 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=208.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
..++|...+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999999743 2479999997543 34557899999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccC-----------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT-----------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE 653 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 653 (834)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 9999999999999999886431 1345899999999999999999999998 9999999999999999
Q ss_pred CCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhH
Q 003272 654 MNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLG 732 (834)
Q Consensus 654 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 732 (834)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+....... .
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~--- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K--- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H---
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H---
Confidence 9999999999987644333323334567889999999999999999999999999999998 888865322111 0
Q ss_pred HHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 733 HAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.......... ...+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 276 -~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 -FYKLVKDGYQ---------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111100 011111234678899999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=344.35 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=203.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||+++... |+.||+|++++. .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 578899999999999999999764 899999999754 3345678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999988854 346899999999999999999999998 999999999999999999999999999864322
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+ .........
T Consensus 159 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~------- 222 (337)
T 1o6l_A 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEI------- 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-------
T ss_pred CC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC-------
Confidence 21 223468999999999999999999999999999999999999997432111 11 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||++|| ++.||++
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01112234678899999999999999 8999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=336.38 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=199.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||+||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578899999999999999999864 8899999997543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|++++.+..+. . ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444443 2 2356999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc------
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA------ 744 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 744 (834)
.. .....+|+.|+|||++.+.. ++.++||||||++++||++|..|+-. .....................
T Consensus 156 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 22 23357899999999998765 89999999999999999999888421 111111111111111111000
Q ss_pred cccCc---------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDK---------SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+. .............+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0001111223446788999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.61 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=203.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..++||+|+||.||++.... |+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999864 89999999976432 2357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC----CeEEeeec
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 662 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfG 662 (834)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999843 456999999999999999999999998 99999999999998877 79999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ........
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~----~~~i~~~~ 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET----LANITAVS 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH----HHHHHTTC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhcC
Confidence 998764322 123367999999999999999999999999999999999999997532111 11 11111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. -.++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y--DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C--CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001111111 1235778999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.85 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=192.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCe----EEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQ----EIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
..++|+..+.||+|+||.||+|...... .||||+++.. .....+++.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999875432 7999999754 345567899999999999999999999999877655
Q ss_pred ------EEEEeecCCCChhhHhhccC---CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 587 ------VLVYEYLPNKSLDYFIFDTT---RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 587 ------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999885432 2235899999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHH
Q 003272 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQ 736 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 736 (834)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY----N 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----H
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH----H
Confidence 999999987654433333333556789999999999999999999999999999999 888875322211 11 1
Q ss_pred HhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 737 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....... ...+......+.+++.+||+.||++||++.++++.|+..
T Consensus 251 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 251 YLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 011122334688999999999999999999999999866
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.08 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=194.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--------------------------ccHHHHHHHHHHHH
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--------------------------QGVEEFKNEALLIA 566 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 566 (834)
.++|+..++||+|+||.||+|... +++.||||++..... ...+++.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999875 488999999865421 12357899999999
Q ss_pred hccCCceeeEEEEEEe--CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCC
Q 003272 567 KLQHRNLVKLLGCCTQ--RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLK 644 (834)
Q Consensus 567 ~l~H~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 644 (834)
+++||||+++++++.. .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3456999999999999999999999998 9999999
Q ss_pred CCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 645 ASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 645 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987643322 123367899999999998765 47899999999999999999999753
Q ss_pred CCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 722 YHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... .. ........... ..+ .......+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~------~~-~~~~~~~~~~~-~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------MC-LHSKIKSQALE-FPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------HH-HHHHHHHCCCC-CCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------HH-HHHHHhcccCC-CCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 10 11111111110 000 1112346788999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=342.35 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=202.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|...+.||+|+||.||++.... ++.||||++..... ...+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568889999999999999999854 89999999975432 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC----CeEEeeec
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 662 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfG 662 (834)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999843 456899999999999999999999988 99999999999999887 79999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ... .......
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANVSAVN 233 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHHTC
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHH----HHHHhcC
Confidence 9988643322 22367999999999999999999999999999999999999997432111 011 1111100
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. . ........ ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 Y-E-FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-C-CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-C-cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 00000011 1236778999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.46 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=211.5
Q ss_pred HHhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD 584 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 584 (834)
...++|+..++||+|+||.||+|+.. .++.||||++.... .....++.+|+.++++++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 35678999999999999999999865 26789999997543 334567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccC-------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeE
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTT-------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 9999999999999999886421 1245789999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHH
Q 003272 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQ 736 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 736 (834)
|+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... ....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~ 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLR 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------HHHH
Confidence 999999987643332222333567889999999999999999999999999999999 78886432211 1111
Q ss_pred HhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 737 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
....+.... .+......+.+++.+||+.||++||++.|+++.|+....
T Consensus 252 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111111 112223467889999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.52 Aligned_cols=261 Identities=17% Similarity=0.196 Sum_probs=208.1
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+..+.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35789999999999999999996 459999999986543 234688899999999 89999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC-----eEEeeeccccc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA 666 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DfGla~~ 666 (834)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998643 345899999999999999999999988 999999999999987776 99999999987
Q ss_pred cCCCccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 667 FGLDQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 667 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6443221 11234679999999999999999999999999999999999999986543322211111111111111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...++ ... .+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 241 ~~~~~-----~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLREL-----CAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHH-----TTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHH-----Hhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 11111 111 234678899999999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=341.37 Aligned_cols=251 Identities=18% Similarity=0.264 Sum_probs=203.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|+..++||+|+||.||++.... ++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4689999999999999999999764 889999998643 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC--CCCeEEeeeccccccCCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGLD 670 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~ 670 (834)
+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999998 999999999999987 789999999999886433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..||...... .. .......... .+..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i~~~~~~--~~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI----IENIMNAEYT--FDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHHTCCC--CCHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HH----HHHHHcCCCC--CChh
Confidence 22 23367899999999999988999999999999999999999997532211 11 1111111110 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... ....+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011 1346788999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.82 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=209.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe--------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++|...+.||+|+||.||+|... +++.||||+++... ....+++.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 46789999997543 34567899999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999865332 234899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----
Confidence 9999999999999987754433333334567889999999999899999999999999999999 99886532211
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
............ ..+......+.+++.+||+.||++||++.||++.|+.+.
T Consensus 267 ---~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 ---ELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp ---HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111110 111222346788999999999999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=347.89 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..++||+|+||+||+++... ++.||||++++.. ....+.+.+|..++.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3578899999999999999999865 8899999997642 33445688899999887 89999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988854 346899999999999999999999998 9999999999999999999999999998642
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc--cchhHHHHHHhhccCcccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR--HNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 746 (834)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 221 223347899999999999999999999999999999999999999864322111 1111111111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
..+......+.+|+.+||+.||++||++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111223467889999999999999995
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.62 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=210.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+..++||+|+||.||+|...+ +..||+|++... ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678889999999999999999865 889999999643 4456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998653 3356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. ......+++.|+|||.+.+..++.++||||||++++||++ |..|+....... .. ......
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~----~~~~~~--------- 228 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLEKD--------- 228 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTT---------
T ss_pred cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcc---------
Confidence 22 2223556788999999999999999999999999999999 888865322211 11 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.....+......+.+++.+||+.||++||++.||++.|+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 01111122234688899999999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.50 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=199.0
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..++||+|+||.||+++... ++.||||++++. .....+.+.+|..++..+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4789999999999999999999764 899999999754 234556788999999988 79999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999988543 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~----~~~~i~~~~~----- 241 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---D----LFEAILNDEV----- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC-----
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCC-----
Confidence 222 2233468999999999999989999999999999999999999997532211 1 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM------LSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~ev~~ 786 (834)
..+......+.+++.+||+.||++||++ .||++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111123467789999999999999998 67764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.09 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=195.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccC--CceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQH--RNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568899999999999999999888999999998654 33455789999999999976 9999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899998854 346899999999999999999999998 99999999999997 57899999999988754
Q ss_pred CccccccccccccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~--- 231 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH--- 231 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH---
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH---
Confidence 433333344679999999999865 6789999999999999999999999753211 111111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+++......+......+.+++.+||+.||++|||+.|+++.
T Consensus 232 ------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111122223467889999999999999999999853
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=334.02 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=198.3
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||.||+|....++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788899999999999999998779999999986542 23457889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 887777432 356899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc------c
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA------E 745 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 745 (834)
......+|+.|+|||++.+. .++.++||||||+++|||++|+.||....... ............... +
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 12235789999999999764 58999999999999999999999975422111 111111111110000 0
Q ss_pred --ccCcccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 --LIDKSLY-------DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 --~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011000 0111122346788999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.37 Aligned_cols=244 Identities=22% Similarity=0.247 Sum_probs=191.7
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||+||+|... +++.||||++.... .....++..|+..+.++ +|+||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 58999999986542 23334555666666555 8999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+ +++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 66888877543 346999999999999999999999988 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. .....||+.|+|||++.+ .++.++||||||+++|||++|..|+... ..+........ .+.
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~~ 272 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CHH
T ss_pred CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----Ccc
Confidence 22 223568999999998876 7999999999999999999997764211 01111111111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 12346788999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=348.27 Aligned_cols=265 Identities=28% Similarity=0.377 Sum_probs=210.4
Q ss_pred cCCcccCccccCCcccEEEEEE-----eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEE--eCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGML-----IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT--QRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 587 (834)
++|+..++||+|+||.||++++ ..++.||||++........+.+.+|+.++++++|+||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788999999999999999984 348899999998776667788999999999999999999999987 455689
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999998542 235899999999999999999999988 999999999999999999999999999887
Q ss_pred CCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc--------ccchhHHHHHHh
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH--------RHNLLGHAWQLW 738 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~--------~~~~~~~~~~~~ 738 (834)
...... .......+|..|+|||++.+..++.++||||||++++||++|+.|+....... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL--- 254 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH---
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH---
Confidence 543322 12233567888999999999999999999999999999999999864321110 000000011
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
+.+........+......+.+++.+||+.||++||++.||++.|+....
T Consensus 255 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ------HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111112233344578899999999999999999999999987744
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=347.48 Aligned_cols=268 Identities=27% Similarity=0.349 Sum_probs=205.5
Q ss_pred CcccCccccCCcccEEEEEEe-----CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEE
Q 003272 517 FSEENKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVL 588 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 588 (834)
|+..++||+|+||+||++.+. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 58899999997653 34467899999999999999999999999884 57899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ................+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43221 122335678889999999999999999999999999999999998643211000 0000000000000011111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
+.......+......+.+++.+||+.||++||++.|+++.|+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111112222333457889999999999999999999999998763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=345.33 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=202.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-----SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
.++|+..++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999875 4899999998642 1234678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC---eEEeeecc
Q 003272 588 LVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN---PKISDFGM 663 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGl 663 (834)
+||||+++++|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777543 22345899999999999999999999998 999999999999986654 99999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ........+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~----~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E----RLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H----HHHHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H----HHHHHHHcCCC
Confidence 988654322 2233679999999999999999999999999999999999999975311 0 11111111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ..+..... ....+.+++.+||+.||++||++.|+++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000011 1246788999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.85 Aligned_cols=255 Identities=29% Similarity=0.414 Sum_probs=205.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788899999999999999998888899999996543 34678999999999999999999999986 45689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998432 1235899999999999999999999998 999999999999999999999999999876533222
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... . .......+..
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~~~--------- 228 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---E----VIQNLERGYR--------- 228 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCC---------
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---H----HHHHHhcccC---------
Confidence 1223456788999999998899999999999999999999 88886532211 1 1111111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+.+++.+||+.||++||++.++++.|+..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 011112234678899999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.84 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=207.7
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5788889999999999999999889999999997543 345789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+++|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 99999998543 346899999999999999999999998 99999999999999999999999999987643221 1
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......++..|+|||++.+..++.++||||||++++||++ |+.|+...... ........+.. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~~~---------~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFR---------L 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCC---------C
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcCCc---------C
Confidence 1223456788999999999999999999999999999999 88886532211 11111111100 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111234678899999999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.61 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=199.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
.++|+..++||+|+||.||+|.... ++ .||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3678999999999999999999743 44 3678877543 3456788999999999999999999999998754 88
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999988643 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... +. .......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~~---- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGE---- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTC----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCC----
Confidence 54433333334567889999999999999999999999999999999 999975432221 11 1111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
....+......+.+++.+||+.||++||++.|+++.|+.....
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111222334678899999999999999999999999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.18 Aligned_cols=266 Identities=18% Similarity=0.188 Sum_probs=202.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeC------CeEEEEEEecccCccc-----------HHHHHHHHHHHHhccCCceeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQG-----------VEEFKNEALLIAKLQHRNLVKL 576 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 576 (834)
.++|+..++||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998865 4789999986543211 1123345556667789999999
Q ss_pred EEEEEeC----CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-
Q 003272 577 LGCCTQR----DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD- 651 (834)
Q Consensus 577 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~- 651 (834)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9998775 4589999999 99999998642 356999999999999999999999998 99999999999999
Q ss_pred -CCCCeEEeeeccccccCCCcccc-----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcc
Q 003272 652 -NEMNPKISDFGMARAFGLDQTEA-----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHAD 725 (834)
Q Consensus 652 -~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~ 725 (834)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764332211 112345999999999999999999999999999999999999997632211
Q ss_pred cccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 726 HRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
. ...... .......+.+++++.+... ..+..+.+++..||+.||++||++.+|+++|+..
T Consensus 268 ~--~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 268 P--KYVRDS-KIRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp H--HHHHHH-HHHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred H--HHHHHH-HHHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1 111111 1111223334444333211 1234678899999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=354.76 Aligned_cols=263 Identities=18% Similarity=0.193 Sum_probs=206.9
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEE
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 581 (834)
.++++....++|+..++||+|+||+||+|+..+ ++.||||++++.. ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 344555567899999999999999999999865 7899999996531 223345889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 582 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
+.+..++||||+++|+|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999998542 356999999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ 736 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 736 (834)
|+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .......
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~ 295 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMN 295 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHT
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhh
Confidence 999876443222 223368999999999997 5678999999999999999999999975322111 1111100
Q ss_pred HhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 003272 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED--RPNMLSVVL 786 (834)
Q Consensus 737 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~ 786 (834)
.... +.-+.... .....+.+|+.+||+.+|++ ||+++|+++
T Consensus 296 ~~~~-----~~~p~~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 HKER-----FQFPTQVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHH-----CCCCSSCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccc-----ccCCcccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000 00000001 12236778999999888888 999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.25 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=203.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-C-------eEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-G-------QEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
.++|...++||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578889999999999999998754 3 5799999987777777899999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC--------eE
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN--------PK 657 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------~k 657 (834)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998643 344899999999999999999999998 999999999999998887 99
Q ss_pred EeeeccccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCcccccchhHHHH
Q 003272 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNR-GFYHADHRHNLLGHAW 735 (834)
Q Consensus 658 l~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~ 735 (834)
|+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|||++|..|+ ...... . ..
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~-~~ 228 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------R-KL 228 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------H-HH
Confidence 9999998764321 22457889999999987 67999999999999999999966543 211110 0 00
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
..... .... +......+.+++.+||+.||++||++.|+++.|+....
T Consensus 229 ~~~~~--~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYED--RHQL---------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHT--TCCC---------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhc--cCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11110 0000 00112246789999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=335.49 Aligned_cols=260 Identities=24% Similarity=0.409 Sum_probs=194.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999863 36999998654 334557899999999999999999999965 4567899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999998853 2456899999999999999999999998 9999999999999999999999999998764333
Q ss_pred cccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.........||+.|+|||.+. +..++.++||||||++++||++|+.|+....... . ...............
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHHHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHHhcccccCcchh
Confidence 333333467899999999986 5678999999999999999999999975322111 1 111111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
......+..+.+++.+||+.||++||++.||+++|+...
T Consensus 249 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111223357889999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.83 Aligned_cols=269 Identities=26% Similarity=0.364 Sum_probs=213.4
Q ss_pred cCHHHHHHHhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeE
Q 003272 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKL 576 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 576 (834)
++........++|+..++||+|+||.||+|... .++.||||+++... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555556788999999999999999999852 36889999997643 33456899999999999 79999999
Q ss_pred EEEEEeCC-eeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEecc
Q 003272 577 LGCCTQRD-ERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRD 642 (834)
Q Consensus 577 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 642 (834)
++++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987765 48999999999999999865432 223889999999999999999999998 99999
Q ss_pred CCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 003272 643 LKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGF 721 (834)
Q Consensus 643 Lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~ 721 (834)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333344667889999999999999999999999999999998 9988753
Q ss_pred CCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 722 YHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..... ........+.... .+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 254 ~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE------EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH------HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH------HHHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22111 1111111111111 1111234678899999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.10 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=194.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678899999999999999998743 557999998754 3344578999999999999999999999984 567899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998543 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... .. .........
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~----~~i~~~~~~--- 236 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGERL--- 236 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCC---
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH----HHHHcCCCC---
Confidence 33221 1223456788999999999999999999999999999996 888875332211 11 111111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+......+.+++.+||+.||++||++.||++.|+..
T Consensus 237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122334678899999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.87 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=202.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 578899999999999999999765 889999998653 2345678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999853 346899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+ .........
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~----~~~~~~~~~---- 237 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI----VHTFETTVV---- 237 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH----HHHHHHCCC----
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH----HHHHhhccc----
Confidence 2 2234689999999999974 4589999999999999999999999864332221111 111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-MLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~ev~~ 786 (834)
..+......+.+|+.+||+.||++||+ +.+|.+
T Consensus 238 ------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111122346788999999999999998 777764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.51 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=198.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+++... ++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 578889999999999999999864 8899999997642 33456788999999988 899999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999988542 45899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc--chhHHHHHHhhccCccccc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH--NLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 1233468999999999999999999999999999999999999998542211110 111111111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 781 (834)
..+......+.+++.+||+.||++||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111223467889999999999999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=368.54 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=209.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..++|+..++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 346788899999999999999999888899999997543 345789999999999999999999999876 678999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999998532 2245899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.......++..|+|||++....++.++|||||||+||||++ |+.|+...... ........+.
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-------~~~~~i~~~~--------- 481 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGY--------- 481 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------HHHHHHHTTC---------
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCC---------
Confidence 11222456788999999999999999999999999999999 88886532211 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSL 794 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~ 794 (834)
....+......+.+|+.+||+.||++||++.+|+++|+.....
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0111222344688899999999999999999999999987543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.16 Aligned_cols=204 Identities=19% Similarity=0.253 Sum_probs=176.4
Q ss_pred hcCCcccCccccC--CcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G--~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999986 48999999997543 3445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999986532 345899999999999999999999998 9999999999999999999999999987542
Q ss_pred CCcc-----ccccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 669 LDQT-----EANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 669 ~~~~-----~~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 2111 111123478899999999987 6799999999999999999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=340.80 Aligned_cols=269 Identities=24% Similarity=0.317 Sum_probs=198.0
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe----
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE---- 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 585 (834)
.++|+..++||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 458999999997642 2345678999999999999999999999876554
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 39999999999999998543 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 666 AFGLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 666 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence 76433221 2223356899999999999999999999999999999999999997532211 1111111111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhccCCCCCCCCCCC
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS-VVLMLSGERSLPQPKQPG 801 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e-v~~~L~~~~~~~~p~~p~ 801 (834)
. ..... .....+.+++.+||+.||++||++.+ +.+.|........|..|.
T Consensus 239 ~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~ 289 (311)
T 3ork_A 239 P---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289 (311)
T ss_dssp H---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred c---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence 0 00001 12346788999999999999996555 445555443333333333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=345.12 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
..++|+..++||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34679999999999999999999754 899999999654 234456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC---CCeEEeeeccccc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARA 666 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~ 666 (834)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999888843 356899999999999999999999998 9999999999999865 4599999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......+... .
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~----~~~i~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YAQIKAGAYD-Y 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCCC-C
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhCCCC-C
Confidence 643221 2236799999999999999999999999999999999999999743211 111 1111111110 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+ . .......+.+++.+||+.||++||++.|+++
T Consensus 250 ~~~-~----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSP-E----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTT-G----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccc-c----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0 0112346788999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=350.08 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=196.0
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhcc--CCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQ--HRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ |+||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999877999999998654 3345678999999999996 599999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6788999988643 46889999999999999999999988 99999999999995 589999999999887544
Q ss_pred ccccccccccccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~-----------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..... .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~-~--- 278 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKL-H--- 278 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHH-H---
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHH-H---
Confidence 33333344679999999999875 4689999999999999999999999753211 01111 1
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.++++......+......+.+|+.+||+.||++||++.||++.
T Consensus 279 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111111123467889999999999999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.37 Aligned_cols=254 Identities=26% Similarity=0.470 Sum_probs=200.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcc-------cHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQ-------GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||.||+|... +++.||||++...... ..+++.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367899999999999999999985 5889999998654321 1268899999999999999999999986554
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC-----eEEee
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN-----PKISD 660 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~D 660 (834)
++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888754 3456999999999999999999999875 34999999999999988776 99999
Q ss_pred eccccccCCCccccccccccccccccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAI--DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 661 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
||+++..... .....||+.|+|||++. ...++.++||||||+++|||++|+.|+........ ... ...
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~-~~~ 242 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFI-NMI 242 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHH-HHH
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHH-HHH
Confidence 9999854321 22367899999999984 45678999999999999999999999764322211 000 111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..... ....+......+.+++.+||+.||++||++.||++.|+.
T Consensus 243 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 REEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred hccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 111122233478899999999999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=353.22 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=202.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
..++|+..++||+|+||.||++... .|+.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999875 48999999986543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec---CCCCeEEeeeccccc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARA 666 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~ 666 (834)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999888854 345899999999999999999999998 99999999999998 567899999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... .....||+.|+|||++.+..++.++||||+||++|||++|..||..... .. .......+... .
T Consensus 163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~----~~~~i~~~~~~-~ 232 (444)
T 3soa_A 163 VEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HR----LYQQIKAGAYD-F 232 (444)
T ss_dssp CCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH----HHHHHHHTCCC-C
T ss_pred ecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HH----HHHHHHhCCCC-C
Confidence 6433221 2336799999999999999999999999999999999999999743211 11 11111111110 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00112346788999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.02 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=188.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+|.... ++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678899999999999999998754 8999999997543 3345788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhcc---CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDT---TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888877532 12245899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc----
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP---- 743 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 743 (834)
.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..............
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 3222 1223578999999999976 468999999999999999999999976432211 11111111100000
Q ss_pred --ccc--cCccc------------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 --AEL--IDKSL------------YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 --~~~--~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+ ..+.+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 00000 00001112346789999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=352.17 Aligned_cols=259 Identities=19% Similarity=0.200 Sum_probs=205.0
Q ss_pred HHHHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 508 ~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
.++....++|+..++||+|+||+||+++... ++.||+|++++. .....+.+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3444456889999999999999999999865 889999999652 223345688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998853 34899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ... ....
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~ 286 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTY----SKIM 286 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHH
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHH----HHHH
Confidence 987643322 1223478999999999998765 789999999999999999999997532211 111 1111
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED--RPNMLSVVLM 787 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~ev~~~ 787 (834)
.... .+.-+ ........+.+|+.+||+.+|.+ ||++.||++-
T Consensus 287 ~~~~-~~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 287 NHKN-SLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp THHH-HCCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred hccc-cccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1000 00000 00112246778999999999988 9999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.68 Aligned_cols=253 Identities=22% Similarity=0.242 Sum_probs=204.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|+..++||+|+||.||+|... +++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999985 4889999999766555667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC--CCCeEEeeeccccccCCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGLD 670 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~ 670 (834)
+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988843 2346899999999999999999999998 999999999999974 578999999999886433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ ..+..
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~i~~~~~--~~~~~ 272 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL----QNVKRCDW--EFDED 272 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHHCCC--CCCSS
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC--CCCcc
Confidence 22 22357899999999999999999999999999999999999997532211 111 11111110 01111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. .......+.+++.+||+.||++||++.|+++-
T Consensus 273 ~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 A----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 11223467889999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=338.92 Aligned_cols=266 Identities=19% Similarity=0.220 Sum_probs=198.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe----CCeEEEEEEecccCcc-----------cHHHHHHHHHHHHhccCCceeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSSGQ-----------GVEEFKNEALLIAKLQHRNLVKLLG 578 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 578 (834)
.++|...++||+|+||.||+|... .+..+|||++...... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999985 4778999998754321 1234667888899999999999999
Q ss_pred EEEe----CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC
Q 003272 579 CCTQ----RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM 654 (834)
Q Consensus 579 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 654 (834)
++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998532 37999999999999999999999998 99999999999999887
Q ss_pred --CeEEeeeccccccCCCccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 003272 655 --NPKISDFGMARAFGLDQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR 727 (834)
Q Consensus 655 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~ 727 (834)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 11133578999999999999999999999999999999999999975221111
Q ss_pred cchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.................+. .... ....+..+.+++.+||+.||++||++.+|++.|+...
T Consensus 268 -~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 -VAVQTAKTNLLDELPQSVL-KWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHHHHHHHTTTHHHH-HHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHHHHHHhhcccccHHHH-hhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111111111111111 1000 0012346888999999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=348.30 Aligned_cols=213 Identities=29% Similarity=0.350 Sum_probs=182.6
Q ss_pred ccCCcCccCHHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-----CC
Q 003272 498 EEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-----HR 571 (834)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~ 571 (834)
++.+...+++++.....++|...++||+|+||.||+|... +++.||||+++. .....+.+..|+.++.+++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCC
Confidence 3444555666666667789999999999999999999984 488999999964 3344567888999999986 99
Q ss_pred ceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 572 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 899999886532 345899999999999999999999998 99999999999997
Q ss_pred C-------------------------CCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHH
Q 003272 652 N-------------------------EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 706 (834)
Q Consensus 652 ~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~G 706 (834)
. ++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 789999999999865322 2236789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 003272 707 VLVLEIVSGKRNRGF 721 (834)
Q Consensus 707 vil~elltg~~p~~~ 721 (834)
|++|||++|+.||..
T Consensus 247 ~il~ell~g~~pf~~ 261 (360)
T 3llt_A 247 CVLAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHHHSSCSCCC
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999999854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=341.66 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=199.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999974 5899999998653 223346889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788777744 245899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ...+.
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~ 221 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVN 221 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCC
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH
Confidence 32 2233679999999999988776 7899999999999999999999753221110 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ....+......+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 00112222346788999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.22 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=192.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|...++||+|+||.||+++.. .++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999986 48899999996543 3346789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC--eEEeeeccccccCCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARAFGLD 670 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DfGla~~~~~~ 670 (834)
+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998854 245899999999999999999999988 999999999999987765 999999999754222
Q ss_pred ccccccccccccccccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~-sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... .... ..........
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~-~~~~~~~~~~------ 239 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRK-TIQRILSVKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHH-HHHHHHTTCC------
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHH-HHHHHhcCCC------
Confidence 1 1223579999999999988887666 899999999999999999975322211 1111 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...........+.+|+.+||+.||++|||+.|+++
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 00001112246788999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.38 Aligned_cols=264 Identities=22% Similarity=0.284 Sum_probs=197.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||.||+|.... |+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 678999999999999999999865 89999999865432 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH--------HHHhhccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA--------WQLWIQDR 742 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 742 (834)
. ......+|+.|+|||++.+ ..++.++||||||++++||++|+.|+............... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 1223578999999999976 67899999999999999999999997543322111100000 00000000
Q ss_pred c---ccccCccccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 P---AELIDKSLYDS---CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~---~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ....++..... ........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000000000 00112345788999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.87 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=202.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+++.. +|+.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999985 4899999999754 2245677889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999854 345899999999999999999999988 999999999999999999999999999875322
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ..........
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~------- 220 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------K-TYEKILNAEL------- 220 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHCCC-------
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC-------
Confidence 22367999999999999999999999999999999999999997532111 1 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||++|| +++||++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01112234678899999999999999 8899883
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.76 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=204.9
Q ss_pred cCCcccCccccCCcccEEEEEE-----eCCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC--Cee
Q 003272 515 DNFSEENKLGEGGFGPVYKGML-----IEGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DER 586 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 586 (834)
++|+..++||+|+||.||++++ ..++.||||++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 35889999999754 344567899999999999999999999999876 668
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998543 345899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------ccccchhHHHHHH
Q 003272 667 FGLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA--------DHRHNLLGHAWQL 737 (834)
Q Consensus 667 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~--------~~~~~~~~~~~~~ 737 (834)
....... .......+|..|+|||.+.+..++.++||||||++++||++|..|+..... .............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7543321 222345678889999999999999999999999999999999987432110 0000000000111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
... ......+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 256 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111 111112223345788999999999999999999999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=332.09 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=202.8
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC--CeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR--DERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 590 (834)
++|...++||+|+||.||+|+. +++.||||+++... ....++|.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788899999999999999998 58999999997542 34456899999999999999999999999887 7789999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++... ....+++..+..++.||+.||.|||+.+ .+|+||||||+|||++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999643 2336899999999999999999999864 3599999999999999999999999998765321
Q ss_pred ccccccccccccccccCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t---~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....+|+.|+|||.+.+..++ .++||||||+++|||++|+.|+....... ...........
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~---- 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR---- 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC----
Confidence 225678999999999876544 48999999999999999999975322111 11111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
+ ..+......+.+++.+||+.||++||++.|+++.|+...
T Consensus 230 -~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 -P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 111222346788999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.62 Aligned_cols=250 Identities=22% Similarity=0.223 Sum_probs=178.7
Q ss_pred cCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
.++||+|+||.||++.... ++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 4789999999999999864 899999999643 3467889999999997 9999999999999999999999999999
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC---CeEEeeeccccccCCCcccc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DfGla~~~~~~~~~~ 674 (834)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9999854 356999999999999999999999998 99999999999998765 799999999987643322
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
......+|+.|+|||++.+..++.++||||||+++|||++|+.||.....................+... ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 1223578999999999999999999999999999999999999986433221111111111222111110 0000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
........+.+|+.+||+.||++||++.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00112346788999999999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.32 Aligned_cols=248 Identities=26% Similarity=0.304 Sum_probs=195.4
Q ss_pred cccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCC
Q 003272 518 SEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 596 (834)
...+.||+|+||.||+|... +|+.||+|+++.......+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33568999999999999975 48999999998766566788999999999999999999999999999999999999999
Q ss_pred ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee--cCCCCeEEeeeccccccCCCcccc
Q 003272 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 597 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 998887542 345899999999999999999999998 9999999999999 5678999999999987643322
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ .... .....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~i~~~~~-~~~~-~~~~~ 314 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETL----NNILACRW-DLED-EEFQD 314 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCC-CSCS-GGGTT
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhccC-CCCh-hhhcc
Confidence 22356899999999999999999999999999999999999997532211 111 11111110 0000 00111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....+.+++.+||+.||++||++.|+++
T Consensus 315 ----~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ----ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2346788999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.86 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=197.2
Q ss_pred cCCccc-CccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEE-NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~-~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|... +.||+|+||.||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 68999999999999864 5899999999876666678899999999985 79999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC---eEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGla~~~~ 668 (834)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999998543 45899999999999999999999998 999999999999998776 9999999998764
Q ss_pred CCcc-----ccccccccccccccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch--------
Q 003272 669 LDQT-----EANTNRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL-------- 730 (834)
Q Consensus 669 ~~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~-------- 730 (834)
.... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223568999999999875 5588999999999999999999999864332111000
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
............. .... .... .....+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~i~~~~~-~~~~-~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKY-EFPD-KDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCC-CCCH-HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCc-ccCc-hhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0001111111110 0000 0000 11346788999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.35 Aligned_cols=263 Identities=23% Similarity=0.272 Sum_probs=205.3
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 588 (834)
.++|+..++||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999997 4589999999977666677889999999999999999999999873 346899
Q ss_pred EEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 589 VYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999888642 23456999999999999999999999998 999999999999999999999999998765
Q ss_pred CCCcccc-------ccccccccccccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 668 GLDQTEA-------NTNRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 668 ~~~~~~~-------~~~~~~gt~~y~APE~~~~~~---~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
....... ......||+.|+|||++.... ++.++||||||+++|||++|+.|+........ .... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence 3211110 012245789999999987654 68999999999999999999999742111110 0100 0
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
... .............+.+++.+||+.||++||++.||++.|+.+..
T Consensus 260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00001111223468889999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.99 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=197.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-----cccHHHHHHHHHHHHhcc---CCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-----GQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 583 (834)
..++|+..++||+|+||+||+|+.. .++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999964 48899999986432 122356777888777764 99999999999876
Q ss_pred C-----eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 584 D-----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 584 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
. ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 59988885432 334899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 99999987643222 234678999999999999999999999999999999999999975322211 111111111
Q ss_pred hccCcccc------cCcccc--CC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 739 IQDRPAEL------IDKSLY--DS-----CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 739 ~~~~~~~~------~d~~l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
........ ...... .. ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11000000 000000 00 01122346788999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=343.02 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=202.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 587 (834)
..++|...+.||+|+||.||+++... ++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999999864 8999999997542 34566788899999887 9999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999854 245899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ .........
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~---- 235 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL----FHSIRMDNP---- 235 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC----
T ss_pred ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHhCCC----
Confidence 32221 233478999999999999999999999999999999999999997532211 11 111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNML-SVV 785 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~ 785 (834)
. .+......+.+++.+||+.||++||++. ||+
T Consensus 236 --~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --C----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 1111234678899999999999999997 664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.05 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=199.6
Q ss_pred HHHHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc-----CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 510 IVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-----SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 510 ~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
+....++|+..++||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 34456789999999999999999999754 889999998653 345567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccC-------------------------------------CCCCCCHHhHHHHHHHHHHH
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTT-------------------------------------RSKVLDWQNRCHIIGGIARG 626 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 626 (834)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01224577788999999999
Q ss_pred HHHhhhcCCCceEeccCCCCceeecCCC--CeEEeeeccccccCCCcc--ccccccccccccccCcccccc--CCCCchh
Q 003272 627 LLYLHHDSRLRIIHRDLKASNVLLDNEM--NPKISDFGMARAFGLDQT--EANTNRVVGTYGYMSPEYAID--GLFSVKS 700 (834)
Q Consensus 627 L~yLH~~~~~~ivH~DLkp~NILl~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~--~~~t~~s 700 (834)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987532211 112234678999999999975 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 003272 701 DVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN 780 (834)
Q Consensus 701 DV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 780 (834)
||||||+++|||++|+.|+....... .. ........ ....+. .......+.+++.+||+.||++||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~------~~-~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD------TI-SQVLNKKL-CFENPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCC-CTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH------HH-HHHHhccc-ccCCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999975322111 11 11111110 000010 0112346788999999999999999
Q ss_pred HHHHHH
Q 003272 781 MLSVVL 786 (834)
Q Consensus 781 ~~ev~~ 786 (834)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.02 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=187.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+..++||+|+||.||+|+... ++.||||+++... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 35679999999999999999999865 7899999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla~~~~ 668 (834)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 346899999999999999999999998 999999999999975 8899999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ............ ...
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-CCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-cCC
Confidence 321 1233678999999999999999999999999999999999999974322111 011111111110 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.........+.+++.+||+.||++||++.|+++
T Consensus 273 -----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122346788999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.39 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=196.2
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe-
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE- 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 585 (834)
..++|...+.||+|+||.||+|.... ++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45778899999999999999998753 458999998654 33445789999999999999999999999987653
Q ss_pred ----eEEEEeecCCCChhhHhhcc---CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEE
Q 003272 586 ----RVLVYEYLPNKSLDYFIFDT---TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKI 658 (834)
Q Consensus 586 ----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 658 (834)
.++||||+++++|..++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 49999999999999988532 23456999999999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHH
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...... ... ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~ 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMY----DY 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH----HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH----HH
Confidence 99999987654332222333567889999999999999999999999999999999 88886532221 111 11
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+... ..+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 262 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 262 LLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111110 11112234688899999999999999999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.66 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=205.0
Q ss_pred cCCcccC-ccccCCcccEEEEEEe---CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEEN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~-~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|...+ +||+|+||.||+|... .++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999863 47889999997643 34567899999999999999999999999 56679999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999988754
Q ss_pred Cccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 670 DQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... .......+|+.|+|||++.+..++.++||||||++++||++ |+.|+....... . ......+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~i~~~~~---- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKR---- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCC----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHhcCCc----
Confidence 3222 11223456889999999998899999999999999999998 999975322211 1 111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 232 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222344788899999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=344.49 Aligned_cols=268 Identities=22% Similarity=0.277 Sum_probs=212.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC--eeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD--ERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 590 (834)
++|...++||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 578899999999999999999865 8999999997543 345678889999999999999999999998765 679999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee----cCCCCeEEeeeccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARA 666 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DfGla~~ 666 (834)
||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999965544455999999999999999999999998 9999999999999 7788899999999987
Q ss_pred cCCCccccccccccccccccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
...... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......... .. .....
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~-~~~~~ 239 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE-VMYKI 239 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HH-HHHHH
T ss_pred ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HH-HHHHH
Confidence 643322 223678999999999865 56788999999999999999999997543322111 11 11111
Q ss_pred hccCccccc---------------CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 739 IQDRPAELI---------------DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 739 ~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+.+...+ +..............+.+++.+||+.||++||++.|+++.|+.+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 222211110 00111233456677888999999999999999999999988765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.39 Aligned_cols=262 Identities=21% Similarity=0.224 Sum_probs=204.9
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEE
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCT 581 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 581 (834)
.++++....++|+..++||+|+||+||+++.. +|+.||||++++. .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34445556788999999999999999999985 4899999999653 2233456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 582 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
+.+..++||||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999998643 246899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAI-------DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA 734 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 734 (834)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~-- 280 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYG-- 280 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH--
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHH--
Confidence 99987644322 1223368999999999997 3578999999999999999999999975322111 111
Q ss_pred HHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 003272 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDR---PNMLSVVL 786 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~ev~~ 786 (834)
...... ..+.-+... ......+.+++.+||+ +|++| |+++||++
T Consensus 281 --~i~~~~-~~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 --KIVHYK-EHLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --HHHTHH-HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred --HHHhcc-cCcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111000 000001111 1123467889999999 99998 68999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.97 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=203.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367889999999999999999986 48999999986543 3455789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988842 346899999999999999999999988 9999999999999999999999999998764333
Q ss_pred cccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.........|++.|+|||++.+..+ +.++||||||++++||++|+.|+........ ....+...... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--~--- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--L--- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTT--S---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccc--c---
Confidence 2222334678999999999987765 7899999999999999999999764322110 01111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.........+.+++.+||+.||++||++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001112346778999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.55 Aligned_cols=243 Identities=22% Similarity=0.306 Sum_probs=200.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--------ccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
..++|+..++||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999864 489999999975421 1334678899999999999999999999999
Q ss_pred CeeEEEEeecCCC-ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 584 DERVLVYEYLPNK-SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 584 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
+..++||||+..| +|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 89888853 345999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.....
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9987643322 223678999999999988876 8899999999999999999999743111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 742 RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 742 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....... .+......+.+++.+||+.||++||++.|+++-
T Consensus 236 ----~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 011123367889999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.30 Aligned_cols=257 Identities=23% Similarity=0.246 Sum_probs=189.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEe--------C
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQ--------R 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--------~ 583 (834)
..+|+..++||+|+||.||++... .++.||||++........+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357889999999999999999975 48999999997766666778999999999996 9999999999943 3
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
...++|+||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 34799999996 788888765444567999999999999999999999874 3499999999999999999999999999
Q ss_pred ccccCCCcccc----------ccccccccccccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 003272 664 ARAFGLDQTEA----------NTNRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730 (834)
Q Consensus 664 a~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 730 (834)
++......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.|+.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98764332211 11134689999999998 56678999999999999999999999975321110
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.................+.+++.+||+.||++||++.|+++.|+..
T Consensus 261 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 ---------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000000001111122467899999999999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.08 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=202.0
Q ss_pred HhcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEE-EeCCeeEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC-TQRDERVLVY 590 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 590 (834)
..++|+..+.||+|+||.||+|+. ..++.||||++..... .+++.+|+.++.+++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 4589999998754332 24588899999999888777666655 6677889999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~ 667 (834)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999988532 345899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 668 GLDQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 668 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 443221 112346789999999999999999999999999999999999999865443333222222111111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
... +.... +..+.+++.+||+.||++||++.+|++.|+..
T Consensus 239 ~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhh-----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 110 01111 23678899999999999999999999999865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.72 Aligned_cols=244 Identities=21% Similarity=0.229 Sum_probs=202.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999986 4899999999654 2345678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999998543 45899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+...
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~----~~~~~i~~~~~~------ 256 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---I----QIYEKIVSGKVR------ 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHHHHHHHCCCC------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---H----HHHHHHHcCCCC------
Confidence 2236799999999999999999999999999999999999999753211 1 111112221110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
.+......+.+++.+||+.||++||+ +.||++
T Consensus 257 ----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11122346788999999999999998 888874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.81 Aligned_cols=265 Identities=26% Similarity=0.375 Sum_probs=207.1
Q ss_pred hcCCcccCccccCCcccEEEEEE-----eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC--ee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-----IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD--ER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 586 (834)
.++|+..++||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 358899999998776667788999999999999999999999987654 68
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998643 345899999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCcccc-ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc----
Q 003272 667 FGLDQTEA-NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD---- 741 (834)
Q Consensus 667 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 741 (834)
........ ......++..|+|||.+.+..++.++||||||++++||++|..|+...... ........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhccccchh
Confidence 75433221 122345677899999999988999999999999999999999885421100 00000000
Q ss_pred ----CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 742 ----RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 742 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+.+........+......+.+++.+||+.||++||++.||++.|+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00011111111111222345788899999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=365.28 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=197.6
Q ss_pred ccccCCcccEEEEEEe---CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 522 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
+||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 36679999997653 3467889999999999999999999999976 56999999999999
Q ss_pred hhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc-cc
Q 003272 598 LDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA-NT 676 (834)
Q Consensus 598 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~ 676 (834)
|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+....... ..
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999854 2456899999999999999999999998 9999999999999999999999999998764332211 11
Q ss_pred ccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCC
Q 003272 677 NRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSC 755 (834)
Q Consensus 677 ~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 755 (834)
....+++.|+|||++.+..++.++|||||||++|||++ |+.|+......+ .......+.. ...
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR---------MEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCC---------CCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC---------CCC
Confidence 22345689999999999999999999999999999998 999975432211 1111111111 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 756 SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 756 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+...+..+.+|+.+||+.||++||++.+|++.|+..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 223345788999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=336.82 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=199.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc--cCCceeeEEEEEEeC----Cee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL--QHRNLVKLLGCCTQR----DER 586 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~----~~~ 586 (834)
..++|+..++||+|+||.||+|+. .++.||||++... ....+..|.+++..+ +||||+++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 457899999999999999999987 5899999998543 234455566666554 899999999999887 678
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC-----CCceEeccCCCCceeecCCCCeEEeee
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS-----RLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 999999999999999853 35899999999999999999999871 113999999999999999999999999
Q ss_pred ccccccCCCccccc--cccccccccccCccccccCCCCch------hhHHHHHHHHHHHHhCC----------CCCCCCC
Q 003272 662 GMARAFGLDQTEAN--TNRVVGTYGYMSPEYAIDGLFSVK------SDVFSFGVLVLEIVSGK----------RNRGFYH 723 (834)
Q Consensus 662 Gla~~~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~t~~------sDV~S~Gvil~elltg~----------~p~~~~~ 723 (834)
|+++.+........ .....||+.|+|||++.+...+.+ +|||||||++|||++|. .|+....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99987644332211 123579999999999987766654 99999999999999994 4433221
Q ss_pred cccccchhHHHHHHhhccCcccccCccccC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 724 ADHRHNLLGHAWQLWIQDRPAELIDKSLYD-SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
.... .............. .+.+.. .........+.+++.+||+.||++||++.||++.|+....
T Consensus 267 ~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 267 PSDP--SYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CSSC--CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC--chhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 1111 11111111111111 111111 1122556788999999999999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.73 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=199.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-----CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|...++||+|+||.||+|.... +..||||+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778899999999999998753 2459999997543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999998642 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 669 LDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 669 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ........+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~--- 268 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFR--- 268 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCC---
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHCCCc---
Confidence 33221 11222456788999999999999999999999999999999 99997432211 11111111100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
...+......+.+++.+||+.||++||++.+|++.|+...
T Consensus 269 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111223346788999999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=327.49 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=198.9
Q ss_pred CCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 516 NFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
+|.....||+|+||.||+|... +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555668999999999999974 488999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeeccccccCCCccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGla~~~~~~~~~ 673 (834)
+++|.+++........+++..+..++.||+.||.|||+.+ |+|+||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999876544456789999999999999999999988 999999999999987 89999999999987643221
Q ss_pred cccccccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~--~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.|+....... .......... ..+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-----~~~-- 245 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK-----VHP-- 245 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC-----CCC--
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc-----ccc--
Confidence 122357899999999997654 8899999999999999999999974221110 0000000000 011
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++||++.|+++
T Consensus 246 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 --EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112222346788999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.41 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=201.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.++|...+.||+|+||.||+|...+ +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678899999999999999998754 346999999764 33456789999999999999999999999764 45789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999998543 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... ... ........
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~----~~~~~~~~--- 233 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG----VLEKGDRL--- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH----HHHHTCCC---
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH----HHhcCCCC---
Confidence 33221 1223556789999999999999999999999999999998 999975332221 111 11111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01111234678899999999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.96 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=202.2
Q ss_pred hcCCcccC-ccccCCcccEEEEEEe---CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 514 TDNFSEEN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 514 ~~~~~~~~-~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
.++|...+ .||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999653 36889999997543 23467899999999999999999999999 667889
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999864 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCcccc-ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 668 GLDQTEA-NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 668 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..........
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--
Confidence 5433221 1122456788999999998889999999999999999999 999975322111 1111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222334688899999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.93 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=203.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..+.||+|+||.||++.... |+.||||++..... ...+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3578899999999999999999764 89999999975432 1367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC----CeEEeeec
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 662 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfG 662 (834)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999853 346899999999999999999999998 99999999999999888 79999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+++....... .....||+.|+|||++.+..++.++||||||++++||++|+.|+...... . .........
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~----~~~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---E----TLANITSVS 234 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---H----HHHHHHTTC
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhcc
Confidence 9987643321 22357899999999999999999999999999999999999997532111 0 111111110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ..++..... ....+.+++.+||+.||++||++.|+++
T Consensus 235 ~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 011111111 1235788999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=352.47 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=192.8
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||++.... |+.||||+++.. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3678999999999999999999754 889999999753 334456788899999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|||+++++|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988854 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ .........
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~----- 366 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL----FELILMEEI----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-----
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH----HHHHHhCCC-----
Confidence 2222 223478999999999999999999999999999999999999997432211 11 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+|+.+||+.||++|| ++.|+++
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01111234678899999999999999 9999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.77 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=203.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+..++||+|+||.||+|.... +..||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999865 77899999987666677899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 668 (834)
|+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999888754 345899999999999999999999998 9999999999999 788999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... ......+|+.|+|||++.+. ++.++||||||++++||++|+.|+....... .......+... ..
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-~~- 227 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFT-FP- 227 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-CC-
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-CC-
Confidence 332 22335789999999988654 8999999999999999999999975322111 11111111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..... .....+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 11346788999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.21 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=199.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4678999999999999999998765 778999998653 223456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999888543 45899999999999999999999988 99999999999999999999999999866432
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. .....+++.|+|||.+.+..++.++||||||++++||++|+.|+....... .........
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------- 223 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVE------- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTC-------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCC-------
Confidence 22 223578999999999999999999999999999999999999975322111 111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...+......+.+++.+||+.||++||++.||++-
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111123467789999999999999999999963
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.23 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=192.3
Q ss_pred hcCCcccCccccCCcccEEEEEE----eCCeEEEEEEecccC----cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML----IEGQEIAVKRLSKSS----GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||.||+++. ..++.||+|++++.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36789999999999999999997 368999999997542 2345678899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998854 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. .........
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~----~~~i~~~~~-- 238 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KT----IDKILKCKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCC--
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHhCCC--
Confidence 6432221 223367899999999999999999999999999999999999997532211 11 111111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||++|| ++.|+++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11112234678899999999999999 7778775
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.66 Aligned_cols=259 Identities=30% Similarity=0.423 Sum_probs=202.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|...+.||+|+||.||+|++. .++.||||++... ......++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467999999999999999999842 3778999999654 344566899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCC----CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEe
Q 003272 587 VLVYEYLPNKSLDYFIFDTTR----SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKIS 659 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~ 659 (834)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999875432 245899999999999999999999998 999999999999984 4569999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... . .....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~----~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---E----VLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H----HHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---H----HHHHH
Confidence 9999986543332222334567889999999999999999999999999999998 88886532111 1 11111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...... ..+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 259 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111110 11112234678899999999999999999999999765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=339.07 Aligned_cols=248 Identities=27% Similarity=0.332 Sum_probs=202.0
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..+.||+|+||.||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999999865 789999999754 234567788999999887 89999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999998542 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~----~~~~i~~~~~----- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---E----LFQSIMEHNV----- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC-----
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---H----HHHHHHhCCC-----
Confidence 222 1233468999999999999999999999999999999999999997532111 1 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
..+......+.+++.+||+.||++||+ +.||++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011122346788999999999999995 567663
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.80 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=205.1
Q ss_pred hcCCcccCccccCCcccEEEEEE-eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEE-EeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML-IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCC-TQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 591 (834)
.++|+..+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++..++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 4599999999865432 34689999999999988866666555 66677899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 668 (834)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 89999998532 346999999999999999999999998 9999999999999 588999999999998764
Q ss_pred CCcccc-----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 669 LDQTEA-----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 669 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 432211 123467899999999999999999999999999999999999998754433322222222111111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 744 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
.. +.... +..+.+++.+||+.||++||++.+|++.|+..
T Consensus 240 ~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 EV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HH-----HHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 10 11111 24678899999999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.96 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=202.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe----------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ---------- 582 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 582 (834)
.++|+..+.||+|+||.||+|... +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457889999999999999999986 58999999996543 356789999999999999999998854
Q ss_pred ------CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 583 ------RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 583 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999998643 2356899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ 736 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 736 (834)
||+|||++........ .....+++.|+|||++.+..++.++||||||++++||++|..|+.. ......
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHH
Confidence 9999999987644322 2235689999999999999999999999999999999999987321 000111
Q ss_pred HhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCC
Q 003272 737 LWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLP 795 (834)
Q Consensus 737 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~ 795 (834)
...... +... ....+.+++.+||+.||++||++.|+++.|+.....+
T Consensus 230 ~~~~~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 DLRDGI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHTTC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred Hhhccc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111111 1111 2235778999999999999999999999998765443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=332.05 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=198.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357899999999999999999974 5899999999753 234557889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988542 23456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ..... .............
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHH-HHHHHTTCSCCCC-
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHH-HHHhhcccCCCCc-
Confidence 3222 12235689999999999999999999999999999999999999742211 11111 1111111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
.......+.+++.+||+.||++||++.+|++.|+...+
T Consensus 260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11123467889999999999999999999999987644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=340.09 Aligned_cols=247 Identities=29% Similarity=0.429 Sum_probs=197.5
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...++||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 355888899999999999999974 58999999997543 23346789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||++ |+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 5776666432 356899999999999999999999998 99999999999999999999999999987532
Q ss_pred CccccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
. ....||+.|+|||++. ...++.++||||||++++||++|+.|+..... ...... .........
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~ 273 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESPAL 273 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCCC
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH-HHhcCCCCC
Confidence 2 2357899999999985 56789999999999999999999999743211 111111 111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. .......+.+++.+||+.||++||++.++++.
T Consensus 274 ~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 11122357789999999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.05 Aligned_cols=256 Identities=27% Similarity=0.327 Sum_probs=201.7
Q ss_pred CCcccCccccCCcccEEEEEEeC----CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee-EEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER-VLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 589 (834)
.|...++||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998643 2379999997543 34567899999999999999999999999876665 999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
+||+.+++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc--ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 670 DQT--EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~--~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ........+++.|+|||.+.+..++.++||||||+++|||++|..|+.. ......+.. .......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~--~~~~~~~~~----~~~~~~~---- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR--HIDPFDLTH----FLAQGRR---- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCGGGHHH----HHHTTCC----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc--cCCHHHHHH----HhhcCCC----
Confidence 321 1222345678899999999999999999999999999999996666321 111111111 1111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+......+.+++.+||+.||++|||+.++++.|+..
T Consensus 247 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 -----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112234678899999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.88 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=201.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..++||+|+||.||+|.... ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4689999999999999999999754 889999998654 3344577889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC---eEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfGla~~~ 667 (834)
||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998887542 45899999999999999999999998 999999999999986655 999999999876
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... .....|++.|+|||++.+..++.++||||||++++||++|+.|+...... . .......+... ..
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~----~~~~~~~~~~~-~~ 227 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---R----LYAQIKAGAYD-YP 227 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCCC-CC
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---H----HHHHHHhcccc-CC
Confidence 43322 22367899999999999999999999999999999999999997432111 1 11111111110 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+. .......+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 0112246788999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.82 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=204.6
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.+.|+..++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467889999999999999999875 48899999997543 4456889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999884 346899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ......|++.|+|||++.+..++.++||||||++++||++|+.|+....... .......... +.+
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~ 239 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNP-----PTL 239 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC-----CCC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCC-----CCC
Confidence 2 2233678999999999999999999999999999999999999975322111 0011111111 111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.... ...+.+++.+||+.||++||++.|+++.
T Consensus 240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1122 3367889999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.20 Aligned_cols=261 Identities=18% Similarity=0.184 Sum_probs=198.5
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 58899999997542 23347889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ......... ... +
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~~~---~ 254 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQA-IPR---P 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSC-CCC---G
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccC-CCC---c
Confidence 3221 122357899999999999999999999999999999999999997532111 111111111 100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCCCC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-NMLSVVLMLSGERSLP 795 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~~~~~~ 795 (834)
.......+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 001111223677899999999999999 9999999999775443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.74 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=202.8
Q ss_pred HHHHHHHhcCCccc-CccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhc-cCCceeeEEEEEE
Q 003272 507 WKTIVDATDNFSEE-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCT 581 (834)
Q Consensus 507 ~~~~~~~~~~~~~~-~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 581 (834)
++......++|... ++||+|+||.||++.... ++.||||++... ......++.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444456677776 789999999999999764 899999999754 234467899999999999 5699999999999
Q ss_pred eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEE
Q 003272 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKI 658 (834)
Q Consensus 582 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl 658 (834)
..+..++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999988432 3456999999999999999999999998 999999999999998 789999
Q ss_pred eeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHh
Q 003272 659 SDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 659 ~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....... . ....
T Consensus 176 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~----~~~i 245 (327)
T 3lm5_A 176 VDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---T----YLNI 245 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHH
T ss_pred eeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---H----HHHH
Confidence 99999987643221 223678999999999999999999999999999999999999975322111 0 0111
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..... . ............+.+++.+||+.||++||++.|+++-
T Consensus 246 ~~~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQVNV-D-----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHTCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hhccc-c-----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11000 0 0011111223467889999999999999999999853
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.91 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=196.4
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|...++||+|+||.||++.... +..||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 578899999999999999999754 8899999987643 34568899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeeccccccC
Q 003272 593 LPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 668 (834)
Q Consensus 593 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 668 (834)
+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998887543 22356999999999999999999999998 9999999999999 456789999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.... .....+++.|+|||++. ..++.++||||||++++||++|+.|+....... ...............
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQKATYKEPNYAVE 247 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCCC-
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHhhhccCCcccccc
Confidence 3222 23367899999999875 578999999999999999999999975322111 111111111100000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... ....+.+++.+||+.||++||++.||++
T Consensus 248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1236778999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=338.90 Aligned_cols=252 Identities=17% Similarity=0.121 Sum_probs=203.0
Q ss_pred HhcCCcccCccccCCcccEEEEE------EeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc---CCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGM------LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 583 (834)
..++|...++||+|+||+||+|. ...++.||||+++.. ...++..|+.++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35678999999999999999994 345889999999654 3457788888888886 99999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhcc--CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---------
Q 003272 584 DERVLVYEYLPNKSLDYFIFDT--TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN--------- 652 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--------- 652 (834)
+..++||||+++|+|.+++... .....+++..++.++.||++||+|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 9999999999999999998642 23456999999999999999999999988 999999999999998
Q ss_pred --CCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 003272 653 --EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730 (834)
Q Consensus 653 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 730 (834)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999976543323333344679999999999999999999999999999999999999964211110
Q ss_pred hHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhccC
Q 003272 731 LGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDR-PNMLSVVLMLSGE 791 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~ev~~~L~~~ 791 (834)
..+...+.... ....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 --------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 --------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 01111111111 13356678889999999998 6888888888754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.58 Aligned_cols=248 Identities=24% Similarity=0.312 Sum_probs=203.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...+.||+|+||.||++...+ ++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4678999999999999999999865 789999998654 234557889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998754 246899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... .....|++.|+|||++.+..++.++||||||+++|||++|+.|+....... ..........
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~------ 258 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY------ 258 (335)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC------
T ss_pred Cccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCCC------
Confidence 3221 233678999999999999999999999999999999999999975322111 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+ +......+.+++.+||+.||++||++.|+++
T Consensus 259 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SI----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 1112235778999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.92 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=192.2
Q ss_pred CCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEe-CCeeEEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-RDERVLV 589 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV 589 (834)
.|...++||+|+||.||+|.+.+ +..||||.++.. .....++|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46667899999999999998743 246899998654 33456789999999999999999999999765 4578999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999854 3345889999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc--cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 670 DQTE--ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 670 ~~~~--~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+|+..... ..... ....+.. .
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~----~~~~~~~--~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV----YLLQGRR--L 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHH----HHHTTCC--C
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHH----HHHcCCC--C
Confidence 2211 11223457789999999999999999999999999999999 5666543221 11111 1111110 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
. .+......+.+++.+||+.||++||++.||++.|+...
T Consensus 316 ~-------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 316 L-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 11122346788999999999999999999999998763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.92 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=182.5
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357888999999999999999974 58999999996532 23457899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999854 2356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... .....+++.|+|||.+.+..++.++||||||++++||++|+.|+......... . .....
T Consensus 165 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~--------~~~~~ 227 (278)
T 3cok_A 165 PHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------N--------KVVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------H--------HHhhc
Confidence 2221 22357899999999999989999999999999999999999997543221100 0 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ..+......+.+++.+||+.||++||++.++++
T Consensus 228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 011122346788999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.54 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=192.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcc-cHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQ-GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|...++||+|+||+||+|... +++.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999986 4889999999654321 222456799999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++ ++|..++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 98 4787777543 346899999999999999999999998 99999999999999999999999999986543222
Q ss_pred ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc---ccccC
Q 003272 673 EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP---AELID 748 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d 748 (834)
......+|+.|+|||++.+ ..++.++||||||++++||++|+.||....... .............. .....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 1223578999999999876 578999999999999999999999976432211 11111111111000 00000
Q ss_pred c---------cccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 K---------SLYD----SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~---------~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. .... .........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0000 000112346788999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.05 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=204.7
Q ss_pred HHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHh--ccCCceeeEEEEEEeCC----
Q 003272 511 VDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAK--LQHRNLVKLLGCCTQRD---- 584 (834)
Q Consensus 511 ~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---- 584 (834)
....++|...++||+|+||.||+|+. +++.||||++... ..+.+..|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34567899999999999999999998 6899999999643 34678889998887 78999999999998876
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhh--------hcCCCceEeccCCCCceeecCCCCe
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH--------HDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999853 35899999999999999999999 555 9999999999999999999
Q ss_pred EEeeeccccccCCCcccc--ccccccccccccCccccccCC------CCchhhHHHHHHHHHHHHhC----------CCC
Q 003272 657 KISDFGMARAFGLDQTEA--NTNRVVGTYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVSG----------KRN 718 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~------~t~~sDV~S~Gvil~elltg----------~~p 718 (834)
||+|||+++......... ......||+.|+|||++.+.. ++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998764332211 223457899999999998762 34789999999999999999 555
Q ss_pred CCCCCcccccchhHHHHHHhhccCcccccCccccC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 719 RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD-SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+........ ............. ..+.+.. .........+.+++.+||+.||++||++.||++.|+.+
T Consensus 267 ~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDP--SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSC--CHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcc--cHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 432211111 1111111111111 1111111 12235567889999999999999999999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.07 Aligned_cols=265 Identities=24% Similarity=0.343 Sum_probs=199.0
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..++||+|+||.||++.... ++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3679999999999999999999865 89999999865432 33466889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999887643 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------HHHHHHhhcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL--------GHAWQLWIQD 741 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~ 741 (834)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||............ ......+...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 22 12235789999999999875 7899999999999999999999997543221110000 0000000100
Q ss_pred -CcccccCccccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 -RPAELIDKSLYDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 -~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.+..... ......+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001111111111111 122457889999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=340.96 Aligned_cols=201 Identities=27% Similarity=0.466 Sum_probs=162.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCC--ee
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRD--ER 586 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 586 (834)
..++|+..++||+|+||.||+|... .++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999875 4899999998643 3345567889999999997 999999999997654 68
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 588888743 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCc-------------------cccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 667 FGLDQ-------------------TEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 667 ~~~~~-------------------~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
+.... .........||+.|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 63211 1111233679999999999986 6799999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=347.88 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=202.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...+.||+|+||.||+|+.. .|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999986 58999999996532 234568999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999843 456999999999999999999999988 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..+ ......+..
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~----~~~i~~~~~------ 233 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTL----FKKICDGIF------ 233 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHH----HHHHHTTCC------
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHH----HHHHhcCCc------
Confidence 2 1233679999999999988765 7899999999999999999999753221 111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++|||+.||++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011112236788999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=334.20 Aligned_cols=266 Identities=26% Similarity=0.345 Sum_probs=194.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHH--HhccCCceeeEEEEEEe-----CCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLI--AKLQHRNLVKLLGCCTQ-----RDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~~-----~~~~ 586 (834)
.++|+..++||+|+||.||+|+. +++.||||++.... ...+..|.+++ ..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36789999999999999999987 78999999996432 34455555544 45899999999986643 2256
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc---------CCCceEeccCCCCceeecCCCCeE
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD---------SRLRIIHRDLKASNVLLDNEMNPK 657 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~DLkp~NILl~~~~~~k 657 (834)
++||||+++|+|.+++... ..++..+..++.||++||.|||+. + |+||||||+||||+.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 8999999999999998532 358999999999999999999998 6 99999999999999999999
Q ss_pred EeeeccccccCCCcc------ccccccccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 003272 658 ISDFGMARAFGLDQT------EANTNRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHA 724 (834)
Q Consensus 658 l~DfGla~~~~~~~~------~~~~~~~~gt~~y~APE~~~~-------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~ 724 (834)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 111223579999999999986 4567799999999999999999877532211
Q ss_pred ccc-cchh----------HHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 725 DHR-HNLL----------GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 725 ~~~-~~~~----------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
... .... ...............+... -.........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 111 0000 0000001101000000000 0112335567899999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=364.95 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=196.2
Q ss_pred CccccCCcccEEEEEEe---CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999764 36789999997643 344678999999999999999999999986 4568899999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-c
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE-A 674 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 674 (834)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999853 346899999999999999999999998 999999999999999999999999999887543321 1
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+....... .......+.. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------M 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 1223456788999999999999999999999999999998 999975322211 1111111111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+......+.+|+.+||+.||++||++.+|++.|+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122234578899999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.98 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=205.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||++... +|+.||||++.+. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999985 4899999999653 234556789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++|+|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999886432 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ .
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~i~~~~-~----- 406 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEVP-E----- 406 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHHHHHCC-C-----
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHHhhccc-c-----
Confidence 322 2235899999999999999999999999999999999999999864322111 111111111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+|+.+||+.||++|| ++.||++
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11112234678899999999999999 7888874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.79 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=200.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC----CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEe-CCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-RDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 588 (834)
.+|+..++||+|+||.||+|...+ ...+|+|.+.... ....+++.+|+.++++++||||+++++++.+ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998643 3368999987543 3455789999999999999999999999754 457899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999854 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc--cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCcccccchhHHHHHHhhccCccc
Q 003272 669 LDQTE--ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR-NRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 669 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... .......+|+.|+|||.+.+..++.++||||||++++||++|.. |+..... ..... ........
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~----~~~~~~~~- 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV----YLLQGRRL- 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHH----HHHTTCCC-
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHH----HHhcCCCC-
Confidence 33221 12223567789999999999999999999999999999999554 4332111 11111 11111100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..+......+.+++.+||+.||++||++.|+++.|+...
T Consensus 252 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 252 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001112346788999999999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.83 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=197.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC-------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------- 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 583 (834)
.++|+..++||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367999999999999999999984 58999999986543 23356788999999999999999999999773
Q ss_pred -CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 584 -DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 584 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 66555533 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc--ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 663 MARAFGLDQT--EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 663 la~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++.+..... ........||+.|+|||++.+ ..++.++||||||++++||++|+.|+....... ..........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 9987643221 122234678999999999876 468999999999999999999999976432211 1111111111
Q ss_pred ccCc---ccc-----cCc---cccCCCCHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 QDRP---AEL-----IDK---SLYDSCSLSE-------AIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 ~~~~---~~~-----~d~---~l~~~~~~~~-------~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... ... .+. .......... ...+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 000 000 0000011111 235778999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=334.08 Aligned_cols=256 Identities=28% Similarity=0.433 Sum_probs=201.9
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeE--EEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQE--IAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..+.||+|+||.||+|+... +.. ||||+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 478899999999999999999754 664 499998653 334556799999999999 999999999999999999999
Q ss_pred EeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 590 YEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... ...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY 251 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH
Confidence 99999999754221 11223456789999999998899999999999999999998 99997532211 111
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.....+. ....+......+.+++.+||+.||++||++.|+++.|+...
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 252 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111110 01111222346888999999999999999999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.61 Aligned_cols=198 Identities=23% Similarity=0.394 Sum_probs=156.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----Ce
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 585 (834)
.++|+..++||+|+||.||+|... .++.||||++... .....+++.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999875 4889999999653 334557899999999999999999999998543 56
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 688887743 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------cccccccccccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 666 AFGLDQTE-------------------------ANTNRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 666 ~~~~~~~~-------------------------~~~~~~~gt~~y~APE~~-~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 76432211 112346789999999986 456799999999999999999995443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.52 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=198.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||+|... +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467899999999999999999986 5899999999754 234556788999999999 999999999999999999999
Q ss_pred EeecCCCChhhHhhccCC-CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC----------------
Q 003272 590 YEYLPNKSLDYFIFDTTR-SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---------------- 652 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---------------- 652 (834)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999864321 256899999999999999999999998 999999999999984
Q ss_pred ---CCCeEEeeeccccccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc
Q 003272 653 ---EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH 728 (834)
Q Consensus 653 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~ 728 (834)
...+||+|||++....... ...||+.|+|||++.+. .++.++||||||++++||++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4479999999998764322 24589999999999876 66789999999999999999987642110
Q ss_pred chhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 729 NLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.... .+......+.+++.+||+.||++||++.|+++
T Consensus 236 -----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -----QWHEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111112221111 11112346788999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=334.97 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=197.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..+.||+|+||.||++.... ++.||||++.+.... +.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4679999999999999999999864 889999999765432 35688888888 79999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC----CCeEEeeecccccc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARAF 667 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~~ 667 (834)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999988853 346899999999999999999999998 9999999999998543 34999999999876
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......+...
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~--- 241 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFS--- 241 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCC---
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCcc---
Confidence 43322 2233678999999999988889999999999999999999999986422221111 11112211111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+...........+.+++.+||+.||++||++.|+++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111122346788999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.98 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=196.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-CeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-DERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~ 592 (834)
.++|+..+.||+|+||.||++.. .|+.||||+++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 36788999999999999999987 6899999998653 3457899999999999999999999997655 468999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998542 1234889999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
....+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... . ......+.
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~----~~~~~~~~--------- 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGY--------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTTC---------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcCC---------
Confidence 12456889999999999999999999999999999998 999875332111 1 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111222334688899999999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=347.55 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=193.0
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------C
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------D 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 584 (834)
.++|+..++||+|+||+||+|.... ++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4689999999999999999998754 899999999754 334567889999999999999999999999654 3
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 444442 23899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh-----
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI----- 739 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 739 (834)
+..... .......||+.|+|||++.+..++.++|||||||+++||++|+.||......+ ..........
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 876432 12234689999999999999999999999999999999999999985432111 1111111000
Q ss_pred -------------ccCc-------ccccCccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 -------------QDRP-------AELIDKSLYDSC---SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 -------------~~~~-------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... .......+.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000000000 0112456889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.65 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=186.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
..++|+..+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999864 58899999986542 344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhcc-----CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 591 EYLPNKSLDYFIFDT-----TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 591 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988531 12456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcc---ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 666 AFGLDQT---EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 666 ~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
....... ........||+.|+|||.+.+ ..++.++||||||++++||++|+.|+....... .. .. ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-~~~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---ML-TLQN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HH-HHTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HH-Hhcc
Confidence 7643221 111223578999999999876 568999999999999999999999976433221 11 01 1111
Q ss_pred Cccc----ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 RPAE----LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 ~~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... ..++..... ....+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111 111111122 2346788999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.54 Aligned_cols=263 Identities=24% Similarity=0.293 Sum_probs=201.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||++... .++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357889999999999999999986 4889999999765 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|+++++|.+++... ..+++..+..++.+|+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999998543 3589999999999999999999985 6 99999999999999999999999999976521
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH---------HHH----
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA---------WQL---- 737 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~---------~~~---- 737 (834)
.......||+.|+|||++.+..++.++||||||++++||++|+.||............... ...
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 1122367899999999999999999999999999999999999998643221110000000 000
Q ss_pred ----------hhccCcccccCccc----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 738 ----------WIQDRPAELIDKSL----YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 738 ----------~~~~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.++... ...........+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000 00011112346788999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=337.40 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=201.6
Q ss_pred hcCCcccCccccCCcccEEEEEE----eCCeEEEEEEecccC----cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML----IEGQEIAVKRLSKSS----GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
.++|+..++||+|+||.||+++. ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999997 358999999986532 23446678899999999 6999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 45899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+.+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....... .... .........
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAE-ISRRILKSE 282 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHH-HHHHHHHCC
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHH-HHHHHhccC
Confidence 876433222 2233679999999999986 357899999999999999999999975432211 1111 111111110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVLML 788 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~~L 788 (834)
...+......+.+++.+||+.||++|| ++.|+++..
T Consensus 283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011122234677899999999999999 999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.54 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=199.7
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++|+..++||+|+||.||++... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999986 489999999865421 24678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC----CeEEeeecc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM----NPKISDFGM 663 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfGl 663 (834)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999854 345899999999999999999999988 99999999999998877 899999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+........ .....+++.|+|||++.+..++.++||||||++++||++|+.|+....... ..........
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhccc
Confidence 987643221 223568999999999999999999999999999999999999975322110 1111111100
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......... ....+.+++.+||+.||++||++.|+++
T Consensus 229 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 --DFDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCcchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 001111111 1236788999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=347.56 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=204.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...+.||+|+||.||+++... |+.||+|++.+.. ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678888999999999999999854 8999999996542 34557889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCC-CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDTTR-SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|||+++|+|..++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998865432 456999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ............
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~-~~~~~~i~~~~~----- 410 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--EN-KELKQRVLEQAV----- 410 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CH-HHHHHHHHHCCC-----
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hH-HHHHHHHhhccc-----
Confidence 33221 233589999999999999999999999999999999999999975432111 11 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM-----LSVV 785 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~ 785 (834)
..+......+.+++.+||+.||++||++ .+|+
T Consensus 411 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 411 -----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred -----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 1112223467889999999999999975 5665
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.88 Aligned_cols=245 Identities=21% Similarity=0.239 Sum_probs=189.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHH-HHhccCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALL-IAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..+.||+|+||.||+++... ++.||||++++.. ....+.+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3578999999999999999999865 8899999997643 2334556667766 467899999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998854 345889999999999999999999998 9999999999999999999999999998642
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~----~~~~i~~~~~----- 256 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---E----MYDNILNKPL----- 256 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---H----HHHHHHHSCC-----
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H----HHHHHHhccc-----
Confidence 221 2233478999999999999999999999999999999999999997532111 1 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 783 (834)
. .+......+.+++.+||+.||.+||++.+
T Consensus 257 -~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 -Q----LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -C----CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -C----CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0 11112336788999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.60 Aligned_cols=252 Identities=19% Similarity=0.197 Sum_probs=189.4
Q ss_pred cCCccc-CccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHh-ccCCceeeEEEEEEe----CCeeE
Q 003272 515 DNFSEE-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAK-LQHRNLVKLLGCCTQ----RDERV 587 (834)
Q Consensus 515 ~~~~~~-~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 587 (834)
++|... ++||+|+||+||++.... ++.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456655 689999999999999764 889999999532 467788888754 489999999999875 56689
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeeccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA 664 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla 664 (834)
+||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998643 2346899999999999999999999988 999999999999997 789999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ......+...
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~ 285 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE 285 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCccc
Confidence 8764322 123467899999999999999999999999999999999999998543322111100 0111111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
...+ ........+.+|+.+||+.||++|||+.||++-
T Consensus 286 -~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 -FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 001123467889999999999999999999963
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.02 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=203.2
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe--CCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 588 (834)
.++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999985 4899999999754 23455789999999999999999999998854 567899
Q ss_pred EEeecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcC--CCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 589 VYEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ........+....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRR 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhccccc
Confidence 7643221 112356899999999999999999999999999999999999997543211 1111112221111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
.+......+.+++.+||+.||++||++.||++.+..
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111223467889999999999999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=335.42 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=191.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
..++|+..++||+|+||+||++... +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4578999999999999999999865 48999999996543 23345788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-----CCCCeEEeeeccc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-----NEMNPKISDFGMA 664 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-----~~~~~kl~DfGla 664 (834)
|||+++ +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||++
T Consensus 112 ~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999985 888887543 35899999999999999999999998 99999999999994 5556999999999
Q ss_pred cccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+.+...... .....+|+.|+|||++.+. .++.++|||||||+++||++|+.||....... ..............
T Consensus 185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCch
Confidence 876433221 2235679999999999874 58999999999999999999999975322111 11111111100000
Q ss_pred cc----------------ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AE----------------LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~----------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. .....+...........+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00000000000112346788999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=339.40 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=190.1
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--------cccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--------GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
..++|...++||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 46789999999999999999999755 8899999986532 122235889999999999999999999975 5
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC---CCeEEee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISD 660 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~D 660 (834)
+..++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999988874 3456999999999999999999999988 9999999999999754 4599999
Q ss_pred eccccccCCCccccccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 661 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+.. .
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~----~ 356 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKD----Q 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHH----H
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHH----H
Confidence 99998764321 2234679999999999863 57889999999999999999999997532211 11111 1
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+.... .+..... ....+.+++.+||+.||++||++.|+++
T Consensus 357 i~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11111100 0000011 1346788999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.49 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=203.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|...+.||+|+||.||++...+ ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3678899999999999999999865 7889999986542 33457789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988753 246899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.... .....+++.|+|||.+.+..++.++||||||++++||++|+.|+......+ ..........
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~------ 232 (294)
T 2rku_A 168 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY------ 232 (294)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC------
T ss_pred Cccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC------
Confidence 3221 233678999999999999899999999999999999999999975322111 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++||++.|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011112236778999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.79 Aligned_cols=265 Identities=24% Similarity=0.306 Sum_probs=196.0
Q ss_pred HHhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-----ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-----QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 585 (834)
...++|+..+.||+|+||.||+|.... |+.||||++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999754 89999999965322 123478899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||+++ +|..++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 77777743 2346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.+..... ......+|+.|+|||++.+. .++.++||||||+++|||++|..|+...... ................
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChh
Confidence 7643322 22336789999999999764 5899999999999999999999886532211 1111111111111110
Q ss_pred c------ccCc---cccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 E------LIDK---SLYDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ~------~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. +.+. ......+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000 0000111 1123578889999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.48 Aligned_cols=261 Identities=16% Similarity=0.175 Sum_probs=203.5
Q ss_pred cCCcccCccccCCcccEEEEEEeC---------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceee----------
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE---------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVK---------- 575 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 575 (834)
++|...++||+|+||.||+|.... ++.||||++... +.+.+|+.++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999764 789999998643 46889999999999999987
Q ss_pred -----EEEEEEe-CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcee
Q 003272 576 -----LLGCCTQ-RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649 (834)
Q Consensus 576 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 649 (834)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6777776 67889999999 99999999643 2356999999999999999999999998 999999999999
Q ss_pred ecCCC--CeEEeeeccccccCCCccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003272 650 LDNEM--NPKISDFGMARAFGLDQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722 (834)
Q Consensus 650 l~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~ 722 (834)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876433221 1112357899999999999999999999999999999999999997643
Q ss_pred CcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 723 HADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..... .+ ......+ ......+.+..... ......+.+++.+||+.||++||++.+|+++|+..
T Consensus 272 ~~~~~-~~-~~~~~~~-~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 272 LPNTE-DI-MKQKQKF-VDKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TTCHH-HH-HHHHHHH-HHSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CcCHH-HH-HHHHHhc-cCChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 21111 11 1111111 11222222211110 01124678899999999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.95 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=201.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 578899999999999999999864 789999998653 2234578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999988543 35899999999999999999999988 999999999999999999999999999765332
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
. .....|++.|+|||++.+..++.++||||||++++||++|+.|+....... ..........
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~------- 229 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVDL------- 229 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-------
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhcccc-------
Confidence 1 223578999999999999999999999999999999999999975322111 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++||++.|+++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111122346788999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.23 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=198.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+..+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34789999999999999999999864 88999999987766777899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|..++... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999887542 345899999999999999999999988 9999999999999999999999999876431111
Q ss_pred cccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.......|++.|+|||++. ...++.++||||||++++||++|+.|+...... ... ...........
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~ 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVL-LKIAKSDPPTL 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSCCCCC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHH-HHHhccCCccc
Confidence 1112357899999999983 667899999999999999999999997543211 111 11111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. .+......+.+++.+||+.||++||++.++++
T Consensus 243 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 L-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 11122346788999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.56 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=197.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEe--CCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQ--RDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 589 (834)
.++|+..++||+|+||.||+|... +++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367999999999999999999874 5899999998643 3468899999999997 9999999999988 5678999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFG 668 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~ 668 (834)
|||+++++|..++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3889999999999999999999998 99999999999999776 89999999998764
Q ss_pred CCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC-----
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR----- 742 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 742 (834)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ..+.. .........
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~-~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVR-IAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHH-HHHHHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHH-HHHhcCCchhhhHH
Confidence 3322 223578999999999987 679999999999999999999999974322111 00100 000000000
Q ss_pred ------------------cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 ------------------PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....................+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000001111111113457889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.85 Aligned_cols=259 Identities=20% Similarity=0.358 Sum_probs=205.2
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--------ccHHHHHHHHHHHHhc-cCCceee
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--------QGVEEFKNEALLIAKL-QHRNLVK 575 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~ 575 (834)
.+.......++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34445556678999999999999999999986 599999999865432 1245688899999999 8999999
Q ss_pred EEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC
Q 003272 576 LLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN 655 (834)
Q Consensus 576 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 655 (834)
+++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999999999999999854 246899999999999999999999988 999999999999999999
Q ss_pred eEEeeeccccccCCCccccccccccccccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccc
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~ 729 (834)
+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... .
T Consensus 239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~ 312 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L 312 (365)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H
Confidence 99999999987653322 233678999999999863 35889999999999999999999997432111 1
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ......... ...+. ... ....+.+++.+||+.||++||++.|+++
T Consensus 313 ~~----~~i~~~~~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 ML----RMIMEGQYQ-FSSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH----HHHHHTCCC-CCHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH----HHHHhCCCC-CCCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111111110 00000 011 1235788999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.80 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=202.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|...+.||+|+||.||+++.. +|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467889999999999999999975 4899999999766555557789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeeccccccCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~~ 669 (834)
+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||++ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999998888542 45899999999999999999999998 9999999999999 7889999999999976432
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
. ......|++.|+|||++.+..++.++||||||++++||++|+.|+...... .+ ......+... . .
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~~~~-~-~- 227 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KL----FEKIKEGYYE-F-E- 227 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH----HHHHHHCCCC-C-C-
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCCC-C-C-
Confidence 2 122356899999999999999999999999999999999999997532111 11 1111111110 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL--MLSGE 791 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 791 (834)
..........+.+++.+||+.||++||++.|+++ .+++.
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 ---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0111122346788999999999999999999986 44443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.98 Aligned_cols=253 Identities=11% Similarity=0.076 Sum_probs=181.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc---ccHHHHHHHHHHHHhc--cCCceeeEE-------EEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG---QGVEEFKNEALLIAKL--QHRNLVKLL-------GCCT 581 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~~ 581 (834)
.+|...++||+|+||.||+|... +++.||||++..... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888899999999999999975 589999999976432 3456778886655555 599988855 4443
Q ss_pred eC-----------------CeeEEEEeecCCCChhhHhhccCCCCCCCHHhH------HHHHHHHHHHHHHhhhcCCCce
Q 003272 582 QR-----------------DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNR------CHIIGGIARGLLYLHHDSRLRI 638 (834)
Q Consensus 582 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 638 (834)
.. ...++||||++ ++|.+++... ...+.+..+ ..++.||++||+|||+.+ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 33 23799999999 8999998643 223455666 788899999999999998 9
Q ss_pred EeccCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCC
Q 003272 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGK 716 (834)
Q Consensus 639 vH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~ 716 (834)
+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998764221 12456799999999987 67999999999999999999999
Q ss_pred CCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 717 RNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 717 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.||.......... +........................+.+|+.+||+.||++||++.|+++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9986432221110 0000000000111111111123447888999999999999999999964
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=338.41 Aligned_cols=199 Identities=23% Similarity=0.391 Sum_probs=167.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----Ce
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 585 (834)
.++|...++||+|+||.||+|.... ++.||||++... .....+++.+|+.++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999754 889999999754 334457899999999999999999999999776 56
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||++ ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 589888843 356999999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCccc--------------------cccccccccccccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003272 666 AFGLDQTE--------------------ANTNRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIVSGKRNR 719 (834)
Q Consensus 666 ~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~t~~sDV~S~Gvil~elltg~~p~ 719 (834)
........ .......||+.|+|||++ ....++.++|||||||+++||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 87433211 112447889999999986 5567999999999999999999876654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=339.89 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=204.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccC-CceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH-RNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||.||+|... +++.||||++..... .+++..|+.++..++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 368999999999999999999974 489999998865432 2458899999999976 666677777788889999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~~~ 668 (834)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998542 346999999999999999999999998 9999999999999 688999999999998764
Q ss_pred CCcccc-----ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 669 LDQTEA-----NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 669 ~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 432211 122467999999999999999999999999999999999999998654333222222111111111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 744 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+. ..+ ...+.+++..||+.+|++||++.+|+++|+..
T Consensus 238 ~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111 111 24678899999999999999999999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=326.86 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=196.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeC--C--eEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~--g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..++||+|+||.||+|++.. + ..||||+++.. .....+++.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3578899999999999999998643 3 36899998654 2345678999999999999999999999997654 8
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++|+||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988643 345899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 667 FGLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 667 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
....... .......++..|+|||++.+..++.++||||||++++||++ |+.|+...... .. .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI----LHKIDKEGE- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTSCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HH----HHHHHccCC-
Confidence 7543322 12223567788999999998889999999999999999999 99997532211 11 111111100
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
....+......+.+++.+||+.||++||++.++++.|+...
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00111223346888999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=319.13 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=196.2
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 587 (834)
+.|...++||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 346777899999999999998754 788999998654 33456789999999999999999999999865 34589
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeEEeeeccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA 666 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~ 666 (834)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999998542 45899999999999999999999875 3599999999999998 789999999999976
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
..... .....|++.|+|||++. +.++.++||||||++++||++|+.|+...... ...............
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence 53322 22357899999999876 45899999999999999999999997532211 111111111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ... ....+.+++.+||+.||++||++.|+++
T Consensus 251 ~----~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 F----DKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----GGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----CCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 111 1235788999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.51 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=195.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 584 (834)
.++|+..+.||+|+||.||+|... .|+.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999975 4899999999653 2334567899999999999999999999997653
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++||||+ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899988853 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC-
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR- 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 742 (834)
+..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||......+ .............
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 876432 223678999999999987 689999999999999999999999975332211 1111100000000
Q ss_pred -----------------cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003272 743 -----------------PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL--MLSGE 791 (834)
Q Consensus 743 -----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 791 (834)
........+ ..........+.+|+.+||+.||++|||+.|+++ .++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000000 0111122346788999999999999999999987 34443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.10 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=197.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC----cccHHHHHHHHHHHHhccCCceeeEEEEEE--eCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS----GQGVEEFKNEALLIAKLQHRNLVKLLGCCT--QRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 586 (834)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 48899999996542 345678999999999999999999999984 44578
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 65555432 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
..............|++.|+|||++.+.. ++.++||||||++++||++|+.|+...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCCC-
Confidence 65433333333467899999999997654 478999999999999999999997532111 11111111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+ +......+.+++.+||+.||++||++.|+++.
T Consensus 231 -----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 11223467789999999999999999999963
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.89 Aligned_cols=259 Identities=19% Similarity=0.268 Sum_probs=194.7
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe------eEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE------RVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 588 (834)
.+|+..++||+|+||.||+|+..++..||+|++...... ..+|+.+++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 568899999999999999999988778999998654322 2369999999999999999999965443 789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeEEeeecccccc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAF 667 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~ 667 (834)
||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998766554433334567999999999999999999999998 99999999999999 7999999999999876
Q ss_pred CCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc---
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP--- 743 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 743 (834)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+ ............
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l-~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QL-VEIIKVLGTPSREQI 266 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-HHHHHHHCCCCHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHHHHHhCCCCHHHH
Confidence 43322 2235789999999998765 59999999999999999999999975432211 11 111111000000
Q ss_pred ----ccccCcc--------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 ----AELIDKS--------LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ----~~~~d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....... ............+.+|+.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000 000111123347889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.82 Aligned_cols=269 Identities=21% Similarity=0.253 Sum_probs=190.8
Q ss_pred HHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe-
Q 003272 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE- 585 (834)
Q Consensus 508 ~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 585 (834)
.+.....++|...++||+|+||.||+|+.. +++.||||++.... ...+.+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999985 48999999986543 334567788888999999999999999976443
Q ss_pred ------eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhh--hcCCCceEeccCCCCceeecC-CCCe
Q 003272 586 ------RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH--HDSRLRIIHRDLKASNVLLDN-EMNP 656 (834)
Q Consensus 586 ------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~DLkp~NILl~~-~~~~ 656 (834)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999997544433332344567899999999999999999999 777 999999999999996 8999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHH
Confidence 9999999987643322 2235789999999998765 48999999999999999999999975432211 111111
Q ss_pred HHhhccC------------cccccC------ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 QLWIQDR------------PAELID------KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ~~~~~~~------------~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....... .....+ ..............+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1100000 000000 00011122224567889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=326.27 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=184.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..++||+|+||.||++... +++.||||+++.... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999974 589999999975422 22334455556678889999999999999999999999
Q ss_pred eecCCCChhhHhhc-cCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 591 EYLPNKSLDYFIFD-TTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 591 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||+++ +|.+++.. ......+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99984 77776643 12345799999999999999999999997 7 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYA----IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... .....||+.|+|||++ .+..++.++||||||++++||++|+.|+...... .......... ...
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~~~ 232 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEE-PSP 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHS-CCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhcc-CCC
Confidence 3322 2234789999999996 5567899999999999999999999997532211 1111111111 111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QLP--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccc--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 1112346788999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.47 Aligned_cols=269 Identities=21% Similarity=0.253 Sum_probs=198.2
Q ss_pred CHHHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcc-----------cHHHHHHHHHHHHhccCCcee
Q 003272 506 DWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ-----------GVEEFKNEALLIAKLQHRNLV 574 (834)
Q Consensus 506 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv 574 (834)
..+++....++|...++||+|+||.||+|...+|+.||||++...... ..+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778889999999999999999999999888999999998653221 237899999999999999999
Q ss_pred eEEEEEEeC-----CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcee
Q 003272 575 KLLGCCTQR-----DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649 (834)
Q Consensus 575 ~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 649 (834)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998553 35799999998 577777653 3456999999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc
Q 003272 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH 728 (834)
Q Consensus 650 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~ 728 (834)
++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.|+.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999998643222 2233678899999999887 679999999999999999999999975422111
Q ss_pred chhHHHHHHhhccCc-----------ccccCccccC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 729 NLLGHAWQLWIQDRP-----------AELIDKSLYD-------SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~-----------~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.............. ...+...+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111000000 0001000000 001112346788999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.68 Aligned_cols=260 Identities=28% Similarity=0.406 Sum_probs=198.5
Q ss_pred cCHHHHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEe
Q 003272 505 FDWKTIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ 582 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 582 (834)
+++.++....++|+..+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344445556789999999999999999999985 5889999998654 33457899999999999 89999999999987
Q ss_pred ------CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 583 ------RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 583 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999998643 2356899999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL 731 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~ 731 (834)
||+|||++........ ......|++.|+|||++. +..++.++||||||+++|||++|+.|+......
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 240 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------ 240 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------
Confidence 9999999987643221 122357899999999987 567899999999999999999999997432211
Q ss_pred HHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 732 GHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... ............ .......+.+++.+||+.||++||++.++++
T Consensus 241 ~~~-~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 RAL-FLIPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH-HHHHHSCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH-HHhhcCccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 111111111111 1111236788999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=333.87 Aligned_cols=261 Identities=24% Similarity=0.267 Sum_probs=199.8
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhcc--------CCceeeEEEEEE---
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ--------HRNLVKLLGCCT--- 581 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 581 (834)
.++|+..++||+|+||.||+|+... ++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3689999999999999999998754 889999999643 345578899999999985 788999999987
Q ss_pred -eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCC-----
Q 003272 582 -QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEM----- 654 (834)
Q Consensus 582 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~----- 654 (834)
.....++||||+.+ +|...+... ....+++..+..++.||+.||.|||+. + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 45678999999955 554444332 235699999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CeEEeeeccccccCCCccccccccccccccccCccc
Q 003272 655 --------------------------------------------NPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690 (834)
Q Consensus 655 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~ 690 (834)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999876432 223578999999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh---HHHHHHhhccCcc----------cccCcc-------
Q 003272 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL---GHAWQLWIQDRPA----------ELIDKS------- 750 (834)
Q Consensus 691 ~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~----------~~~d~~------- 750 (834)
+.+..++.++|||||||++|||++|+.||............ ....... ...+. +.....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL-GKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH-CSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc-CCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999998654332211111 1111100 00000 000000
Q ss_pred ------------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 ------------LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 ------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
-....+......+.+|+.+||+.||++|||+.||++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001234566778899999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.62 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=198.7
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+..+.||+|+||.||+|.... |+.||||++.... ..+++.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45789999999999999999999864 8999999996543 45789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++.. ....+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998853 2356899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ............
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~---- 246 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAI-FMIPTNPPPTFR---- 246 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSCCCCCS----
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHH-HHHhcCCCcccC----
Confidence 2 122357899999999999999999999999999999999999997532211 001 111111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+++.+||+.||++||++.++++
T Consensus 247 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11112346788999999999999999999975
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.40 Aligned_cols=217 Identities=17% Similarity=0.186 Sum_probs=170.7
Q ss_pred ccccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceE
Q 003272 21 STRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTAL 100 (834)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~l 100 (834)
++.|+|++||+|.+|++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| ..+.|+|+.||| |
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGn---L 68 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDGL---L 68 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSC---SCCBCCBCSSSC---B
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCCc---E
Confidence 567999999999999999 59999999987654 334 432 799999999998 468899999999 9
Q ss_pred EEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCcccc-ccCCeeeeee-ccCC---
Q 003272 101 VLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTL-LAGMKLGVNL-VTGL--- 175 (834)
Q Consensus 101 vl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtl-Lpg~~l~~~~-~tg~--- 175 (834)
||.|++|.+||+|++... ....+|+|+|+|||||+ + .++||||||||||+ ||+| +.|. .+|+
T Consensus 69 vl~d~~~~~vW~s~~~~~-~~~~~~~l~d~Gnlvl~--~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~ 135 (236)
T 1dlp_A 69 VILTAQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIY--G--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGND 135 (236)
T ss_dssp CCBCTTTCCSCCCCCCCC-SSCCEEEECSSSCEEEE--C--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CC
T ss_pred EEEcCCCcEEEeCCcccc-CCcEEEEEeCCCCEEEe--c--------CCEEECCCCCCcccccCCc--cceEEecCCcCC
Confidence 999999999999996322 23357999999999999 2 28999999999887 6665 5565 5555
Q ss_pred --ceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCCCCcceeecCCCcCCCCceEEEEeecCceEEEEEE
Q 003272 176 --NRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEFVSNENEVFYRFK 253 (834)
Q Consensus 176 --~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~w~g~~~~~~p~~~~~~~~~~~~~~n~~~~~~~~~ 253 (834)
++.|+ +.+||++|.|+|.++++| +++++++..+||++++|++. +...+++..+.. .+.|..+..+.+++|.
T Consensus 136 ~~~~~L~---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gn-l~ly~~~~~~vw~s~~ 208 (236)
T 1dlp_A 136 NHPQTLH---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGR-MDVLTNQNIAVWTSGN 208 (236)
T ss_dssp CCCCEEC---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTE-EEEEETTTEEEEECCC
T ss_pred CccceEE---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCc-EEEEeCCCcEEEEeCC
Confidence 56777 478999999999999999 67888888899999999754 556667655442 2334445556666665
Q ss_pred ecCCCceeEEEEcccCcEEEEE
Q 003272 254 LINSSVPTMMVINTIGDVQRFT 275 (834)
Q Consensus 254 ~~~~s~~~~~~l~~~G~l~~~~ 275 (834)
.... ...|++|+.+|++++|.
T Consensus 209 ~~~~-~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 209 SRSA-GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCSS-SCCEEEECSSSCEEEEC
T ss_pred CCCC-CCEEEEEcCCCcEEEeC
Confidence 4433 46899999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.97 Aligned_cols=242 Identities=17% Similarity=0.167 Sum_probs=188.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHH---HHHHhccCCceeeEE-------EE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEA---LLIAKLQHRNLVKLL-------GC 579 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 579 (834)
.++|...++||+|+||.||+|+.. +|+.||||++... .....+.+.+|+ ..+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999964 5999999999743 334567899999 455566899999998 66
Q ss_pred EEeCC-----------------eeEEEEeecCCCChhhHhhccC----CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCce
Q 003272 580 CTQRD-----------------ERVLVYEYLPNKSLDYFIFDTT----RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRI 638 (834)
Q Consensus 580 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 638 (834)
+...+ ..++||||+ +|+|.+++.... ....+++..++.++.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 689999886421 1223556888999999999999999998 9
Q ss_pred EeccCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccC-----------CCCchhhHHHHHH
Q 003272 639 IHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-----------LFSVKSDVFSFGV 707 (834)
Q Consensus 639 vH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~t~~sDV~S~Gv 707 (834)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 1223567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 708 LVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 708 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
++|||++|+.||........ ...+.. . .... ...+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999753221110 011111 0 0112 246788999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.21 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=194.5
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+..+++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67889999999999999999986 5899999998653 2344578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999998543 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. .....+++.|+|||.+.+..+ +.++||||||++++||++|+.|+...... . .......+..
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~------ 228 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---T----LFKKIRGGVF------ 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC------
T ss_pred cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---H----HHHHhhcCcc------
Confidence 21 223568899999999988765 68999999999999999999997532111 1 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
..+......+.+++.+||+.||++||++.|+++.
T Consensus 229 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111123467789999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.49 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=195.5
Q ss_pred HHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhcc--CCceeeEEEEEEeCCee
Q 003272 511 VDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQ--HRNLVKLLGCCTQRDER 586 (834)
Q Consensus 511 ~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~ 586 (834)
....++|+..++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||+++++++...+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3345779999999999999999999888999999998653 3345678999999999997 59999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||| +.+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||+++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999 678899998854 346899999999999999999999998 999999999999975 8999999999987
Q ss_pred cCCCccccccccccccccccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 735 (834)
..............|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ....
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~- 249 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL- 249 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH-
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHH-
Confidence 654433333334678999999999875 47889999999999999999999997532111 0111
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. .+++......+......+.+++.+||+.||++||++.|+++
T Consensus 250 ~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 HA--------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HH--------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH--------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11 11111111111112346788999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.00 Aligned_cols=198 Identities=22% Similarity=0.291 Sum_probs=171.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhc------cCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL------QHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 586 (834)
..+|+..++||+|+||.||+|.... ++.||||+++.. ....+++.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4679999999999999999998765 899999999643 34456788899888887 577999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC--eEEeeeccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMA 664 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DfGla 664 (834)
++||||+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999997 5888877543 2345899999999999999999999998 999999999999999987 999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~ 722 (834)
+..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 764322 22367899999999999999999999999999999999999997543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=344.31 Aligned_cols=251 Identities=25% Similarity=0.299 Sum_probs=200.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..++||+|+||+||++... .++.||||++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999975 4899999998643 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec---CCCCeEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~ 667 (834)
||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999998887543 45899999999999999999999998 99999999999995 5567999999999876
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .+ ......+.....
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i~~~~~~~~- 242 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI----LKRVETGKYAFD- 242 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCCSC-
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCCCCC-
Confidence 4332 1233679999999999875 5999999999999999999999997432111 11 111111111000
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred Ccc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 01123467889999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.81 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=193.1
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEE-----------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCT----------- 581 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 581 (834)
.++|...++||+|+||.||+|.... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3679999999999999999999865 8999999998766667788999999999999999999999873
Q ss_pred ---eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeE
Q 003272 582 ---QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPK 657 (834)
Q Consensus 582 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~k 657 (834)
+....++||||++ ++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 68988883 346899999999999999999999998 99999999999997 567999
Q ss_pred EeeeccccccCCCcc-ccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 003272 658 ISDFGMARAFGLDQT-EANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 658 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 735 (834)
|+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987643221 112233567899999998876 679999999999999999999999976432211 010000
Q ss_pred HHhh----------ccCcccccCcccc-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 QLWI----------QDRPAELIDKSLY-DSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ~~~~----------~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... .......+..... ...+ ......+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 0000000000000 0000 112346788999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=340.20 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=190.6
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------eeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 587 (834)
.+|+..++||+|+||.||+|+... ++.||||++..... .+.+|++++++++|+||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468888999999999999999864 89999999865322 2346999999999999999999985421 267
Q ss_pred EEEeecCCCChhhHhhc-cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-CCeEEeeecccc
Q 003272 588 LVYEYLPNKSLDYFIFD-TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 665 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DfGla~ 665 (834)
+||||+++ +|...+.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999987 44444322 223457999999999999999999999988 9999999999999965 568999999998
Q ss_pred ccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh-----
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI----- 739 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 739 (834)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.. ......
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~-i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHH
Confidence 7643322 2236789999999999765 79999999999999999999999975422111 1111 111100
Q ss_pred -----ccCcccccCccccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 740 -----QDRPAELIDKSLYD-----SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 740 -----~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+..-+.+.. .+.......+.+|+.+||+.||++||++.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00011111111100 011122357889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.69 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=202.8
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCccc-----------------HHHHHHHHHHHHhccCCceeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQG-----------------VEEFKNEALLIAKLQHRNLVKL 576 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 576 (834)
.++|...+.||+|+||.||++.. +++.||||++....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999998 99999999996542211 1889999999999999999999
Q ss_pred EEEEEeCCeeEEEEeecCCCChhhH------hhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCcee
Q 003272 577 LGCCTQRDERVLVYEYLPNKSLDYF------IFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVL 649 (834)
Q Consensus 577 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NIL 649 (834)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 124679999999999999999999998 77 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcccc
Q 003272 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSV-KSDVFSFGVLVLEIVSGKRNRGFYHADHR 727 (834)
Q Consensus 650 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~-~sDV~S~Gvil~elltg~~p~~~~~~~~~ 727 (834)
++.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||++++||++|+.|+......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876432 22346789999999999887 6666 999999999999999999997643221
Q ss_pred cchhHHHHHHhhccCccccc------Cccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 728 HNLLGHAWQLWIQDRPAELI------DKSL---YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~------d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ............... .+.. ...........+.+++.+||+.||++||++.|+++
T Consensus 259 ~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 V----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111111111111000 0000 00001223347788999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=335.08 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=193.5
Q ss_pred HHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------
Q 003272 511 VDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------ 583 (834)
Q Consensus 511 ~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 583 (834)
....++|+..++||+|+||.||+|... +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999874 589999999865432 234699999999999999999998543
Q ss_pred --------------------------------CeeEEEEeecCCCChhhHhhcc-CCCCCCCHHhHHHHHHHHHHHHHHh
Q 003272 584 --------------------------------DERVLVYEYLPNKSLDYFIFDT-TRSKVLDWQNRCHIIGGIARGLLYL 630 (834)
Q Consensus 584 --------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL 630 (834)
...++||||++ ++|...+... .....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 4776666431 2345699999999999999999999
Q ss_pred hhcCCCceEeccCCCCceeec-CCCCeEEeeeccccccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHH
Q 003272 631 HHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVL 708 (834)
Q Consensus 631 H~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvi 708 (834)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....+|+.|+|||++.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9988 99999999999998 688999999999987643322 2235789999999998875 59999999999999
Q ss_pred HHHHHhCCCCCCCCCcccccchhHHHHHHhhcc----------Ccccc-----cCccccCCCCHHHHHHHHHHHHHcccC
Q 003272 709 VLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD----------RPAEL-----IDKSLYDSCSLSEAIRCIQVGLLCVQQ 773 (834)
Q Consensus 709 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 773 (834)
++||++|+.||......+ ............ ...+. .........+......+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999975432211 111111111000 00000 000000111222334678999999999
Q ss_pred CCCCCCCHHHHHH
Q 003272 774 IPEDRPNMLSVVL 786 (834)
Q Consensus 774 dP~~RPt~~ev~~ 786 (834)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=345.17 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=195.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..++||+|+||+||+++.. .+..||||++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457899999999999999999986 48899999997542 344678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC---CCeEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~~ 667 (834)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999998877542 45899999999999999999999998 9999999999999764 55999999999876
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... ......||+.|+|||++. ..++.++||||+||++|||++|+.||...... . .......+... ..
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~----~~~~i~~~~~~-~~ 257 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---E----ILRKVEKGKYT-FD 257 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCCC-CC
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHhCCCC-CC
Confidence 4322 223367999999999876 56999999999999999999999997532211 1 11111111110 00
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+. ... ....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~-~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPE-WKN----VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGG-GTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chh-ccc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 011 1236778999999999999999999884
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.15 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=201.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---------cccHHHHHHHHHHHHhcc-CCceeeEEEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---------GQGVEEFKNEALLIAKLQ-HRNLVKLLGCCT 581 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 581 (834)
..++|+..++||+|+||.||++... +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999985 48999999996542 123467889999999995 999999999999
Q ss_pred eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 582 QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 582 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
.....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999854 346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 735 (834)
|++........ .....+++.|+|||++. ...++.++||||||++++||++|+.|+...... . ..
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~ 238 (298)
T 1phk_A 169 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L----ML 238 (298)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HH
T ss_pred cchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---H----HH
Confidence 99987643321 22357899999999985 456889999999999999999999997432211 0 11
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
......... ... .........+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~-~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQ-FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCC-CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcc-cCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111110 000 001122346888999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=355.72 Aligned_cols=249 Identities=27% Similarity=0.331 Sum_probs=203.4
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 587 (834)
..++|+..++||+|+||.||++.... ++.||||++++. .....+.+..|..++..+ +|+||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34679999999999999999999865 888999999753 234567788899999887 7999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998643 45899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~----~~~~i~~~~~---- 559 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---E----LFQSIMEHNV---- 559 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHSSCC----
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---H----HHHHHHhCCC----
Confidence 32222 233478999999999999999999999999999999999999997532211 1 1111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM-----LSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~ev~~ 786 (834)
.++......+.+|+.+||+.||++||++ +||++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1112233467889999999999999997 66653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.43 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=201.5
Q ss_pred hcCCcccCccccCCcccEEEEEE--eCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc------eeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGML--IEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN------LVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999987 25889999999643 344577899999999987665 9999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-------------
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN------------- 652 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~------------- 652 (834)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888543 2346889999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 003272 653 ------EMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726 (834)
Q Consensus 653 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~ 726 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999875322 223578999999999999999999999999999999999999986433221
Q ss_pred ccchhHHHHHHhhccCcccc------------------------------cCcc-ccCCCCHHHHHHHHHHHHHcccCCC
Q 003272 727 RHNLLGHAWQLWIQDRPAEL------------------------------IDKS-LYDSCSLSEAIRCIQVGLLCVQQIP 775 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~------------------------------~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP 775 (834)
.... . .......+..+ ..+. ............+.+++.+||+.||
T Consensus 242 ~~~~---~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 242 HLAM---M-ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHHH---H-HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHHH---H-HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 1100 0 00000000000 0000 0011233456788999999999999
Q ss_pred CCCCCHHHHHH
Q 003272 776 EDRPNMLSVVL 786 (834)
Q Consensus 776 ~~RPt~~ev~~ 786 (834)
++|||+.||++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.84 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=198.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----Cee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 586 (834)
.++|+..++||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999875 48899999997533 33457889999999999999999999999765 368
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++|+||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 488888743 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-ccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 667 FGLDQTEA-NTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 667 ~~~~~~~~-~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence 65332221 1234679999999998765 458999999999999999999999975432221 111111111000000
Q ss_pred c---ccC--------ccc-cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 E---LID--------KSL-YDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~---~~d--------~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ..+ ... ....+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000 000 00000 112346788999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=325.23 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=198.2
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..+.||+|+||.||+|...+ .+|+|+++.. .....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4688899999999999999998743 5999998653 23344678889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999998542 346899999999999999999999998 99999999999998 6799999999987653221
Q ss_pred c---ccccccccccccccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 672 T---EANTNRVVGTYGYMSPEYAID---------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 672 ~---~~~~~~~~gt~~y~APE~~~~---------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
. ........|++.|+|||.+.. ..++.++||||||+++|||++|+.|+....... ......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHhc
Confidence 1 122223568999999999874 457899999999999999999999975322111 111111
Q ss_pred ccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 740 QDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 740 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
.+........ . ....+.+++.+||+.||++||++.+|+++|+....
T Consensus 257 ~~~~~~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 257 TGMKPNLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TTCCCCCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred cCCCCCCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111111110 1 12257789999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.32 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=190.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 584 (834)
.++|+..+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999875 4889999999753 2344567889999999999999999999997665
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 68999999985 6766663 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHH--------
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQ-------- 736 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-------- 736 (834)
+...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||....... .......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 8754321 1223678999999999999999999999999999999999999975432111 0000000
Q ss_pred ----------HhhccCc-------ccccCccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 737 ----------LWIQDRP-------AELIDKSLYDSC---SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 737 ----------~~~~~~~-------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+..... ............ .......+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000 000000000000 1122457889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=345.95 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=201.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
.++|+..++||+|+||.||++... .++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999986 58999999986542 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---cCCCCeEEeeeccccc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARA 666 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DfGla~~ 666 (834)
|||+++++|.+.+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999888853 346899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+..... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...... .. ......+.....
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i~~~~~~~~ 247 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DI----LKKVEKGKYTFE 247 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCCCCC
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCCCCC
Confidence 643321 223579999999999876 6999999999999999999999997532211 11 111111111100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+ ........+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 -LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00112346788999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=343.08 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=198.6
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-------------ccHHHHHHHHHHHHhccCCceeeEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-------------QGVEEFKNEALLIAKLQHRNLVKLLG 578 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 578 (834)
..++|...++||+|+||+||++.... ++.||||++..... ...+++.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999865 78999999965421 34578999999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC---C
Q 003272 579 CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM---N 655 (834)
Q Consensus 579 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~ 655 (834)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999888754 245899999999999999999999998 99999999999998776 6
Q ss_pred eEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHH
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 735 (834)
+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... . ..
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~----~~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---D----II 256 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---H----HH
Confidence 9999999998764332 223367999999999887 56999999999999999999999997532211 1 11
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.....+... .+...... ....+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~i~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYY--FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCC--CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111110 00000011 1246788999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.22 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=194.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC--------cccHHHHHHHHHHHHhccCCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--------GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 583 (834)
..++|...+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999754 8899999986432 12234688999999999999999999998765
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC---eEEee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN---PKISD 660 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~D 660 (834)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999888843 456899999999999999999999998 999999999999987654 99999
Q ss_pred eccccccCCCccccccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 661 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.|+....... .+...
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---- 231 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ---- 231 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----
Confidence 99998764321 122356899999999974 4678999999999999999999999975322211 11111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+... ..+..... ....+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111110 00011111 2346788999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.02 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=181.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------C
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------D 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 584 (834)
.++|+..+.||+|+||.||+|... .|+.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 4899999999653 233457888999999999999999999998654 5
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++|+|++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6788888742 46999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||....... ........... ..
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~-p~ 250 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGT-PG 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCS-CC
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC-CC
Confidence 875322 223678999999999987 679999999999999999999999975432211 11111111000 00
Q ss_pred ccccCc-----------ccc--CCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDK-----------SLY--DSCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~-----------~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+.+.. .+. ..... .....+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000 000 00011 11246788999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.92 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=192.2
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe----------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ---------- 582 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 582 (834)
.++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467889999999999999999975 5899999999543 3455789999999999999999999999865
Q ss_pred ---CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 583 ---RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 583 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34679999999999999998642 345788999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCcc------------ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 003272 660 DFGMARAFGLDQT------------EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726 (834)
Q Consensus 660 DfGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~ 726 (834)
|||+++....... ........|++.|+|||++.+. .++.++||||||+++|||++ |+.. ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence 9999987643211 1112335689999999999864 78999999999999999998 3221 101
Q ss_pred ccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
... ........ ...+....+......+.+++.+||+.||++||++.|+++.
T Consensus 234 ~~~----~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVN----ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHH----HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHH----HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 000 11111111 0111112233334567889999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.04 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=198.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEe--CCeEEEEEEecccC--cccHHHHHHHHHHHHhc---cCCceeeEEEEEE----
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI--EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKL---QHRNLVKLLGCCT---- 581 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 581 (834)
+.++|+..++||+|+||.||++... +++.||||+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 58899999986532 22234567787777766 8999999999987
Q ss_pred -eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEee
Q 003272 582 -QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISD 660 (834)
Q Consensus 582 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 660 (834)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69988886432 345899999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 661 FGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 661 fGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
||+++...... ......+++.|+|||++.+..++.++||||||+++|||++|+.|+...... ............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence 99998764322 223367899999999999999999999999999999999999997532221 111111111110
Q ss_pred cCccc----------ccCc---cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 741 DRPAE----------LIDK---SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 741 ~~~~~----------~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..... .... .............+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000 0000111223346788999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=331.00 Aligned_cols=200 Identities=25% Similarity=0.382 Sum_probs=152.6
Q ss_pred CCcc-cCccccCCcccEEEEEEe---CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe--CCeeEEE
Q 003272 516 NFSE-ENKLGEGGFGPVYKGMLI---EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDERVLV 589 (834)
Q Consensus 516 ~~~~-~~~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 589 (834)
.|+. .++||+|+||+||+|+.. .++.||||++.... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 458999999999999975 37889999996542 23578899999999999999999999965 6678999
Q ss_pred EeecCCCChhhHhhcc------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee----cCCCCeEEe
Q 003272 590 YEYLPNKSLDYFIFDT------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL----DNEMNPKIS 659 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~ 659 (834)
|||+++ +|..++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 666655321 12235899999999999999999999998 9999999999999 778899999
Q ss_pred eeccccccCCCccc-cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 660 DFGMARAFGLDQTE-ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 660 DfGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999876432211 222346789999999999874 599999999999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=352.40 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=201.9
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
..++|+..+.||+|+||.||+|.+.. +..||||+++.. .....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678889999999999999998743 567999998654 3344578999999999999999999999985 46689
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998642 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |..|+...... .. ......+...
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~----~~~i~~~~~~-- 611 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DV----IGRIENGERL-- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHHTCCC--
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HH----HHHHHcCCCC--
Confidence 433221 1223556789999999999999999999999999999997 88887532211 11 1111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+...+..+.+++.+||+.||++||++.||++.|+.+
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122334678899999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.35 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=196.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----Cee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 586 (834)
.++|...+.||+|+||.||+|... .|+.||||++.... .....++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999985 48999999996433 33456788999999999999999999998764 678
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+. ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588888743 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc--------ccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 667 FGLDQTEA--------NTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 667 ~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
........ ......||+.|+|||++.+ ..++.++||||||++++||++|+.||........ .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHH
Confidence 64322111 1123578999999998765 6799999999999999999999999754321110 0000000
Q ss_pred hhccCcc------------cccCccc-cCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 738 WIQDRPA------------ELIDKSL-YDSC-----SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 738 ~~~~~~~------------~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
....... +.+.... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 0000000 0000 0122346788999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.68 Aligned_cols=266 Identities=22% Similarity=0.284 Sum_probs=200.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-----------CCceeeEEEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-----------HRNLVKLLGCCT 581 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 581 (834)
.++|...++||+|+||.||+|... +++.||||++.. .....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 367999999999999999999974 589999999964 3334567889999999886 899999999987
Q ss_pred eCC----eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeec-----
Q 003272 582 QRD----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLD----- 651 (834)
Q Consensus 582 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~----- 651 (834)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 889998886532 34589999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch
Q 003272 652 -NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL 730 (834)
Q Consensus 652 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 730 (834)
..+.+||+|||+++..... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999876432 2235789999999999999999999999999999999999999864332111100
Q ss_pred ---hHHHHHHhhccCccc----------ccC------c-------------cccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 003272 731 ---LGHAWQLWIQDRPAE----------LID------K-------------SLYDSCSLSEAIRCIQVGLLCVQQIPEDR 778 (834)
Q Consensus 731 ---~~~~~~~~~~~~~~~----------~~d------~-------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 778 (834)
........ ...+.. .++ . .-....+......+.+|+.+||+.||++|
T Consensus 247 ~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHhc-CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111000 000000 000 0 00112345667788999999999999999
Q ss_pred CCHHHHHH--HhccC
Q 003272 779 PNMLSVVL--MLSGE 791 (834)
Q Consensus 779 Pt~~ev~~--~L~~~ 791 (834)
||+.||++ .+.+.
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 99999987 44443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.23 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=176.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHH-HHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEAL-LIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999985 48999999997643 233445566665 6677899999999999999999999999
Q ss_pred ecCCCChhhHhhc--cCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 592 YLPNKSLDYFIFD--TTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 592 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
|+++ +|.+++.. ......+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9986 77666542 12245689999999999999999999998 7 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYA----IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~----~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.|+........ . ......+...
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~-----~~~~~~~~~~ 248 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-Q-----LTQVVKGDPP 248 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCC
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-H-----HHHHhcCCCC
Confidence 3221 2224689999999998 456789999999999999999999999753221100 0 0000001111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+...........+.+++.+||+.||++||++.||++
T Consensus 249 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 -----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111111122346888999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.34 Aligned_cols=200 Identities=25% Similarity=0.349 Sum_probs=169.5
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CC-----ceeeEEEEEEeCCe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HR-----NLVKLLGCCTQRDE 585 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 585 (834)
..++|+..++||+|+||+||+|... +++.||||+++.. ....+++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999975 4889999999643 344567888999988885 44 49999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec--CCCCeEEeeecc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD--NEMNPKISDFGM 663 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DfGl 663 (834)
.++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++. .+|+||||||+||||+ .++.+||+|||+
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999964 8888886532 345899999999999999999999531 2499999999999994 578899999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
++..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 2236789999999999999999999999999999999999999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=325.63 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=193.9
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee----
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER---- 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 586 (834)
.++|...++||+|+||.||+|.... |+.||||++... .....+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4688899999999999999998754 899999999754 233457889999999999999999999999877655
Q ss_pred --EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 587 --VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 587 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
++||||+. ++|...+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 5777766 234899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+..... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||......+ .......... ...
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~-~~~ 262 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTG-VPG 262 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC-CCC
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC-CCc
Confidence 865322 223578999999999987 689999999999999999999999975322111 1110100000 000
Q ss_pred ccccC---------------ccccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 744 AELID---------------KSLYD---SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 744 ~~~~d---------------~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.+... ..... .........+.+|+.+||+.||++|||+.|+++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 00000 0011123467889999999999999999999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=329.56 Aligned_cols=253 Identities=25% Similarity=0.284 Sum_probs=186.4
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++...+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556789999999998776667999999998643 245678899999887 8999999999999999999999999
Q ss_pred CCCChhhHhhccCCCC----CCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC-------------CCe
Q 003272 594 PNKSLDYFIFDTTRSK----VLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE-------------MNP 656 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-------------~~~ 656 (834)
. |+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986532211 1244566889999999999999988 9999999999999754 489
Q ss_pred EEeeeccccccCCCcccc--ccccccccccccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 003272 657 KISDFGMARAFGLDQTEA--NTNRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADH 726 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~-------~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~ 726 (834)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|++......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875433221 1234679999999999975 678999999999999999999 898875321110
Q ss_pred ccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ........ . +.+...........+.+++.+||+.||++||++.||++
T Consensus 248 ----~-----~i~~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----S-----NIIRGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----H-----HHHHTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H-----HHhcCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 00111000 0 01111123445668889999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=323.53 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=193.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe------
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE------ 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 585 (834)
++|...+.||+|+||.||+|... .|+.||||++.... ....+++.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 67888999999999999999975 48999999996542 3345688999999999999999999999987654
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||++ ++|..++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 57777662 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc---
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD--- 741 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 741 (834)
..... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||....... ............
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE 246 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 75322 223578999999999887 678999999999999999999999975432111 111111100000
Q ss_pred ---------------CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 ---------------RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 ---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.......+.+ ..........+.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 1111223457888999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.90 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=197.8
Q ss_pred hcCCcccCccccCCcccEEEEEEeC--CeEEEEEEecccCcccHHHHHHHHHHHHhccCCc------eeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN------LVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||.||++.... ++.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3689999999999999999999753 478999999643 344577889999999998766 9999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee---------------
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL--------------- 650 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl--------------- 650 (834)
.++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 45555555432 2346899999999999999999999988 9999999999999
Q ss_pred ----cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccc
Q 003272 651 ----DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726 (834)
Q Consensus 651 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~ 726 (834)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999874322 123578999999999999999999999999999999999999986432211
Q ss_pred ccchhHHHHHHhhccCccccc----------C--------------------c-cccCCCCHHHHHHHHHHHHHcccCCC
Q 003272 727 RHNLLGHAWQLWIQDRPAELI----------D--------------------K-SLYDSCSLSEAIRCIQVGLLCVQQIP 775 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~----------d--------------------~-~l~~~~~~~~~~~l~~l~~~Cl~~dP 775 (834)
. ...... .....+..+. . + .............+.+|+.+||+.||
T Consensus 247 ~---~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 247 H---LVMMEK-ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp H---HHHHHH-HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred H---HHHHHH-HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1 000000 0000000000 0 0 00011223345678899999999999
Q ss_pred CCCCCHHHHHH
Q 003272 776 EDRPNMLSVVL 786 (834)
Q Consensus 776 ~~RPt~~ev~~ 786 (834)
++|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.20 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=200.0
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
..++|+..++||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3568999999999999999999986 58899999986542 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC---CCeEEeeeccccc
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARA 666 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DfGla~~ 666 (834)
+||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999998887542 35899999999999999999999998 9999999999999754 4699999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
...... .....+++.|+|||.+.+ .++.++||||||++++||++|+.|+...... . .......+.....
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~~~ 242 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D----ILKRVETGKYAFD 242 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCCCCC
T ss_pred ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCCCCC
Confidence 643321 223468899999998875 4899999999999999999999997532111 1 1111111111100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. + .... ....+.+++.+||+.||++||++.|+++
T Consensus 243 ~-~-~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-P-QWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-G-GGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-h-hhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0 0011 1236788999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=318.84 Aligned_cols=252 Identities=19% Similarity=0.199 Sum_probs=171.7
Q ss_pred hcCCcccC-ccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeE
Q 003272 514 TDNFSEEN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERV 587 (834)
Q Consensus 514 ~~~~~~~~-~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 587 (834)
.++|...+ .||+|+||.||+|... +++.||||++.... +...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46888855 6999999999999986 48999999986431 222233344566799999999999876 44589
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeeccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA 664 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla 664 (834)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998643 2346999999999999999999999998 999999999999976 455999999999
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.|+........... ......... .
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~-~ 250 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQ-Y 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhccc-c
Confidence 8754221 2235789999999999888899999999999999999999999753222111000 000000000 0
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.............+.+++.+||+.||++|||+.|+++
T Consensus 251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 -----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011122346788999999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.23 Aligned_cols=241 Identities=23% Similarity=0.359 Sum_probs=196.8
Q ss_pred HhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcc------cHHHHHHHHHHHHhcc--CCceeeEEEEEEeC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQ------GVEEFKNEALLIAKLQ--HRNLVKLLGCCTQR 583 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~ 583 (834)
..++|+..++||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4578999999999999999999864 5899999999754221 2346778999999996 59999999999999
Q ss_pred CeeEEEEeecCC-CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeEEeee
Q 003272 584 DERVLVYEYLPN-KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDF 661 (834)
Q Consensus 584 ~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~Df 661 (834)
+..++|+|++.. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 899988854 346899999999999999999999988 99999999999999 7899999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.... ....
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~ 257 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIR 257 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHH
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhhc
Confidence 9998764322 223568999999999987765 688999999999999999999975311 0000
Q ss_pred cCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 741 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... ..... ....+.+++.+||+.||++||++.||++
T Consensus 258 ~~~------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQV------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCC------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 100 01111 2236788999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.98 Aligned_cols=246 Identities=22% Similarity=0.360 Sum_probs=189.6
Q ss_pred HHHHHhcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc------ccHHHHHHHHHHHHhc----cCCceeeEE
Q 003272 509 TIVDATDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG------QGVEEFKNEALLIAKL----QHRNLVKLL 577 (834)
Q Consensus 509 ~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~ 577 (834)
+.....++|+..++||+|+||.||+|... +++.||||++..... .....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 33445678999999999999999999874 488999999965432 1223456799999998 899999999
Q ss_pred EEEEeCCeeEEEEee-cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCC
Q 003272 578 GCCTQRDERVLVYEY-LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMN 655 (834)
Q Consensus 578 g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~ 655 (834)
+++...+..++|+|+ +++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999854 235899999999999999999999998 99999999999999 8899
Q ss_pred eEEeeeccccccCCCccccccccccccccccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHH
Q 003272 656 PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHA 734 (834)
Q Consensus 656 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 734 (834)
+||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.|+....
T Consensus 179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 9999999998764332 2235689999999999877664 58999999999999999999975210
Q ss_pred HHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 735 WQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 735 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
....... ..+......+.+++.+||+.||++||++.|+++.
T Consensus 244 --~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 --EILEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HHHHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --HHhhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0111223467889999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=310.00 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=177.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc--ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG--QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
.++|+..++||+|+||.||+|... +|+.||||++..... ...+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367888899999999999999985 489999999975432 22334455556778889999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455554432 235689999999999999999999985 7 99999999999999999999999999977643
Q ss_pred CccccccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
... .....+++.|+|||++. ...++.++||||||+++|||++|+.|+....... . ...........
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~ 248 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----E-VLTKVLQEEPP 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H-HHHHHHHSCCC
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----H-HHHHHhccCCC
Confidence 221 22357899999999994 5578999999999999999999999975322110 1 11111111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... .......+.+++.+||+.||.+||++.||++
T Consensus 249 ~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1110 0112236788999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=324.67 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=185.4
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..+|...++||+|+||+||.....+++.||||++...... .+.+|+.+++++ +|||||++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4568888999999999976555567999999999654322 356799999999 899999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-----CCCeEEeeecccccc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF 667 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DfGla~~~ 667 (834)
++ |+|.+++.... ..+.+..+..++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 97 58888885432 23455667899999999999999998 999999999999943 346889999999887
Q ss_pred CCCccc-cccccccccccccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~---~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... .......||+.|+|||++. ...++.++|||||||+++||++ |..|++..... .... .....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~-~~~~~ 245 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANI-LLGAC 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHH-HTTCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHH-HhccC
Confidence 533221 2223467999999999997 4567889999999999999999 88887422111 0101 11110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..... .........+.+|+.+||+.||++||++.||++
T Consensus 246 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01111 111233445778999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=339.26 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=197.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEe------CCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ------RDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 585 (834)
.++|+..++||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 4899999998654 34456789999999999999999999999755 667
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCC---eEEeeec
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMN---PKISDFG 662 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DfG 662 (834)
.++||||+++++|.+++........+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999988 999999999999997765 8999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCccccc--chhHHHHH-Hhh
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH--NLLGHAWQ-LWI 739 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~-~~~ 739 (834)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........ ...
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9987643322 23367899999999999999999999999999999999999997532110000 00000000 000
Q ss_pred ccCcccc--cCcc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003272 740 QDRPAEL--IDKS--LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783 (834)
Q Consensus 740 ~~~~~~~--~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 783 (834)
....... .... ............+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 0000 011233445678889999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=339.04 Aligned_cols=237 Identities=22% Similarity=0.293 Sum_probs=191.0
Q ss_pred cCCcccCccccCCcccEEEEEEe--CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe-----e
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI--EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE-----R 586 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 586 (834)
++|++.++||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999985 4899999998654 33455678999999999999999999999987765 6
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++||||+++++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887632 6899999999999999999999998 9999999999999986 999999999987
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... ....||+.|+|||++.+.. +.++|||||||+++||++|..|+....... +
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~ 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------c
Confidence 6432 2367899999999987654 899999999999999999987753211000 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcc
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-NMLSVVLMLSG 790 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~ 790 (834)
. ...........+.+++.+||+.||++|| +++++.+.|.+
T Consensus 285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 0000111234678899999999999999 56666666653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=296.04 Aligned_cols=230 Identities=10% Similarity=0.031 Sum_probs=181.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+|.... ++.||||++.... ....++|.+|+..+.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 679999999999999999999865 8999999997543 234478999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++++|.+++.. . ....++.+++.||+.||.|||+.+ |+||||||+||||+.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999832 2 355678899999999999999998 9999999999999999999998443
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
|++| ++.++||||||+++|||++|+.||............ . ....+. ...+.
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~-~~~~~~---~~~~~ 226 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---E-RDTAGQ---PIEPA 226 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---C-BCTTSC---BCCHH
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---H-HHhccC---CCChh
Confidence 3333 688999999999999999999997643222110000 0 000000 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.........+.+++.+||+.||++| |+.|+++.|+...
T Consensus 227 ---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 227 ---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp ---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0011123467889999999999999 9999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-32 Score=290.58 Aligned_cols=226 Identities=20% Similarity=0.233 Sum_probs=175.8
Q ss_pred cCCccc-CccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHH-HhccCCceeeEEEEEEe----CCeeE
Q 003272 515 DNFSEE-NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLI-AKLQHRNLVKLLGCCTQ----RDERV 587 (834)
Q Consensus 515 ~~~~~~-~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 587 (834)
++|... +.||+|+||.||++... +++.||||+++. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567666 67999999999999974 488999999854 24677888888 55599999999999877 66789
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeeccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA 664 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGla 664 (834)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998653 2346899999999999999999999998 999999999999998 789999999998
Q ss_pred cccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... +..++.++||||||+++|||++|+.|+........ ......
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 7542 13467899999999999999999999753221110 000000
Q ss_pred cccCccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDKSLYDSCS----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+.... ...+ ......+.+++.+||+.||++||++.|+++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0011 112346788999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=312.63 Aligned_cols=240 Identities=17% Similarity=0.179 Sum_probs=176.5
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccC-Cc----------eee----
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQH-RN----------LVK---- 575 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~n----------iv~---- 575 (834)
..|...++||+|+||.||+|... +|+.||||++.... ....+.|.+|+.+++.++| +| ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45677789999999999999964 48999999987432 2346789999999999977 21 111
Q ss_pred -------EEEEEEe-----CCeeEEEEeecCCCChhhHhhc----cCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceE
Q 003272 576 -------LLGCCTQ-----RDERVLVYEYLPNKSLDYFIFD----TTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRII 639 (834)
Q Consensus 576 -------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 639 (834)
+..+... ....+++|+++ .++|.+++.. ......+++..++.++.||++||+|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12356666654 6788888741 223456889999999999999999999998 99
Q ss_pred eccCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCcccc----------ccCCCCchhhHHHHHHHH
Q 003272 640 HRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA----------IDGLFSVKSDVFSFGVLV 709 (834)
Q Consensus 640 H~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~t~~sDV~S~Gvil 709 (834)
||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999999875322 233567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 710 LEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 710 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
|||++|+.|+........ ...++... ... +..+.+|+.+||+.||++||++.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG---------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC---------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhh---------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999753221111 01111100 111 24688899999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=294.07 Aligned_cols=242 Identities=15% Similarity=0.114 Sum_probs=183.5
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccC--------cccHHHHHHHHHHHHhcc---------CCceeeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSS--------GQGVEEFKNEALLIAKLQ---------HRNLVKL 576 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 576 (834)
.++|+..++||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 78999999997542 234478999999999886 8888888
Q ss_pred EEEEE------------------------------eCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHH
Q 003272 577 LGCCT------------------------------QRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626 (834)
Q Consensus 577 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 626 (834)
.+.+. ..+..++||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 88753 2678999999999997655552 2468999999999999999
Q ss_pred HHHhh-hcCCCceEeccCCCCceeecCCC--------------------CeEEeeeccccccCCCccccccccccccccc
Q 003272 627 LLYLH-HDSRLRIIHRDLKASNVLLDNEM--------------------NPKISDFGMARAFGLDQTEANTNRVVGTYGY 685 (834)
Q Consensus 627 L~yLH-~~~~~~ivH~DLkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 685 (834)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999875321 25799999
Q ss_pred cCccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHH
Q 003272 686 MSPEYAIDGLFSVKSDVFSFGVL-VLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCI 764 (834)
Q Consensus 686 ~APE~~~~~~~t~~sDV~S~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 764 (834)
+|||++.+.. +.++||||++++ .+++++|..|+... .............. .................+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh---ccCcccchhhhhhcCHHHH
Confidence 9999998766 899999998777 77788888885210 00000001111000 0000111111234566889
Q ss_pred HHHHHcccCCCCCCCCHHHHH
Q 003272 765 QVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 765 ~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
+|+.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-27 Score=275.61 Aligned_cols=184 Identities=18% Similarity=0.160 Sum_probs=129.6
Q ss_pred ccccCCcccEEEEEEe-CCeEEEEEEecccC----------cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 522 KLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS----------GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
..+.|++|.+..++.. -|+.+|||.+.+.. ....++|.+|+++|+++ .|+||+++++++.+....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566666666554432 38889999996531 23456799999999999 799999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++++|.+.+.. ...++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999954 3345543 58999999999999998 99999999999999999999999999998754
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~ 717 (834)
+... ....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 3322 234789999999999875 46678999999999988876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=251.48 Aligned_cols=185 Identities=19% Similarity=0.191 Sum_probs=145.2
Q ss_pred CcccCccccCCcccEEEEEEeCCeEEEEEEecccCc--------ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 517 FSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG--------QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
+...++||+|+||.||+|.. .++.+++|+...... ...+++.+|++++++++||||+++..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567899999999999954 678899998643211 123568999999999999999976666667888899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++++|.+++.. +..++.||++||.|||+.+ |+||||||+|||+++ .+||+|||+++...
T Consensus 417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999999843 5689999999999999998 999999999999999 99999999999875
Q ss_pred CCcccc-----ccccccccccccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 669 LDQTEA-----NTNRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 669 ~~~~~~-----~~~~~~gt~~y~APE~~~~--~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
...... ......||+.|||||++.. ..|+..+|+||..+-..+.+.++.+
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 432211 1234689999999999987 5688889999999999988877765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=206.16 Aligned_cols=152 Identities=20% Similarity=0.154 Sum_probs=121.0
Q ss_pred HHHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCc------------------ccHHHHHHHHHHHHhcc
Q 003272 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG------------------QGVEEFKNEALLIAKLQ 569 (834)
Q Consensus 508 ~~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~ 569 (834)
..+......|...++||+|+||.||+|...+|+.||||.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455566777899999999999999996699999999964321 13467899999999998
Q ss_pred CCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCcee
Q 003272 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649 (834)
Q Consensus 570 H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 649 (834)
| +++.+++. .+..++||||+++++|.+ +. ......++.||+.||.|||+.+ |+||||||+|||
T Consensus 163 ~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 55555443 356799999999999987 41 1234579999999999999988 999999999999
Q ss_pred ecCCCCeEEeeeccccccCCCccccccccccccccccCccccc
Q 003272 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692 (834)
Q Consensus 650 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~ 692 (834)
++ ++.+||+|||+++.. ..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 99 999999999998643 3578898774
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-19 Score=159.73 Aligned_cols=105 Identities=18% Similarity=0.396 Sum_probs=89.0
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
+|+|.+||.|.+|+.|.| |.|.|.|...++ |.++. ..++||+|||++|... .+.|+|+.||| |||
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGn---LvL 65 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGN---FVV 65 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSC---EEE
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCcc---EEE
Confidence 478999999999999998 789999987665 66654 3589999999999876 67899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
.|+++.+||+|++.. .....+|+|+|+|||||++ ..||||
T Consensus 66 ~d~~~~~vWss~t~~-~~~~~~l~L~ddGNlVly~----------~~~W~S 105 (105)
T 4h3o_A 66 YDSSGRSLWASHSTR-GSGNYILILQDDGNVIIYG----------SDIWST 105 (105)
T ss_dssp ECTTCCEEEECCCCC-CSSCEEEEECTTSCEEEEE----------SEEEEC
T ss_pred ECCCcEEEEEecCCC-CCCCEEEEEeCCCeEEEEC----------CcEecC
Confidence 999999999999633 2344679999999999993 269998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-19 Score=161.50 Aligned_cols=108 Identities=19% Similarity=0.329 Sum_probs=91.8
Q ss_pred ccccccCCCccccCCCEEE--eCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcc
Q 003272 21 STRDAISLGQSIREGETVV--SASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGT 98 (834)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~--S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~ 98 (834)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ | +||++ +++||+|||+.| +.++.|+|..|||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGN-- 72 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGV-- 72 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSC--
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCE--
Confidence 4679999999999999999 999999999998765 2 57875 799999999877 3357899999999
Q ss_pred eEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 99 ALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 99 ~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
|||.|.++.++|+|++..+ ....+++|+|+|||||++ .++|||
T Consensus 73 -LVl~d~~~~~lW~S~~~~~-~g~~~l~l~~~Gnlvl~~----------~~~W~S 115 (119)
T 1b2p_A 73 -LVVITNENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYG----------DALWAT 115 (119)
T ss_dssp -EEEECTTCCEEEECSCCCC-SSCEEEEECTTSCEEEEE----------SEEEEC
T ss_pred -EEEEeCCCcEEEcCCCCCC-CCCEEEEEECCCcEEEEC----------ccEeCC
Confidence 9999999999999986332 234579999999999993 279998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=155.33 Aligned_cols=110 Identities=20% Similarity=0.420 Sum_probs=92.0
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
.|+|.+||.|.+|++|+ ++|.|.|+|+..|+ | |+|+ ..++||.||++.|. .++.|+|..||| |||
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGN---LVl 65 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGN---LVI 65 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSC---EEE
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCC---EEE
Confidence 37899999999999999 99999999988765 3 6676 37999999998763 357899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCc
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPS 158 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PT 158 (834)
.|.++.++|+|++..+ ....+++|+|+|||||+ + ..+||||+||.
T Consensus 66 ~~~~~~~~W~S~t~~~-~g~~~l~l~~dGnlvl~--~--------~~~W~S~~~~~ 110 (110)
T 3a0c_A 66 YDQSNRVIWQTKTNGK-EDHYVLVLQQDRNVVIY--G--------PVVWATGSGPA 110 (110)
T ss_dssp ECTTCCEEEECCCCCS-SSCCEEEECTTSCEEEE--C--------SEEEECSCCC-
T ss_pred ECCCCcEEEecCCCCC-CCCEEEEEeCCccEEEE--C--------CCEecCCCcCC
Confidence 9999999999986432 23347999999999999 2 17999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=155.06 Aligned_cols=110 Identities=21% Similarity=0.376 Sum_probs=91.1
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
.|||.+||+|.+|++|+ +|.|+|+|+..++ | ++|+ ..++||+|||+.|. .++.|.|..+|| |||
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~---~~~~vW~sn~~~~~--~~~~l~l~~~Gn---Lvl 65 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGN---LVI 65 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE---TTEEEEECSCTTSC--SSCEEEECTTSC---EEE
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe---CCEEEEeCCCCCCC--CceEEEECCCCc---EEE
Confidence 58999999999999998 7999999987664 2 2354 47899999999883 357899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCcc
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSH 159 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTD 159 (834)
.|.++.++|+|++... ....+|+|+|+|||||+ + .++||||.+++.
T Consensus 66 ~d~~~~~vW~S~~~~~-~g~~~l~l~~dGnlvl~--~--------~~~W~S~~~~~~ 111 (115)
T 2dpf_A 66 YDHNNNDVWGSACWGD-NGKYALVLQKDGRFVIY--G--------PVLWSLGPNGCR 111 (115)
T ss_dssp ECTTCCEEEECCCCCS-SSCCEEEECTTSCEEEE--C--------SEEECSSTTCBC
T ss_pred ECCCceEEEEcCCCCC-CCCEEEEEeCCCeEEEE--C--------CCEEECCCCCCc
Confidence 9998999999986422 23457999999999999 2 179999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=150.18 Aligned_cols=110 Identities=19% Similarity=0.428 Sum_probs=89.6
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
.|||.+||+|.+|++| ++|.|+|+|+.+++ | ++|++ .++||+||++.+ +.++.|+|..+|| |||
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GN---Lvl 64 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGN---LVI 64 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSEEEEECTTSC---EEE
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCC---EEE
Confidence 4899999999999999 57899999998876 2 35664 689999999864 3357899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCC
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYP 157 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~P 157 (834)
.| ++.++|+|++... ....+++|+++|||||++.+ +.++||||++.
T Consensus 65 ~d-~~~~~W~S~~~~~-~g~~~l~l~~dGnlvl~~~~-------~~~~W~S~~~~ 110 (112)
T 1xd5_A 65 YS-GSRAIWASNTNRQ-NGNYYLILQRDRNVVIYDNS-------NNAIWATHTNV 110 (112)
T ss_dssp EE-TTEEEEECCCCCS-CCCCEEEECTTSCEEEECTT-------SCEEEECCCCC
T ss_pred Ec-CCEEEEECCccCC-CCCEEEEEeCCCcEEEECCC-------CceEEECCCcc
Confidence 99 8899999986332 22357999999999999422 45999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-17 Score=173.49 Aligned_cols=136 Identities=15% Similarity=0.167 Sum_probs=106.7
Q ss_pred CcccCccccCCcccEEEEEE-eCCeE--EEEEEecccCcc------------------------cHHHHHHHHHHHHhcc
Q 003272 517 FSEENKLGEGGFGPVYKGML-IEGQE--IAVKRLSKSSGQ------------------------GVEEFKNEALLIAKLQ 569 (834)
Q Consensus 517 ~~~~~~LG~G~fg~Vy~g~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 569 (834)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67999 999987543111 1136888999999998
Q ss_pred CCce--eeEEEEEEeCCeeEEEEeecCC-C----ChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhh-hcCCCceEec
Q 003272 570 HRNL--VKLLGCCTQRDERVLVYEYLPN-K----SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH-HDSRLRIIHR 641 (834)
Q Consensus 570 H~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~ 641 (834)
|+++ ..++.+ ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 444442 357899999942 4 55554421 235567889999999999999 887 9999
Q ss_pred cCCCCceeecCCCCeEEeeecccccc
Q 003272 642 DLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 642 DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=146.21 Aligned_cols=104 Identities=25% Similarity=0.417 Sum_probs=85.4
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
++||.+||.|.+|++|+ +|.|.|+|+..|+ |-+ |.. .++||+||++.+ ++.+.|.|..||| |||
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGN---Lvl 64 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGN---LVV 64 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSC---EEE
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCC---EEE
Confidence 36899999999999997 7999999988765 333 554 589999999876 3357899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
.|.++.++|+|++... ....+|+|+|+|||||++ ..+|||
T Consensus 65 ~~~~~~~~W~S~t~~~-~~~~~~~L~ddGNlvly~----------~~~W~s 104 (109)
T 3dzw_A 65 YSPRNNPIWASNTGGE-NGNYVCVLQKDRNVVIYG----------TARWAT 104 (109)
T ss_dssp ECTTSCEEEECCCCCS-SSCEEEEECTTSCEEEEE----------SCCCCC
T ss_pred ECCCCCEEEECCCCCC-CCCEEEEEeCCCEEEEEC----------CCEEeC
Confidence 9999999999996432 233579999999999993 269998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.8e-16 Score=136.76 Aligned_cols=105 Identities=17% Similarity=0.306 Sum_probs=83.4
Q ss_pred ccccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceE
Q 003272 21 STRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTAL 100 (834)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~l 100 (834)
.+.|||.+||.|..|++|+|. .|.|-|...|+ |.+ |.. ++||.+|++.. ...+.|.|..||| |
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGN---L 66 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGE---L 66 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSC---E
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCc---E
Confidence 478999999999999999984 58886654443 555 543 48999999863 3357899999999 9
Q ss_pred EEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 101 VLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 101 vl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
||.|.++.++|+|++... ....+|+|+|+|||||++ ..+|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~-~~~~~~~L~~dGNlvly~----------~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSK-QGEYVLILQDDGFGVIYG----------PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCS-SSCCEEEECTTSCEEEEC----------SEEEES
T ss_pred EEEeCCCCEEEEcCCcCC-CCCEEEEEcCCccEEEec----------CCEecC
Confidence 999999999999996332 233679999999999993 279987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.60 E-value=6.6e-15 Score=132.16 Aligned_cols=108 Identities=16% Similarity=0.274 Sum_probs=87.0
Q ss_pred ccccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceE
Q 003272 21 STRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTAL 100 (834)
Q Consensus 21 ~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~l 100 (834)
.+.|+|.+||.|..|+.|.+ |.|.|-|...|+ |.++.. ...++||.+|+..+- ..+.|.|..||| |
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~--~~~~~vWssnt~~~~--~~~~l~l~~dGN---L 69 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG--SKTNIVWESGTSGRG--QHCFMRLGHSGE---L 69 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET--TTTEEEEECCCTTSC--SSCEEEECTTSC---E
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC--CCCEEEEECCcccCC--cCEEEEEeCCCc---E
Confidence 46799999999999999975 789998876654 666432 147899999998762 357899999999 9
Q ss_pred EEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 101 VLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 101 vl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
||.|.++.++|+|++... ....+|+|+|+|||||++ ..+|+|
T Consensus 70 Vl~d~~~~~iW~S~t~~~-~~~~~~~L~~dGnlvly~----------~~~W~s 111 (113)
T 3mez_B 70 DITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAVVYG----------PAVWST 111 (113)
T ss_dssp EEECTTSCEEEECSCCCS-SSCCEEEECTTSCEEEEC----------SEEEES
T ss_pred EEECCCCCEEEECCCcCC-CCCEEEEEcCCceEEEec----------CCEecC
Confidence 999999999999996432 223679999999999993 379997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.7e-15 Score=133.93 Aligned_cols=96 Identities=20% Similarity=0.336 Sum_probs=76.5
Q ss_pred CCCCCCceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccc
Q 003272 81 PLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHT 160 (834)
Q Consensus 81 p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDt 160 (834)
|+.+...+|.|..||| |||.+. +++||++|+... ..+.+|+|+|+|||||++ + +.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgn---lvl~~~-~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~d-~-------~~~~W~S~~----- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCN---LVLYDN-NRAVWASGTNGK-ASGCVLKMQNDGNLVIYS-G-------SRAIWASNT----- 76 (112)
T ss_dssp EEEETTEEEEECTTSC---EEEEET-TEEEEECCCTTS-CSSEEEEECTTSCEEEEE-T-------TEEEEECCC-----
T ss_pred EEeCCCEEEEEcCCCc---EEEEEC-CEEEEeCCCcCC-CCCEEEEEeCCCCEEEEc-C-------CEEEEECCc-----
Confidence 3434467899999999 999987 789999996432 345689999999999995 2 459999994
Q ss_pred cccCCeeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEec-CCeeEEeeCCCCc
Q 003272 161 LLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKK-GSTIRYRAGSWNG 222 (834)
Q Consensus 161 lLpg~~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~y~~sg~w~g 222 (834)
+|++|.|++.++++|. ++++. ...+||++++|+|
T Consensus 77 --------------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567889999999998 44444 5679999999976
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.7e-16 Score=166.62 Aligned_cols=136 Identities=14% Similarity=0.197 Sum_probs=99.4
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccCc--------------ccHHHH--------HHHHHHHHhccCCce
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG--------------QGVEEF--------KNEALLIAKLQHRNL 573 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~--------------~~~~~~--------~~E~~~l~~l~H~ni 573 (834)
-|++.++||+|+||.||+|...+|+.||||+++.... ...... ..|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999988899999998753210 011112 235556666654443
Q ss_pred e--eEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec
Q 003272 574 V--KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD 651 (834)
Q Consensus 574 v--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 651 (834)
. ..+++ ...+|||||++++.|..+. .......++.||+.+|.|||+.+ ||||||||.||||+
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 2 22222 1237999999998875543 11234678899999999999988 99999999999998
Q ss_pred CCC----------CeEEeeecccccc
Q 003272 652 NEM----------NPKISDFGMARAF 667 (834)
Q Consensus 652 ~~~----------~~kl~DfGla~~~ 667 (834)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999987654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=6.2e-15 Score=131.75 Aligned_cols=88 Identities=23% Similarity=0.355 Sum_probs=71.3
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
..+|.|..||| |||++ .+++||+||+... ..+.+|+|+|+|||||++.+ +.++||||
T Consensus 21 ~~~l~~~~dGn---lvl~~-~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~~~~-------~~~~W~S~----------- 77 (110)
T 3a0c_A 21 SYRLIMQGDCN---FVLYD-SGKPVWASNTGGL-GSGCRLTLHNNGNLVIYDQS-------NRVIWQTK----------- 77 (110)
T ss_dssp TEEEEECTTSC---EEEEE-TTEEEEECCCTTS-CSSCEEEECTTSCEEEECTT-------CCEEEECC-----------
T ss_pred CEEEEEcCCCc---EEEEE-CCEEEEECCCCCC-CCcEEEEEeCCCCEEEECCC-------CcEEEecC-----------
Confidence 67899999999 99998 5899999997433 34568999999999999543 45999999
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCCC
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSW 220 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~w 220 (834)
++|++|.|++.++++|. ++++++ +||+++++
T Consensus 78 --------------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 --------------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp --------------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred --------------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35667899999999998 455554 89999875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.53 E-value=3e-14 Score=126.91 Aligned_cols=102 Identities=24% Similarity=0.370 Sum_probs=82.4
Q ss_pred cccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEE
Q 003272 22 TRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALV 101 (834)
Q Consensus 22 ~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lv 101 (834)
+.|||.|||.|..|+.| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ ..++.|+|..||| ||
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGn---Lv 62 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGE---LV 62 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSC---EE
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCe---EE
Confidence 67999999999999999 47899999976655 333 442 699999865 3357899999999 99
Q ss_pred EecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 102 LLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 102 l~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
|.|.++.++|+|++.. .....+|+|+|+|||||++ ..+|+|
T Consensus 63 l~d~~~~~vWss~t~~-~~~~~~~~L~~dGNlvly~----------~~~W~s 103 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQS-VKGNYAAVVHPDGRLVVFG----------PSVFKI 103 (109)
T ss_dssp EECTTSCEEEECCCCC-SSSCCEEEEETTTEEEEEC----------SEEEEE
T ss_pred EEeCCCCEEEcCCCcC-CCcCEEEEEcCCCeEEEEe----------cCEECC
Confidence 9999999999998633 2234579999999999993 379998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=8.8e-14 Score=125.87 Aligned_cols=87 Identities=23% Similarity=0.316 Sum_probs=69.6
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
..+|.|..||| |||++. +++||++|+... ..+.+|+|+|+|||||++.+ +.++||||
T Consensus 31 ~~~L~~~~dgn---lvly~~-~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~d~~-------~~~lW~S~----------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCN---LVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITNE-------NVTVWQSP----------- 87 (119)
T ss_dssp EEEEEECTTSC---EEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECTT-------CCEEEECS-----------
T ss_pred CEEEEEecCCC---EEEEEC-CEEEEeCCCccC-CCceEEEEccCCEEEEEeCC-------CcEEEcCC-----------
Confidence 35688888999 999987 899999997433 33468999999999999533 45999999
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
++|++|.|++.++++|. +++++ .+||++|+
T Consensus 88 --------------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 44554 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.5e-13 Score=123.96 Aligned_cols=91 Identities=21% Similarity=0.355 Sum_probs=72.6
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
..+|.|..||| |||.+ .+++||++|+... ..+.+++|+++|||||++.+ +.++|||||+
T Consensus 21 ~~~L~~~~dgn---lvly~-~~~~vW~sn~~~~-~~~~~l~l~~~GnLvl~d~~-------~~~vW~S~~~--------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCN---LVKYQ-NGRQIWASNTDRR-GSGCRLTLLSDGNLVIYDHN-------NNDVWGSACW--------- 79 (115)
T ss_dssp TEEEEECTTSC---EEEEE-TTEEEEECSCTTS-CSSCEEEECTTSCEEEECTT-------CCEEEECCCC---------
T ss_pred CEEEEEcCCCc---EEEEe-CCEEEEeCCCCCC-CCceEEEECCCCcEEEECCC-------ceEEEEcCCC---------
Confidence 56788888999 99988 5889999996433 34568999999999999532 4599999997
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCCCCcc
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNGL 223 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~w~g~ 223 (834)
|++|.|++.++++|+ +++++. +||++++|...
T Consensus 80 ----------------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346789999999998 455544 89999999643
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=116.96 Aligned_cols=104 Identities=15% Similarity=0.256 Sum_probs=81.4
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
.|+|.+||.|.+|+.|. +|.|.|-|...|+ |.+ |.. .. ||.+|+..+ ...+.|.|..||| |||
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGN---LVl 64 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQ---LEI 64 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSC---EEE
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCc---EEE
Confidence 58999999999999994 6889999976654 444 543 23 999999876 2257899999999 999
Q ss_pred ecCCCc-eEEEeecccc-cCCCcEEEEecCCCEEEEecCCCCCCCCCceeeee
Q 003272 103 LNSTND-IVWSSNIVSR-AAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQS 153 (834)
Q Consensus 103 ~~~~~~-~vWst~~~~~-~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQS 153 (834)
.|.++. ++|+|++... .....+|.|+|+|||||++ ..+|+|
T Consensus 65 ~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----------~~~W~s 107 (111)
T 3mez_A 65 HSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----------PAIWST 107 (111)
T ss_dssp ECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----------SEEEEC
T ss_pred EeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----------cCEEcc
Confidence 998875 5999996332 2234579999999999993 379987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=7.1e-11 Score=123.35 Aligned_cols=146 Identities=16% Similarity=0.086 Sum_probs=114.6
Q ss_pred HHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEE
Q 003272 512 DATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 512 ~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 590 (834)
.....|+....++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3456788888888899999999875 47899999986532223346889999999884 677889999998888999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-------------------------------------
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD------------------------------------- 633 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------- 633 (834)
||+++.+|..... +......++.+++++|..||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 1223457889999999999981
Q ss_pred -------------------CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 634 -------------------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 634 -------------------~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998766667999987743
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.6e-10 Score=120.57 Aligned_cols=113 Identities=18% Similarity=0.345 Sum_probs=87.1
Q ss_pred ccccccCCCcc----ccCCCEEEeCCCeEEEeeecCC--CCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEec
Q 003272 21 STRDAISLGQS----IREGETVVSASESFELGFFSPG--KSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRR 94 (834)
Q Consensus 21 ~~~~~~~~~~~----l~~~~~l~S~~g~F~lgFf~~~--~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~ 94 (834)
...||+.||+. |..|++|.|+ ..++.|+|... .....+ + |.+ ..+++|.+++.++ + ...|.+..+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~--~-~~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGK--G-AVRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTT--T-CCEEEECTT
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCC--c-cEEEEEcCC
Confidence 46799999999 8899999664 57888877642 222333 3 332 3689999999876 2 268999999
Q ss_pred CCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccC
Q 003272 95 GNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDY 156 (834)
Q Consensus 95 G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~ 156 (834)
|+ |++.|.++.++|+|++.. ....+|+|.++|||||++. .++||||||
T Consensus 205 Gn---Lvl~d~~~~~vWsS~t~~--~~~~rl~Ld~dGnLvly~~---------~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GN---LVVYGAGNAVLWHSHTGG--HASAVLRLQANGSIAILDE---------KPVWARFGF 252 (276)
T ss_dssp SC---EEEECTTSCEEEECSCTT--CTTCEEEECTTSCEEEEEE---------EEEEESSSC
T ss_pred Ce---EEEEeCCCcEEEEecCCC--CCCEEEEEcCCccEEEEcC---------CCeEEccCc
Confidence 99 999999889999998643 2346899999999999942 389999997
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.06 E-value=4e-10 Score=100.46 Aligned_cols=94 Identities=20% Similarity=0.239 Sum_probs=69.3
Q ss_pred CCCCCCceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccc
Q 003272 81 PLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHT 160 (834)
Q Consensus 81 p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDt 160 (834)
++.+...+|.+..||| |||.+.++ +|+|++... ..+..++|+++|||||++.++ +.++|||.-+
T Consensus 16 ~L~~g~~~L~~q~dGn---Lvl~~~~~--vW~snt~~~-~~~~~l~l~~dGNLVl~~~~~------~~~vW~S~t~---- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCN---LVLYNEAG--GFQSNTHGR-GVDCTLRLNNRGQLEIHSANS------NTPVWVYPRS---- 79 (111)
T ss_dssp EEEETTEEEEECTTSC---EEEECSSC--CEECCCTTS-CSSCEEEECTTSCEEEECSSC------SSCSEEESSS----
T ss_pred EEecCCEEEEEccCCe---EEEECCCC--EEECCcccC-CcCEEEEEcCCCcEEEEeCCC------CEEEEEeccc----
Confidence 3334457899999999 99999877 999997433 234679999999999995432 2359999731
Q ss_pred cccCCeeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 161 LLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 161 lLpg~~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
.....|.|.+.++++|+..+|- .++|.+++
T Consensus 80 -------------------------~~~~~~~~~l~Lq~dGNlvly~----~~~W~s~t 109 (111)
T 3mez_A 80 -------------------------VNTVRGNYAATLGPDQHVTIYG----PAIWSTPA 109 (111)
T ss_dssp -------------------------CCCCSSCCEEEECTTSCEEEEC----SEEEECCC
T ss_pred -------------------------cCCCCcCEEEEECCCCeEEEec----cCEEccCC
Confidence 0113468999999999887763 67898774
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.06 E-value=4.5e-10 Score=100.50 Aligned_cols=95 Identities=23% Similarity=0.290 Sum_probs=70.8
Q ss_pred CCCCCCCCceEEEEecCCcceEEEecC-CCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCC
Q 003272 79 DAPLSDRSGVLSMSRRGNGTALVLLNS-TNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYP 157 (834)
Q Consensus 79 ~~p~~~~~~~l~l~~~G~~~~lvl~~~-~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~P 157 (834)
++|+.+...+|.+..||| |||.+. .+.++|+|++... ..+..++|+++|||||++.+ +.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q~dGN---LvL~~~~~~~~vWssnt~~~-~~~~~l~l~~dGNLVl~d~~-------~~~iW~S~t~- 85 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCN---LVLTKGSKTNIVWESGTSGR-GQHCFMRLGHSGELDITDDR-------LNTVFVSNTV- 85 (113)
T ss_dssp TCEEEETTEEEEECTTSC---EEEEETTTTEEEEECCCTTS-CSSCEEEECTTSCEEEECTT-------SCEEEECSCC-
T ss_pred CCEeEcCCEEEEEcCCCE---EEEEECCCCEEEEECCcccC-CcCEEEEEeCCCcEEEECCC-------CCEEEECCCc-
Confidence 455555568899999999 999998 5899999997433 23467999999999999543 3589997321
Q ss_pred ccccccCCeeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 158 SHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 158 TDtlLpg~~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
-..|.|.+.++.+|+..++- ...|.+|+
T Consensus 86 ------------------------------~~~~~~~~~L~~dGnlvly~----~~~W~s~~ 113 (113)
T 3mez_B 86 ------------------------------GQEGDYVLILQINGQAVVYG----PAVWSTAA 113 (113)
T ss_dssp ------------------------------CSSSCCEEEECTTSCEEEEC----SEEEESCC
T ss_pred ------------------------------CCCCCEEEEEcCCceEEEec----CCEecCCC
Confidence 01245889999999877662 57888774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=4.3e-10 Score=116.98 Aligned_cols=137 Identities=17% Similarity=0.157 Sum_probs=100.8
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeeEEEEEEeCCeeEEEEeec
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN--LVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~ 593 (834)
.+......+.|..+.||+....+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333456669999998766888999997543 2346788999999986545 456888888777889999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS--------------------------------------- 634 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 634 (834)
++.+|. ... . ....++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998874 210 1 12357778888888888743
Q ss_pred ----------------CCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 635 ----------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 635 ----------------~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.86 E-value=5.7e-09 Score=92.75 Aligned_cols=86 Identities=23% Similarity=0.333 Sum_probs=64.0
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
..+|.+..||| |||++. .++|++++... ..+..++|+|+|||||++.+ +.++|||-.+-
T Consensus 25 ~~~L~~q~dGn---Lvl~~~--~~vW~snt~~~-~~~~~l~l~~dGNLvl~d~~-------~~~iW~S~t~~-------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCN---LVLYGG--KYGWQSNTHGN-GEHCFLRLNHKGELIIKDDD-------FKTIWSSRSSS-------- 83 (110)
T ss_dssp SCEEEECTTSC---EEEECS--SSCEECCCTTS-SSSCEEEECTTSCEEEECTT-------CCEEEECCCCC--------
T ss_pred CEEEEEcCCCe---EEEECC--eEEEECCCcCC-CcCEEEEEeCCCcEEEEeCC-------CCEEEEcCCcC--------
Confidence 57889999999 999876 59999997432 23457999999999999543 35899985310
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
..|.|.+.++++|+..++- ...|.+|+
T Consensus 84 -----------------------~~~~~~~~L~~dGNlvly~----~~~W~t~~ 110 (110)
T 3r0e_B 84 -----------------------KQGEYVLILQDDGFGVIYG----PAIFETSS 110 (110)
T ss_dssp -----------------------SSSCCEEEECTTSCEEEEC----SEEEESCC
T ss_pred -----------------------CCCCEEEEEcCCccEEEec----CCEecCCC
Confidence 1245888999999877663 47787763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.1e-08 Score=112.09 Aligned_cols=142 Identities=15% Similarity=0.231 Sum_probs=107.1
Q ss_pred ccCccccCCcccEEEEEEeCCeEEEEEEec--ccC-cccHHHHHHHHHHHHhcc--CCceeeEEEEEEeC---CeeEEEE
Q 003272 519 EENKLGEGGFGPVYKGMLIEGQEIAVKRLS--KSS-GQGVEEFKNEALLIAKLQ--HRNLVKLLGCCTQR---DERVLVY 590 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 590 (834)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4568999999999998874 4678888875 321 123457788999999986 45678899988776 3489999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC------------------------------------
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS------------------------------------ 634 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 634 (834)
||+++..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 233678888899999999999999831
Q ss_pred -------------------CCceEeccCCCCceeecCCCC--eEEeeeccccc
Q 003272 635 -------------------RLRIIHRDLKASNVLLDNEMN--PKISDFGMARA 666 (834)
Q Consensus 635 -------------------~~~ivH~DLkp~NILl~~~~~--~kl~DfGla~~ 666 (834)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998865
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=1e-08 Score=91.14 Aligned_cols=87 Identities=22% Similarity=0.296 Sum_probs=65.0
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
..+|.|..||| |||++. +.++|++++... ..+..++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGn---Lvly~~-~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~~-------~~~~W~S~t~~-------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCN---LVLYDV-DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSPR-------NNPIWASNTGG-------- 79 (109)
T ss_dssp TEEEEECTTSC---EEEEET-TEEEEECCCTTS-SSSCEEEECTTSCEEEECTT-------SCEEEECCCCC--------
T ss_pred CEEEEEcCCCc---EEEEeC-CEEEEECCcccC-CCCEEEEEeCCCCEEEECCC-------CCEEEECCCCC--------
Confidence 56799999999 999987 789999997432 23467999999999999433 45899986321
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
..+.|.+.++++|+..++- .+.|.+|.
T Consensus 80 -----------------------~~~~~~~~L~ddGNlvly~----~~~W~s~t 106 (109)
T 3dzw_A 80 -----------------------ENGNYVCVLQKDRNVVIYG----TARWATGT 106 (109)
T ss_dssp -----------------------SSSCEEEEECTTSCEEEEE----SCCCCCCC
T ss_pred -----------------------CCCCEEEEEeCCCEEEEEC----CCEEeCCC
Confidence 1245788999999876663 26677664
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.80 E-value=9.2e-09 Score=91.25 Aligned_cols=91 Identities=25% Similarity=0.415 Sum_probs=67.0
Q ss_pred CCCCCCCceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCcc
Q 003272 80 APLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSH 159 (834)
Q Consensus 80 ~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTD 159 (834)
.|+.+....|.+..||| |||.++ +|+|++... ..+..++|.++|||||++.+ +.++|+|-..
T Consensus 16 ~~L~~g~~~L~~q~dGN---Lvl~~~----~Wssnt~~~-~~~~~l~l~~dGnLvl~d~~-------~~~vWss~t~--- 77 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCN---LVLYNG----NWQSNTANN-GRDCKLTLTDYGELVIKNGD-------GSTVWKSGAQ--- 77 (109)
T ss_dssp CEEEETTEEEEECTTSC---EEEETT----TEECCCTTS-CSSCEEEECTTSCEEEECTT-------SCEEEECCCC---
T ss_pred CEeECCCEEEEEecCCe---EEEEeC----eEEcCCCCC-CCcEEEEEcCCCeEEEEeCC-------CCEEEcCCCc---
Confidence 44444467899999999 999985 799997543 33567999999999999433 3588975210
Q ss_pred ccccCCeeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCCC
Q 003272 160 TLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSW 220 (834)
Q Consensus 160 tlLpg~~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~w 220 (834)
...+.|.+.++++|+..++- .+.|.+++|
T Consensus 78 ----------------------------~~~~~~~~~L~~dGNlvly~----~~~W~s~t~ 106 (109)
T 3r0e_A 78 ----------------------------SVKGNYAAVVHPDGRLVVFG----PSVFKIDPW 106 (109)
T ss_dssp ----------------------------CSSSCCEEEEETTTEEEEEC----SEEEEECTT
T ss_pred ----------------------------CCCcCEEEEEcCCCeEEEEe----cCEECCCCc
Confidence 02356889999999877663 688999987
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=1.4e-08 Score=108.25 Aligned_cols=186 Identities=18% Similarity=0.211 Sum_probs=120.8
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCc--eeeEEEEEEeCC---eeEEEEeec
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRN--LVKLLGCCTQRD---ERVLVYEYL 593 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~E~~ 593 (834)
.+.++.|....||+.. ..+++|+.... .....+.+|+.+++.+ .+.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999753 56888886432 3456789999999888 4433 344555443333 347899999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc----------------------------------------
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD---------------------------------------- 633 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 633 (834)
++..+..... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865332 2356677788888888888888862
Q ss_pred ---------------CCCceEeccCCCCceeecC--CCCeEEeeeccccccCCCccccccc------------ccccccc
Q 003272 634 ---------------SRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGLDQTEANTN------------RVVGTYG 684 (834)
Q Consensus 634 ---------------~~~~ivH~DLkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~------------~~~gt~~ 684 (834)
....++|+|++|.||++++ ...+.|+||+.+..-.....-.... ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 4567899999887542211000000 0000011
Q ss_pred ccC-ccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 685 YMS-PEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 685 y~A-PE~~~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
... |+.... .....+.|+++.+++++.+|..+
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 122 222211 12236899999999999999865
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=1.6e-07 Score=95.91 Aligned_cols=89 Identities=26% Similarity=0.321 Sum_probs=66.0
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
.-+|.|..+|| +++.++ +++||++|+... .+..++|.++|||||++.+ +.++|+|+++.
T Consensus 27 ~f~l~f~~~gn---l~ly~~-~~~vW~an~~~~--~~~~l~l~~dGnLvl~d~~-------~~~vW~s~~~~-------- 85 (236)
T 1dlp_A 27 SFRFTMQSDCN---LVLFDS-DVRVWASNTAGA--TGCRAVLQSDGLLVILTAQ-------NTIRWSSGTKG-------- 85 (236)
T ss_dssp TEEEEECTTSC---EEEEES-SSEEECCCCCSC--SCCBCCBCSSSCBCCBCTT-------TCCSCCCCCCC--------
T ss_pred CEEEEECCCCc---EEEEEC-CEEEEECCCCCC--CCeEEEEcCCCcEEEEcCC-------CcEEEeCCccc--------
Confidence 45677777888 888886 789999996433 4557899999999999543 45899998751
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCCCCc
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNG 222 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~w~g 222 (834)
+.|.|.+.++++|+..++ . .++|.+..+..
T Consensus 86 -----------------------~~~~~~~~l~d~Gnlvl~--~--~~~W~S~~~p~ 115 (236)
T 1dlp_A 86 -----------------------SIGNYVLVLQPDRTVTIY--G--PGLWDSGTSNK 115 (236)
T ss_dssp -----------------------CSSCCEEEECSSSCEEEE--C--SEEEECSCCCS
T ss_pred -----------------------cCCcEEEEEeCCCCEEEe--c--CCEEECCCCCC
Confidence 235578888888886665 2 27898877653
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.60 E-value=2.1e-07 Score=81.75 Aligned_cols=79 Identities=25% Similarity=0.338 Sum_probs=59.7
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
.-+|.+..||| |||.+. +.+||++|+......+..+.|.++|||||++.+ ++++|+|=-
T Consensus 20 ~y~l~~q~DgN---Lvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-------~~~vWss~t---------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCN---LVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-------GRSLWASHS---------- 78 (105)
T ss_dssp TEEEEECTTSC---EEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-------CCEEEECCC----------
T ss_pred CEEEEECCCCe---EEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-------cEEEEEecC----------
Confidence 35688889999 999975 689999997554555567999999999999543 458887621
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeE
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAM 206 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~ 206 (834)
....+.+.+.++++|+..++
T Consensus 79 ---------------------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ---------------------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ---------------------CCCSSCEEEEECTTSCEEEE
T ss_pred ---------------------CCCCCCEEEEEeCCCeEEEE
Confidence 11345688999999987665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-05 Score=85.32 Aligned_cols=136 Identities=21% Similarity=0.150 Sum_probs=92.8
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCC---ceeeEEEEEE-eCCeeEEEEeecCC
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHR---NLVKLLGCCT-QRDERVLVYEYLPN 595 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~E~~~~ 595 (834)
.+.++.|....||+. +..++||+-.. ......+..|+.++..+.+. .+.+.+.+.. ..+..++|||++++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346788888899986 56788887532 23456789999999999642 3566666664 34457899999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc------------------------------------------
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD------------------------------------------ 633 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 633 (834)
..+...... .++...+..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 123444444555555555555542
Q ss_pred ---------------CCCceEeccCCCCceeecC---CCCe-EEeeeccccc
Q 003272 634 ---------------SRLRIIHRDLKASNVLLDN---EMNP-KISDFGMARA 666 (834)
Q Consensus 634 ---------------~~~~ivH~DLkp~NILl~~---~~~~-kl~DfGla~~ 666 (834)
....++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-05 Score=83.55 Aligned_cols=135 Identities=18% Similarity=0.154 Sum_probs=95.6
Q ss_pred ccccCCcc-cEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 522 KLGEGGFG-PVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 522 ~LG~G~fg-~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
.+..|..+ .||+-... ++..++||+-... ....+.+|...|+.+. +--+.++++++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 58987654 3667899986432 3456888999998873 44467889999999999999999999887
Q ss_pred hhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 003272 599 DYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD--------------------------------------------- 633 (834)
Q Consensus 599 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 633 (834)
...... .......+..++++.|..||+.
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 655421 1123344555666666666642
Q ss_pred ----------CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 634 ----------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 634 ----------~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887777999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.1e-05 Score=87.65 Aligned_cols=80 Identities=8% Similarity=-0.027 Sum_probs=56.4
Q ss_pred cCcc-ccCCcccEEEEEEe-------CCeEEEEEEecccC---cccHHHHHHHHHHHHhcc-C--CceeeEEEEEEeC--
Q 003272 520 ENKL-GEGGFGPVYKGMLI-------EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQ-H--RNLVKLLGCCTQR-- 583 (834)
Q Consensus 520 ~~~L-G~G~fg~Vy~g~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~-- 583 (834)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3467 88888999998764 26788999864432 111246788888888884 3 3567788887655
Q ss_pred -CeeEEEEeecCCCChh
Q 003272 584 -DERVLVYEYLPNKSLD 599 (834)
Q Consensus 584 -~~~~lV~E~~~~gsL~ 599 (834)
...++|||++++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00011 Score=80.96 Aligned_cols=75 Identities=12% Similarity=0.185 Sum_probs=50.5
Q ss_pred cCccccCCcccEEEEEEe-CCeEEEEEEecccCc-------ccHHHHHHHHHHHHhccC--Cc-eeeEEEEEEeCCeeEE
Q 003272 520 ENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG-------QGVEEFKNEALLIAKLQH--RN-LVKLLGCCTQRDERVL 588 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 588 (834)
.+.||.|.++.||++... +++.++||....... ...+++..|.+++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 467899998643211 234567889998888742 33 4455544 3456789
Q ss_pred EEeecCCC
Q 003272 589 VYEYLPNK 596 (834)
Q Consensus 589 V~E~~~~g 596 (834)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00013 Score=78.62 Aligned_cols=141 Identities=16% Similarity=0.193 Sum_probs=80.0
Q ss_pred CccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccC--CceeeEEE------EEEeCCeeEEEEee
Q 003272 521 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH--RNLVKLLG------CCTQRDERVLVYEY 592 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~E~ 592 (834)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.++..+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999877444 5899988642 2344455555555531 12333332 12245678899999
Q ss_pred cCCCChh--------------hHhhccCC----C-------CCCCHHhHH------------------------------
Q 003272 593 LPNKSLD--------------YFIFDTTR----S-------KVLDWQNRC------------------------------ 617 (834)
Q Consensus 593 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~------------------------------ 617 (834)
+++..+. ..+|.... . ....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01111000 0 112332211
Q ss_pred -HHHHHHHHHHHHhhh----------cCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 618 -HIIGGIARGLLYLHH----------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 618 -~i~~~ia~gL~yLH~----------~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
.+...+.+++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223445666663 1245699999999999998888999999997743
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0005 Score=72.85 Aligned_cols=140 Identities=19% Similarity=0.148 Sum_probs=93.3
Q ss_pred cccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc---CCceeeEEEEEEeCCeeEEEEeecC
Q 003272 518 SEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ---HRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
...+.|+.|....+|+... ++..++||+.... ....|..|+..|+.+. ...+.+++.++...+..++|||+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999876 5678889987532 3567889999998884 3568888888887788999999999
Q ss_pred CCChhh-----------HhhccCC-C------------------CCCCHHhHH---HHH----------------HHHHH
Q 003272 595 NKSLDY-----------FIFDTTR-S------------------KVLDWQNRC---HII----------------GGIAR 625 (834)
Q Consensus 595 ~gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia~ 625 (834)
+..+.. .++.... . -.-+|.... ++. ..+.+
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 1222111 0 012454322 111 11111
Q ss_pred HH-HHhhh-cCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 626 GL-LYLHH-DSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 626 gL-~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
.+ ..|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 12 23322 2346799999999999999887 8899973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00025 Score=74.49 Aligned_cols=79 Identities=20% Similarity=0.246 Sum_probs=58.6
Q ss_pred CCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc-C--CceeeEEEEEEeCCeeEEEEee
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-H--RNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV~E~ 592 (834)
+....+.+|.|..+.||+.++.+|+.++||+...........|..|+..|+.|. . --+.++++.. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455567899999999999999999999999876554444557889999998884 2 2244455442 34789999
Q ss_pred cCCCCh
Q 003272 593 LPNKSL 598 (834)
Q Consensus 593 ~~~gsL 598 (834)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=73.76 Aligned_cols=78 Identities=9% Similarity=0.077 Sum_probs=48.7
Q ss_pred CCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccccccccc--ccccccCccccccC---CCCchhhHHHHHHHH
Q 003272 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV--GTYGYMSPEYAIDG---LFSVKSDVFSFGVLV 709 (834)
Q Consensus 635 ~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~APE~~~~~---~~t~~sDV~S~Gvil 709 (834)
...++|+|++|.|||++.++ ++|+||+.+..-.... ...... -...|++|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34699999999999998876 9999999887632110 000001 11346666654321 112245666888888
Q ss_pred HHHHhCC
Q 003272 710 LEIVSGK 716 (834)
Q Consensus 710 ~elltg~ 716 (834)
|+.+.+.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0018 Score=68.95 Aligned_cols=159 Identities=14% Similarity=0.102 Sum_probs=87.0
Q ss_pred cCHHHHHHHhcCCcc-----cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeeEE
Q 003272 505 FDWKTIVDATDNFSE-----ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN--LVKLL 577 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~-----~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 577 (834)
++.+++.....+|.. .+.|+.|....+|+....+| .+++|+..... ..+++..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555543 34567788889999887555 68889886521 2234566777777764222 22333
Q ss_pred EE------EEeCCeeEEEEeecCCCChhh--------------HhhccCC----C--C---CCCHHhHHH----------
Q 003272 578 GC------CTQRDERVLVYEYLPNKSLDY--------------FIFDTTR----S--K---VLDWQNRCH---------- 618 (834)
Q Consensus 578 g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~----~--~---~l~~~~~~~---------- 618 (834)
.. ....+..+++++++++..+.. .++.... . . ...|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 11 122356789999999865421 0111100 0 0 012322111
Q ss_pred --HHHHHHHHHHHhhhc----CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 619 --IIGGIARGLLYLHHD----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 619 --i~~~ia~gL~yLH~~----~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
+...+.+.+..+++. .+..++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234445555432 234699999999999999876668999987743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.002 Score=71.69 Aligned_cols=73 Identities=19% Similarity=0.306 Sum_probs=50.2
Q ss_pred cCccccCCcccEEEEEEeC--------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEE
Q 003272 520 ENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVY 590 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 590 (834)
.+.|+.|....+|+....+ ++.+++|+.... ...+.+..|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3468888889999998753 478999987431 122556689999988854344 567766532 3899
Q ss_pred eecCCCCh
Q 003272 591 EYLPNKSL 598 (834)
Q Consensus 591 E~~~~gsL 598 (834)
||+++..+
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0041 Score=67.70 Aligned_cols=141 Identities=18% Similarity=0.229 Sum_probs=83.7
Q ss_pred CccccCCcccEEEEEEeC--------CeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeEEEEe
Q 003272 521 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 591 (834)
+.|..|-...+|+....+ ++.+++|+.... ........+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467778888999988642 478999986332 234556678999998884 3223566666543 29999
Q ss_pred ecCCCChhhH-----------------hhccC--CCCCCC--HHhHHHHHHHHHH-------------------HHHHh-
Q 003272 592 YLPNKSLDYF-----------------IFDTT--RSKVLD--WQNRCHIIGGIAR-------------------GLLYL- 630 (834)
Q Consensus 592 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------gL~yL- 630 (834)
|+++..|..- +|... ..+... |..+.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 11110 111222 4455555544322 12233
Q ss_pred ---hhc-CCCceEeccCCCCceeecCC----CCeEEeeeccccc
Q 003272 631 ---HHD-SRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 666 (834)
Q Consensus 631 ---H~~-~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~ 666 (834)
... .+..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 23469999999999999876 7899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0028 Score=66.79 Aligned_cols=138 Identities=14% Similarity=0.114 Sum_probs=75.8
Q ss_pred cCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEeec-CCCC
Q 003272 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYEYL-PNKS 597 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~-~~gs 597 (834)
.+.|+.|....+|+. +.+++|+........ ....+|+..++.+...++ .+++++ ..+.-++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567889999999987 568888875432211 123568887877743333 455544 344457899999 6554
Q ss_pred hhhH------------------hhccCC--CCCCC-HHhHHHHHHH--------------HHHHHH----Hhhh-cCCCc
Q 003272 598 LDYF------------------IFDTTR--SKVLD-WQNRCHIIGG--------------IARGLL----YLHH-DSRLR 637 (834)
Q Consensus 598 L~~~------------------l~~~~~--~~~l~-~~~~~~i~~~--------------ia~gL~----yLH~-~~~~~ 637 (834)
+... +|.... ....+ +..+..+... +.+.+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4311 111100 00011 1111111110 111111 1111 22345
Q ss_pred eEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 638 IIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 638 ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6667889999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0068 Score=64.76 Aligned_cols=141 Identities=16% Similarity=0.128 Sum_probs=71.3
Q ss_pred CccccCCccc-EEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccC--CceeeEEEEEEeCCeeEEEEeecCCCC
Q 003272 521 NKLGEGGFGP-VYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH--RNLVKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 521 ~~LG~G~fg~-Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
+.|+.|+... +|+....+++.+++|....... +.+..|+.++..+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665544 6676653467777776543221 234456666666632 2345666664322 378999997765
Q ss_pred hhhHhhc---------------------cCCC--CCCCHHhHH-------H-------------HHHHHHHHHHHhh---
Q 003272 598 LDYFIFD---------------------TTRS--KVLDWQNRC-------H-------------IIGGIARGLLYLH--- 631 (834)
Q Consensus 598 L~~~l~~---------------------~~~~--~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 631 (834)
+...+.. .... ..++..... . ....+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 5432211 0000 111111000 0 0011112222221
Q ss_pred hcCCCceEeccCCCCceeecCC----CCeEEeeeccccc
Q 003272 632 HDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA 666 (834)
Q Consensus 632 ~~~~~~ivH~DLkp~NILl~~~----~~~kl~DfGla~~ 666 (834)
......++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6789999998865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.01 Score=66.32 Aligned_cols=74 Identities=12% Similarity=0.103 Sum_probs=48.1
Q ss_pred cCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEeecCCCC
Q 003272 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYEYLPNKS 597 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gs 597 (834)
.+.|+.|-...+|+....+ +..+++|+......... .-..|..++..+...++ .++++.+. + .+|+||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3478888889999988755 47888998744322211 12578888888865445 56777662 2 25999998755
Q ss_pred h
Q 003272 598 L 598 (834)
Q Consensus 598 L 598 (834)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.015 Score=61.72 Aligned_cols=141 Identities=13% Similarity=0.154 Sum_probs=80.8
Q ss_pred ccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCc--eeeEEEE-----EEeCCeeEEEEeecC
Q 003272 522 KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN--LVKLLGC-----CTQRDERVLVYEYLP 594 (834)
Q Consensus 522 ~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~E~~~ 594 (834)
.|+ |....||+....+|+.+++|...... .....+..|..++..+.... +++++.. ....+..++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889998877667789999985321 23456777888888774222 3444432 122445678999998
Q ss_pred CCChhh-----H---------hhcc----C--CCCCCCHHhH----------------------HHHHHHHHHHHHHhhh
Q 003272 595 NKSLDY-----F---------IFDT----T--RSKVLDWQNR----------------------CHIIGGIARGLLYLHH 632 (834)
Q Consensus 595 ~gsL~~-----~---------l~~~----~--~~~~l~~~~~----------------------~~i~~~ia~gL~yLH~ 632 (834)
+..+.. . ++.. . .....++... ...+..++..+.-+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 854321 0 1110 0 0112222211 0111112222222111
Q ss_pred -cCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 633 -DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 633 -~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0087 Score=64.98 Aligned_cols=73 Identities=14% Similarity=0.121 Sum_probs=44.3
Q ss_pred CccccCCcccEEEEEEeC---------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCc-eeeEEEEEEeCCeeEEEE
Q 003272 521 NKLGEGGFGPVYKGMLIE---------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN-LVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 590 (834)
+.|+.|....+|+....+ ++.+++|+....... ......|..++..+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888888999988754 268888887543221 112367888888775334 34666544 2 37899
Q ss_pred eecCCCCh
Q 003272 591 EYLPNKSL 598 (834)
Q Consensus 591 E~~~~gsL 598 (834)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.047 Score=58.40 Aligned_cols=32 Identities=31% Similarity=0.416 Sum_probs=28.1
Q ss_pred CCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 635 ~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.08 E-value=0.08 Score=51.93 Aligned_cols=103 Identities=9% Similarity=0.016 Sum_probs=65.8
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccccc
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN 675 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 675 (834)
-+|.+.|.. ...++++++++.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 367777743 3568999999999999999987762211 01 1222457999999999988764 1110
Q ss_pred cccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003272 676 TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN 718 (834)
Q Consensus 676 ~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p 718 (834)
.....+.|||... ...+.+.-|||+|+++|..+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122467888763 4557889999999999998865444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.58 E-value=0.25 Score=54.35 Aligned_cols=141 Identities=13% Similarity=0.143 Sum_probs=84.3
Q ss_pred cCccccCCcccEEEEEEeC--------CeEEEEEEecccCcccHHHHHHHHHHHHhccCCc-eeeEEEEEEeCCeeEEEE
Q 003272 520 ENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRN-LVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 590 (834)
.+.|..|-...+|+....+ ++.+++|+........ -...+|..+++.+.-.+ ..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3467778888999988753 5789999864432221 12357888888774323 34555533 2 37899
Q ss_pred eecCCCChhh--H---------------hhc--c-----C---CCCCCCHHhHHHHHHHHH-------------------
Q 003272 591 EYLPNKSLDY--F---------------IFD--T-----T---RSKVLDWQNRCHIIGGIA------------------- 624 (834)
Q Consensus 591 E~~~~gsL~~--~---------------l~~--~-----~---~~~~l~~~~~~~i~~~ia------------------- 624 (834)
||+++..|.. + +|. . . ...+.-|..+.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999866421 0 010 0 0 111112444444443221
Q ss_pred HHHHHhh---------------------hcCCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 625 RGLLYLH---------------------HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 625 ~gL~yLH---------------------~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
..+..|. ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223322 112346899999999999 8888999999988754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.70 E-value=0.98 Score=49.24 Aligned_cols=30 Identities=23% Similarity=0.371 Sum_probs=25.2
Q ss_pred ceEeccCCCCceee------cCCCCeEEeeeccccc
Q 003272 637 RIIHRDLKASNVLL------DNEMNPKISDFGMARA 666 (834)
Q Consensus 637 ~ivH~DLkp~NILl------~~~~~~kl~DfGla~~ 666 (834)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999988754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.98 E-value=3.5 Score=40.44 Aligned_cols=115 Identities=10% Similarity=0.030 Sum_probs=76.3
Q ss_pred cCCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHH-HhhhcCCCceEeccCCCCc
Q 003272 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL-YLHHDSRLRIIHRDLKASN 647 (834)
Q Consensus 569 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~DLkp~N 647 (834)
.||++ -...-.+.+...+.|+.-+++.--.-+ +.++...+++++..|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 68888 334446667777777765333211122 34778899999999988777 5654 6788899999
Q ss_pred eeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 648 VLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 648 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
|+++.++.++|.-.|+- .-++|.-+ +..-=.-.+=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~-------------------~~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK-------------------ESLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEET-------------------TTBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCc-------------------ccCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999865543 23344321 112223367778888888887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.92 E-value=3.1 Score=40.63 Aligned_cols=116 Identities=13% Similarity=0.075 Sum_probs=78.5
Q ss_pred cCCceeeEEEEEEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCce
Q 003272 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNV 648 (834)
Q Consensus 569 ~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 648 (834)
.||+++.. ..-.+.+...+.|+.-+. ...+- .-+.++...+++++..|+....+++. -+|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68888876 455556666666665432 22221 12447889999999999998866664 57888999999
Q ss_pred eecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003272 649 LLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRG 720 (834)
Q Consensus 649 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~ 720 (834)
+++.++.+++.-.|+-.. ++|. ..+...=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999986655322 2232 11222334467788889999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 834 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-17 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-11 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-08 | |
| d2qfra1 | 112 | b.1.12.1 (A:9-120) Purple acid phosphatase, N-term | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 7e-71
Identities = 64/286 (22%), Positives = 138/286 (48%), Gaps = 21/286 (7%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+ ++G G FG VYKG + + ++ + Q ++ FKNE ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+G T + +V ++ SL + + + I A+G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA--- 691
IIHRDLK++N+ L ++ KI DFG+A ++ G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
+S +SDV++FG+++ E+++G+ + + ++R ++ + ++ +++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRS--- 236
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG-ERSLPQ 796
+ +A++ ++ C+++ ++RP ++ + RSLP+
Sbjct: 237 ----NCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-64
Identities = 79/274 (28%), Positives = 131/274 (47%), Gaps = 22/274 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+ +LG G FG V+ G ++AVK L + S + F EA L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L TQ + ++ EY+ N SL F+ + K L + IA G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
IHRDL+A+N+L+ + ++ KI+DFG+AR ++ A + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754
F++KSDV+SFG+L+ EIV+ R Y ++ + + + RP +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPE------ 237
Query: 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
Q+ LC ++ PEDRP + +L
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-64
Identities = 80/309 (25%), Positives = 138/309 (44%), Gaps = 33/309 (10%)
Query: 494 GSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQ 553
G +K+ E+P ++ E KLG+G FG V+ G +A+K L +
Sbjct: 6 GLAKDAWEIPR----------ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-M 54
Query: 554 GVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDW 613
E F EA ++ KL+H LV+L ++ + +V EY+ SL F+ K L
Sbjct: 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRL 112
Query: 614 QNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673
+ IA G+ Y+ + +HRDL+A+N+L+ + K++DFG+AR ++
Sbjct: 113 PQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169
Query: 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH 733
A + +PE A+ G F++KSDV+SFG+L+ E+ + R Y +L
Sbjct: 170 ARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVL-- 224
Query: 734 AWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793
+ +++ C + C ++ PE+RP + L +
Sbjct: 225 -----------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
Query: 794 LPQPK-QPG 801
+P+ QPG
Sbjct: 274 STEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 8e-63
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 23/280 (8%)
Query: 510 IVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ 569
++D + ++G G FG V+ G + ++A+K + + + E+F EA ++ KL
Sbjct: 1 VIDP-SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS 58
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H LV+L G C ++ LV+E++ + L ++ + + + + + G
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG--- 113
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
+ + +IHRDL A N L+ K+SDFGM R DQ ++ + SPE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPE 172
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
+S KSDV+SFGVL+ E+ S + Y ++ + +P
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGFRLYKPRLAST- 229
Query: 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
Q+ C ++ PEDRP ++ L+
Sbjct: 230 ------------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 8e-62
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGV-EEFKNEALLIAKLQH 570
D+F + ++LG G G V+K G +A K + + + E ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
+V G E + E++ SLD + ++ + Q + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
+ +I+HRD+K SN+L+++ K+ DFG++ ++ N VGT YMSPE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKR 717
+SV+SD++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-61
Identities = 61/292 (20%), Positives = 116/292 (39%), Gaps = 28/292 (9%)
Query: 520 ENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGC 579
+ +G+G FG V++G G+E+AVK S + + E L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 580 CTQRD----ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-- 633
+ + + LV +Y + SL ++ + + + A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 634 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GLDQTEANTNRVVGTYGYMSP 688
+ I HRDLK+ N+L+ I+D G+A D + N VGT YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 689 EYAIDGL------FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH----NLLGHAWQLW 738
E D + ++D+++ G++ EI G + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 739 IQDRPAELIDKSLYDSCSLSEAIRCI-QVGLLCVQQIPEDRPNMLSVVLMLS 789
+ + + ++ + EA+R + ++ C R L + LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (529), Expect = 1e-61
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 37/301 (12%)
Query: 505 FDWKTIVDATDNFSEE---------NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKS- 550
F ++ +A F++E +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 551 SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV 610
+ + +F +EA ++ + H N++ L G T+ +++ E++ N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 611 LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670
++ GIA G+ YL + +HRDL A N+L+++ + K+SDFG++R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 671 QTEANTNRVVG---TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR 727
++ +G + +PE F+ SDV+S+G+++ E++S Y
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--YGERPYWDMTN 239
Query: 728 HNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787
+++ I++ + Q+ L C Q+ RP +V
Sbjct: 240 QDVI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 788 L 788
L
Sbjct: 287 L 287
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-61
Identities = 64/274 (23%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+ + +LG G FG V G ++A+K + + S +EF EA ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
+L G CT++ ++ EY+ N L ++ + Q + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDG 694
+ +HRDL A N L++++ K+SDFG++R D ++ + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 695 LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754
FS KSD+++FGVL+ EI S + ++ + AE I + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
+ + + C + ++RP ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 2e-60
Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
+ + ++KLG G +G VY+G+ + +AVK L + + + VEEF EA ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V+LLG CT+ ++ E++ +L ++ + R + + ++ I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE-- 132
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
+ IHRDL A N L+ K++DFG++R D A+ + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753
FS+KSDV++FGVL+ EI + + Y + EL++K
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY-------------ELLEKDYRM 235
Query: 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
+ ++ C Q P DRP+ +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 71/275 (25%), Positives = 115/275 (41%), Gaps = 28/275 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLV 574
+G+G FG V G G ++AVK + + + F EA ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 575 KLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+LLG + + +V EY+ SL ++ R VL + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID 693
+HRDL A NVL+ + K+SDFG+ + + + + + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753
FS KSDV+SFG+L+ EI S R Y +++ + + D P D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDAP---------D 223
Query: 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
C + +V C RP+ L + L
Sbjct: 224 GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 2e-59
Identities = 72/319 (22%), Positives = 123/319 (38%), Gaps = 56/319 (17%)
Query: 498 EEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSK-S 550
+E P +N +GEG FG V++ +AVK L + +
Sbjct: 6 LSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 55
Query: 551 SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV 610
S +F+ EA L+A+ + N+VKLLG C L++EY+ L+ F+ + V
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 611 ---------------------LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVL 649
L + I +A G+ YL + +HRDL N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172
Query: 650 LDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 709
+ M KI+DFG++R +M PE ++ +SDV+++GV++
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 710 LEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLL 769
EI S Y+ ++ + +C + + + L
Sbjct: 233 WEIFSYGLQ--PYYGMAHEEVI-------------YYVRDGNILACPENCPLELYNLMRL 277
Query: 770 CVQQIPEDRPNMLSVVLML 788
C ++P DRP+ S+ +L
Sbjct: 278 CWSKLPADRPSFCSIHRIL 296
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 51/334 (15%)
Query: 501 ELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-SSGQGVE 556
P+ DW ++ ++ +GEG FG V K + + + A+KR+ + +S
Sbjct: 3 IYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 557 EFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFI------------- 602
+F E ++ KL H N++ LLG C R L EY P+ +L F+
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 603 FDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662
+ + L Q H +ARG+ YL + IHRDL A N+L+ KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFY 722
++R + +M+ E +++ SDV+S+GVL+ EIVS Y
Sbjct: 173 LSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PY 227
Query: 723 HADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNML 782
L Q + ++P D+ + C ++ P +RP+
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFA 274
Query: 783 SVVLMLSGERSLPQPKQPGFFTERNLPESESSSS 816
+++ L R L + K + L E + +
Sbjct: 275 QILVSL--NRMLEERKT---YVNTTLYEKFTYAG 303
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-59
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 27/282 (9%)
Query: 513 ATDNFS-EENKLGEGGFGPVYKGMLI---EGQEIAVKRLSKSSGQG-VEEFKNEALLIAK 567
DN + +LG G FG V +G+ + ++A+K L + + + EE EA ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
L + +V+L+G C Q + +LV E L F+ + + + N ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEAN-TNRVVGTYGYM 686
YL +HRDL A NVLL N KISDFG+++A G D + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746
+PE FS +SDV+S+GV + E +S + Y ++ Q + P E
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMECPPE- 236
Query: 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
LY + C EDRP+ L+V +
Sbjct: 237 CPPELYA------------LMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (513), Expect = 4e-59
Identities = 78/323 (24%), Positives = 124/323 (38%), Gaps = 47/323 (14%)
Query: 512 DATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG---VEEFKNEALLIAK 567
D FS+ ++G G FG VY + + +A+K++S S Q ++ E + K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
L+H N ++ GC + LV EY + D K L + G +GL
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGL 128
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
YLH +IHRD+KA N+LL K+ DFG A A N VGT +M+
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMA 179
Query: 688 PEYAI---DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744
PE + +G + K DV+S G+ +E+ K + + L H Q +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQNESPALQS 236
Query: 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQPGFFT 804
+ + C+Q+IP+DRP ++ K F
Sbjct: 237 GHWSEYFRN------------FVDSCLQKIPQDRPTSEVLL------------KHR-FVL 271
Query: 805 ERNLPESESSSSKQNLSSTNEIS 827
P ++ + E+
Sbjct: 272 RERPPTVIMDLIQRTKDAVRELD 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-59
Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 519 EENKLGEGGFGPVYKGMLIE---GQEIAVKRLSKSSGQG--VEEFKNEALLIAKLQHRNL 573
E+ +LG G FG V KG + +AVK L + +E EA ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V+++G C + + +LV E L+ ++ + +N ++ ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 634 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTN-RVVGTYGYMSPEYAI 692
+HRDL A NVLL + KISDFG+++A D+ + +PE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 693 DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752
FS KSDV+SFGVL+ E S + Y + +++K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT-------------AMLEKGER 228
Query: 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
C + LC E+RP +V L L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-58
Identities = 63/277 (22%), Positives = 119/277 (42%), Gaps = 27/277 (9%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ 569
++ D + +LG+G FG VYK E A K + S + +E++ E ++A
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H N+VKLL + ++ E+ ++D + + + L + L Y
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNY 125
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH +IIHRDLKA N+L + + K++DFG++ ++ +GT +M+PE
Sbjct: 126 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 180
Query: 690 YAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744
+ D + K+DV+S G+ ++E+ + +H + +L + P
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL----LKIAKSEPP 233
Query: 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
L S + S ++ C+++ + R
Sbjct: 234 TLAQPSRWS----SNFKDFLK---KCLEKNVDARWTT 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 77/325 (23%), Positives = 143/325 (44%), Gaps = 29/325 (8%)
Query: 510 IVDATDNFSEENKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKS-SGQGVEEFKNEAL 563
I+ T+ F + LG G FG VYKG+ I E +A+K L ++ S + +E +EA
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 564 LIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
++A + + ++ +LLG C + L+ + +P L ++ + + Q + I
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 120
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
A+G+ YL R++HRDL A NVL+ + KI+DFG+A+ G ++ E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743
+M+ E + +++ +SDV+S+GV V E+++ Y +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS------------ 223
Query: 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQPGFF 803
+++K I + + C + RP +++ S PQ
Sbjct: 224 -SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282
Query: 804 TER-NLPESESSSSKQNLSSTNEIS 827
ER +LP S+ + L ++
Sbjct: 283 DERMHLPSPTDSNFYRALMDEEDMD 307
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-58
Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 27/288 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKSSGQG-VEEFKNEALLIAKL 568
+ + +G G FG VYKGML +A+K L + +F EA ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 569 QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLL 628
H N+++L G ++ +++ EY+ N +LD F+ + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGM- 123
Query: 629 YLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT-NRVVGTYGYMS 687
+ + + +HRDL A N+L+++ + K+SDFG++R D T + + +
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
PE F+ SDV+SFG+++ E+++ Y H ++ + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVM-------------KAI 226
Query: 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLP 795
+ + Q+ + C QQ RP +V +L P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-57
Identities = 65/272 (23%), Positives = 108/272 (39%), Gaps = 27/272 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-QGVEEFKNEALLIAKLQHRN 572
+++ LGEG +G V + + +AVK + E K E + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+VK G + + + L EY L I + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
+ I HRD+K N+LLD N KISDFG+A F + E N++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 693 DGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
F + DV+S G+++ +++G+ + + P + ID +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 752 YDSCSLSEAIRCIQVGLL--CVQQIPEDRPNM 781
LL + + P R +
Sbjct: 237 LA--------------LLHKILVENPSARITI 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 30/282 (10%)
Query: 516 NFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSSGQG-VEEFKNEALLIAKLQH 570
+F+E +G G FG VY G L++ AVK L++ + G V +F E +++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 571 RNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
N++ LLG C + + +V Y+ + L FI + + ++ +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM-- 143
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR--VVGTYGYMS 687
+ + +HRDL A N +LD + K++DFG+AR + ++ N+ +M+
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
E F+ KSDV+SFGVL+ E+++ Y + ++ + Q +P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCP 260
Query: 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
D +V L C E RP+ +V +S
Sbjct: 261 DP-------------LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 2e-57
Identities = 74/308 (24%), Positives = 135/308 (43%), Gaps = 34/308 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGML------IEGQEIAVKRLSKS-SGQGVEEFKNEALLIAK 567
+ + +LG+G FG VY+G+ +A+K ++++ S + EF NEA ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF-------DTTRSKVLDWQNRCHII 620
++V+LLG +Q +++ E + L ++ + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 621 GGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVV 680
G IA G+ YL+ + + +HRDL A N ++ + KI DFGM R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 681 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQ 740
+MSPE DG+F+ SDV+SFGV++ EI + Y +L + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLL 254
Query: 741 DRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPKQP 800
D+P D ++ +C Q P+ RP+ L ++ + E P ++
Sbjct: 255 DKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREV 300
Query: 801 GFF-TERN 807
F+ +E N
Sbjct: 301 SFYYSEEN 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 5e-57
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 26/275 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHR 571
+++ +G G +G K G+ + K L S + +E L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 572 NLVKLLGCCTQRDERVL--VYEYLPNKSLDYFIFDTTRSK-VLDWQNRCHIIGGIARGLL 628
N+V+ R L V EY L I T+ + LD + ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 629 YLH--HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
H D ++HRDLK +NV LD + N K+ DFG+AR D + A VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746
SPE ++ KSD++S G L+ E+ + + A + L G + + P
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
D E I + RP++
Sbjct: 239 SD----------ELNEIIT---RMLNLKDYHRPSV 260
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-56
Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 31/270 (11%)
Query: 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKL 576
+ ++G G F VYKG+ E E+A L + + FK EA ++ LQH N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 577 LGCC----TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+ VLV E + + +L ++ R KV+ + I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 633 DSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
+ IIHRDLK N+ + + KI D G+A V+GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
+ + DV++FG+ +LE+ + + + + + + +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVT---------SGVKPAS 233
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
+D ++ E I+ C++Q ++R ++
Sbjct: 234 FDKVAIPEVKEIIE---GCIRQNKDERYSI 260
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-56
Identities = 71/317 (22%), Positives = 120/317 (37%), Gaps = 42/317 (13%)
Query: 500 MELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQ 553
+LP +D K + S LG G FG V + +AVK L S+
Sbjct: 10 TQLP-YDHKWEFPR-NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 554 G-VEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKV- 610
E +E +++ L H N+V LLG CT +++ EY L F+ S +
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 611 --------------LDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656
LD ++ +A+G+ +L IHRDL A N+LL +
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184
Query: 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
KI DFG+AR D +M+PE + +++ +SDV+S+G+ + E+ S
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 717 RNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPE 776
+ + + + ++I + + C P
Sbjct: 245 SS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 777 DRPNMLSVVLMLSGERS 793
RP +V ++ + S
Sbjct: 291 KRPTFKQIVQLIEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-56
Identities = 68/305 (22%), Positives = 114/305 (37%), Gaps = 45/305 (14%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQG-VEEFKNEALLIAK 567
+N LG G FG V ++AVK L + + E +E ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 568 L-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFD--------------------TT 606
L H N+V LLG CT L++EY L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666
VL +++ +A+G+ +L +HRDL A NVL+ + KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADH 726
D +M+PE +G++++KSDV+S+G+L+ EI S +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 727 RHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786
N + D+P ++ + C RP+ ++
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 787 MLSGE 791
L +
Sbjct: 320 FLGCQ 324
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 9e-55
Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 24/274 (8%)
Query: 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAK 567
++ D ++ K+G+G G VY M + GQE+A+++++ E NE L++ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
++ N+V L DE +V EYL SL + +T D + + L
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
+LH ++IHRD+K+ N+LL + + K++DFG +Q++ +T +VGT +M+
Sbjct: 130 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184
Query: 688 PEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747
PE + K D++S G++ +E++ G+ Y ++ L L + EL
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL----YLIATNGTPELQ 237
Query: 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
+ LS R L + E R +
Sbjct: 238 NPE-----KLSAIFRDFLNRCLDMD--VEKRGSA 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-54
Identities = 71/286 (24%), Positives = 109/286 (38%), Gaps = 36/286 (12%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSK---SSGQGVEEFKNEALLIAK 567
+ KLG+G FG V +G + +AVK L S + +++F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
L HRNL++L G + +V E P SL + +A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE-ANTNRVVGTYGYM 686
YL R IHRDL A N+LL KI DFG+ RA + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746
+PE FS SD + FGV + E+ + + + WI +++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNGSQI 223
Query: 747 IDKSLYDSCSLSEAIRC----IQVGLLCVQQIPEDRPNMLSVVLML 788
+ K + L C V + C PEDRP +++ L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 7e-53
Identities = 61/273 (22%), Positives = 106/273 (38%), Gaps = 35/273 (12%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
++F LG+G FG VY + +A+K L K+ + + E + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
N+++L G L+ EY P ++ + ++ D Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H R+IHRD+K N+LL + KI+DFG + + + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750
+ K D++S GVL E + GK + + E +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------PFEANTYQETYKRI 216
Query: 751 LYDSCSLSEAI--RCIQVGLLCVQQIPEDRPNM 781
+ + + + ++ P RP +
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPML 249
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 8e-51
Identities = 58/324 (17%), Positives = 111/324 (34%), Gaps = 32/324 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
D++ +LG G FG V++ G A K + E + E ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
V L +E V++YE++ L + D + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 634 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
+H DLK N++ + + K+ DFG+ + + GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
+D++S GVL ++SG + ++ L + +D S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKSCDWN------MDDSA 248
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNM--------LSVVLMLSGERSLPQPKQPGFF 803
+ S + I+ + P R + L+ + +P +
Sbjct: 249 FSGIS-EDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 804 TERNLPESESSSSKQNLSSTNEIS 827
L + S
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYS 328
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 67/280 (23%), Positives = 113/280 (40%), Gaps = 27/280 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKSSGQGV-EEFKNEALLIAKLQ 569
+ +GEG FG V++G+ + +A+K + V E+F EAL + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H ++VKL+G T+ + ++ E L F+ S LD + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
L R +HRD+ A NVL+ + K+ DFG++R D T ++ +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
F+ SDV+ FGV + EI+ + ++++G P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPN-CPP 236
Query: 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+LY + C P RP + LS
Sbjct: 237 TLYS------------LMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 68/297 (22%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKSSGQG--VEEFKNEALLIA 566
D LG G FG V + + +AVK L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 567 KLQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIF-------------DTTRSKVLD 612
H N+V LLG CT+ + ++ E+ +L ++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 613 WQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672
++ +A+G+ +L + IHRDL A N+LL + KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 673 EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLG 732
+M+PE D +++++SDV+SFGVL+ EI S +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 733 HAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+ + D + + Q L C P RP +V L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-50
Identities = 76/312 (24%), Positives = 126/312 (40%), Gaps = 43/312 (13%)
Query: 501 ELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSK-SS 551
ELP D + + D LGEG FG V I ++AVK L ++
Sbjct: 1 ELP-EDPRWELPR-DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 552 GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIF------- 603
+ + + +E ++ + +H+N++ LLG CTQ ++ EY +L ++
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 604 ------DTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPK 657
+ L ++ +ARG+ YL + IHRDL A NVL+ + K
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175
Query: 658 ISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
I+DFG+AR T +M+PE D +++ +SDV+SFGVL+ EI +
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 718 NRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPED 777
+ Y L + D+P+ ++ + C +P
Sbjct: 236 S--PYPGVPVEELFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQ 280
Query: 778 RPNMLSVVLMLS 789
RP +V L
Sbjct: 281 RPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 10/207 (4%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
++F LGEG F V + +E A+K L K V E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
VKL ++ Y N L +I + D I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
H IIHRDLK N+LL+ +M+ +I+DFG A+ + +A N VGT Y+SPE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKR 717
+ SD+++ G ++ ++V+G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 5e-48
Identities = 61/315 (19%), Positives = 115/315 (36%), Gaps = 26/315 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
D + +LG G FG V++ + G+ K ++ KNE ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+ L + E VL+ E+L L I + + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 634 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
I+H D+K N++ + + KI DFG+A D+ T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
+D+++ GVL ++SG + + L + + + D+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDWE------FDEDA 251
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM--LSGERSLPQPKQPGFFTERNLP 809
+ S S EA I+ +Q+ P R + + L G+ S + P +
Sbjct: 252 FSSVS-PEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307
Query: 810 ESESSSSKQNLSSTN 824
+ + +
Sbjct: 308 KIKEKYADWPAPQPA 322
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 2e-47
Identities = 63/321 (19%), Positives = 121/321 (37%), Gaps = 24/321 (7%)
Query: 507 WKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEE-FKNEALL 564
WK D D + + LG G F V + +A+K ++K + +G E +NE +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIA 624
+ K++H N+V L L+ + + L I ++ +I +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117
Query: 625 RGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
+ YLH + + LD + ISDFG+++ + GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744
Y++PE +S D +S GV+ ++ G ++ ++ L + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYE---- 227
Query: 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM--LSGERSLPQPKQPGF 802
D +D S A I+ +++ PE R + ++G+ +L +
Sbjct: 228 --FDSPYWDDIS-DSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ-S 280
Query: 803 FTERNLPESESSSSKQNLSST 823
+E+ S KQ ++T
Sbjct: 281 VSEQIKKNFAKSKWKQAFNAT 301
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-45
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 7/212 (3%)
Query: 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG-VEEFKNEALLIA 566
+ D ++ + +GEG +G V +A+K++S Q + E ++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 567 KLQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARG 626
+ +H N++ + + YL + ++ +++ L + C+ + I RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 627 LLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANT-NRVVGTYGY 685
L Y+H ++HRDLK SN+LL+ + KI DFG+AR D V T Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 686 MSPEYAIDGLFSVKS-DVFSFGVLVLEIVSGK 716
+PE ++ KS D++S G ++ E++S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (415), Expect = 5e-45
Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 32/277 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQ- 569
++FS +G GGFG VY + G+ A+K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 570 --HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
+V + D+ + + + L Y + + V + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMS 687
++H+ +++RDLK +N+LLD + +ISD G+A F + + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 688 PEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746
PE G+ + +D FS G ++ +++ G H+ ++ +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTMAV--- 226
Query: 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783
L DS S E ++ +Q+ R L
Sbjct: 227 ---ELPDSFS-PELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (404), Expect = 1e-44
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 28/282 (9%)
Query: 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG---VEEFKNEALLIAKLQ 569
+D + LG GG V+ + +++AVK L + F+ EA A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 570 HRNLVKLLGCCTQRDER----VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
H +V + +V EY+ +L + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE-ANTNRVVGTYG 684
L + H + IIHRD+K +N+++ K+ DFG+ARA T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744
Y+SPE A +SDV+S G ++ E+++G+ F H + I
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSA- 236
Query: 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786
++ S ++ + + + PE+R + +
Sbjct: 237 ------RHEGLS-ADLDAVVL---KALAKNPENRYQTAAEMR 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 6e-44
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
+F LG G FG V+ G+ A+K L K + VE +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
++++ G + ++ +Y+ L + + R + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
+ II+RDLK N+LLD + KI+DFG A+ + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKR 717
++ D +SFG+L+ E+++G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 52/270 (19%), Positives = 104/270 (38%), Gaps = 25/270 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
+ + LG G FG V++ + + K + K G K E ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+ L +E V+++E++ + I T + L+ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLH-- 119
Query: 634 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
I H D++ N++ + KI +FG AR N + Y +PE
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
+ S +D++S G LV ++SG + A+ ++ + + D+
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN---PFLAETNQQII----ENIMNAEY--TFDEEA 226
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
+ S EA+ + + + + R
Sbjct: 227 FKEIS-IEAMDFVD---RLLVKERKSRMTA 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 1e-43
Identities = 58/299 (19%), Positives = 103/299 (34%), Gaps = 36/299 (12%)
Query: 500 MELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEF 558
MEL + + + K+G G FG +Y G I G+E+A+K + +
Sbjct: 1 MELRV---------GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQL 49
Query: 559 KNEALLIAKLQHRNLVKLLG-CCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRC 617
E+ + +Q + + C + D V+V E L D F F S+ +
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVL 106
Query: 618 HIIGGIARGLLYLHHDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGLDQTEA 674
+ + + Y+H IHRD+K N L I DFG+A+ + +T
Sbjct: 107 LLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
Query: 675 N-----TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHN 729
+ + GT Y S + S + D+ S G +++ G A +
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
Query: 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLML 788
+ + L SE + C +D+P+ + +
Sbjct: 224 KYERISEKKMSTPIEVLCKG-----YP-SEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 72/277 (25%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---QGVEEFKNEA-LLIAKLQ 569
++F LG+G FG V+ + Q A+K L K VE E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 570 HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLY 629
H L + ++ V EYL L Y I + D I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 630 LHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
LH I++RDLK N+LLD + + KI+DFGM + L + NT GT Y++PE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 690 YAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749
+ ++ D +SFGVL+ E++ G+ +H L + D P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEEL----FHSIRMDNP------ 220
Query: 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786
+ L + + + V L + PE R + +
Sbjct: 221 --FYPRWLEKEAKDLLVKLFVRE--PEKRLGVRGDIR 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 6e-43
Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 39/284 (13%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG---------QGVEEFKNEALL 564
+N+ + LG G V + + +E AVK + + G + E E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 565 IAKLQ-HRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
+ K+ H N+++L LV++ + L ++ T L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
+ LH +L I+HRDLK N+LLD++MN K++DFG + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 684 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737
Y++PE + + + D++S GV++ +++G + + +L
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG 230
Query: 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
Q E D S + + P+ R
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVS---RFLVVQPQKRYTA 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 65/308 (21%), Positives = 122/308 (39%), Gaps = 21/308 (6%)
Query: 521 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEE-----FKNEALLIAKLQHRNLV 574
+ LGEG F VYK Q +A+K++ ++ E L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 575 KLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS 634
LL + LV++++ S VL + + +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 635 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAID- 693
I+HRDLK +N+LLD K++DFG+A++FG V T Y +PE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 694 GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753
++ V D+++ G ++ E++ F D + L ++ + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER--SLPQPKQPGFFTERNLPES 811
++ I + + +D +++ + + + + Q + +F+ R P
Sbjct: 233 DYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
Query: 812 ESSSSKQN 819
+ N
Sbjct: 292 GCQLPRPN 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 3e-41
Identities = 64/285 (22%), Positives = 118/285 (41%), Gaps = 29/285 (10%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVK--RLSKSSGQGVEEFKNEALLIAKLQHRN 572
+ + K+GEG +G VYK G+ A+K RL K E ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+VKL + VLV+E+L L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 633 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAI 692
R++HRDLK N+L++ E KI+DFG+ARAFG+ + + T Y +P+ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 693 -DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLW----------IQD 741
+S D++S G + E+V+G + + L +++ + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 742 RPAELIDKSLYDSCSLSEAIRCIQVGLL-----CVQQIPEDRPNM 781
P + ++Y+ ++ + + ++ P R
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 17/211 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
++++ +G G FG VY+ L + G+ +A+K++ + E ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 574 VKLLGCCTQRDER------VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
V+L E+ LV +Y+P + + L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGLDQTEANTNRVVGTYGYM 686
Y+H I HRD+K N+LLD + K+ DFG A+ + E N + + Y
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190
Query: 687 SPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR 717
++ DV+S G ++ E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 61/292 (20%), Positives = 114/292 (39%), Gaps = 32/292 (10%)
Query: 513 ATDNFSEENKLGEGGFGPVYKGMLIE--GQEIAVKRLSKSSGQG--VEEFKNEALLIAKL 568
A + ++GEG +G V+K ++ G+ +A+KR+ +G+ E ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 569 ---QHRNLVKLLGCCTQRDERVLVYEYLPNKSLD---YFIFDTTRSKVLDWQNRCHIIGG 622
+H N+V+L CT L + +D D + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 623 IARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGT 682
+ RGL +LH R++HRDLK N+L+ + K++DFG+AR + VV T
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
Query: 683 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL----- 737
Y +PE + ++ D++S G + E+ K + + LG +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
Query: 738 ---WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLL-----CVQQIPEDRPNM 781
W +D + + + + I C+ P R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 57/278 (20%), Positives = 110/278 (39%), Gaps = 33/278 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS------GQGVEEFKNEALLIAK 567
D + +LG G F V K G + A K + K G E+ + E ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 568 LQHRNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGL 627
+QH N++ L + + +L+ E + L F+ + L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 628 LYLHHDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGLDQTEANTNRVVGTY 683
+++ L+I H DLK N++L + P KI DFG+A + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743
+++PE +++D++S GV+ ++SG + D + L + + +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNYEFED 237
Query: 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
+ S + A I+ + + P+ R +
Sbjct: 238 EYFSNTS-------ALAKDFIR---RLLVKDPKKRMTI 265
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHR 571
+NF + K+GEG +G VYK G+ +A+K++ + E L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
N+VKLL ++ LV+E+L + D + + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE-Y 690
R++HRDLK N+L++ E K++DFG+ARAFG+ V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKR 717
+S D++S G + E+V+ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 3e-39
Identities = 42/286 (14%), Positives = 96/286 (33%), Gaps = 27/286 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL 573
++ ++GEG FG +++G + Q++A+K + S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 574 VKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
+ + Q ++ L SL+ + + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 634 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGLDQTEAN-----TNRVVGTY 683
+++RD+K N L+ + + DFGM + + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 684 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743
YMS + S + D+ + G + + + G A I ++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----ERIGEKK 232
Query: 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789
+ L E + + + P+ + + S
Sbjct: 233 QSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 51/271 (18%), Positives = 98/271 (36%), Gaps = 30/271 (11%)
Query: 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLL 577
LG G G V + ++ A+K L + + E L + Q ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 578 GCC----TQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD 633
R ++V E L L I D + + I+ I + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 634 SRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
+ I HRD+K N+L ++ K++DFG A+ + T Y++PE
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750
+ D++S GV++ ++ G ++++H + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYE--FPNP 239
Query: 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
+ S E I+ ++ P R +
Sbjct: 240 EWSEVS-EEVKMLIR---NLLKTEPTQRMTI 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 14/217 (6%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQH 570
++F LG+G FG V G+ A+K L K + V E+ ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
L L D V EY L + + +R +V + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSAL--- 118
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY 690
+ +++RD+K N++LD + + KI+DFG+ + A GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHR 727
D + D + GV++ E++ G+ FY+ DH
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 3e-37
Identities = 50/221 (22%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 511 VDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQG--VEEFKNEALLIAK 567
D + + K+G+G FG V+K + GQ++A+K++ + + E ++
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 568 LQHRNLVKLLGCCTQRDERV--------LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHI 619
L+H N+V L+ C + LV+++ + + + + + +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 620 IGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR- 678
+ L L++ R +I+HRD+KA+NVL+ + K++DFG+ARAF L +
Sbjct: 126 L------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 679 -VVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVSGKR 717
V T Y PE + + + D++ G ++ E+ +
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 59/271 (21%), Positives = 99/271 (36%), Gaps = 43/271 (15%)
Query: 522 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEE------FKNEALLIAKLQ--HRN 572
LG GGFG VY G+ + +A+K + K E E +L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 573 LVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH 632
+++LL + D VL+ E + T L + + + + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 633 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEY- 690
++HRD+K N+L+D N K+ DFG + GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 691 AIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750
+ V+S G+L+ ++V G F H + E+I
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDE-------------------EIIRGQ 220
Query: 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNM 781
++ +S C + C+ P DRP
Sbjct: 221 VFFRQRVSSE--CQHLIRWCLALRPSDRPTF 249
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 60/296 (20%), Positives = 121/296 (40%), Gaps = 14/296 (4%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHR 571
+ + K+GEG +G V+K E + +A+KR+ E L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 572 NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLH 631
N+V+L + LV+E+ YF + LD + + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 632 HDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYA 691
++HRDLK N+L++ K+++FG+ARAFG+ + VV +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174
Query: 692 IDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751
L+S D++S G + E+ + R + + + L ++L + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER--SLPQPKQPGFFTE 805
+ V ++ ++L +L + + S + Q +F++
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (346), Expect = 4e-36
Identities = 66/306 (21%), Positives = 108/306 (35%), Gaps = 32/306 (10%)
Query: 481 KTDDRQELYSNEKGSSKEEMELPIFDWKTIVDATDNFSEENKLGEGGFGPVYKGMLIE-G 539
K QE +KE+ D F LG G FG V E G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 540 QEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPNK 596
A+K L K + +E NE ++ + LVKL +V EY+
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 597 SLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656
+ + R + I YLH L +I+RDLK N+L+D +
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+++DFG A+ + + T + GT ++PE + ++ D ++ GVL+ E+ +G
Sbjct: 181 QVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 717 RNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPE 776
+ AD + ++ S ++ + LL V
Sbjct: 236 P---PFFADQPIQIYEKIVSGKVRFPS------------HFSSDLKDLLRNLLQVD--LT 278
Query: 777 DRPNML 782
R L
Sbjct: 279 KRFGNL 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALL 564
KT + + + +G G +G V + G ++A+K+L + S + E L
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 565 IAKLQHRNLVKLLGCCTQRDERVLVYE-YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
+ ++H N++ LL T + + YL + + + + L ++ +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
+GL Y+H IIHRDLK N+ ++ + KI DFG+AR Q ++ V T
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTR 182
Query: 684 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
Y +PE ++ + ++ D++S G ++ E+++GK
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 5e-33
Identities = 55/275 (20%), Positives = 114/275 (41%), Gaps = 23/275 (8%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRN 572
D++ KLG G + V++ + I +++ VK L ++ K E ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 573 LVKLLGCCTQRDER--VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
++ L R LV+E++ N + L + + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 631 HHDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPE 689
H + I+HRD+K NV++D+E ++ D+G+A + Q N V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 690 YAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748
+D ++ D++S G ++ ++ K F+H ++ L ++ + + ID
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLS 783
K + I + + + +++S
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-33
Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKSS----GQGVEEFKNEALLIA 566
+NF LG G +G V+ I G+ A+K L K++ + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 567 KLQHR-NLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
++ LV L + L+ +Y+ L + R +G I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
L +LH +L II+RD+K N+LLD+ + ++DFG+++ F D+TE GT Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 686 MSPEYAIDGL--FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743
M+P+ G D +S GVL+ E+++G + D N + ++ P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253
Query: 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP 779
+ S + A IQ + + P+ R
Sbjct: 254 PYPQEMS-------ALAKDLIQ---RLLMKDPKKRL 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-31
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHR 571
+ +G G G V + +A+K+LS+ + + E +L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 572 NLVKLLGCCTQRD------ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIAR 625
N++ LL T + + LV E + + D + +++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGY 685
G+ +LH IIHRDLK SN+++ ++ KI DFG+AR G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 686 MSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
+PE + + D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 508 KTIVDATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALL 564
KTI + + + + +G G +G V + G +AVK+LS+ S + E L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 565 IAKLQHRNLVKLLGCCTQRDERV-LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGI 623
+ ++H N++ LL T YL + + + + + L + +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 624 ARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTY 683
RGL Y+H IIHRDLK SN+ ++ + KI DFG+AR + T T
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TR 182
Query: 684 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGK 716
Y +PE ++ + ++ D++S G ++ E+++G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 7e-27
Identities = 38/212 (17%), Positives = 78/212 (36%), Gaps = 18/212 (8%)
Query: 520 ENKLGEGGFGPVYKGM-LIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLG 578
KLG G F V+ ++ +A+K + E ++E L+ ++ + K
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76
Query: 579 CCTQRDERVLVYEYLPNKSLDYF-------------IFDTTRSKVLDWQNRCHIIGGIAR 625
++L + + + + + + I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 626 GLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGLDQTEANTNRVVGTYG 684
GL Y+H R IIH D+K NVL++ + + +A + + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 685 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK 716
Y SPE + + +D++S L+ E+++G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.6 bits (237), Expect = 3e-23
Identities = 45/202 (22%), Positives = 69/202 (34%), Gaps = 27/202 (13%)
Query: 521 NKLGEGGFGPVYKGMLIEGQEIAVK--RLSKSSGQGV--------EEFKNEALLIAKLQH 570
+GEG V+ + E VK ++ +S + V F A+ A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 571 RNLVKLLGCCTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYL 630
R L KL G VY + N L I +V ++ I +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 631 HHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNR-VVGTYGYMSPE 689
+H I+H DL NVL+ E I DF + G + R V Y S
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 690 YAIDGLFSVKSDVFSFGVLVLE 711
Y + D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 75.0 bits (184), Expect = 6e-17
Identities = 24/134 (17%), Positives = 48/134 (35%), Gaps = 26/134 (19%)
Query: 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPL 82
R+ ++ G+ + A +S ++ + + L ++ T W +N
Sbjct: 1 RNLLTNGEGL-------YAGQSLDVEPYHFIMQEDCNLVLY----DHSTSVWASNTGILG 49
Query: 83 SDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGND 142
+ GN V+ ++ +W+S+ R N V VL E GN+V+
Sbjct: 50 KKGCK-AVLQSDGN---FVVYDAEGRSLWASH-SVRGNGNYVLVLQEDGNVVIY------ 98
Query: 143 NDDPDHFLWQSFDY 156
+W + Y
Sbjct: 99 ----GSDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.3 bits (159), Expect = 2e-13
Identities = 17/97 (17%), Positives = 29/97 (29%), Gaps = 12/97 (12%)
Query: 62 IWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQ 121
I + + L LSM N LVL + + + ++ +
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCN---LVLFDRDDRVWSTNT--AGKGT 66
Query: 122 NPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPS 158
AVL +G + V +W S + S
Sbjct: 67 GCRAVLQPNGRMDVLTNQNI-------AVWTSGNSRS 96
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 58.1 bits (140), Expect = 5e-11
Identities = 28/133 (21%), Positives = 46/133 (34%), Gaps = 27/133 (20%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
+ + G+++ GE + S F L ++ W N
Sbjct: 2 NILYSGETLSTGEFLNYGS--FVFIMQEDCN-----LVLYD----VDKPIWATNTGGL-- 48
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDN 143
RS LSM GN LV+ N +N +W+SN N V +L + N+V+
Sbjct: 49 SRSCFLSMQTDGN---LVVYNPSNKPIWASN-TGGQNGNYVCILQKDRNVVIY------- 97
Query: 144 DDPDHFLWQSFDY 156
W + +
Sbjct: 98 ---GTDRWATGTH 107
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 57.3 bits (138), Expect = 1e-10
Identities = 24/93 (25%), Positives = 31/93 (33%), Gaps = 13/93 (13%)
Query: 62 IWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQ 121
I F G+ + L S +M N LVL +S + VW+SN A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCN---LVLFDS-DVRVWASNTAG--AT 56
Query: 122 NPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSF 154
AVL G LV+ W S
Sbjct: 57 GCRAVLQSDGLLVILTAQNT-------IRWSSG 82
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 53.3 bits (127), Expect = 3e-09
Identities = 20/134 (14%), Positives = 40/134 (29%), Gaps = 25/134 (18%)
Query: 24 DAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLS 83
D ++ G + G ++ + + W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCNLVLYD---------NNRAVWASGTNGKAS 50
Query: 84 DRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDN 143
VL M GN LV+ + + I + +R N +L N+V+ + N
Sbjct: 51 GC--VLKMQNDGN---LVIYSGSRAIWA--SNTNRQNGNYYLILQRDRNVVIYDNSNN-- 101
Query: 144 DDPDHFLWQSFDYP 157
+W +
Sbjct: 102 -----AIWATHTNV 110
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.0 bits (119), Expect = 5e-08
Identities = 19/144 (13%), Positives = 41/144 (28%), Gaps = 29/144 (20%)
Query: 13 LFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTV 72
+F + + +S+ ++ + + + L ++
Sbjct: 4 IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY----DNNNP 50
Query: 73 TWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGN 132
W N + G V++ + N VW S + + A + V VL N
Sbjct: 51 IWATNTGGL--GNGCRAVLQPDGVL---VVITNENVTVWQSPV-AGKAGHYVLVLQPDRN 104
Query: 133 LVVKEKDGNDNDDPDHFLWQSFDY 156
+V+ LW +
Sbjct: 105 VVIY----------GDALWATQTV 118
|
| >d2qfra1 b.1.12.1 (A:9-120) Purple acid phosphatase, N-terminal domain {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Purple acid phosphatase, N-terminal domain family: Purple acid phosphatase, N-terminal domain domain: Purple acid phosphatase, N-terminal domain species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.7 bits (90), Expect = 3e-04
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 4/75 (5%)
Query: 181 SWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSWNG--LHWTGMPQLQPNPVYT 238
SW + D+P S Y + +G + KG YR +++ +H T + +L+ N Y
Sbjct: 37 SWVTMDEPGSSAVRYWSEKNGRKRIA--KGKMSTYRFFNYSSGFIHHTTIRKLKYNTKYY 94
Query: 239 FEFVSNENEVFYRFK 253
+E + F
Sbjct: 95 YEVGLRNTTRRFSFI 109
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.77 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.75 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.59 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.46 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.45 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.19 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.77 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.71 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.58 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.57 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.73 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.38 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.95 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.0 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 88.99 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 88.46 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 85.99 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.92 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 82.34 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.26 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.45 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=406.38 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=198.7
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..++||+|+||+||+|.+.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468888999999999999999988999999999653 3455789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|+|.+++.. ....+++..++.++.|||+||.|||+.+ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998854 3456899999999999999999999988 9999999999999999999999999998764432222
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN-RGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||+|+..| +.... ...+. .....+.. .
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~----~~i~~~~~--~------- 221 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVV----EDISTGFR--L------- 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHH----HHHHHTCC--C-------
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHH----HHHHhcCC--C-------
Confidence 2235789999999999999999999999999999999996544 33211 11111 11111110 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+.....++.+++.+||+.||++||||+||++.|+++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11122234678999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-48 Score=412.65 Aligned_cols=258 Identities=27% Similarity=0.385 Sum_probs=211.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
..++|+..++||+|+||+||+|++.+ ++.||||+++.. ....++|.+|+.++++++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34678889999999999999999865 889999999654 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|..++... ....+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+....+.
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998653 3456899999999999999999999988 9999999999999999999999999999875433
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
... .....|++.|+|||++.+..++.++|||||||++|||++|..|+.... .... .......+ .
T Consensus 170 ~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~----~~~~i~~~---------~ 233 (287)
T d1opja_ 170 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQ----VYELLEKD---------Y 233 (287)
T ss_dssp SEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHH----HHHHHHTT---------C
T ss_pred cee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHH----HHHHHhcC---------C
Confidence 322 223568899999999999999999999999999999999877642211 1111 11111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+...+..+.+|+.+||+.||++||||.||++.|+..
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112222345788999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=406.18 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=201.7
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||+||+|++. ..||||+++.. .....++|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999864 36999998654 44567899999999999999999999999864 56899999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998643 346999999999999999999999987 9999999999999999999999999998875444
Q ss_pred cccccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 672 TEANTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.........||+.|||||++.. ..++.++|||||||+||||+||+.||....... ........+...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~---- 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLS---- 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCC----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----
Confidence 4344445789999999999864 358999999999999999999999975322111 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
+.+ ...+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 110 011222334788999999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=405.91 Aligned_cols=255 Identities=29% Similarity=0.407 Sum_probs=205.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
.++|+..++||+|+||+||+|.+.+++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999988899999999654 3456789999999999999999999998854 5679999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++|+|.+++... ....+++..+++++.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999877432 2335899999999999999999999988 999999999999999999999999999987543322
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
. .....||+.|+|||++.+..++.++|||||||++|||+||..|+.... .... .......+.. .
T Consensus 166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~----~~~~i~~~~~---------~ 229 (272)
T d1qpca_ 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPE----VIQNLERGYR---------M 229 (272)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHH----HHHHHHTTCC---------C
T ss_pred c-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHH----HHHHHHhcCC---------C
Confidence 2 233678999999999999999999999999999999999766532111 1111 1111111110 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+...+..+.+|+.+||+.||++||||.||+++|+.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1112223467889999999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=401.32 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=202.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||+||+|+.. +|+.||||++.... ....+++.+|+.++++++|||||++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999985 48999999996543 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+++|+|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999884 3456999999999999999999999998 99999999999999999999999999998754443
Q ss_pred ccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 673 EANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.......+||+.|||||++.+..+ +.++||||+||++|||++|+.||....... ... ..........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~----~~~~~~~~~~------ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY----SDWKEKKTYL------ 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH----HHHHTTCTTS------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH----HHHhcCCCCC------
Confidence 333445789999999999988876 578999999999999999999985322111 010 1111111000
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.........+.+|+.+||+.||++|||++|+++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112246778999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-48 Score=411.03 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=196.8
Q ss_pred cCCcccCccccCCcccEEEEEEeC-C---eEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..++||+|+||+||+|.+.. + ..||||++... .....++|.+|+.++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 446667899999999999999753 2 35899998654 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++|+|.+++.. ....++|.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998753 2346999999999999999999999988 99999999999999999999999999998754
Q ss_pred Cccccc---cccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 670 DQTEAN---TNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 670 ~~~~~~---~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... .....+|+.|||||.+.+..++.++|||||||++|||+| |+.|+...... .+. .....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~----~~i~~~---- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI----NAIEQD---- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTT----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC----
Confidence 332211 122457899999999999999999999999999999998 89887532211 111 111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.....+...+..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111122233457889999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=394.97 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=210.4
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..++||+|+||+||+|++++++.||||++++.. ...++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788899999999999999999889999999997643 455789999999999999999999999999999999999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|+|..++... ...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999887543 456899999999999999999999988 999999999999999999999999999876543332
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......+|+.|+|||.+.+..++.++|||||||++|||+| |+.|++.....+ .......+.. .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~--~------- 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLR--L------- 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC--C-------
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCC--C-------
Confidence 2233678999999999999999999999999999999998 788875432211 1111221111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+......+.+|+.+||+.||++|||++||++.|..
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1112223467899999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=395.39 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=206.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999964 49999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999988743 35899999999999999999999998 99999999999999999999999999998753322
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~------- 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL------- 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-------
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CC-------
Confidence 223468999999999999999999999999999999999999997532211 111111111111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122346788999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=400.00 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=205.1
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLP 594 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 594 (834)
++|+..++||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578999999999999999999988889999999644 4456789999999999999999999999854 56889999999
Q ss_pred CCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcccc
Q 003272 595 NKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTEA 674 (834)
Q Consensus 595 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 674 (834)
+|+|..++... ....++|..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99999887543 2345999999999999999999999988 999999999999999999999999999876433222
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccccCC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDS 754 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 754 (834)
......||+.|+|||.+.++.++.++|||||||++|||++|..|+..... ...+. .....+. ...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~----~~i~~~~---------~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVL----DQVERGY---------RMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH----HHHHTTC---------CCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHH----HHHHhcC---------CCC
Confidence 22336789999999999999999999999999999999997766432111 11111 1111111 111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCCCCCCC
Q 003272 755 CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERSLPQPK 798 (834)
Q Consensus 755 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~~~~p~ 798 (834)
.+.....++.+++.+||+.||++||+|++|+++|+.......|+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 22223346889999999999999999999999999875444443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=406.82 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=206.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeC------CeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||+||+|++.. ...||||++... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678889999999999999999754 236999998654 344567899999999998 89999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCC--------------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCC
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTR--------------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKA 645 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 645 (834)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999865321 245899999999999999999999988 99999999
Q ss_pred CceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 003272 646 SNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHA 724 (834)
Q Consensus 646 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~ 724 (834)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333344678999999999999999999999999999999998 8999753222
Q ss_pred ccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003272 725 DHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLS 789 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~ 789 (834)
.. .+. .....+ .....+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 273 ~~--~~~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--NFY----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--HHH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHH----HHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 111 111111 111122223457889999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=399.55 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=200.8
Q ss_pred cCCcccCccccCCcccEEEEEEeCC-----eEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
+.|+..++||+|+||+||+|.+... ..||||+++... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577888999999999999998642 469999996543 3445679999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+.++++.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999998877543 356999999999999999999999988 9999999999999999999999999998875
Q ss_pred CCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+...... .. .......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~----~~~~i~~~------ 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE----VMKAINDG------ 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH----HHHHHHTT------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH----HHHHHhcc------
Confidence 43222 2223356899999999999999999999999999999999976664321111 11 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
.....+...+..+.+|+.+||+.||++||+|.||+++|+.+..
T Consensus 230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1112222334578899999999999999999999999987644
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=392.80 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=204.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||+||+|+... ++.||+|++.+. .....+++.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 568899999999999999999854 889999998643 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999998854 345899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~----~~~~i~~~~~------- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---E----TYKRISRVEF------- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HHHHHHTTCC-------
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCC-------
Confidence 2 23467999999999999999999999999999999999999997532211 1 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011122346788999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=397.72 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=197.7
Q ss_pred CccccCCcccEEEEEEeC---CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeecCC
Q 003272 521 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYLPN 595 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 595 (834)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+.++++++|||||+++|+|. .+..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999998754 468999999653 2334578999999999999999999999985 4567899999999
Q ss_pred CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc-c
Q 003272 596 KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE-A 674 (834)
Q Consensus 596 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 674 (834)
|+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999854 346999999999999999999999988 999999999999999999999999999987544332 2
Q ss_pred ccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCccccC
Q 003272 675 NTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLYD 753 (834)
Q Consensus 675 ~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 753 (834)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... . .......+...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~----~~~~i~~~~~~--------- 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERM--------- 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCC---------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H----HHHHHHcCCCC---------
Confidence 2234678999999999999999999999999999999998 89997532211 1 11112221111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 754 SCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 754 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1122234578899999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=396.95 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=204.7
Q ss_pred cCCcccC-ccccCCcccEEEEEEe---CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEEN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~-~LG~G~fg~Vy~g~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|...+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455555 5999999999999864 35679999997543 3456789999999999999999999999864 568999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 2356999999999999999999999988 99999999999999999999999999998754
Q ss_pred Cccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 670 DQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 670 ~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+ ......+...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~----~~~i~~~~~~--- 231 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQGKRM--- 231 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH----HHHHHTTCCC---
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCC---
Confidence 3322 22234578999999999999999999999999999999998 89997533211 11 1122222111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
..+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus 232 ------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122233578899999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=393.24 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=205.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
+.|+..++||+|+||+||+|+.. +++.||||+++.......++|.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56888999999999999999975 48899999998777777789999999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++|+|..++... ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999987542 346999999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccccccccccccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccC
Q 003272 674 ANTNRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELID 748 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~-----~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 748 (834)
.......||+.|+|||++. +..|+.++|||||||++|||++|+.||....... .. ..........+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~----~~i~~~~~~~~~- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL----LKIAKSEPPTLA- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH----HHHHHSCCCCCS-
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH----HHHHcCCCCCCC-
Confidence 1223468999999999984 4568999999999999999999999975332211 11 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 749 KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 749 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346788999999999999999999965
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=395.16 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=194.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEe--CCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ--RDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 589 (834)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999975 48999999997543 3445679999999999999999999999865 4558999
Q ss_pred EeecCCCChhhHhhccC-CCCCCCHHhHHHHHHHHHHHHHHhhhcCC--CceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 590 YEYLPNKSLDYFIFDTT-RSKVLDWQNRCHIIGGIARGLLYLHHDSR--LRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885432 34569999999999999999999998752 3599999999999999999999999999998
Q ss_pred cCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 667 FGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+..+.. ......||+.|||||++.+..++.++|||||||++|||++|+.||...... . .......+....+
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~----~~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E----LAGKIREGKFRRI 234 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H----HHHHHHHTCCCCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---H----HHHHHHcCCCCCC
Confidence 753322 223478999999999999999999999999999999999999997532211 1 1112222222111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
+......+.+|+.+||+.||++|||+.|+++
T Consensus 235 ---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122346788999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-46 Score=399.66 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=212.7
Q ss_pred HHHHhcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEe
Q 003272 510 IVDATDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ 582 (834)
Q Consensus 510 ~~~~~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 582 (834)
++...++|+..++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++||||+++++++..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999974 35789999997543 3346789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChhhHhhccCC---------------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEec
Q 003272 583 RDERVLVYEYLPNKSLDYFIFDTTR---------------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHR 641 (834)
Q Consensus 583 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 641 (834)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 9999999999999999999864321 234899999999999999999999988 9999
Q ss_pred cCCCCceeecCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCC
Q 003272 642 DLKASNVLLDNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR-NRG 720 (834)
Q Consensus 642 DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~-p~~ 720 (834)
||||+||||+.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||++|||++|.. |+.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987654444444445678899999999999999999999999999999999964 543
Q ss_pred CCCcccccchhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 721 FYHADHRHNLLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
..... . .......+.... .+...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 245 ~~~~~---e----~~~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE---E----VIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH---H----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH---H----HHHHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22111 1 111222222111 12223347889999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=394.77 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=201.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56899999999999999999975 4899999999653 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999888753 346999999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~----~~~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YL----IFQKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHHHHHTTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HH----HHHHHHcCCC-------
Confidence 444444457899999999999999999999999999999999999999753211 11 1111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVV 785 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~ 785 (834)
..+......+.+|+.+||+.||++|||++|++
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 01112234678899999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=399.51 Aligned_cols=198 Identities=27% Similarity=0.364 Sum_probs=175.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
.++|+..++||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+.++++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 48999999997543 3445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+||||++++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 99999999998643 4589999999999999999999974 6 99999999999999999999999999987532
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 721 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~ 721 (834)
......+||+.|+|||++.+.+|+.++||||+||++|||++|+.||..
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 222346899999999999999999999999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=381.59 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=194.7
Q ss_pred cccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe----CCeeEEEE
Q 003272 518 SEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ----RDERVLVY 590 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 590 (834)
+..++||+|+||+||+|+... ++.||+|++... .....+.|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999999864 889999998654 33456789999999999999999999999865 34579999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec-CCCCeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DfGla~~~~~ 669 (834)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999854 346899999999999999999999875 4599999999999996 578999999999986532
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
.. .....||+.|||||++.+ .++.++|||||||++|||++|+.||...... .........+.....+
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~-- 234 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF-- 234 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG--
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCccc--
Confidence 22 234689999999998865 6999999999999999999999997522111 1111122221111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.... ...+.+|+.+||+.||++|||+.|+++
T Consensus 235 --~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 --DKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 235778999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-45 Score=392.26 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=189.3
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC-CeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
..++|+..++||+|+||+||+|+... ++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34679999999999999999999754 8899999997543 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec---CCCCeEEeeecccccc
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAF 667 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~ 667 (834)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999853 456999999999999999999999998 99999999999994 5789999999999876
Q ss_pred CCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||...... . ...........
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~----~~~~i~~~~~~--- 227 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---K----LFEQILKAEYE--- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H----HHHHHHTTCCC---
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---H----HHHHHhccCCC---
Confidence 4322 223467999999999999999999999999999999999999997532111 1 11111111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
............+.+|+.+||+.||++|||+.|+++
T Consensus 228 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 001111122346788999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-45 Score=393.66 Aligned_cols=245 Identities=29% Similarity=0.426 Sum_probs=199.6
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc---ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG---QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
+.|+..++||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999975 488999999975432 34467899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|+.++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999999776643 356999999999999999999999998 999999999999999999999999999875322
Q ss_pred ccccccccccccccccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~---~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... .... ............
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~-~~i~~~~~~~~~ 235 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSAL-YHIAQNESPALQ 235 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH-HHHHHSCCCCCS
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHhCCCCCCC
Confidence 23679999999999864 4689999999999999999999999753211 1111 111111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ......+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 112346788999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=391.05 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=201.1
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce----EEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
++|+..++||+|+||+||+|.+.. |+ .||||+++.. .....++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358899999999999999998743 43 5899998654 445678899999999999999999999999865 5678
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
++||+.+++|.+++.. ....+++..+++++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999887754 3456999999999999999999999988 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
............||+.|+|||++.++.++.++|||||||++|||+| |+.|++...... +.. ....+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~----- 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE----- 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTC-----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCC-----
Confidence 5544444445678999999999999999999999999999999998 788865332211 111 111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
....+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 231 ----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1111222345788999999999999999999999988654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=389.12 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=199.7
Q ss_pred HhcCCcccCccccCCcccEEEEEEeC------CeEEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCC
Q 003272 513 ATDNFSEENKLGEGGFGPVYKGMLIE------GQEIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRD 584 (834)
Q Consensus 513 ~~~~~~~~~~LG~G~fg~Vy~g~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 584 (834)
..++|+..++||+|+||.||+|++.. ++.||||+++.. .....+++.+|...+.++ +|+||+.+++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34679999999999999999999743 468999999754 334556788888888877 7899999999987654
Q ss_pred -eeEEEEeecCCCChhhHhhccC-------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 585 -ERVLVYEYLPNKSLDYFIFDTT-------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 585 -~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 6899999999999999986432 1345899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR-NRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~-p~~~~~~~~~~~ 729 (834)
++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. |+.......
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--- 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--- 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999998755544444455789999999999999999999999999999999999754 553221111
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
........+.... .+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 245 ---~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 ---EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ---HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111112221111 1112234678999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-44 Score=391.98 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=206.9
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|++.++||+|+||.||+|+.. .|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999975 4999999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec--CCCCeEEeeeccccccCCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DfGla~~~~~~ 670 (834)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999988843 2346999999999999999999999998 99999999999996 4678999999999887533
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...... ... ......... ....
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~~~~~--~~~~ 247 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL----RNVKSCDWN--MDDS 247 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCC--SCCG
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCC--CCcc
Confidence 22 23368999999999999999999999999999999999999997532211 111 111111110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.. ......+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GG----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1122467889999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=380.21 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=196.1
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-CeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-DERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 593 (834)
++|+..++||+|+||.||+|++ .|..||||+++.. ...++|.+|+.++++++||||++++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4677888999999999999998 6889999999653 3457899999999999999999999999764 5689999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++|+|.+++... ....++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999998643 2335899999999999999999999987 999999999999999999999999999875322
Q ss_pred cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCcccccCcccc
Q 003272 674 ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSLY 752 (834)
Q Consensus 674 ~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 752 (834)
.....++..|+|||++.+..++.++|||||||++|||+| |+.|+...... .+. .....+. .
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~----~~i~~~~---------~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEKGY---------K 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTTTC---------C
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCC---------C
Confidence 223567889999999999999999999999999999998 67765432211 111 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 753 DSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 753 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
...+.....++.+|+.+||+.||++||||.||+++|+.+
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112222334778999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=387.36 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=210.3
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCe
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 585 (834)
.++|+..++||+|+||.||+|++. .++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888999999999999999863 35789999997643 34556799999999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhHhhccC---------------CCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 586 RVLVYEYLPNKSLDYFIFDTT---------------RSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
.++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986543 1235899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRN-RGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p-~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+++..| +.......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--- 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999987654444444557899999999999999999999999999999999995544 33221111
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
. .......+ .....+...+..+.+|+.+||+.||++||||.||+++|++.
T Consensus 256 ~---~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 K---FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp H---HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 11111111 11111222335788999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-44 Score=388.20 Aligned_cols=256 Identities=22% Similarity=0.259 Sum_probs=208.1
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEeec
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEYL 593 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 593 (834)
++|+..++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 49999999997766556678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec--CCCCeEEeeeccccccCCCc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DfGla~~~~~~~ 671 (834)
++|+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999877632 3346999999999999999999999988 99999999999998 67899999999999875432
Q ss_pred cccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ......... .
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~----~~i~~~~~~------~ 247 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL----QNVKRCDWE------F 247 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHHCCCC------C
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCC------C
Confidence 2 23367899999999999999999999999999999999999997532211 111 111111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL--MLSGE 791 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 791 (834)
...........+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11111122346788999999999999999999987 35543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=385.50 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=207.6
Q ss_pred hcCCcccCccccCCcccEEEEEEeC--------CeEEEEEEecccC-cccHHHHHHHHHHHHhc-cCCceeeEEEEEEeC
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKSS-GQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQR 583 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 583 (834)
.++|+..++||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678889999999999999998643 3479999997654 34557889999999988 899999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCC-------------CCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceee
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTR-------------SKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLL 650 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 650 (834)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964321 245899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccc
Q 003272 651 DNEMNPKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHN 729 (834)
Q Consensus 651 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 729 (834)
+.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |+.|+......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999998765544444555788999999999999999999999999999999998 67776432211
Q ss_pred hhHHHHHHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 730 LLGHAWQLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
........+... ..+...+.++.+|+.+||+.||++|||+.||+++|+++.
T Consensus 245 ---~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ---ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 122222222111 111222346889999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=379.39 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=195.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 588 (834)
.++|+..++||+|+||.||+|++.. +..||||+++.. .....+.|.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678899999999999999998743 457999998654 3344578999999999999999999999985 467899
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccC
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 668 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~ 668 (834)
||||+++|+|..++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988754 2356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccccc
Q 003272 669 LDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI 747 (834)
Q Consensus 669 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |.+|+...... .+. .....+...
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~----~~i~~~~~~--- 228 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH----HHHHTTCCC---
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCC---
Confidence 33222 2334678999999999999999999999999999999998 88886543221 111 111221111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 748 DKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 748 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222334688999999999999999999999988753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=386.69 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=202.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-Ce--EEEEEEeccc-CcccHHHHHHHHHHHHhc-cCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKS-SGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|++++.++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999999865 43 5788888643 344567899999999998 799999999999999999999
Q ss_pred EeecCCCChhhHhhcc-------------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCe
Q 003272 590 YEYLPNKSLDYFIFDT-------------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNP 656 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 656 (834)
|||+++|+|.++++.. .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCcccccchhHHHH
Q 003272 657 KISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKR-NRGFYHADHRHNLLGHAW 735 (834)
Q Consensus 657 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~ 735 (834)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+..... .. ..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~----~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE----LY 236 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH----HH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HH----HH
Confidence 999999998653222 2233578999999999999999999999999999999999765 4432111 11 11
Q ss_pred HHhhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 736 QLWIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 736 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.....+. ....+......+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 237 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111111 11112223347889999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=380.30 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=195.0
Q ss_pred cCCcccCccccCCcccEEEEEEeC----CeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE----GQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~----g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++|+..++||+|+||.||+|++.. ...||||++++. .....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998743 247899998653 33456789999999999999999999999965 5678
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++|++.+.+... ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999998877542 346999999999999999999999988 999999999999999999999999999987
Q ss_pred CCCccc-cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcccccchhHHHHHHhhccCccc
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVS-GKRNRGFYHADHRHNLLGHAWQLWIQDRPAE 745 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ . .......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~---~~~i~~~~~--- 232 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LHKIDKEGE--- 232 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTSCC---
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---H---HHHHHhCCC---
Confidence 544332 22334567889999999999999999999999999999998 899875322111 1 111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 003272 746 LIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSG 790 (834)
Q Consensus 746 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~ 790 (834)
....+...+..+.+|+.+||+.||++||||.||+++|++
T Consensus 233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 011112223468899999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=387.73 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=211.5
Q ss_pred hcCCcccCccccCCcccEEEEEEe------CCeEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI------EGQEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|...++||+|+||+||+|.+. .++.||||+++.. .......|.+|+.++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999874 2578999999754 334456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhcc-------CCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 587 VLVYEYLPNKSLDYFIFDT-------TRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
++||||+++|+|.+++... .....+++..+.+++.|||+||.|||+.+ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999987532 22345799999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcccccchhHHHHHHh
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGK-RNRGFYHADHRHNLLGHAWQLW 738 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 738 (834)
|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++|. .|+..... . ......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~----~~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---E----QVLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---H----HHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---H----HHHHHH
Confidence 999998875544444444567899999999999999999999999999999999986 45432111 1 111112
Q ss_pred hccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCC
Q 003272 739 IQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGERS 793 (834)
Q Consensus 739 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~~ 793 (834)
..+.... .+...+..+.+|+.+||+.||++||||.+|+++|+...+
T Consensus 249 ~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2221111 111223468899999999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=375.96 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=203.4
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC------cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS------GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDER 586 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 586 (834)
.++|+..++||+|+||+||+|+.. +|+.||||++++.. ....+.|.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999985 48999999986532 23467899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC----CeEEeeec
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM----NPKISDFG 662 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DfG 662 (834)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999854 346999999999999999999999998 99999999999998776 49999999
Q ss_pred cccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 663 MARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 663 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .........
T Consensus 163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~----~~~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---E----TLANVSAVN 232 (293)
T ss_dssp TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHTTC
T ss_pred hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---H----HHHHHHhcC
Confidence 9988743322 23367899999999999999999999999999999999999997532111 1 111111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ........ ....+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YE--FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC--CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC--CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000011 1236778999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=383.68 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=198.0
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHH--HHHHHHhccCCceeeEEEEEEeCC----eeEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKN--EALLIAKLQHRNLVKLLGCCTQRD----ERVL 588 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~l 588 (834)
++|...++||+|+||.||+|++ +|+.||||+++... .+++.. |+..+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567788999999999999997 78999999996432 234444 455556789999999999998754 5789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC-----CCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS-----RLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
||||+++|+|..++.. ..++|..+++++.|+|.||+|||+.. ..+|+||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999954 35899999999999999999999751 34699999999999999999999999999
Q ss_pred ccccCCCccc--cccccccccccccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCccccc-------
Q 003272 664 ARAFGLDQTE--ANTNRVVGTYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRH------- 728 (834)
Q Consensus 664 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~------~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~------- 728 (834)
++........ .......||+.|+|||++.+.. ++.++|||||||+||||++|..|+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9887443222 2233478999999999987643 677999999999999999998876432211110
Q ss_pred -chhHHHHHHhhccCcccccCccccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 729 -NLLGHAWQLWIQDRPAELIDKSLYDS-CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 729 -~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
............+ ..++.+... .+.+.+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011111111111 112221111 1233456688999999999999999999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=380.07 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=204.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..+.||+|+||.||+++.. +|+.||||++++. .....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57899999999999999999974 4999999999754 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999998854 346889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|++||...... .+ ........+.
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~----~~~i~~~~~~------ 223 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEIR------ 223 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCCC------
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HH----HHHHhcCCCC------
Confidence 22 233478999999999999999999999999999999999999997532211 11 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
.+......+.+|+.+||+.||++||+ ++|+++
T Consensus 224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11122346788999999999999995 788875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=379.55 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=201.2
Q ss_pred cCccccCCcccEEEEEEeCC----eEEEEEEeccc-CcccHHHHHHHHHHHHhccCCceeeEEEEEEeC-CeeEEEEeec
Q 003272 520 ENKLGEGGFGPVYKGMLIEG----QEIAVKRLSKS-SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-DERVLVYEYL 593 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E~~ 593 (834)
.++||+|+||+||+|++.+. ..||||+++.. .....++|.+|++++++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 45899999999999997542 35899999753 445668899999999999999999999998765 5789999999
Q ss_pred CCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCccc
Q 003272 594 PNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQTE 673 (834)
Q Consensus 594 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 673 (834)
++|+|.+++.. ....+++..+++++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998854 3445788999999999999999999988 999999999999999999999999999987543322
Q ss_pred --cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCccc
Q 003272 674 --ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKSL 751 (834)
Q Consensus 674 --~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 751 (834)
.......||+.|+|||.+....++.++||||||+++|||++|+.|+...... ..+.. ....+... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~----~i~~g~~~--~---- 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV----YLLQGRRL--L---- 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCC--C----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH----HHHcCCCC--C----
Confidence 1223357899999999999999999999999999999999988875432111 11111 11111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 003272 752 YDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGER 792 (834)
Q Consensus 752 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~~ 792 (834)
.+......+.+|+.+||+.||++||+|.||++.|+.+.
T Consensus 255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122346788999999999999999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-43 Score=377.19 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=202.7
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56889999999999999999975 4899999999653 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888753 345788999999999999999999998 999999999999999999999999999886432
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i~~~~~------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAEL------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHCCC-------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHHHHcCCC-------
Confidence 22368999999999999999999999999999999999999997532111 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||.+|| +++|+++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01112234678899999999999996 8999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-43 Score=368.36 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=199.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC---cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCe----
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS---GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDE---- 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 585 (834)
.++|++.+.||+|+||+||+|+.. .|+.||||+++... ....++|.+|+.++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 59999999997543 3345679999999999999999999999876543
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||+++++|..++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988754 346899999999999999999999988 9999999999999999999999999988
Q ss_pred ccCCCcc-ccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 666 AFGLDQT-EANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 666 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence 7643322 2223346799999999999999999999999999999999999999753221 11111111111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcc
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-NMLSVVLMLSG 790 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~ev~~~L~~ 790 (834)
. ..... ..+..+.+++.+||+.||++|| +++++++.|..
T Consensus 234 ~---~~~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 P---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp G---GGTSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred C---chhcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 00111 1234678899999999999999 89999888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-42 Score=377.34 Aligned_cols=244 Identities=21% Similarity=0.232 Sum_probs=203.1
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc---CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS---SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 590 (834)
++|+..++||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|+.+++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 4999999998643 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLD 670 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~ 670 (834)
||+.+|+|..++... ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999888543 45899999999999999999999998 999999999999999999999999999986432
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ...+ ..........
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~----~~~i~~~~~~------ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQI----YEKIVSGKVR------ 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHHCCCC------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHH----HHHHhcCCCC------
Confidence 223679999999999999999999999999999999999999975321 1111 1111111110
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
.+......+.+++.+||+.||.+|+ +++|+++
T Consensus 257 ----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112234678899999999999994 8999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-42 Score=365.02 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=202.2
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc---------ccHHHHHHHHHHHHhcc-CCceeeEEEEEEeC
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG---------QGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQR 583 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 583 (834)
++|+..++||+|+||+||+++.. +|+.||||++++... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 589999999975421 12346889999999997 99999999999999
Q ss_pred CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecc
Q 003272 584 DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 663 (834)
Q Consensus 584 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGl 663 (834)
+..++||||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999954 346999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHH
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQL 737 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 737 (834)
++.+..... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||...... .....
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~ 226 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRM 226 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHH
Confidence 998754322 233679999999999863 35788999999999999999999997532211 11111
Q ss_pred hhccCcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 738 WIQDRPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 738 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+... .. ..........+.+++.+||+.||++||++.||++
T Consensus 227 i~~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222111 00 1111122347889999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=371.40 Aligned_cols=257 Identities=23% Similarity=0.274 Sum_probs=194.2
Q ss_pred ccCccccCCcccEEEEEEeC-CeEEEEEEecccCc-----ccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 519 EENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSG-----QGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 519 ~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
..++||+|+||+||+|+... |+.||||+++.... ...+.+.+|+.++++++|||||++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 35689999999999999754 89999999865422 1235789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
++++++..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998776665 23456899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCccccc----
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELI---- 747 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 747 (834)
. .....||+.|+|||++... .++.++|||||||++|||++|+.||......+ ..................
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhc
Confidence 2 2236799999999998754 68999999999999999999999875332211 111111111110000000
Q ss_pred --Cc---cccCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 748 --DK---SLYDSCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 748 --d~---~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.. ......+. .....+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00001111 12346788999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-42 Score=378.95 Aligned_cols=248 Identities=24% Similarity=0.290 Sum_probs=196.3
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHH---HHHHHhccCCceeeEEEEEEeCCeeE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNE---ALLIAKLQHRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~ 587 (834)
++|++.++||+|+||.||+|+... |+.||||++.+. .......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999754 899999998643 12233344444 56666778999999999999999999
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
+||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999854 345889999999999999999999998 999999999999999999999999999976
Q ss_pred CCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccc
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAEL 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||....... ... ........ ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~-~~~~~~~~-~~-- 226 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHE-IDRMTLTM-AV-- 226 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHH-HHHHSSSC-CC--
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHH-HHHhcccC-CC--
Confidence 4332 234679999999999975 568999999999999999999999986432221 110 11110000 00
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003272 747 IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPN-----MLSVVL 786 (834)
Q Consensus 747 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~ev~~ 786 (834)
..+......+.+|+.+||+.||++||| ++|+++
T Consensus 227 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011112336788999999999999999 688864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=375.98 Aligned_cols=247 Identities=27% Similarity=0.392 Sum_probs=200.7
Q ss_pred cCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc---CcccHHHHHHHHHHHH-hccCCceeeEEEEEEeCCeeEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS---SGQGVEEFKNEALLIA-KLQHRNLVKLLGCCTQRDERVLV 589 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 589 (834)
++|+..++||+|+||+||+|+... ++.||||++++. .....+.+..|..++. .++|||||++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578999999999999999999864 899999999753 2344566777777665 68999999999999999999999
Q ss_pred EeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCC
Q 003272 590 YEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGL 669 (834)
Q Consensus 590 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~ 669 (834)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999854 345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCc
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDK 749 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 749 (834)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ......+.+
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~----~~~i~~~~~------ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL----FHSIRMDNP------ 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC------
Confidence 322 233468999999999999999999999999999999999999997532211 11 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 003272 750 SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNML-SVVL 786 (834)
Q Consensus 750 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-ev~~ 786 (834)
. .+......+.+|+.+||+.||++||++. |+++
T Consensus 221 ~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 1111234678899999999999999995 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=368.92 Aligned_cols=251 Identities=18% Similarity=0.253 Sum_probs=202.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
.++|++.++||+|+||+||+|... +++.||||+++... .....+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999985 48899999996543 3345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCC--CCeEEeeeccccccCCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGLD 670 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DfGla~~~~~~ 670 (834)
+++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2336899999999999999999999988 9999999999999854 58999999999876433
Q ss_pred ccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcccccCcc
Q 003272 671 QTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPAELIDKS 750 (834)
Q Consensus 671 ~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 750 (834)
.. .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... . ........... ++..
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~----~~~~i~~~~~~--~~~~ 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---Q----IIENIMNAEYT--FDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HHHHHHHTCCC--CCHH
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHhCCCC--CChh
Confidence 22 23367899999999999999999999999999999999999997532211 1 11111111110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 751 LYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 751 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..... ...+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 235788999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=364.52 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=198.4
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||+||+|+.. .|+.||||+++... ....+++.+|+.++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 48999999996542 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
|+.++.+..... .....+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765544432 23456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC------cc
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR------PA 744 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~ 744 (834)
. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||....... ............. ..
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccc
Confidence 2 223367999999999987765 5889999999999999999999975322111 1111111100000 00
Q ss_pred cccCc--cc--cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDK--SL--YDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~--~l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+. .. ..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 00 00000 111246788999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=368.04 Aligned_cols=250 Identities=20% Similarity=0.195 Sum_probs=195.1
Q ss_pred hcCCcccC-ccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhc-cCCceeeEEEEEEe----CCee
Q 003272 514 TDNFSEEN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKL-QHRNLVKLLGCCTQ----RDER 586 (834)
Q Consensus 514 ~~~~~~~~-~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~ 586 (834)
.++|.+.. .||+|+||+||+|+.. +++.||||+++. .+.+.+|+.++.++ +|||||++++++.. ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 5999999999999974 489999999854 25678899887655 89999999999865 3568
Q ss_pred EEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC---CCCeEEeeecc
Q 003272 587 VLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM 663 (834)
Q Consensus 587 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DfGl 663 (834)
++|||||++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998642 2346999999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
|+....... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~------- 227 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKT------- 227 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHH-------
Confidence 988654322 2346899999999999999999999999999999999999999753221110 000000
Q ss_pred ccccCccccCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 744 AELIDKSLYDS--CSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
.+........ .......++.+|+.+||+.||++|||+.|+++
T Consensus 228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000000 01122357889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-42 Score=362.97 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=200.5
Q ss_pred cCCcccCccccCCcccEEEEEEeCCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||+||+|+..+|+.||||+++.. .....+++.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999988999999999654 334467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCcc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQT 672 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~~ 672 (834)
+.++.+..+.. ..+.+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 99887777653 3467999999999999999999999988 99999999999999999999999999988643322
Q ss_pred ccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc------c
Q 003272 673 EANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA------E 745 (834)
Q Consensus 673 ~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 745 (834)
......+++.|+|||.+.+. .++.++|||||||+++||++|+.||...... ................ .
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence 22335688999999999764 5799999999999999999999997532211 1111111111110000 0
Q ss_pred c---------cCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 746 L---------IDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 746 ~---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ..+.............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000001111122346788999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=359.13 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=193.1
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCc------ccHHHHHHHHHHHHhcc--CCceeeEEEEEEeCCe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSG------QGVEEFKNEALLIAKLQ--HRNLVKLLGCCTQRDE 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 585 (834)
++|++.++||+|+||+||+|+.. +|+.||||++++... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 489999999865321 12244678999999996 8999999999999999
Q ss_pred eEEEEeecCC-CChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-CCCeEEeeecc
Q 003272 586 RVLVYEYLPN-KSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-EMNPKISDFGM 663 (834)
Q Consensus 586 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DfGl 663 (834)
.++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 566666643 346899999999999999999999998 999999999999985 47999999999
Q ss_pred ccccCCCccccccccccccccccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 664 ARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 664 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ......
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~ 220 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ 220 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc
Confidence 98754322 234679999999999987765 567999999999999999999975311 001111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
. ...... ...+.+++.+||+.||++|||++|+++
T Consensus 221 ~------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 111122 246788999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=360.75 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=195.8
Q ss_pred hcCCcccCccccCCcccEEEEEEe-C-CeEEEEEEecccC--cccHHHHHHHHHHHHhc---cCCceeeEEEEEEe----
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-E-GQEIAVKRLSKSS--GQGVEEFKNEALLIAKL---QHRNLVKLLGCCTQ---- 582 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 582 (834)
.++|+..++||+|+||+||+|+.. . ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 6789999986532 22334566777777666 79999999999853
Q ss_pred -CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeee
Q 003272 583 -RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDF 661 (834)
Q Consensus 583 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~Df 661 (834)
....+++|||++++++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 245799999999987765443 24456899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc
Q 003272 662 GMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD 741 (834)
Q Consensus 662 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ............
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 999875432 22334789999999999999999999999999999999999999985432211 111111111000
Q ss_pred Ccc----------cccCc---cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 742 RPA----------ELIDK---SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 742 ~~~----------~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
... ..... .............+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000 0000111112346778999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=360.46 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=193.5
Q ss_pred CCcccCccccCCcccEEEEEEeC-CeEEEEEEecccCcccHHHHHHHHHHHHhccCCceeeEEEEEEeC------CeeEE
Q 003272 516 NFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------DERVL 588 (834)
Q Consensus 516 ~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 588 (834)
+|+..++||+|+||+||+|+... |+.||||++..... .+.+|+.++++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57788899999999999999864 89999999965432 234799999999999999999998643 24789
Q ss_pred EEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeecccccc
Q 003272 589 VYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF 667 (834)
Q Consensus 589 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~ 667 (834)
||||++++.+..+.........+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999998765555443344567999999999999999999999988 99999999999999775 8999999999877
Q ss_pred CCCccccccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH----------HHH
Q 003272 668 GLDQTEANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH----------AWQ 736 (834)
Q Consensus 668 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~----------~~~ 736 (834)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +... .+.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhh
Confidence 44322 223678999999998875 4789999999999999999999999854322111 1100 001
Q ss_pred Hhhcc----CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 737 LWIQD----RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 737 ~~~~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
..... .....................+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10000 000000000001111122346788999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=354.40 Aligned_cols=265 Identities=21% Similarity=0.299 Sum_probs=196.0
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEe--------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQ-------- 582 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 582 (834)
.++|+..++||+|+||+||+|+.. +|+.||||++... .....+++.+|+.++++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 5999999998543 33456788999999999999999999999855
Q ss_pred CCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeec
Q 003272 583 RDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFG 662 (834)
Q Consensus 583 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfG 662 (834)
....++||||+..+.+.... .....++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999988776554 33456889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhh
Q 003272 663 MARAFGLDQTE--ANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWI 739 (834)
Q Consensus 663 la~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++.+...... .......||+.|+|||++.+. .++.++||||+||+++||++|+.||........ .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcC
Confidence 99876543222 122235799999999998765 689999999999999999999999753222111 111111111
Q ss_pred cc--C-cccc--------cCccccCCCCHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 740 QD--R-PAEL--------IDKSLYDSCSLSE-------AIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 740 ~~--~-~~~~--------~d~~l~~~~~~~~-------~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
.. . .... ............. ...+++|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0 0000 0000000111111 2355689999999999999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=347.44 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=195.3
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 592 (834)
++|+..++||+|+||.||+|+.. +|+.||||++..... .+++..|++++++++|+|+ +.+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999974 489999999865433 2467899999999987665 4555666778889999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeec---CCCCeEEeeeccccccCC
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGL 669 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DfGla~~~~~ 669 (834)
+.+ ++...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 955 55444432 2356899999999999999999999998 99999999999985 456799999999998743
Q ss_pred Cccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc
Q 003272 670 DQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA 744 (834)
Q Consensus 670 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 12234679999999999999999999999999999999999999986543332222111111111111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 745 ELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 745 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
. +.... +.++.+++..||+.+|++||++.++.+.|+..
T Consensus 239 ~-----~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 V-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp H-----HTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred H-----hccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1 11112 23678899999999999999999999888753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=344.14 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=202.4
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCCeeEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 591 (834)
++|+..++||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 4889999998654 23456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccccccCCCc
Q 003272 592 YLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGLDQ 671 (834)
Q Consensus 592 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~~~~~ 671 (834)
++.+++|..++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888774 3456889999999999999999999988 9999999999999999999999999999875433
Q ss_pred cccccccccccccccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc------c
Q 003272 672 TEANTNRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP------A 744 (834)
Q Consensus 672 ~~~~~~~~~gt~~y~APE~~~~~~-~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ 744 (834)
.. .....+++.|+|||.+.... ++.++||||+||+++||++|+.|+... ................... .
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC--CCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 22 22356778999999988765 689999999999999999999996321 1111111111111111000 0
Q ss_pred cccCc---------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 745 ELIDK---------SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 745 ~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...+. .-...........+.+|+.+||+.||++|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001111222346778999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=351.85 Aligned_cols=264 Identities=21% Similarity=0.304 Sum_probs=195.7
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC-cccHHHHHHHHHHHHhccCCceeeEEEEEEeCC----eeE
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS-GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD----ERV 587 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 587 (834)
+++|+..++||+|+||+||+|+.. +|+.||||++++.. ....+++++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999874 59999999997543 344678999999999999999999999996653 345
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccccc
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 667 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~~ 667 (834)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66677789999999853 35899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCcc-
Q 003272 668 GLDQTE-ANTNRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRPA- 744 (834)
Q Consensus 668 ~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 744 (834)
...... .......||+.|+|||++.. ..++.++||||+||+++||++|+.||......+. ..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 443222 22344679999999999854 5678999999999999999999999754322111 00000000000000
Q ss_pred ----------c-ccCccccCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003272 745 ----------E-LIDKSLYDSCSL-----SEAIRCIQVGLLCVQQIPEDRPNMLSVVLM 787 (834)
Q Consensus 745 ----------~-~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~ 787 (834)
. ..........+. ....++.+|+.+||+.||++|||+.|+++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000000011 112357889999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=351.08 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=193.3
Q ss_pred hcCCcccCccccCCcccEEEEEEeC-CeEEEEEEeccc--CcccHHHHHHHHHHHHhccCCceeeEEEEEEeCC------
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS--SGQGVEEFKNEALLIAKLQHRNLVKLLGCCTQRD------ 584 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 584 (834)
.++|+..++||+|+||+||+|.... |+.||||+++.. .....+++.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3689999999999999999999754 999999999753 3344568899999999999999999999997655
Q ss_pred eeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeeccc
Q 003272 585 ERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 664 (834)
Q Consensus 585 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla 664 (834)
..++||||+ +.+|..+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 456766653 345999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhcc--
Q 003272 665 RAFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQD-- 741 (834)
Q Consensus 665 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 741 (834)
+..... .....||+.|+|||++.+. .++.++||||+||+++||++|+.|+........ + ..........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~-~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--L-KEIMKVTGTPPA 240 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--H-HHHHhccCCCcH
Confidence 876432 2336789999999998764 578999999999999999999999754322111 0 0000000000
Q ss_pred ----------------CcccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccCC
Q 003272 742 ----------------RPAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLM--LSGER 792 (834)
Q Consensus 742 ----------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~--L~~~~ 792 (834)
...+.....+ ..........+.+|+.+||+.||++|||+.|+++- ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000 01111122356789999999999999999999873 55443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.7e-39 Score=340.05 Aligned_cols=260 Identities=17% Similarity=0.199 Sum_probs=203.1
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhccC-CceeeEEEEEEeCCeeEEEEee
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH-RNLVKLLGCCTQRDERVLVYEY 592 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~ 592 (834)
++|++.++||+|+||+||+|+.. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 67999999999999999999975 48999999886543 22457889999999965 8999999999999999999999
Q ss_pred cCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecC-----CCCeEEeeecccccc
Q 003272 593 LPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF 667 (834)
Q Consensus 593 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DfGla~~~ 667 (834)
+ +++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 8 67888877542 346899999999999999999999998 999999999999974 578999999999986
Q ss_pred CCCccc-----cccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccC
Q 003272 668 GLDQTE-----ANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDR 742 (834)
Q Consensus 668 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...... .......||+.|||||++.+..++.++||||||+++|||++|+.|+.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 432211 122346799999999999999999999999999999999999999864333222111111111111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 003272 743 PAELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVLMLSGE 791 (834)
Q Consensus 743 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~~L~~~ 791 (834)
..++ ....+ .++.+++..|++.+|++||+++.+.+.|+..
T Consensus 237 ~~~l-----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 237 LREL-----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHH-----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHHh-----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111 12222 3577899999999999999999998888654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=345.56 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=199.6
Q ss_pred cCCcccCccccCCcccEEEEEEe----CCeEEEEEEeccc----CcccHHHHHHHHHHHHhccC-CceeeEEEEEEeCCe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI----EGQEIAVKRLSKS----SGQGVEEFKNEALLIAKLQH-RNLVKLLGCCTQRDE 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 585 (834)
++|+..++||+|+||+||+|... .|+.||||++++. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999862 3789999998653 22345678899999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.+++|||+.+|+|..++... ..++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999988543 35678889999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP 743 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
.+....... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||....... ..............
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHCCC
T ss_pred hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccCCC
Confidence 765433322 2346799999999999764 47889999999999999999999975432222 11111111111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003272 744 AELIDKSLYDSCSLSEAIRCIQVGLLCVQQIPEDRP-----NMLSVVL 786 (834)
Q Consensus 744 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~ev~~ 786 (834)
..+......+.+++.+||+.||++|| +++|+++
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11122334788899999999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-39 Score=345.97 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=194.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeC--CeeEEEE
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQR--DERVLVY 590 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 590 (834)
++|++.++||+|+||+||+|+.. .|+.||||+++.. ..+++.+|+.++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999974 4899999999643 3467899999999995 99999999998754 4689999
Q ss_pred eecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCC-CeEEeeeccccccCC
Q 003272 591 EYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGL 669 (834)
Q Consensus 591 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DfGla~~~~~ 669 (834)
||+++++|..+. +.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 35899999999999999999999998 99999999999998665 589999999987643
Q ss_pred CccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccch-hHH---------HHHHh
Q 003272 670 DQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNL-LGH---------AWQLW 738 (834)
Q Consensus 670 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~-~~~---------~~~~~ 738 (834)
... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+........... ... .....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 322 2346789999999998775 579999999999999999999999754332111000 000 00000
Q ss_pred hccCcc---cccC--------ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 739 IQDRPA---ELID--------KSLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 739 ~~~~~~---~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
...... .... .............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000 00000111112346788999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=344.08 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=188.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC------Ce
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR------DE 585 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 585 (834)
++|++.++||+|+||+||+|... .|+.||||++.... ....+++.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 49999999997542 34456789999999999999999999999643 67
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.++||||+.++++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876554432 34899999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchh--------------
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLL-------------- 731 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~-------------- 731 (834)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||............
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 764322 223467899999999999999999999999999999999999997532211100000
Q ss_pred -HHHHHHhhccCc-------ccccCccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003272 732 -GHAWQLWIQDRP-------AELIDKSLYDSC---SLSEAIRCIQVGLLCVQQIPEDRPNMLSVVL 786 (834)
Q Consensus 732 -~~~~~~~~~~~~-------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~ 786 (834)
............ ............ .......+.+|+.+||+.||++|||++||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000001100 011111111111 1233557889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=345.53 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=195.1
Q ss_pred hcCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccC--cccHHHHHHHHHHHHhccCCceeeEEEEEEeC-----Ce
Q 003272 514 TDNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSS--GQGVEEFKNEALLIAKLQHRNLVKLLGCCTQR-----DE 585 (834)
Q Consensus 514 ~~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 585 (834)
.++|+..++||+|+||+||+|+.. +|+.||||++++.. ....+++.+|+.++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999974 59999999997543 33456789999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEeeecccc
Q 003272 586 RVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 665 (834)
Q Consensus 586 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~ 665 (834)
.+++++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999883 345999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCccccccccccccccccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHHHHHHhhccCc-
Q 003272 666 AFGLDQTEANTNRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGHAWQLWIQDRP- 743 (834)
Q Consensus 666 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 743 (834)
..... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ..............
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAE 241 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHH
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChH
Confidence 65322 2336789999999987765 46899999999999999999999975332111 11100000000000
Q ss_pred ----------ccccCccc-cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccC
Q 003272 744 ----------AELIDKSL-YDSCS-----LSEAIRCIQVGLLCVQQIPEDRPNMLSVVL--MLSGE 791 (834)
Q Consensus 744 ----------~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~ev~~--~L~~~ 791 (834)
........ ..... ......+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000000 00000 011235778999999999999999999987 45543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-34 Score=315.70 Aligned_cols=263 Identities=20% Similarity=0.215 Sum_probs=191.8
Q ss_pred cCCcccCccccCCcccEEEEEEe-CCeEEEEEEecccCcccHHHHHHHHHHHHhcc-----------CCceeeEEEEEEe
Q 003272 515 DNFSEENKLGEGGFGPVYKGMLI-EGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-----------HRNLVKLLGCCTQ 582 (834)
Q Consensus 515 ~~~~~~~~LG~G~fg~Vy~g~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 582 (834)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999974 59999999996542 33467788999888875 5789999988754
Q ss_pred C--CeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhh-cCCCceEeccCCCCceeecCCCC----
Q 003272 583 R--DERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHH-DSRLRIIHRDLKASNVLLDNEMN---- 655 (834)
Q Consensus 583 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~---- 655 (834)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777777665544444344556678999999999999999999998 55 999999999999986653
Q ss_pred --eEEeeeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcccccchhHH
Q 003272 656 --PKISDFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGKRNRGFYHADHRHNLLGH 733 (834)
Q Consensus 656 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~ 733 (834)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865321 2336799999999999999999999999999999999999999864332211111000
Q ss_pred ---HHHHhhc--------c-CcccccC---------c----------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 003272 734 ---AWQLWIQ--------D-RPAELID---------K----------SLYDSCSLSEAIRCIQVGLLCVQQIPEDRPNML 782 (834)
Q Consensus 734 ---~~~~~~~--------~-~~~~~~d---------~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 782 (834)
....... . ......+ . .............+.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000 0 0000000 0 001123455677889999999999999999999
Q ss_pred HHHH
Q 003272 783 SVVL 786 (834)
Q Consensus 783 ev~~ 786 (834)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.4e-21 Score=192.44 Aligned_cols=169 Identities=21% Similarity=0.185 Sum_probs=121.2
Q ss_pred cccCccccCCcccEEEEEEeCCeEEEEEEecccCc------------------ccHHHHHHHHHHHHhccCCceeeEEEE
Q 003272 518 SEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSG------------------QGVEEFKNEALLIAKLQHRNLVKLLGC 579 (834)
Q Consensus 518 ~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 579 (834)
...++||+|+||+||+|+..+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35679999999999999988899999998753210 011334568888999999999998866
Q ss_pred EEeCCeeEEEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcCCCceEeccCCCCceeecCCCCeEEe
Q 003272 580 CTQRDERVLVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDSRLRIIHRDLKASNVLLDNEMNPKIS 659 (834)
Q Consensus 580 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 659 (834)
. ..+++|||+++..+.. ++......++.||+++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2479999998865432 344556789999999999999998 99999999999999754 8999
Q ss_pred eeccccccCCCccccccccccccccccCccccccCCCCchhhHHHHHHHH
Q 003272 660 DFGMARAFGLDQTEANTNRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 709 (834)
Q Consensus 660 DfGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~~sDV~S~Gvil 709 (834)
|||+|.....+.......+.+. . -.|. ....|..++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9999987643322110000000 0 0111 235677889999986544
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.77 E-value=1e-18 Score=154.97 Aligned_cols=112 Identities=19% Similarity=0.395 Sum_probs=91.0
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
.|||.|||.|..|+.|+| |.|+|.|...|+ |.|+. ..++||.||++.|.. .+.|.|..||+ |||
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGn---Lvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGN---LVI 64 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSC---EEE
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEecccc---EEE
Confidence 489999999999999985 889999988766 66655 358999999998854 46899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCcc
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSH 159 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTD 159 (834)
.++ +.++|+|++.. .....+|+|+|+|||||++.+ +.++|||+.+|+|
T Consensus 65 ~~~-~~~~w~s~t~~-~~~~~~l~L~ddGNlvly~~~-------~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSG-SRAIWASNTNR-QNGNYYLILQRDRNVVIYDNS-------NNAIWATHTNVGN 112 (112)
T ss_dssp EET-TEEEEECCCCC-SCCCCEEEECTTSCEEEECTT-------SCEEEECCCCCCC
T ss_pred Eec-CCeEEEEeecc-CCCceEEEEcCCCCEEEECCC-------CcEEecCCCccCC
Confidence 996 56778777533 223457999999999999543 4589999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.76 E-value=2.2e-18 Score=151.18 Aligned_cols=108 Identities=22% Similarity=0.399 Sum_probs=89.5
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
+|+|.+||.|.+|+.|.+ |.|.|+|...++ |.++. ..++||+||++.|... .+.|.|..||+ |||
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGn---Lvl 65 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGN---FVV 65 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSC---EEE
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCce---EEE
Confidence 478999999999999974 789999987655 55543 3578999999999876 67899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccC
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDY 156 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~ 156 (834)
.|++|.+||+|++.. +....+|+|+|+|||||+ + ..+|||+-|
T Consensus 66 ~~~~g~~vW~s~t~~-~~~~~~l~L~ddGNlvly--~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 66 YDAEGRSLWASHSVR-GNGNYVLVLQEDGNVVIY--G--------SDIWSTGTY 108 (109)
T ss_dssp ECSSSCEEEECCCCC-CSSCCEEEECTTSCEEEE--C--------CEEEECCCC
T ss_pred EeCCCcEEEEEeeEC-CCCCEEEEEeCCCcEEEE--C--------CCEecCCCc
Confidence 999999999998632 234457999999999999 2 269999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.75 E-value=1.4e-18 Score=152.53 Aligned_cols=107 Identities=25% Similarity=0.353 Sum_probs=89.3
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
+|+|.+||.|.+|+.|. +|.|.|.|...|+ |.|+. ..++||.||++.|-. .+.|.|..+|+ |||
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~~Gn---lvl 64 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLSR--SCFLSMQTDGN---LVV 64 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SCEEEECTTSC---EEE
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCCC--ccEEEEeccce---EEE
Confidence 47899999999999995 6899999998876 77765 357899999998743 46799999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccC
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDY 156 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~ 156 (834)
.+++|.+||||++.. .....+|+|+|+|||||+++ .+||||+|
T Consensus 65 ~~~~g~~vWsS~t~~-~~~~~~l~L~ddGNlVly~~----------~~W~S~t~ 107 (108)
T d1jpca_ 65 YNPSNKPIWASNTGG-QNGNYVCILQKDRNVVIYGT----------DRWATGTH 107 (108)
T ss_dssp ECTTCCEEEECCCCC-SCSCEEEEECTTSCEEEEEC----------CCCCCCCC
T ss_pred ECCCccceEEccccC-CCCcEEEEEcCCCCEEEeCC----------CcccCCCC
Confidence 999999999998633 23345689999999999932 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.59 E-value=7.7e-16 Score=137.01 Aligned_cols=103 Identities=22% Similarity=0.326 Sum_probs=84.3
Q ss_pred EEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCC
Q 003272 61 GIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDG 140 (834)
Q Consensus 61 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~ 140 (834)
-|||.+++..+.+|++|++.|+.....+|.+..||| |||.+. +.++|++++... ....+|+|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGN---LvL~~~-~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCN---LVLFDR-DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQ- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTE---EEEEBT-TBCCSCCCCCSS-CSSCEEEEETTTEEEEEETT-
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCc---EEEecC-CcEEEEEccccC-CCcEEEEEeCCeeEEEEcCC-
Confidence 589999999999999999999988677899999999 999986 678999986432 34567999999999999543
Q ss_pred CCCCCCCceeeeeccCCccccccCCeeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeE
Q 003272 141 NDNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAM 206 (834)
Q Consensus 141 ~~~~~~~~~lWQSFd~PTDtlLpg~~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~ 206 (834)
+.+|||||. +.+.|.|.+.++++|...+|
T Consensus 85 ------~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 ------NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ------TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred ------CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 469999983 23567899999999987665
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.46 E-value=1.3e-13 Score=121.88 Aligned_cols=104 Identities=18% Similarity=0.331 Sum_probs=80.9
Q ss_pred ccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEE
Q 003272 23 RDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVL 102 (834)
Q Consensus 23 ~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl 102 (834)
.++|.++|+| .+.+..|.|.|.|...|+ |.+ |. ..++||.||+..+.. ...|.|..||+ |+|
T Consensus 14 ~~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGn---LvL 75 (119)
T d1b2pa_ 14 PQILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGV---LVV 75 (119)
T ss_dssp CCEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSC---EEE
T ss_pred CCEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCC---EEE
Confidence 3556666665 457789999999988776 544 43 467899999987743 46899999999 999
Q ss_pred ecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeecc
Q 003272 103 LNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFD 155 (834)
Q Consensus 103 ~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd 155 (834)
.|++|.+||++++... ....+|+|+|+|||||++ ..+|||-.
T Consensus 76 ~d~~g~~vWsS~t~~~-~~~~~l~Lq~DGNlvlYg----------~~~W~S~T 117 (119)
T d1b2pa_ 76 ITNENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYG----------DALWATQT 117 (119)
T ss_dssp ECTTCCEEEECSCCCC-SSCEEEEECTTSCEEEEE----------SEEEECCC
T ss_pred ECCCCcEEEECCCcCC-CCceEEEEcCCCCEEEEC----------CCEeccCC
Confidence 9999999999986432 234468999999999993 37999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.45 E-value=2.2e-14 Score=126.05 Aligned_cols=110 Identities=25% Similarity=0.305 Sum_probs=89.1
Q ss_pred EEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCC
Q 003272 62 IWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGN 141 (834)
Q Consensus 62 iw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~ 141 (834)
|||.-.+..+..|..+.+.++.+...+|.+..||| |||.++ +.++|++++.. ..+..|.|+|+|||||++.+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGN---LvL~~~-~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~~-- 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCN---LVLFDS-DVRVWASNTAG--ATGCRAVLQSDGLLVILTAQ-- 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSC---EEEEES-SSEEECCCCCS--CSCCBCCBCSSSCBCCBCTT--
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCe---EEEEcC-CeeEEEcccCC--CCceEEEEeccCCEEEEccC--
Confidence 67776677788899999999988778899999999 999884 68899999643 34567999999999999543
Q ss_pred CCCCCCceeeeeccCCccccccCCeeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 142 DNDDPDHFLWQSFDYPSHTLLAGMKLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 142 ~~~~~~~~lWQSFd~PTDtlLpg~~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
+.+||||+- +.+.|.|.+.++++|...+| ...+|.+|.
T Consensus 75 -----~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 75 -----NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp -----TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred -----CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 458999863 34678999999999987655 357898875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.19 E-value=1.1e-11 Score=108.59 Aligned_cols=109 Identities=25% Similarity=0.322 Sum_probs=78.6
Q ss_pred HHhhccccccccccCCCccccCCCEEEeCCCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEE
Q 003272 13 LFCNIRTASTRDAISLGQSIREGETVVSASESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMS 92 (834)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~l~~~~~l~S~~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~ 92 (834)
||++.+...+..||.++|+ | .+|.|.|.|...|+ |.++. ..++||.+|...+ ..+.+.|.
T Consensus 4 ~~~~~~~~~~~~tl~~~~~------l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~ 63 (115)
T d1dlpa1 4 LFGLSHEGSHPQTLHAAQS------L--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQ 63 (115)
T ss_dssp CBCSSSSSCSCSCCCTTCE------E--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBC
T ss_pred EEecCCCCCCcceecCCCc------E--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEe
Confidence 3444444344455555555 4 35779999988776 66654 3578999997542 35789999
Q ss_pred ecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeecc
Q 003272 93 RRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFD 155 (834)
Q Consensus 93 ~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd 155 (834)
.+|| |||.|.++.+||+|++.. .....+++|.++|||||+ +..+|+|-.
T Consensus 64 ~dGN---Lvl~d~~~~~vWsS~t~~-~~g~y~l~Lq~DGNlvlY----------~~~~Wssgt 112 (115)
T d1dlpa1 64 SDGL---LVILTAQNTIRWSSGTKG-SIGNYVLVLQPDRTVTIY----------GPGLWDSGT 112 (115)
T ss_dssp SSSC---BCCBCTTTCCSCCCCCCC-CSSCCEEEECSSSCEEEE----------CSEEEECSC
T ss_pred ccCC---EEEEccCCCEEEEcCCCC-CCCCEEEEECCCCcEEEe----------CCCeecCCC
Confidence 9999 999999999999998633 233457999999999999 237999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.77 E-value=7.3e-09 Score=91.15 Aligned_cols=80 Identities=20% Similarity=0.253 Sum_probs=58.7
Q ss_pred CCeEEEeeecCCCCCceEEEEEeccCCCCcEEEeeCCCCCCCCCCceEEEEecCCcceEEEecCCCceEEEeecccccCC
Q 003272 42 SESFELGFFSPGKSKSRYLGIWFKKIATGTVTWVANRDAPLSDRSGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQ 121 (834)
Q Consensus 42 ~g~F~lgFf~~~~~~~~~lgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~ 121 (834)
.|.|.|.|-..|+ |.|+- ...+||.+|- +.......+.|..+|| |||.|.++.++|+|++... ..
T Consensus 34 ~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t--~~~~~~~~~~l~~~Gn---Lvl~d~~~~~lW~S~t~~~-~~ 98 (120)
T d1dlpa2 34 LSPYRLSMETDCN-----LVLFD----RDDRVWSTNT--AGKGTGCRAVLQPNGR---MDVLTNQNIAVWTSGNSRS-AG 98 (120)
T ss_dssp CSSCEEEEETTTE-----EEEEB----TTBCCSCCCC--CSSCSSCEEEEETTTE---EEEEETTTEEEEECCCCCS-SS
T ss_pred cCCEEEEEcCCCc-----EEEec----CCcEEEEEcc--ccCCCcEEEEEeCCee---EEEEcCCCCEEEEeCCCCC-CC
Confidence 3557777755444 55543 3467899884 3334457899999999 9999999999999986332 23
Q ss_pred CcEEEEecCCCEEEE
Q 003272 122 NPVAVLLESGNLVVK 136 (834)
Q Consensus 122 ~~~a~Lld~GNlVl~ 136 (834)
..++.|.++|||||+
T Consensus 99 ~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 99 RYVFVLQPDRNLAIY 113 (120)
T ss_dssp CCEEEECSSSCEEEE
T ss_pred cEEEEECCCCcEEEe
Confidence 457899999999999
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.71 E-value=3.5e-08 Score=85.24 Aligned_cols=88 Identities=25% Similarity=0.363 Sum_probs=65.2
Q ss_pred ceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCCe
Q 003272 87 GVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMK 166 (834)
Q Consensus 87 ~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~~ 166 (834)
-.|.+..||| |||.+ .+.+||++|+.........+.|.++|||||++.+ +.++|+|=
T Consensus 21 ~~l~~q~dgn---Lvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-------g~~vW~s~------------ 77 (109)
T d1kj1a_ 21 YHFIMQEDCN---LVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-------GRSLWASH------------ 77 (109)
T ss_dssp EEEEECTTSC---EEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-------SCEEEECC------------
T ss_pred EEEEecCCCe---EEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-------CcEEEEEe------------
Confidence 5677778999 99986 5689999997655555677999999999999543 45889861
Q ss_pred eeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCCC
Q 003272 167 LGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGSW 220 (834)
Q Consensus 167 l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~w 220 (834)
+.-+.|.|.+.++++|+..++ ....|.|+.+
T Consensus 78 -------------------t~~~~~~~~l~L~ddGNlvly----~~~~W~S~t~ 108 (109)
T d1kj1a_ 78 -------------------SVRGNGNYVLVLQEDGNVVIY----GSDIWSTGTY 108 (109)
T ss_dssp -------------------CCCCSSCCEEEECTTSCEEEE----CCEEEECCCC
T ss_pred -------------------eECCCCCEEEEEeCCCcEEEE----CCCEecCCCc
Confidence 111346788999999987665 2457877653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.58 E-value=1.3e-07 Score=82.75 Aligned_cols=85 Identities=24% Similarity=0.323 Sum_probs=63.1
Q ss_pred eEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCCee
Q 003272 88 VLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGMKL 167 (834)
Q Consensus 88 ~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~~l 167 (834)
.|.+-.||| |||.++ +.++|++++.+. .....+.|.++|||||++.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGN---LVLy~~-~~~vWssnt~~~-~~~~~l~l~~dGnLvL~d~~-------g~~vWsS~t------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCN---LVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITNE-------NVTVWQSPV------------ 88 (119)
T ss_dssp EEEECTTSC---EEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECTT-------CCEEEECSC------------
T ss_pred EEEECCCCc---EEEEEC-CeEEEEecCCCC-CcceEEEEEeCCCEEEECCC-------CcEEEECCC------------
Confidence 467778999 999875 568999996433 33467999999999999543 458887531
Q ss_pred eeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 168 GVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 168 ~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
.-+.|.|.+.++++|...++ ..+.|.++.
T Consensus 89 -------------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp -------------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred -------------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11346788999999988776 246888875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.57 E-value=9.2e-08 Score=82.44 Aligned_cols=86 Identities=23% Similarity=0.344 Sum_probs=62.0
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
.-+|.+..||| |||.+. +.+||++++... .....+.|.++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~DGN---Lvly~~-~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~~-------g~~vWsS------------ 75 (108)
T d1jpca_ 20 SFVFIMQEDCN---LVLYDV-DKPIWATNTGGL-SRSCFLSMQTDGNLVVYNPS-------NKPIWAS------------ 75 (108)
T ss_dssp TEEEEECTTSC---EEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECTT-------CCEEEEC------------
T ss_pred CEEEEECCCCe---EEEEeC-CceeeEeCCCCC-CCccEEEEeccceEEEECCC-------ccceEEc------------
Confidence 35678888999 999874 679999996443 33457999999999999443 4589976
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeC
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAG 218 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg 218 (834)
.+....+.|.+.++++|+..++ +...|.++
T Consensus 76 -------------------~t~~~~~~~~l~L~ddGNlVly----~~~~W~S~ 105 (108)
T d1jpca_ 76 -------------------NTGGQNGNYVCILQKDRNVVIY----GTDRWATG 105 (108)
T ss_dssp -------------------CCCCSCSCEEEEECTTSCEEEE----ECCCCCCC
T ss_pred -------------------cccCCCCcEEEEEcCCCCEEEe----CCCcccCC
Confidence 1112356788999999987666 23456554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=7.8e-07 Score=89.83 Aligned_cols=149 Identities=16% Similarity=0.087 Sum_probs=102.1
Q ss_pred HHHHHhcCCcccCccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhcc-CCceeeEEEEEEeCCeeE
Q 003272 509 TIVDATDNFSEENKLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQ-HRNLVKLLGCCTQRDERV 587 (834)
Q Consensus 509 ~~~~~~~~~~~~~~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 587 (834)
++....+.|+..+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+....+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555556777666555555578998764 56678889886655444556788888888773 444677888888888899
Q ss_pred EEEeecCCCChhhHhhccCCCCCCCHHhHHHHHHHHHHHHHHhhhcC---------------------------------
Q 003272 588 LVYEYLPNKSLDYFIFDTTRSKVLDWQNRCHIIGGIARGLLYLHHDS--------------------------------- 634 (834)
Q Consensus 588 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 634 (834)
+||+++++..+...... ......++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999877554311 1112334455555555555421
Q ss_pred -----------------------CCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 635 -----------------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 635 -----------------------~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
...++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12279999999999999877677999987753
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.07 E-value=1.1e-05 Score=69.72 Aligned_cols=89 Identities=19% Similarity=0.298 Sum_probs=63.5
Q ss_pred CceEEEEecCCcceEEEecCCCceEEEeecccccCCCcEEEEecCCCEEEEecCCCCCCCCCceeeeeccCCccccccCC
Q 003272 86 SGVLSMSRRGNGTALVLLNSTNDIVWSSNIVSRAAQNPVAVLLESGNLVVKEKDGNDNDDPDHFLWQSFDYPSHTLLAGM 165 (834)
Q Consensus 86 ~~~l~l~~~G~~~~lvl~~~~~~~vWst~~~~~~~~~~~a~Lld~GNlVl~~~~~~~~~~~~~~lWQSFd~PTDtlLpg~ 165 (834)
.-.|.+..||| |||.+ .+.+||++++... ..+..+.|..+|||||++. +..+|-|
T Consensus 20 ~~~l~~q~DGN---Lvly~-~~~~vW~s~~~~~-~~~~~l~l~~dGnLvl~~~--------~~~~w~s------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCN---LVLYD-NNRAVWASGTNGK-ASGCVLKMQNDGNLVIYSG--------SRAIWAS------------ 74 (112)
T ss_dssp TEEEEECTTSC---EEEEE-TTEEEEECCCTTS-CSSEEEEECTTSCEEEEET--------TEEEEEC------------
T ss_pred CEEEEEcCCCC---EEEEc-CCcEEEEccCccC-CCCcEEEEeccccEEEEec--------CCeEEEE------------
Confidence 45788888999 99987 4689999986432 3456799999999999942 2245543
Q ss_pred eeeeeeccCCceEEEEeccCCCCCCceeEEeecCCCCCeeEEecCCeeEEeeCC
Q 003272 166 KLGVNLVTGLNRLMSSWKSADDPARSEYTYGIDPSGVPQAMLKKGSTIRYRAGS 219 (834)
Q Consensus 166 ~l~~~~~tg~~~~l~sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~y~~sg~ 219 (834)
.+.-..|.|.+.++++|...++- ....+.|.|+.
T Consensus 75 -------------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT 108 (112)
T ss_dssp -------------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred -------------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence 22223467899999999876653 33457898875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.73 E-value=6.6e-05 Score=74.70 Aligned_cols=74 Identities=18% Similarity=0.148 Sum_probs=53.1
Q ss_pred ccccCCc-ccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccC--CceeeEEEEEEeCCeeEEEEeecCCCCh
Q 003272 522 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQH--RNLVKLLGCCTQRDERVLVYEYLPNKSL 598 (834)
Q Consensus 522 ~LG~G~f-g~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL 598 (834)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 578998887788889998654332 346778887777643 3356778888888889999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00042 Score=73.58 Aligned_cols=76 Identities=14% Similarity=0.188 Sum_probs=49.5
Q ss_pred cCccccCCcccEEEEEEeC-CeEEEEEEeccc-------CcccHHHHHHHHHHHHhcc-C--CceeeEEEEEEeCCeeEE
Q 003272 520 ENKLGEGGFGPVYKGMLIE-GQEIAVKRLSKS-------SGQGVEEFKNEALLIAKLQ-H--RNLVKLLGCCTQRDERVL 588 (834)
Q Consensus 520 ~~~LG~G~fg~Vy~g~~~~-g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l 588 (834)
.+.||.|....||+....+ ++.++||.-... .....++...|.+.++.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3478999999999988654 678999975321 1123345667888887662 2 345556544 4566789
Q ss_pred EEeecCCCC
Q 003272 589 VYEYLPNKS 597 (834)
Q Consensus 589 V~E~~~~gs 597 (834)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.03 E-value=0.011 Score=60.36 Aligned_cols=135 Identities=13% Similarity=0.160 Sum_probs=78.1
Q ss_pred ccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCce--eeEE-----EEEEeCCeeEEEEeecCCCChhh-
Q 003272 529 GPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL--VKLL-----GCCTQRDERVLVYEYLPNKSLDY- 600 (834)
Q Consensus 529 g~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~E~~~~gsL~~- 600 (834)
-.||+....+|+.+++|..+.. ....+++..|...+..|...++ +..+ .........+.+++++++..++.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999989999999998643 3345778889988888753332 1111 11234556788999988644311
Q ss_pred ----H---------hhc------cCCCCCCCHH-------------------hHHHHHHHHHHHHHHhh----hcCCCce
Q 003272 601 ----F---------IFD------TTRSKVLDWQ-------------------NRCHIIGGIARGLLYLH----HDSRLRI 638 (834)
Q Consensus 601 ----~---------l~~------~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH----~~~~~~i 638 (834)
+ ++. ...+..+++. .+..+...+.+.+..+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 010 0111122221 11112222222333332 2234568
Q ss_pred EeccCCCCceeecCCCCeEEeeeccccc
Q 003272 639 IHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 639 vH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.93 E-value=0.013 Score=61.56 Aligned_cols=72 Identities=19% Similarity=0.315 Sum_probs=48.6
Q ss_pred CccccCCcccEEEEEEeCC--------eEEEEEEecccCcccHHHHHHHHHHHHhccCCce-eeEEEEEEeCCeeEEEEe
Q 003272 521 NKLGEGGFGPVYKGMLIEG--------QEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL-VKLLGCCTQRDERVLVYE 591 (834)
Q Consensus 521 ~~LG~G~fg~Vy~g~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 591 (834)
++|+.|-.=.+|+....++ +.|.+++.- .. .......+|..+++.+.-.++ .++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5788888889999887543 456776664 22 233455678888888843344 567777642 68999
Q ss_pred ecCCCCh
Q 003272 592 YLPNKSL 598 (834)
Q Consensus 592 ~~~~gsL 598 (834)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.38 E-value=0.13 Score=51.61 Aligned_cols=159 Identities=13% Similarity=0.031 Sum_probs=81.4
Q ss_pred cCHHHHHHHhcCCcccC-----ccccCCcccEEEEEEeCCeEEEEEEecccCcccHHHHHHHHHHHHhccCCce--eeEE
Q 003272 505 FDWKTIVDATDNFSEEN-----KLGEGGFGPVYKGMLIEGQEIAVKRLSKSSGQGVEEFKNEALLIAKLQHRNL--VKLL 577 (834)
Q Consensus 505 ~~~~~~~~~~~~~~~~~-----~LG~G~fg~Vy~g~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~ 577 (834)
.+.++++....+|...+ .|..|---+.|+.+..+| .+++|+..... ..++...|+.++..+.+.++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 35567777777776543 344566677899887665 48899885432 22344556666666643222 1111
Q ss_pred E------EEEeCCeeEEEEeecCCCChhhH--------------hhcc------CCCCC------------------CCH
Q 003272 578 G------CCTQRDERVLVYEYLPNKSLDYF--------------IFDT------TRSKV------------------LDW 613 (834)
Q Consensus 578 g------~~~~~~~~~lV~E~~~~gsL~~~--------------l~~~------~~~~~------------------l~~ 613 (834)
- +.........++.+..+...... ++.. ..... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 0 11223445566666655332110 0000 00000 011
Q ss_pred HhHHHHHHHHHHHHHHhhhc-CCCceEeccCCCCceeecCCCCeEEeeeccccc
Q 003272 614 QNRCHIIGGIARGLLYLHHD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 666 (834)
Q Consensus 614 ~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DfGla~~ 666 (834)
......+..+...+...+.. -+.++||+|+.+.||+++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11112222333333333321 234699999999999999887778999998753
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.95 E-value=0.033 Score=34.84 Aligned_cols=33 Identities=36% Similarity=0.820 Sum_probs=25.7
Q ss_pred ccCCCCCCCCCCccCCCCCCCCCccccCCCccCC
Q 003272 295 DQCDNYALCGPYASCNIHSDSPDCECLEGFEPKS 328 (834)
Q Consensus 295 d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~~ 328 (834)
|+|.+-..|| +|.|+.--..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6899999998 58897432344799999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.00 E-value=0.035 Score=37.43 Aligned_cols=32 Identities=28% Similarity=0.699 Sum_probs=26.0
Q ss_pred cccCCC-CCCCCCCccCCCCCCCCCccccCCCc
Q 003272 294 LDQCDN-YALCGPYASCNIHSDSPDCECLEGFE 325 (834)
Q Consensus 294 ~d~C~~-~~~CG~~g~C~~~~~~~~C~C~~Gf~ 325 (834)
.|+|.. ...|..+|.|.....+.+|.|++||.
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 367875 46899999998655677899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.99 E-value=0.13 Score=34.67 Aligned_cols=32 Identities=25% Similarity=0.487 Sum_probs=25.8
Q ss_pred cccCCCCCCCCCCccCCCCCCCCCccccCCCcc
Q 003272 294 LDQCDNYALCGPYASCNIHSDSPDCECLEGFEP 326 (834)
Q Consensus 294 ~d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~ 326 (834)
.|+|..+. |+.++.|...+.+-.|.|++||..
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 47897654 557899987767889999999975
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.46 E-value=0.094 Score=34.50 Aligned_cols=31 Identities=39% Similarity=0.809 Sum_probs=23.8
Q ss_pred ccCCCCCCCCCCccCCCCCCCCCccccCCCcc
Q 003272 295 DQCDNYALCGPYASCNIHSDSPDCECLEGFEP 326 (834)
Q Consensus 295 d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~ 326 (834)
|+|. ...|...|.|.......+|.|++||.-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4565 467888899976556789999999863
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.99 E-value=0.15 Score=33.96 Aligned_cols=31 Identities=29% Similarity=0.702 Sum_probs=24.5
Q ss_pred ccCCCCCCCCCCccCCCCCCCCCccccCCCccC
Q 003272 295 DQCDNYALCGPYASCNIHSDSPDCECLEGFEPK 327 (834)
Q Consensus 295 d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 327 (834)
|+|...+.| ..+|.....+-.|+|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678877777 4589766678899999999864
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.92 E-value=0.12 Score=35.03 Aligned_cols=33 Identities=30% Similarity=0.678 Sum_probs=25.2
Q ss_pred ccCCCC-CCCCCCccCCCCCCCCCccccCCCccCC
Q 003272 295 DQCDNY-ALCGPYASCNIHSDSPDCECLEGFEPKS 328 (834)
Q Consensus 295 d~C~~~-~~CG~~g~C~~~~~~~~C~C~~Gf~~~~ 328 (834)
|+|... ..| .++.|.....+..|.|++||+...
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESGF 37 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECT
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCC
Confidence 788764 456 479998666778999999998543
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.34 E-value=0.12 Score=34.01 Aligned_cols=31 Identities=39% Similarity=0.628 Sum_probs=24.8
Q ss_pred cccCCCCCCCCCCccCCCCCCCCCccccCCCc
Q 003272 294 LDQCDNYALCGPYASCNIHSDSPDCECLEGFE 325 (834)
Q Consensus 294 ~d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~ 325 (834)
.|+|. ..-|...|.|.....+.+|.|++||.
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCC
Confidence 36786 57799999997555677899999986
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.26 E-value=0.14 Score=33.57 Aligned_cols=31 Identities=26% Similarity=0.608 Sum_probs=23.6
Q ss_pred ccCCCCCCCCCCccCCCCCCCCCccccCCCcc
Q 003272 295 DQCDNYALCGPYASCNIHSDSPDCECLEGFEP 326 (834)
Q Consensus 295 d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~ 326 (834)
|+|. ..-|...|.|.....+.+|.|++||.-
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 4564 456889999975546778999999863
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.45 E-value=0.11 Score=35.08 Aligned_cols=33 Identities=24% Similarity=0.547 Sum_probs=25.8
Q ss_pred cccCCCCCCCCCCccCCCCCCCCCccccCCCccC
Q 003272 294 LDQCDNYALCGPYASCNIHSDSPDCECLEGFEPK 327 (834)
Q Consensus 294 ~d~C~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 327 (834)
.|+|.....| -.+.|.....+..|+|++||+..
T Consensus 3 idEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 3 VNECLDPTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CCGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred ccccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 3789877665 47899866567789999999865
|